Citrus Sinensis ID: 040687
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 740 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S7D9 | 775 | Serine/threonine-protein | yes | no | 0.991 | 0.947 | 0.669 | 0.0 | |
| O80963 | 776 | Serine/threonine-protein | no | no | 0.987 | 0.942 | 0.567 | 0.0 | |
| O24585 | 901 | Putative receptor protein | N/A | no | 0.935 | 0.768 | 0.345 | 1e-101 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.918 | 0.759 | 0.323 | 5e-94 | |
| Q9FIJ6 | 751 | Serine/threonine-protein | no | no | 0.862 | 0.849 | 0.283 | 3e-66 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.362 | 0.377 | 0.390 | 3e-51 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.362 | 0.411 | 0.378 | 1e-50 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.358 | 0.285 | 0.4 | 5e-50 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.362 | 0.373 | 0.376 | 8e-50 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.368 | 0.407 | 0.371 | 4e-49 |
| >sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 999 bits (2582), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/753 (66%), Positives = 603/753 (80%), Gaps = 19/753 (2%)
Query: 2 GPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFS-------NIPSMA 54
GPI+ASFG ++FFCAIDASG+QDVICW KN SSPSS S++S+S + NIPSMA
Sbjct: 28 GPIAASFGGSAFFCAIDASGRQDVICWGKNYSSPSSPSSSSSSSSIASSTSASYNIPSMA 87
Query: 55 VLSGGEGLLCGILANTSQAFCWSS-NSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRG 113
VLSGG+G LCGIL+NTSQAFC+SS SS G DLVP Y+ TAYS+IAAG +HVCAVRG
Sbjct: 88 VLSGGDGFLCGILSNTSQAFCFSSLGSSSG--MDLVPLAYRTTAYSQIAAGNSHVCAVRG 145
Query: 114 SYYSYHDLGTVDCWDIVR-KGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDG 172
+YYS HD GT+DCW+I R NN+L + + FYD+ VS +V +++SGDGFSCGG+RDG
Sbjct: 146 AYYSDHDSGTIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDGFSCGGIRDG 205
Query: 173 GIVCWGPDSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNND-FVSVPPVGIRF 231
G++C+GP+S +LG +++F+VLA+GK+S+C I LS EVKCWG ++ FV+ P RF
Sbjct: 206 GMLCFGPNSSNLGFNTTSDNFQVLAAGKNSVCAILNLSREVKCWGEDESFVNSPMNDSRF 265
Query: 232 VSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
VSL AG HFCGIREDNH VECWG+ N+S +PK SGF AIASSDF CGIRE DLVLDCW
Sbjct: 266 VSLTAGPRHFCGIREDNHEVECWGNSNFSLIPKGSGFKAIASSDFIVCGIREEDLVLDCW 325
Query: 292 FANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCG 351
N SS +DPPLELCSPG+C GPC+ EFAFNASILNE DLTSLCVRK+L +CSPCG
Sbjct: 326 MVNGSSTLAYDPPLELCSPGMCRAGPCNEKEFAFNASILNEPDLTSLCVRKELMVCSPCG 385
Query: 352 SNCSEGFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS--QKHWHQLHRLVLIIGC 409
S+CS GFFLSS CTA +DR+CT CSLCQNSSC DIC L S+ KHWHQL RLVLIIG
Sbjct: 386 SDCSHGFFLSSSCTANSDRICTPCSLCQNSSCSDICKLHNSNFPDKHWHQLQRLVLIIGS 445
Query: 410 SALGLLLIVISWCIVPRLFTT-RKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGM 468
A LL+I+I C+VPR+ T+ KE+G+ QFKSCIGK +LDTD +++ PA +
Sbjct: 446 CASALLIIIIGCCVVPRIVTSPNKEDGAANQFKSCIGKPDLDTDQPLENV-SPAPSVTPF 504
Query: 469 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFE 528
AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVL DGRQVAVKRANAATIIHTN REFE
Sbjct: 505 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTREFE 564
Query: 529 MELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM 588
ELE+LCNIRH NIVNLLGY EMGERLLVYE+MP GTLHDHLH G SPL+WSLR+KI+M
Sbjct: 565 TELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIAM 624
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC-ERDLTTDMKSDVH 647
Q AKGLEYLH +A P IIH DVK+ N+LLDS+W AR+ADFGL+TS E++L D+K DV+
Sbjct: 625 QTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNEKNL--DIKRDVY 682
Query: 648 NFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707
+FG+VLLEIL+GRK YD + PP IVEW +P+I++GKAAAI+D +ALPRNVEPL KLAD
Sbjct: 683 DFGVVLLEILTGRKRYDRDCDPPEIVEWTVPVIREGKAAAIVDTYIALPRNVEPLLKLAD 742
Query: 708 IAELAIRENPSELPTMSQVATWLEQIVKDGLIL 740
+AEL +RE+P++ PTMS++A WLE + +D LI
Sbjct: 743 VAELCVREDPNQQPTMSELANWLEHVARDALIF 775
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80963|ACCR2_ARATH Serine/threonine-protein kinase-like protein CCR2 OS=Arabidopsis thaliana GN=CCR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/758 (56%), Positives = 544/758 (71%), Gaps = 27/758 (3%)
Query: 2 GPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGEG 61
G I+A+FG+N FFCAIDASGKQ+VICW + +++ S + + +S P M LSGGEG
Sbjct: 27 GTIAAAFGENGFFCAIDASGKQEVICWDRGNTNRSLNRPPGEISGYS--PPMTSLSGGEG 84
Query: 62 LLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDL 121
LC I +NTS+AFCW+ N LVP ++ +Y +IA+G NHVCA+ G YYS D
Sbjct: 85 FLCAITSNTSRAFCWNLEDPSEN---LVPRAFQYNSYLQIASGNNHVCAISGLYYSGPDY 141
Query: 122 GTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDS 181
G V CW+ N T + + F++ Y+ +++ + ++SGDGFSCG +DG +VCWGP S
Sbjct: 142 GPVHCWEYSDNTNFTSGLLWNSSFHNPYIDSLMFRKIVSGDGFSCGVTKDGDLVCWGPKS 201
Query: 182 ESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGANHF 241
L F+ E F+VLASG++S+CG+S+ SG++ C+G+ P RF++L+AGANH+
Sbjct: 202 NLLN-FSNNEEFEVLASGRNSVCGVSKDSGQLHCFGDETEFGSLPNRPRFIALSAGANHY 260
Query: 242 CGIREDNHGVECWG----SFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVSS 297
CGIRED+HGVECWG S + SS P SGF+AI+SSD TTCG+RE DLVLDCW + SS
Sbjct: 261 CGIREDDHGVECWGRNLNSSSSSSAPNTSGFVAISSSDSTTCGVRELDLVLDCWRVHDSS 320
Query: 298 PTDFDPPLELCSPGLCTP-GPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSE 356
D+ PPLELCSPG+C+P G C G FAFNASIL E +LTSLC +L IC CG +C E
Sbjct: 321 KADYSPPLELCSPGMCSPRGNCGDGWFAFNASILKESELTSLCSFHNLNICLRCGISCLE 380
Query: 357 GFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS-----QKHWHQLHRLVLIIGCSA 411
G+F SS C ADRVCT CSLCQNSSC+ IC ++ + QK ++ RLV+IIGCS
Sbjct: 381 GYFPSSTCNPNADRVCTPCSLCQNSSCYGICKIRATKSKEHEQKEQREVRRLVIIIGCSV 440
Query: 412 LGLLLIVISWCIVPRLFTTRK---EEGSKKQFKSCIGKHELDTDAIADSLPH-----PAS 463
LG L+++I +P++ K EE SK C K+ ++ D D +PH P +
Sbjct: 441 LGFLVMLIGLSFIPKMTKGSKRDDEERSKMTCCFCFDKNSVEADP--DPVPHQSVLLPTA 498
Query: 464 ACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN 523
G ++FRLSELKDAT+GFKEFNELGRGS+GFVYKAVL DG VAVKRANAATIIH+N
Sbjct: 499 VSLGETKIFRLSELKDATHGFKEFNELGRGSFGFVYKAVLSDGIHVAVKRANAATIIHSN 558
Query: 524 IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR 583
R FE ELE+LC IRH+NIVNLLGYC EMGERLLVYE+MP GTLHDHLHG LS L+WS+R
Sbjct: 559 NRGFESELEILCKIRHNNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGDLSQLDWSMR 618
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT-TDM 642
LKI +QAA+GL+YLH + PPIIHRDVKT NILLD + ARIADFGL++S ERD + +D
Sbjct: 619 LKIMLQAARGLDYLHNEVDPPIIHRDVKTSNILLDGEMCARIADFGLVSSNERDSSNSDR 678
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702
+ DV++FGIVLLEILSGRKA D E P GI EWA+PLI++GKAAAIIDRN+ LPRNVEPL
Sbjct: 679 EGDVYDFGIVLLEILSGRKAIDRESDPAGIAEWAVPLIRKGKAAAIIDRNICLPRNVEPL 738
Query: 703 FKLADIAELAIRENPSELPTMSQVATWLEQIVKDGLIL 740
KLA++AELA+REN +E P + + +L+ IVK GL
Sbjct: 739 LKLAELAELAVRENSNERPNIRNILCFLDLIVKSGLTF 776
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (949), Expect = e-101, Method: Compositional matrix adjust.
Identities = 274/793 (34%), Positives = 406/793 (51%), Gaps = 101/793 (12%)
Query: 1 MGPISASFGQNS-FFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGG 59
M I+ S+G++ FC +++ G V C+ ++S + NIP + L+ G
Sbjct: 28 MSSIAVSYGEDGPVFCGLNSDGSHLVACFGADAS--------VLYGAPPNIPFLG-LTAG 78
Query: 60 EGLLCGILANTSQAFCWSSNSSPGNTTDLVPS-VYKNTAYSRIAAGTNHVCAVR----GS 114
+G +CG+L +T Q +CW SNS VP + + YS ++AG NH+CA+R G
Sbjct: 79 DGFVCGLLLDTRQPYCWGSNS---YVKSGVPQPMVEGARYSELSAGDNHLCALRAAQDGG 135
Query: 115 YYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCG-GVRDGG 173
S +DCW G N ++ DE VST V +G F+CG R+
Sbjct: 136 RGSSAATSLIDCW-----GYNMTATHAV----DEAVST-----VSAGSVFNCGLFARNRT 181
Query: 174 IVCWGPDSES--LGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVS--VPPVGI 229
+ CWG ++ S +G+ F+ + +G +CG+ E + +V CWG + + VP I
Sbjct: 182 VFCWGDETVSGVVGLAPRDLHFQSIGAGGYHVCGVLE-NAQVFCWGRSLEMQQVVPSSAI 240
Query: 230 -----------RFVSLAAGANHFCGIREDNHGVECWGS--FNYSSVPKNSGFMAIASSDF 276
++ G H CGIR +H V CWG N +S PK A+ + D+
Sbjct: 241 GDGDVNIVPMDAMSTVVGGRFHACGIRSLDHQVACWGFTLHNSTSPPKGLKMYALVAGDY 300
Query: 277 TTCGI-RENDLVLDCWFANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDL 335
TCG+ E L+ CW S P P+ + PG+C P CS G + + +N ++
Sbjct: 301 FTCGVPAETSLMPRCW--GNSGPLAL--PMAV-PPGICVPTACSHGYYEY----VNHGEV 351
Query: 336 TSL--CVRKDLKICSPCGSNCSEGFFLSSPCTAIADRVCT-ACSLCQNSSCWDICGLQPS 392
S+ C + ++C PC + C EG + SSPC A ADRVC C C C C Q
Sbjct: 352 GSIKVCKPANSRLCLPCSTGCPEGLYESSPCNATADRVCQFDCLKCVTDECLSFCLSQKR 411
Query: 393 SQKH---WHQLHRLVLIIGCSALGLLLIVISWCIVPRLFTTRKEEGSKKQF---KSCIGK 446
++ Q+ V I + + +L + ++ C+ R R + S ++ KS
Sbjct: 412 TKSRKLMAFQMRIFVAEIVFAVVLVLSVSVTTCLYVR-HKLRHCQCSNRELRLAKSTAYS 470
Query: 447 HELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDG 506
D I P AQ F EL+ AT GF E +++G+GS+ V+K +L DG
Sbjct: 471 FRKDNMKIQ---PDMEDLKIRRAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDG 527
Query: 507 RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGT 566
VAVKRA A+ + + +EF EL++L + H++++NLLGYC + ERLLVYEFM G+
Sbjct: 528 TVVAVKRAIKASDVKKSSKEFHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGS 587
Query: 567 LHDHLHGG----LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622
L+ HLHG LNW+ R+ I++QAA+G+EYLH A PP+IHRD+K+ NIL+D D
Sbjct: 588 LYQHLHGKDPNLKKRLNWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHN 647
Query: 623 ARIADFGLLTSCERDLTTDM-----------------------KSDVHNFGIVLLEILSG 659
AR+ADFGL D T + KSDV++FG+VLLEILSG
Sbjct: 648 ARVADFGLSILGPADSGTPLSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSG 707
Query: 660 RKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSE 719
RKA D+++ IVEWA+PLIK G AI+D ++ P ++E L K+A +A +R +
Sbjct: 708 RKAIDMQFEEGNIVEWAVPLIKAGDIFAILDPVLSPPSDLEALKKIASVACKCVRMRGKD 767
Query: 720 LPTMSQVATWLEQ 732
P+M +V T LE
Sbjct: 768 RPSMDKVTTALEH 780
|
Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 261/807 (32%), Positives = 390/807 (48%), Gaps = 127/807 (15%)
Query: 1 MGPISASFGQN-SFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGG 59
M I+ S+G+ S FC + + G V+C+ NS+ L I L+GG
Sbjct: 33 MSSIAISYGEGGSVFCGLKSDGSHLVVCYGSNSA-----ILYGTPGHLQFIG----LTGG 83
Query: 60 EGLLCGILANTSQAFCWSSNSSPGNTTDL---VPS-VYKNTAYSRIAAGTNHVCAVR--- 112
+G +CG+L + Q +CW GN+ + VP + K Y ++AG H+C +R
Sbjct: 84 DGFMCGLLMLSHQPYCW------GNSAFIQMGVPQPMTKGAEYLEVSAGDYHLCGLRKPI 137
Query: 113 -GSYYSYHDLGT--VDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCG-G 168
G + + + + VDCW G N + N +D+ L + +G F+C
Sbjct: 138 VGRRKNSNIISSSLVDCW-----GYN----MTRNFVFDKQ-----LHSLSAGSEFNCALS 183
Query: 169 VRDGGIVCWGPD--SESLGVFNVTESFKVLASGKSSLCGISE-LSGEVKCWGNN------ 219
+D + CWG + S+ + + + F+ +A+G +CGI + L V CWG +
Sbjct: 184 SKDKSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLCWGKSLEFEEE 243
Query: 220 --------DFVSVPPVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNSG--FM 269
+ +PP +++ G + CGI+ +H CWG F S P +G F
Sbjct: 244 VTGTSTEEKILDLPPKE-PLLAVVGGKFYACGIKRYDHSAVCWGFFVNRSTPAPTGIGFY 302
Query: 270 AIASSDFTTCGIRE-NDLVLDCWFANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNAS 328
+A+ ++ TCG+ + CW + P PL + SPGLC PC G +
Sbjct: 303 DLAAGNYFTCGVLTGTSMSPVCW--GLGFPASI--PLAV-SPGLCIDTPCPPGTHELS-- 355
Query: 329 ILNEQDLTSLCVRKDLKICSPCGSNCSEGFFLSSPCTAIADRVCT--ACSLCQNSSCWDI 386
N+++ S C IC PC ++C G + S CT +D+VC S + +
Sbjct: 356 --NQEN--SPCKFTGSHICLPCSTSCPPGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNC 411
Query: 387 CGLQPSSQKHWHQLHRLVLIIGCSALGLLLIVISWC-------IVPRLFTTRKEEGSKKQ 439
S K + L L I + +G L +++ I RL R E +
Sbjct: 412 SSSATSGGKEKGKFWSLQLPIATAEIGFALFLVAVVSITAALYIRYRLRNCRCSENDTRS 471
Query: 440 FKSCI-----GKHELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEFNELGRGS 494
K GK D D + A+VF EL+ A +GFKE + +G+GS
Sbjct: 472 SKDSAFTKDNGKIRPDLDELQKRR---------RARVFTYEELEKAADGFKEESIVGKGS 522
Query: 495 YGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554
+ VYK VL DG VAVKRA ++ N EF EL++L + H+++++LLGYC E GE
Sbjct: 523 FSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRTELDLLSRLNHAHLLSLLGYCEECGE 582
Query: 555 RLLVYEFMPRGTLHDHLHGG----LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDV 610
RLLVYEFM G+LH+HLHG L+W R+ I++QAA+G+EYLH A PP+IHRD+
Sbjct: 583 RLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDI 642
Query: 611 KTLNILLDSDWGARIADFGLLTSCERD-------------------------LTTDMKSD 645
K+ NIL+D + AR+ADFGL D LTT KSD
Sbjct: 643 KSSNILIDEEHNARVADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYRLHYLTT--KSD 700
Query: 646 VHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705
V++FG++LLEILSGRKA D+ Y IVEWA+PLIK G A++D + P +E L ++
Sbjct: 701 VYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPLIKAGDINALLDPVLKHPSEIEALKRI 760
Query: 706 ADIAELAIRENPSELPTMSQVATWLEQ 732
+A +R + P+M +V T LE+
Sbjct: 761 VSVACKCVRMRGKDRPSMDKVTTALER 787
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 219/773 (28%), Positives = 333/773 (43%), Gaps = 135/773 (17%)
Query: 16 AIDASGKQDVICWAKNSSSPSSSFLSANSASFS------NIPSMAVLSGGEGLLCGILA- 68
+I Q ++C N S S NS FS N V+SG G +CG+++
Sbjct: 36 SISHISNQTLVCALNNHSYLQCSSFPLNSIPFSLTGNLRNRRFSGVVSGN-GFVCGLISR 94
Query: 69 ---NTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVD 125
NTS CW S T L +Y + AG +C V +
Sbjct: 95 LDSNTSTLLCW--RFSVDGTNMLHKRIYHGPELEELEAGNFRICGVERVSRR------LR 146
Query: 126 CWD---IVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDSE 182
CW + R N + + GD F CG + G++ E
Sbjct: 147 CWQPYYLPRPDN--------------------YRSIALGDNFFCGLSQPPGMI----SCE 182
Query: 183 SLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGANHFC 242
+ + + +A+G C I+ + +V+CWG S+P +F++LA G + C
Sbjct: 183 GIAKVPSGDHYIAIAAGSRQACAIT-VDNDVECWGQTQ--SLPRE--KFLALAVGEDRGC 237
Query: 243 GIREDNHGVECWGSFNYSSVP---KNSGFMAIASSDFTTCGIRENDLVLDCWFANVSSPT 299
G+R N V CWG+ N S+P K+ F +I + CG+ + L CW N + +
Sbjct: 238 GVRWSNGTVVCWGNNNNFSLPQTLKDIHFTSIYAKGPMFCGVATRNYTLICW-GNENFKS 296
Query: 300 DFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEGFF 359
P + + PGPC R++ GS
Sbjct: 297 GVFTPFQGLISQVVMPGPC----------------------RRECPYRPLSGSQ------ 328
Query: 360 LSSPCTAIADRVCTACSLCQNSSCWDICGLQPSSQKHWHQLHRLVLIIGCSALGLLLIVI 419
++ C L +N + Q S K W + + L++GC LL+VI
Sbjct: 329 ------SLCGNELMICDLKRNDGEFPDTRAQNSKNKTWSRRNIAFLVVGCVGTFSLLLVI 382
Query: 420 SWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPAS-ACPGMAQVFRLSELK 478
S+ I R + + +D + L AS PG F + EL
Sbjct: 383 SFLIFKSHCRCRVHDSGRLD-----DTRTIDIPKLEKRLCTLASLGNPGQLMEFSIDELA 437
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAA--TIIHTNIRE--------FE 528
AT+GF LG GS+G VY+ VL DGR VA+KRA T+ T +R F
Sbjct: 438 LATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTTMRHRRADKDSAFV 497
Query: 529 MELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKIS 587
ELE + + H N+V LLG+ + ER+LVYE+M G+L DHLH PL+W RL I+
Sbjct: 498 NELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHLHNPQFDPLSWQTRLMIA 557
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTTDM--- 642
+ AA+G++YLH+ PP+IHRD+K+ NILLD+ W A+++DFGL + E D + +
Sbjct: 558 LDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGLSQMGPTEEDDVSHLSLH 617
Query: 643 --------------------KSDVHNFGIVLLEILSGRKAY--DIEYVPPGIVEWALPLI 680
KSDV++FG+VLLE+LSG KA + + P +VE+ +P I
Sbjct: 618 AAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHNNEDENPRNLVEYVVPYI 677
Query: 681 KQGKAAAIIDRNV--ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731
+A I+D+ + P +E + + +A + + P+M +V + LE
Sbjct: 678 LLDEAHRILDQRIPPPTPYEIEAVAHVGYLAAECLMPCSRKRPSMVEVVSKLE 730
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 118/302 (39%), Positives = 174/302 (57%), Gaps = 34/302 (11%)
Query: 461 PASACPGMAQV-FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATI 519
P SA G Q F EL D T GF + N LG G +G VYK L DG+ VAVK+ +
Sbjct: 329 PDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGS- 387
Query: 520 IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSP-L 578
REF+ E+E++ + H ++V+L+GYC+ ERLL+YE++P TL HLHG P L
Sbjct: 388 -GQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVL 446
Query: 579 NWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT---SCE 635
W+ R++I++ +AKGL YLH+D P IIHRD+K+ NILLD ++ A++ADFGL S +
Sbjct: 447 EWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQ 506
Query: 636 RDLTTDM-------------------KSDVHNFGIVLLEILSGRKAYDIEYVPPG---IV 673
++T + +SDV +FG+VLLE+++GRK D +Y P G +V
Sbjct: 507 THVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVD-QYQPLGEESLV 565
Query: 674 EWALPL----IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATW 729
EWA PL I+ G + ++DR + +F++ + A +R + + P M QV
Sbjct: 566 EWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRA 625
Query: 730 LE 731
L+
Sbjct: 626 LD 627
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 117/309 (37%), Positives = 171/309 (55%), Gaps = 41/309 (13%)
Query: 458 LPHPASACPGMA-----QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVK 512
LP P+ PG+ F EL ATNGF E N LG+G +G+V+K +L G++VAVK
Sbjct: 252 LPPPS---PGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVK 308
Query: 513 RANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH 572
+ A + REF+ E+E++ + H ++V+L+GYC+ +RLLVYEF+P L HLH
Sbjct: 309 QLKAGS--GQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLH 366
Query: 573 GGLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631
G P + WS RLKI++ +AKGL YLH+D P IIHRD+K NIL+D + A++ADFG L
Sbjct: 367 GKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFG-L 425
Query: 632 TSCERDLTTDM-----------------------KSDVHNFGIVLLEILSGRKAYDIE-- 666
D T + KSDV +FG+VLLE+++GR+ D
Sbjct: 426 AKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNV 485
Query: 667 YVPPGIVEWALPLI----KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPT 722
YV +V+WA PL+ ++G + D + + E + ++ A +R + P
Sbjct: 486 YVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPR 545
Query: 723 MSQVATWLE 731
MSQ+ LE
Sbjct: 546 MSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 5e-50, Method: Compositional matrix adjust.
Identities = 118/295 (40%), Positives = 167/295 (56%), Gaps = 30/295 (10%)
Query: 467 GMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE 526
G+A L L++AT+ F + ++GRGS+G VY + DG++VAVK A H N R+
Sbjct: 591 GVAYFISLPVLEEATDNFSK--KVGRGSFGSVYYGRMKDGKEVAVK-ITADPSSHLN-RQ 646
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGG--LSPLNWSLRL 584
F E+ +L I H N+V L+GYC E R+LVYE+M G+L DHLHG PL+W RL
Sbjct: 647 FVTEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRL 706
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT----- 639
+I+ AAKGLEYLH P IIHRDVK+ NILLD + A+++DFGL E DLT
Sbjct: 707 QIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSV 766
Query: 640 -----------------TDMKSDVHNFGIVLLEILSGRKAYDIEYVPP--GIVEWALPLI 680
KSDV++FG+VL E+LSG+K E P IV WA LI
Sbjct: 767 AKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLI 826
Query: 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
++G IID +A +E ++++A++A + + P M +V ++ ++
Sbjct: 827 RKGDVCGIIDPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIR 881
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 8e-50, Method: Compositional matrix adjust.
Identities = 117/311 (37%), Positives = 171/311 (54%), Gaps = 43/311 (13%)
Query: 458 LPHPASACPGMA-------QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVA 510
LP P+ PG+A F EL ATNGF E N LG+G +G+V+K +L +G++VA
Sbjct: 324 LPPPS---PGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVA 380
Query: 511 VKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDH 570
VK+ + REF+ E+ ++ + H ++V L+GYC+ +RLLVYEF+P TL H
Sbjct: 381 VKQLKEGS--SQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFH 438
Query: 571 LHGGLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
LHG P + WS RLKI++ +AKGL YLH++ P IIHRD+K NIL+D + A++ADFG
Sbjct: 439 LHGKGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFG 498
Query: 630 LLTSCERDLTTDM-----------------------KSDVHNFGIVLLEILSGRKAYDIE 666
L D T + KSDV +FG+VLLE+++GR+ D+
Sbjct: 499 -LAKIASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVN 557
Query: 667 YVPP--GIVEWALPLIKQ----GKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSEL 720
V +V+WA PL+ Q G ++D+ + + E + ++ A +R
Sbjct: 558 NVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRR 617
Query: 721 PTMSQVATWLE 731
P M QVA LE
Sbjct: 618 PRMDQVARVLE 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 4e-49, Method: Compositional matrix adjust.
Identities = 113/304 (37%), Positives = 170/304 (55%), Gaps = 31/304 (10%)
Query: 457 SLPHPASACPGMAQ-VFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRAN 515
++P P +A G Q F EL AT GF + N LG+G +G+V+K VL G++VAVK
Sbjct: 284 AIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLK 343
Query: 516 AATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL 575
+ REF+ E++++ + H ++V+L+GYC+ G+RLLVYEF+P TL HLHG
Sbjct: 344 LGS--GQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKG 401
Query: 576 SP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
P L+W R+KI++ +A+GL YLH+D P IIHRD+K NILLD + ++ADFGL
Sbjct: 402 RPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLS 461
Query: 635 ERDLTT----------------------DMKSDVHNFGIVLLEILSGRKAYDIE-YVPPG 671
+ + T KSDV +FG++LLE+++GR D+ +
Sbjct: 462 QDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDS 521
Query: 672 IVEWALPL----IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVA 727
+V+WA PL + G + D + L + + + ++A A AIR + P MSQ+
Sbjct: 522 LVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIV 581
Query: 728 TWLE 731
LE
Sbjct: 582 RALE 585
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 740 | ||||||
| 224140187 | 765 | predicted protein [Populus trichocarpa] | 0.995 | 0.963 | 0.741 | 0.0 | |
| 225439974 | 767 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.954 | 0.736 | 0.0 | |
| 147770087 | 767 | hypothetical protein VITISV_005074 [Viti | 0.989 | 0.954 | 0.735 | 0.0 | |
| 255557016 | 765 | ATP binding protein, putative [Ricinus c | 0.990 | 0.958 | 0.719 | 0.0 | |
| 449451209 | 770 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.949 | 0.682 | 0.0 | |
| 356536932 | 767 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.947 | 0.670 | 0.0 | |
| 449482594 | 770 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.949 | 0.680 | 0.0 | |
| 356545977 | 762 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.954 | 0.667 | 0.0 | |
| 15232759 | 775 | serine/threonine-protein kinase-like pro | 0.991 | 0.947 | 0.669 | 0.0 | |
| 297833746 | 775 | kinase family protein [Arabidopsis lyrat | 0.991 | 0.947 | 0.657 | 0.0 |
| >gi|224140187|ref|XP_002323466.1| predicted protein [Populus trichocarpa] gi|222868096|gb|EEF05227.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1128 bits (2918), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/744 (74%), Positives = 625/744 (84%), Gaps = 7/744 (0%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
MGPISA+FG ++FFCAIDASGKQDVICW KN++ P SS ++ SA FSNI +A LSGGE
Sbjct: 25 MGPISAAFGDHAFFCAIDASGKQDVICWIKNNTLPPSSSSASTSAYFSNIGPIAALSGGE 84
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILAN SQ FCWSS S DLVPSVY+NTAYS IAAG NHVCA+RGSYYS HD
Sbjct: 85 GFLCGILANNSQVFCWSSVYS---GPDLVPSVYRNTAYSHIAAGKNHVCAIRGSYYSDHD 141
Query: 121 LGTVDCWDIVRKGNNTLSSVQ-TNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGP 179
GT+DCW+I+ NN+L+SVQ T +FYD+ +S +V V+SG+ FSCGGVR G+VCWGP
Sbjct: 142 SGTIDCWNIINGANNSLTSVQGTGVFYDQSISNLVFDKVVSGEEFSCGGVRGRGVVCWGP 201
Query: 180 DSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNN-DFVSVPPVGIRFVSLAAGA 238
+ + GV N +E++ VLASG+ S+CGI E S +VKCWGN+ + S PPVG RFVSL AG
Sbjct: 202 NKDRFGVSNFSENYMVLASGRDSVCGILEGSNDVKCWGNSTNSYSTPPVGTRFVSLTAGT 261
Query: 239 NHFCGIREDNHGVECWGSFNYSSVPKN-SGFMAIASSDFTTCGIRENDLVLDCWFANVSS 297
NHFC IREDNH VECWGSFN S +PK SGFMAIASSDFTTCGIRE+DLV+DCWFAN +
Sbjct: 262 NHFCRIREDNHAVECWGSFNSSLIPKGGSGFMAIASSDFTTCGIREDDLVIDCWFANGTL 321
Query: 298 PTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEG 357
P D+ PPLELCSPGLC+P C GEF FNASILNE DLTSLCVRKDLKICSPCGSNCSEG
Sbjct: 322 PPDYSPPLELCSPGLCSPRSCGEGEFVFNASILNEPDLTSLCVRKDLKICSPCGSNCSEG 381
Query: 358 FFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSSQKHWHQLHRLVLIIGCSALGLLLI 417
FFLSSPCT ADRVCTACSLCQNSSCWD+CGL+ S++K WH L RL +IIG SALG LLI
Sbjct: 382 FFLSSPCTENADRVCTACSLCQNSSCWDVCGLKSSNEKQWHNLRRLAVIIGSSALGFLLI 441
Query: 418 VISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADS-LPHPASACPGMAQVFRLSE 476
++SWC++P LF++R EE +K QF SCIGK EL+ D +DS LP + CPG AQVFRLSE
Sbjct: 442 LVSWCVLPCLFSSRNEERAKNQFHSCIGKPELEADVASDSHLPQSITPCPGKAQVFRLSE 501
Query: 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN 536
LKD TNGF+EFNELGRGSYGFVYKAVL DGRQVAVKRANAATIIH+N R F+MELEVLCN
Sbjct: 502 LKDVTNGFREFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHSNSRNFDMELEVLCN 561
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+RH NIVNLLGYC EMGERLLVYE+MP GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY
Sbjct: 562 VRHCNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 621
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEI 656
LHK+A PPI+H +V+T NILLDSDWGARIADFGLL++ E+DL DMKSDV+NFGIVLLEI
Sbjct: 622 LHKEAEPPIVHHNVQTSNILLDSDWGARIADFGLLSANEKDLCGDMKSDVYNFGIVLLEI 681
Query: 657 LSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIREN 716
LSGRK YD +Y PP IVEWA+PLIKQGKAAAIIDR V PRNVE L K+ADIAELA+REN
Sbjct: 682 LSGRKTYDRDYTPPNIVEWAVPLIKQGKAAAIIDRYVTFPRNVESLLKVADIAELAVREN 741
Query: 717 PSELPTMSQVATWLEQIVKDGLIL 740
P+E PTMS VAT+LEQIVKDGL+L
Sbjct: 742 PNERPTMSDVATFLEQIVKDGLLL 765
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439974|ref|XP_002276043.1| PREDICTED: serine/threonine-protein kinase-like protein CCR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1123 bits (2904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/744 (73%), Positives = 616/744 (82%), Gaps = 12/744 (1%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
MGPISA+FG++ FFCAIDA G+Q+VICW KNSSS SASFSNIP M+ LSGG
Sbjct: 32 MGPISAAFGEHGFFCAIDAGGEQNVICWGKNSSS-----FPTPSASFSNIPPMSALSGGN 86
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILANTSQA+CWS +S +LVPSV++NTAYS +AAG NHVCA+RGSYYS +D
Sbjct: 87 GFLCGILANTSQAYCWSLVAS---GINLVPSVFRNTAYSHVAAGKNHVCAIRGSYYSDND 143
Query: 121 LGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPD 180
GT+DCW I + NN+L+SV+ + F D+ ++++V + V+SG+GFSCGG+R+GGIVCWGP+
Sbjct: 144 SGTIDCWVISGRPNNSLASVENSNFVDQSINSLVFRKVVSGEGFSCGGIREGGIVCWGPN 203
Query: 181 SESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGANH 240
+ LGV V+E+FK LASG+ S+CGIS +SGEV CWG+ND PP+G RF++L+AGA H
Sbjct: 204 ASKLGVSGVSENFKALASGRGSVCGISGVSGEVTCWGDNDTSGAPPIGTRFIALSAGARH 263
Query: 241 FCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVSSPTD 300
FCGIRED H V CWGSFN S VPK GFMAIASSDFTTCGIRE+DLVL CWFAN+SSP D
Sbjct: 264 FCGIREDTHEVGCWGSFNSSLVPKGPGFMAIASSDFTTCGIREDDLVLACWFANLSSPPD 323
Query: 301 FDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEGFFL 360
DPPL+LCSPGLCTPGPC G+FA+NASILNE DLTSLCVRKDL ICSPCG NCSEG+F
Sbjct: 324 SDPPLQLCSPGLCTPGPCDEGQFAYNASILNEPDLTSLCVRKDLSICSPCGLNCSEGYFQ 383
Query: 361 SSPCTAIADRVCTACSLCQNSSCWDICGLQPSS---QKHWHQLHRLVLIIGCSALGLLLI 417
SS CT DRVCTACSLCQNSSCWDICG Q SS QKH HQ RL LI+G S LG LLI
Sbjct: 384 SSSCTKNVDRVCTACSLCQNSSCWDICGFQSSSEMRQKHRHQFERLALIVGSSVLGCLLI 443
Query: 418 VISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADS-LPHPASACPGMAQVFRLSE 476
+I WC++PR TR EEG KKQF SC+GK L+TD ADS L A+ C G AQVFRLSE
Sbjct: 444 LIGWCLLPRFIGTRNEEGVKKQFTSCMGKPVLETDIDADSNLSVSAAPCLGTAQVFRLSE 503
Query: 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN 536
LKDATNGFKEFNELGRG+YGFVYKAVL DGRQVAVKRANAATIIHTN R+FEMELEVLC
Sbjct: 504 LKDATNGFKEFNELGRGNYGFVYKAVLADGRQVAVKRANAATIIHTNSRDFEMELEVLCK 563
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+RH NIVNLLGYC EMGERLLVYEFMP GTLHDHLHGGLSPLNW LRLKI+MQAAKGLEY
Sbjct: 564 VRHCNIVNLLGYCSEMGERLLVYEFMPHGTLHDHLHGGLSPLNWGLRLKIAMQAAKGLEY 623
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEI 656
LHK+A PPIIHRDVKT NILLDSDWGARIADFGLL +RD DMKSDV+NFGIVLLEI
Sbjct: 624 LHKEAVPPIIHRDVKTSNILLDSDWGARIADFGLLIPNDRDFNGDMKSDVYNFGIVLLEI 683
Query: 657 LSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIREN 716
LSGRKAYD +Y+PP IVEWA+P I+QGKA IID ALPRNVEPL KLADIA+LA+REN
Sbjct: 684 LSGRKAYDRDYMPPSIVEWAVPRIRQGKAGVIIDCYTALPRNVEPLLKLADIADLAVREN 743
Query: 717 PSELPTMSQVATWLEQIVKDGLIL 740
PSE PTMS VA WLEQIVKDGLIL
Sbjct: 744 PSERPTMSDVAIWLEQIVKDGLIL 767
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147770087|emb|CAN69888.1| hypothetical protein VITISV_005074 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1119 bits (2894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/744 (73%), Positives = 614/744 (82%), Gaps = 12/744 (1%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
MGPISA+FG++ FFCAIDA G+Q+VICW KNSSS SASFSNIP M LSGG
Sbjct: 32 MGPISAAFGEHGFFCAIDAGGEQNVICWGKNSSS-----FPTPSASFSNIPPMXALSGGN 86
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILANTSQA+CWS +S +LVPSV++NTAYS +AAG NHVCA+RGSYYS +D
Sbjct: 87 GFLCGILANTSQAYCWSLVAS---GINLVPSVFRNTAYSHVAAGKNHVCAIRGSYYSDND 143
Query: 121 LGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPD 180
GT+DCW I + NN+L+SV+ + F D+ ++++V + V+SG+GFSCGG+R+GGIVCWGP+
Sbjct: 144 SGTIDCWVISGRPNNSLASVENSNFVDQSINSLVFRKVVSGEGFSCGGIREGGIVCWGPN 203
Query: 181 SESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGANH 240
+ LGV V+E+FK LASG+ S+CGIS +SGEV CWG+ND PP+G RF++L+AGA H
Sbjct: 204 ASKLGVSGVSENFKALASGRGSVCGISGVSGEVTCWGDNDTSGAPPIGTRFIALSAGARH 263
Query: 241 FCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVSSPTD 300
FCGIRED H V CWGSFN S VPK GFMAIASSDFTTCGIRE+DLVL CWFAN+SSP D
Sbjct: 264 FCGIREDTHEVGCWGSFNSSLVPKGPGFMAIASSDFTTCGIREDDLVLACWFANLSSPPD 323
Query: 301 FDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEGFFL 360
DPPL+LCSPGLCTPGPC G+FA+NASILNE DLTSLCVRKDL ICSPCG NCSEG+F
Sbjct: 324 SDPPLQLCSPGLCTPGPCDEGQFAYNASILNEPDLTSLCVRKDLSICSPCGLNCSEGYFQ 383
Query: 361 SSPCTAIADRVCTACSLCQNSSCWDICGLQPSS---QKHWHQLHRLVLIIGCSALGLLLI 417
SS CT DRVCTACSLCQNSSCWDICG Q SS QKH HQ RL LI+G S LG LLI
Sbjct: 384 SSSCTKNVDRVCTACSLCQNSSCWDICGFQSSSEMRQKHRHQFERLALIVGSSVLGCLLI 443
Query: 418 VISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADS-LPHPASACPGMAQVFRLSE 476
+I WC++PR TR EEG KK F SC+GK L+TD ADS L A+ C G AQVFRLSE
Sbjct: 444 LIGWCLLPRFIGTRNEEGVKKXFTSCMGKPVLETDIDADSNLSVSAAPCLGTAQVFRLSE 503
Query: 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN 536
LKDATNGFKEFNELGRG+YGFVYKAVL DGRQVAVKRANAATIIHTN R+FEMELEVLC
Sbjct: 504 LKDATNGFKEFNELGRGNYGFVYKAVLADGRQVAVKRANAATIIHTNSRDFEMELEVLCK 563
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+RH NIVNLLGYC EMGERLLVYEFMP GTLHDHLHGGLSPLNW LRLKI+MQAAKGLEY
Sbjct: 564 VRHCNIVNLLGYCSEMGERLLVYEFMPHGTLHDHLHGGLSPLNWGLRLKIAMQAAKGLEY 623
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEI 656
LHK+A PPIIHRDVKT NILLDSDWGARIADFGLL +RD DMKSDV+NFGIVLLEI
Sbjct: 624 LHKEAVPPIIHRDVKTSNILLDSDWGARIADFGLLIPNDRDFNGDMKSDVYNFGIVLLEI 683
Query: 657 LSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIREN 716
LSGRKAYD +Y+PP IVEWA+P I+QGKA IID ALPRNVEPL KLADIA+LA+REN
Sbjct: 684 LSGRKAYDRDYMPPSIVEWAVPRIRQGKAGVIIDCYTALPRNVEPLLKLADIADLAVREN 743
Query: 717 PSELPTMSQVATWLEQIVKDGLIL 740
PSE PTMS VA WLEQIVKDGLIL
Sbjct: 744 PSERPTMSDVAIWLEQIVKDGLIL 767
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557016|ref|XP_002519541.1| ATP binding protein, putative [Ricinus communis] gi|223541404|gb|EEF42955.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/746 (71%), Positives = 621/746 (83%), Gaps = 13/746 (1%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANS--ASFSNIPSMAVLSG 58
MGPISA+FG N FFCAIDASGKQ+VICW KN++ SS ++ A FS+IP+MA LSG
Sbjct: 25 MGPISAAFGDNGFFCAIDASGKQEVICWTKNTTLSLSSSSPPSTSSAYFSSIPAMAALSG 84
Query: 59 GEGLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSY 118
GEG LCGILAN+SQAFCWSS DLVPS+YKNTAY IAAG NHVCA+RGSYYS
Sbjct: 85 GEGFLCGILANSSQAFCWSSGG-----LDLVPSIYKNTAYFHIAAGRNHVCAIRGSYYSD 139
Query: 119 HDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWG 178
HD GT+DCW+IV+ NN+L+S+Q++ FYD+ +S +V V+SG+GFSCG VR+GG CWG
Sbjct: 140 HDSGTIDCWEIVKGANNSLTSIQSSNFYDQSISNLVFSKVVSGEGFSCGSVREGGAFCWG 199
Query: 179 PDSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWG-NNDFVSVPPVGIRFVSLAAG 237
P+S LGV + +F LASG SS+CGI E S EV+CWG +ND PPVG +FVSL AG
Sbjct: 200 PNSLRLGVSKGSVNFVALASGISSVCGILEESNEVQCWGTSNDVFLSPPVGTQFVSLTAG 259
Query: 238 ANHFCGIREDNHGVECWGSFNYSSVPKN-SGFMAIASSDFTTCGIRENDLVLDCWFANVS 296
ANHFCGIR+DNH VECWGSFN SS PK SGFMAIASSDFTTC IRENDLV+DCWF N +
Sbjct: 260 ANHFCGIRKDNHAVECWGSFNLSSAPKGGSGFMAIASSDFTTCAIRENDLVIDCWFINGT 319
Query: 297 SPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSE 356
SP +++PPLELCSPGLC PG C+ GEF FNAS+L+E DLTSLCVRKDL+ICSPCGSNCS+
Sbjct: 320 SPPEYNPPLELCSPGLCGPGSCADGEFVFNASMLSEPDLTSLCVRKDLRICSPCGSNCSQ 379
Query: 357 GFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPS-SQKHWHQLHRL--VLIIGCSALG 413
GFFLSSPCT DRVCT CSLCQNSSC D+CG+QPS +K W L+RL V+IIG + LG
Sbjct: 380 GFFLSSPCTENTDRVCTDCSLCQNSSCRDVCGMQPSEKEKLWLHLNRLQLVIIIGSTVLG 439
Query: 414 LLLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPA-SACPGMAQVF 472
LL++I I P L +RKEEGSKKQFKSCIGK EL+TD +DS P+ ++CPG+AQVF
Sbjct: 440 FLLLIICCYIRPCLIASRKEEGSKKQFKSCIGKSELETDNASDSCQPPSMTSCPGVAQVF 499
Query: 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELE 532
RLSELKDATNGFKEFNELGRGSYGFVYKAVL DGRQVAVKRANAATIIH+N R+FEMELE
Sbjct: 500 RLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHSNSRDFEMELE 559
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK 592
VLCN RH NIVNLLGYC EMGERLLVYE+MP GTLHDHLH GLSPLNWSLRLK+SMQ AK
Sbjct: 560 VLCNARHCNIVNLLGYCAEMGERLLVYEYMPHGTLHDHLHSGLSPLNWSLRLKVSMQVAK 619
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIV 652
GLEYLHK+A PPI+HR+VKT NILLD++WGARIADFGL+TS E+D DMK+DV++FGIV
Sbjct: 620 GLEYLHKEAEPPIVHRNVKTSNILLDTEWGARIADFGLITSNEKDFCGDMKTDVYDFGIV 679
Query: 653 LLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELA 712
LLEILSGRKAYD ++ PP IVEWA+PLI+QGK AAIID +VALP+NVEPL KL+DIAELA
Sbjct: 680 LLEILSGRKAYDRDHTPPSIVEWAVPLIRQGKGAAIIDEDVALPKNVEPLLKLSDIAELA 739
Query: 713 IRENPSELPTMSQVATWLEQIVKDGL 738
++E+P + PTMS +ATWLEQIVKD L
Sbjct: 740 VKEDPKDRPTMSDLATWLEQIVKDTL 765
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451209|ref|XP_004143354.1| PREDICTED: serine/threonine-protein kinase-like protein CCR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/746 (68%), Positives = 604/746 (80%), Gaps = 15/746 (2%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
M PISA+FG + FFCAIDASGKQ+VICW KNSSS S S S+ S +IP+MA LSGG+
Sbjct: 34 MAPISAAFGLDGFFCAIDASGKQEVICWGKNSSSLSPSSSSSTSIFSVDIPAMAALSGGD 93
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILANTS A+CW S +PG TDLVP V++ TAYS IAAG +HVCA+RGSYYS +D
Sbjct: 94 GFLCGILANTSHAYCWGS-VNPG--TDLVPLVFRTTAYSHIAAGKSHVCAIRGSYYSDND 150
Query: 121 LGTVDCWDIVRKG-NNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGP 179
G VDCWDI R NNTLSS Q+ LFY++ ++++V K V+SG+GFSC +RDGGI+CWGP
Sbjct: 151 SGPVDCWDISRNSINNTLSSKQSTLFYNQSIASLVFKRVVSGEGFSCAELRDGGILCWGP 210
Query: 180 DSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGAN 239
+S +L V NV+E+F VLA+GK +LCGISE++G VKCWGN D + P R+V+L AG
Sbjct: 211 NSTNLDVSNVSENFIVLAAGKDALCGISEVTGGVKCWGNADSFAGLPTTARYVTLTAGEQ 270
Query: 240 HFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVS--S 297
HFCGIR D+H V+CWGS N SS+PKN+GFMAIASSD + CGIRE++LVLDCWF + S +
Sbjct: 271 HFCGIRWDSHEVDCWGSLNSSSIPKNTGFMAIASSDRSICGIREDNLVLDCWFFSHSFEA 330
Query: 298 PTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEG 357
+DPPLELCSPGLC GPC GEF+FNASILNE DL SLCVRKDL IC CG NCS+G
Sbjct: 331 APGYDPPLELCSPGLCAAGPCREGEFSFNASILNEPDLKSLCVRKDLSICFRCGVNCSDG 390
Query: 358 FFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPS---SQKHWHQLHRLVLIIGCSALGL 414
FFLSSPCT +DR+CTACSLCQNSSCWDICG+Q S QKHWHQ +++I+G S GL
Sbjct: 391 FFLSSPCTLNSDRICTACSLCQNSSCWDICGVQSSPETKQKHWHQWRSILVIVGASVAGL 450
Query: 415 LLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGMAQVFRL 474
+LI++ WC+ R+ + K+ GSKKQ KS EL+T DS CPG+AQ+FRL
Sbjct: 451 VLILLGWCLHLRVIASTKD-GSKKQHKS-----ELETGTETDSCAPLVPLCPGIAQIFRL 504
Query: 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVL 534
SELKDATNGFKEFNELGRG YGFVYKAVL DG+QVAVKRANAATIIHTN R+FEMEL++L
Sbjct: 505 SELKDATNGFKEFNELGRGRYGFVYKAVLADGQQVAVKRANAATIIHTNSRDFEMELDIL 564
Query: 535 CNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
C IRH NIVNLLGYC EMGERLLVYE+MP GTL+DHLHGGLSPLNW+LRLKI+MQAA+GL
Sbjct: 565 CKIRHCNIVNLLGYCSEMGERLLVYEYMPHGTLYDHLHGGLSPLNWTLRLKIAMQAARGL 624
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLL 654
EYLHK+ PP++HR+VKT NILLD WGARIADFGL+TS + D++ D+ SDV++FGIVLL
Sbjct: 625 EYLHKELVPPVVHRNVKTSNILLDVHWGARIADFGLITSNDDDVSGDLTSDVYDFGIVLL 684
Query: 655 EILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIR 714
EI+SGRKAYD +Y P I++WA+PLIKQGKAAAIIDR ALPRNVEPL KLADIAELA+R
Sbjct: 685 EIISGRKAYDRDYTPSSIIDWAVPLIKQGKAAAIIDRYTALPRNVEPLLKLADIAELAVR 744
Query: 715 ENPSELPTMSQVATWLEQIVKDGLIL 740
NPS+ PT+S +A+WLEQIVKDGLIL
Sbjct: 745 VNPSDRPTISDIASWLEQIVKDGLIL 770
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356536932|ref|XP_003536986.1| PREDICTED: serine/threonine-protein kinase-like protein CCR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/750 (67%), Positives = 595/750 (79%), Gaps = 23/750 (3%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
MGPISASFG++ FC+IDASGKQDVICW N++SPS S A + IP+M+ LSGGE
Sbjct: 31 MGPISASFGRDEVFCSIDASGKQDVICWGNNATSPSLS------AVANAIPAMSALSGGE 84
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILANTSQAFCWS+ + P LVP Y+NTAYS IAAG NHVCAV+GSY++ D
Sbjct: 85 GFLCGILANTSQAFCWSAVTKPSADLILVPPAYRNTAYSHIAAGQNHVCAVKGSYFADRD 144
Query: 121 LGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPD 180
GTVDCW+I + N TL++ Q++ F D+ +S + +K V+SG+GF+CG V DGG++CWGP
Sbjct: 145 SGTVDCWEITKTANKTLTAKQSDKFNDQLMSNLEVKRVVSGEGFTCGEVNDGGLICWGPT 204
Query: 181 SESLG---VFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPV-GIRFVSLAA 236
SE+LG + NVT+SF VL +G+S++CG+ +SGE+KCWG+ S PP+ +R VSL+A
Sbjct: 205 SENLGNINISNVTDSFAVLVAGRSAVCGVFNVSGELKCWGDPVSYSDPPLDSVRLVSLSA 264
Query: 237 GANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVS 296
GANHFCG+R DNH VECWG N S VPK +GFMAIASSDFTTCGIRE+DL+LDCW N S
Sbjct: 265 GANHFCGVRMDNHEVECWGDLNSSVVPKGNGFMAIASSDFTTCGIREDDLLLDCWLVNAS 324
Query: 297 SPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSE 356
P DFDPPLEL SPGLC C EFAFN S+LNE LTSLCVR+DL+ICSPCGSNCS+
Sbjct: 325 KP-DFDPPLELSSPGLCRASECGVDEFAFNVSVLNELALTSLCVREDLRICSPCGSNCSK 383
Query: 357 GFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS----QKHWHQLHRLVLIIGCSAL 412
G+FLSS CT ADRVCTACSLCQNSSC+++CGL SS HWH L + V+I+GC L
Sbjct: 384 GYFLSSECTRNADRVCTACSLCQNSSCFNVCGLHSSSGLHLHWHWHDLRKWVVIVGCPVL 443
Query: 413 GLLLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPAS--ACPGMAQ 470
G L+I++ C L RK SKKQ KSC+GK + + D + +L S +CPG+ Q
Sbjct: 444 GFLVILLCGC----LLMVRKR--SKKQSKSCMGKPDQEDDHVNVALNSTPSVNSCPGVPQ 497
Query: 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEME 530
VFRLSELKDATNGFKEFNELGRGSYGFVYKA L DGR VAVKRANAATIIHTN R+FE E
Sbjct: 498 VFRLSELKDATNGFKEFNELGRGSYGFVYKAALADGRVVAVKRANAATIIHTNNRDFETE 557
Query: 531 LEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590
LE+LC IRH N+VNLLGYC EMGERLLVYE+MP GTL+DHLHGGLSPL WSLRLKI+MQA
Sbjct: 558 LEILCKIRHCNVVNLLGYCAEMGERLLVYEYMPHGTLYDHLHGGLSPLTWSLRLKIAMQA 617
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFG 650
AKGLEYLHK+ PPI+H D+K+ NILLDS+WGARI+DFGLL S ++DL D++SDV+NFG
Sbjct: 618 AKGLEYLHKEPVPPIVHNDLKSSNILLDSEWGARISDFGLLASSDKDLNGDLESDVYNFG 677
Query: 651 IVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAE 710
IVLLE+LSGRKAYD +Y P +VEWA+PLIKQGK AAIIDR VALPRNVEPL KLADIAE
Sbjct: 678 IVLLEVLSGRKAYDRDYTPSNMVEWAVPLIKQGKGAAIIDRYVALPRNVEPLLKLADIAE 737
Query: 711 LAIRENPSELPTMSQVATWLEQIVKDGLIL 740
LA+RE PSE P MS +A+WLEQIVKDGLIL
Sbjct: 738 LAVRERPSERPPMSDIASWLEQIVKDGLIL 767
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449482594|ref|XP_004156339.1| PREDICTED: serine/threonine-protein kinase-like protein CCR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1024 bits (2648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/746 (68%), Positives = 604/746 (80%), Gaps = 15/746 (2%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
M PISA+FG + FFCAIDASGKQ+VICW KNSSS S S S+ S +IP+MA LSGG+
Sbjct: 34 MAPISAAFGLDGFFCAIDASGKQEVICWGKNSSSLSPSSSSSTSIFSVDIPAMAALSGGD 93
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILANTS A+CW S +PG TDLVP V++ TAYS IAAG +HVCA+RGSYYS +D
Sbjct: 94 GFLCGILANTSHAYCWGS-VNPG--TDLVPLVFRTTAYSHIAAGKSHVCAIRGSYYSDND 150
Query: 121 LGTVDCWDIVRKG-NNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGP 179
G VDCWDI R NNTLSS Q+ LFY++ ++++V K V+SG+GFSC +RDGGI+CWGP
Sbjct: 151 SGPVDCWDISRNSINNTLSSKQSTLFYNQSIASLVFKRVVSGEGFSCAELRDGGILCWGP 210
Query: 180 DSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGAN 239
+S +L V NV+E+F VLA+GK +LCGISE++G VKCWG+ D + P R+V+L AG
Sbjct: 211 NSTNLDVSNVSENFIVLAAGKDALCGISEVTGGVKCWGSADSFAGLPTTARYVTLTAGEQ 270
Query: 240 HFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVS--S 297
HFCGIR D+H V+CWGS N SS+PKN+GFMAIASSD + CGIRE++LVLDCWF + S +
Sbjct: 271 HFCGIRWDSHEVDCWGSLNSSSIPKNTGFMAIASSDRSICGIREDNLVLDCWFFSHSFEA 330
Query: 298 PTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEG 357
+DPPLELCSPGLC GPC GEF+FNA ILNE DL SLCVRKDL IC CG NCS+G
Sbjct: 331 APGYDPPLELCSPGLCAAGPCREGEFSFNAGILNEPDLKSLCVRKDLSICFRCGVNCSDG 390
Query: 358 FFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPS---SQKHWHQLHRLVLIIGCSALGL 414
FFLSSPCT +DR+CTACSLCQNSSCWDICG+Q S QKHWHQ +++I+G S GL
Sbjct: 391 FFLSSPCTLNSDRICTACSLCQNSSCWDICGVQSSPETKQKHWHQWRSILVIVGASVAGL 450
Query: 415 LLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGMAQVFRL 474
+LI++ WC+ R+ + K+ GSKKQ KS EL+T DS CPG+AQ+FRL
Sbjct: 451 VLILLGWCLHLRVIASTKD-GSKKQHKS-----ELETGTETDSCAPLVPLCPGIAQIFRL 504
Query: 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVL 534
SELKDATNGFKEFNELGRG YGFVYKAVL DG+QVAVKRANAATIIHTN R+FEMEL++L
Sbjct: 505 SELKDATNGFKEFNELGRGRYGFVYKAVLADGQQVAVKRANAATIIHTNSRDFEMELDIL 564
Query: 535 CNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
C IRH NIVNLLGYC EMGERLLVYE+MP GTL+DHLHGGLSPLNW+LRLKI+MQAA+GL
Sbjct: 565 CKIRHCNIVNLLGYCSEMGERLLVYEYMPHGTLYDHLHGGLSPLNWTLRLKIAMQAARGL 624
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLL 654
EYLHK+ PP++HR+VKT NILLD WGARIADFGL+TS + D++ D+ SDV++FGIVLL
Sbjct: 625 EYLHKELVPPVVHRNVKTSNILLDVHWGARIADFGLITSNDDDVSGDLTSDVYDFGIVLL 684
Query: 655 EILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIR 714
EI+SGRKAYD +Y P I++WA+PLIKQGKAAAIIDR ALPRNVEPLFKLADIAELA+R
Sbjct: 685 EIISGRKAYDRDYTPSSIIDWAVPLIKQGKAAAIIDRYTALPRNVEPLFKLADIAELAVR 744
Query: 715 ENPSELPTMSQVATWLEQIVKDGLIL 740
NPS+ PT+S +A+WLEQIVKDGLIL
Sbjct: 745 VNPSDRPTISDIASWLEQIVKDGLIL 770
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545977|ref|XP_003541409.1| PREDICTED: serine/threonine-protein kinase-like protein CCR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1020 bits (2637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/748 (66%), Positives = 598/748 (79%), Gaps = 21/748 (2%)
Query: 1 MGPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGE 60
MGPISASFG++ FC+IDASGKQDVICW N++SPS S +S + +P+M+ LSGGE
Sbjct: 28 MGPISASFGKDEVFCSIDASGKQDVICWGSNATSPSLSTVS------NALPAMSALSGGE 81
Query: 61 GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHD 120
G LCGILANTSQAFCWS+ + P LVP Y+NTAYS++AAG +HVCA+RGSYY+ D
Sbjct: 82 GFLCGILANTSQAFCWSAVTRPSADLILVPPAYRNTAYSQVAAGKSHVCAIRGSYYADRD 141
Query: 121 LGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPD 180
GTVDCW+I + N TL++ Q++ F D+ +S + +K V+SG+GF+CG V DGG++CWGP
Sbjct: 142 SGTVDCWEITKTANKTLTAKQSDKFIDQLISNLEVKRVVSGEGFTCGEVNDGGLICWGPT 201
Query: 181 SESLG-VFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPV-GIRFVSLAAGA 238
SE+LG + NV+++F VLA+G+S++CG+ +SGE+KCWG+ S PP+ +R VSL+AGA
Sbjct: 202 SENLGNISNVSDTFAVLAAGRSAVCGVFNVSGELKCWGDPVSFSDPPLDSVRLVSLSAGA 261
Query: 239 NHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVSSP 298
NHFCG+R DNH VECWG N S +PK +GFMAIASSDFTTCGIRE+DL+LDCW N S P
Sbjct: 262 NHFCGVRMDNHEVECWGDLNSSVIPKGNGFMAIASSDFTTCGIREDDLLLDCWLVNASKP 321
Query: 299 TDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCSEGF 358
DFDPPLEL SPGLC C EFAFN S+LNE LTS+CVR+DL+ICSPCGSNCS+GF
Sbjct: 322 -DFDPPLELSSPGLCRASECGVDEFAFNVSVLNELALTSVCVREDLRICSPCGSNCSKGF 380
Query: 359 FLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSSQKHWHQL----HRLVLIIGCSALGL 414
FLSS C+ ADRVCTACSLCQNSSC+ +CGL SS +H H + V+I+GC LG
Sbjct: 381 FLSSECSRNADRVCTACSLCQNSSCFGVCGLHSSSGQHLHLHWHHLRKWVVIVGCPVLGF 440
Query: 415 LLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPAS--ACPGMAQVF 472
L+I++ C LF RK +KKQ KSCIGK + + D + +L S +CPG QVF
Sbjct: 441 LVILLCGC----LFMVRKR--TKKQSKSCIGKPDQEEDHVNVALNSTLSVNSCPGAPQVF 494
Query: 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELE 532
RLSELKDATNGFKEFNELGRGSYGFVYKA L DGR VAVKRANAATIIHTN R+FE ELE
Sbjct: 495 RLSELKDATNGFKEFNELGRGSYGFVYKAALADGRVVAVKRANAATIIHTNNRDFETELE 554
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK 592
+LC IRH N+VNLLGYC EMGERLLVYE+MP GTL+DHLHGGLSPLNWSLRLK +MQAAK
Sbjct: 555 ILCKIRHCNVVNLLGYCAEMGERLLVYEYMPHGTLYDHLHGGLSPLNWSLRLKTAMQAAK 614
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIV 652
GLEYLHK+ PPI+H+D+K+ NILLDS+WGARI+DFGLL S ++DL D++SDV+NFGIV
Sbjct: 615 GLEYLHKELVPPIVHKDLKSSNILLDSEWGARISDFGLLASSDKDLNGDLESDVYNFGIV 674
Query: 653 LLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELA 712
LLEILSGRKAYD +Y PP +VEWA+PLIKQGK AAIIDR VALPRNVEPL KLADIAELA
Sbjct: 675 LLEILSGRKAYDRDYTPPNVVEWAVPLIKQGKGAAIIDRYVALPRNVEPLLKLADIAELA 734
Query: 713 IRENPSELPTMSQVATWLEQIVKDGLIL 740
+RENPSE P MS +A+WLEQIVKDGL L
Sbjct: 735 VRENPSERPPMSDIASWLEQIVKDGLFL 762
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15232759|ref|NP_187589.1| serine/threonine-protein kinase-like protein CCR1 [Arabidopsis thaliana] gi|75313027|sp|Q9S7D9.1|ACCR1_ARATH RecName: Full=Serine/threonine-protein kinase-like protein CCR1; AltName: Full=Protein CRINKLY 4 RELATED 1; Short=AtCRR1; Flags: Precursor gi|6681340|gb|AAF23257.1|AC015985_15 putative protein kinase [Arabidopsis thaliana] gi|6682254|gb|AAF23306.1|AC016661_31 putative protein kinase [Arabidopsis thaliana] gi|332641291|gb|AEE74812.1| serine/threonine-protein kinase-like protein CCR1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2582), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/753 (66%), Positives = 603/753 (80%), Gaps = 19/753 (2%)
Query: 2 GPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFS-------NIPSMA 54
GPI+ASFG ++FFCAIDASG+QDVICW KN SSPSS S++S+S + NIPSMA
Sbjct: 28 GPIAASFGGSAFFCAIDASGRQDVICWGKNYSSPSSPSSSSSSSSIASSTSASYNIPSMA 87
Query: 55 VLSGGEGLLCGILANTSQAFCWSS-NSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRG 113
VLSGG+G LCGIL+NTSQAFC+SS SS G DLVP Y+ TAYS+IAAG +HVCAVRG
Sbjct: 88 VLSGGDGFLCGILSNTSQAFCFSSLGSSSG--MDLVPLAYRTTAYSQIAAGNSHVCAVRG 145
Query: 114 SYYSYHDLGTVDCWDIVR-KGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDG 172
+YYS HD GT+DCW+I R NN+L + + FYD+ VS +V +++SGDGFSCGG+RDG
Sbjct: 146 AYYSDHDSGTIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDGFSCGGIRDG 205
Query: 173 GIVCWGPDSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNND-FVSVPPVGIRF 231
G++C+GP+S +LG +++F+VLA+GK+S+C I LS EVKCWG ++ FV+ P RF
Sbjct: 206 GMLCFGPNSSNLGFNTTSDNFQVLAAGKNSVCAILNLSREVKCWGEDESFVNSPMNDSRF 265
Query: 232 VSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
VSL AG HFCGIREDNH VECWG+ N+S +PK SGF AIASSDF CGIRE DLVLDCW
Sbjct: 266 VSLTAGPRHFCGIREDNHEVECWGNSNFSLIPKGSGFKAIASSDFIVCGIREEDLVLDCW 325
Query: 292 FANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCG 351
N SS +DPPLELCSPG+C GPC+ EFAFNASILNE DLTSLCVRK+L +CSPCG
Sbjct: 326 MVNGSSTLAYDPPLELCSPGMCRAGPCNEKEFAFNASILNEPDLTSLCVRKELMVCSPCG 385
Query: 352 SNCSEGFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS--QKHWHQLHRLVLIIGC 409
S+CS GFFLSS CTA +DR+CT CSLCQNSSC DIC L S+ KHWHQL RLVLIIG
Sbjct: 386 SDCSHGFFLSSSCTANSDRICTPCSLCQNSSCSDICKLHNSNFPDKHWHQLQRLVLIIGS 445
Query: 410 SALGLLLIVISWCIVPRLFTT-RKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGM 468
A LL+I+I C+VPR+ T+ KE+G+ QFKSCIGK +LDTD +++ PA +
Sbjct: 446 CASALLIIIIGCCVVPRIVTSPNKEDGAANQFKSCIGKPDLDTDQPLENV-SPAPSVTPF 504
Query: 469 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFE 528
AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVL DGRQVAVKRANAATIIHTN REFE
Sbjct: 505 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTREFE 564
Query: 529 MELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM 588
ELE+LCNIRH NIVNLLGY EMGERLLVYE+MP GTLHDHLH G SPL+WSLR+KI+M
Sbjct: 565 TELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIAM 624
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC-ERDLTTDMKSDVH 647
Q AKGLEYLH +A P IIH DVK+ N+LLDS+W AR+ADFGL+TS E++L D+K DV+
Sbjct: 625 QTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNEKNL--DIKRDVY 682
Query: 648 NFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707
+FG+VLLEIL+GRK YD + PP IVEW +P+I++GKAAAI+D +ALPRNVEPL KLAD
Sbjct: 683 DFGVVLLEILTGRKRYDRDCDPPEIVEWTVPVIREGKAAAIVDTYIALPRNVEPLLKLAD 742
Query: 708 IAELAIRENPSELPTMSQVATWLEQIVKDGLIL 740
+AEL +RE+P++ PTMS++A WLE + +D LI
Sbjct: 743 VAELCVREDPNQQPTMSELANWLEHVARDALIF 775
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297833746|ref|XP_002884755.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297330595|gb|EFH61014.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/753 (65%), Positives = 596/753 (79%), Gaps = 19/753 (2%)
Query: 2 GPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFS-------NIPSMA 54
GPI+A+FG ++FFCAIDASG+QDVICW KN SSPSS S++S+S + NIPSMA
Sbjct: 28 GPIAAAFGGSAFFCAIDASGRQDVICWGKNYSSPSSPSSSSSSSSLASSTSASYNIPSMA 87
Query: 55 VLSGGEGLLCGILANTSQAFCWSS-NSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRG 113
VLSGG+G LCGIL+NTSQAFC+SS SS G DLVP Y+ TAYS+IAAGT+HVCAVRG
Sbjct: 88 VLSGGDGFLCGILSNTSQAFCFSSLGSSSG--MDLVPLAYRTTAYSQIAAGTSHVCAVRG 145
Query: 114 SYYSYHDLGTVDCWDIVR-KGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDG 172
+YYS HD GTVDCW+I R NN+L + + FYD+ V +V +++SGDGFSCGG+RDG
Sbjct: 146 AYYSDHDSGTVDCWEIARATNNNSLIAKENPNFYDQIVRNLVFNNIVSGDGFSCGGIRDG 205
Query: 173 GIVCWGPDSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNND-FVSVPPVGIRF 231
G++C+GP+S +LG +++F+VLA+GK+S+C I S EVKCWG ++ FV P RF
Sbjct: 206 GLLCFGPNSSNLGFNTTSDNFQVLAAGKNSVCAILNSSREVKCWGEDESFVDSPMNDSRF 265
Query: 232 VSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
VSL AG HFCGIREDNH VECWG+ N+S +PK SGF AIASSDF CGIRE DLVLDCW
Sbjct: 266 VSLTAGPRHFCGIREDNHEVECWGNSNFSLIPKGSGFKAIASSDFIVCGIREEDLVLDCW 325
Query: 292 FANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCG 351
N SS +DPPLELCSPG+C GPC EFAFNASILNE DLTSLCVR++L +CSPCG
Sbjct: 326 MVNGSSTLAYDPPLELCSPGMCRAGPCYEKEFAFNASILNEPDLTSLCVRRELMVCSPCG 385
Query: 352 SNCSEGFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS--QKHWHQLHRLVLIIGC 409
S+CS GFFLSS CT +DR+CT CSLCQNSSC DIC L S+ KHWHQL RLVLIIG
Sbjct: 386 SDCSHGFFLSSSCTENSDRICTPCSLCQNSSCSDICKLHNSNFPDKHWHQLQRLVLIIGS 445
Query: 410 SALGLLLIVISWCIVPRLFTT--RKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPG 467
A LL+++I CIVPR+ T KE+G+ QFKSCIGK +LDT+ + + P P S P
Sbjct: 446 CASALLILIIGCCIVPRVIITSPNKEDGAANQFKSCIGKPDLDTEPLENVSPAP-SVTP- 503
Query: 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREF 527
AQVFRLSELKDATNGFKEFNELGRGSYGFVYKA+L DGRQVAVKRANAATIIHTN REF
Sbjct: 504 FAQVFRLSELKDATNGFKEFNELGRGSYGFVYKALLPDGRQVAVKRANAATIIHTNTREF 563
Query: 528 EMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKIS 587
E ELE+LCNIRH NIVNLLGY EMGERLLVYE+MP GTLHDHLH G SPL+WSLR+KI+
Sbjct: 564 ETELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIA 623
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVH 647
MQ AKGLEYLH +A P I+H DVK+ N+LLD++W AR+ADFGL+TS + D+K DV+
Sbjct: 624 MQTAKGLEYLHNEAEPRIVHGDVKSSNVLLDAEWVARVADFGLVTS-SNEKKLDIKRDVY 682
Query: 648 NFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707
+FG+VLLEIL+GRK +D + PP I EWA+ +I++G+AAAI+D+ +ALPRNVEPL KLAD
Sbjct: 683 DFGVVLLEILTGRKRHDRDCDPPEIAEWAVTVIREGRAAAIVDKYIALPRNVEPLLKLAD 742
Query: 708 IAELAIRENPSELPTMSQVATWLEQIVKDGLIL 740
+AEL +RE+P++ PTMS++A WLEQ+ +D LI
Sbjct: 743 VAELCVREDPNQRPTMSELANWLEQVARDALIF 775
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 740 | ||||||
| TAIR|locus:2075074 | 775 | CCR1 "CRINKLY4 related 1" [Ara | 0.989 | 0.944 | 0.660 | 3.2e-271 | |
| TAIR|locus:2056033 | 776 | CCR2 "CRINKLY4 related 2" [Ara | 0.983 | 0.938 | 0.568 | 2.4e-225 | |
| UNIPROTKB|O24585 | 901 | CR4 "Putative receptor protein | 0.922 | 0.758 | 0.327 | 6e-87 | |
| TAIR|locus:2081227 | 895 | CR4 "crinkly4" [Arabidopsis th | 0.910 | 0.753 | 0.309 | 2.3e-78 | |
| TAIR|locus:2160952 | 751 | CCR4 "CRINKLY4 related 4" [Ara | 0.716 | 0.705 | 0.302 | 9.8e-68 | |
| TAIR|locus:2082033 | 814 | CCR3 "CRINKLY4 related 3" [Ara | 0.218 | 0.199 | 0.476 | 2.8e-53 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.340 | 0.495 | 0.377 | 1e-48 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.256 | 0.386 | 0.403 | 1.8e-47 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.289 | 0.535 | 0.390 | 1.8e-47 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.270 | 0.306 | 0.429 | 1.2e-46 |
| TAIR|locus:2075074 CCR1 "CRINKLY4 related 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2608 (923.1 bits), Expect = 3.2e-271, P = 3.2e-271
Identities = 497/753 (66%), Positives = 591/753 (78%)
Query: 2 GPISASFGQNSFFCAIDASGKQDVICWAKX-------XXXXXXXXXXXXXXXXXXIPSMA 54
GPI+ASFG ++FFCAIDASG+QDVICW K IPSMA
Sbjct: 28 GPIAASFGGSAFFCAIDASGRQDVICWGKNYSSPSSPSSSSSSSSIASSTSASYNIPSMA 87
Query: 55 VLSGGEGLLCGILANTSQAFCWSS-NSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRG 113
VLSGG+G LCGIL+NTSQAFC+SS SS G DLVP Y+ TAYS+IAAG +HVCAVRG
Sbjct: 88 VLSGGDGFLCGILSNTSQAFCFSSLGSSSG--MDLVPLAYRTTAYSQIAAGNSHVCAVRG 145
Query: 114 SYYSYHDLGTVDCWDIVRK-GNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDG 172
+YYS HD GT+DCW+I R NN+L + + FYD+ VS +V +++SGDGFSCGG+RDG
Sbjct: 146 AYYSDHDSGTIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDGFSCGGIRDG 205
Query: 173 GIVCWGPDSESLGVFNVT-ESFKVLASGKSSLCGISELSGEVKCWGNND-FVSVPPVGIR 230
G++C+GP+S +LG FN T ++F+VLA+GK+S+C I LS EVKCWG ++ FV+ P R
Sbjct: 206 GMLCFGPNSSNLG-FNTTSDNFQVLAAGKNSVCAILNLSREVKCWGEDESFVNSPMNDSR 264
Query: 231 FVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDC 290
FVSL AG HFCGIREDNH VECWG+ N+S +PK SGF AIASSDF CGIRE DLVLDC
Sbjct: 265 FVSLTAGPRHFCGIREDNHEVECWGNSNFSLIPKGSGFKAIASSDFIVCGIREEDLVLDC 324
Query: 291 WFANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPC 350
W N SS +DPPLELCSPG+C GPC+ EFAFNASILNE DLTSLCVRK+L +CSPC
Sbjct: 325 WMVNGSSTLAYDPPLELCSPGMCRAGPCNEKEFAFNASILNEPDLTSLCVRKELMVCSPC 384
Query: 351 GSNCSEGFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS--QKHWHQLHRLVLIIG 408
GS+CS GFFLSS CTA +DR+CT CSLCQNSSC DIC L S+ KHWHQL RLVLIIG
Sbjct: 385 GSDCSHGFFLSSSCTANSDRICTPCSLCQNSSCSDICKLHNSNFPDKHWHQLQRLVLIIG 444
Query: 409 CSALGLLLIVISWCIVPRLFTT-RKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPG 467
A LL+I+I C+VPR+ T+ KE+G+ QFKSCIGK +LDTD +++ PA +
Sbjct: 445 SCASALLIIIIGCCVVPRIVTSPNKEDGAANQFKSCIGKPDLDTDQPLENVS-PAPSVTP 503
Query: 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREF 527
AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVL DGRQVAVKRANAATIIHTN REF
Sbjct: 504 FAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTREF 563
Query: 528 EMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKIS 587
E ELE+LCNIRH NIVNLLGY EMGERLLVYE+MP GTLHDHLH G SPL+WSLR+KI+
Sbjct: 564 ETELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIA 623
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC-ERDLTTDMKSDV 646
MQ AKGLEYLH +A P IIH DVK+ N+LLDS+W AR+ADFGL+TS E++L D+K DV
Sbjct: 624 MQTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNEKNL--DIKRDV 681
Query: 647 HNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLA 706
++FG+VLLEIL+GRK YD + PP IVEW +P+I++GKAAAI+D +ALPRNVEPL KLA
Sbjct: 682 YDFGVVLLEILTGRKRYDRDCDPPEIVEWTVPVIREGKAAAIVDTYIALPRNVEPLLKLA 741
Query: 707 DIAELAIRENPSELPTMSQVATWLEQIVKDGLI 739
D+AEL +RE+P++ PTMS++A WLE + +D LI
Sbjct: 742 DVAELCVREDPNQQPTMSELANWLEHVARDALI 774
|
|
| TAIR|locus:2056033 CCR2 "CRINKLY4 related 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2175 (770.7 bits), Expect = 2.4e-225, P = 2.4e-225
Identities = 430/757 (56%), Positives = 540/757 (71%)
Query: 2 GPISASFGQNSFFCAIDASGKQDVICWAKXXXXXXXXXXXXXXXXXXXIPSMAVLSGGEG 61
G I+A+FG+N FFCAIDASGKQ+VICW + P M LSGGEG
Sbjct: 27 GTIAAAFGENGFFCAIDASGKQEVICWDRGNTNRSLNRPPGEISGYS--PPMTSLSGGEG 84
Query: 62 LLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDL 121
LC I +NTS+AFCW+ N LVP ++ +Y +IA+G NHVCA+ G YYS D
Sbjct: 85 FLCAITSNTSRAFCWNLEDPSEN---LVPRAFQYNSYLQIASGNNHVCAISGLYYSGPDY 141
Query: 122 GTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDS 181
G V CW+ N T + + F++ Y+ +++ + ++SGDGFSCG +DG +VCWGP S
Sbjct: 142 GPVHCWEYSDNTNFTSGLLWNSSFHNPYIDSLMFRKIVSGDGFSCGVTKDGDLVCWGPKS 201
Query: 182 ESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNN-DFVSVPPVGIRFVSLAAGANH 240
L F+ E F+VLASG++S+CG+S+ SG++ C+G+ +F S+P RF++L+AGANH
Sbjct: 202 NLLN-FSNNEEFEVLASGRNSVCGVSKDSGQLHCFGDETEFGSLPNRP-RFIALSAGANH 259
Query: 241 FCGIREDNHGVECWG----SFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVS 296
+CGIRED+HGVECWG S + SS P SGF+AI+SSD TTCG+RE DLVLDCW + S
Sbjct: 260 YCGIREDDHGVECWGRNLNSSSSSSAPNTSGFVAISSSDSTTCGVRELDLVLDCWRVHDS 319
Query: 297 SPTDFDPPLELCSPGLCTP-GPCSTGEFAFNASILNEQDLTSLCVRKDLKICSPCGSNCS 355
S D+ PPLELCSPG+C+P G C G FAFNASIL E +LTSLC +L IC CG +C
Sbjct: 320 SKADYSPPLELCSPGMCSPRGNCGDGWFAFNASILKESELTSLCSFHNLNICLRCGISCL 379
Query: 356 EGFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSS-----QKHWHQLHRLVLIIGCS 410
EG+F SS C ADRVCT CSLCQNSSC+ IC ++ + QK ++ RLV+IIGCS
Sbjct: 380 EGYFPSSTCNPNADRVCTPCSLCQNSSCYGICKIRATKSKEHEQKEQREVRRLVIIIGCS 439
Query: 411 ALGLLLIVISWCIVPRLFTTRK---EEGSKKQFKSCIGKHELDTDAIADSLPH-----PA 462
LG L+++I +P++ K EE SK C K+ ++ D D +PH P
Sbjct: 440 VLGFLVMLIGLSFIPKMTKGSKRDDEERSKMTCCFCFDKNSVEADP--DPVPHQSVLLPT 497
Query: 463 SACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT 522
+ G ++FRLSELKDAT+GFKEFNELGRGS+GFVYKAVL DG VAVKRANAATIIH+
Sbjct: 498 AVSLGETKIFRLSELKDATHGFKEFNELGRGSFGFVYKAVLSDGIHVAVKRANAATIIHS 557
Query: 523 NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSL 582
N R FE ELE+LC IRH+NIVNLLGYC EMGERLLVYE+MP GTLHDHLHG LS L+WS+
Sbjct: 558 NNRGFESELEILCKIRHNNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGDLSQLDWSM 617
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT-TD 641
RLKI +QAA+GL+YLH + PPIIHRDVKT NILLD + ARIADFGL++S ERD + +D
Sbjct: 618 RLKIMLQAARGLDYLHNEVDPPIIHRDVKTSNILLDGEMCARIADFGLVSSNERDSSNSD 677
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701
+ DV++FGIVLLEILSGRKA D E P GI EWA+PLI++GKAAAIIDRN+ LPRNVEP
Sbjct: 678 REGDVYDFGIVLLEILSGRKAIDRESDPAGIAEWAVPLIRKGKAAAIIDRNICLPRNVEP 737
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738
L KLA++AELA+REN +E P + + +L+ IVK GL
Sbjct: 738 LLKLAELAELAVRENSNERPNIRNILCFLDLIVKSGL 774
|
|
| UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
Identities = 253/773 (32%), Positives = 382/773 (49%)
Query: 1 MGPISASFGQNS-FFCAIDASGKQDVICWAKXXXXXXXXXXXXXXXXXXXIPSMAVLSGG 59
M I+ S+G++ FC +++ G V C+ IP + L+ G
Sbjct: 28 MSSIAVSYGEDGPVFCGLNSDGSHLVACFG--------ADASVLYGAPPNIPFLG-LTAG 78
Query: 60 EGLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVR----GSY 115
+G +CG+L +T Q +CW SNS + P V + YS ++AG NH+CA+R G
Sbjct: 79 DGFVCGLLLDTRQPYCWGSNSYVKSGVPQ-PMV-EGARYSELSAGDNHLCALRAAQDGGR 136
Query: 116 YSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCG-GVRDGGI 174
S +DCW G N ++ DE VST V +G F+CG R+ +
Sbjct: 137 GSSAATSLIDCW-----GYNMTATHAV----DEAVST-----VSAGSVFNCGLFARNRTV 182
Query: 175 VCWGPDSESLGVFNVTES---FKVLASGKSSLCGISELSGEVKCWGNN-DFVSVPP---V 227
CWG ++ S GV + F+ + +G +CG+ E + +V CWG + + V P +
Sbjct: 183 FCWGDETVS-GVVGLAPRDLHFQSIGAGGYHVCGVLE-NAQVFCWGRSLEMQQVVPSSAI 240
Query: 228 G---IRFVSLAA------GANHFCGIREDNHGVECWGS--FNYSSVPKNSGFMAIASSDF 276
G + V + A G H CGIR +H V CWG N +S PK A+ + D+
Sbjct: 241 GDGDVNIVPMDAMSTVVGGRFHACGIRSLDHQVACWGFTLHNSTSPPKGLKMYALVAGDY 300
Query: 277 TTCGI-RENDLVLDCWFANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILNEQDL 335
TCG+ E L+ CW N S P P+ + PG+C P CS G + + +N ++
Sbjct: 301 FTCGVPAETSLMPRCW-GN-SGPLAL--PMAV-PPGICVPTACSHGYYEY----VNHGEV 351
Query: 336 TSL--CVRKDLKICSPCGSNCSEGFFLSSPCTAIADRVCTA-CSLCQNSSCWDICGLQP- 391
S+ C + ++C PC + C EG + SSPC A ADRVC C C C C Q
Sbjct: 352 GSIKVCKPANSRLCLPCSTGCPEGLYESSPCNATADRVCQFDCLKCVTDECLSFCLSQKR 411
Query: 392 -SSQKHW-HQLHRLVLIIGCSALGLLLIVISWCIVPRLFTTRKEEGSKKQF---KSCIGK 446
S+K Q+ V I + + +L + ++ C+ R R + S ++ KS
Sbjct: 412 TKSRKLMAFQMRIFVAEIVFAVVLVLSVSVTTCLYVR-HKLRHCQCSNRELRLAKSTAYS 470
Query: 447 HELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDG 506
D I P AQ F EL+ AT GF E +++G+GS+ V+K +L DG
Sbjct: 471 FRKDNMKIQ---PDMEDLKIRRAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDG 527
Query: 507 RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGT 566
VAVKRA A+ + + +EF EL++L + H++++NLLGYC + ERLLVYEFM G+
Sbjct: 528 TVVAVKRAIKASDVKKSSKEFHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGS 587
Query: 567 LHDHLHG---GLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622
L+ HLHG L LNW+ R+ I++QAA+G+EYLH A PP+IHRD+K+ NIL+D D
Sbjct: 588 LYQHLHGKDPNLKKRLNWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHN 647
Query: 623 ARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP--GIVEWALPLI 680
AR+ADFGL D T + S++ + L+ + Y + Y+ + + + L+
Sbjct: 648 ARVADFGLSILGPADSGTPL-SELPAGTLGYLD----PEYYRLHYLTTKSDVYSFGVVLL 702
Query: 681 KQGKAAAIIDRNVALPRNVE---PLFKLADIAELA--IRENPSELPTMSQVAT 728
+ ID VE PL K DI + + PS+L + ++A+
Sbjct: 703 EILSGRKAIDMQFEEGNIVEWAVPLIKAGDIFAILDPVLSPPSDLEALKKIAS 755
|
|
| TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 788 (282.4 bits), Expect = 2.3e-78, P = 2.3e-78
Identities = 243/784 (30%), Positives = 370/784 (47%)
Query: 1 MGPISASFGQN-SFFCAIDASGKQDVICWAKXXXXXXXXXXXXXXXXXXXIPSMAVLSGG 59
M I+ S+G+ S FC + + G V+C+ L+GG
Sbjct: 33 MSSIAISYGEGGSVFCGLKSDGSHLVVCYGSNSAILYGTPGHLQFIG---------LTGG 83
Query: 60 EGLLCGILANTSQAFCWSSNSSPGNTTDLVPS-VYKNTAYSRIAAGTNHVCAVR----GS 114
+G +CG+L + Q +CW NS+ VP + K Y ++AG H+C +R G
Sbjct: 84 DGFMCGLLMLSHQPYCWG-NSAFIQMG--VPQPMTKGAEYLEVSAGDYHLCGLRKPIVGR 140
Query: 115 YYSYHDLGT--VDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCG-GVRD 171
+ + + + VDCW G N + N +D+ L + +G F+C +D
Sbjct: 141 RKNSNIISSSLVDCW-----GYN----MTRNFVFDKQ-----LHSLSAGSEFNCALSSKD 186
Query: 172 GGIVCWGPDSES--LGVFNVTESFKVLASGKSSLCGISE-LSGEVKCWGNN-DF------ 221
+ CWG ++ S + + + F+ +A+G +CGI + L V CWG + +F
Sbjct: 187 KSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLCWGKSLEFEEEVTG 246
Query: 222 -------VSVPPVGIRFVSLAAGANHFCGIREDNHGVECWGSF-NYSS-VPKNSGFMAIA 272
+ +PP +++ G + CGI+ +H CWG F N S+ P GF +A
Sbjct: 247 TSTEEKILDLPPKE-PLLAVVGGKFYACGIKRYDHSAVCWGFFVNRSTPAPTGIGFYDLA 305
Query: 273 SSDFTTCGIRENDLVLD-CWFANVSSPTDFDPPLELCSPGLCTPGPCSTGEFAFNASILN 331
+ ++ TCG+ + CW + P PL + SPGLC PC G + N
Sbjct: 306 AGNYFTCGVLTGTSMSPVCW--GLGFPASI--PLAV-SPGLCIDTPCPPGTHELS----N 356
Query: 332 EQDLTSLCVRKDLKICSPCGSNCSEGFFLSSPCTAIADRVCTA-CSLCQNSSCWDICGLQ 390
+++ S C IC PC ++C G + S CT +D+VC CS C + C C
Sbjct: 357 QEN--SPCKFTGSHICLPCSTSCPPGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNCSSS 414
Query: 391 PSSQ-KHWHQLHRLVLIIGCSALGLLLIVISWCIVP-------RLFTTRKEEGSKKQFK- 441
+S K + L L I + +G L +++ + RL R E + K
Sbjct: 415 ATSGGKEKGKFWSLQLPIATAEIGFALFLVAVVSITAALYIRYRLRNCRCSENDTRSSKD 474
Query: 442 SCIGKHELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKA 501
S K D I L A+VF EL+ A +GFKE + +G+GS+ VYK
Sbjct: 475 SAFTK---DNGKIRPDLDELQKR--RRARVFTYEELEKAADGFKEESIVGKGSFSCVYKG 529
Query: 502 VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561
VL DG VAVKRA ++ N EF EL++L + H+++++LLGYC E GERLLVYEF
Sbjct: 530 VLRDGTTVAVKRAIMSSDKQKNSNEFRTELDLLSRLNHAHLLSLLGYCEECGERLLVYEF 589
Query: 562 MPRGTLHDHLHG---GLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL 617
M G+LH+HLHG L L+W R+ I++QAA+G+EYLH A PP+IHRD+K+ NIL+
Sbjct: 590 MAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 649
Query: 618 DSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAY-DIEY-------VP 669
D + AR+ADFGL L + S G L E+ +G Y D EY
Sbjct: 650 DEEHNARVADFGL------SLLGPVDS-----GSPLAELPAGTLGYLDPEYYRLHYLTTK 698
Query: 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVE---PLFKLADIAELA--IRENPSELPTMS 724
+ + + L++ ID + VE PL K DI L + ++PSE+ +
Sbjct: 699 SDVYSFGVLLLEILSGRKAIDMHYEEGNIVEWAVPLIKAGDINALLDPVLKHPSEIEALK 758
Query: 725 QVAT 728
++ +
Sbjct: 759 RIVS 762
|
|
| TAIR|locus:2160952 CCR4 "CRINKLY4 related 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 9.8e-68, Sum P(2) = 9.8e-68
Identities = 180/595 (30%), Positives = 277/595 (46%)
Query: 62 LLCGILANTSQAFCWSS--NSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYH 119
L+C L N S C S NS P + T + +N +S + +G VC + S
Sbjct: 45 LVCA-LNNHSYLQCSSFPLNSIPFSLTGNL----RNRRFSGVVSGNGFVCGLISRLDS-- 97
Query: 120 DLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVR-DGGIVCWG 178
+ T+ CW G N L +++ L+++ +G+ CG R + CW
Sbjct: 98 NTSTLLCWRFSVDGTNMLHK---RIYHGPE-----LEELEAGNFRICGVERVSRRLRCWQ 149
Query: 179 PDSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPPVGIRFVSLAAGA 238
P ++++ +A G + CG+S+ G + C G ++ P G ++++AAG+
Sbjct: 150 PY-----YLPRPDNYRSIALGDNFFCGLSQPPGMISCEG----IAKVPSGDHYIAIAAGS 200
Query: 239 NHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIRENDLVLDCWFANVSSP 298
C I DN VECWG S+P+ F+A+A + CG+R ++ + CW N
Sbjct: 201 RQACAITVDND-VECWGQTQ--SLPREK-FLALAVGEDRGCGVRWSNGTVVCWGNN---- 252
Query: 299 TDFDPPLELCS---PGLCTPGPCSTGEFAFNASIL---NEQDLTSLCVR-----KDLKIC 347
+F P L + GP G N +++ NE + + + +
Sbjct: 253 NNFSLPQTLKDIHFTSIYAKGPMFCGVATRNYTLICWGNENFKSGVFTPFQGLISQVVMP 312
Query: 348 SPCGSNCSEGFFLSSPCTAIADRVCTACSLCQNSSCWDICGLQPSSQKHWHQLHRLVLII 407
PC C + S ++ C L +N + Q S K W + + L++
Sbjct: 313 GPCRRECP--YRPLSGSQSLCGNELMICDLKRNDGEFPDTRAQNSKNKTWSRRNIAFLVV 370
Query: 408 GCSALGLLLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPAS-ACP 466
GC LL+VIS+ I R + + +D + L AS P
Sbjct: 371 GCVGTFSLLLVISFLIFKSHCRCRVHDSGRLD-----DTRTIDIPKLEKRLCTLASLGNP 425
Query: 467 GMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAA--TIIHTNI 524
G F + EL AT+GF LG GS+G VY+ VL DGR VA+KRA T+ T +
Sbjct: 426 GQLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTTM 485
Query: 525 RE--------FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGG-L 575
R F ELE + + H N+V LLG+ + ER+LVYE+M G+L DHLH
Sbjct: 486 RHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHLHNPQF 545
Query: 576 SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
PL+W RL I++ AA+G++YLH+ PP+IHRD+K+ NILLD+ W A+++DFGL
Sbjct: 546 DPLSWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGL 600
|
|
| TAIR|locus:2082033 CCR3 "CRINKLY4 related 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 398 (145.2 bits), Expect = 2.8e-53, Sum P(3) = 2.8e-53
Identities = 82/172 (47%), Positives = 113/172 (65%)
Query: 469 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANA-ATIIHTNIRE- 526
A+ F SEL AT F N++G GS+G VY+ L DGR+VA+KR A + +E
Sbjct: 481 AEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKRGEVNAKMKKFQEKET 540
Query: 527 -FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGG------LSPLN 579
F+ E+ L + H ++V L+GYC E E+LLVY++M G L+DHLH S +N
Sbjct: 541 AFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDHLHDKNNVEKHSSLIN 600
Query: 580 -WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
W +R+KI++ AA+G+EYLH A PPIIHRD+K+ NILLDS+W AR++DFGL
Sbjct: 601 SWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVARVSDFGL 652
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 1.0e-48, Sum P(2) = 1.0e-48
Identities = 99/262 (37%), Positives = 150/262 (57%)
Query: 405 LIIGCSALGLLLIVISWCIVPRLFTTRKEEGSKKQ---FKSCIGKHELDTDAIADSLPHP 461
LI G LG +++ CI + +K + KK+ ++ I + LD +++L
Sbjct: 63 LITGV-VLGATFVLLGVCIFVCFYKRKKRKLKKKKKEDIEASINRDSLDPKDDSNNLQQW 121
Query: 462 ASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH 521
+S+ G +F +L AT+ F N LG+G +G+V++ VLVDG VA+K+ + +
Sbjct: 122 SSSEIGQ-NLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGS--G 178
Query: 522 TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSP-LNW 580
REF+ E++ + + H ++V+LLGYC+ +RLLVYEF+P TL HLH P + W
Sbjct: 179 QGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEW 238
Query: 581 SLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT 640
S R+KI++ AAKGL YLH+D P IHRDVK NIL+D + A++ADFGL S D T
Sbjct: 239 SKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARS-SLDTDT 297
Query: 641 DMKSDVHN-FGIVLLEILSGRK 661
+ + + FG + E S K
Sbjct: 298 HVSTRIMGTFGYLAPEYASSGK 319
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 1.8e-47, Sum P(3) = 1.8e-47
Identities = 79/196 (40%), Positives = 115/196 (58%)
Query: 467 GMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE 526
G + L EL+ +TNGF + N +G+G YG VY+ VL D VA+K N +E
Sbjct: 145 GWGHWYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIK--NLLNNRGQAEKE 202
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGG----LSPLNWSL 582
F++E+E + +RH N+V LLGYC+E R+LVYE++ G L +HGG SPL W +
Sbjct: 203 FKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEI 262
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM 642
R+ I + AKGL YLH+ P ++HRD+K+ NILLD W ++++DFGL +++
Sbjct: 263 RMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSEMSYVT 322
Query: 643 KSDVHNFGIVLLEILS 658
+ FG V E S
Sbjct: 323 TRVMGTFGYVAPEYAS 338
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 402 (146.6 bits), Expect = 1.8e-47, Sum P(2) = 1.8e-47
Identities = 91/233 (39%), Positives = 139/233 (59%)
Query: 404 VLIIGCSALGLLLIVISWCIVPRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPAS 463
++++ C AL L + S+ R +++ SK+ F C K D + D +
Sbjct: 18 IVVLACLALSSLFVAFSYYCYIRNKVSKRHRISKR-F-DCEEKG--DCQKVQDVTEN--- 70
Query: 464 ACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN 523
G+ Q+F +L AT GF + N +G G +G VY+ VL DGR+VA+K + A
Sbjct: 71 ---GL-QIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAG--KQG 124
Query: 524 IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH-----GGLSP- 577
EF+ME+E+L +R ++ LLGYC + +LLVYEFM G L +HL+ G + P
Sbjct: 125 EEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPR 184
Query: 578 LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
L+W R++I+++AAKGLEYLH+ +PP+IHRD K+ NILLD ++ A+++DFGL
Sbjct: 185 LDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGL 237
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 1.2e-46, Sum P(2) = 1.2e-46
Identities = 88/205 (42%), Positives = 123/205 (60%)
Query: 459 PHPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAAT 518
P P F EL ATNGF E N LG+G +G+V+K +L G++VAVK+ A +
Sbjct: 255 PSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGS 314
Query: 519 IIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG-GLSP 577
REF+ E+E++ + H ++V+L+GYC+ +RLLVYEF+P L HLHG G
Sbjct: 315 --GQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT 372
Query: 578 LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637
+ WS RLKI++ +AKGL YLH+D P IIHRD+K NIL+D + A++ADFGL D
Sbjct: 373 MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGL-AKIASD 431
Query: 638 LTTDMKSDVHN-FGIVLLEILSGRK 661
T + + V FG + E + K
Sbjct: 432 TNTHVSTRVMGTFGYLAPEYAASGK 456
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S7D9 | ACCR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6693 | 0.9918 | 0.9470 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00023189001 | SubName- Full=Chromosome chr8 scaffold_29, whole genome shotgun sequence; (736 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 740 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-05 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 1e-42
Identities = 80/271 (29%), Positives = 115/271 (42%), Gaps = 48/271 (17%)
Query: 489 ELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+LG G++G VYK L +VAVK I EF E ++ + H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ-QIEEFLREARIMRKLDHPNVV 64
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
LLG C E +V E+M G L +L L+ S L ++Q A+G+EYL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTTDM------------------ 642
IHRD+ N L+ + +I+DFGL L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 643 -KSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQGKAAAIIDRNVALPRNV 699
KSDV +FG++L EI + G + Y PG+ E L +K G R P N
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPY------PGMSNEEVLEYLKNGY------RL-PQPPNC 228
Query: 700 EPLFKLADIAELAIRENPSELPTMSQVATWL 730
P +L D+ E+P + PT S++ L
Sbjct: 229 PP--ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 81/272 (29%), Positives = 119/272 (43%), Gaps = 49/272 (18%)
Query: 489 ELGRGSYGFVYKAVLVDG-----RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+LG G++G VYK L +VAVK I EF E ++ + H NIV
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE-QQIEEFLREARIMRKLDHPNIV 64
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
LLG C E ++V E+MP G L D+L L+ S L ++Q A+G+EYL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGL---LTSCE-------------------RDLTT 640
IHRD+ N L+ + +I+DFGL L + ++
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 641 DMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQGKAAAIIDRNVALPRN 698
KSDV +FG++L EI + G + Y PG+ L +K+G R P N
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPY------PGMSNAEVLEYLKKGY------RL-PKPPN 228
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQVATWL 730
P +L + E+P + PT S++ L
Sbjct: 229 CPP--ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 82/275 (29%), Positives = 121/275 (44%), Gaps = 63/275 (22%)
Query: 489 ELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+LG G++G VYK L +VAVK EF E ++ + H NIV
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-EEEREEFLEEASIMKKLSHPNIV 64
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
LLG C + +V E+MP G L D L L L++++Q AKG+EYL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD---------------M------ 642
+HRD+ N L+ + +I+DFGL RD+ D M
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLS----RDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 643 ------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQGKAAAIIDRNVA 694
KSDV +FG++L EI + G + Y PG+ E L L++ G R
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPY------PGMSNEEVLELLEDGY------R--- 222
Query: 695 LPRNVEPLFKLADIAELAIR---ENPSELPTMSQV 726
LPR P ++ EL ++ +P + PT S++
Sbjct: 223 LPR---PENCPDELYELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 77/277 (27%), Positives = 114/277 (41%), Gaps = 58/277 (20%)
Query: 488 NELGRGSYGFVYKAVLVDG----RQVAVKRA-NAATIIHTNIREFEMELEVLCNIRHSNI 542
+LG G++G VYK L +VAVK A+ ++F E V+ + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHL--------HGGLSPLNWSLRLKISMQAAKGL 594
V LLG C E LV E+M G L D+L S L+ L ++Q AKG+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------------ 642
EYL +HRD+ N L+ D +I+DFGL D
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 643 -----------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQGKAAAII 689
KSDV +FG++L EI + G Y PG+ E L +++G
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY------PGLSNEEVLEYLRKGY----- 224
Query: 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
R P +L ++ + +P + PT S++
Sbjct: 225 -RL-PKPEYCPD--ELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 68/191 (35%), Positives = 94/191 (49%), Gaps = 28/191 (14%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG G +G VY A G++VA+K + + E E+E+L + H NIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
+ LV E+ G+L D L L+ L+I +Q +GLEYLH + IIHR
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 609 DVKTLNILLDSDWG-ARIADFGL---LTSCERDLTT-------------------DMKSD 645
D+K NILLDSD G ++ADFGL LTS + L T KSD
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 646 VHNFGIVLLEI 656
+ + G++L E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 62/196 (31%), Positives = 85/196 (43%), Gaps = 30/196 (15%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
+LG GS+G VY A G+ VA+K I R E+++L ++H NIV L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIVRLY 63
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ + LV E+ G L D L G LS Q LEYLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSK---G 117
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTT------------------DMKS 644
I+HRD+K NILLD D ++ADFGL LTT
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 645 DVHNFGIVLLEILSGR 660
D+ + G++L E+L+G+
Sbjct: 178 DIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 68/196 (34%), Positives = 92/196 (46%), Gaps = 31/196 (15%)
Query: 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG GS+G VYKA G+ VAVK + + E+ +L + H NIV L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 549 CLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
+ LV E+ G L D+L G LS KI++Q +GLEYLH + II
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLS---EDEAKKIALQILRGLEYLHSNG---II 120
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCE---RDLTT-------------------DMKS 644
HRD+K NILLD + +IADFGL LTT K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 645 DVHNFGIVLLEILSGR 660
DV + G++L E+L+G+
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 30/200 (15%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LGRGS+G VY A+ D G +AVK + + E E+ +L +++H NIV G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 549 CL--EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
E + E++ G+L L L + K + Q +GL YLH + I+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNG---IV 123
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-----------------------K 643
HRD+K NIL+DSD ++ADFG T +
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 644 SDVHNFGIVLLEILSGRKAY 663
+D+ + G ++E+ +G+ +
Sbjct: 184 ADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 40/219 (18%)
Query: 485 KEFNELGRGSYGFVYKA---VLVD--GRQVAVKRANAATIIHTNIREFEMELEVLCNIRH 539
K +LG G +G V L D G QVAVK N + + +FE E+E+L + H
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTLDH 65
Query: 540 SNIVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
NIV G C + G R L+ E++P G+L D+L +N L S Q KG++YL
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-------------------- 637
+ IHRD+ NIL++S+ +I+DFGL D
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 638 -LTTD---MKSDVHNFGIVLLEILS-GRKAYDIEYVPPG 671
L T SDV +FG+ L E+ + G + PP
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS----QSPPA 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 30/200 (15%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRAN--AATIIHTNIREFEMELEVLCNIRHS 540
F+ ++G+G +G VYKA G++VA+K + I E +++L +H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINE----IQILKKCKHP 57
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
NIV G L+ E +V EF G+L D L L S + + KGLEYLH +
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------------- 640
IIHRD+K NILL SD ++ DFGL
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 641 DMKSDVHNFGIVLLEILSGR 660
D K+D+ + GI +E+ G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRAN---AATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG+G++G VY VD GR++AVK+ + + E E+++L N++H IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 546 LGYCLEMGERLLVY-EFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
G CL E L ++ E+MP G++ D L +G L ++ K + Q +G+EYLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM- 124
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTTDMKSDVHNFGIVLLEILS 658
I+HRD+K NIL DS ++ DFG L T C T MKS + E++S
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS--GTGMKSVTGTPYWMSPEVIS 180
Query: 659 ----GRKAYDIEYVPPGIVE 674
GRKA D+ V +VE
Sbjct: 181 GEGYGRKA-DVWSVGCTVVE 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 30/196 (15%)
Query: 489 ELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
LG+GS G VYK G+ A+K+ + ++ EL+ L + +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ GE +V E+M G+L D L G + + I+ Q KGL+YLH I
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHTKRH--I 121
Query: 606 IHRDVKTLNILLDSDWGARIADFG----LLTSCERDLT-----TDM------------KS 644
IHRD+K N+L++S +IADFG L + ++ T T M +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 645 DVHNFGIVLLEILSGR 660
D+ + G+ LLE G+
Sbjct: 182 DIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
+ +GRG++G VYK + L G VA+K+ + I ++ E+++L N++H NIV +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
G ++ E+ G+L + G P SL Q +GL YLH+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG--- 119
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT------------------DMK 643
+IHRD+K NIL D ++ADFG+ L +D +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 644 SDVHNFGIVLLEILSGRKAY 663
SD+ + G ++E+L+G Y
Sbjct: 180 SDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 484 FKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F+ N++G+GS+G V+K V D R A+K+ + + + E E VL + S I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDA 601
+ L+ G+ +V E+ G LH L PL + +Q GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTS----------------------CERDLT 639
I+HRD+K+LN+ LD+ +I D G+ CE D
Sbjct: 122 ---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE-DKP 177
Query: 640 TDMKSDVHNFGIVLLEILSGRKAYDIE 666
+ KSDV G+VL E +G+ +D
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 55/222 (24%)
Query: 489 ELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
ELG G++G V+ D VAVK ++FE E E+L N +H NI
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREAELLTNFQHENI 70
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHL--HG-----------GLSPLNWSLRLKISMQ 589
V G C E ++V+E+M G L+ L HG + L S L+I++Q
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD------- 641
A G+ YL A+ +HRD+ T N L+ D +I DFG+ RD+ TTD
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM----SRDVYTTDYYRVGGH 183
Query: 642 -------------------MKSDVHNFGIVLLEILS-GRKAY 663
+SDV +FG+VL EI + G++ +
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 31/196 (15%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+G+G +G V G++VAVK + ++ + F E V+ +RH N+V LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAA-----QAFLAEASVMTTLRHPNLVQLLG 67
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
L+ +V E+M +G+L D+L G + + + +L ++ +G+EYL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------DMKSDVHN 648
HRD+ N+L+ D A+++DFGL + + KSDV +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 649 FGIVLLEILS-GRKAY 663
FGI+L EI S GR Y
Sbjct: 185 FGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 70/266 (26%), Positives = 113/266 (42%), Gaps = 40/266 (15%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
D +K ++G G+ G VYKA G++VA+K+ + N E+ ++ +
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDC 72
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
+H NIV+ L E +V E+M G+L D + +N + + +GLEYL
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT-------------- 640
H +IHRD+K+ NILL D ++ADFG LT + +
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 641 ----DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696
K D+ + GI+ +E+ G Y + PP AL LI + + P
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPY-LRE-PP---LRALFLITTKGIPPLKN-----P 239
Query: 697 RNVEPLFKLADIAELAIRENPSELPT 722
P FK D + ++P + P+
Sbjct: 240 EKWSPEFK--DFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFE-----MELEVLC 535
+ + ELG G+ G V K + G+ +AVK I I E EL++L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKT------IRLEINEAIQKQILRELDILH 54
Query: 536 NIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE 595
IV G G+ + E+M G+L L + + KI++ KGL
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLT 114
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT-----------------SCER-- 636
YLH+ IIHRDVK NIL++S ++ DFG+ + ER
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQ 172
Query: 637 DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG 671
+KSD+ + G+ L+E+ +GR Y E PP
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.9 bits (242), Expect = 8e-22
Identities = 71/278 (25%), Positives = 113/278 (40%), Gaps = 42/278 (15%)
Query: 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRH-S 540
++ +LG GS+G VY A D + VA+K + E F E+++L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLH 598
NIV L + + G LV E++ G+L D L G PL+ S L I Q LEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 599 KDAAPPIIHRDVKTLNILLDSD-WGARIADFGLLTSCERDLTT----------------- 640
IIHRD+K NILLD D ++ DFGL +T
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 641 -------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA 687
SD+ + GI L E+L+G ++ E + +++ +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQ 725
+ + P + D+ + + ++P + S
Sbjct: 236 ASPLSPSNPELISKAAS--DLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 46/281 (16%)
Query: 490 LGRGSYGFVYKAV---LVD--GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
LG+G++G V L D G VAVK+ +T H +R+FE E+E+L +++H NIV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--LRDFEREIEILKSLQHDNIVK 69
Query: 545 LLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
G C G R LV E++P G+L D+L L+ L + Q KG+EYL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERDL------------------TTDM 642
+HRD+ T NIL++S+ +I DFGL + +++ T+
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 643 K----SDVHNFGIVLLEILSGRKAY-DIEYVPPGIVEWALPLIKQGKAAA-----IIDRN 692
K SDV +FG+VL E+ + Y D PP + KQG+ ++ N
Sbjct: 187 KFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242
Query: 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
LP ++ I + +PS+ P+ S++A +E I
Sbjct: 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 62/192 (32%), Positives = 88/192 (45%), Gaps = 34/192 (17%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH---------TNIREFEMELEVLCNIRH 539
LG G+YG VYKA G VA+K+ I T +RE + +L ++H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKK-----IRLDNEEEGIPSTALRE----ISLLKELKH 57
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
NIV LL + LV+E+ L +L PL+ +L I Q +GL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH- 115
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLL----- 654
+ I+HRD+K NIL++ D ++ADFGL R +++ H +V L
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGL----ARAFGIPLRTYTHE--VVTLWYRAP 167
Query: 655 EILSGRKAYDIE 666
EIL G K Y
Sbjct: 168 EILLGSKHYSTA 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 45/201 (22%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAAT------IIHTNIREFEMELEVLCNIRHS 540
++G G+YG VYKA G VA+K+ I T IRE +++L +RH
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPI--TAIRE----IKLLQKLRHP 58
Query: 541 NIVNLLGYCLEM--GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM--------QA 590
NIV L G +V+E+M HD L+ L S +K + Q
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HD-----LTGLLDSPEVKFTESQIKCYMKQL 109
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFG 650
+GL+YLH + I+HRD+K NIL+++D ++ADFGL + + D + V
Sbjct: 110 LEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV---- 162
Query: 651 IVLL-----EILSGRKAYDIE 666
+ L E+L G Y E
Sbjct: 163 -ITLWYRPPELLLGATRYGPE 182
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 70/291 (24%), Positives = 112/291 (38%), Gaps = 75/291 (25%)
Query: 489 ELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
ELG+GS+G VY+ + +VA+K N + I EF E V+ ++
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHV 71
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHL---------HGGLSPLNWSLRLKISMQAAKG 593
V LLG L+V E M +G L +L + GL P ++++ + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------- 640
+ YL AA +HRD+ N ++ D +I DFG+ RD+
Sbjct: 132 MAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGM----TRDIYETDYYRKGGKGLLP 184
Query: 641 --------------DMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKA 685
KSDV +FG+VL E+ + + Y QG +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY------------------QGLS 226
Query: 686 AA-----IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731
+ID L KL ++ + + NP PT ++ + L+
Sbjct: 227 NEEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 50/146 (34%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN---IREFEMELEVLCNIRHSNIVNL 545
LG GS+G VY+ + L DG AVK + A T +++ E E+ +L ++H NIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 546 LGYCLEMGERLLVY-EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
LG E + L ++ E +P G+L L + + Q GLEYLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--- 122
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL 630
+HRD+K NIL+D++ ++ADFG+
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGM 148
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 31/195 (15%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549
+G+G++G VYK VL +VAVK + T+ R+F E E+L H NIV L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRS-TLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 550 LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRD 609
++ +V E +P G+L L + L L++S+ AA G+EYL + IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 610 VKTLNILLDSDWGARIADFGLLTSCERD-----LTTDMK--------------------S 644
+ N L+ + +I+DFG+ S E + ++ +K S
Sbjct: 119 LAARNCLVGENNVLKISDFGM--SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 645 DVHNFGIVLLEILSG 659
DV ++GI+L E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 48/211 (22%)
Query: 490 LGRGSYGFVYKAV-LVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
LG G++G VYK V + +G + VA+K T +E E V+ ++ H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVR 73
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLH------GGLSPLNWSLRLKISMQAAKGLEYL 597
LLG C + ++ L+ + MP G L D++ G LNW + Q AKG+ YL
Sbjct: 74 LLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------QIAKGMSYL 125
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------- 640
+ ++HRD+ N+L+ + +I DFGL + D
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 641 ------DMKSDVHNFGIVLLEILS-GRKAYD 664
KSDV ++G+ + E+++ G K Y+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 60/174 (34%), Positives = 89/174 (51%), Gaps = 31/174 (17%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKR----ANAATIIHTNIREFEMELEVLCNIR 538
++E E+G G+YG VYKA L GR VA+K+ + I + +RE + L+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFE 59
Query: 539 HSNIVNLLGYCL-EMGER----LLVYEFMPRGTLHDHLH----GGLSPLNWSLRLKISMQ 589
H NIV LL C +R LV+E + + L +L GL P +++ + Q
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP--ETIK-DLMRQ 115
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---------LTSC 634
+G+++LH I+HRD+K NIL+ SD +IADFGL LTS
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 49/151 (32%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHT----NIREFEMELEVLCNIR 538
++ +G G+YG VYKA + G VA+K +I + + E+ +L R
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIK------VIKLEPGDDFEIIQQEISMLKECR 58
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
H NIV G L + +V E+ G+L D PL+ + + KGL YLH
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
+ IHRD+K NILL D ++ADFG
Sbjct: 119 ETG---KIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 36/202 (17%)
Query: 485 KEF---NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
+EF +LG G +G V++ + + +VA+K + ++ ++F+ E++ L +RH +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK--QQDFQKEVQALKRLRHKH 63
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR----LKISMQAAKGLEYL 597
+++L C ++ E M +G+L L SP L + ++ Q A+G+ YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLR---SPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--LTTD-------------- 641
IHRD+ NIL+ D ++ADFGL + D L++D
Sbjct: 121 E---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 642 -----MKSDVHNFGIVLLEILS 658
KSDV +FGI+L E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 38/202 (18%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN----IREFEMELEVLCNIRHSNIVN 544
ELG G++G VYKA + A AA II + +F +E+++L +H NIV
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFA-----AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L + ++ EF G L + L + Q + L +LH +
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL------------------------LTSCE--RDL 638
+IHRD+K NILL D ++ADFG+ + +CE +D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 639 TTDMKSDVHNFGIVLLEILSGR 660
D K+D+ + GI L+E+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 77/285 (27%), Positives = 115/285 (40%), Gaps = 60/285 (21%)
Query: 490 LGRGSYGFVYKAVLV--DGRQ--VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG G +G V + L DG Q VAVK ++ I EF E + + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 546 LGYCLEMGER------LLVYEFMPRGTLHDHL---HGGLSPLNWSLR--LKISMQAAKGL 594
+G C E +++ FM G LH L G P L+ LK + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL------------------------ 630
EYL + IHRD+ N +L D +ADFGL
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 631 LTSCERDLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWAL-PLIKQGKAAAI 688
+ S + T KSDV FG+ + EI + G+ Y PG+ + ++ G
Sbjct: 184 IESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY------PGVENHEIYDYLRHGN---- 232
Query: 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
L + + L +L D+ R +P + PT +++ LE I
Sbjct: 233 -----RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 50/217 (23%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ ++G+GS+G VY DG+ +K + + + + E+++L + H NI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLH-----GGLSP----LNWSLRLKISMQAAKG 593
+ E G+ +V E+ G L + G P L+W + Q
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV------QLCLA 115
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTTDM-------- 642
L+YLH I+HRD+K NI L S+ ++ DFG+ L+S T D+
Sbjct: 116 LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-----TVDLAKTVVGTP 167
Query: 643 ---------------KSDVHNFGIVLLEILSGRKAYD 664
KSD+ + G VL E+ + + ++
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 61/193 (31%), Positives = 86/193 (44%), Gaps = 30/193 (15%)
Query: 488 NELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
++LG G YG VY+ V VAVK T+ + EF E V+ I+H N+V LL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHLH-GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
G C ++ EFM G L D+L +N + L ++ Q + +EYL K
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMK 643
IHRD+ N L+ + ++ADFGL D T +K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 644 SDVHNFGIVLLEI 656
SDV FG++L EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 482 NGFKEFNELGRGSYGFVYKA-VLVDGRQVAVKR---ANAATIIH-TNIREFEMELEVLCN 536
N ++ +G G+YG V K G VA+K+ + + T +RE ++VL
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALRE----VKVLRQ 56
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKG 593
+RH NIVNL G LV+E++ R TL + L GGL P ++R Q +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD--AVRS-YIWQLLQA 112
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
+ Y H IIHRD+K NIL+ ++ DFG
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 82/268 (30%), Positives = 127/268 (47%), Gaps = 49/268 (18%)
Query: 490 LGRGSYGFVYKAVLVD--GRQVAVK-RANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
+G+G +G V +L D G +VAVK N AT + F E V+ +RHSN+V LL
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQLL 65
Query: 547 GYCLE-MGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
G +E G +V E+M +G+L D+L G S L LK S+ + +EYL +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--- 122
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLL----------------TSCE--RDLTTDMKSDV 646
+HRD+ N+L+ D A+++DFGL T+ E R+ KSDV
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 647 HNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705
+FGI+L EI S GR Y P ++ +P +++G + P P+ +
Sbjct: 183 WSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKG-------YKMDAPDGCPPV--V 228
Query: 706 ADIAELAIRENPSELPTMSQVATWLEQI 733
D+ + + + P+ Q+ LE I
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 84/301 (27%), Positives = 127/301 (42%), Gaps = 84/301 (27%)
Query: 490 LGRGSYGFVYKAVLVD-----GRQ-VAVK--RANAATIIHTNIREFEMELEVLCNI-RHS 540
LG G++G V KA V VAVK + +A ++ + E+E++ I +H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHK 76
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG-----------GLSPLNWSLRLK---- 585
NI+NLLG C + G +V E+ G L D L P +L K
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL------- 638
+ Q A+G+E+L A+ IHRD+ N+L+ D +IADFGL RD+
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHIDYYR 189
Query: 639 -TTD-------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWAL 677
TT+ +SDV +FG++L EI + G Y PGI L
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY------PGIPVEEL 243
Query: 678 -PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAI---RENPSELPTMSQVATWLEQI 733
L+K+G R +P ++ L E PS+ PT Q+ L+++
Sbjct: 244 FKLLKEGY------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
Query: 734 V 734
+
Sbjct: 292 L 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 64/222 (28%)
Query: 489 ELGRGSYGFVYKAVLV------DGRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHS 540
ELG G++G VYK L VA+K + NA + EF E E++ +++H
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHP 68
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRLK 585
NIV LLG C + +++E++ G LH+ L S L+ S L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL------- 638
I++Q A G+EYL ++ +HRD+ N L+ +I+DFGL RD+
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGL----SRDIYSADYYR 181
Query: 639 ----------------------TTDMKSDVHNFGIVLLEILS 658
TT+ SD+ +FG+VL EI S
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTE--SDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 470 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFE 528
+VF + E LG GSYG VYKA+ G+ VA+K + +++E
Sbjct: 3 EVFDILEK------------LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEII 46
Query: 529 MELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM 588
E+ +L IV G + + +V E+ G++ D + L I
Sbjct: 47 KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY 106
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT----- 640
Q KGLEYLH + IHRD+K NILL+ + A++ADFG+ LT T
Sbjct: 107 QTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP 163
Query: 641 -------------DMKSDVHNFGIVLLEILSGRKAY 663
+ K+D+ + GI +E+ G+ Y
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 80/295 (27%), Positives = 129/295 (43%), Gaps = 76/295 (25%)
Query: 490 LGRGSYGFVYKAVLV-DGRQV--AVK--RANAATIIHTNIREFEMELEVLCNI-RHSNIV 543
+G G++G V +A++ DG ++ A+K + A+ H R+F ELEVLC + H NI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH---RDFAGELEVLCKLGHHPNII 66
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRLKISM 588
NLLG C G + E+ P G L D L HG S L L+ +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------ 642
A G++YL + IHRD+ N+L+ + ++IADFGL E + M
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 643 --------------KSDVHNFGIVLLEILS-------GRKAYDI-EYVPPGIVEWALPLI 680
KSDV +FG++L EI+S G ++ E +P G
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-------- 235
Query: 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
+ PRN + ++ ++ R+ P E P +Q++ L ++++
Sbjct: 236 -----------RMEKPRNCDD--EVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 81/295 (27%), Positives = 127/295 (43%), Gaps = 76/295 (25%)
Query: 490 LGRGSYGFVYKAVLV-DGRQV--AVK--RANAATIIHTNIREFEMELEVLCNI-RHSNIV 543
+G G++G V KA + DG ++ A+K + A+ H R+F ELEVLC + H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNII 59
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRLKISM 588
NLLG C G L E+ P G L D L + S L+ L +
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------ 642
A+G++YL + IHRD+ NIL+ ++ A+IADFGL E + M
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 643 --------------KSDVHNFGIVLLEILS-------GRKAYDI-EYVPPGIVEWALPLI 680
SDV ++G++L EI+S G ++ E +P G
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-------- 228
Query: 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
+ P N + ++ D+ RE P E P+ +Q+ L ++++
Sbjct: 229 -----------RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTN-IREFEMELEVLCNI-RHS 540
FK +G GS+ V A ++ A+K + +I ++ ++E EVL + H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 541 NIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYL 597
I+ L Y + E L V E+ P G L ++ G L R + + LEYL
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK--CTRFYAA-EILLALEYL 118
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
H IIHRD+K NILLD D +I DFG
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFG 147
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 490 LGRGSYGFVYKA-VLVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIRHSNIVN 544
+G G++G V+KA G VA+K+ I + +RE ++ L +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
LL +LV E+MP L + L PL + KG+ Y+H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--- 119
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYD 664
I+HRD+K N+L+ +D +IADFGL + V E+L G + YD
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 665 IEYVPPGIVEWALPLI 680
PG+ WA+ I
Sbjct: 180 -----PGVDLWAVGCI 190
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNI--REFEMELEVLCNIRHSNIVNLLG 547
+G G +G V + G++VAVK I ++ + F E V+ + H N+V LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK------NIKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
L G +V E M +G L + L G + ++ L+ S+ A+G+EYL + ++
Sbjct: 67 VILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLV 122
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------------------KSDVHN 648
HRD+ NIL+ D A+++DFGL + KSDV +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 649 FGIVLLEILS-GRKAY 663
+G++L E+ S GR Y
Sbjct: 183 YGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 47/210 (22%)
Query: 490 LGRGSYGFVYKA-VLVDGRQV--AVKRAN--AATIIHTNIREFEMELEVLCNI-RHSNIV 543
+G G++G V KA + DG ++ A+KR A+ H R+F ELEVLC + H NI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNII 71
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRLKISM 588
NLLG C G L E+ P G L D L + S L+ L +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------ 642
A+G++YL + IHRD+ NIL+ ++ A+IADFGL E + M
Sbjct: 132 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 643 --------------KSDVHNFGIVLLEILS 658
SDV ++G++L EI+S
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 29/199 (14%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
E+G G +G V+ ++ R+VA+K + +F E +V+ + H +V L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
C E LV+EFM G L D+L + L + + +G+ YL +IHR
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKSDV 646
D+ N L+ + +++DFG+ D T KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 647 HNFGIVLLEILS-GRKAYD 664
+FG+++ E+ S G+ Y+
Sbjct: 185 WSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 53/153 (34%), Positives = 70/153 (45%), Gaps = 26/153 (16%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLG 547
LG+GS+G V D G+ A+K II + E +L I H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYLH 598
Y + E+L LV E+ P G L HL S + S + A+ LEYLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---------SKEGRFSEERARFYAAEIVLALEYLH 110
Query: 599 -KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
II+RD+K NILLD+D ++ DFGL
Sbjct: 111 SLG----IIYRDLKPENILLDADGHIKLTDFGL 139
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ +G G+ VY A+ + +VA+KR + T++ E E++ + H N+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHPNV 61
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHL-----HGGLSPLNWSLRLKISMQAAKGLEYL 597
V + E LV ++ G+L D + GGL + LK + KGLEYL
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---EVLKGLEYL 118
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL-------------------TSC---- 634
H + IHRD+K NILL D +IADFG+ T C
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 635 ---ERDLTTDMKSDVHNFGIVLLEILSGRKAY 663
E+ D K+D+ +FGI +E+ +G Y
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 37/207 (17%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
K +LG G +G V + D G QVAVK + +I + + E+E+L N+
Sbjct: 6 LKRIRDLGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNL 63
Query: 538 RHSNIVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE 595
H NIV G C E G L+ EF+P G+L ++L + +N +LK ++Q KG++
Sbjct: 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-----LTTDMK------- 643
YL + +HRD+ N+L++S+ +I DFGL + E D + D+
Sbjct: 124 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 644 ------------SDVHNFGIVLLEILS 658
SDV +FG+ L E+L+
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 49/152 (32%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVK----RANAATIIHTNIREFEMELEVLCNIR 538
+++ ++G G+YG VYKA + G VA+K R + I T +RE ++ E+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL----N 56
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
H NI+ LL G+ LV+EFM L+ + L SL Q +GL + H
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
I+HRD+K N+L++++ ++ADFGL
Sbjct: 116 SHG---ILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 51/195 (26%), Positives = 80/195 (41%), Gaps = 28/195 (14%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
ELG G +G V+ VA+K + + +F E +V+ + H N+V L G
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
C + +V E+M G L ++L L L + + +EYL + IHR
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKSDV 646
D+ N L+ D +++DFGL D T KSDV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 647 HNFGIVLLEILSGRK 661
+FG+++ E+ S K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 43/175 (24%)
Query: 480 ATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH--------TNIREFEME 530
++ +LG G++G VYKA + GR VA+K+ ++H T +RE
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK----ILMHNEKDGFPITALRE---- 57
Query: 531 LEVLCNIRHSNIVNLLGYCLEM---------GERLLVYEFMPRGTLHDHLHGGLSPLNWS 581
+++L ++H N+V L+ +M +R VY P HD L G L N S
Sbjct: 58 IKILKKLKHPNVVPLI----DMAVERPDKSKRKRGSVYMVTPY-MDHD-LSGLLE--NPS 109
Query: 582 LRLKIS------MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
++L S +Q +G+ YLH++ I+HRD+K NIL+D+ +IADFGL
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 75/268 (27%), Positives = 117/268 (43%), Gaps = 44/268 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549
LG G +G V+ +VAVK T+ + F E +++ +RH +V L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 550 LEMGERLLVYEFMPRGTLHDHLH-GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
E +V E+M +G+L D L G L + ++ Q A+G+ YL IHR
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKSDV 646
D+ NIL+ + +IADFGL E D T +KSDV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 647 HNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705
+FGI+L EI++ GR Y PG+ +++Q ++R +PR +L
Sbjct: 188 WSFGILLTEIVTYGRVPY------PGMTN--REVLEQ------VERGYRMPRPPNCPEEL 233
Query: 706 ADIAELAIRENPSELPTMSQVATWLEQI 733
D+ ++P E PT + ++LE
Sbjct: 234 YDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 54/161 (33%), Positives = 77/161 (47%), Gaps = 32/161 (19%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVK------RANAATIIH-TNIREFEMELEVLCNIRHSN 541
LG G+Y VYKA GR VA+K R A I+ T +RE +++L ++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALRE----IKLLQELKHPN 63
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPL--NWSLRLK------ISMQAAKG 593
I+ LL LV+EFM L + + S+ L + +G
Sbjct: 64 IIGLLDVFGHKSNINLVFEFM---------ETDLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
LEYLH + I+HRD+K N+L+ SD ++ADFGL S
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 44/249 (17%)
Query: 484 FKEFNELGRGSYGFV----YKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIR 538
K+ LG G +G V Y G VAVK N ++ E+ +L +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLY 64
Query: 539 HSNIVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
H NIV G C E G + L+ E++P G+L D+L LN + L + Q +G+ Y
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAY 122
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL------------------------T 632
LH + IHRD+ N+LLD+D +I DFGL
Sbjct: 123 LH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 633 SCERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG----IVEWALPLIKQGKAAAI 688
C ++ SDV +FG+ L E+L+ D + PP ++ + + +
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236
Query: 689 IDRNVALPR 697
++R + LP
Sbjct: 237 LERGMRLPC 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 44/266 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549
LG G +G V++ + + VAVK T+ + ++F E +++ +RH ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 550 LEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
+V E M G+L ++L G L + ++ Q A G+ YL IHR
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKSDV 646
D+ N+L+ + ++ADFGL + D+ +KSDV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 647 HNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705
+FGI+L EI++ GR Y PG+ + +D+ +P +L
Sbjct: 188 WSFGILLTEIVTYGRMPY------PGMT--------NAEVLQQVDQGYRMPCPPGCPKEL 233
Query: 706 ADIAELAIRENPSELPTMSQVATWLE 731
DI +E+P + PT + LE
Sbjct: 234 YDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 47/144 (32%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 488 NELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
N++G G++G VY AV +D G +AVK I+E E++VL ++H N+V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
G + + + E+ GTL + L HG + + ++Q +GL YLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLHSHG---I 120
Query: 606 IHRDVKTLNILLDSDWGARIADFG 629
+HRD+K NI LD + ++ DFG
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFG 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 64/209 (30%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 488 NELGRGSYGFVYKAVLV--DGRQ--VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G++G V K V + G++ VAVK I +EF E V+ + H IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIV 59
Query: 544 NLLGYCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISM-QAAKGLEYLHK 599
L+G C GE L LV E P G L +L + + LK Q A G+ YL
Sbjct: 60 RLIGVCK--GEPLMLVMELAPLGPLLKYLKKRREIPVSD----LKELAHQVAMGMAYLES 113
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS------------------------CE 635
+HRD+ N+LL + A+I+DFG+ + C
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 636 RDLTTDMKSDVHNFGIVLLEILS-GRKAY 663
KSDV ++G+ L E S G K Y
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 56/199 (28%), Positives = 83/199 (41%), Gaps = 34/199 (17%)
Query: 489 ELGRGSYGFVYKAVLVD--GR--QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+LG GS+G V + G+ VAVK + + + +F E ++ ++ H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLH-GGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G L ++V E P G+L D L L S ++Q A G+ YL
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTS------------------------CERDLT 639
IHRD+ NILL SD +I DFGL+ + R T
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 640 TDMKSDVHNFGIVLLEILS 658
SDV FG+ L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 34/210 (16%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQV----AVKRANAATIIHTNIREFEMELEVLCNIR 538
K LG G++G VYK + V +G V A+K N T N+ EF E ++ ++
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALIMASMD 67
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
H ++V LLG CL +L V + MP G L D++H + L L +Q AKG+ YL
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFG---LLTSCERDLTTD-------------- 641
+ ++HRD+ N+L+ S +I DFG LL E++ D
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 642 ------MKSDVHNFGIVLLEILS-GRKAYD 664
+SDV ++G+ + E+++ G K YD
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 49/146 (33%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRAN---AATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG+G++G VY VD GR++A K+ + + E E+++L N++H IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 546 LGYCLEMGERLLV--YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
G + E+ L E+MP G++ D L L S+ K + Q +G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNM-- 126
Query: 604 PIIHRDVKTLNILLDSDWGARIADFG 629
I+HRD+K NIL DS ++ DFG
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 65/223 (29%), Positives = 95/223 (42%), Gaps = 49/223 (21%)
Query: 477 LKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVL- 534
L D T F+ +G G+YG VYKA G+ VA+K + II E + E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILR 57
Query: 535 --CNIRHSNIVNLLGYCLEMGERL------LVYEFMPRGTLHDHLHGGLSPLNWSLRLK- 585
N H NI G ++ LV E G++ D L GL L+ +
Sbjct: 58 KYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEW 114
Query: 586 ---ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTS------ 633
I + +GL YLH++ +IHRD+K NILL + ++ DFG+ L S
Sbjct: 115 IAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 634 ---------------CE--RDLTTDMKSDVHNFGIVLLEILSG 659
C+ D + D +SDV + GI +E+ G
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 46/216 (21%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIR 538
FK+ LG G++G VYK + + +G + VA+K AT N +E E V+ ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVD 67
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH------GGLSPLNWSLRLKISMQAAK 592
+ ++ LLG CL +L + + MP G L D++ G LNW + Q AK
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAK 120
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG---LLTSCERDLTTD-------- 641
G+ YL + ++HRD+ N+L+ + +I DFG LL + E++ +
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 642 ------------MKSDVHNFGIVLLEILS-GRKAYD 664
+SDV ++G+ + E+++ G K YD
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 81/284 (28%), Positives = 119/284 (41%), Gaps = 69/284 (24%)
Query: 490 LGRGSYGFVYKAVLVD-GR-----QVAVKRANAATIIHTNIREFEM-ELEVLCNI-RHSN 541
LG G++G V +A + +VAVK H++ RE M EL+++ ++ H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHEN 100
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKD 600
IVNLLG C G L++ E+ G L + L S L L S Q AKG+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL--- 157
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------- 641
A+ IHRD+ N+LL +I DFGL RD+ D
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGL----ARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 642 --------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWAL--PLIKQGKAAAIID 690
+SDV ++GI+L EI S G Y PG+ + LIK+G
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNPY------PGMPVDSKFYKLIKEGY------ 261
Query: 691 RNVALPRNVEPLFKLADIAELAIR---ENPSELPTMSQVATWLE 731
R +P A+I ++ +P + PT Q+ +
Sbjct: 262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 68/201 (33%), Positives = 99/201 (49%), Gaps = 25/201 (12%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRAN---AATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG+G++G VY D GR++AVK+ + + E E+++L N+ H IV
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 546 LGYCLEMGERLL--VYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
G + ER L E MP G++ D L +G L+ ++ K + Q +G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLHSNM 126
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTTDMKSDVHNFGIVLLEIL 657
I+HRD+K NIL DS ++ DFG L T C T MKS + E++
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG--TGMKSVTGTPYWMSPEVI 181
Query: 658 S----GRKAYDIEYVPPGIVE 674
S GRKA DI V +VE
Sbjct: 182 SGEGYGRKA-DIWSVGCTVVE 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEM-----ELEVLCNIR 538
++ +GRG+YG VY+ G+ V R A II+ + + ++ E+ +L +R
Sbjct: 3 YQRLELIGRGAYGAVYR-----GKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR 57
Query: 539 HSNIVNLLGY--CLEMGERL-LVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGL 594
S N+ Y G RL ++ E+ G++ + G ++ S+ ++ + A L
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA---L 114
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG---LLTSCERDLTT----------- 640
+Y+HK +IHRD+K NIL+ + ++ DFG LL +T
Sbjct: 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 641 --------DMKSDVHNFGIVLLEILSGRKAY 663
D K+D+ + GI + E+ +G Y
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 46/212 (21%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRAN-AATIIHTN-------IREFEMELEVLCNIRHS 540
+G+G+YG VY A+ V G +AVK+ ATI + ++ E+E L ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 541 NIVNLLGYCLEMGERLL--VYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEY 596
NIV LG+ E E L E++P G++ L +G L + Q +GL Y
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTEQVLEGLAY 123
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE----RDLTTDM---------- 642
LH I+HRD+K N+L+D+D +I+DFG+ + D M
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 643 -----------KSDVHNFGIVLLEILSGRKAY 663
K D+ + G V+LE+ +GR+ +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 52/149 (34%), Positives = 82/149 (55%), Gaps = 16/149 (10%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRAN---AATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LGRG++G VY D GR++AVK+ + + E E+++L N+RH IV
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 546 LGYCLEMGE--RLLVY-EFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
G CL E +L ++ E+MP G++ D L +G L+ ++ + + Q +G+ YLH +
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE---NVTRRYTRQILQGVSYLHSN 125
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFG 629
I+HRD+K NIL DS ++ DFG
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 56/217 (25%)
Query: 489 ELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
ELG G++G V+ A D VAVK A+ + ++F+ E E+L ++H +I
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHI 69
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHL--HG------------GLSPLNWSLRLKISM 588
V G C E L+V+E+M G L+ L HG L L I+
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD------ 641
Q A G+ YL A+ +HRD+ T N L+ +I DFG+ RD+ +TD
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDYYRVGG 182
Query: 642 --------------------MKSDVHNFGIVLLEILS 658
+SD+ +FG+VL EI +
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-15
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 477 LKDATNGFKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEMELEVLC 535
+ D + KE N + RG G YK + +G Q VK N I E+ +
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMG 738
Query: 536 NIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE 595
++H NIV L+G C L++E++ L + L L+W R KI++ AK L
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALR 794
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARI---------ADFGLLTSC-----ERDLTTD 641
+LH +P ++ ++ I++D + D S E T D
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKD 854
Query: 642 M--KSDVHNFGIVLLEILSGRKAYDIEY-VPPGIVEWA 676
+ KSD++ FG++L+E+L+G+ D E+ V IVEWA
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892
|
Length = 968 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 41/213 (19%)
Query: 485 KEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN-- 541
K+ E+GRG++G V K + G +AVKR + T+ + M+L+V+ +R S+
Sbjct: 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRS-TVDEKEQKRLLMDLDVV--MRSSDCP 63
Query: 542 -IVNLLGYCLEMGERLLVYEFMPRG------TLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
IV G G+ + E M +++ L S + + KI++ K L
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK---SVIPEEILGKIAVATVKAL 120
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTS--------C------ER 636
YL ++ IIHRDVK NILLD + ++ DFG L+ S C ER
Sbjct: 121 NYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 178
Query: 637 DLTT-----DMKSDVHNFGIVLLEILSGRKAYD 664
+ D++SDV + GI L E+ +G+ Y
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 47/275 (17%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
K +LG G +G V+ +VA+K ++ + F E ++ ++H
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPR 62
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHK 599
+V L Y + E + ++ E+M G+L D L L + + ++ Q A+G+ ++ +
Sbjct: 63 LVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------- 640
IHRD++ NIL+ +IADFGL E + T
Sbjct: 121 KNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 641 ---DMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696
+KSDV +FGI+L EI++ GR Y PG+ P + Q ++R +P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY------PGMTN---PEVIQN-----LERGYRMP 223
Query: 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731
R +L ++ L +E P E PT + + LE
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 62/224 (27%)
Query: 489 ELGRGSYGFVYKAV---LVDGRQ---VAVK--RANAATIIHTNIREFEMELEVLCNIRHS 540
++G+G++G V++A L+ VAVK + A+ + +F+ E ++ H
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAALMAEFDHP 68
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH---------------------GGLSPLN 579
NIV LLG C L++E+M G L++ L PL+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--------- 630
+ +L I+ Q A G+ YL + +HRD+ T N L+ + +IADFGL
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 631 LTSCERDL----------------TTDMKSDVHNFGIVLLEILS 658
+ E D TT+ SDV +G+VL EI S
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTE--SDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 64/259 (24%)
Query: 489 ELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
ELG G++G V+ A D VAVK T+ ++F+ E E+L N++H +I
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHI 69
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHL--HG-------------GLSPLNWSLRLKIS 587
V G C + ++V+E+M G L+ L HG L S L I+
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD----- 641
Q A G+ YL A+ +HRD+ T N L+ ++ +I DFG+ RD+ +TD
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM----SRDVYSTDYYRVG 182
Query: 642 ---------------------MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI 680
+SDV +FG++L EI + K + ++E I
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----CI 238
Query: 681 KQGKAAAIIDRNVALPRNV 699
QG+ +++R P+ V
Sbjct: 239 TQGR---VLERPRVCPKEV 254
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 53/271 (19%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+LG+G +G V+ +VA+K T+ + F E +V+ +RH +V L Y
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 549 CLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRL----KISMQAAKGLEYLHKDAAP 603
+ E + +V E+M +G+L D L G + LRL ++ Q A G+ Y+ +
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVER---M 121
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------D 641
+HRD++ NIL+ + ++ADFGL E + T
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 642 MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
+KSDV +FGI+L E+ + GR Y PG+V ++ Q ++R +P E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPY------PGMVN--REVLDQ------VERGYRMPCPPE 227
Query: 701 PLFKLADIAELAIRENPSELPTMSQVATWLE 731
L D+ R+ P E PT + +LE
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 42/270 (15%)
Query: 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
K +LG G +G V+ + +VAVK T+ +++ F E ++ ++H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVR 65
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L + ++ E+M +G+L D L + + S Q A+G+ Y+ +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------D 641
IHRD++ N+L+ +IADFGL E + T
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701
+KSDV +FGI+L EI++ K I Y P + + + R +PR
Sbjct: 183 IKSDVWSFGILLYEIVTYGK---IPY----------PGMSNSDVMSALQRGYRMPRMENC 229
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLE 731
+L DI + +E E PT + + L+
Sbjct: 230 PDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 483 GFKEFNELGRGSYGFVYKAVL---VDGRQVAVK-----RANAATIIHTNIREFEMELEVL 534
++ +GRG+YG VYKA DG++ A+K + I + RE + E
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE-- 58
Query: 535 CNIRHSNIVNLLGYCLEMGERL--LVYEFMPR---GTLHDHLHGGLSPLNWSLRLKISMQ 589
++H N+V+L+ LE ++ L++++ + H + S+ + Q
Sbjct: 59 --LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR----IADFGL 630
G+ YLH + ++HRD+K NIL+ + R I D GL
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 43/265 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F +G+GS+G VYKA+ + VA+K + I + + E++ L R I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-DEIEDIQQEIQFLSQCRSPYI 61
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
G L+ G +L ++ E+ G+ D L G L+ + I + GLEYLH++
Sbjct: 62 TKYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG 118
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL-----LTSCERDLTT---------------- 640
IHRD+K NILL + ++ADFG+ T +R+
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 641 DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
D K+D+ + GI +E+ G + P L LI + ++ +
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLS-DLHPMR----VLFLIPKNNPPSLEGNKFS------ 224
Query: 701 PLFKLADIAELAIRENPSELPTMSQ 725
FK D L + ++P E P+ +
Sbjct: 225 KPFK--DFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 23/158 (14%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIR 538
F++ N +G G+YG VY+A G VA+K+ I +++RE + +L N+R
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLR 64
Query: 539 HSNIVNLLGYCLEMGERL----LVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISMQAAK 592
H NIV L + +G+ L LV E+ + +L D++ +P + S + +Q +
Sbjct: 65 HPNIVELKE--VVVGKHLDSIFLVMEYCEQDLASLLDNMP---TPFSESQVKCLMLQLLR 119
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GL+YLH++ IIHRD+K N+LL +IADFGL
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGL 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 44/214 (20%)
Query: 483 GFKEFNELGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTN-IREFEMELEVLCNIRHS 540
F+ +G+G++G V D +++ A+K N + +R E +L + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 541 NIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK------- 592
+VNL Y + E + LV + + G L HL S ++K S + K
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL---------SQKVKFSEEQVKFWICEIV 110
Query: 593 -GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-LTTDM-------- 642
LEYLH IIHRD+K NILLD I DF + T D LTT
Sbjct: 111 LALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMA 167
Query: 643 ----KSDVHNF-------GIVLLEILSGRKAYDI 665
++ G+ E L G++ Y
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 40/201 (19%)
Query: 489 ELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIR-EFEMELEVLCNIRHSN 541
ELG G++G V+ A D VAVK A+ N R +F E E+L N++H +
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEH 68
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HG--------GLSP--LNWSLRLKISMQ 589
IV G C+E ++V+E+M G L+ L HG G P L S L I+ Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNF 649
A G+ YL A+ +HRD+ T N L+ + +I DFG+ RD+ + +D +
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGM----SRDVYS---TDYYRV 178
Query: 650 GIVLLEILSGRKAYDIEYVPP 670
G G I ++PP
Sbjct: 179 G--------GHTMLPIRWMPP 191
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 44/204 (21%)
Query: 490 LGRGSYGFVYKAVLVDG----RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
+G+G +G VY L+D AVK N T + + +F E ++ + H N+++L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-EVEQFLKEGIIMKDFSHPNVLSL 61
Query: 546 LGYCL-EMGERLLVYEFMPRGTLHDHLHGGLSPL-NWSLRLKIS--MQAAKGLEYLHKDA 601
LG CL G L+V +M G L + + S N +++ I +Q AKG+EYL A
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIR---SETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL--------------------------LTSCE 635
+ +HRD+ N +LD + ++ADFGL L S +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 636 -RDLTTDMKSDVHNFGIVLLEILS 658
+ TT KSDV +FG++L E+++
Sbjct: 176 TQKFTT--KSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 64/287 (22%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG+G +G V +A L ++VAVK A ++I EF E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 546 LGYCLEMGER------LLVYEFMPRGTLHDHL---HGGLSPLNWSLR--LKISMQAAKGL 594
+G L + +++ FM G LH L G P L+ ++ + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL------------------------ 630
EYL ++ IHRD+ N +L+ + +ADFGL
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 631 LTSCERDLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689
L S ++ T SDV FG+ + EI++ G+ Y G+ + + I
Sbjct: 184 LESLADNVYT-THSDVWAFGVTMWEIMTRGQTPY------AGV-----------ENSEIY 225
Query: 690 DRNVALPRNVEPLFKLADIAELAIR---ENPSELPTMSQVATWLEQI 733
+ + R +P L D+ EL + P P+ + LE I
Sbjct: 226 NYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G G+YG V A+ G++VA+K+ A + T + EL++L + +H NI+ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 549 CL----EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ + +V + M LH +H PL Q +GL+Y+H +
Sbjct: 73 LRPPGADFKDVYVVMDLM-ESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIH---SAN 127
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL 630
+IHRD+K N+L++ D RI DFG+
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGM 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 47/268 (17%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+LG+G +G V+ +VA+K T++ F E +++ +RH +V L Y
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP---EAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 549 CLEMGERL-LVYEFMPRGTLHDHLHGGLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPII 606
+ E + +V EFM +G+L D L G L + ++ Q A G+ Y+ + I
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYI 124
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKS 644
HRD++ NIL+ + +IADFGL E + T +KS
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 645 DVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703
DV +FGI+L E+++ GR Y PG+V +++Q ++R +P
Sbjct: 185 DVWSFGILLTELVTKGRVPY------PGMVN--REVLEQ------VERGYRMPCPQGCPE 230
Query: 704 KLADIAELAIRENPSELPTMSQVATWLE 731
L ++ +L +++P E PT + ++LE
Sbjct: 231 SLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 44/262 (16%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+GRG++G V+ D + V +K+ + + E +VL + H NI+
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
LE ++V E+ P GTL +++ S L+ L +Q L ++H I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124
Query: 608 RDVKTLNILLDSDWG-ARIADFGL---LTSCERDLTT-----------------DMKSDV 646
RD+KT NILLD +I DFG+ L+S + T + KSD+
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDI 184
Query: 647 HNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL-IKQGKAAAIIDR-NVALPRNVEPLFK 704
G VL E+ S ++A++ +P AL L I G A I DR + L + + +
Sbjct: 185 WALGCVLYELASLKRAFEAANLP------ALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238
Query: 705 LADIAELAIRENPSELPTMSQV 726
L +PS+ P +SQ+
Sbjct: 239 L----------DPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 44/201 (21%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN----IREFEMELEVLCNIRHSNIVN 544
ELG G++G VYKA ++ AA +I T + ++ +E+E+L H IV
Sbjct: 19 ELGDGAFGKVYKA---KNKETGA--LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHD---HLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
LLG G+ ++ EF P G + L GL+ + I Q + L+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLH--- 127
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL------------------------LTSCE-- 635
+ IIHRD+K N+LL D ++ADFG+ + CE
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 636 RDLTTDMKSDVHNFGIVLLEI 656
+D D K+D+ + GI L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKR----ANAATIIHTNIREFEMELEVLCNIR 538
+++ ++G G+YG VYKA + G VA+K+ + T IRE + +L +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELN 56
Query: 539 HSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEY 596
H NIV LL + +L LV+EF+ L ++ L+ L+ L Q +G+ Y
Sbjct: 57 HPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H ++HRD+K N+L+D + ++ADFGL
Sbjct: 115 CHSHR---VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 15/147 (10%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFE---MELEVLCNIRHSNIVNL 545
LG+G+YG VY A L ++A+K I + R + E+ + ++H NIV
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKE-----IPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPL--NWSLRLKISMQAAKGLEYLHKDAAP 603
LG E G + E +P G+L L PL N + + Q +GL+YLH +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-- 128
Query: 604 PIIHRDVKTLNILLDSDWGA-RIADFG 629
I+HRD+K N+L+++ G +I+DFG
Sbjct: 129 -IVHRDIKGDNVLVNTYSGVVKISDFG 154
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 64/220 (29%), Positives = 88/220 (40%), Gaps = 54/220 (24%)
Query: 490 LGRGSYGFVYKAVLVD------GRQ-VAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
LG G++G VY+ D G VAVK EF E ++ N H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHG------GLSPLNWSLRLKISMQAAKGLEY 596
V LLG CL + ++ E M G L +L G L L I + AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 597 LHKDAAPPIIHRDVKTLNILL-----DSDWGARIADFGLLTSCERDLTTD---------- 641
L + IHRD+ N L+ D+D +I DFGL RD+
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL----ARDIYKSDYYRKEGEGL 174
Query: 642 -----------------MKSDVHNFGIVLLEILS-GRKAY 663
+SDV +FG+++ EIL+ G++ Y
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 82/301 (27%)
Query: 490 LGRGSYGFVY--KAVLVDGRQ------VAVK--RANAATIIHTNIREFEMELEVLCNI-R 538
LG G +G V +A+ +D + VAVK +++A ++ + E+E++ I +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGK 82
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSP---------------LNWSLR 583
H NI+NLLG C + G ++ E+ +G L ++L P L++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL----- 638
+ + Q A+G+EYL A+ IHRD+ N+L+ D +IADFGL RD+
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL----ARDIHHIDY 195
Query: 639 ---TTD-------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VE 674
TT+ +SDV +FG++L EI + G Y PG+ VE
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVE 249
Query: 675 WALPLIKQGKAAAIIDRNVALPRN-VEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
L+K+G +D+ P N L+ + A+ PS+ PT Q+ L++I
Sbjct: 250 ELFKLLKEGHR---MDK----PSNCTNELYMMMRDCWHAV---PSQRPTFKQLVEDLDRI 299
Query: 734 V 734
+
Sbjct: 300 L 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
F + +G+GS+G VYK + ++V + I + + E+ VL I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
G L+ + ++ E++ G+ D L G PL + I + KGL+YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERK- 122
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT------------------DM 642
IHRD+K N+LL ++ADFG+ LT + T D
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 643 KSDVHNFGIVLLEILSGRKAY 663
K+D+ + GI +E+ G
Sbjct: 181 KADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 42/206 (20%)
Query: 489 ELGRGSYGFVY----KAVLVDG--RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
ELG+GS+G VY K V+ D +VA+K N A + I EF E V+ ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHV 71
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHG---------GLSPLNWSLRLKISMQAAKG 593
V LLG + L++ E M RG L +L +P + ++++ + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE------------------ 635
+ YL+ A +HRD+ N ++ D+ +I DFG+
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 636 -----RDLTTDMKSDVHNFGIVLLEI 656
+D SDV +FG+VL EI
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 25/191 (13%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIR 538
F++ ++G G+YG VYKA + G VA+K+ T + T IRE + +L +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELN 57
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYL 597
H NIV LL + LV+EF+ + L + LS + L Q +GL +
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLL--- 654
H + ++HRD+K N+L++++ ++ADFGL R +++ H +V L
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGL----ARAFGVPVRTYTHE--VVTLWYR 167
Query: 655 --EILSGRKAY 663
EIL G K Y
Sbjct: 168 APEILLGCKYY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 72/314 (22%), Positives = 122/314 (38%), Gaps = 80/314 (25%)
Query: 458 LPHPASACPGMAQVFRLSELKDATNGFKEF---NELGRGSYGFVYKAV-LVDGRQVAVKR 513
LP P+S+ + A E N +G G+ G VYK + GR A+K
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK- 105
Query: 514 ANAATIIHTN-----IREFEMELEVLCNIRHSNIVNLLGYCLEM----GERLLVYEFMPR 564
+I+ N R+ E+E+L ++ H N+V C +M GE ++ EFM
Sbjct: 106 -----VIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDG 156
Query: 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR 624
G+L L ++ Q G+ YLH+ I+HRD+K N+L++S +
Sbjct: 157 GSLEGTHIADEQFLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVK 208
Query: 625 IADFGL-------------------LTSCERDLTTDMK--------SDVHNFGIVLLEIL 657
IADFG+ S ER + TD+ D+ + G+ +LE
Sbjct: 209 IADFGVSRILAQTMDPCNSSVGTIAYMSPER-INTDLNHGAYDGYAGDIWSLGVSILEFY 267
Query: 658 SGRKAYDIEYVPPGIVEWALPLIKQGKAAAII-----DRNVALPRNVEPLFKLADIAELA 712
GR + + +QG A+++ + P F+
Sbjct: 268 LGR--------------FPFGVGRQGDWASLMCAICMSQPPEAPATASREFR--HFISCC 311
Query: 713 IRENPSELPTMSQV 726
++ P++ + Q+
Sbjct: 312 LQREPAKRWSAMQL 325
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 59/277 (21%)
Query: 469 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREF 527
A++ + +EL+ + LG G +G V+K + + +G + + A + + F
Sbjct: 1 ARILKETELR-------KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 528 EM---ELEVLCNIRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLH---GGLSP--- 577
+ + + ++ H+ IV LLG C G L LV + P G+L DH+ L P
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 578 LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG---LLTSC 634
LNW + Q AKG+ YL + ++HR++ NILL SD +IADFG LL
Sbjct: 112 LNWCV------QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
Query: 635 ER-----DLTTDMK---------------SDVHNFGIVLLEILS-GRKAYDIEYVP--PG 671
++ + T +K SDV ++G+ + E++S G + Y P
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
Query: 672 IVE----WALPLIKQGKAAAIIDRNVALPRNVEPLFK 704
++E A P I ++ + + NV P FK
Sbjct: 223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 33/158 (20%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---------ELEVLCNIRH 539
+G G+YG V AV GR+VA+K+ + F+ E+++L ++RH
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS---------NVFDDLIDAKRILREIKLLRHLRH 58
Query: 540 SNIVNLL-----GYCLEMGERLLVYEFMPRGT-LHDHLHGGLSPLNWSLRLKISM-QAAK 592
NI+ LL + + +V E M T LH + PL ++ + Q +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSP-QPLT-DDHIQYFLYQILR 114
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GL+YLH + +IHRD+K NIL++S+ +I DFGL
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN--------IREFEMELEVLCNIRH 539
LG+G+YG VY + G+ +AVK+ + T+ + + E+++L +++H
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQ----VELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
NIV LG CL+ + EF+P G++ L+ PL + K + Q G+ YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638
+ ++HRD+K N++L + ++ DFG C R L
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFG----CARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 60/196 (30%), Positives = 87/196 (44%), Gaps = 50/196 (25%)
Query: 528 EMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSP---------- 577
EMEL L +H NI+NLLG C + G ++ E+ +G L + L P
Sbjct: 67 EMELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 578 -----LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL- 631
L++ + + Q A+G+EYL + IHRD+ N+L+ D +IADFGL
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 632 ----------TSCER------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYV 668
TS R D +SDV +FGI++ EI + G Y
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY----- 237
Query: 669 PPGI-VEWALPLIKQG 683
PGI VE L+++G
Sbjct: 238 -PGIPVEELFKLLREG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 68/294 (23%)
Query: 490 LGRGSYGFVY--KAVLVDGRQVAVKRANAATIIHTNIREFEM-----ELEVLCNI-RHSN 541
LG G +G V +A+ +D + A ++ + E ++ E+E++ I +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG----GL-----------SPLNWSLRLKI 586
I+NLLG C + G ++ E+ +G L ++L G+ + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL-----------TSCE 635
+ Q A+G+EYL A+ IHRD+ N+L+ + +IADFGL T+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 636 R------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIK 681
R D +SDV +FG+++ EI + G Y PGI VE L+K
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------PGIPVEELFKLLK 253
Query: 682 QGKAAAIIDRNVALPRN-VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734
+G +D+ P N L+ + AI PS PT Q+ L++I+
Sbjct: 254 EGHR---MDK----PANCTNELYMMMRDCWHAI---PSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 60/214 (28%), Positives = 84/214 (39%), Gaps = 45/214 (21%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE-----FEMELEVLCNIRHSNIVN 544
LG G++G VY+ + AV+ A + + E F ME ++ H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGL------SPLNWSLRLKISMQAAKGLEYLH 598
L+G E R ++ E M G L L S L L + AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 599 KDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTSCERD------------------ 637
++ IHRD+ N LL A+IADFG+ R
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 638 -------LTTDMKSDVHNFGIVLLEILS-GRKAY 663
T+ K+DV +FG++L EI S G Y
Sbjct: 191 EAFLDGIFTS--KTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 33/204 (16%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F ++G GS G V A GRQVAVK+ + + RE E+ ++ + +H N
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPN 77
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
IV + L E +V EF+ G L D + H ++ + + + K L +LH
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLAVLKALSFLH-- 132
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---------------------LT 639
A +IHRD+K+ +ILL SD +++DFG ++ L
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 640 TDMKSDVHNFGIVLLEILSGRKAY 663
+ D+ + GI+++E++ G Y
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 51/270 (18%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+LG G +G V+ A +VAVK ++ ++ F E V+ ++H +V L +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKL--H 67
Query: 549 CLEMGERL-LVYEFMPRGTLHDHL---HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ E + ++ EFM +G+L D L G PL + S Q A+G+ ++ +
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN--- 122
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DM 642
IHRD++ NIL+ + +IADFGL E + T +
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 643 KSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701
KSDV +FGI+L+EI++ GR Y P + + ++R +PR
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPY--------------PGMSNPEVIRALERGYRMPRPENC 228
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLE 731
+L +I + P E PT + + L+
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 45/141 (31%), Positives = 65/141 (46%), Gaps = 4/141 (2%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549
LG+G++G V+K L D VAVK I+ F E +L H NIV L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGVC 61
Query: 550 LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRD 609
+ +V E +P G L L +K ++ AA G+ YL IHRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC---IHRD 118
Query: 610 VKTLNILLDSDWGARIADFGL 630
+ N L+ + +I+DFG+
Sbjct: 119 LAARNCLVGENNVLKISDFGM 139
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 47/145 (32%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKR----ANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+G GSYG V K + G+ VA+K+ + + +RE M L +RH N+VN
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRM----LKQLRHENLVN 64
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L+ LV+EF+ T+ D L + L+ S K Q +G+E+ H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 605 IIHRDVKTLNILLDSDWGARIADFG 629
IIHRD+K NIL+ ++ DFG
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 43/215 (20%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS-- 540
+ ELGRG+YG V K V G +AVKR AT+ + M+L++ ++R
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDI--SMRSVDC 59
Query: 541 -NIVNLLGYCLEMGERLLVYEFMPRGTLHD------HLHGGLSPLNWSLRLKISMQAAKG 593
V G G+ + E M T D + G P + + KI++ K
Sbjct: 60 PYTVTFYGALFREGDVWICMEVM--DTSLDKFYKKVYDKGLTIPED--ILGKIAVSIVKA 115
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTT--------- 640
LEYLH + +IHRDVK N+L++ + ++ DFG L+ S + +
Sbjct: 116 LEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPE 173
Query: 641 -----------DMKSDVHNFGIVLLEILSGRKAYD 664
D+KSDV + GI ++E+ +GR YD
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 24/162 (14%)
Query: 490 LGRGSYGFVYKAVLVDGRQ-VAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
+G GSYG V+K + Q VA+K+ + I++ + E+ +L ++H N+VNL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLI- 66
Query: 548 YCLEMGERL----LVYEFMPRGTLHD---HLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
E+ R LV+E+ L++ + G + L KI Q + + + HK
Sbjct: 67 ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKH 119
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFG---LLTSCERDLT 639
IHRDVK NIL+ ++ DFG +LT D T
Sbjct: 120 NC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMEL-EV--LCNI-R 538
+K +LG G++G VY A + G VA+K+ + E M L EV L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEEC-MNLREVKSLRKLNE 56
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYL 597
H NIV L E E V+E+M G L+ + P + S+ I Q +GL ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
HK HRD+K N+L+ +IADFGL
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGL 145
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 28/202 (13%)
Query: 483 GFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
FK +LG+GSYG VYK L D + A+K + ++ + E+ +L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLS---PLNWSLRLKISMQAAKGLEYL 597
I++ L+ G +L +V E+ P G L + + +I +Q +GL+ L
Sbjct: 61 IISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------- 640
H I+HRD+K+ NILL ++ +I D G+ ++++
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 641 --DMKSDVHNFGIVLLEILSGR 660
KSD+ + G +L E+ +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 42/206 (20%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG+G++G +A L D V K N + R+ E+ +L ++H NI+
Sbjct: 8 LGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 546 LGYCLEMGERLLVYEFMPRGTLHD---HLHGGLSP---LNWSLRLKISMQAAKGLEYLHK 599
+ ++ L+ E+ GTL+D G L + W L Q + Y+HK
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-----FQIVSAVSYIHK 119
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGL-------LTSCERDLTT------------ 640
I+HRD+KTLNI L ++ DFG+ + E + T
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYD 664
+ KSD+ G VL E+L+ ++ +D
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 50/226 (22%)
Query: 474 LSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELE 532
L L D T+ ++ +G+G+YG VYK DG AVK I I + + E+E
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-------ILDPISDVDEEIE 66
Query: 533 VLCNI-----RHSNIVNLLGYCLEM-----GERLLVYEFMPRGTLHDHLHGGL---SPLN 579
NI H N+V G + G+ LV E G++ + + G L L+
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTS--- 633
++ I A GL++LH + IIHRDVK NILL ++ G ++ DFG+ LTS
Sbjct: 127 EAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 634 ------------------CER--DLTTDMKSDVHNFGIVLLEILSG 659
CE+ D + D + DV + GI +E+ G
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 52/182 (28%), Positives = 76/182 (41%), Gaps = 40/182 (21%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATI---------------IH-TNIREFEME 530
LG G+YG V KA + G+ VA+K+ I IH T +RE
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE---- 70
Query: 531 LEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPL-NWSLRLKIS-- 587
L+++ I+H NI+ L+ +E LV + M L + + +RL S
Sbjct: 71 LKIMNEIKHENIMGLVDVYVEGDFINLVMDIM---------ASDLKKVVDRKIRLTESQV 121
Query: 588 ----MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMK 643
+Q GL LHK +HRD+ NI ++S +IADFGL +D
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 644 SD 645
S
Sbjct: 179 SK 180
|
Length = 335 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 16/161 (9%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-------IREFEMELEVLCNIRHSN 541
+G GS+G VY + G +AVK+ ++ ++ + E+ +L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHK 599
IV LG L+ + E++P G++ L +G +L Q KGL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT 640
IIHRD+K NIL+D+ G +I+DFG+ E + +
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 55/168 (32%), Positives = 78/168 (46%), Gaps = 35/168 (20%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIRE-FEM----ELEVLCNI 537
F ++G G+YG VYKA D G VA+K+ N +E F + E+++L +
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILRQL 63
Query: 538 RHSNIVNL----------LGYCLEMGERLLVYEFMPRGTLHDH-----LHGGLSPLNWSL 582
H NIVNL L + + G LV+E+M DH L GL +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDH 117
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Q +GL Y HK +HRD+K NILL++ ++ADFGL
Sbjct: 118 IKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 72/296 (24%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT----------NIREFEMELEVLCNI-R 538
LG G +G + V+ + + + N + ++ + E+E++ I +
Sbjct: 20 LGEGCFG---QVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSP-LNWSLR-------------- 583
H NI+NLLG C + G ++ E+ +G L ++L P +++S
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------- 636
+ + Q A+G+EYL A+ IHRD+ N+L+ D +IADFGL
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 637 ----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALP 678
D +SDV +FG++L EI + G Y PGI VE
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY------PGIPVEELFK 247
Query: 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734
L+K+G +D+ P N +L I PS+ PT Q+ L++++
Sbjct: 248 LLKEGHR---MDK----PANCT--HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 47/268 (17%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+LG G +G V+ +VAVK T+ + F E +++ +RH +V L Y
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQL--Y 67
Query: 549 CLEMGERL-LVYEFMPRGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
+ E + +V E+M +G+L D L G L + ++ Q A G+ Y+ + I
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKS 644
HRD+++ NIL+ +IADFGL E + T +KS
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 645 DVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703
DV +FGI+L E+++ GR Y P + + ++R +P +
Sbjct: 185 DVWSFGILLTELVTKGRVPY--------------PGMNNREVLEQVERGYRMPCPQDCPI 230
Query: 704 KLADIAELAIRENPSELPTMSQVATWLE 731
L ++ +++P E PT + ++LE
Sbjct: 231 SLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAAT------IIHTNIREFEMEL 531
D + F ++G+G+ G VY A+ V G++VA+K+ N II+ E+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN--------EI 67
Query: 532 EVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAA 591
V+ +H NIVN L L E +V E++ G+L D + + ++ + +
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECL 125
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT--SCERDLTTDM------- 642
+ LE+LH + +IHRD+K+ NILL D ++ DFG + E+ + M
Sbjct: 126 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 643 ------------KSDVHNFGIVLLEILSGRKAY 663
K D+ + GI+ +E++ G Y
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 29/199 (14%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
ELG G +G V VA+K ++ EF E +V+ + H +V L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
C + +V E+M G L ++L S L++ +G+ YL + IHR
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKSDV 646
D+ N L+D +++DFGL D T KSDV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 647 HNFGIVLLEILS-GRKAYD 664
FG+++ E+ S G+ Y+
Sbjct: 185 WAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 28/192 (14%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
ELG G +G V+ +VA+K N + + E E +V+ + H +V L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
C + +V EFM G L ++L L+ + L + +G+EYL +++ IHR
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DMKSDV 646
D+ N L+ S +++DFG+ D T KSDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 647 HNFGIVLLEILS 658
+FG+++ E+ +
Sbjct: 185 WSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 31/171 (18%)
Query: 478 KDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEM----EL 531
D + +++ ++G+G++G V+KA + VA+K+ ++ N +E F + E+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK-----VLMENEKEGFPITALREI 62
Query: 532 EVLCNIRHSNIVNLLGYC---LEMGER-----LLVYEFMPRGTLHDHLHGGLSPLNWSLR 583
++L ++H N+VNL+ C R LV+EF HD L G LS N
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HD-LAGLLSNKNVKFT 117
Query: 584 L----KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
L K+ GL Y+H++ I+HRD+K NIL+ D ++ADFGL
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 478 KDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE----FEMELEV 533
++ F+ +G G+YG VYKA R V A +I E + E+ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKA-----RNVNTGELAAIKVIKLEPGEDFAVVQQEIIM 59
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHD--HLHGGLSPLNWSLRLKISMQAA 591
+ + +HSNIV G L + + EF G+L D H+ G LS + +S +
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETL 116
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+GL YLH +HRD+K NILL + ++ADFG+
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 42/213 (19%)
Query: 483 GFKEFNELGRGSYGFVYKA-----VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+E LGRG +G V+ A G + + +A T EF EL++ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLS--------PLNWSLRLKISMQ 589
H N+V LLG C E ++ E+ G L L S PL+ ++ + Q
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC--------------- 634
A G+++L +HRD+ N L+ S +++ L
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 635 ---------ERDLTTDMKSDVHNFGIVLLEILS 658
E D +T KSDV +FG+++ E+ +
Sbjct: 183 RWLAPEAVQEDDFST--KSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 37/202 (18%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIR 538
+++ ++G G+YG VYKA G+ VA+K+ I T +RE + +L +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE----ISLLQMLS 58
Query: 539 HSN-IVNLLGYCLEMGER-------LLVYEFMP---RGTLHDHLHGGLSPLNWSLRLKIS 587
S IV LL +E E LV+E++ + + + G PL
Sbjct: 59 ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFGLLTSCERDLTTDMKSDV 646
Q KG+ + HK ++HRD+K N+L+D G +IAD GL R + +KS
Sbjct: 117 YQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL----GRAFSIPVKSYT 169
Query: 647 HNFGIVLL-----EILSGRKAY 663
H IV L E+L G Y
Sbjct: 170 HE--IVTLWYRAPEVLLGSTHY 189
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 77/291 (26%), Positives = 119/291 (40%), Gaps = 73/291 (25%)
Query: 489 ELGRGSYGFVYKAV---LVDGR---QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
ELG+GS+G VY+ ++ G +VAVK N + + I EF E V+ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 71
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLH----------GGLSPLNWSLRLKISMQA-- 590
V LLG + L+V E M G L +L G P +L+ I M A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP---TLQEMIQMAAEI 128
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTDM------- 642
A G+ YL+ A +HRD+ N ++ D+ +I DFG+ RD+ TD
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIYETDYYRKGGKG 181
Query: 643 -------------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGIV-EWALPLIK 681
SD+ +FG+VL EI S + Y G+ E L +
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ------GLSNEQVLKFVM 235
Query: 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732
G +D+ P N ++ D+ + + NP PT ++ L+
Sbjct: 236 DG---GYLDQ----PDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 42/217 (19%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
D ++ ++ +G+G+YG V+K + +G + AVK + IH E E E +L +
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IHDIDEEIEAEYNILKAL 71
Query: 538 R-HSNIVNLLGYCLEM----GERL-LVYEFMPRGTLHDHLHGGL---SPLNWSLRLKISM 588
H N+V G + G++L LV E G++ D + G L + + I
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTS------------ 633
+A GL++LH + IHRDVK NILL ++ G ++ DFG+ LTS
Sbjct: 132 EALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 634 ---------CER--DLTTDMKSDVHNFGIVLLEILSG 659
CE+ D T D + DV + GI +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 72/305 (23%), Positives = 127/305 (41%), Gaps = 85/305 (27%)
Query: 490 LGRGSYGFVYKAVL--VDGR----QVAVK--RANAATIIHTNIREFEMELEVLCNIRHSN 541
LG G +G V KA + GR VAVK + NA++ + +R+ E +L + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS---SELRDLLSEFNLLKQVNHPH 64
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL-----------------------HGGLSPL 578
++ L G C + G LL+ E+ G+L L + L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 579 NWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638
+ + Q ++G++YL A ++HRD+ N+L+ +I+DFGL RD+
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL----SRDV 177
Query: 639 TTD---------------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPP 670
+ +SDV +FG++L EI++ G Y P
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY------P 231
Query: 671 GIV-EWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATW 729
GI E L+K G ++R P N ++ ++ ++ P + PT + ++
Sbjct: 232 GIAPERLFNLLKTGYR---MER----PENCSE--EMYNLMLTCWKQEPDKRPTFADISKE 282
Query: 730 LEQIV 734
LE+++
Sbjct: 283 LEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 46/214 (21%)
Query: 484 FKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH 539
+ + ++G GS+G KA+LV DG+Q +K N + + E E+ VL N++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH---GGLSP----LNWSLRLKISMQAAK 592
NIV E G +V ++ G L+ ++ G L P L+W +++ +
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ 112
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTS---------------- 633
L+++H I+HRD+K+ NI L D ++ DFG+ L S
Sbjct: 113 ALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 634 ---CERDLTTDMKSDVHNFGIVLLEILSGRKAYD 664
CE + + KSD+ G VL E+ + + A++
Sbjct: 170 PEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 38/198 (19%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN----IREFEMELEVLCNIRHSNIVN 544
ELG G++G VYKA + +A AA +I T + ++ +E+++L + H NIV
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
LL ++ EF G + + PL + Q + L YLH++
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--- 123
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL------------------------LTSCE--RDL 638
IIHRD+K NIL D ++ADFG+ + CE +D
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 639 TTDMKSDVHNFGIVLLEI 656
D K+DV + GI L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 49/212 (23%)
Query: 481 TNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---------- 529
FK ++G+G + VYKA+ L+DGR VA+K+ ++ FEM
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK----------VQIFEMMDAKARQDCL 50
Query: 530 -ELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLH---DHLHGGLSPLNWSLRLK 585
E+++L + H N++ L +E E +V E G L H + K
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--------------- 630
+Q LE++H I+HRD+K N+ + + ++ D GL
Sbjct: 111 YFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167
Query: 631 ----LTSCERDLTT--DMKSDVHNFGIVLLEI 656
S ER + KSD+ + G +L E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 10/146 (6%)
Query: 490 LGRGSYGFVYKAVLV-DGRQVAVKRA----NAATIIHTNIREFEMELEVLCNIRHSNIVN 544
LG G++ Y+A V G +AVK+ N ++ + E+ ++ + H +I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+LG E L E+M G++ L ++ + + Q +GL YLH++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ--- 123
Query: 605 IIHRDVKTLNILLDSDWG-ARIADFG 629
IIHRDVK N+L+DS RIADFG
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+ TN + + +G G++G V A + G+ VA+K+ + EL++L ++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 538 RHSNIVNLLGYCLEMGERL-LVYEFMPRGT-LHDHLHGGLSPLNWSLRLKISMQAAKGLE 595
RH NI++L + E + V E + GT LH L PL Q +GL+
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR--PLEKQFIQYFLYQILRGLK 122
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Y+H ++HRD+K NIL++ + +I DFGL
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEM-ELEVLCN 536
D F ++G GS G V A G+QVAVK+ + + RE E+ ++ +
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRD 75
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
H N+V++ L E +V EF+ G L D + + +N + + + L Y
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSY 133
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD------------------- 637
LH +IHRD+K+ +ILL SD +++DFG ++
Sbjct: 134 LHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190
Query: 638 --LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP 670
L + D+ + GI+++E++ G Y E PP
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--PP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 45/214 (21%)
Query: 490 LGRGSYGFVYKAVLVDGR---QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
LG G +G V + L +VAVK A + + +F E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 547 GYCLEMGER------LLVYEFMPRGTLHDHL---HGGLSP--LNWSLRLKISMQAAKGLE 595
G CL+ E +++ FM G LH L G P L + +K A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS---------------------- 633
YL ++ IHRD+ N +L+ + +ADFGL
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 634 ---CERDLTTDMKSDVHNFGIVLLEILS-GRKAY 663
+R TT KSDV +FG+ + EI + G+ Y
Sbjct: 184 ESLADRVYTT--KSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 46/216 (21%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIR 538
K+ LG G++G VYK + + DG VA+K T N +E E V+ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVG 67
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH------GGLSPLNWSLRLKISMQAAK 592
+ LLG CL +L V + MP G L D++ G LNW + Q AK
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV------QIAK 120
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG---LLTSCERDLTTD-------- 641
G+ YL + ++HRD+ N+L+ S +I DFG LL E + D
Sbjct: 121 GMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 642 ------------MKSDVHNFGIVLLEILS-GRKAYD 664
+SDV ++G+ + E+++ G K YD
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 53/160 (33%), Positives = 72/160 (45%), Gaps = 30/160 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQV-AVKRANAATII------HTNIREFEMELEVLCN 536
F+ LG GS+G V + A+K + A I+ H E +L +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-----NEKRILQS 57
Query: 537 IRHSNIVNLLG-----YCLEMGERLLVYEFMPRGTLHDHLH-GGLSPLNWSLRLKISMQA 590
IRH +VNL G L + V E++P G L HL G P + R + Q
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYL-----VMEYVPGGELFSHLRKSGRFPEPVA-RFYAA-QV 110
Query: 591 AKGLEYLH-KDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
LEYLH D I++RD+K N+LLDSD +I DFG
Sbjct: 111 VLALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFG 146
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 65/280 (23%), Positives = 113/280 (40%), Gaps = 62/280 (22%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATII-----HTNIREFEMELEV 533
D F + ++G+GS+G V+K + D R ++ A II I + + E+ V
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGI--DNR---TQKVVAIKIIDLEEAEDEIEDIQQEITV 55
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKG 593
L + G L+ + ++ E++ G+ D L G PL+ + I + KG
Sbjct: 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKG 113
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCE--------------- 635
L+YLH + IHRD+K N+LL ++ADFG+ LT +
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 636 ---RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692
+ D K+D+ + GI +E+ G + E P ++
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHS-ELHPMKVL------------------- 210
Query: 693 VALPRNVEPLFK------LADIAELAIRENPSELPTMSQV 726
+P+N P + L + E + + PS PT ++
Sbjct: 211 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 54/155 (34%), Positives = 81/155 (52%), Gaps = 20/155 (12%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVK--RANAAT-IIHTNIREFEMELEVLCNIRH 539
+K+ ++LG GSY VYK + G+ VA+K R T IRE +L +++H
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKH 62
Query: 540 SNIVNLLGYCLEMGERL-LVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+NIV L + + L LV+E++ D GGLS N L L Q +GL Y
Sbjct: 63 ANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL---FQLLRGLAY 118
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFGL 630
H+ ++HRD+K N+L+ S+ G ++ADFGL
Sbjct: 119 CHQRR---VLHRDLKPQNLLI-SERGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 26/202 (12%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR 538
D F + +G+GS+G V+K + +QV + I + + E+ VL
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ G L+ + ++ E++ G+ D L G P + + + KGL+YLH
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH 118
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT--------------- 640
+ IHRD+K N+LL ++ADFG+ LT + T
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 641 ---DMKSDVHNFGIVLLEILSG 659
D K+D+ + GI +E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 26/159 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH---------TNIREFEMELEV 533
FK+ +LG G+Y VYK G VA+K IH T IRE + E
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKE- 54
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAA 591
++H NIV L + +LV+E+M L ++ HG L+ + + Q
Sbjct: 55 ---LKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
KG+ + H++ ++HRD+K N+L++ ++ADFGL
Sbjct: 111 KGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGL 146
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 57/269 (21%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
+G+GSYG V LV DG+Q +K+ N + E E ++L ++H NIV
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 546 L-GYCLEMGERLLVYEFMPRGTLHDHL---HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
+ E G +V F G L+ L G L P N + + Q A L+YLH+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV--QIAMALQYLHEKH 122
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--DLTTDM----------------- 642
I+HRD+KT N+ L ++ D G+ E D+ + +
Sbjct: 123 ---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 643 --KSDVHNFGIVLLEILSGRKAY---DIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697
KSDV G + E+ + + A+ D+ + I+E LP +P+
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---------------PMPK 224
Query: 698 NVEPLFKLADIAELAIRENPSELPTMSQV 726
+ P +L ++ + + P + P++ +
Sbjct: 225 DYSP--ELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 39/170 (22%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAA--TIIHTNIREFEMELEVLCNIRHSNIVNLL 546
+G G+YG V A GR+VA+K+ + + IH R + EL +L ++ H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK-RTYR-ELRLLKHMDHENVIGLL 80
Query: 547 GYCLEMGERLLVYEFMPRGTLHD--------HLHGGLSPLNWSLRLK---------ISMQ 589
F P +L D HL G + LN ++ + + Q
Sbjct: 81 DV------------FTPASSLEDFQDVYLVTHLMG--ADLNNIVKCQKLSDDHIQFLVYQ 126
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
+GL+Y+H + IIHRD+K NI ++ D +I DFGL + ++T
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT 173
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 35/164 (21%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH--------TNIREFEMELEVL 534
+++ N + G+YG VY+A G VA+K+ + T++RE +L
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKK----LKMEKEKEGFPITSLREIN----IL 58
Query: 535 CNIRHSNIVNLLGYCLEM--GERL----LVYEFMPRG--TLHDHLHGGLSPLNWSLRLKI 586
++H NIV + E+ G L +V E++ +L + + S +
Sbjct: 59 LKLQHPNIVTVK----EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQ---SEVKCL 111
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+Q G+ +LH + I+HRD+KT N+LL++ +I DFGL
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL 152
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 22/160 (13%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
G EF LG G+ F + VLV + + RA+ T +F E++++ +++ N
Sbjct: 27 EGLAEF--LGEGAPEFDGQPVLVAVKML---RADVTK---TARNDFLKEIKIMSRLKNPN 78
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLH-----------GGLSPLNWSLRLKISMQA 590
I+ LLG C+ ++ E+M G L+ L + ++ + L +++Q
Sbjct: 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI 138
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
A G++YL A+ +HRD+ T N L+ + + +IADFG+
Sbjct: 139 ASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/217 (25%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKR---ANAATIIHTNIREFEMELEVLCNIR 538
E + LG G+ G V K L + + + + + I ELE+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57
Query: 539 HSNIVNLLGYCLEMGERLL--VYEFMPRGTLHDHLHGGLSPLNWSLR----LKISMQAAK 592
IV G L+ + E+ G+L D ++ + + KI+ K
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSC-------------E 635
GL YLH IIHRD+K NILL ++ DFG L+ S E
Sbjct: 117 GLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPE 173
Query: 636 R--DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP 670
R + SDV + G+ LLE+ R + E PP
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCN 536
D + F ++G+G+ G VY A+ + G++VA+++ N + +E + E+ V+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRE 73
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
++ NIVN L L E +V E++ G+L D + + ++ + + + LE+
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEF 131
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC--ERDLTTDM------------ 642
LH + +IHRD+K+ NILL D ++ DFG E+ + M
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 643 -------KSDVHNFGIVLLEILSGRKAY 663
K D+ + GI+ +E++ G Y
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 48/275 (17%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+ELG+G+YG VYK + + + + + MEL++L IV+ G
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNW----SLRLKISMQAAKGLEYLHKDAAP 603
G + E+M G+L D L+ G LR +I+ KGL++L ++
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEEHN- 123
Query: 604 PIIHRDVKTLNILLDSDWGARIADFG----LLTS-------C------ER--------DL 638
IIHRDVK N+L++ + ++ DFG L+ S C ER +
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 639 TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN-VALPR 697
T ++SDV + G+ +LE+ GR Y PP E + Q +AI+D + LP
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPY-----PP---ETYANIFAQ--LSAIVDGDPPTLPS 232
Query: 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT--WL 730
D + + P+ PT +Q+ WL
Sbjct: 233 GYSD--DAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 478 KDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH----TNIREFEMELEV 533
++ + ++ +G G+YG VYKA R + A II + + E+ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKA-----RNLHTGELAAVKIIKLEPGDDFSLIQQEIFM 59
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHD--HLHGGLSPLNWSLRLKISMQAA 591
+ +H NIV G L + + E+ G+L D H+ G LS L + + ++Q
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ-- 117
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GL YLH +HRD+K NILL + ++ADFG+
Sbjct: 118 -GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 489 ELGRGSYGFVYKAVLVDG---RQVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
E+G G +G V + G QV VK R +A+ +F E + +++HSN++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ---EQMKFLEEAQPYRSLQHSNLL 58
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHG-----GLSPLNWSLRLKISMQAAKGLEYLH 598
LG C E+ LLV EF P G L +L ++P +L+ +++ + A GL +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLLHLH 117
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
K+ IH D+ N LL +D +I D+GL
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/198 (27%), Positives = 79/198 (39%), Gaps = 37/198 (18%)
Query: 490 LGRGSYGFVYKAVLVDGR----QVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVN 544
+G G +G VY+ V + VAVK T ++RE F E ++ H +IV
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L+G E +V E P G L +L L+ + + S Q + L YL +
Sbjct: 72 LIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCE------------------------RDLTT 640
+HRD+ N+L+ S ++ DFGL E R T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT- 186
Query: 641 DMKSDVHNFGIVLLEILS 658
SDV FG+ + EIL
Sbjct: 187 -SASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIRE 526
M ++ + + D + + ++G+G+ G V+ A+ V G++VA+K+ N + +E
Sbjct: 5 MEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKE 61
Query: 527 FEM-ELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLK 585
+ E+ V+ +++ NIVN L L E +V E++ G+L D + + ++ +
Sbjct: 62 LIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAA 119
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC--ERDLTTDM- 642
+ + + LE+LH A +IHRD+K+ N+LL D ++ DFG E+ + M
Sbjct: 120 VCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 643 ------------------KSDVHNFGIVLLEILSGRKAY 663
K D+ + GI+ +E++ G Y
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 53/154 (34%), Positives = 76/154 (49%), Gaps = 28/154 (18%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAA----TIIHTNIREFEMELEVLCNIRHSNIVN 544
LG+G+YG V+KA+ VA+K+ A T RE M L+ L + H NIV
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREI-MFLQELGD--HPNIVK 71
Query: 545 LLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLK------ISMQAAKGLEY 596
LL ++ LV+E+M LH + + L+ I Q K L+Y
Sbjct: 72 LLNVIKAENDKDIYLVFEYM-ETDLHAVIRANI--------LEDVHKRYIMYQLLKALKY 122
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+H + +IHRD+K NILL+SD ++ADFGL
Sbjct: 123 IH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCN 536
D + F ++G+G+ G VY A+ + G++VA+K+ N + +E + E+ V+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
++ NIVN L L E +V E++ G+L D + + ++ + + + L++
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDF 130
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC--ERDLTTDM------------ 642
LH + +IHRD+K+ NILL D ++ DFG E+ + M
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 643 -------KSDVHNFGIVLLEILSGRKAY 663
K D+ + GI+ +E++ G Y
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 53/218 (24%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---ELEVLCNIRH 539
++ +G+GS+G V K DG+ + K + + +E + E+ +L ++H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKH 58
Query: 540 SNIVNLLGYCLEMGERLL--VYEFMPRGTLHDHLHGGL--------SPLNWSLRLKISMQ 589
NIV ++ + L V E+ G L L + +I Q
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-----AQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 590 AAKGLEYLH--KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------ 641
L H D ++HRD+K NI LD++ ++ DFGL + L D
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL----AKILGHDSSFAKT 169
Query: 642 -------M------------KSDVHNFGIVLLEILSGR 660
M KSD+ + G ++ E+ +
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 39/206 (18%)
Query: 490 LGRGSYGFVYKAVL-VDGRQ---VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
+G G +G V++ +L + GR+ VA+K ++F E ++ H NI+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
G + +++ E+M G L +L G S L+ A G++YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SD 125
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-----LTTDMK-------------- 643
+HRD+ NIL++S+ +++DFGL E D T+ K
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 644 -----SDVHNFGIVLLEILS-GRKAY 663
SDV +FGIV+ E++S G + Y
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 20/157 (12%)
Query: 482 NGFKEFNELGRGSYGFVYKA-VLVDGRQVAVK----RANAATIIHTNIREFEMELEVLCN 536
+ +++ +LG GSY VYK V+G+ VA+K + T T IRE + L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF-TAIREASL----LKG 59
Query: 537 IRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLH--DHLHGGLSPLNWSLRLKISMQAAKG 593
++H+NIV LL + E L LV+E++ D GGL P N L L Q +G
Sbjct: 60 LKHANIV-LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL---FQLLRG 115
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
L Y+H+ I+HRD+K N+L+ ++ADFGL
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 55/159 (34%), Positives = 82/159 (51%), Gaps = 20/159 (12%)
Query: 480 ATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAAT---IIHTNIREFEMELEVLC 535
A + +LG GSY VYK + ++G+ VA+K + T + T IRE + L
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASL----LK 58
Query: 536 NIRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHL--H-GGLSPLNWSLRLKISMQAA 591
++H+NIV LL + E L V+E+M L ++ H GGL P N L + Q
Sbjct: 59 GLKHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFM---FQLL 113
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+GL Y+H I+HRD+K N+L+ ++ADFGL
Sbjct: 114 RGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 35/204 (17%)
Query: 489 ELGRGSYGFVYKAVL-VDGRQ--VAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVN 544
ELG G++G V K V + +Q VA+K ++R+ M E E++ + + IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
++G C E +LV E G L+ L G + S +++ Q + G++YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------------ 640
+HRD+ N+LL + A+I+DFGL + D +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 641 DMKSDVHNFGIVLLEILS-GRKAY 663
+SDV ++GI + E S G+K Y
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 9/167 (5%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLG 547
+ +G+YG V+ A G A+K A +I N + + E ++L + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
Y + + L LV E++P G L L + L+ + + LEYLH + II
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNG---II 115
Query: 607 HRDVKTLNILLDSDWGARIADFGL-LTSCERDLTTDMKSDVHNFGIV 652
HRD+K NIL+DS+ ++ DFGL R + + IV
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 56/194 (28%), Positives = 79/194 (40%), Gaps = 28/194 (14%)
Query: 489 ELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+GRG++G V+ L D VAVK T+ +F E +L H NIV L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
C + +V E + G L L +++ AA G+EYL IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IH 117
Query: 608 RDVKTLNILLDSDWGARIADFGLLTSCERDL---TTDMK--------------------S 644
RD+ N L+ +I+DFG+ E + T MK S
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 645 DVHNFGIVLLEILS 658
DV +FGI+L E S
Sbjct: 178 DVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 6/148 (4%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQ-VAVKRAN-AATIIHTNIREFEMELEVLCNIRHSN 541
F +E+G GS+G VY A + VAVK+ + + + ++ E++ L ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
+ G L+ LV E+ G+ D L PL I+ A +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFG 629
+IHRD+K NILL ++ADFG
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 57/205 (27%)
Query: 490 LGRGSYGFVYKAVLVDGRQ----VAVKRANAATII-------HTNIREFEMELEVLCNIR 538
LG+G YG V++ V G A+K ATI+ HT + E +L ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT-----KAERNILEAVK 58
Query: 539 HSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK----- 592
H IV+L+ Y + G +L L+ E++ G L HL R I M+
Sbjct: 59 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLE----------REGIFMEDTACFYLS 107
Query: 593 ----GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHN 648
LE+LH+ II+RD+K NILLD+ ++ DFGL C+ + + H
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGL---CKESIHEGTVT--HT 159
Query: 649 FGIVLLEILSGRKAYDIEYVPPGIV 673
F IEY+ P I+
Sbjct: 160 F------------CGTIEYMAPEIL 172
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 60/224 (26%)
Query: 482 NGFKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
N + E+G G+ G VYK G +AVK+ N R M+L+V+
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL-MDLDVVLKSHDC 73
Query: 541 -NIVNLLGY---------CLE-MG---ERLL--VYEFMPRGTLHDHLHGGLSPLNWSLRL 584
IV GY C+E M ++LL + +P + + G
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIP-----EDILG----------- 117
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTS------- 633
K+++ K L YL + +IHRDVK NILLD+ ++ DFG L+ S
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 634 -C------ER------DLTTDMKSDVHNFGIVLLEILSGRKAYD 664
C ER + D+++DV + GI L+E+ +G+ Y
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 59/205 (28%), Positives = 85/205 (41%), Gaps = 43/205 (20%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQV----AVKRANAATIIHT--NIREFEMELEVLCNI 537
F+ LG G+YG V+ V G A+K ATI+ E +VL +I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 538 RHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK---- 592
R S + L Y + +L L+ +++ G L HL S R + Q +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---------SQRERFKEQEVQIYSG 112
Query: 593 ----GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHN 648
LE+LHK II+RD+K NILLDS+ + DFGL ++ D ++
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL----SKEFHEDEVERAYS 165
Query: 649 FGIVLLEILSGRKAYDIEYVPPGIV 673
F IEY+ P IV
Sbjct: 166 F------------CGTIEYMAPDIV 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 51/191 (26%), Positives = 77/191 (40%), Gaps = 49/191 (25%)
Query: 507 RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGT 566
VAVK + +F E+++L + NI LLG C ++ E+M G
Sbjct: 47 VLVAVKVLRPDASDNARE-DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 567 LHDHLH----------GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616
L+ L L++S L ++ Q A G+ YL + +HRD+ T N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCL 162
Query: 617 LDSDWGARIADFGLLTSCERDL-----------------------------TTDMKSDVH 647
+ ++ +IADFG+ R+L TT KSDV
Sbjct: 163 VGKNYTIKIADFGM----SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT--KSDVW 216
Query: 648 NFGIVLLEILS 658
FG+ L EIL+
Sbjct: 217 AFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 13/151 (8%)
Query: 488 NELGRGSYGFVYKA---VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+E+G G +G V + +V VK A+ + F E++ + H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHL-----HGGLSPLNWSLRLKISMQAAKGLEYLHK 599
LG C+E LLV EF P G L ++L + +++ + A GL +LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQ 118
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
IH D+ N L +D +I D+GL
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 50/215 (23%)
Query: 489 ELGRGSYGFVYKAVL----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
ELG ++G +YK L +D Q+ + EF+ E ++ + H NIV
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHL-----HGGL-----------SPLNWSLRLKISM 588
LLG + +++E++ +G LH+ L H + S L+ L I++
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCER--------- 636
Q A G+EYL ++ +H+D+ NIL+ +I+D GL + S +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 637 -------------DLTTDMKSDVHNFGIVLLEILS 658
++D SD+ +FG+VL EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSD--SDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG+G +G V + G+ A K+ + + + + E ++L + S + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
Y E + L LV M G L H+ + G + + + Q GLE+LH+ I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYD 664
++RD+K N+LLD RI+D GL + E +K G + E+L G + YD
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGL--AVELKGGKKIKGRAGTPGYMAPEVLQG-EVYD 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 15/154 (9%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIR 538
+ + ++G G+YG VYK G+ VA+K+ + + T IRE + +L ++
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQ 57
Query: 539 HSNIVNLLGYCLEMGERLLVYEF--MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
H NIV L ++ L++EF M D L G ++ L Q +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY-MDAELVKSYLYQILQGILF 116
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H + ++HRD+K N+L+D+ ++ADFGL
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIR--EFEMELEVLCN 536
D F + E+G GS+G VY A V +V + + + +N + + E+ L
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+RH N + G L LV E+ G+ D L PL ++ A +GL Y
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
LH +IHRDVK NILL ++ DFG
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 51/146 (34%), Positives = 75/146 (51%), Gaps = 12/146 (8%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLG 547
+GRG++G V+ D QV A+K + +I N I E ++L + IV L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKIS-MQAAKGLEYLHKDAAPP 604
Y + E L LV E+MP G L + L + P + R I+ + A L+ +HK
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVLA--LDSVHKLG--- 121
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL 630
IHRD+K NIL+D+D ++ADFGL
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 6/163 (3%)
Query: 469 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQ-VAVKRAN-AATIIHTNIRE 526
++ L D F + E+G GS+G VY A V + VA+K+ + + + ++
Sbjct: 2 PEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKI 586
E+ L +RH N + G L LV E+ G+ D L PL I
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAI 120
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
A +GL YLH IHRD+K NILL ++ADFG
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 489 ELGRGSYGFVYKA--VLVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIRHSNI 542
E+G G+YG V+KA + GR VA+KR T + + IRE + L L H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNV 66
Query: 543 VNLLGYC-LEMGER----LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM-QAAKGLEY 596
V L C + +R LV+E + + L +L P + +K M Q +GL++
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
LH ++HRD+K NIL+ S ++ADFGL
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 27/161 (16%)
Query: 490 LGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEME----LEVLCNIRHSN 541
LGRG +G K +L + G A+K II + E M E + RH
Sbjct: 7 LGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK---GLEYL 597
+VNL C + + + V E+ G L H+H + + AA GL+YL
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----EPRAVFYAACVVLGLQYL 117
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638
H++ I++RD+K N+LLD++ +IADFGL C+ +
Sbjct: 118 HENK---IVYRDLKLDNLLLDTEGFVKIADFGL---CKEGM 152
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 53/227 (23%)
Query: 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH-TNIREFEMELE 532
LS L+D F+ +G G+YG VYK GR V + A ++ T E E++LE
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYK-----GRHVKTGQLAAIKVMDVTEDEEEEIKLE 62
Query: 533 VLCNI-----RHSNIVNLLGYCLEMG------ERLLVYEFMPRGTLHD---HLHGGLSPL 578
+ N+ H NI G ++ + LV EF G++ D + G
Sbjct: 63 I--NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 579 NWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636
+W I + +GL +LH A +IHRD+K N+LL + ++ DFG+ +R
Sbjct: 121 DWIAY--ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 637 ------------------------DLTTDMKSDVHNFGIVLLEILSG 659
D T D +SD+ + GI +E+ G
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 22/150 (14%)
Query: 530 ELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQ 589
EL+++ R IV+ G L + EFM G+L D ++ P+ + KI++
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVA 111
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDL---TTDM 642
+GL YL+ I+HRD+K NIL++S ++ DFG L+ S +T M
Sbjct: 112 VVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYM 169
Query: 643 ------------KSDVHNFGIVLLEILSGR 660
KSDV + GI ++E+ G+
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 36/165 (21%), Positives = 78/165 (47%), Gaps = 27/165 (16%)
Query: 524 IREFEMELEVLCNIRHSNIVNLLGYCLEMGERL----LVYEFMPRGTLHDHLHGGLSPLN 579
I E E++ L I +NI+ + G+ +++ + L L+ E+ RG L + L L+
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-LS 120
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--------- 630
+ +L +++ KGL L+K P ++++ +++ L+ ++ +I GL
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178
Query: 631 -----LTSCERDLTTDM------KSDVHNFGIVLLEILSGRKAYD 664
+ + D+ K D+++ G+VL EI +G+ ++
Sbjct: 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 55/164 (33%), Positives = 82/164 (50%), Gaps = 18/164 (10%)
Query: 489 ELGRGSYGFVYKAVLVD-GRQVAVKRANAAT----IIHTNIREFEMELEVLCNIRHSNIV 543
E+G G+YG VYKA G VA+K T + + +RE + L+ L H NIV
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIV 65
Query: 544 NLLGYCLEM-----GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM-QAAKGLEYL 597
L+ C + LV+E + + L +L P + +K M Q +GL++L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLT 639
H + I+HRD+K NIL+ S ++ADFGL + SC+ LT
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 26/172 (15%)
Query: 493 GSYGFVYKAVLVDG-----RQVAVKR-ANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
G++G ++ +L+D +V VK + A+ I + E +L + H NI+ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGLSHQNILPIL 74
Query: 547 GYCLEMGERLLV-YEFMPRGTLHDHLH-----GGLSPLNWSLRLKISM--QAAKGLEYLH 598
C+E GE V Y +M G L L +P S + + M Q A G+ YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFG 650
K +IH+D+ N ++D + +I D L RDL D H G
Sbjct: 135 KRG---VIHKDIAARNCVIDEELQVKITDNAL----SRDL---FPMDYHCLG 176
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 466 PGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHT-N 523
P +A++F +D F + E+G GS+G VY A V +V A+K+ + +
Sbjct: 12 PEIAELFFK---EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 68
Query: 524 IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR 583
++ E++ L I+H N + G L LV E+ G+ D L PL
Sbjct: 69 WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEI 127
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
I+ A +GL YLH +IHRD+K NILL ++ADFG
Sbjct: 128 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 489 ELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLL 546
+ +G++G VY A G A+K + +I N + + E ++ S V L
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + + L LV E++ G + GGL P +W+ + + G+E LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL-PEDWAK--QYIAEVVLGVEDLHQRG-- 117
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGL 630
IIHRD+K N+L+D ++ DFGL
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGL 143
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 36/206 (17%)
Query: 488 NELGRGSYGFVYKAVL-VDGRQ---VAVK--RANAATIIHTNIREFEMELEVLCNIRHSN 541
+G G +G V + L + G++ VA+K +A ++ +F E ++ H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD---KQRLDFLTEASIMGQFDHPN 66
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
I+ L G + +++ E+M G+L L + + A G++YL +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTTD----------------- 641
+HRD+ NIL++S+ +++DFGL L E TT
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 642 ---MKSDVHNFGIVLLEILS-GRKAY 663
SDV +FGIV+ E++S G + Y
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 48/187 (25%)
Query: 574 GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633
PL+ L+ S Q A+G+++L A+ IHRDV N+LL A+I DFGL
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL--- 258
Query: 634 CERDLTTD---------------------------MKSDVHNFGIVLLEILS-GRKAYDI 665
RD+ D ++SDV ++GI+L EI S G+ Y
Sbjct: 259 -ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-- 315
Query: 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQ 725
PGI + K ++ R + R ++ I ++ P+E PT SQ
Sbjct: 316 ----PGI-------LVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQ 364
Query: 726 VATWLEQ 732
++ +++
Sbjct: 365 ISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 53/173 (30%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFE---------MELEV 533
++ + +G G+YG V A G +VA+K+ I FE E+++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKK----------ISPFEHQTFCQRTLREIKI 56
Query: 534 LCNIRHSNIVNLL------GYCLEMGERLLVYEFMPRGTLH----------DHLHGGLSP 577
L +H NI+ +L + + +V E M L+ DH+ L
Sbjct: 57 LRRFKHENIIGILDIIRPPSFE-SFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFL-- 112
Query: 578 LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Q +GL+Y+H + ++HRD+K N+LL+++ +I DFGL
Sbjct: 113 ----------YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 76/292 (26%), Positives = 117/292 (40%), Gaps = 68/292 (23%)
Query: 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN 536
L+D F+ +G G+YG VYK GR V + A ++ E E E++ N
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYK-----GRHVKTGQLAAIKVMDVTGDE-EEEIKQEIN 54
Query: 537 I-----RHSNIVNLLGYCLE-----MGERL-LVYEFMPRGTLHD---HLHGGLSPLNWSL 582
+ H NI G ++ M ++L LV EF G++ D + G W
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636
I + +GL +LH+ +IHRD+K N+LL + ++ DFG+ +R
Sbjct: 115 Y--ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676
D T D KSD+ + GI +E+ G PP
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG--------APP------ 215
Query: 677 LPLIKQGKAAAIIDRNVALPRNVEPLF--KLADIAELAIRENPSELPTMSQV 726
L + +A +I RN A PR + K E + +N S+ PT Q+
Sbjct: 216 LCDMHPMRALFLIPRNPA-PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 47/185 (25%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD---------------GRQ--VAVK--RANAATIIHTNI 524
FKE +LG G +G V+ +V+ GR VAVK R +A N
Sbjct: 9 FKE--KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK----NA 62
Query: 525 R-EFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL-----HDHLHGGLSP- 577
R +F E+++L ++ NI+ LLG C++ ++ E+M G L HL
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 578 ------------LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI 625
+++S L +++Q A G++YL ++ +HRD+ T N L+ + +I
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKI 179
Query: 626 ADFGL 630
ADFG+
Sbjct: 180 ADFGM 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 49/282 (17%)
Query: 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIR-----EFEME 530
ELKD + F++ +ELG G+ G V+K + ++ +IH I+ + E
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARK-----LIHLEIKPAIRNQIIRE 53
Query: 531 LEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590
L+VL IV G GE + E M G+L D + + + K+S+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAV 112
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL-----------------LTS 633
KGL YL + I+HRDVK NIL++S ++ DFG+ S
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 170
Query: 634 CERDLTT--DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691
ER T ++SD+ + G+ L+E+ GR Y I PP E L +
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR--YPIP--PPDAKELELMFGCPVEGDPAESE 226
Query: 692 NVALPR-----------NVEPLFKLADIAELAIRENPSELPT 722
PR + P + ++ + + E P +LP+
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS 268
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 37/202 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATII-------HTNIREFEMELE 532
F+ LG G+YG V+ V G+ A+K ATI+ HT E +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-----RTERQ 56
Query: 533 VLCNIRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAA 591
VL +R + L Y + +L L+ +++ G L HL+ +R+ I+ +
Sbjct: 57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIV 115
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGI 651
L++LH+ II+RD+K NILLDS+ + DFGL ++ + + ++F
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL----SKEFLAEEEERAYSF-- 166
Query: 652 VLLEILSGRKAYDIEYVPPGIV 673
IEY+ P ++
Sbjct: 167 ----------CGTIEYMAPEVI 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 25/166 (15%)
Query: 478 KDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCN 536
+ +K N +G GS+G VY+A+ +D +VA+K+ + + + EL ++ N
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK------VLQDPQYKNRELLIMKN 115
Query: 537 IRHSNIVNLLGY----CLEMGERLL----VYEFMPRGTLHDHLHGGLSPLNWSLRLKI-- 586
+ H NI+ L Y C + E+ + V EF+P+ T+H ++ + N +L L +
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMK-HYARNNHALPLFLVK 173
Query: 587 --SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFG 629
S Q + L Y+H I HRD+K N+L+D + ++ DFG
Sbjct: 174 LYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216
|
Length = 440 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 479 DATNGFKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCN 536
D F ++G GS G V A V G+ VAVK+ + + RE E+ ++ +
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRD 73
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+H N+V + L E +V EF+ G L D + + +N + + K L
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSV 131
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD------------------- 637
LH A +IHRD+K+ +ILL D +++DFG ++
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188
Query: 638 --LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP 670
L + D+ + GI+++E++ G Y E PP
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLCNI-RHSNIVNLL 546
LG+GS+G V A L ++ AVK I+ + E M E VL +H + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLK------ISMQAAKGLEYLHK 599
C + +RL V E++ G L H+ S R + + GL++LH+
Sbjct: 63 S-CFQTKDRLFFVMEYVNGGDLMFHIQR-------SGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS--CERDLTT----------------- 640
II+RD+K N+LLDS+ +IADFG+ T+
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYDIE 666
D G++L E+L+G+ ++ +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKR-ANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+G G++G V+ DG++VA+K+ N + + R F EL++LC +H N+++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 548 Y-------CLEMGERLLVYEFMPRGTLHDHLHG------GLSPLNWSLRLKISMQAAKGL 594
E E +V E M LH LS + + L Q +GL
Sbjct: 67 ILQPPHIDPFE--EIYVVTELM-----QSDLHKIIVSPQPLSSDHVKVFL---YQILRGL 116
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLL 654
+YLH + I+HRD+K N+L++S+ +I DFGL E D + M +V
Sbjct: 117 KYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 655 EILSGRKAY 663
EIL G + Y
Sbjct: 174 EILMGSRHY 182
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 70/232 (30%)
Query: 484 FKEFNELGRGSYG------------FVYKAVLVDGRQ-----VAVK--RANAATIIHTNI 524
FKE +LG G +G F+ K +D VAVK R +A + N
Sbjct: 9 FKE--KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNA 62
Query: 525 R-EFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL----------HG 573
R +F E++++ ++ NI+ LL C+ ++ E+M G L+ L
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 574 GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633
+ +++S + ++ Q A G++YL ++ +HRD+ T N L+ ++ +IADFG+
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGM--- 176
Query: 634 CERDLTT---------------------------DMKSDVHNFGIVLLEILS 658
R+L + SDV FG+ L EIL+
Sbjct: 177 -SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIR-----EFEME 530
ELKD + F+ +ELG G+ G V K + ++ +IH I+ + E
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARK-----LIHLEIKPAIRNQIIRE 53
Query: 531 LEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590
L+VL IV G GE + E M G+L D + + + K+S+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAV 112
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL-----------------LTS 633
+GL YL + I+HRDVK NIL++S ++ DFG+ S
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMS 170
Query: 634 CERDLTT--DMKSDVHNFGIVLLEILSGR 660
ER T ++SD+ + G+ L+E+ GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 32/161 (19%)
Query: 484 FKEFNELGRGSYGFVYKAV------LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+ + ++LG G+Y V+K LV +++ ++ A T IRE + +L N+
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIRE----VSLLKNL 60
Query: 538 RHSNIVNL-----LGYCLEMGERLLVYEFMPRGTLH--DHLHGGLSPLNWSLRLKISM-Q 589
+H+NIV L CL LV+E++ D+ +S N +KI M Q
Sbjct: 61 KHANIVTLHDIIHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMHN----VKIFMFQ 111
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+GL Y HK I+HRD+K N+L++ ++ADFGL
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 62/204 (30%), Positives = 89/204 (43%), Gaps = 38/204 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIR-----EFEMELEVL--CN 536
F++ ELG G+ G V K A +IH I+ + EL+VL CN
Sbjct: 3 FEKLGELGAGNGGVVTKV-----LHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN 57
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLE 595
+ IV G GE + E M G+L L G P N + KIS+ +GL
Sbjct: 58 SPY--IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN--ILGKISIAVLRGLT 113
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL-----------------LTSCERDL 638
YL + I+HRDVK NIL++S ++ DFG+ S ER
Sbjct: 114 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 171
Query: 639 TT--DMKSDVHNFGIVLLEILSGR 660
T ++SD+ + G+ L+E+ GR
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 49/145 (33%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELEVLC-NIRHSNIVNLL 546
+G+GS+G V A DG+ AVK I+ ++ M E VL N++H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
Y + ++L V +++ G L HL S R + + A L YLH + I
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNI 117
Query: 606 IHRDVKTLNILLDSDWGARIADFGL 630
I+RD+K NILLDS + DFGL
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 10/144 (6%)
Query: 490 LGRGSYGFVYKAVLVDGRQ-VAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLG 547
+G G++G V+ A+K +I + E VL + H I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 548 YCLEMGERLL--VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ E +R L + E++P G L +L + S L + + LEYLH + I
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLH---SKEI 122
Query: 606 IHRDVKTLNILLDSDWGARIADFG 629
++RD+K NILLD + ++ DFG
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 31/157 (19%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRAN--------AATIIHTNIREFEMELEVLCNIRHS 540
+G+GSYG V A+ G +VA+K+ N A I+ E+++L +RH
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR--------EIKLLRLLRHP 59
Query: 541 NIVNLLGYCL-----EMGERLLVYEFMPRGTLHDHLHGG--LSPLNWSLRLKISMQAAKG 593
+IV + L E + +V+E M LH + L+P + L Q +
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFL---YQLLRA 115
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
L+Y+H + HRD+K NIL ++D +I DFGL
Sbjct: 116 LKYIH---TANVFHRDLKPKNILANADCKLKICDFGL 149
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGR---QVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
+++ ++G G+YG V A+ D R +VA+K+ + EL +L +++H
Sbjct: 17 YRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 541 NIVNLLGYCL------EMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISMQAAK 592
N++ LL + LV FM G L H + + + Q K
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-----LVYQMLK 129
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
GL+Y+H A IIHRD+K N+ ++ D +I DFGL + ++T
Sbjct: 130 GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 54/209 (25%), Positives = 79/209 (37%), Gaps = 52/209 (24%)
Query: 490 LGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG G +G V V R A+K I+ T +E E E+L H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 548 YCLEMGERLLVY---EFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
++ +Y E+ G L L G ++ R I+ EYLH
Sbjct: 61 T---FKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLHNRG- 113
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKA 662
II+RD+K N+LLDS+ ++ DFG + ++ SG+K
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFG----FAK------------------KLKSGQKT 149
Query: 663 YDI----EYVPPGIVE----------WAL 677
+ EYV P I+ W+L
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSL 178
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 43/209 (20%)
Query: 490 LGRGSYGFVYKAVL-VDGRQ---VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
+G G +G V + L + G++ VA+K + R+F E ++ H NI++L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
G + +++ EFM G L L G + + L+ A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---SE 124
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD--------------------- 641
+HRD+ NIL++S+ +++DFGL E D T+D
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD-TSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 642 ------MKSDVHNFGIVLLEILS-GRKAY 663
SDV ++GIV+ E++S G + Y
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 58/219 (26%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANA--ATIIHTNIREFEMELEVLCNIRHS 540
++ + +G G+YG V A G +VAVK+ + +IIH R + EL +L +++H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYR-ELRLLKHMKHE 76
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHD--------HLHGGLSPLNWSLRLK------- 585
N++ LL F P +L + HL G + LN ++ +
Sbjct: 77 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMG--ADLNNIVKCQKLTDDHV 122
Query: 586 --ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--- 640
+ Q +GL+Y+H + IIHRD+K N+ ++ D +I DFGL + ++T
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 179
Query: 641 ----------------DMKSDVHNFGIVLLEILSGRKAY 663
+ D+ + G ++ E+L+GR +
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+GRG+YG V A + +VA+K+ A + + E+++L ++ H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71
Query: 549 CLEMGER------LLVYEFM----------PRGTLHDHLHGGLSPLNWSLRLKISMQAAK 592
+ R +VYE M + DH L Q +
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFL------------YQLLR 119
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL-TSCERD 637
GL+Y+H + ++HRD+K N+LL+++ +I DFGL T+ E+
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 41/201 (20%)
Query: 483 GFKEFNELGRGSYGFVYKAVLVDGR--QVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
G+ L GS G V+ A G+ V +K T + +E +L N+ H
Sbjct: 67 GYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTTL--------IEAMLLQNVNHP 117
Query: 541 NIVNLLGYCLEMGERLLVYEFMP--RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
+++ + + +V +P L+ +L PL L I Q +GL YLH
Sbjct: 118 SVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 599 KDAAPPIIHRDVKTLNILLDS-------DWGA------RIADFGLLTSCE--------RD 637
A IIHRDVKT NI ++ D GA A GL + E RD
Sbjct: 175 ---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231
Query: 638 LTTDMKSDVHNFGIVLLEILS 658
+ K+D+ + GIVL E+L+
Sbjct: 232 -KYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 39/176 (22%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQ-VAVKRANA--ATIIHTNIREFEMELEVLCNIRHS 540
++ +G G+YG V A RQ VAVK+ + ++IH R EL +L +++H
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA--RRTYRELRLLKHMKHE 74
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHD--------HLHGGLSPLNWSLRLK------- 585
N++ LL F P ++ + +L G + LN ++ +
Sbjct: 75 NVIGLLDV------------FTPATSIENFNEVYLVTNLMG--ADLNNIVKCQKLSDEHV 120
Query: 586 --ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
+ Q +GL+Y+H IIHRD+K N+ ++ D RI DFGL + ++T
Sbjct: 121 QFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 41/207 (19%)
Query: 489 ELGRGSYGFVYKAVLV---DGRQVAVK----RANAATIIHTNIREFEMELEVLCNIRHSN 541
ELG G++G V K + + VAVK N + +RE V+ + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLRE----ANVMQQLDNPY 57
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
IV ++G C E +LV E G L+ L ++ ++ Q + G++YL +
Sbjct: 58 IVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEETN 115
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL---LTS---------------------CERD 637
+HRD+ N+LL + A+I+DFGL L + C
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 638 LTTDMKSDVHNFGIVLLEILS-GRKAY 663
KSDV +FG+++ E S G+K Y
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 51/205 (24%)
Query: 490 LGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNI-----REFEMELEVLCNIRHSNIV 543
LG G+ G VYKA L+ R +AVK +I +I ++ ELE+L I+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVK------VIPLDITVELQKQIMSELEILYKCDSPYII 62
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLH------DHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
G + EFM G+L +H+ G +I++ KGL YL
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLTYL 111
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------- 640
+ I+HRDVK N+L+++ ++ DFG+ T +
Sbjct: 112 W---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGE 168
Query: 641 --DMKSDVHNFGIVLLEILSGRKAY 663
+ SDV + GI +E+ GR Y
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 51/221 (23%)
Query: 506 GRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIVNLL--GYCLEMGERLLVYEF 561
G +VA+K R +A H R F E + + H NIV LL G G V+E+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRAR-FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 562 MPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL-- 617
+P TL + L G L + RL +Q L H I+HRD+K NI++
Sbjct: 61 VPGRTLREVLAADGALPAGE-TGRLM--LQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 618 -DSDWGARIADFGL--LTSCERD-------LTTDM-------------------KSDVHN 648
A++ DFG+ L RD TT++ SD++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 649 FGIVLLEILSGRKAY------DIEYVPPGIVEWALPLIKQG 683
+G++ LE L+G++ +I Y V+ +LP G
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 37/206 (17%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
+ + ++G GS G V A GRQVAVK + + RE E+ ++ + +H N
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQN 79
Query: 542 IVNLLGYCLEMGERLLV-YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+V + L +GE L V EF+ G L D + + LN + + L YLH
Sbjct: 80 VVEMYKSYL-VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ 136
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL---------------------- 638
+IHRD+K+ +ILL D +++DFG +D+
Sbjct: 137 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193
Query: 639 -TTDMKSDVHNFGIVLLEILSGRKAY 663
T++ D+ + GI+++E++ G Y
Sbjct: 194 YGTEV--DIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 8/151 (5%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F+++ LG+G +G V V G+ A KR I + E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLR-LKISMQAAKGLEYLHK 599
+VNL Y E + L LV M G L H++ +P R L + + GLE LH+
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ ++RD+K NILLD RI+D GL
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 17/156 (10%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVDGRQ-VAVKRANAAT----IIHTNIREFEMELEVLCN 536
N F+ +G G+YG V K + ++ VA+K+ + + T +RE +M L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKM----LRT 56
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLH--DHLHGGLSPLNWSLRLKISMQAAKGL 594
++ NIV L G+ LV+E++ + L + + G+ P +R I Q K +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK--VRSYI-YQLIKAI 113
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ HK+ I+HRD+K N+L+ + ++ DFG
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGF 146
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 8/181 (4%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F+++ LG+G +G V V G+ A K+ I + + + +S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
V L Y E + L LV M G L H+ H G + + + + GLE LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGR 660
I++RD+K NILLD RI+D GL T +K V G + E++
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 176
Query: 661 K 661
+
Sbjct: 177 R 177
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 19/150 (12%)
Query: 490 LGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG+GS+G V A L GR AVK I+ + E M E +L R+ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 548 YCLEMGERLL-VYEFMPRGTLHDHLHGGLSPLNWSLRLK------ISMQAAKGLEYLHKD 600
C + +RL V EF+ G L H+ S R + + L +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK-------SRRFDEARARFYAAEITSALMFLHDK 115
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGL 630
II+RD+K N+LLD + ++ADFG+
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRA----NAATIIHTNIREFEMELEVLCNIR 538
+++ ++G G+YG V+KA + VA+KR + + + +RE + +L ++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELK 57
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRG--TLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
H NIV L + LV+E+ + D +G + P + Q KGL +
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---EIVKSFMFQLLKGLAF 114
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H ++HRD+K N+L++ + ++ADFGL
Sbjct: 115 CHSHN---VLHRDLKPQNLLINKNGELKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-----TNIREFEMELEVLCNI 537
+K ++G G++ V KA G+ A+K N+RE L L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREI-QALRRLSP- 56
Query: 538 RHSNIVNLLGYCLE--MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM-QAAKGL 594
H NI+ L+ + G LV+E M L++ + G PL R+K M Q K L
Sbjct: 57 -HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSL 113
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
+++H++ I HRD+K NIL+ D ++ADFG SC
Sbjct: 114 DHMHRNG---IFHRDIKPENILIKDDIL-KLADFG---SC 146
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 41/201 (20%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVN 544
LG+G++G K +LV GR A+K II + + E VL N RH +
Sbjct: 3 LGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLT 58
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L Y + +RL V E+ G L HL R + LEYLH +
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SR 114
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD--MKS----------------- 644
+++RD+K N++LD D +I DFGL C+ ++ MK+
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 645 -----DVHNFGIVLLEILSGR 660
D G+V+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAAT----IIHTNIREFEMELEVLCNIR 538
+++ ++G G+YG VYKA V +A+K+ + T IRE + +L ++
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIRE----ISLLKEMQ 59
Query: 539 HSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSP-LNWSLRL-KISM-QAAKGL 594
H NIV L + +RL LV+E++ L H SP + RL K + Q +G+
Sbjct: 60 HGNIVRLQD-VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFGLLTSCERDLTTDMKSDVHNFGIVL 653
Y H ++HRD+K N+L+D A ++ADFGL R +++ H +V
Sbjct: 116 AYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGL----ARAFGIPVRTFTHE--VVT 166
Query: 654 L-----EILSGRKAY 663
L EIL G + Y
Sbjct: 167 LWYRAPEILLGSRHY 181
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 29/168 (17%)
Query: 483 GFKEFNELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEM-------ELE 532
++ ELG+G+YG V A + VA+K+ TN+ ++ EL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKI-------TNVFSKKILAKRALRELK 53
Query: 533 VLCNIR-HSNIVNLLGYCLEMG-----ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKI 586
+L + R H NI L Y +++ L +YE + LH + G PL +
Sbjct: 54 LLRHFRGHKNITCL--YDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSF 110
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
Q GL+Y+H + ++HRD+K N+L+++D +I DFGL
Sbjct: 111 IYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 484 FKEFNELGRGSYGFVYKAV------LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+ + ++LG G+Y VYK LV +++ ++ A T IRE + +L ++
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPC--TAIRE----VSLLKDL 61
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
+H+NIV L LV+E++ + L +L + +N Q +GL Y
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H+ ++HRD+K N+L++ ++ADFGL
Sbjct: 121 HRRK---VLHRDLKPQNLLINERGELKLADFGL 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 489 ELGRGSYGFVYKAVLVDG---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
++GRG+YG VYKA DG ++ A+K+ I + R E+ +L ++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63
Query: 546 LGYCLEMGER--LLVYEFMPRGTLH-DHLHGGLSPLNWSLRLKISM------QAAKGLEY 596
L +R L++++ H H ++L SM Q G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGAR----IADFG---LLTSCERDLTTDMKSDVHNF 649
LH A ++HRD+K NIL+ + R IAD G L S + L D+ V F
Sbjct: 124 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTF 179
Query: 650 GIVLLEILSGRKAY 663
E+L G + Y
Sbjct: 180 WYRAPELLLGARHY 193
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 15/165 (9%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+++ +G G+ G V A V G VAVK+ + T+ + EL +L + H NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 543 VNLLGYCL------EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
++LL E + LV E M L +H L S L Q G+++
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLL---YQMLCGIKH 138
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL-TSCERDLTT 640
LH IIHRD+K NI++ SD +I DFGL T+C + T
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT 180
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 40/171 (23%), Positives = 65/171 (38%), Gaps = 17/171 (9%)
Query: 489 ELGRGSYG----FVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+G+ + K VAVK+ N + +++ + E+ ++H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 545 LLGYCLEMGERLLVYEFMPRGT----LHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+ + E +V M G+ L H GL L + LK L+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIHSK 120
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGI 651
IHR VK +ILL D ++ GL S + VH+F
Sbjct: 121 G---FIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPK 166
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 14/153 (9%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSN 541
F+ ++G+G YG V+ A D G VA+KR + + N +R E ++L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLH--GGLSPLNWSLRLKIS-MQAAKGLEYL 597
+V LL Y + E L L E++P G L+ G LS R ++ M A ++ L
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS--EDHARFYMAEMFEA--VDAL 117
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H+ IHRD+K N L+D+ ++ DFGL
Sbjct: 118 HELG---YIHRDLKPENFLIDASGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 490 LGRGSYGFVY---KAVLVDGRQV-AVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVN 544
LG+GS+G V+ K D Q+ A+K AT+ + +R +ME ++L + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 545 LLGYCLEM-GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L Y + G+ L+ +F+ G L L + ++ ++ + A L++LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG-- 118
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGL 630
II+RD+K NILLD + ++ DFGL
Sbjct: 119 -IIYRDLKPENILLDEEGHIKLTDFGL 144
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 484 FKEFNELGRGSYGFVY---KAVLVD-GRQVAVKRANAATIIH--TNIREFEMELEVLCNI 537
F+ LG G+YG V+ K D G+ A+K A ++ + E VL ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 538 RHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
R S + L Y + +L L+ +++ G + HL+ + +R S + LE+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-YSGEIILALEH 120
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNF------- 649
LHK I++RD+K NILLDS+ + DFGL ++ ++ K ++F
Sbjct: 121 LHKLG---IVYRDIKLENILLDSEGHVVLTDFGL----SKEFLSEEKERTYSFCGTIEYM 173
Query: 650 --------------------GIVLLEILSGRKAYDIE 666
GI++ E+L+G + +E
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 36/168 (21%)
Query: 525 REFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSL 582
R+F E ++ H NI++L G + ++V E+M G+L L H G +++
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG----QFTV 105
Query: 583 RLKISM--QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637
+ M A G++YL +HRD+ NIL++S+ +++DFGL E D
Sbjct: 106 IQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 638 --LTTDMK-------------------SDVHNFGIVLLEILS-GRKAY 663
T K SDV ++GIV+ E++S G + Y
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 46/148 (31%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G G+ G V A V G+ VA+K+ + T+ + EL ++ + H NI+ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 549 CL------EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
E + LV E M L + L S L Q G+++LH +
Sbjct: 84 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLL---YQMLCGIKHLH---S 136
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGL 630
IIHRD+K NI++ SD +I DFGL
Sbjct: 137 AGIIHRDLKPSNIVVKSDCTLKILDFGL 164
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVN 544
LG+G++G K +LV G+ A+K II + + E VL N RH + +
Sbjct: 3 LGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L Y + +RL V E++ G L HL R + L+YLH +
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SG 114
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKS------------------- 644
I++RD+K N++LD D +I DFGL D T MK+
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-MKTFCGTPEYLAPEVLEDNDYG 173
Query: 645 ---DVHNFGIVLLEILSGR 660
D G+V+ E++ GR
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 27/161 (16%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATII------HTNIREFEMELEVLCNIRH 539
LG+G++G K +LV G+ A+K II HT E VL N RH
Sbjct: 3 LGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHT-----LTESRVLQNTRH 54
Query: 540 SNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ L Y + +RL V E+ G L HL R + L YLH
Sbjct: 55 PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH 112
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
+++RD+K N++LD D +I DFGL C+ ++
Sbjct: 113 SCD---VVYRDLKLENLMLDKDGHIKITDFGL---CKEGIS 147
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 18/150 (12%)
Query: 490 LGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G GS+G +Y A D +K + + + E+ +L ++H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 549 CLEMGERLLVYEFMPRGTLHDHL---HGGL----SPLNWSLRLKISMQAAKGLEYLHKDA 601
E G +V E+ G L + G L L+W + Q + GL+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV------QISLGLKHIHDRK 121
Query: 602 APPIIHRDVKTLNILLDSDWG-ARIADFGL 630
I+HRD+K+ NI L + A++ DFG+
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 33/180 (18%)
Query: 476 ELKDATNGFKEFNELGRGSYGFVYKAVL---VDGRQ---VAVKRANAATIIHTNIREFEM 529
E+ +T F E ELG +G VYK L G Q VA+K EF+
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR-EEFKH 57
Query: 530 ELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL------------------ 571
E + ++H NIV LLG + +++ + LH+ L
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 572 HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631
L P ++ + I Q A G+E+L ++ ++H+D+ T N+L+ +I+D GL
Sbjct: 118 KSTLEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLF 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 490 LGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEM-ELEVLC-NIRHSNIVNLL 546
+G+GS+G V A +DG+ AVK +++ ++ M E VL N++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
Y + E+L V +F+ G L HL S R + + A L YLH + I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 606 IHRDVKTLNILLDSDWGARIADFGL 630
++RD+K NILLDS + DFGL
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 51/182 (28%), Positives = 73/182 (40%), Gaps = 58/182 (31%)
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD-- 641
L S Q AKG+ +L A+ IHRD+ NILL +I DFGL RD+ D
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGL----ARDIRNDSN 269
Query: 642 -------------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VE 674
+SDV ++GI+L EI S G Y PG+ V+
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY------PGMPVD 323
Query: 675 WAL-PLIKQGKAAAIIDRNVALPRNVEPLF---KLADIAELAIRENPSELPTMSQVATWL 730
+IK+G R + P ++ DI + +P + PT Q+ +
Sbjct: 324 SKFYKMIKEGY------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
Query: 731 EQ 732
EQ
Sbjct: 372 EQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 46/148 (31%), Positives = 67/148 (45%), Gaps = 12/148 (8%)
Query: 490 LGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG+G +G V + G+ A K+ N + E M E +L + HS + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLR----LKISMQAAKGLEYLHKDAA 602
Y + L LV M G L H++ + N + Q GLE+LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLHQRR- 117
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGL 630
II+RD+K N+LLD+D RI+D GL
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 34/164 (20%)
Query: 484 FKEFNELGRGSYGFV---YKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
++ +G G+ G V Y AVL R VA+K+ + T+ + EL ++ + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHD----HLHGGLSPLNWSLRLKISM-------- 588
NI++LL F P+ +L + +L L N +++ +
Sbjct: 77 NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 589 --QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Q G+++LH IIHRD+K NI++ SD +I DFGL
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 484 FKEFNELGRGSYGFVYKAV------LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+ + +LG G+Y V+K LV +++ ++ A T IRE + +L ++
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIRE----VSLLKDL 61
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLH--DHLHGGLSPLNWSLRLKISMQAAKGLE 595
+H+NIV L LV+E++ + D +S N + L Q +GL
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---YQILRGLA 118
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Y H+ ++HRD+K N+L++ ++ADFGL
Sbjct: 119 YCHRRK---VLHRDLKPQNLLINERGELKLADFGL 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 36/152 (23%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F+ ++GRG + VY+A L+D + VA+K+ ++ R+ + E+++L + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHD---HLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
++ L +E E +V E G L + + K +Q +E++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ ++HRD+K N+ + + ++ D GL
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 483 GFKEFNELGRGSYGFVYKAVLVDGRQ--VAVKRAN--------AATIIHTNIREFEMELE 532
+ LG G++G VYK + Q +A+K N +I + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 533 VLC-NIRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLK----- 585
++ +RH NIV LE +RL +V + + L +H + SL+ K
Sbjct: 61 IIKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFN--------SLKEKKQRFT 111
Query: 586 ------ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
I +Q L YLHK+ I+HRD+ NI+L D I DFGL
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGL 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 36/199 (18%)
Query: 490 LGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVN 544
LG+G++G K +LV GR A+K I+ + + E VL N RH +
Sbjct: 3 LGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLT 58
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L Y + +RL V E+ G L HL R + L+YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEK 115
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKS------------------- 644
+++RD+K N++LD D +I DFGL +D T MK+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCGTPEYLAPEVLEDNDYG 174
Query: 645 ---DVHNFGIVLLEILSGR 660
D G+V+ E++ GR
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 27/194 (13%)
Query: 489 ELGRGSYGFVYKAVLVDG---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
++GRG+YG VYKA DG R A+K+ I + R E+ +L ++H N+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR----EIALLRELKHPNVISL 63
Query: 546 LGYCLEMGER--LLVYEFMPRGTLH-DHLHGGLSPLNWSLRLKISM------QAAKGLEY 596
L +R L++++ H H ++L M Q G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGAR----IADFG---LLTSCERDLTTDMKSDVHNF 649
LH A ++HRD+K NIL+ + R IAD G L S + L D+ V F
Sbjct: 124 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL-ADLDPVVVTF 179
Query: 650 GIVLLEILSGRKAY 663
E+L G + Y
Sbjct: 180 WYRAPELLLGARHY 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-----SNIVN 544
+GRGSY K +LV +R A +I + + +++ + +H SN
Sbjct: 3 IGRGSYA---KVLLV--ELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 545 LLGY--CLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L+G C + RL V EF+ G L H+ R S + + L +LH+
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNFLHERG 116
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--DLTTD------------MKSDVH 647
II+RD+K N+LLD++ ++ D+G+ R D T+ ++ + +
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 648 NF-------GIVLLEILSGRKAYDI 665
F G+++ E+++GR +DI
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 8/152 (5%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F+ ++GRG + VY+A L+DG VA+K+ ++ R + E+++L + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHD---HLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
++ +E E +V E G L H + K +Q LE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ ++HRD+K N+ + + ++ D GL
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 62/251 (24%), Positives = 90/251 (35%), Gaps = 63/251 (25%)
Query: 446 KHELDTDAIADSL---------PHPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYG 496
H D DA +SL P ++ A V R+ + + L GS G
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQ--------YNILSSLTPGSEG 106
Query: 497 FVYKAVL---VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553
V+ ++V VK T + E+++L I H I+NL+
Sbjct: 107 EVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISHRAIINLIH---AYR 156
Query: 554 ERLLVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVK 611
+ V MP+ D PL + I + + L YLH IIHRDVK
Sbjct: 157 WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVK 212
Query: 612 TLNILLDSDWGARIADFGLLTSCERDLTTD-------------------------MKSDV 646
T NI LD A + DFG +C+ D D K+D+
Sbjct: 213 TENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270
Query: 647 HNFGIVLLEIL 657
+ G+VL E+
Sbjct: 271 WSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G G+YG V A+ G +VA+K+ + + EL +L +++H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 549 CL------EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM---QAAKGLEYLHK 599
E + LV +M + L + LS K+ Q GL+Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLS------EDKVQYLVYQMLCGLKYIHS 135
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
IIHRD+K N+ ++ D +I DFGL + ++T
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 56/212 (26%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG- 547
LG+GS+G V+ A L Q A+K ++ M+ +V C + +++L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--------MDDDVECTMVEKRVLSLAWE 54
Query: 548 -------YC-LEMGERLL-VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK---GLE 595
YC + E L V E++ G L H+ S + L + + AA+ GL+
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLP-RATFYAAEIICGLQ 110
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKS----------- 644
+LH I++RD+K NILLD+D +IADFG+ C+ ++ D K+
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIA 164
Query: 645 -------------DVHNFGIVLLEILSGRKAY 663
D +FG++L E+L G+ +
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 9/145 (6%)
Query: 490 LGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEM-ELEVLC-NIRHSNIVNLL 546
+G+GS+G V A DG AVK TI+ + M E VL N++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
Y + E+L V +++ G L HL L R + + A + YLH + I
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 606 IHRDVKTLNILLDSDWGARIADFGL 630
I+RD+K NILLDS + DFGL
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 47/237 (19%)
Query: 490 LGRGSYGFVYKAVLVDGRQV----AVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVN 544
LG+GS+G K +L + + A+K II + E M E VL +
Sbjct: 8 LGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L C + +RL V E++ G L H+ + + + + A GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKG-- 121
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLL--------TSCERDLTTDM------------K 643
II+RD+K N++LD++ +IADFG+ T+ T D K
Sbjct: 122 -IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 644 S-DVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699
S D FG++L E+L+G+ +D G E L +I++ NV+ P+++
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFD------GEDEDEL-------FQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 16/182 (8%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN---IVNL 545
+GRG +G VY D G+ A+K + I + ++ ++ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 546 LGYCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
+ Y ++L + + M G LH HL HG S + + GLE++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF---YATEIILGLEHMHNRF- 117
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKA 662
+++RD+K NILLD RI+D GL +C+ S V G + E+L A
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGL--ACDFSKKKPHAS-VGTHGYMAPEVLQKGTA 172
Query: 663 YD 664
YD
Sbjct: 173 YD 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 38/180 (21%)
Query: 472 FRLSELKDAT----NGFKEFNELGRGSYGFV---YKAVLVDGRQVAVKRANAATIIHTNI 524
F E+ D+T ++ +G G+ G V Y A+L R VA+K+ + T+
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHA 67
Query: 525 REFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHD--HLHGGLSPLNWSL 582
+ EL ++ + H NI+ LL F P+ +L + ++ + ++ +L
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 583 RLKISM------------QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
I M Q G+++LH IIHRD+K NI++ SD +I DFGL
Sbjct: 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 34/110 (30%), Positives = 47/110 (42%), Gaps = 34/110 (30%)
Query: 576 SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635
PL + S Q A+G+E+L A+ IHRD+ NILL + +I DFGL
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL----A 220
Query: 636 RDLTTD---------------------------MKSDVHNFGIVLLEILS 658
RD+ D +SDV +FG++L EI S
Sbjct: 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 40/207 (19%)
Query: 490 LGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVN 544
LG+GS+G K +L + A+K +I + E M E VL +
Sbjct: 8 LGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L C + +RL V E++ G L H+ + + + + + GL +LH+
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG-- 121
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKS------------------- 644
II+RD+K N++LDS+ +IADFG+ C+ + + +
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 645 -----DVHNFGIVLLEILSGRKAYDIE 666
D +G++L E+L+G+ +D E
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 70/280 (25%), Positives = 113/280 (40%), Gaps = 69/280 (24%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLC-NIRHSNIVNLL 546
LG+GS+G V A L + A+K ++ + E M E VL H + +L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 547 GYC-LEMGERLL-VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK---GLEYLHKDA 601
+C + E L V E++ G L H+ S + + AA+ GL++LHK
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFDEA-RARFYAAEIICGLQFLHKKG 116
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKS----------------- 644
II+RD+K N+LLD D +IADFG+ C+ ++ + K+
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGM---CKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 645 -------DVHNFGIVLLEILSGRKAY--------------DIEYVPPGIVEWALPLIKQG 683
D +FG++L E+L G+ + D + P I + A + +
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSK- 229
Query: 684 KAAAIIDRN------VALPRNVEPLFKLADIAELAIRENP 717
+ +R+ V P F+ D L RE P
Sbjct: 230 ----LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIP 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F+ + LG+G +G V V G+ A K+ I + E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKI-SMQAAKGLEYLHK 599
+V+L Y E + L LV M G L H++ +P R + + GLE LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632
+ I++RD+K NILLD RI+D GL
Sbjct: 121 ER---IVYRDLKPENILLDDYGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 16/149 (10%)
Query: 488 NELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNL 545
LG GS+G V A G A+K I+ ++ E +L + H IVN+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 546 LGYCLEMGERLL--VYEFMPRGTLHDHLH-GGLSPLNWSLRLKI-SMQAAKGLEYLH-KD 600
C E + + EF+ G L HL G P + + K + EYLH KD
Sbjct: 84 --MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA---KFYHAELVLAFEYLHSKD 138
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFG 629
II+RD+K N+LLD+ ++ DFG
Sbjct: 139 ----IIYRDLKPENLLLDNKGHVKVTDFG 163
|
Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 492 RGSYGFVYKAVL-VDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLGYC 549
RG++G VY + + AVK A +I+ N + + + E + L + IV+L Y
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YS 72
Query: 550 LEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
L+ + LV E++ G + LH + + +K + A L+YLH+ IIHR
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHG---IIHR 128
Query: 609 DVKTLNILLDSDWGARIADFGL 630
D+K N+L+ ++ ++ DFGL
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGL 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 30/166 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKR---ANAATIIHTNIREFEMELEVLCNIRH 539
+ + LG GS G V+ AV D ++VAVK+ + ++ H +RE ++++ + H
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHA-LRE----IKIIRRLDH 61
Query: 540 SNIVNLLGYCLEMGERL--------------LVYEFMPRGTLHDHLHGGLSPLNWSLRLK 585
NIV + G L +V E+M + G LS RL
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLS--EEHARL- 118
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGL 630
Q +GL+Y+H + ++HRD+K N+ +++ D +I DFGL
Sbjct: 119 FMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGL 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 41/153 (26%), Positives = 66/153 (43%), Gaps = 21/153 (13%)
Query: 490 LGRGSYGFVYKAVLV-------DGRQVAVKRANAATIIHTNIREFEMEL----EVLCNIR 538
LGRG+ +Y +L DG + ++ + R+ + ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
H +IV L G C+ E ++V EF+ G L +H L + K++ Q A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 599 -KDAAPPIIHRDVKTLNILL-----DSDWGARI 625
KD ++H +V T NILL D + G I
Sbjct: 123 DKD----LVHGNVCTKNILLAREGIDGECGPFI 151
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 28/200 (14%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIH--TNIREFEMELEVLCNIRHSNIVNLLG 547
+GRGSY V L Q+ + ++H +I + E V + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
C + RL LV E++ G L H+ R + + L +LH+ II
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERG---II 118
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCER--DLTTD------------MKSDVHNF--- 649
+RD+K N+LLD+D ++ D+G+ D T+ ++ + + F
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 650 ----GIVLLEILSGRKAYDI 665
G+++ E+++GR +DI
Sbjct: 179 WWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 41/205 (20%)
Query: 490 LGRGSYGFVYKAV---LVDGRQ-----VAVKRANAATIIHTNIRE-FEMELEVLCNIRHS 540
LG+G++ ++K + + D + V +K + + H N E F ++ + H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
++V G C+ E ++V E++ G+L +L + +N S +L+++ Q A L +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 601 AAPPIIHRDVKTLNILL----DSDWGA----RIADFGL-LTSCERDLTTD---------- 641
+ H +V N+LL D G +++D G+ +T +++ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 642 -------MKSDVHNFGIVLLEILSG 659
+ +D +FG L EI SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 38/205 (18%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-----SNIVN 544
+GRGSY K +LV R +R A ++ + + +++ + +H SN
Sbjct: 3 IGRGSYA---KVLLV--RLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 545 LLGY--CLEMGERLL-VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L+G C + RL V E++ G L H+ R S + + L YLH+
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHERG 116
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--DLTTD------------MKSDVH 647
II+RD+K N+LLDS+ ++ D+G+ R D T+ ++ + +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 648 NF-------GIVLLEILSGRKAYDI 665
F G+++ E+++GR +DI
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 35/111 (31%), Positives = 48/111 (43%), Gaps = 34/111 (30%)
Query: 575 LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
SPL + S Q A+G+E+L A+ IHRD+ NILL + +I DFGL
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL---- 220
Query: 635 ERDLTTD---------------------------MKSDVHNFGIVLLEILS 658
RD+ D +SDV +FG++L EI S
Sbjct: 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 6/152 (3%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F+ + LG+G +G V V G+ A K+ I + + + +S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKD 600
V L Y E + L LV M G L H++ G + + + + GLE L ++
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632
I++RD+K NILLD RI+D GL
Sbjct: 122 R---IVYRDLKPENILLDDRGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVA---VK--RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
E+G G +G V + + VA VK +ANA++ EF + + ++H NI+
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS---KEQNEFLQQGDPYRILQHPNIL 58
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRL-KISMQAAKGLEYLHKD 600
LG C+E LLV+E+ G L +L + L L +++ + A G+ ++HK
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+H D+ N L SD ++ D+G+
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 34/138 (24%), Positives = 64/138 (46%), Gaps = 16/138 (11%)
Query: 490 LGRGSYGFVYKAVL-------VDGRQVAVKRANAATIIHTNIREFEMELE---VLCNIRH 539
LG+G++ +YK VL + G V ++ ++ R+ E ++ + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVS--VVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
++V L G C+ E ++V E++ G L LH + ++ +L ++ Q A L YL
Sbjct: 61 KHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 600 DAAPPIIHRDVKTLNILL 617
++H +V NIL+
Sbjct: 120 KK---LVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 484 FKEFN---ELGRGSYGFVYKAVLVDGR--QVAVKRANAATII-HTNIREFEMELEVLCNI 537
+++FN LG GS+G V A + VA+KR + II + E ++L I
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
H VNL G + LV EF+ G L N + + Q EYL
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVLIFEYL 147
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ I++RD+K N+LLD D ++ DFG
Sbjct: 148 Q---SLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
|
Length = 340 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 46/146 (31%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 490 LGRGSYGFVYKAVLVD--GRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLL 546
LG+G +G V AV V G+ A K+ + + + + + E E+L + IVNL
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL- 58
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
Y E L LV M G L H+ + G L + S Q G+ +LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL 630
I++RD+K N+LLD R++D GL
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 22/185 (11%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN---IVNL 545
+GRG +G VY D G+ A+K + I + ++ ++ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 546 LGYCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAK---GLEYLHK 599
+ Y ++L + + M G LH HL HG S ++ AA+ GLE++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS------EAEMRFYAAEIILGLEHMHN 115
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSG 659
+++RD+K NILLD RI+D GL +C+ S V G + E+L
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGL--ACDFSKKKPHAS-VGTHGYMAPEVLQK 169
Query: 660 RKAYD 664
AYD
Sbjct: 170 GVAYD 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 19/54 (35%), Positives = 27/54 (50%), Gaps = 9/54 (16%)
Query: 484 FKEFNE--LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE-FEMELEVL 534
F EF + S V++AVL G +VAVK + IRE E +L++L
Sbjct: 125 FSEFEPEPIASASIAQVHRAVLKSGEEVAVK------VQRPGIRERIEADLKLL 172
|
Length = 517 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 33/99 (33%), Positives = 45/99 (45%), Gaps = 34/99 (34%)
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----- 641
S Q AKG+E+L A+ IHRD+ NILL + +I DFGL RD+ D
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL----ARDIYKDPDYVR 237
Query: 642 ----------------------MKSDVHNFGIVLLEILS 658
++SDV +FG++L EI S
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 58/208 (27%)
Query: 490 LGRGSYGFVY-----KAV----LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
LG+GS+G VY KAV L +++ V N + N E ++L + H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-----EAQLLSKLDHP 62
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH-----GGLSPLN----WSLRLKISMQAA 591
IV LE ++ E+ L L G N W ++L +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 592 KGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTT------- 640
G+ Y+H+ I+HRD+K NI L ++ +I DFG L+ SC DL T
Sbjct: 118 -GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSC--DLATTFTGTPY 170
Query: 641 ------------DMKSDVHNFGIVLLEI 656
D KSD+ + G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 40/207 (19%)
Query: 490 LGRGSYGFVYKAVLVDGRQV----AVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVN 544
LG+GS+G K +L + + A+K +I + E M E VL +
Sbjct: 8 LGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 545 LLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L C + +RL V E++ G L + + + + + A GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKG-- 121
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-----------TTDM---------- 642
II+RD+K N++LDS+ +IADFG+ C+ ++ T D
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 643 --KS-DVHNFGIVLLEILSGRKAYDIE 666
KS D FG++L E+L+G+ ++ E
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 67/278 (24%), Positives = 108/278 (38%), Gaps = 57/278 (20%)
Query: 490 LGRGSYGFVYKAVL-VDGRQ---VAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
LG G +G + + L + ++ VA+ RA + R F E L HSNIV
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---KQRRGFLAEALTLGQFDHSNIV 69
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G ++V E+M G L L L + + A G++YL +
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERD----LTTDMK---------------- 643
+H+ + +L++SD +I+ F L + D + T M
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 644 -----SDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR-NVALP 696
SDV +FGIV+ E++S G + Y W + Q A+ D + P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPY-----------WDMS--GQDVIKAVEDGFRLPAP 230
Query: 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734
RN L L + ++ E P SQ+ + L ++V
Sbjct: 231 RNCPNL--LHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTN-IREFEMELEVLCNIRHSN 541
F + +G G++G V VD + A+K A ++ N + E ++L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHK 599
+V L Y + + L V +++P G + L G+ + + R I+ + +E +HK
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIA-ELTCAIESVHK 119
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632
IHRD+K NIL+D D ++ DFGL T
Sbjct: 120 MG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 26/149 (17%)
Query: 539 HSNIVNLLGYCLE-MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
+ N + L Y + + +L+ +++ G L D L L+ + KI Q + L L
Sbjct: 68 NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDL 125
Query: 598 HKDAAPPIIHRDVKTLNILLD-SDWGARIADFGLL----TSCERDLTTDMKS-------- 644
HK IIH D+K N+L D + + D+GL T D T D S
Sbjct: 126 HKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHN 182
Query: 645 -DVHNF-----GIVLLEILSGRKAYDIEY 667
DV F G++ E+L+G+ + +
Sbjct: 183 YDVS-FDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 493 GSYGFVYKAVLVDGRQ-VAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLGYCL 550
G+YG VY + RQ A+K+ N +I N I++ +E ++L + +V++
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC-SF 70
Query: 551 EMGERL-LVYEFMPRG---TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
E L +V E++ G TL ++ G P++ + R+ + + LEYLH I+
Sbjct: 71 ETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMA-RMYFA-ETVLALEYLHNYG---IV 123
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM 642
HRD+K N+L+ S ++ DFGL LTT++
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 14/92 (15%)
Query: 490 LGRGSYGFVYKAVLV------DGRQVAVK--RANAATIIHTNIREFEM-ELEVLCNI-RH 539
LG G++G V +A + +VAVK +A+A HT+ RE M EL++L ++ +H
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQH 101
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL 571
NIVNLLG C G L++ E+ G L + L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 15/31 (48%), Positives = 20/31 (64%), Gaps = 2/31 (6%)
Query: 484 FKEFNE--LGRGSYGFVYKAVLVDGRQVAVK 512
F EF+E + S V++AVL DG +VAVK
Sbjct: 11 FAEFDEEPIAAASIAQVHRAVLKDGEEVAVK 41
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 483 GFKEFNELGRGSYGFVYKAVLVDGRQ-VAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
GF L GS G V+++ D Q V VK A+ +H E +L + H
Sbjct: 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVH--------EARLLRRLSHPA 221
Query: 542 IVNLLGYCLEMGERLLVYEFMP--RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
++ LL + G LV +P R L+ +L L PL + ++ Q ++Y+H
Sbjct: 222 VLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG 278
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFG 629
+ IIHRD+KT N+L++ + DFG
Sbjct: 279 EG---IIHRDIKTENVLVNGPEDICLGDFG 305
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 490 LGRGSYGFVYKAVLVD------GRQVAVKR-ANAATIIHTNIREFEMELEVLCNI-RHSN 541
LGRG++G V +A R VAVK AT + + EL++L +I H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLN 72
Query: 542 IVNLLGYCLEMGERLLV-YEFMPRGTLHDHLHG 573
+VNLLG C + G L+V E+ G L ++L
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRS 105
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 10/156 (6%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG+GS+G V A L +V A+K I+ + + M E +L + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 548 YCLEMGERLL-VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
C + +RL V E++ G L + + + + L +LH+ +I
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VI 118
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM 642
+RD+K NILLD++ ++ADFG+ C+ + +
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM---CKEGILNGV 151
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELEVLC-NIRHSNIVNLL 546
+G+GS+G V A + + AVK I+ + M E VL N++H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ + ++L V +++ G L HL L R + + A L YLH + I
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117
Query: 606 IHRDVKTLNILLDSDWGARIADFGL 630
++RD+K NILLDS + DFGL
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 42/205 (20%)
Query: 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG+GS+G V A L G AVK ++ + E M E VL + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 548 YCLEMGERLL-VYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAK---GLEYLHKDAA 602
+ E L V EF+ G L H+ G L + + AA+ GL++LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHSKG- 116
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKS------------------ 644
II+RD+K N++LD D +IADFG+ C+ ++ D ++
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 645 ------DVHNFGIVLLEILSGRKAY 663
D +FG++L E+L G+ +
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 34/168 (20%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSN 541
FK+ LG+G G V+ L G+ A+K + +I N ++ E E+L + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 542 IVNLLGYC-LEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLK-----ISMQAAK-- 592
+ L Y + L LV ++ P G L L + +S + A+
Sbjct: 63 LPTL--YASFQTETYLCLVMDYCPGGELF------------RLLQRQPGKCLSEEVARFY 108
Query: 593 ------GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
LEYLH I++RD+K NILL ++DF L
Sbjct: 109 AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM 529
++++L+ F +GRG++G V +QV A+K + +I + F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 530 ELEVLCNIRHSN---IVNLLGYCLEMGERLL--VYEFMPRGTLHDHLHGGLSPLNWSLRL 584
E + + H+N IV L + ++ L V E+MP G L + + P W+
Sbjct: 92 EERDI--MAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY 147
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
+ + L+ +H IHRDVK N+LLD ++ADFG
Sbjct: 148 --TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 490 LGRGSYGFVYKA------VLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNI 542
LGRG++G V +A R VAVK H+ R EL++L +I H N+
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNV 73
Query: 543 VNLLGYCLEMGERLLV-YEFMPRGTLHDHL 571
VNLLG C + G L+V EF G L ++L
Sbjct: 74 VNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 38/170 (22%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G+G++G VY+ D R A+K + I+ EV I NI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK--------EVAHTIGERNIL----V 48
Query: 549 CLEMGERLLV----YEFMPRGTLH---DHLHGGLSPLNWSLRL--KISMQAAK------- 592
+ E + + F L+ D++ GG L W L+ + S AK
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG--ELFWHLQKEGRFSEDRAKFYIAELV 106
Query: 593 -GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
LE+LHK I++RD+K NILLD+ + DFGL + +LT +
Sbjct: 107 LALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL---SKANLTDN 150
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 37/119 (31%)
Query: 567 LHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIA 626
L D GL+ L+ L + Q A+G+E+L A+ +HRD+ N+LL +I
Sbjct: 226 LSDDGSEGLTTLDL---LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 627 DFGLLTSCERDLTTDMK---------------------------SDVHNFGIVLLEILS 658
DFGL RD+ D SDV ++GI+L EI S
Sbjct: 280 DFGL----ARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 18/196 (9%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVDGRQV----AVKR-ANAATIIHTNIREFEMELEVLCN 536
F + +GRG +G V +V + A+K + + + FE E ++L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQ---VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-S 56
Query: 537 IRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE 595
I +S + L Y + + L LV E+ P G L L+ + + A+ +
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVL 113
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLE 655
+H +HRD+K N+L+D ++ADFG + + K V + E
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 656 IL-----SGRKAYDIE 666
+L G+ Y +E
Sbjct: 174 VLTTMNGDGKGTYGVE 189
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 45/206 (21%)
Query: 490 LGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
+G GS+G +A+LV ++ A+K + + E +L ++H NIV
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSS-AVEDSRKEAVLLAKMKHPNIVAF 63
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHL---HGGLSP----LNWSLRLKISMQAAKGLEYLH 598
G +V E+ G L + G L P L W +Q G++++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQHIH 117
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFG---LLTS-----CE-------------RD 637
+ ++HRD+K+ NI L + ++ DFG LLTS C +
Sbjct: 118 EKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 638 LTTDMKSDVHNFGIVLLEILSGRKAY 663
+ + KSD+ + G +L E+ + + +
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 42/165 (25%)
Query: 526 EFEMELEVLCNIRHSNIVNL--------LGYCLEMGERLLVYEFMPRGTLH--DHLHGGL 575
+ E E+ L + H NI+ + Y + +Y FM D
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKD------ 262
Query: 576 SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635
PL R I Q +EY+H +IHRD+K NI L+ D + DFG E
Sbjct: 263 RPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 636 RD-----------LTTDMK-----------SDVHNFGIVLLEILS 658
++ + T+ +D+ + G++LL++LS
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSN 541
F+ +GRG++G V D G A+K A ++ + E ++L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+V + Y + L L+ EF+P G + L + + + I+ + ++ +H+
Sbjct: 63 VVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQL 120
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE--------RDLTTDMKSD 645
IHRD+K N+LLD+ +++DFGL T + R+LT + SD
Sbjct: 121 G---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 7/167 (4%)
Query: 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEMEL 531
++ +L+ ++ +GRG++G V R+V A+K + +I + F E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 532 EVLCNIRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590
+ +S V L Y + L +V E+MP G L + + P W+ R + +
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RF-YTAEV 151
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637
L+ +H IHRDVK N+LLD ++ADFG ++
Sbjct: 152 VLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 15/36 (41%), Positives = 24/36 (66%)
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
IHRD+K N+LLD+ +++DFGL T ++ T+
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSN 541
F + LG G++G V A VD A+K +++ N + + E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHK 599
+V L Y + + L V +++P G + L + P + R I+ + +E +HK
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA-RFYIA-ELTLAIESVHK 119
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632
IHRD+K NIL+D D ++ DFGL T
Sbjct: 120 MG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 6/167 (3%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSN 541
F+ +GRG++G V D G A+K A ++ + E ++L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
+V + + L+ EF+P G + L + + I+ + ++ +H+
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG 121
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHN 648
IHRD+K N+LLDS +++DFGL T ++ T+ ++++
Sbjct: 122 ---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLG 547
+G+GS+G V + D +++ A+K A I+ + + E VL + IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
+ + E+L LV F+ G L HL + S + + LE LHK +I
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VI 115
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSD 645
+RD+K NILLD + DFGL C+ ++ D K++
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGL---CKLNMKDDDKTN 151
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 740 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.62 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.31 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.92 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 98.77 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.61 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 98.58 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.01 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 97.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.93 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.72 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 97.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.51 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.18 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.87 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.85 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.51 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.42 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.15 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.09 | |
| PLN02236 | 344 | choline kinase | 96.05 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.84 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.02 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-53 Score=458.17 Aligned_cols=266 Identities=49% Similarity=0.784 Sum_probs=238.4
Q ss_pred CccccChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEe
Q 040687 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547 (740)
Q Consensus 468 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g 547 (740)
..+.|++.+++.+|++|+..+.||+|+||.||+|.+.+++.||||++....... .++|.+|+++|.+++|||||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 467899999999999999999999999999999999999999999887654321 567999999999999999999999
Q ss_pred EEEeCC-eEEEEEecCCCCChHHhHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEE
Q 040687 548 YCLEMG-ERLLVYEFMPRGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI 625 (740)
Q Consensus 548 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 625 (740)
||.+.+ +++||||||++|+|.++|+.... +++|..|++||.++|+||+|||+...|+||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999998 59999999999999999998766 8999999999999999999999999999999999999999999999999
Q ss_pred eecCCCccccC---------CC-------------CCCcccceehhHHHHHHHHhCCCCCCCC--CCCchhHHhhhhHHh
Q 040687 626 ADFGLLTSCER---------DL-------------TTDMKSDVHNFGIVLLEILSGRKAYDIE--YVPPGIVEWALPLIK 681 (740)
Q Consensus 626 ~DFGla~~~~~---------~~-------------~~~~ksDVwSfGvvl~ElltG~~p~~~~--~~~~~~~~~~~~~~~ 681 (740)
+|||||+.... .. ..++|+|||||||+|+||+||++|.+.. ..+.++++|+.+.+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999876653 11 1267999999999999999999999864 345569999999999
Q ss_pred hCccchhcccccC-CCCCc-hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 682 QGKAAAIIDRNVA-LPRNV-EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 682 ~~~~~~i~d~~~~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
++++.+++|+++. ..... +.+.++.+++.+|++.+|.+||+|.||++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999999987 44443 678889999999999999999999999999977653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=409.34 Aligned_cols=237 Identities=30% Similarity=0.479 Sum_probs=210.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.+.++..++||+|.||+||+|.++....||+|.++...+ ...+|.+|+++|++|+|+|||+|+|+|..++.++||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 344667789999999999999998888999999987643 33689999999999999999999999999989999999
Q ss_pred cCCCCChHHhHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-
Q 040687 561 FMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL- 638 (740)
Q Consensus 561 y~~~gsL~~~l~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~- 638 (740)
||++|+|.+||+. ....+...+++.++.|||+||+||+++. +|||||.++||||+++..+||+|||||+...++.
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999986 4467899999999999999999999999 9999999999999999999999999999654322
Q ss_pred ---------------------CCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 639 ---------------------TTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 639 ---------------------~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
..+.|||||||||+||||+| |+.||.... ..++.+.+++..++|
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------------n~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------------NEEVLELLERGYRLP 424 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------------HHHHHHHHhccCcCC
Confidence 22679999999999999999 999996432 234556677889999
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
.+..++.++++||..||+.+|++||||+.+...|+++....
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 99999999999999999999999999999999999987654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=404.64 Aligned_cols=234 Identities=26% Similarity=0.398 Sum_probs=203.1
Q ss_pred ccccceecccCceEEEEEEEe-CC----cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DG----RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g----~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
++..++||+|+||+||||.+. ++ -+||||.+..... .+...+|..|+.+|.+|+||||+||+|+|.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 455678999999999999974 33 4799999877654 344578999999999999999999999998765 7899
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
++|||.|+|.||++.++.++..+..+.|..|||+||.|||+++ ++||||..+|||+++...+||.|||+++....+
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999999899999999999999999999999999 999999999999999999999999999866542
Q ss_pred ----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 638 ----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 638 ----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
..++.+||||||||++||++| |.+||+... ..++..+++...+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--------------~~eI~dlle~geR 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--------------AEEIPDLLEKGER 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--------------HHHhhHHHhcccc
Confidence 234779999999999999999 999997431 2234455556666
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
++.++-+..+++.+|.+||..|++.||+++++...+.++.++
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 777888888999999999999999999999999999887765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=385.18 Aligned_cols=238 Identities=34% Similarity=0.469 Sum_probs=197.0
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-eEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-ERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~ 562 (740)
+...+.||+|+||+||+|.++....||||++..........++|.+|+.+|++++|||||+|+|+|.+.. ...||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3444569999999999999966555999999876654444679999999999999999999999999987 789999999
Q ss_pred CCCChHHhHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC----
Q 040687 563 PRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER---- 636 (740)
Q Consensus 563 ~~gsL~~~l~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~---- 636 (740)
++|+|.++|+. ....+++..+++|+.|||+||+|||+... ||||||||+|||++.++ ++||+|||+++....
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 99999999988 36789999999999999999999999874 99999999999999998 999999999864331
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.|+|||||||+||||+||+.||..... ...+... +....+.+.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v---------~~~~~Rp~~ 267 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAV---------VVGGLRPPI 267 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHH---------HhcCCCCCC
Confidence 12468899999999999999999999974321 1111111 112222233
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+.++...+..||.+||+.||++||++.+|+..|+.+...
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 333556888999999999999999999999999988764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=403.52 Aligned_cols=241 Identities=30% Similarity=0.435 Sum_probs=204.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..+.+....++||+|.||+||+|+.. +...||||.++.... .+...+|++|+++|+.|+|||||+|+|+|.++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 34456677789999999999999953 346799999987763 34568999999999999999999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL-------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS 619 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 619 (740)
+..+||+|||.+|||.+||+.+. .+|+..+.+.||.|||.||+||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999996321 23889999999999999999999998 999999999999999
Q ss_pred CCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHh
Q 040687 620 DWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEW 675 (740)
Q Consensus 620 ~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~ 675 (740)
+..+||+||||++..-. ..+++++||||||||+|||++| |+.||..... +.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----~E 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----QE 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----HH
Confidence 99999999999875432 2345889999999999999999 9999964321 12
Q ss_pred hhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 676 ALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 676 ~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
++..+.+ .++ ++.++.++.+++.||..||+.+|++||+++||-..|+++.++.
T Consensus 714 VIe~i~~--------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRA--------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHc--------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2233332 333 6778888889999999999999999999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=402.26 Aligned_cols=236 Identities=24% Similarity=0.373 Sum_probs=210.9
Q ss_pred CccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++.++||.|.||+|++|+++. ...||||.|+.... ++..++|+.|+.||.+++||||++|.|+.......+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45677899999999999999853 45799999987653 45668999999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 638 (740)
+|||+||+|+.||+.+...+++.++.-+.++||.||+||-+.+ +|||||.++|||++++..+||+||||++.++++.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999998888999999999999999999999998 9999999999999999999999999999776533
Q ss_pred ------------------------CCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 639 ------------------------TTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 639 ------------------------~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
+.|.+||||||||||||.++ |.+||.+. ..+++...++..+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------------SNQdVIkaIe~gy 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------------SNQDVIKAIEQGY 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--------------chHHHHHHHHhcc
Confidence 12568999999999999999 99999532 2234455567788
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
++|.+++++..|++||+.||++|-.+||.|.||+..|+++++.
T Consensus 852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999999863
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=395.40 Aligned_cols=239 Identities=30% Similarity=0.456 Sum_probs=201.9
Q ss_pred hcCccccceecccCceEEEEEEEeC--Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD--GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++.+..+.||+|.||.||+|...+ +. .||||.++.... .+...+|.+|..+|++++|||||+++|+|.+...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3456777889999999999999754 43 499999887543 4566889999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 555 RLLVYEFMPRGTLHDHLHGG------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
++|++|||++|+|..||++. ...|+..+++.++.|||+|++|||++. +|||||..+|+||++...+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999977 467999999999999999999999999 999999999999999999999999
Q ss_pred CCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 629 GLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 629 Gla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
|||+...+ +...+.|||||||||+|||++| |..||......+ +.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-----v~------- 914 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-----VL------- 914 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-----HH-------
Confidence 99984332 2233789999999999999999 999997432211 11
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
..++... +++.+..++..+++||..||+.+|++||++..|++.++.+.++-
T Consensus 915 -~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 915 -LDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred -HHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1112222 55566677779999999999999999999999999999988754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.77 Aligned_cols=237 Identities=29% Similarity=0.403 Sum_probs=192.9
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-eEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-ERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 560 (740)
+++..+.||+|..|+|||++++. ++.+|+|.+.... .....+++.+|++++++.+|||||+++|.|..+. ...|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34456789999999999999864 7889999995433 3455688999999999999999999999999998 5999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||.+|+|.+++... ..+++..+-+|+.+|++||.|||+ .. ||||||||+|||+++.+++||+|||.+..+.+
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 99999999999754 569999999999999999999996 55 99999999999999999999999998765432
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCC-CCchhHHhhhhHHhhCccchhcc-cccCCCCC
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEY-VPPGIVEWALPLIKQGKAAAIID-RNVALPRN 698 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~i~d-~~~~~~~~ 698 (740)
...|+.++||||||++++|+.+|+.||.... ...+..+. +..|++ +....|..
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L---------l~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL---------LCAIVDEPPPRLPEG 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH---------HHHHhcCCCCCCCcc
Confidence 3356789999999999999999999997541 12222221 223344 22333333
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
....++..++..||++||.+||+.+|+++ +|.+..
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 45668899999999999999999999997 555443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.60 Aligned_cols=245 Identities=28% Similarity=0.406 Sum_probs=214.8
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (740)
++++....++...++||-|.||.||.|.|+. .-.||||.++.+.+ ...+|++|..+|+.|+|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4555555667888899999999999999976 67899999987653 4579999999999999999999999999999
Q ss_pred eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
.+|||+|||..|+|.|||++.. ..++...++.++.||+.||+||..+. +|||||.++|+|+.++..+||+||||++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999998755 35788889999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCC----------------------CCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 633 SCERDLT----------------------TDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 633 ~~~~~~~----------------------~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
.+..+.+ .+.|||||+|||+|||+.| |-.||..- +...+..++
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--------------dlSqVY~LL 479 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--------------DLSQVYGLL 479 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--------------cHHHHHHHH
Confidence 8765322 2569999999999999999 99999532 223445566
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhccC
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGLI 739 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~~ 739 (740)
+..+++..++.++.++++||+.||+++|.+||++.||-+.||.++.+..|
T Consensus 480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 77888888888999999999999999999999999999999999887654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.11 Aligned_cols=243 Identities=29% Similarity=0.442 Sum_probs=205.7
Q ss_pred ChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..++++...+.+...+.||+|+||+||+|+|. ..||||.++......+..++|++|+..+++-+|.||+-|.|||...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34667777788888999999999999999984 3699999998887777889999999999999999999999999987
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
.. .||+.++++-+|+.|||-....++....+.||.|||+||.|||.+. |||||||+.||+|.+++++||+||||+.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 76 8999999999999999988788999999999999999999999999 9999999999999999999999999975
Q ss_pred ccc--------------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 633 SCE--------------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 633 ~~~--------------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
... ++..++..|||||||+|+|||+||..||..+..+..+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-------------- 602 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-------------- 602 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------------
Confidence 321 2445688999999999999999999999743221111
Q ss_pred hhcccccCCCC----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 687 AIIDRNVALPR----NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 687 ~i~d~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
-.+.+.+..+. ...+..+|.+|+..||..++++||.+.+|+..|+.+..
T Consensus 603 fmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 603 FMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11111111111 23455688999999999999999999999999998876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.15 Aligned_cols=246 Identities=29% Similarity=0.425 Sum_probs=205.4
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeCC-----cEEEEEEeccc-ccchhcHHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVDG-----RQVAVKRANAA-TIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g-----~~vAiK~l~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
..++..-++....++||+|+||.||+|++... ..||||..+.+ ........+|.+|+++|++++|||||+|+|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34444456667778999999999999997542 23899998853 2445677899999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
+..+..+|||||+|++|+|.+||+.....++..++++++.++|.||+|||++. +|||||.++|+|++.+..+||+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999999987667999999999999999999999999 999999999999999999999999
Q ss_pred CCCccccC---------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 629 GLLTSCER---------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 629 Gla~~~~~---------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
||++.... ...++.|+|||||||++||+++ |..||...... .-..
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------------~v~~ 373 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------------EVKA 373 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------------HHHH
Confidence 99875531 2234789999999999999999 89999643210 1112
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.++....+.+.+...+..+..++.+||..+|++||+|.++.+.|+.+.+.
T Consensus 374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 23234455555556677888999999999999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.46 Aligned_cols=182 Identities=30% Similarity=0.455 Sum_probs=164.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..+|...++||+|+|++||+|+++ ++..||||.+......++..+....|+.+|+.|+|||||+|+++++.++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888889999999999999985 4899999999888766666777899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC------CCEEEeecCCCcc
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD------WGARIADFGLLTS 633 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~------~~~ki~DFGla~~ 633 (740)
|||.+|+|.+||+.+ ..+++.....++.|||.||++||++. ||||||||.||||+.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999865 47999999999999999999999999 9999999999999875 4589999999987
Q ss_pred ccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 040687 634 CER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE 666 (740)
Q Consensus 634 ~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~ 666 (740)
+.. ..+|+.|+|+||.|++||||++|+.||+..
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 654 356789999999999999999999999743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=341.24 Aligned_cols=235 Identities=28% Similarity=0.404 Sum_probs=194.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchh-----cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHT-----NIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.+.|...+.||+|+||.|-+|.- ++++.||||++++...... ......+|+++|++|+|||||+++++++..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45678889999999999999996 4599999999987653321 22345799999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CCEEEeecCCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD---WGARIADFGLL 631 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DFGla 631 (740)
.|||||||++|+|.+++-.+ +.+.+..-..++.|++.|+.|||+.+ |+||||||+|||+..+ ..+||+|||||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999755 45777777889999999999999999 9999999999999766 78999999999
Q ss_pred ccccCC-----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 632 TSCERD-----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 632 ~~~~~~-----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
+...+. ..+..|+|+||+||+||-++||..||..++.+..+.+. |
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ------------I 394 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ------------I 394 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH------------H
Confidence 866431 11134899999999999999999999987766655432 2
Q ss_pred cccccC--CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 689 IDRNVA--LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 689 ~d~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
...++. .+.+.+..++..+||.+||..||++||++.|+++ |+.
T Consensus 395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 333332 2335556678889999999999999999999997 655
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.35 Aligned_cols=228 Identities=29% Similarity=0.440 Sum_probs=194.7
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhc-HHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..|...+.||+|+|+.+|.++. ..|+.||+|++.+..+.+.. .....+|++|.++|+|||||+|+++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999997 66999999999886654443 456899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL- 638 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~- 638 (740)
|+|++++|.++++ ..+++++.++..+..||+.||.|||+.+ |||||||..|+||++++++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999998 5578999999999999999999999999 9999999999999999999999999998776321
Q ss_pred --------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 639 --------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 639 --------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
..+..+||||+|||||-||.|++||+... ++..+..++ ...+.+|..
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik--------~~~Y~~P~~ 240 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIK--------LNEYSMPSH 240 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHH--------hcCcccccc
Confidence 12458999999999999999999997432 222333333 234445554
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... +..+||.++|+.||.+|||+++|+.
T Consensus 241 ls~--~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 241 LSA--EAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cCH--HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 443 5569999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=343.38 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=198.9
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.+.+...++||+|.||+|.++....+..||||+++..... ...++|.+|+++|.+|+||||++|+|+|..++.+++|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3456677899999999999999977899999999987632 235789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 561 FMPRGTLHDHLHGGLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~-l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||++|+|.+||..+..+ +.-...++|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++.+-..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999877544 355667789999999999999998 999999999999999999999999999844321
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHh--CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILS--GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
.+.+++||||+|||+|||+++ ..+||....+ +.+++..-.....+... .-
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~------~~ 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQ------VV 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcc------ee
Confidence 234789999999999999998 7889964322 22333322233222221 22
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
++.+.-++.+++++|.+||+.|-++||++++|...|++..
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 3445566678999999999999999999999999888754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.08 Aligned_cols=240 Identities=30% Similarity=0.450 Sum_probs=190.1
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (740)
+.++|+..++||+|+||.||++.+. +++.||+|+++.... ....+.+.+|+.+|.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3467899999999999999999742 256899999875432 23446799999999999 899999999998765
Q ss_pred C-eEEEEEecCCCCChHHhHhCCC--------------------------------------------------------
Q 040687 553 G-ERLLVYEFMPRGTLHDHLHGGL-------------------------------------------------------- 575 (740)
Q Consensus 553 ~-~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------- 575 (740)
. ..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 5889999999999999996431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------------
Q 040687 576 -----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------------- 636 (740)
Q Consensus 576 -----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------------- 636 (740)
.++++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 24788899999999999999999998 99999999999999999999999999864311
Q ss_pred ---------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHH
Q 040687 637 ---------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLA 706 (740)
Q Consensus 637 ---------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~ 706 (740)
...++.++||||||++||||++ |+.||........+ ...+..+. ....+ ......+.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~----~~~~~~~~-------~~~~~--~~~~~~l~ 307 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF----CQRLKDGT-------RMRAP--ENATPEIY 307 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH----HHHHhcCC-------CCCCC--CCCCHHHH
Confidence 1224679999999999999998 99999753322211 11111111 11111 22334788
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 707 DIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 707 ~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+|+.+||+.||++||++.||++.|++++++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.50 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=190.4
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+.|+.+.++|+|+||.|||++.++ |+.||||++......+.-.+-.++|+++|++|+|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457778889999999999999866 9999999997654333333446899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|++. ++.+-|......++.....++..|+++|+.|+|++. +|||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 9987 666666666567899999999999999999999999 99999999999999999999999999987652
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh-hCc----cchhccc--
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK-QGK----AAAIIDR-- 691 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-~~~----~~~i~d~-- 691 (740)
+..|...+|||++||++.||+||...|..+.+-+.+.- ..+ -+. -.+++..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~----I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL----IRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH----HHHHHcccCHHHHHHhccCC
Confidence 23345689999999999999999999876543332211 110 000 0111111
Q ss_pred ---ccCCCC--Cch--------hHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 040687 692 ---NVALPR--NVE--------PLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVK 735 (740)
Q Consensus 692 ---~~~~~~--~~~--------~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~ 735 (740)
.+.+|. .++ ...-+.++++.||+.||++|++-+|++. .++.+++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 111221 111 2235779999999999999999999986 4444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.31 Aligned_cols=242 Identities=29% Similarity=0.406 Sum_probs=184.2
Q ss_pred CccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHH--hCCCCCcceEEeEEEeCC----eEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLC--NIRHSNIVNLLGYCLEMG----ERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~ 556 (740)
.....+.||+|.||.||||++. ++.||||++.. ++.+.|.+|-+|.+ .|+|+||++|+++..... +++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4556678999999999999994 59999999874 34578999999887 468999999999988766 899
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA------APPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
||+||.++|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|+++.|+||||
T Consensus 285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999875 5999999999999999999999853 57999999999999999999999999999
Q ss_pred CccccCCCCC-----------------------------CcccceehhHHHHHHHHhCCCCCCC-C---CC--------C
Q 040687 631 LTSCERDLTT-----------------------------DMKSDVHNFGIVLLEILSGRKAYDI-E---YV--------P 669 (740)
Q Consensus 631 a~~~~~~~~~-----------------------------~~ksDVwSfGvvl~ElltG~~p~~~-~---~~--------~ 669 (740)
|..+...... -.+.||||+|.|||||++.-..++. . +. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9776542211 1268999999999999996554431 1 00 0
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
..-.+.....+.+.+.+..+..... .-..+..+.+.+..||..||+.|.|+.=+.+.+.++..
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0011122222212111111111111 11345578899999999999999999888887777653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=334.71 Aligned_cols=224 Identities=29% Similarity=0.428 Sum_probs=187.4
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+.+.+++-||+|+.|.||+|++ .++.||||+++.- -..+|+-|++|+|+||+.|.|+|.....++|||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 3345667899999999999998 4688999987532 23578889999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc------
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE------ 635 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~------ 635 (740)
|+.|-|+..|+.. .+++...+..|..+||.||.|||.+. |||||||+-||||..+-.+||+|||.+++..
T Consensus 194 Ca~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 194 CAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred cccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhh
Confidence 9999999999876 46888899999999999999999998 9999999999999999999999999866543
Q ss_pred --------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 636 --------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 636 --------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
++...++|+|||||||||||||||..||..-+... .+.-+=...+.+|.+.++
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------------IIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------------IIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------------eEEeccCCcccccCcccC
Confidence 24455789999999999999999999996322100 011111223456677778
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
+.-+.-|++.||+-.|..||+|++|+..|+=
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 8889999999999999999999999998864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=331.17 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=192.2
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERL 556 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 556 (740)
..+.|+.+++||+|.||.||||+. .+|+.||+|+++.+........-..+||.||++|+||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345688889999999999999995 5699999999998775555566678999999999999999999999887 6899
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||+|||++ +|.-++....-.++..++..++.|++.||+|+|+.+ |+|||||.+|||||+++.+||+|||||+.+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999987 999999876667999999999999999999999999 99999999999999999999999999986543
Q ss_pred C-----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH-------HhhCccc
Q 040687 637 D-----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL-------IKQGKAA 686 (740)
Q Consensus 637 ~-----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 686 (740)
. ..|+.+.|+||.||||.||++|+..|+...+-..+...+... +...++.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 2 234679999999999999999999998654333221111000 0000000
Q ss_pred --hhcccccCCCCC-----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 --AIIDRNVALPRN-----VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 --~i~d~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+.+....... ........+|+..+|..||++|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111111110 111235678999999999999999998875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.88 Aligned_cols=243 Identities=24% Similarity=0.266 Sum_probs=191.6
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCC-eEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMG-ERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 557 (740)
.++|...++||.|.||.||+|+. .+++.||||+++.+...-++ -.=++|+..|++|+ |||||+|..++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46789999999999999999996 45889999999876543221 12367999999998 999999999999888 8999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 637 (740)
|||||+. +|++.++.+...+++..+.+|+.||.+||+|+|.++ ++||||||+|||+.....+||+|||||++....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence 9999965 999999988889999999999999999999999999 999999999999999999999999999987543
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHh--hhhHHhh------Cccchh
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEW--ALPLIKQ------GKAAAI 688 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~--~~~~~~~------~~~~~i 688 (740)
..|+.+.|||++|+|++|+.+-+..|.+..+-+.+... ++-.... ..+...
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 33467899999999999999999999765544433220 0000000 011111
Q ss_pred cccccCC--CC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNVAL--PR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.-+.+. +. -..+..+..+||.+|+++||++|||+.|.++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 1111110 00 1124557889999999999999999999886
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.71 Aligned_cols=230 Identities=21% Similarity=0.339 Sum_probs=184.5
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCeEEEEEec
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLE----MGERLLVYEF 561 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey 561 (740)
...|++|+++.||+|++ +++.||||+++....... ..+.|.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 789999999876532222 24678899999999999999999999877 3468899999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++|+|.+++... ..++|...++++.|+++||.|||+. + ++||||||+|||+++++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK 179 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccccc
Confidence 9999999999764 4689999999999999999999985 5 77999999999999999999999999763211
Q ss_pred --------------C--CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 --------------D--LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 --------------~--~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
. ..++.|+|||||||++|||+||+.||..... ..+. ..+ +......+.+..
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~~~~----~~i--------~~~~~~~~~~~~ 246 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIY----DLI--------INKNNSLKLPLD 246 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-HHHH----HHH--------HhcCCCCCCCCc
Confidence 1 2457799999999999999999999974321 1111 111 111111122223
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 4457889999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=311.68 Aligned_cols=235 Identities=23% Similarity=0.362 Sum_probs=189.9
Q ss_pred cCccccceecccCceEEEEEE-EeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeE-EEeCCe-EEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY-CLEMGE-RLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lV 558 (740)
.+|...++||+|+||+|||+. +.++..||.|.++...+..+..++...|+.+|++|+|||||+++++ +.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357888899999999999999 4679999999999777767777889999999999999999999994 444444 8999
Q ss_pred EecCCCCChHHhHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP--IIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
|||+..|+|...++ +....++++.++++..|+++||.++|++- |. |+||||||.||+|+.++.+||.||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999885 33356899999999999999999999832 33 99999999999999999999999999887
Q ss_pred ccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 634 CER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 634 ~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
+.. +..++.||||||+||++|||..-..||..+ ++.+. -..+.+++...+-
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L-~~KI~qgd~~~~p--- 249 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSL-CKKIEQGDYPPLP--- 249 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHH-HHHHHcCCCCCCc---
Confidence 654 334578999999999999999999999754 33221 2233333222111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
..-...++.+|+..|+..||+.||+...++..+
T Consensus 250 -----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 250 -----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 133455788999999999999999954444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.08 Aligned_cols=222 Identities=26% Similarity=0.395 Sum_probs=183.5
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||+||.++.++ ++.+|+|.+++..+... ..+..++|..||.+++||.||+|+-.+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999765 88999999998776544 456789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
+||+.||.|..+|.+. ..+++..+.-++.+|+.||.|||+++ ||||||||+|||||+++.++|+||||++.....
T Consensus 104 ld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999999854 46888888889999999999999999 999999999999999999999999998754321
Q ss_pred --------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc-CCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV-ALP 696 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~-~~~ 696 (740)
..++..+|.||+|++||||++|..||..+... + .... ++..+. ..|
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----~-~~~~--------I~~~k~~~~p 246 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----K-MYDK--------ILKGKLPLPP 246 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----H-HHHH--------HhcCcCCCCC
Confidence 23467899999999999999999999754321 1 1122 222221 122
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCC
Q 040687 697 RNVEPLFKLADIAELAIRENPSELP 721 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RP 721 (740)
.-. ..+..+++.+.++.||++|.
T Consensus 247 ~~l--s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYL--SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccC--CHHHHHHHHHHhccCHHHhc
Confidence 212 23567899999999999995
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.87 Aligned_cols=234 Identities=24% Similarity=0.315 Sum_probs=190.5
Q ss_pred cCccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||.||+|.+. .+..||+|.++.... ......|.+|+.++++++||||+++++++......+|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 56888899999999999999864 356899999876532 2334679999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876567999999999999999999999998 99999999999999999999999997643211
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...++.++||||||+++|||++ |+.||...... . ....+.+ ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~----~~~~~~~---------~~~ 226 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-D----VIKAVED---------GFR 226 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-H----HHHHHHC---------CCC
Confidence 1223568999999999999886 99999643211 1 1111211 112
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.+.+......+.+++.+||+.+|++||+++||.+.|+++
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 222334445788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.79 Aligned_cols=236 Identities=28% Similarity=0.424 Sum_probs=205.5
Q ss_pred cCccccceecccCceEEEEEEEeC---C--cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD---G--RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~---g--~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
+.....+.||.|-||.||+|...+ | -.||||.-+.+... .+.+.|+.|..+|++++||||++|+|+|.+. ..|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 445566789999999999999633 3 35899998875543 3467899999999999999999999999874 789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||||+++-|.|..||..+...|+...+..++.||..+|.|||+.. +|||||..+|||+.+.--+|++||||++.++.
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999987765
Q ss_pred CCCC----------------------CcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 DLTT----------------------DMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 ~~~~----------------------~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
+..| +++||||-|||-|||+++ |.+||..- +..++.-.++...
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv--------------kNsDVI~~iEnGe 609 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV--------------KNSDVIGHIENGE 609 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc--------------cccceEEEecCCC
Confidence 4332 679999999999999999 99999742 2334455566677
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
++|.++.++..++.||.+||..||.+||++.||...|++++++
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 8888888989999999999999999999999999999998875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=367.06 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=197.7
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
...|+..+.||+|+||.||+|+. .+++.||||+++.... ....|+++|++++|||||++++++.+....++||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 34577888999999999999997 4689999999864321 2235688999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc-------
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT------- 632 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~------- 632 (740)
|||++|+|.++++. ++|.++.+|+.|+|+||+|||+...++|+||||||+|||++.+..+++. |+++.
T Consensus 763 Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~ 837 (968)
T PLN00113 763 EYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837 (968)
T ss_pred eCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCC
Confidence 99999999999963 8999999999999999999997766679999999999999999888875 55432
Q ss_pred ----------cccCCCCCCcccceehhHHHHHHHHhCCCCCCCCC-CCchhHHhhhhHHhhCccchhcccccCC--CCCc
Q 040687 633 ----------SCERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEY-VPPGIVEWALPLIKQGKAAAIIDRNVAL--PRNV 699 (740)
Q Consensus 633 ----------~~~~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~i~d~~~~~--~~~~ 699 (740)
+......++.|+|||||||++|||+||+.||+... ....+.+|+...........++|+.+.. +.+.
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 11123345789999999999999999999997543 2345666665544444455556655532 2344
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+...++.+++.+||+.||++||+|+||++.|+++.+.
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 5566788999999999999999999999999998764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.86 Aligned_cols=237 Identities=26% Similarity=0.431 Sum_probs=190.7
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||.||+|++.+ ++ .||+|.++... .....++|.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 458899999999999999999643 33 48999987533 223456799999999999999999999999865 567
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+|+||+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999877667899999999999999999999998 99999999999999999999999999864321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+| |+.||+.... ..+ ..++...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-~~~-------------~~~~~~~ 227 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI-------------SSILEKG 227 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH-------------HHHHhCC
Confidence 1123568999999999999998 9999964311 011 1111112
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+.+.....++.+++.+||+.+|++||++.+++..|.++.++.
T Consensus 228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 222222334457889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.03 Aligned_cols=239 Identities=31% Similarity=0.407 Sum_probs=189.0
Q ss_pred HHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL 550 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (740)
....++|+..++||+|+||.||++++. .+..||||+++.... ....+.+.+|+++|+.+ +||||+++++++.
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 334567889999999999999999742 356899999875432 23345789999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCCC-------------------------------------------------------
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGGL------------------------------------------------------- 575 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------- 575 (740)
+....++||||+++|+|.++++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986421
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 576 -------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 576 -------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
..++|..+++++.||++||+|||+.+ |+||||||+|||++++..+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 14789999999999999999999998 99999999999999999999999999764321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+| |+.||........+. ..+..+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~----~~~~~~--------- 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY----KMIKEG--------- 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH----HHHHhC---------
Confidence 1123678999999999999998 889986432222111 112111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.....+.....++.+|+.+||+.||++||++.||++.|++.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111112234788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.87 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=191.4
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHh--CCCCCcceEEeEEEe
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN--IRHSNIVNLLGYCLE 551 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~ 551 (740)
+--......+....+.||+|.||+||+|.| .|+.||||++.. .+.+.|.+|.+|.+. |+|+||+.|++.-..
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 334455567788999999999999999999 678999999864 344789999999885 599999999998755
Q ss_pred C----CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEECCCCC
Q 040687 552 M----GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-----DAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 552 ~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-----~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
+ .++|||++|+++|+|+|||.. ..++-...++++..+|.||+|||. +++|.|.|||||++|||++++++
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 4 368999999999999999976 469999999999999999999996 57899999999999999999999
Q ss_pred EEEeecCCCccccCCCCC-------------------------------CcccceehhHHHHHHHHhC----------CC
Q 040687 623 ARIADFGLLTSCERDLTT-------------------------------DMKSDVHNFGIVLLEILSG----------RK 661 (740)
Q Consensus 623 ~ki~DFGla~~~~~~~~~-------------------------------~~ksDVwSfGvvl~ElltG----------~~ 661 (740)
+.|+|+|||......... -..+||||||.||||+.-. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999998654332100 0247999999999999852 35
Q ss_pred CCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 662 AYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 662 p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
||.+-...+.-.+.....+-.++++..+..+. ...+.+..+.+||+.||..||.-|-|+-.|.+.|.++.
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 66432211111121112111111111111111 13466778999999999999999999999999998876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=297.95 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=203.5
Q ss_pred hhcCccccceecccCceEEEEEE-EeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----C
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----G 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 553 (740)
..++|+..++||+|+|..||+++ +.+++.+|+|++.-.. .++.+..++|++.-++++||||++++++...+ .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 45689999999999999999999 4668899999987655 45667889999999999999999999987654 3
Q ss_pred eEEEEEecCCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
+.||++.|...|+|.+++.... ..+++.+.+.|+.+|.+||++||+.. ||++||||||.|||+.+++.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 5899999999999999986432 46899999999999999999999986 6899999999999999999999999998
Q ss_pred CccccC---------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh
Q 040687 631 LTSCER---------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 631 a~~~~~---------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 677 (740)
+....- ....++++|||||||+||+|+.|..||+..+...+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg------ 249 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG------ 249 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC------
Confidence 754321 11237899999999999999999999975433211
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
.-...+....+..|.+....+.+.++++.|++.||.+||++.+++..++.++
T Consensus 250 -----SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 -----SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1233455667778877778889999999999999999999999999998875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.46 Aligned_cols=227 Identities=33% Similarity=0.530 Sum_probs=178.3
Q ss_pred ccceecccCceEEEEEEEe-----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 486 EFNELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~-----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
..+.||.|.||.||+|.+. .+..|+||.++... .....++|.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4568999999999999987 25789999996532 23346789999999999999999999999998888999999
Q ss_pred cCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++|+|.++|+.. ...+++.+++.|+.||++||+|||+.. ++|+||+++|||+++++.+||+|||++.....
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999876 567999999999999999999999998 99999999999999999999999999876521
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.|+||||||+++|||+| |+.||.... ... ....+.+. ...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-~~~----~~~~~~~~---------~~~ 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-NEE----IIEKLKQG---------QRL 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-HHH----HHHHHHTT---------EET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-ccc----cccccccc---------ccc
Confidence 1113679999999999999999 788885331 111 11122211 112
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
+.+......+.+++..||+.||++||+|.+|++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22223344788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.72 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=204.1
Q ss_pred hcCccccceecccCceEEEEEEEeCC-cEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEe-EEEeC-----
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDG-RQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLG-YCLEM----- 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g-~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g-~~~~~----- 552 (740)
..++++.+.|.+|+|+.||++++..+ .++|+|++-... +...+..++|+++|++|+ |||||.+++ .....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d--e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND--EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC--HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34577888999999999999998776 999999987653 556788999999999997 999999999 33322
Q ss_pred -CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 553 -GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 553 -~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
-+.+|+||||++|.|-|++..+. ..|++.++++|+.|+++|+++||... |||||||||.+||||+.+++.||+|||-
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 36899999999999999997543 34999999999999999999999875 8899999999999999999999999998
Q ss_pred CccccC---------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh
Q 040687 631 LTSCER---------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 631 a~~~~~---------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 677 (740)
|..... ....++|+|||+|||+||-|.....||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s----------- 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES----------- 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-----------
Confidence 753211 122367999999999999999999999632
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
-...|++..+.+|....+...+.+||+.||+.||++||++.+|+..+-++...-+
T Consensus 262 ------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 262 ------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 2456888999999988889999999999999999999999999999998876543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.31 Aligned_cols=239 Identities=31% Similarity=0.453 Sum_probs=189.7
Q ss_pred HhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
-..++|...+.||+|+||.||+++.. +...||+|+++.... ......+.+|+++|+++ +|+||+++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34457889999999999999999852 235799999975432 23345789999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC--------------------------------------------------------
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL-------------------------------------------------------- 575 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------- 575 (740)
....++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999985321
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 576 -------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 576 -------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
.++++.++++|+.||++||+|||+.+ |+||||||+|||++++..+||+|||+++....
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 24788999999999999999999998 99999999999999999999999999764321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||++ |+.||........+. ..+ ......+.+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~----~~~---------~~~~~~~~~ 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY----KMV---------KRGYQMSRP 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH----HHH---------HcccCccCC
Confidence 1224679999999999999998 999996432221111 111 111111111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
.....++.+++.+||+.||++||++.+|++.|++++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 122347889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.77 Aligned_cols=230 Identities=27% Similarity=0.407 Sum_probs=183.0
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC--eEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG--ERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 558 (740)
.++...+.||+|+||+||++...+ |+..|||.+..... ...+.+.+|+.+|++|+|||||+++|...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 446777889999999999999865 89999999876532 22567899999999999999999999855444 68999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCER- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~- 636 (740)
|||+++|+|.+++.+....|+...+.++..||++||+|||+++ ||||||||+|||++. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999999876547999999999999999999999999 999999999999999 79999999998875441
Q ss_pred -----------------------CC-CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DL-TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~-~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
+. ....++|||||||++.||+||+.||... ....++..........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~------- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSL------- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCC-------
Confidence 00 0123899999999999999999999642 1111211122111101
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...|. ....+..+++.+|++.||++|||+.+++.
T Consensus 242 P~ip~--~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 242 PEIPD--SLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCCCc--ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12222 23346779999999999999999999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.28 Aligned_cols=241 Identities=26% Similarity=0.378 Sum_probs=185.8
Q ss_pred hcCccccceecccCceEEEEEEEeC-----------------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcc
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-----------------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv 543 (740)
.++|...++||+|+||.||++.+.+ +..||+|.+..... .....+|.+|+++|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCee
Confidence 3568888999999999999998632 33699999876432 33456799999999999999999
Q ss_pred eEEeEEEeCCeEEEEEecCCCCChHHhHhCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 040687 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605 (740)
Q Consensus 544 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 605 (740)
++++++.+.+..+|||||+++++|.+++.... ..++|.++++++.||++||.|||+.+ |
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999985421 24788999999999999999999998 9
Q ss_pred EecCCCCCCEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh--CC
Q 040687 606 IHRDVKTLNILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS--GR 660 (740)
Q Consensus 606 iHrDlk~~NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt--G~ 660 (740)
+||||||+|||+++++.+||+|||+++.... ...++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999864311 1234678999999999999997 55
Q ss_pred CCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 661 KAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 661 ~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.||.... ...+.+.......... .......+......+.+|+.+||+.||++|||+.||.+.|++
T Consensus 240 ~p~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELT-DEQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCC-HHHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6775322 1122222111111110 011111122334578899999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=309.99 Aligned_cols=229 Identities=24% Similarity=0.413 Sum_probs=186.9
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..+.||+|+||.||++.+.++..+|+|.++... ....+|.+|+++|++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4577888999999999999999888899999876543 2346789999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++|+|.++++.....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999865557899999999999999999999998 99999999999999999999999998764321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||+++|||++ |+.||...... .. ...+.++. +. ..+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~----~~~i~~~~-------~~--~~~ 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EV----VEMISRGF-------RL--YRP 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH----HHHHHCCC-------CC--CCC
Confidence 1123568999999999999999 89999643211 11 11121111 11 111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
......+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 12234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=333.21 Aligned_cols=230 Identities=27% Similarity=0.419 Sum_probs=197.1
Q ss_pred cCccccceecccCceEEEEEEEeC--Cc--EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD--GR--QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~--g~--~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
+..+..++||+|+||.|++|.|.. |+ .||||.++...... ...+|++|+.+|.+|+|||+++|+|+..+ ....|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 345667789999999999999853 43 58999998776533 56899999999999999999999999988 67889
Q ss_pred EEecCCCCChHHhHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|+|+++.|+|.+.|+. ....|-...+..++.|||.||.||..++ +|||||..+|+||-..-++||+||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999987 4456788888899999999999999999 99999999999999999999999999876544
Q ss_pred C------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 D------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ~------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
+ .+.+.+||||+|||+||||+| |..||.... ...+.+.+|.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------------g~qIL~~iD~ 330 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------------GIQILKNIDA 330 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------------HHHHHHhccc
Confidence 2 223669999999999999999 999996432 1233455677
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
+.+++.+..+.++++++|+.||..+|.+||+|..|.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 788889999999999999999999999999999998533
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.11 Aligned_cols=232 Identities=27% Similarity=0.352 Sum_probs=193.5
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCe
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNI-RHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (740)
+...++|...+.||+|+|.+|++|+.++ ++++|||++.+..+.++ ..+-...|-++|.+| .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3344679999999999999999999754 89999999988765544 344577899999999 89999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+|+|+||+++|+|.++|+.. ..|+......++.+|+.||+|||+.+ ||||||||+|||||.|+.+||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999854 67899999999999999999999999 999999999999999999999999998765
Q ss_pred cCC----------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH
Q 040687 635 ERD----------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI 680 (740)
Q Consensus 635 ~~~----------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 680 (740)
... ...+..+|+|+|||+||.|+.|++||....+-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----------- 293 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----------- 293 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----------
Confidence 421 11145899999999999999999999753210
Q ss_pred hhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
-.+++|++-.+.+|.... +.+.+|+++.|..||++|++..||.+
T Consensus 294 --liFqkI~~l~y~fp~~fp--~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 --LIFQKIQALDYEFPEGFP--EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --HHHHHHHHhcccCCCCCC--HHHHHHHHHHHccCccccccHHHHhh
Confidence 123445555555555433 36679999999999999999988876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.76 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=194.3
Q ss_pred HHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
....+.|+..++||.|.-++||+|+. +.++.||||+++.+... ...+++.+|+..|+.++||||++++..|..+..+|
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 33456799999999999999999995 45899999999987653 34688999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 557 LVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+||.||..|++.+.++... ..+++..+..|..++++||.|||.++ .||||||+.||||+++|.+||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999997654 34889999999999999999999999 9999999999999999999999998642211
Q ss_pred ---------------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 636 ---------------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 636 ---------------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
....|+.|+||||||++..||.+|..||.... +. +..+..+ ++.....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-Pm---kvLl~tL-qn~pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-PM---KVLLLTL-QNDPPTL 252 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-hH---HHHHHHh-cCCCCCc
Confidence 12345789999999999999999999997321 11 1111112 2222211
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.....+..........+.+++..||+.||.+|||++++++ ++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 1111122222223346789999999999999999999987 4444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=294.48 Aligned_cols=243 Identities=25% Similarity=0.311 Sum_probs=191.2
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...++||+|.||.||+|+. ..|+.||||+++.......-.....+|++.|+.++|+||+.|++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577888999999999999996 459999999998775433334567899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
||+. +|...++++...++..+...++.++++||+|||++. |+||||||.|+|+++++.+||+|||||+.+..
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 999999988888999999999999999999999999 99999999999999999999999999987652
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH--HhhCc------cchhcc
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL--IKQGK------AAAIID 690 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~--~~~~~------~~~i~d 690 (740)
...|+...||||.||++.||+-+.+-|.++.+-+++...+... ...+. +...++
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2334678999999999999999988776654333322211100 00000 011111
Q ss_pred cc-cCCC----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RN-VALP----RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~-~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
-+ .+.+ .-..+..+..+|+..+|..||.+|+++.|.++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11 1111 01223346689999999999999999999886
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=330.65 Aligned_cols=243 Identities=27% Similarity=0.376 Sum_probs=192.4
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGY 548 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~ 548 (740)
.+....++|...++||+|+||.||+|+... ...||||+++.... ....+.|.+|+++|++++ ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 334456788999999999999999998532 34799999975432 233467999999999996 9999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCC-----------------------------------------------------
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGL----------------------------------------------------- 575 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------- 575 (740)
+.+....+|||||+++|+|.++|+...
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999986421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 576 ------------------------------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 576 ------------------------------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
..+++.+++.++.||++||+|||+.+ |+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 24788889999999999999999998 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVP 669 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 669 (740)
|||+++++.+||+|||+++.... ...++.++||||||++||||++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999764321 1123678999999999999998 99998643211
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
..+ ...+.. ....+.+.....++.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 347 ~~~----~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STF----YNKIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----HHHHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111 111111 11222223344578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.21 Aligned_cols=235 Identities=24% Similarity=0.360 Sum_probs=191.5
Q ss_pred cCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||.||+|++.. ...||||.++.... .....+|.+|+.++++++||||+++++++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 568889999999999999999743 45799998875432 3344679999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876667999999999999999999999988 99999999999999999999999998765421
Q ss_pred ----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 ----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 ----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
....+.++||||||+++|||++ |..||..... .. ....+.. ..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~----~~~~~~~---------~~ 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QD----VIKAVED---------GY 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HH----HHHHHHc---------CC
Confidence 1123568999999999999998 9999853211 11 1111111 11
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
..+.+......+.+++.+||+.+|++||++.||++.|++++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11222334457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=310.51 Aligned_cols=233 Identities=27% Similarity=0.453 Sum_probs=190.5
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..++||+|+||.||++...++..||+|.+.... ...+.|.+|+.++++++|+||+++++.+.+....++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 35688999999999999999998888899999987543 234679999999999999999999999999899999999
Q ss_pred cCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 561 FMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
|+++++|.++++.. ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999754 246899999999999999999999988 999999999999999999999999998654321
Q ss_pred --------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...+.++||||||+++|||+| |+.||..... ... ...+... ...+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~----~~~~~~~---------~~~~ 224 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-SDV----MSALQRG---------YRMP 224 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-HHH----HHHHHcC---------CCCC
Confidence 112458999999999999999 9999964321 111 1111111 1122
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.......++.+++.+||+.+|++||+++++.+.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.07 Aligned_cols=233 Identities=28% Similarity=0.440 Sum_probs=191.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..+.||+|+||.||++.+.+++.||+|.++... ...++|.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45688899999999999999998778899999987543 234679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997643 46899999999999999999999998 99999999999999999999999998754321
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++||||||+++|||+| |+.||...... .....+.. ....+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~---------~~~~~ 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQQVDQ---------GYRMP 224 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc---------CCCCC
Confidence 1122568999999999999999 99999643211 11111111 11122
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 2233445788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.67 Aligned_cols=237 Identities=25% Similarity=0.370 Sum_probs=186.4
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||.||++++.. ++ .+++|.+.... ......++.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 357778899999999999999743 44 47888875432 12334678889999999999999999998764 4577
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+++||+++|+|.++++.....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999876667999999999999999999999988 99999999999999999999999999864311
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+| |+.||..... ..+ ...+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~----~~~~~---------~~ 227 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEV----PDLLE---------KG 227 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHH---------CC
Confidence 1123568999999999999998 9999964321 111 11111 11
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+.+......+.+++.+||..||++||++.|+++.|+++.++-
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 111112223346788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=312.59 Aligned_cols=233 Identities=26% Similarity=0.398 Sum_probs=192.0
Q ss_pred HHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchh------------cHHHHHHHHHHHHhCCCCCcce
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHT------------NIREFEMELEVLCNIRHSNIVN 544 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~------------~~~~~~~E~~~l~~l~H~niv~ 544 (740)
....|+|++.+.||+|.||.|-+|+. .+++.||||++.+...... ..+...+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457899999999999999999996 4689999999886543221 1346889999999999999999
Q ss_pred EEeEEEeC--CeEEEEEecCCCCChHHhHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 545 LLGYCLEM--GERLLVYEFMPRGTLHDHLHGGLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 545 l~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~-l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
|+.+..+. +.+|||+|||..|.+...--. ++ ++..+..++..++..||+|||.++ ||||||||+|+||++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99998765 579999999999988755432 34 899999999999999999999999 99999999999999999
Q ss_pred CEEEeecCCCccccCC------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCch
Q 040687 622 GARIADFGLLTSCERD------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG 671 (740)
Q Consensus 622 ~~ki~DFGla~~~~~~------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 671 (740)
++||+|||.+...... .....+.||||+||+||-|+.|+.||..+..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 9999999987644110 0113578999999999999999999964431
Q ss_pred hHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......|++..+.+|...+..+.+.+||+++|.+||++|.+..+|..
T Consensus 325 ----------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 ----------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ----------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 11234566677777877777778999999999999999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.67 Aligned_cols=228 Identities=21% Similarity=0.309 Sum_probs=185.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||+|.+...... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999985 4889999998764322 233467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 999999999999754 46889999999999999999999998 99999999999999999999999999865432
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++||||||+++|||+||+.||..... . .... .+.+.....|...
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~----~~~~--------~i~~~~~~~p~~~-- 238 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-F----RIYE--------KILAGRLKFPNWF-- 238 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-H----HHHH--------HHhcCCcCCCCCC--
Confidence 12236789999999999999999999964321 0 1111 1222233333322
Q ss_pred HHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
..++.+|+.+||+.||.+||+ +++++.
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 236779999999999999997 677774
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.42 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=189.2
Q ss_pred ccccceecccCceEEEEEEE-----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEE
Q 040687 484 FKEFNELGRGSYGFVYKAVL-----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERL 556 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 556 (740)
|+..+.||+|+||+||++.. .+++.||+|.+..... ......|.+|+++|++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37788999999999988753 3477899999875432 23456789999999999999999999998764 3578
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++++|.+++... .+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 85 lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999999764 4999999999999999999999998 99999999999999999999999999764321
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCC-chhHHhhhhHHhhCccchhccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP-PGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
....+.++||||||+++|||+||+.||...... .................+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 122356899999999999999999998642111 0011000001111112222333
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
....+.+.....++.+++..||+.+|++||++++|++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 3333334445568899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.73 Aligned_cols=236 Identities=25% Similarity=0.397 Sum_probs=193.6
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.+.++|+..++||+|+||.||++...+++.+++|.+.... .....++.+|+.++++++|+||+++++++......++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456788999999999999999999889999999987654 22346789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 559 YEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
|||+++++|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999997643 45899999999999999999999998 99999999999999999999999998754321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||+++|||++ |+.||..... ... ...+. .....
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~----~~~~~---------~~~~~ 223 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEV----YDQIT---------AGYRM 223 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHH----HHHHH---------hCCcC
Confidence 1223568999999999999999 8999964321 111 11111 11222
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
+.+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 23334445788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.47 Aligned_cols=232 Identities=25% Similarity=0.344 Sum_probs=192.3
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc---hhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCC
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII---HTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMG 553 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 553 (740)
...++|...+.||+|+||+|++++.. .++.||||.+...... ....+.+.+|+.++++++ ||||++++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34567999999999999999999864 5899999977765221 122345668999999999 999999999999999
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCCCc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGLLT 632 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGla~ 632 (740)
..|+||||+.+|+|++++.+ ..++.+.+..+++.|++.|++|+|+.+ |+||||||+|||+|.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999988 578999999999999999999999999 9999999999999999 999999999988
Q ss_pred ccc-C---------------------CC-CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 633 SCE-R---------------------DL-TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 633 ~~~-~---------------------~~-~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
... . .. +...++||||+||+||.|++|+.||+....+ . . ...+.
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~-l--------~~ki~ 236 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----N-L--------YRKIR 236 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----H-H--------HHHHh
Confidence 662 2 11 2246899999999999999999999853211 1 0 11144
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+..|.... ..++..|+.+|+..||.+|+++.+|+.
T Consensus 237 ~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 237 KGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 44555665542 447789999999999999999999994
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.97 Aligned_cols=232 Identities=30% Similarity=0.430 Sum_probs=189.3
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.+|...++||+|+||.||++.+.+ ++.||+|.+.... ....++.+|++++++++|+||+++++++......++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 347788899999999999999754 8899999987542 334679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++.... ..+++..++.++.|++++|+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997543 45899999999999999999999998 99999999999999999999999998765322
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++||||||+++|||+| |..||..... .. ....+.. ....+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~----~~~~~~~---------~~~~~ 225 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQ----VYELLEK---------GYRME 225 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHHHC---------CCCCC
Confidence 1123568999999999999999 9999864321 11 1111111 11112
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.+.....++.+++.+||+.||++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2223345788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.09 Aligned_cols=232 Identities=21% Similarity=0.246 Sum_probs=183.8
Q ss_pred CccccceecccCceEEEEEEE-eCCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.|+..+.||+|+||+||++.. .+++.||+|.+....... .....+.+|+++|++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377888999999999999997 468999999987654322 223467899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999888643 246899999999999999999999998 99999999999999999999999999865321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++|||||||+||||++|+.||......... +.....+ .......+ .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~--------~~~~~~~~--~ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRV--------KEDQEEYS--E 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHh--------hcccccCC--c
Confidence 123467899999999999999999999754322111 1111111 11111111 2
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
....++.+|+++||+.||++||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 23346789999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.45 Aligned_cols=232 Identities=28% Similarity=0.415 Sum_probs=182.5
Q ss_pred cccceecccCceEEEEEEEeCC-c--EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------CeE
Q 040687 485 KEFNELGRGSYGFVYKAVLVDG-R--QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------GER 555 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g-~--~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 555 (740)
...++||+|+||.||+|++.+. . .||+|.++.........+.|.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999997553 2 699998876544445567899999999999999999999987542 246
Q ss_pred EEEEecCCCCChHHhHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 556 LLVYEFMPRGTLHDHLHG-----GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998742 2235899999999999999999999988 99999999999999999999999999
Q ss_pred CccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 631 LTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 631 a~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
+...... ..++.++||||||+++|||++ |+.||..... ..+ ...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~----~~~~~~~~-- 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEI----YDYLRQGN-- 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHHcCC--
Confidence 8653211 113568999999999999999 8889864321 111 11222111
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
..+........+.+++.+||+.||++||++.+|++.|+++
T Consensus 232 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 -------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223345688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.84 Aligned_cols=234 Identities=30% Similarity=0.451 Sum_probs=186.2
Q ss_pred ccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe-----
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE----- 554 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 554 (740)
|...+.||+|+||.||+|++.. +..||+|+++..........++.+|++++++++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999999753 3679999988655444456789999999999999999999999876554
Q ss_pred -EEEEEecCCCCChHHhHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 555 -RLLVYEFMPRGTLHDHLHGG-----LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 555 -~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
.++|+||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998532 235899999999999999999999998 999999999999999999999999
Q ss_pred CCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 629 GLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 629 Gla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
|+++.... ....+.++||||||+++|||++ |..||..... ..+ ...+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~----~~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEI----YDYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHHcCC
Confidence 99864321 1123568999999999999999 8899864321 111 11111111
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
..+.+.....++.+++.+||+.||++||++.||++.|+++.
T Consensus 233 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 233 ---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred ---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11112233457889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.86 Aligned_cols=230 Identities=27% Similarity=0.380 Sum_probs=186.5
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..+.||+|+||.||++.+.++..+|+|.+..... ...+|.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35778889999999999999987777899998875432 346799999999999999999999999988889999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999765557899999999999999999999998 99999999999999999999999998764321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||+| |+.||..... ..+ ...+.... ..+..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~----~~~~~~~~---------~~~~~ 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SET----VEKVSQGL---------RLYRP 223 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHH----HHHHhcCC---------CCCCC
Confidence 1123568999999999999999 9999863321 111 11111111 11111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
......+.+++.+||+.+|++||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 122357889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.49 Aligned_cols=236 Identities=22% Similarity=0.380 Sum_probs=191.9
Q ss_pred hcCccccceecccCceEEEEEEEeC-C---cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-G---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.++|+..+.||+|+||.||++++.. + ..+|+|.+..... ....++|.+|++++++++|||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3568888999999999999999753 3 3799998865432 234567999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++++|.+++..+...+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999876667999999999999999999999998 99999999999999999999999998764321
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
...++.++||||||+++|||++ |+.||..... .. ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~----~~~~i~~--------- 225 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HE----VMKAIND--------- 225 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HH----HHHHHhc---------
Confidence 1122568999999999999998 9999964321 11 1111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
....+...+....+.+++.+||+.+|++||++.+|++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1222333334457889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.87 Aligned_cols=228 Identities=22% Similarity=0.307 Sum_probs=184.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999975 5889999998754321 123456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999999765432
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++||||||+++|||+||+.||..... ..+ ... +.......+...
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~----~~~--------i~~~~~~~~~~~-- 221 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGI----YEK--------ILAGKLEFPRHL-- 221 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHH----HHH--------HHhCCcCCCccC--
Confidence 12236789999999999999999999964321 111 111 112222233222
Q ss_pred HHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
...+.+|+++||+.||.+||+ ++|+++
T Consensus 222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 336779999999999999995 888775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=309.74 Aligned_cols=234 Identities=29% Similarity=0.461 Sum_probs=188.1
Q ss_pred cCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|+..+.||+|+||.||++.... ...||+|.++.... .....+|.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467888999999999999998643 25799999875432 23346799999999999999999999999988899
Q ss_pred EEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
+++|||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++||||||+|||++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 99999999999999996431 35789999999999999999999998 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 676 (740)
+.+||+|||+++.... ....+.++||||||+++|||+| |..||..... ..+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~---- 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEV---- 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHH----
Confidence 9999999998754211 1223678999999999999998 9999864321 111
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
...+... ...+.+.....++.+|+.+||+.||++||++.||++.|+++
T Consensus 236 ~~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1112111 11122234456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.75 Aligned_cols=228 Identities=25% Similarity=0.391 Sum_probs=186.7
Q ss_pred CccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
+|+..+.||+|+||.||++.+.++..+|+|.+..... ...+|.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4778889999999999999987777899998865432 3357889999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999866567899999999999999999999998 99999999999999999999999998764321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++||||||+++|||+| |+.||+.... .... ..+.. ....+.+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~----~~~~~---------~~~~~~~~ 224 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVV----ESVSA---------GYRLYRPK 224 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHH----HHHHc---------CCcCCCCC
Confidence 1223568999999999999999 8999864321 1111 11111 11112222
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
....++.+++.+||+.+|++||++.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3445788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.79 Aligned_cols=227 Identities=27% Similarity=0.360 Sum_probs=190.9
Q ss_pred CccccceecccCceEEEEEEE-eCCcEEEEEEeccc-ccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAA-TIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
-|++.+.||+|+-|.|-+|+. ..|+.+|||.+.+. ...+.....+.+|+-||+-|.|||+++|+++++++.++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 377888999999999999997 45999999999876 4444456678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++|.|+++|-.+ .+++..+..+++.||..|+.|+|..+ |+||||||+|+|||..+++||+|||+|.....
T Consensus 93 yv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred ecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999999999755 57999999999999999999999999 99999999999999999999999999864332
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
..+...++||||.|||||-||||+.||+++. +. ..+..+++ ..+.+|...
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir-~LLlKV~~--------G~f~MPs~I 235 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IR-VLLLKVQR--------GVFEMPSNI 235 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HH-HHHHHHHc--------CcccCCCcC
Confidence 1122569999999999999999999998432 21 12223332 334455444
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. +..+|+.+|+..||++|.|++||++
T Consensus 236 s~--eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 236 SS--EAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CH--HHHHHHHHHhccCccccccHHHHhh
Confidence 43 5569999999999999999999997
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.56 Aligned_cols=240 Identities=30% Similarity=0.458 Sum_probs=189.3
Q ss_pred hhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (740)
+.++|+..+.||+|+||.||++...+ ++.||+|+++.... ....+.+.+|++++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34578999999999999999997422 47899999875432 23446788999999999 899999999988754
Q ss_pred -CeEEEEEecCCCCChHHhHhCCC--------------------------------------------------------
Q 040687 553 -GERLLVYEFMPRGTLHDHLHGGL-------------------------------------------------------- 575 (740)
Q Consensus 553 -~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------- 575 (740)
...+++|||+++++|.++|....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 56889999999999999985421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------------
Q 040687 576 ----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------------- 636 (740)
Q Consensus 576 ----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------------- 636 (740)
.+++|..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 26899999999999999999999988 99999999999999999999999999865321
Q ss_pred --------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHH
Q 040687 637 --------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707 (740)
Q Consensus 637 --------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~ 707 (740)
...++.|+|||||||+||||++ |+.||........+ ...+... .....+.....++.+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF----CRRLKEG---------TRMRAPEYATPEIYS 307 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH----HHHHhcc---------CCCCCCccCCHHHHH
Confidence 1223668999999999999998 99999643221111 1111111 111112233457889
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 708 IAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 708 l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
++.+||+.+|++||++.||++.|++++++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.64 Aligned_cols=242 Identities=22% Similarity=0.237 Sum_probs=187.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (740)
++|..+++|++|.||.||+|+++ +++.||+|+++.+.......-.-++|+.+|.+++|||||.+-.+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56888899999999999999974 488999999987652222223468999999999999999998887654 579999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
||||++ +|...++....++...+..-++.|+++|++|||+.. |+|||||++|+|+++.+.+||+|||||+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999987 999999987778999999999999999999999999 999999999999999999999999999987652
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH----------HhhCc--
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL----------IKQGK-- 684 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~----------~~~~~-- 684 (740)
.+|++..|+||+|||+.||+++++.|.+..+...+...+..+ +..-.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 345789999999999999999999998765544433211110 00000
Q ss_pred ----cchhccccc--CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 ----AAAIIDRNV--ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ----~~~i~d~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.+..-..+ .++... ..+.-++|+...|..||.+|.|++|.++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence 000000000 011110 2245678999999999999999998875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.36 Aligned_cols=236 Identities=25% Similarity=0.427 Sum_probs=189.0
Q ss_pred CccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
+|...+.||+|+||.||+|+... ...+++|.+..... .....++.+|+.++++++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 46778899999999999998632 35789998865432 234567999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 557 LVYEFMPRGTLHDHLHGGL-----------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
+|+||+++++|.+++.... .++++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence 9999999999999986421 24789999999999999999999988 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVP 669 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 669 (740)
|||+++++.+||+|||+++.... ....+.++||||||+++|||+| |+.||.... +
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~ 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-P 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-H
Confidence 99999999999999999864311 1123568999999999999999 999986432 1
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+. ... +.....+.+.....++.+++..||+.+|++||++.|+++.|++++..
T Consensus 236 ~~~~----~~~---------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ERLF----NLL---------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHH----HHH---------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 111 11122222233345788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.98 Aligned_cols=245 Identities=30% Similarity=0.427 Sum_probs=189.2
Q ss_pred cCccccceecccCceEEEEEEEe-----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--Ce
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 554 (740)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.|.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46888899999999999999853 47899999987543 23456899999999999999999999987543 46
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++||||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 88999999999999999766567899999999999999999999998 999999999999999999999999997743
Q ss_pred cCC------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH----HhhCccc
Q 040687 635 ERD------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL----IKQGKAA 686 (740)
Q Consensus 635 ~~~------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 686 (740)
... ..++.++||||||+++|||++|..|+.... .......... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhhhhhcccccccccchHHHH
Confidence 211 123568999999999999999877654221 0000000000 0000011
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
++++.....+.......++.+|+.+||+.+|++|||+.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 22222233333344455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.85 Aligned_cols=237 Identities=30% Similarity=0.481 Sum_probs=188.1
Q ss_pred cCccccceecccCceEEEEEEEeC-C--cEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-G--RQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g--~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||.||++.+.+ + ..+++|.++... .....+.|.+|+++++++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 568888999999999999999754 3 347888876432 123346789999999999 79999999999999999999
Q ss_pred EEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 558 VYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
||||+++++|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999996532 24889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCccccC--------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHh
Q 040687 623 ARIADFGLLTSCER--------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 623 ~ki~DFGla~~~~~--------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
+||+|||++..... ...++.++||||||+++|||+| |..||..... ..+ ...+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~----~~~~~ 232 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AEL----YEKLP 232 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHh
Confidence 99999998743210 1123678999999999999998 9999964321 111 11111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.....+.+......+.+|+.+||+.+|.+||++.+|++.|+++.+.
T Consensus 233 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 233 ---------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111112222334788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=310.70 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=184.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. +++.||||.++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 467999999999999999999975 588999999875432 223346788999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||++ ++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 9995 6899998776667899999999999999999999998 99999999999999999999999998753211
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc---c------chh
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK---A------AAI 688 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~---~------~~i 688 (740)
...++.++||||||+++|||+||+.||..........+.......... . ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 112356889999999999999999999754322111111111110000 0 000
Q ss_pred cccccC--CCCC-------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNVA--LPRN-------VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~~--~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...... .+.. ......+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000 011235679999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=290.01 Aligned_cols=229 Identities=28% Similarity=0.392 Sum_probs=190.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhc-HHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|.||.||.|+.+. +-.||+|++.+..+.+.. ..++.+|++|-+.|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 568899999999999999999754 678999999877654433 457899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc----
Q 040687 560 EFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC---- 634 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~---- 634 (740)
||.+.|+|+..|.+.. ..++......+..|+|.||.|+|.+. +|||||||+|+|++..+..||+|||-+-..
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 9999999999998543 46888899999999999999999998 999999999999999999999999965332
Q ss_pred ---------------cCCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 635 ---------------ERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 635 ---------------~~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
.+...++.++|+|++|++.||++.|.+||..+.. .....+|..-++..|...
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------------~etYkrI~k~~~~~p~~i 245 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------------SETYKRIRKVDLKFPSTI 245 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------------HHHHHHHHHccccCCccc
Confidence 2234457899999999999999999999964321 112233333344444333
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ....++|.+|+..+|.+|.+..|++.
T Consensus 246 s--~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 246 S--GGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred C--hhHHHHHHHHhccCccccccHHHHhh
Confidence 3 36779999999999999999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.06 Aligned_cols=226 Identities=28% Similarity=0.366 Sum_probs=182.6
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGT 566 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 566 (740)
+.||+|+||.||++++. +++.||+|.+.... .......|.+|++++++++||||+++++++......+|||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999975 58899999876432 23344679999999999999999999999999999999999999999
Q ss_pred hHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----------
Q 040687 567 LHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---------- 636 (740)
Q Consensus 567 L~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---------- 636 (740)
|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999765556899999999999999999999998 99999999999999999999999998753221
Q ss_pred -------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~ 702 (740)
....+.++||||||+++|||++ |..||..... . .....+ ......+.+....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~----~~~~~~---------~~~~~~~~~~~~~ 222 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-Q----QTREAI---------EQGVRLPCPELCP 222 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-H----HHHHHH---------HcCCCCCCcccCC
Confidence 1123567999999999999998 8888853211 0 011111 1111222222334
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 703 FKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 703 ~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
..+.+++.+||+.+|++||++.||.+.|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 57889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.39 Aligned_cols=236 Identities=27% Similarity=0.404 Sum_probs=188.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..++||+|+||+||+|++. +++ .||+|.++.... ....+++.+|+.++++++|+||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 56888899999999999999864 344 489999875432 33456789999999999999999999998754 567
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+++||+++|+|.++++.....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999998 99999999999999999999999999864321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+| |..||+.... ..+. ..+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~----~~~~---------~~ 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIP----DLLE---------KG 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH----HHHH---------CC
Confidence 1123568999999999999999 9999864321 1111 1111 11
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+.....++.+++.+||+.||++||++.++++.|+++..+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11122223345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=310.12 Aligned_cols=239 Identities=30% Similarity=0.442 Sum_probs=191.5
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL 550 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (740)
....++|+..+.||+|+||.||++...+ ...+|+|.+..... .....++.+|++++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3344678889999999999999998743 36799999875432 23446789999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGG---------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
.....+++|||+++++|.++++.. ...+++..+++++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999999642 245899999999999999999999988 99999999999
Q ss_pred EECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCch
Q 040687 616 LLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPG 671 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 671 (740)
|+++++.+||+|||+++.... ....+.++||||||+++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 999999999999998864321 1123568999999999999998 99998632211
Q ss_pred hHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
.....+. .....+.+......+.+|+.+||+.||++|||+.|+++.|++++
T Consensus 242 ---~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ---ELFKLLK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 11122222334457889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.91 Aligned_cols=230 Identities=27% Similarity=0.387 Sum_probs=190.0
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
....|....+||+|+.|.||.++- ..++.||||++.... +...+-+.+|+.+|+..+|+|||+++..+...+++|.|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 345688888999999999999985 458899999998765 23345589999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||||++|+|.|.+... .+++.++..|+.++++||+|||.++ |||||||++|||++.++.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999999999764 4999999999999999999999999 99999999999999999999999999765543
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...|..|.||||||++++||+-|..||-.+.. + .++-++... ....+..
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---l--rAlyLIa~n-------g~P~lk~ 491 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---L--RALYLIATN-------GTPKLKN 491 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---H--HHHHHHhhc-------CCCCcCC
Confidence 23347799999999999999999999964221 1 111222211 1222333
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+.+++.+||+.|+++||++.|+++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3344457889999999999999999999997
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.79 Aligned_cols=222 Identities=23% Similarity=0.299 Sum_probs=179.5
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+.||+|+||.||+++.. +++.||||.++..... ......+.+|+++|++++||||+++++++...+..+|||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999974 5889999998765322 233456889999999999999999999999999999999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------- 636 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------- 636 (740)
+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 999999754 46899999999999999999999999 99999999999999999999999999764211
Q ss_pred ------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHH
Q 040687 637 ------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFK 704 (740)
Q Consensus 637 ------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~ 704 (740)
...++.++|||||||++|||+||+.||..... +.....+ .......|. ....+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~--------~~~~~~~p~--~~~~~ 221 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELI--------LMEEIRFPR--TLSPE 221 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHH--------HcCCCCCCC--CCCHH
Confidence 12236789999999999999999999964321 1111111 111222222 22346
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 705 LADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 705 l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 78999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.95 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=185.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. ++..||+|.+..... ......|.+|+++|++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 367999999999999999999975 478899998875431 233467999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++..+..++.|++.||.|||+.. .|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 999999999999754 46899999999999999999999852 299999999999999999999999999764321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh-HHh--hC--------------
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP-LIK--QG-------------- 683 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~-~~~--~~-------------- 683 (740)
...++.++||||||++||||+||+.||..... ..+...... ... ..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccccccc
Confidence 12246789999999999999999999964321 111000000 000 00
Q ss_pred ----------------c-cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 ----------------K-AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ----------------~-~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ...+...............++.+|+.+||+.||++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00000000000001123447889999999999999999999987
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.89 Aligned_cols=227 Identities=23% Similarity=0.365 Sum_probs=189.7
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.+|+..+.||+|.||.|-++.. ..|+.||||.+++..+.. ++.-.+.+|++||+.|+||||+.++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577788999999999999985 569999999998876533 34556899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||..+|.|+||+.+. ..|++.+...++.||..++.|+|..+ ++|||||.+|||||.++++||+||||+-.+..
T Consensus 133 EYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred EecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 999999999999865 47999999999999999999999999 99999999999999999999999999755433
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
..+....+|-||+||+||-|+.|..||+..+.. . .+.+|-...++.|..
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-~------------lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-R------------LVRQISRGAYREPET 275 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-H------------HHHHhhcccccCCCC
Confidence 122256899999999999999999999864321 1 122333334444433
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+. ...-||+.||..||++|-|+.+|..
T Consensus 276 PS---dA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 276 PS---DASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred Cc---hHHHHHHHHHhcCcccchhHHHHhh
Confidence 32 4457999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.10 Aligned_cols=235 Identities=25% Similarity=0.377 Sum_probs=190.0
Q ss_pred cCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
.+|+..+.||+|+||.||+|++.. ...+|+|.++.... ....+.|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 467888999999999999998742 34799999875432 3345689999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++++|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999876667899999999999999999999998 99999999999999999999999998754321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
....+.++||||||+++||+++ |+.||..... ... ...+.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~----~~~~~~~--------- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDV----IKAIEEG--------- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHH----HHHHhCC---------
Confidence 1123568999999999999997 9999864321 111 1111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
...+........+.+++.+||+.+|.+||+|.++++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 112222333457789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=310.56 Aligned_cols=239 Identities=32% Similarity=0.508 Sum_probs=189.4
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc--EEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR--QVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~--~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||.||++.+.+ +. .+++|+++... .....++|.+|++++.++ +|+||+++++++...+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 568888999999999999999753 43 46888765432 233456789999999999 89999999999999999999
Q ss_pred EEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 558 VYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
||||+++++|.++++... ..+++.+++.++.|+++||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999996432 25789999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccC--------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHh
Q 040687 623 ARIADFGLLTSCER--------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 623 ~ki~DFGla~~~~~--------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
+||+|||++..... ....+.++||||||++||||+| |..||...... .. ...+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~----~~~~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-EL----YEKLP 237 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HH----HHHHh
Confidence 99999999753210 1123678999999999999998 99999643211 11 11111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
.....+.+......+.+|+.+||+.+|++||++.++++.|+++++++.
T Consensus 238 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 ---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111111112233467899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=302.68 Aligned_cols=226 Identities=27% Similarity=0.373 Sum_probs=181.1
Q ss_pred eecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 489 ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+||+|+||.||+|.+. ++..+|+|+++.........++|.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6999999999999753 47889999987654333445689999999999999999999998864 5678999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-------- 637 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-------- 637 (740)
+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999754 46899999999999999999999998 999999999999999999999999997643211
Q ss_pred ----------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 638 ----------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 638 ----------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...+.++||||||+++|||+| |+.||..... ..+ ...+..+ ...+.+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~----~~~i~~~---------~~~~~~~~ 222 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEV----TQMIESG---------ERMECPQR 222 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHHCC---------CCCCCCCC
Confidence 112458999999999999998 9999964321 111 1122211 11122223
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
...++.+++.+||+.||++||++.+|.+.|++.
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.81 Aligned_cols=241 Identities=27% Similarity=0.380 Sum_probs=190.3
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYC 549 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~ 549 (740)
++...++|...++||+|+||.||++++. .++.||+|+++.... ....+.+.+|+++|.++. ||||+++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 4444567888899999999999999863 246899999976432 223457899999999997 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCC------------------------------------------------------
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGL------------------------------------------------------ 575 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------ 575 (740)
......++||||+++|+|.++|+...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999996431
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040687 576 -------------------------------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKT 612 (740)
Q Consensus 576 -------------------------------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~ 612 (740)
..+++..+++++.||++||+|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 13678889999999999999999988 99999999
Q ss_pred CCEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCC
Q 040687 613 LNILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYV 668 (740)
Q Consensus 613 ~NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~ 668 (740)
+|||++++..+||+|||+++.... ...++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999864321 0112568999999999999998 8999864321
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
... ....+. ...+.+.+.....++.+|+.+||+.+|.+||+++||++.|++++
T Consensus 348 ~~~----~~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ----FYNAIK---------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH----HHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111 111111 11112222233457889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.12 Aligned_cols=238 Identities=28% Similarity=0.416 Sum_probs=190.8
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|...+.||+|+||+||++... ++..+|+|.+.... ......|.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 56888899999999999999852 24568999886543 23456799999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCE
Q 040687 556 LLVYEFMPRGTLHDHLHGGL------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA 623 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 623 (740)
++||||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+ ++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999996432 24899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhH
Q 040687 624 RIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPL 679 (740)
Q Consensus 624 ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 679 (740)
||+|||++..... ....+.++||||||+++|||+| |+.||..... .. ....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~----~~~~ 234 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NE----VIEC 234 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHH
Confidence 9999999863311 1223568999999999999999 9999864321 11 1122
Q ss_pred HhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 680 IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 680 ~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
+..+... ..+ ......+.+|+.+||+.||.+||++.|+++.|+++.+...
T Consensus 235 i~~~~~~-------~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 235 ITQGRVL-------QRP--RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred HHcCCcC-------CCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 2222111 111 1223468899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=307.32 Aligned_cols=233 Identities=27% Similarity=0.434 Sum_probs=186.1
Q ss_pred cCccccceecccCceEEEEEEEe-----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..++||+|+||.||+|.+. .+..|++|.+..... .....+|.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45778889999999999999852 357899999875432 234467899999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 557 LVYEFMPRGTLHDHLHGG----------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999999998532 124789999999999999999999998 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 676 (740)
+.+||+|||++..... ...++.++||||||+++|||++ |..||.... +..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~---- 235 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEV---- 235 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHH----
Confidence 9999999999864311 1223678999999999999999 999985321 1111
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
...+. .....+.+......+.+++.+||+.||++||++.+|.+.|..
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVR---------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 111122222334578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.25 Aligned_cols=226 Identities=27% Similarity=0.388 Sum_probs=181.0
Q ss_pred eecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 489 ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
.||+|+||.||+|.+. ++..||+|.+..... ....++|.+|+.++++++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999864 355799999875432 2334679999999999999999999998854 5788999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------- 636 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------- 636 (740)
+|.+++......+++..+++++.|+++||+|||+.+ ++||||||+|||++.+..+||+|||++.....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999999866667999999999999999999999998 99999999999999999999999998753211
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||+++|||++ |+.||..... .. +...+..+ ...+.+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~----~~~~~~~~---------~~~~~~~~ 222 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PE----VMSFIEQG---------KRLDCPAE 222 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HH----HHHHHHCC---------CCCCCCCC
Confidence 0123558999999999999997 9999964321 11 11122111 11122233
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
...++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.35 Aligned_cols=236 Identities=22% Similarity=0.290 Sum_probs=186.5
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++..+ ++.||||+++...... ...+.+.+|++++.+++||||+++++++.+....+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468889999999999999999864 8899999987654322 23457889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 999999999999754 46899999999999999999999999 99999999999999999999999999864321
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++||||||++||||++|+.||....... . ...+... ...+............
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~----~~~i~~~--~~~~~~~~~~~~~~~~ 229 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-T----WENLKYW--KETLQRPVYDDPRFNL 229 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-H----HHHHHhc--cccccCCCCCcccccc
Confidence 1234679999999999999999999997432111 1 1111110 0011110000001123
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..++.+++.+||+.+|++||+++|+++
T Consensus 230 s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 230 SDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 446789999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.06 Aligned_cols=227 Identities=23% Similarity=0.351 Sum_probs=177.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||.||+++.. +++.||||.+..... ......|.+|+++|++++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 45667789999999999999975 589999999865431 2334678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|+++++|.+.. .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999997543 3567788899999999999999998 999999999999999999999999997643211
Q ss_pred -----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 638 -----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 638 -----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...+.++|||||||+||||++|+.||...... ..... ...+.. ...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~-~~~~~~---------~~~ 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASL-MCAICM---------SQP 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHH-HHHHhc---------cCC
Confidence 01124899999999999999999999732211 11110 011100 001
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.........++.+|+.+||+.||++||++.||++
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111223347889999999999999999999987
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.64 Aligned_cols=238 Identities=24% Similarity=0.385 Sum_probs=191.9
Q ss_pred hcCccccceecccCceEEEEEEEeC-----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 554 (740)
.++|...+.||+|+||.||+|...+ +..|++|++.... .......+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678889999999999999999865 6889999886432 23345678999999999999999999998876 467
Q ss_pred EEEEEecCCCCChHHhHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL-------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~-------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
.++++||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999996532 35899999999999999999999988 99999999999999999999999
Q ss_pred cCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhC
Q 040687 628 FGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQG 683 (740)
Q Consensus 628 FGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 683 (740)
||+++.... ...++.++||||||+++||+++ |+.||.... +..+.. .+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~----~~~~- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAA----YLKD- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHHHHH----HHHc-
Confidence 999874321 1123568999999999999999 999996432 111111 1111
Q ss_pred ccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 684 KAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 684 ~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.......++.+++.+||+.||++||++.|+++.|+++.++
T Consensus 235 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 --------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111122222345788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.74 Aligned_cols=220 Identities=25% Similarity=0.289 Sum_probs=176.3
Q ss_pred ecccCceEEEEEEEeC-CcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||.||+++..+ ++.||+|.++.... .......+.+|+++|++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999754 78999999875432 223456788999999999999999999999999999999999999999
Q ss_pred HHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----------
Q 040687 568 HDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----------- 636 (740)
Q Consensus 568 ~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----------- 636 (740)
.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 9999754 46899999999999999999999998 99999999999999999999999999864211
Q ss_pred ----------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHH
Q 040687 637 ----------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLA 706 (740)
Q Consensus 637 ----------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~ 706 (740)
...++.++|||||||++|||+||+.||..... .+. .. .++......+. ....++.
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~-~~--------~~~~~~~~~~~--~~~~~~~ 221 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEM-YR--------KILQEPLRFPD--GFDRDAK 221 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHH-HH--------HHHcCCCCCCC--cCCHHHH
Confidence 11236789999999999999999999964321 111 11 11122222222 2234677
Q ss_pred HHHHHhhhcCCCCCCC---HHHHHH
Q 040687 707 DIAELAIRENPSELPT---MSQVAT 728 (740)
Q Consensus 707 ~l~~~Cl~~dP~~RPt---~~ev~~ 728 (740)
+++.+||+.||++||+ +.|++.
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 9999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.19 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=182.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++.. +++.||+|+++.........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999985 47889999987654333445678899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|++++.|..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999876655443 3456899999999999999999999998 99999999999999999999999999865321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-----------hhC-ccc
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI-----------KQG-KAA 686 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~-----------~~~-~~~ 686 (740)
...++.++|||||||++|||++|+.||........+.. ..... ... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT-IQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhCCCCHHHHHhhhccchhc
Confidence 12236689999999999999999999975322111110 00000 000 000
Q ss_pred hhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 AIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 ~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+....+. .......+.+|+++||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=289.91 Aligned_cols=220 Identities=23% Similarity=0.341 Sum_probs=188.4
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||.|+||.|.+.+.+. +..+|+|.+.+..+.+ ++.+...+|..+|+.+.||++++|.+.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467888899999999999999754 8899999998765433 34556889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||.++|.|..+|++. .+++.....-+|.||+.||+|||+.. |++|||||+|||||.++.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred eccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 999999999999864 47999999999999999999999999 99999999999999999999999999876543
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...+...+|.|+|||++|||+.|..||..... . ...+.|+...+.+|.....
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~------------~iY~KI~~~~v~fP~~fs~ 266 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-I------------QIYEKILEGKVKFPSYFSS 266 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-H------------HHHHHHHhCcccCCcccCH
Confidence 23346689999999999999999999964331 1 1234566777777775554
Q ss_pred HHHHHHHHHHhhhcCCCCC
Q 040687 702 LFKLADIAELAIRENPSEL 720 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~R 720 (740)
++.+|+...++.|-.+|
T Consensus 267 --~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 --DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --HHHHHHHHHHhhhhHhh
Confidence 56799999999999888
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=314.82 Aligned_cols=232 Identities=19% Similarity=0.234 Sum_probs=187.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.. +++.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999975 588999999986543 2234456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++......+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876567999999999999999999999998 99999999999999999999999999864321
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
...++.++||||||+++|||++|+.||....... .. ..+... ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~-~~i~~~------~~ 226 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----TY-NNIMNF------QR 226 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----HH-HHHHcC------CC
Confidence 1123468999999999999999999996432111 11 111110 11
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.......++.+|+..|++ +|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 12223333344577899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=316.85 Aligned_cols=231 Identities=23% Similarity=0.337 Sum_probs=187.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|...+.||+|+||+||+++.. +++.||||+++...... .....+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 58999999987654322 34567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999765 57899999999999999999999988 999999999999999999999999998643321
Q ss_pred ------------------------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCC
Q 040687 638 ------------------------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP 669 (740)
Q Consensus 638 ------------------------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~ 669 (740)
..++.++|||||||+||||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 12356899999999999999999999743311
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPT-MSQVAT 728 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 728 (740)
+ ....+.. .......|.......++.+++.+|++ ||.+||+ ++|+++
T Consensus 237 ----~-~~~~i~~------~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 ----E-TYNKIIN------WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ----H-HHHHHhc------cCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 1 0111111 00222233333234578899999998 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.05 Aligned_cols=231 Identities=28% Similarity=0.448 Sum_probs=187.7
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..++||+|+||.||++...+++.||+|.+..... ...+|.+|+.++++++|+||++++++.. .+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 467888999999999999999988899999999875442 3467999999999999999999999864 457899999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++.... ..+++.+++.++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999986533 46899999999999999999999988 99999999999999999999999999864331
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++||||||+++|||++ |+.||..... ..+. ..+. .....+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~----~~~~---------~~~~~~ 223 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVI----QNLE---------RGYRMP 223 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHH----HHHH---------cCCCCC
Confidence 0112568999999999999999 9999964321 1111 1111 111112
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.......++.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 222334478899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.44 Aligned_cols=233 Identities=24% Similarity=0.368 Sum_probs=188.9
Q ss_pred CccccceecccCceEEEEEEEeC-C---cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-G---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.|+..+.||+|+||.||+|.+.. + ..||||.+.... ......+|.+|+.++++++||||+++++++.+....++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 47788899999999999999753 3 369999987543 233456899999999999999999999999998999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++......+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.+..+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876667899999999999999999999998 99999999999999999999999998753221
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
....+.++||||||+++|||++ |+.||..... ..+. ..+. .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~----~~i~---------~ 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVI----NAIE---------Q 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHH----HHHH---------c
Confidence 1122568999999999999997 9999964321 1111 1111 1
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
....+.+.+.+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112222334445788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.86 Aligned_cols=236 Identities=28% Similarity=0.406 Sum_probs=188.8
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.+|...+.||+|+||.||+++.. +...+++|.+.... ....+.|.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 35777889999999999999853 34568999886543 23346789999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
++||||+++++|.+++.... ..+++..++.++.||+.+|+|||+.+ |+||||||+|||++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999996532 24899999999999999999999998 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 676 (740)
+.+||+|||++..... ....+.++||||||+++|||+| |+.||..... .. .
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~----~ 234 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TE----V 234 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HH----H
Confidence 9999999999853211 1223568999999999999999 9999864321 11 1
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+...... .........+.+++.+||+.||++||++.+|++.|+++.+.
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1112211111 11112334688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.71 Aligned_cols=229 Identities=28% Similarity=0.392 Sum_probs=186.9
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||+++.. +++.|++|.+...........++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999975 588999999876544445667899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.++++.. ...+++..++.++.|++++|.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 356899999999999999999999988 99999999999999999999999998764322
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||+||+.||..... . .....+..+.. .+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~----~~~~~~~~~~~---------~~~~~ 223 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-G----ALILKIIRGVF---------PPVSQ 223 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHHHcCCC---------CCCcc
Confidence 11235689999999999999999999964331 1 11111111111 11111
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+++++||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 33447889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.56 Aligned_cols=233 Identities=28% Similarity=0.452 Sum_probs=187.6
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..++||+|+||.||++++.+...||+|+++.... ...+|.+|++++++++||||+++++++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 356889999999999999999987777899999875432 34578999999999999999999998754 56789999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
|+++++|.+++.... ..+++..++.++.|++++|+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999997543 35899999999999999999999988 999999999999999999999999987643211
Q ss_pred --------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
..++.++||||||+++|||+| |+.||...... .. ...+.. ....+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~----~~~~~~---------~~~~~ 223 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EV----LDQVER---------GYRMP 223 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HH----HHHHhc---------CCCCC
Confidence 123568999999999999999 88888643211 11 111111 11122
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
...+....+.+|+.+||+.||++||++.++.+.|++..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 22334457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.62 Aligned_cols=229 Identities=24% Similarity=0.284 Sum_probs=184.7
Q ss_pred hcCccccceecccCceEEEEEEEeC--CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD--GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
.++|+..+.||+|+||.||++++.. +..||+|++...... ......+.+|++++++++||||+++++++.+....+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998654 368999998754322 2334578899999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999754 46899999999999999999999998 99999999999999999999999999865432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++|||||||++|||+||+.||..... .. .... +.+.....|..
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~----~~~~--------i~~~~~~~p~~- 250 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-LL----IYQK--------ILEGIIYFPKF- 250 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-HH----HHHH--------HhcCCCCCCCC-
Confidence 12236689999999999999999999974321 10 1111 11222222322
Q ss_pred hhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
....+.+++++||+.||++|+ +++++++
T Consensus 251 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 251 -LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 223567999999999999995 8888876
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.75 Aligned_cols=234 Identities=28% Similarity=0.398 Sum_probs=186.3
Q ss_pred hhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (740)
.+++|...+.||+|+||.||++.+.+ +..||+|.+..... .....+|.+|+.++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 35678999999999999999999754 56799998765432 233457999999999999999999999999988
Q ss_pred eEEEEEecCCCCChHHhHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---CEE
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW---GAR 624 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~k 624 (740)
..++||||+++++|.++++... ..++|..++.++.||++||+|||+.+ ++||||||+|||++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 9999999999999999997543 25899999999999999999999998 99999999999998754 599
Q ss_pred EeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHH
Q 040687 625 IADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLI 680 (740)
Q Consensus 625 i~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~ 680 (740)
|+|||+++.... ....+.++|||||||++|||++ |+.||+....+ .+. ..+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~----~~~ 234 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVM----EFV 234 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH----HHH
Confidence 999999864311 1224678999999999999997 99999743211 111 111
Q ss_pred hhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
.. ....+.+......+.+++++||+.+|++||++.+|++.|+
T Consensus 235 ~~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 1111112233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.44 Aligned_cols=235 Identities=26% Similarity=0.398 Sum_probs=186.0
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (740)
.+++|+..++||+|+||.||++.+. .+..||||++..... .....+|.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 5678999999999999999999853 246799998864332 233467899999999999999999999999889
Q ss_pred eEEEEEecCCCCChHHhHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEE
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL---------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR 624 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 624 (740)
..++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999996532 23688999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHH
Q 040687 625 IADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLI 680 (740)
Q Consensus 625 i~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~ 680 (740)
|+|||++..... ....+.++||||||+++|||++ |..||..... .. ....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~----~~~~~ 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQ----VLRFV 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHH
Confidence 999998753211 1223668999999999999999 7888864321 11 11111
Q ss_pred hhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
...... +.+......+.+++.+||+.||++||++.|+++.|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 1112233478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.24 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=183.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...++||+|+||.||+++.. +++.||+|.++.... ......+.+|++++++++||||+++++++......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999975 588999999875432 2233567899999999999999999999999889999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++ +|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9974 999999766556899999999999999999999998 99999999999999999999999998753211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh------------hCccc
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK------------QGKAA 686 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~------------~~~~~ 686 (740)
...++.++||||||+++|||+||+.||........+ ........ .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhccccchhhh
Confidence 122366899999999999999999999754322111 11111000 00000
Q ss_pred hhcccccCCC----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 AIIDRNVALP----RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 ~i~d~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+..... .......+..+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0010100000 00112235779999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.91 Aligned_cols=237 Identities=21% Similarity=0.326 Sum_probs=188.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||||.+..... .......|.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999974 589999998765322 2233457899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||+++++|.+++.. ....++...++.++.|+++||+|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 2345889999999999999999999998 99999999999999999999999998754321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||+++|||++|+.||...... ..+.. ..+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~-~~~~~~~---------~~ 226 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLC-QKIEQCD---------YP 226 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHH-HHHhcCC---------CC
Confidence 112356899999999999999999998643221 11111 1111110 11
Q ss_pred CC-CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 696 PR-NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 696 ~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
+. .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 112334688999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.10 Aligned_cols=231 Identities=28% Similarity=0.471 Sum_probs=187.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..++||+|+||.||++...++..+|+|.+..... ...+|.+|+.++++++|+|++++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 356888899999999999999988888999999876442 3357999999999999999999999875 456889999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
|+++++|.++++... ..+++..++.++.|++.+|+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999997643 45899999999999999999999998 999999999999999999999999997543211
Q ss_pred --------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...+.++||||||+++|||++ |+.||...... .. ...+. .....+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~----~~~~~---------~~~~~~ 223 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EV----LEQVE---------RGYRMP 223 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HH----HHHHH---------cCCCCC
Confidence 123568999999999999999 89999643211 11 11111 112222
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.+......+.+|+.+||+.+|++|||+.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 333444578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.74 Aligned_cols=227 Identities=23% Similarity=0.370 Sum_probs=191.9
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...+.||+|+||.||||+.+. .+.||||.+.+.....+..+.+.+|++|+++|+|||||.++.+++...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888899999999999999654 7889999998877666778889999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+.+ +|+.+|... ..+++..+..|+.|++.||.|||+.+ |+|||+||.||||+..+++|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9976 999999754 57999999999999999999999999 99999999999999999999999999875543
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++..+|.||+||+||||++|++||..+ ++... +..|+....+.|.
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~L---------v~~I~~d~v~~p~-- 221 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQL---------VKSILKDPVKPPS-- 221 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHH---------HHHHhcCCCCCcc--
Confidence 334577899999999999999999999521 11111 1223333344443
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........+++..|++||.+|.+-.+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 33446779999999999999999998875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.41 Aligned_cols=233 Identities=29% Similarity=0.444 Sum_probs=187.2
Q ss_pred cCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|...+.||+|+||.||++...+ ++.||||.++.... .+..+.|.+|+++|++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 458888899999999999998643 47899999875432 22456899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL-------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
++||||+++++|.++++... ..+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996431 34789999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhh
Q 040687 623 ARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALP 678 (740)
Q Consensus 623 ~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 678 (740)
+||+|||++..... ...++.++||||||+++|||++ |+.||...... .. ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~----~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EV----IE 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HH----HH
Confidence 99999998864211 1223568999999999999999 99998643221 11 11
Q ss_pred HHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 679 ~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.+..+. . .+.+......+.+++++||+.||++||++.||++.|++
T Consensus 236 ~~~~~~--------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CITQGR--------L-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHcCC--------c-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 121111 1 11112334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=296.92 Aligned_cols=225 Identities=27% Similarity=0.370 Sum_probs=183.1
Q ss_pred eecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCChH
Q 040687 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLH 568 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 568 (740)
.||+|+||.||++...+++.+|+|.+..... ......|.+|++++++++||||+++++++......++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 6899999999999988889999998875432 233457899999999999999999999999999999999999999999
Q ss_pred HhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------------
Q 040687 569 DHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------------ 636 (740)
Q Consensus 569 ~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------------ 636 (740)
+++......+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999766567899999999999999999999998 99999999999999999999999998753211
Q ss_pred ----------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHH
Q 040687 637 ----------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705 (740)
Q Consensus 637 ----------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l 705 (740)
....+.++||||||+++|||++ |..||...... . ....+... .....+.....++
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~----~~~~~~~~---------~~~~~~~~~~~~~ 223 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-Q----AREQVEKG---------YRMSCPQKCPDDV 223 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-H----HHHHHHcC---------CCCCCCCCCCHHH
Confidence 1123568999999999999999 99999643211 1 11111111 1111122334578
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 706 ADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 706 ~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
.+++.+||+.+|++||++.|+++.|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 89999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.57 Aligned_cols=238 Identities=29% Similarity=0.437 Sum_probs=190.4
Q ss_pred hcCccccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
.++|...+.||+|+||.||+++... ...+|+|.+.... ......++.+|+++++++ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4578999999999999999998532 3469999987543 223456788999999999 79999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 616 (740)
....++||||+++++|.+++.... ..+++.++++++.|++.||+|||+.+ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 999999999999999999997532 24899999999999999999999988 999999999999
Q ss_pred ECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchh
Q 040687 617 LDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI 672 (740)
Q Consensus 617 l~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~ 672 (740)
++.++.+||+|||++..... ...++.++||||||+++|||++ |+.||.... .
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----~ 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----V 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----H
Confidence 99999999999999854321 1123568999999999999999 888885321 1
Q ss_pred HHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 673 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+.....+... ...+.+.....++.+|+.+||+.+|++||++.+|++.|+++.+.
T Consensus 249 -~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 -EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHHHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111112111 11122223345788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.57 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=187.4
Q ss_pred CccccceecccCceEEEEEEE-----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVL-----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (740)
.|+..+.||+|+||.||++++ .+++.||+|.++.... ......|.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468888999999999999985 2478899999875432 23446799999999999999999999998875 568
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++......+++.+++.++.|++.+|+|||+.+ ++||||||+|||+++++.+||+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999999766557899999999999999999999998 9999999999999999999999999876432
Q ss_pred C------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---ccchh
Q 040687 636 R------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---KAAAI 688 (740)
Q Consensus 636 ~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~i 688 (740)
. ....+.++||||||+++|||+|++.|....... ..+...+...+. .....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL--FLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch--hhhhcccccccccHHHHHHH
Confidence 1 112356899999999999999987765321100 000000000000 00011
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
+......+.+.....++.+|+.+||+.||++||++.++++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111122223334557889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.32 Aligned_cols=233 Identities=31% Similarity=0.468 Sum_probs=191.4
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..++|...++||+|+||.||++.+.+++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 346788999999999999999998888899999987543 23467999999999999999999999999888999999
Q ss_pred ecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999997653 46899999999999999999999998 99999999999999999999999998764421
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||+++|||+| |+.||..... ... ...+. .....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~----~~~~~---------~~~~~ 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REV----LEQVE---------RGYRM 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHH---------cCCCC
Confidence 1223668999999999999999 9999964321 111 11111 11112
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
+.+.....++.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2222334578899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.75 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=191.3
Q ss_pred cCccccceecccCceEEEEEEEe-----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--CCe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE--MGE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~ 554 (740)
+.|+..+.||+|+||.||++++. .++.+|||.++..... .....|.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 34677789999999999999964 2678999998765432 245789999999999999999999999887 557
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 89999999999999999876557999999999999999999999998 999999999999999999999999988654
Q ss_pred cC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH---HhhCccch
Q 040687 635 ER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL---IKQGKAAA 687 (740)
Q Consensus 635 ~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 687 (740)
.. ....+.++||||||+++|||+||+.|+....... ....... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF--LRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh--ccccccccccccHHHHHH
Confidence 31 0122458999999999999999999986421110 0000000 00001111
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.+......+.+.....++.+|+.+||+.+|++||++.||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1222222233333445788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=297.25 Aligned_cols=227 Identities=30% Similarity=0.436 Sum_probs=182.3
Q ss_pred ceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 488 NELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
++||+|+||.||+|++.. +..+|+|.+...... ...+++.+|++++++++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 469999999999998633 268999998866542 345679999999999999999999998764 46799999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC------
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD------ 637 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~------ 637 (740)
+++|.+++.... .+++..++.++.|++.+|+|||+.+ ++|+||||+|||+++++.+||+|||++......
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 999999997653 6899999999999999999999998 999999999999999999999999987643211
Q ss_pred ------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...+.++||||||+++|||++ |+.||..... ..+ ...+... ...+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~----~~~~~~~---------~~~~~~ 220 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEV----IAMLESG---------ERLPRP 220 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHH----HHHHHcC---------CcCCCC
Confidence 123568999999999999998 9999964321 111 1112111 111222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 333457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=306.46 Aligned_cols=238 Identities=28% Similarity=0.436 Sum_probs=189.8
Q ss_pred hcCccccceecccCceEEEEEEEe--------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV--------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
.++|...+.||+|+||.||+++.. ++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 456888899999999999999742 24579999887543 234456799999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 616 (740)
....++||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999997532 34789999999999999999999998 999999999999
Q ss_pred ECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchh
Q 040687 617 LDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI 672 (740)
Q Consensus 617 l~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~ 672 (740)
+++++.+||+|||+++.... ...++.++||||||+++|||+| |..||.... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----V 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----H
Confidence 99999999999999764321 1123568999999999999999 888885321 1
Q ss_pred HHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 673 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+.....+... .....+......+.+|+.+||+.+|++||++.||++.|+++...
T Consensus 246 -~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111222211 11112223445788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=300.61 Aligned_cols=228 Identities=33% Similarity=0.526 Sum_probs=180.5
Q ss_pred eecccCceEEEEEEEeC-Cc--EEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 489 ELGRGSYGFVYKAVLVD-GR--QVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~-g~--~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
.||+|+||.||++++.+ +. .+++|.++... .......+.+|++++.++ +||||+++++++......++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999999854 33 57888876432 123446789999999999 899999999999999999999999999
Q ss_pred CChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 565 GTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 565 gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
++|.++++... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997432 24789999999999999999999988 9999999999999999999999999
Q ss_pred CCccccC--------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 630 LLTSCER--------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 630 la~~~~~--------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
++..... ...++.++||||||+++|||+| |..||...... .+. ..+..
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~----~~~~~------ 226 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELY----EKLPQ------ 226 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HHH----HHHhC------
Confidence 9742210 1223568999999999999997 99999643211 111 11111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
....+.......++.+|+.+||+.||.+||++.|++..|++++
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111112223346889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.90 Aligned_cols=222 Identities=23% Similarity=0.316 Sum_probs=179.2
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+.||+|+||.||+++.. +++.||+|.+...... ......+.+|+++|++++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999974 5889999998765322 234567889999999999999999999999999999999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------- 636 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------- 636 (740)
+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 999998754 46899999999999999999999998 99999999999999999999999999764211
Q ss_pred ------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHH
Q 040687 637 ------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFK 704 (740)
Q Consensus 637 ------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~ 704 (740)
...++.++|||||||+||||++|+.||...... .+ ... +.......|. ....+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~----~~~--------~~~~~~~~p~--~~~~~ 221 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KL----FEL--------ILMEDIKFPR--TLSAD 221 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HH----HHH--------hccCCccCCC--CCCHH
Confidence 122367899999999999999999999643211 11 111 1111222222 22346
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 705 LADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 705 l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
+.+++.+||+.||++|| ++.|+++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 78999999999999997 8999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.71 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=182.0
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----eEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-----ERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 556 (740)
+|+..++||+|+||.||+++.. +++.||||++............+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 5899999998754322334467899999999999999999999886432 479
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+. ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 6999998754 46899999999999999999999998 99999999999999999999999999864211
Q ss_pred --------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh-----------hhH
Q 040687 637 --------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA-----------LPL 679 (740)
Q Consensus 637 --------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~-----------~~~ 679 (740)
...++.++||||||+++|||+||+.||........+ ... ...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLITDLLGTPSPETISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHH
Confidence 023356899999999999999999999653221110 000 000
Q ss_pred HhhCccchhc---ccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 680 IKQGKAAAII---DRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 680 ~~~~~~~~i~---d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
+......+.+ ......+. .......+.+++.+||+.||++||+++|+++ +++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 1001111111 11111110 0112346779999999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=300.10 Aligned_cols=237 Identities=26% Similarity=0.430 Sum_probs=191.3
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.+|+..+.||+|+||.||+|.+.+ ++ .+|+|.+..... .....++.+|++++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 457788899999999999999753 32 589998876542 3344678999999999999999999999987 7889
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999876667999999999999999999999988 99999999999999999999999998764321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+| |+.||+.... ..+. ..+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~----~~~~---------~~ 227 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIP----DLLE---------KG 227 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHH----HHHh---------CC
Confidence 1123568999999999999999 9999964321 1111 1111 11
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+.+......+.+++.+||..||++||++.++++.|+++.++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 112222223347889999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.74 Aligned_cols=239 Identities=31% Similarity=0.457 Sum_probs=187.6
Q ss_pred hcCccccceecccCceEEEEEEE------eCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC-
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL------VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM- 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 552 (740)
.++|+..++||+|+||.||+++. ..++.||||+++.... ......+.+|+.+|.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 45789999999999999999974 2467899999875432 23346788999999999 689999999988654
Q ss_pred CeEEEEEecCCCCChHHhHhCCC---------------------------------------------------------
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL--------------------------------------------------------- 575 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 575 (740)
...++||||+++|+|.++++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999999999986421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----------
Q 040687 576 ---------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---------- 636 (740)
Q Consensus 576 ---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---------- 636 (740)
..+++..+..++.||++||+|||+.+ |+||||||+|||+++++++||+|||++.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 23688899999999999999999998 99999999999999999999999998764311
Q ss_pred -------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~ 702 (740)
...++.++||||||+++|||++ |..||........+. ..+..+. ....+. ...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~-------~~~~~~--~~~ 308 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEGT-------RMRAPD--YTT 308 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----HHHhccC-------CCCCCC--CCC
Confidence 1223668999999999999997 999986432221111 1111111 111111 123
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 703 FKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 703 ~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.++.+++..||+.||++||++.||++.|+++++.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3688999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.82 Aligned_cols=232 Identities=25% Similarity=0.362 Sum_probs=185.0
Q ss_pred CccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
+|+..++||+|+||.||+|...+ ++.||||+++.... ......|.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 46778899999999999998643 47899999875432 233456899999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 557 LVYEFMPRGTLHDHLHGG---------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
+++||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998521 134789999999999999999999998 99999999999999999
Q ss_pred CEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhh
Q 040687 622 GARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 622 ~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~ 677 (740)
.+||+|||+++.... ....+.++||||||+++|||+| |..||..... .. ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~----~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QD----VI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HH----HH
Confidence 999999998764321 1123568999999999999998 8888864321 11 11
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
..+.... ..+........+.+|+..||+.+|++||++.+|+..|+.
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1221111 112223445578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.76 Aligned_cols=222 Identities=24% Similarity=0.310 Sum_probs=178.7
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+.||+|+||.||+++.. +++.||+|.++..... ......+.+|++++++++||||+++++++...+..+|||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999974 5899999998765322 233456788999999999999999999999999999999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------- 636 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------- 636 (740)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 999998754 46899999999999999999999998 99999999999999999999999998754211
Q ss_pred ------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHH
Q 040687 637 ------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFK 704 (740)
Q Consensus 637 ------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~ 704 (740)
...++.++||||||+++|||++|+.||....... . .. .+.......|. ....+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~----~~--------~~~~~~~~~p~--~~~~~ 221 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-L----FE--------LILMEEIRFPR--TLSPE 221 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-H----HH--------HHhcCCCCCCC--CCCHH
Confidence 1223678999999999999999999996432111 1 11 11112222232 22346
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 705 LADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 705 l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 77999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.19 Aligned_cols=219 Identities=24% Similarity=0.323 Sum_probs=176.4
Q ss_pred ceecccCceEEEEEEE----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 488 NELGRGSYGFVYKAVL----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
+.||+|+||.||+++. .+++.||+|++............+.+|+++|++++||||+++++++......|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999885 247899999998654333344567889999999999999999999999999999999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC------
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD------ 637 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~------ 637 (740)
+++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 99999999754 46899999999999999999999998 999999999999999999999999998643221
Q ss_pred ---------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhH
Q 040687 638 ---------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702 (740)
Q Consensus 638 ---------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~ 702 (740)
...+.++||||||+++|||+||+.||...... . .... +.......|.. ..
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~----~~~~--------i~~~~~~~p~~--~~ 222 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-E----TMTM--------ILKAKLGMPQF--LS 222 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-H----HHHH--------HHcCCCCCCCC--CC
Confidence 12356899999999999999999999743211 1 1111 11122222222 23
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHH
Q 040687 703 FKLADIAELAIRENPSELPTMSQ 725 (740)
Q Consensus 703 ~~l~~l~~~Cl~~dP~~RPt~~e 725 (740)
..+.+|+++||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 46779999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=296.38 Aligned_cols=238 Identities=23% Similarity=0.341 Sum_probs=190.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||++... +++.||+|.++...... ...+.+.+|++++++++|+|++++++++......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999986 68999999887533222 23567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 245899999999999999999999998 99999999999999999999999998754321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||+++|||++|+.||..... +..+. ...+... ...
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~-~~~~~~~---------~~~ 226 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSL-CKKIEKC---------DYP 226 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHH-HhhhhcC---------CCC
Confidence 11235689999999999999999999964321 11111 0111111 111
Q ss_pred CCCc-hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 696 PRNV-EPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 696 ~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
+.+. .....+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 23347889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.81 Aligned_cols=222 Identities=26% Similarity=0.379 Sum_probs=177.5
Q ss_pred ceecccCceEEEEEEEe----CCcEEEEEEecccccc--hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 488 NELGRGSYGFVYKAVLV----DGRQVAVKRANAATII--HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+.||+|+||.||+++.. .++.||||.++..... ......+.+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 4788999998764321 12335678999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++... ..+.+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999754 46788889999999999999999998 99999999999999999999999999753211
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||++||||++|+.||....... .. ..+.......+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~--------~~~~~~~~~~~~~-- 222 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TI--------DKILKGKLNLPPY-- 222 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HH--------HHHHcCCCCCCCC--
Confidence 1123568999999999999999999997432111 11 1122222222222
Q ss_pred hHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
...++.+++.+||+.||++|| ++.++++
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 234678999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.85 Aligned_cols=242 Identities=23% Similarity=0.281 Sum_probs=177.7
Q ss_pred cCccccceecccCceEEEEEEEe--CCcEEEEEEecccccchhcHHHHHHHHHHHHhC---CCCCcceEEeEEEe-----
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV--DGRQVAVKRANAATIIHTNIREFEMELEVLCNI---RHSNIVNLLGYCLE----- 551 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 551 (740)
++|+..+.||+|+||.||+++.. +++.||+|+++...........+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999873 368899999876543333345667788877766 69999999999863
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
....++||||++ ++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999996 69999997543 45899999999999999999999998 99999999999999999999999999
Q ss_pred CccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh---hCcc--
Q 040687 631 LTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK---QGKA-- 685 (740)
Q Consensus 631 a~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---~~~~-- 685 (740)
+..... ...++.++||||||+++|||++|+.||........+ ........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhchh
Confidence 864321 122366899999999999999999999754322111 11111100 0000
Q ss_pred -----chhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 -----AAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 -----~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..........+. .......+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000000 0112235679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.51 Aligned_cols=237 Identities=30% Similarity=0.411 Sum_probs=189.0
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (740)
..++|...+.||+|+||.||++... .+..||+|+++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3457889999999999999999742 245799998875432 23345789999999999 799999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
+..++||||+++++|.++++... ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.+..+|++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997543 34899999999999999999999998 999999999999999999999999998
Q ss_pred ccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccch
Q 040687 632 TSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAA 687 (740)
Q Consensus 632 ~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (740)
...... ...+.++||||||+++|||+| |+.||........+ ...+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~----~~~~~~----- 259 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF----YKLIKE----- 259 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH----HHHHHc-----
Confidence 643211 112568999999999999998 99998654322111 111111
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
....+.+.....++.+++.+||+.+|++||++.||++.|+++
T Consensus 260 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 ----GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111122234788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.74 Aligned_cols=231 Identities=29% Similarity=0.457 Sum_probs=188.1
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 56788899999999999999874 78999999876542 456899999999999999999999999988899999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~ 158 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS 158 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccccc
Confidence 99999999997543 36899999999999999999999998 99999999999999999999999998765321
Q ss_pred --------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 --------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 --------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
....+.++||||||+++|||++ |+.||.... ...+ ...+... .....+...
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~----~~~~~~~---------~~~~~~~~~ 224 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDV----VPHVEKG---------YRMEAPEGC 224 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHH----HHHHhcC---------CCCCCccCC
Confidence 1123458999999999999998 999986331 1111 1111111 111112223
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
...+.+++++||+.+|++||+++|+++.|+++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 45788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=296.45 Aligned_cols=230 Identities=28% Similarity=0.447 Sum_probs=184.9
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|....+||+|+||.||++.+..+..+|+|++.... ...+.|.+|++++++++|+|++++++++. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4578888999999999999998777789999876543 23357899999999999999999999875 4567899999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
+++++|.++++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997543 35899999999999999999999988 999999999999999999999999998643211
Q ss_pred -------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...+.++||||||+++|||+| |+.||...... .. ...+.. ....+.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~----~~~~~~---------~~~~~~ 224 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EV----LEQVER---------GYRMPC 224 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HH----HHHHHc---------CCCCCC
Confidence 122558999999999999999 89999643211 11 111111 111122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
+......+.+++.+||+.||++||++++|++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.64 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=202.5
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLL 546 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 546 (740)
.++...+++...+.||+|.||.|++|.... ...||||.++..... .+.+.+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 455555666677799999999999998531 357999999876654 5668899999999998 699999999
Q ss_pred eEEEeCCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 040687 547 GYCLEMGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVK 611 (740)
Q Consensus 547 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk 611 (740)
|+|..++..++|+||+++|+|.++|+.+. ..++..+++.++.|||+||+||++.. +|||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999998766 34899999999999999999999988 9999999
Q ss_pred CCCEEECCCCCEEEeecCCCccccC------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCC
Q 040687 612 TLNILLDSDWGARIADFGLLTSCER------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIE 666 (740)
Q Consensus 612 ~~NILl~~~~~~ki~DFGla~~~~~------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~ 666 (740)
.+|||++++..+||+|||||+.... +..++.|||||||||+||||+| |..||..-
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999984322 1234779999999999999999 99999641
Q ss_pred CCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 667 YVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.....+ .+.+....+++.+..+..++++||+.||+.+|++||++.|+++.|+..+.
T Consensus 526 ~~~~~l-------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 PPTEEL-------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CcHHHH-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111111 12333445555666667799999999999999999999999999999765
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.96 Aligned_cols=222 Identities=21% Similarity=0.303 Sum_probs=174.0
Q ss_pred eecccCceEEEEEEEeC-------------------------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcc
Q 040687 489 ELGRGSYGFVYKAVLVD-------------------------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv 543 (740)
.||+|+||.||+|.+.. ...|++|.+.... .....+|.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999998521 1358999886543 22345788999999999999999
Q ss_pred eEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC--
Q 040687 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-- 621 (740)
Q Consensus 544 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-- 621 (740)
++++++.+....+|||||+++++|.+++......+++..+++++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999999766667899999999999999999999988 99999999999997643
Q ss_pred -----CEEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHH-hCCCCCCCCCCCchhHHhhh
Q 040687 622 -----GARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEIL-SGRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 622 -----~~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~Ell-tG~~p~~~~~~~~~~~~~~~ 677 (740)
.+|++|||++..... ....+.++||||||+++|||+ +|+.||..... ....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~---- 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEKE---- 231 (274)
T ss_pred cCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHHH----
Confidence 389999998643211 123467899999999999995 69999864321 1110
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
.........+.+ ...++.+++.+||+.+|++||+|.+|++.|.
T Consensus 232 ---------~~~~~~~~~~~~--~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 ---------RFYEKKHRLPEP--SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---------HHHHhccCCCCC--CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011111112221 1236789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=308.09 Aligned_cols=180 Identities=29% Similarity=0.404 Sum_probs=156.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||.||+++.. ++..+|+|.+.... .......+.+|+++|++++||||+++++++.+.+..+|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 467999999999999999999975 47889999877543 1233467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||+++++|.+++... ..+++.....++.|+++||.|||+. + |+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999999754 4689999999999999999999974 5 99999999999999999999999999764321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDI 665 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~ 665 (740)
...++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12236789999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=297.18 Aligned_cols=239 Identities=20% Similarity=0.310 Sum_probs=189.4
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++. .+++.+|||.+...... .....+|.+|++++++++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688888999999999999996 46899999988654322 233467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||+++++|.+++.. ....+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999863 2245899999999999999999999998 99999999999999999999999998654321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||+++|||++|..||...... ..+. ...+. ......
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~-~~~~~--------~~~~~~ 227 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSL-CKKIE--------QCDYPP 227 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHH-hhhhh--------cCCCCC
Confidence 122356899999999999999999999643211 1110 01111 111110
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
.........+.+++.+||+.||++||||.+|++.|+++.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011223447889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.68 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=187.9
Q ss_pred HhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..+++|+..++||+|+||.||+|..++ +..||+|.++.... .....++.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346789999999999999999997542 45799998765432 22335688999999999999999999999998
Q ss_pred CeEEEEEecCCCCChHHhHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCE
Q 040687 553 GERLLVYEFMPRGTLHDHLHGG---------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA 623 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 623 (740)
...++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 9999999999999999999642 134578889999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhH
Q 040687 624 RIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPL 679 (740)
Q Consensus 624 ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 679 (740)
||+|||+++.... ....+.++||||||+++|||++ |+.||.....+ .....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~ 233 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKF 233 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence 9999998763211 1123668999999999999999 78888642211 11111
Q ss_pred HhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 680 IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 680 ~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
+..... .+.+......+.+++.+||+.||++||++.++++.|++.+.
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 234 VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 111111 11112223578899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=297.08 Aligned_cols=230 Identities=29% Similarity=0.446 Sum_probs=178.8
Q ss_pred ceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCeEEEEEecC
Q 040687 488 NELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGERLLVYEFM 562 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 562 (740)
+.||+|+||.||+|++.+ ...||||++.... .....+.|.+|+.++++++||||+++++++.. +...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999999643 3579999875432 12345678999999999999999999998764 45688999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
++++|.+++......+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999876556788899999999999999999988 99999999999999999999999999864311
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhC-CCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSG-RKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++||||||+++|||++| ..||.... ...+.. .+... ...+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~----~~~~~---------~~~~ 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-SFDITV----YLLQG---------RRLL 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH----HHhcC---------CCCC
Confidence 11235689999999999999995 55564321 111111 11111 1111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111223468899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.14 Aligned_cols=230 Identities=31% Similarity=0.471 Sum_probs=184.5
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 560 (740)
++|...+.||+|+||.||++.. .+..||+|.++... ..+.|.+|+.++++++|+|++++++++.. ....++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4688889999999999999986 47889999886432 34679999999999999999999998654 457899999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.++++... ..+++..++.++.|++.+|+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 999999999997644 34899999999999999999999998 99999999999999999999999998764321
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||+++|||++ |+.||.... ..+ ..+.+..+ ........
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~-~~~~~~~~---------~~~~~~~~ 223 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKD-VVPRVEKG---------YKMDAPDG 223 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHH-HHHHHhcC---------CCCCCCCC
Confidence 1223568999999999999998 999986332 111 11222111 11111223
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
....+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 344788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=301.79 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=185.7
Q ss_pred hcCccccceecccCceEEEEEEEe-----------------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcc
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-----------------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv 543 (740)
.++|+..++||+|+||.||++... +...||+|.++.... .....+|.+|+++|++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcc
Confidence 356889999999999999998642 234689999875432 23446799999999999999999
Q ss_pred eEEeEEEeCCeEEEEEecCCCCChHHhHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL----------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 544 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
++++++...+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999999997532 24788899999999999999999998 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh--CCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS--GRKAYDIEYV 668 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt--G~~p~~~~~~ 668 (740)
|||+++++.+||+|||++..... ...++.++||||||+++|||+| |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999864311 0123568999999999999998 6778853322
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
. .+........... ......+.+......+.+|+.+||+.||++||++.||.+.|++
T Consensus 240 ~-~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 E-QVIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-HHHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111110 0111112222334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=313.60 Aligned_cols=234 Identities=20% Similarity=0.260 Sum_probs=186.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
...++|+..+.||+|+||.||+++.. +++.||+|.+....... .....+.+|+.++++++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567999999999999999999975 48899999987543222 23345788999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999754 4788888899999999999999998 99999999999999999999999999754321
Q ss_pred C--------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 637 D--------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 637 ~--------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
. ..++.++|||||||+||||++|+.||...... . ....+... .
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~-~~~~i~~~------~ 263 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----G-TYSKIMDH------K 263 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----H-HHHHHHcC------C
Confidence 0 11356899999999999999999999753321 1 11111110 0
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSE--LPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 728 (740)
..+..|.......++.+++.+||+.+|++ ||++.|++.
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11223333334457789999999999988 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=313.57 Aligned_cols=231 Identities=21% Similarity=0.284 Sum_probs=180.8
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.|+..+.||+|+||+||+++.. +++.||||++...... ......+.+|+++|++++||||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888899999999999999974 4789999999765432 2345678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc-----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE----- 635 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~----- 635 (740)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999999754 46889999999999999999999998 9999999999999999999999999864210
Q ss_pred ---------------------------------------------------------------CCCCCCcccceehhHHH
Q 040687 636 ---------------------------------------------------------------RDLTTDMKSDVHNFGIV 652 (740)
Q Consensus 636 ---------------------------------------------------------------~~~~~~~ksDVwSfGvv 652 (740)
....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 01223668999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHH--hhhcCCCCCCCHHHHHH
Q 040687 653 LLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAEL--AIRENPSELPTMSQVAT 728 (740)
Q Consensus 653 l~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~ev~~ 728 (740)
+|||+||+.||........ ....+.. ......+.......++.+|+.+ |+..+|.+||++.||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~----~~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET----QLKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH----HHHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999974321110 0111100 1112222222233466788887 45666777999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.42 Aligned_cols=237 Identities=29% Similarity=0.440 Sum_probs=187.4
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||.||++++.. ++ .||+|.+..... .....++.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457788899999999999999743 43 579998865432 22335789999999999999999999998754 467
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+++||+++|+|.+++..+...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999876667899999999999999999999998 99999999999999999999999999864321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
....+.++||||||+++|||++ |+.||.... ...+ ...+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~----~~~~~---------~~ 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREI----PDLLE---------KG 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHH----HHHHH---------CC
Confidence 0122568999999999999998 999986431 1111 11111 11
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+.+......+.+++..||..+|++||+++++++.|+++.++.
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 112222233457889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.35 Aligned_cols=231 Identities=24% Similarity=0.303 Sum_probs=181.7
Q ss_pred CccccceecccCceEEEEEEEe----CCcEEEEEEecccccch--hcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIH--TNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (740)
+|+..+.||+|+||.||+++.. +++.||+|.+....... ...+.+.+|++++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999863 47899999987543221 2345688899999999 599999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999999754 46899999999999999999999998 9999999999999999999999999986431
Q ss_pred C-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 636 R-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 636 ~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
. ....+.++||||||++||||+||+.||........... .... +....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~--------~~~~~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-VSRR--------ILKCD 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-HHHH--------HhcCC
Confidence 1 01235689999999999999999999974332221111 1111 11111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
...+ ......+.+++.+||+.||++|| +++++++
T Consensus 228 ~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1122 22334677999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=294.08 Aligned_cols=226 Identities=29% Similarity=0.414 Sum_probs=184.6
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
++||+|+||.||++.+.+++.||+|.+...... .....|.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999877999999988765432 3456799999999999999999999999999999999999999999
Q ss_pred HHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----------
Q 040687 568 HDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----------- 636 (740)
Q Consensus 568 ~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----------- 636 (740)
.+++......+++..++.++.+++.+|+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999765567899999999999999999999998 99999999999999999999999998764321
Q ss_pred ------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 ------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 ------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
....+.++||||||+++|||+| |..||..... .... ..+ ......+.+.....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~----~~~---------~~~~~~~~~~~~~~ 222 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTR----ERI---------ESGYRMPAPQLCPE 222 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHH----HHH---------hcCCCCCCCccCCH
Confidence 1123568999999999999999 8888854321 1110 111 11112222233345
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 704 KLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
++.+++.+||+.+|++||++.||++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 7889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=303.04 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=184.1
Q ss_pred cCccccceecccCceEEEEEEEeC---------------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD---------------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 546 (740)
++|+..++||+|+||.||+++..+ ...||+|.++... .......|.+|+++|++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 568888999999999999987632 2358999987543 223345799999999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCChHHhHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 547 GYCLEMGERLLVYEFMPRGTLHDHLHGGL-----------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 547 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
+++......++||||+++++|.+++.... ..+++..+++++.|+++||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986432 23789999999999999999999998 99999999999
Q ss_pred EECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh--CCCCCCCCCCCc
Q 040687 616 LLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS--GRKAYDIEYVPP 670 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~ 670 (740)
|+++++.+||+|||++..... ....+.++||||||+++|||++ +..||..... .
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence 999999999999999854311 1123678999999999999998 5667753221 1
Q ss_pred hhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 671 GIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 671 ~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.+........... ........+......+.+|+.+||+.||++||+|.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111100 0111111122233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=304.73 Aligned_cols=237 Identities=28% Similarity=0.452 Sum_probs=189.0
Q ss_pred hcCccccceecccCceEEEEEEEe--------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV--------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
.++|...++||+|+||.||+++.. ....+|+|.++.... .....++.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 356888899999999999999752 245799998875432 23456789999999999 69999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 616 (740)
....++||||+++|+|.+++.... ..+++.++++++.|++.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 889999999999999999996532 34899999999999999999999998 999999999999
Q ss_pred ECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchh
Q 040687 617 LDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI 672 (740)
Q Consensus 617 l~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~ 672 (740)
+++++.+||+|||+++.... ...++.++||||||+++|||++ |+.||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---- 242 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---- 242 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999864321 1123568999999999999999 8999853221
Q ss_pred HHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 673 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
+.....+... ...+.+.....++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 243 -~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 -EELFKLLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111222111 1111122334477899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=295.89 Aligned_cols=226 Identities=28% Similarity=0.426 Sum_probs=181.7
Q ss_pred ceecccCceEEEEEEEeC--C--cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 488 NELGRGSYGFVYKAVLVD--G--RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~--g--~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
++||+|+||.||++.+.+ + ..||||.+...... ...++|.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999999744 2 36999998876543 455789999999999999999999999988 88999999999
Q ss_pred CCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 564 RGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 564 ~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
+++|.+++.+.. ..++|...+.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999997654 56899999999999999999999998 99999999999999999999999998764422
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||+| |+.||..... .+ ....+.. .....+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~-~~~~~~~--------~~~~~~~ 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQ-ILKKIDK--------EGERLER 222 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HH-HHHHHHh--------cCCcCCC
Confidence 1123568999999999999999 9999963211 11 1111110 0111112
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
+......+.+++.+||+.+|++||++.||++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=310.74 Aligned_cols=232 Identities=21% Similarity=0.300 Sum_probs=179.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.. +++.||||++...... ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999975 4889999998764322 223456888999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999754 47899999999999999999999998 99999999999999999999999999753210
Q ss_pred -----------------------------------------------------CCCCCcccceehhHHHHHHHHhCCCCC
Q 040687 637 -----------------------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 637 -----------------------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~ 663 (740)
...++.++|||||||+||||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 112356899999999999999999999
Q ss_pred CCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhh--cCCCCCCCHHHHHH
Q 040687 664 DIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIR--ENPSELPTMSQVAT 728 (740)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPt~~ev~~ 728 (740)
....... . ...+... ...+..|.......++.+++.+++. .++..||+++||++
T Consensus 237 ~~~~~~~-~----~~~i~~~------~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETPQE-T----YKKVMNW------KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCHHH-H----HHHHHcC------cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 6432111 1 1111110 0111222222222355677776443 34445799999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=296.18 Aligned_cols=232 Identities=28% Similarity=0.457 Sum_probs=187.9
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..++|+..++||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 346789999999999999999998778889999887543 234678999999999999999999999887 7789999
Q ss_pred ecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 560 EFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
||+++++|.+++... ...+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999753 245799999999999999999999988 999999999999999999999999987543210
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
...+.++||||||+++|||+| |+.||.....+ .+ ...+.. ....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~----~~~~~~---------~~~~ 222 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EV----IRALER---------GYRM 222 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HH----HHHHhC---------CCCC
Confidence 112558999999999999999 99999643211 11 111111 1122
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
+.......++.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2223334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.04 Aligned_cols=229 Identities=25% Similarity=0.462 Sum_probs=186.1
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.+|+..+.||+|+||.||++.+.+++.+|+|.+..... ...+|.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 35777889999999999999987788999998875432 235789999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++......+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999876667899999999999999999999998 99999999999999999999999998753211
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||+++|||++ |+.||...... .+ ...+..+ .....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~----~~~~~~~---------~~~~~~ 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-EV----VETINAG---------FRLYKP 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-HH----HHHHhCC---------CCCCCC
Confidence 1223568999999999999999 99999643211 11 1111111 011111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
......+.+|+.+||+.+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11234788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=313.69 Aligned_cols=231 Identities=21% Similarity=0.287 Sum_probs=181.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||+||+++.. +++.||||.+..... .....+.+.+|++++++++||||+++++++.+....||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999874 588999999865432 1233467889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999754 46889999999999999999999999 99999999999999999999999999852110
Q ss_pred -----------------------------------------------------------------CCCCCcccceehhHH
Q 040687 637 -----------------------------------------------------------------DLTTDMKSDVHNFGI 651 (740)
Q Consensus 637 -----------------------------------------------------------------~~~~~~ksDVwSfGv 651 (740)
...++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 112367899999999
Q ss_pred HHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 040687 652 VLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSEL---PTMSQVAT 728 (740)
Q Consensus 652 vl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ev~~ 728 (740)
+||||+||+.||...... .. ...+... ...+..|.......++.+++.+|++ +|.+| |++.|++.
T Consensus 237 il~elltG~~Pf~~~~~~-~~----~~~i~~~------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-ET----YRKIINW------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-HH----HHHHHcc------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999999643211 11 1111110 0112223222233467799999997 66665 59999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.88 Aligned_cols=232 Identities=21% Similarity=0.241 Sum_probs=183.5
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+|+..+.||+|+||+||++... +++.||+|.+........ ....+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999974 588999999876443222 23457889999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999999886532 46899999999999999999999998 99999999999999999999999999865321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++||||||+++|||++|+.||......... +.....+. ...... +.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~--------~~~~~~--~~ 226 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVK--------EDQEEY--SE 226 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhh--------hccccc--Cc
Confidence 122356899999999999999999999753321111 11111111 111111 12
Q ss_pred hhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
.....+.+|+.+||+.||++|| +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 2334678999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=324.22 Aligned_cols=236 Identities=22% Similarity=0.265 Sum_probs=187.3
Q ss_pred HHHHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG- 553 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~- 553 (740)
+.+...++|...+.||+|+||+||+++. .+++.||||++............+.+|+.+|..++|+|+++++..+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344557899999999999999999986 45899999998776554555667899999999999999999988765432
Q ss_pred -------eEEEEEecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCE
Q 040687 554 -------ERLLVYEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA 623 (740)
Q Consensus 554 -------~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 623 (740)
..++||||+++|+|.++|+.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 368999999999999999653 246899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH
Q 040687 624 RIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI 680 (740)
Q Consensus 624 ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 680 (740)
||+|||+++.... ...++.++||||||++||||++|+.||.... ..+.. ..+
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----~~~~~-~~~ 257 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVM-HKT 257 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHH-HHH
Confidence 9999999864321 1224678999999999999999999996432 11111 111
Q ss_pred hhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... .. .+.+.....++.+++.+||+.||++||++.+++.
T Consensus 258 ~~~--------~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAG--------RY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcC--------CC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111 11 1112233457889999999999999999999986
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=297.96 Aligned_cols=232 Identities=27% Similarity=0.391 Sum_probs=182.8
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC---
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM--- 552 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--- 552 (740)
+.+++.|+..+.||+|+||.||+|... +++.||+|.+.... ....++.+|+.+++++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 356678999999999999999999975 47899999986543 3346788999999998 799999999998753
Q ss_pred ---CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 553 ---GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 553 ---~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 46899999999999999997643 46899999999999999999999998 999999999999999999999999
Q ss_pred CCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh
Q 040687 629 GLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682 (740)
Q Consensus 629 Gla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 682 (740)
|++..... ...++.++|||||||++|||++|+.||......... .....
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~~ 230 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPR 230 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHhc
Confidence 99754321 112355899999999999999999999632211000 01111
Q ss_pred CccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 GKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. ...........++.+|+.+||+.||.+||++.||++
T Consensus 231 ~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 000111122346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.65 Aligned_cols=230 Identities=23% Similarity=0.349 Sum_probs=175.9
Q ss_pred ceecccCceEEEEEEEeC---CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLVD---GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~---g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+|++.+ +..+|+|+++.... ......|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 369999999999998643 45799998876542 22345789999999999999999999999998899999999999
Q ss_pred CChHHhHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 565 GTLHDHLHGGL----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 565 gsL~~~l~~~~----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|+|.++++... ..+++..++.++.|+++||+|||+.+ ++||||||+|||++.++++||+|||++......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997432 24678888899999999999999998 999999999999999999999999987532110
Q ss_pred ---------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 638 ---------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 638 ---------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
...+.++||||||+++|||++ |+.||......... ..........+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~ 231 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-----TYTVREQQLKLP 231 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-----HHHhhcccCCCC
Confidence 012568999999999999997 99999643221111 111111111111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
++... ......+.+++..|| .+|++||+++||+..|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 112235678999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.95 Aligned_cols=237 Identities=26% Similarity=0.359 Sum_probs=189.5
Q ss_pred cCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|...+.||+|+||.||+|.+.+ ...|+||....... ....+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457888899999999999999744 24689998765432 2344679999999999999999999999875 45789
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999876567899999999999999999999988 99999999999999999999999998754211
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...++.++||||||+++|||++ |+.||....... . ...+..+. .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~----~~~~~~~~---------~ 226 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-V----IGRIENGE---------R 226 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-H----HHHHHcCC---------c
Confidence 1123568999999999999997 999996443211 1 11111111 1
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
.+.+.....++.+++.+|+..+|++||++.++++.|+++..+.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1122233457889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.52 Aligned_cols=222 Identities=21% Similarity=0.315 Sum_probs=177.3
Q ss_pred ceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++... ++.||||.++..... ....+.+..|.+++..+ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999754 789999998765322 23345678899999876 899999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 9999998754 46899999999999999999999998 99999999999999999999999998764211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||+||+.||...... .. .. .+.......|.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~----~~--------~i~~~~~~~p~~--~~~ 221 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DL----FE--------SILHDDVLYPVW--LSK 221 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HH----HH--------HHHcCCCCCCCC--CCH
Confidence 123467899999999999999999999743211 11 11 111122222222 223
Q ss_pred HHHHHHHHhhhcCCCCCC-------CHHHHHH
Q 040687 704 KLADIAELAIRENPSELP-------TMSQVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RP-------t~~ev~~ 728 (740)
++.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=300.15 Aligned_cols=232 Identities=28% Similarity=0.394 Sum_probs=184.3
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|...++||+|+||.||++... ++..+|+|.+.... ......|.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45777889999999999999742 35679999876543 23456799999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL--------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
++||||+++++|.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 99999999999999997542 24899999999999999999999998 99999999999999999
Q ss_pred CEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhh
Q 040687 622 GARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 622 ~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~ 677 (740)
.+||+|||++..... ...++.++||||||+++|||++ |+.||...... .. .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~----~ 234 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EA----I 234 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HH----H
Confidence 999999998753211 1223678999999999999999 99998532211 11 1
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
..+... ...+.+......+.+|+.+||+.||.+||++.||.+.|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111 1111112233467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.49 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=181.7
Q ss_pred ccceeccc--CceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 486 EFNELGRG--SYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 486 ~~~~LG~G--~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
..++||+| +|++||+++.. +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 78999999974 5899999998765433334456788999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc------
Q 040687 563 PRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE------ 635 (740)
Q Consensus 563 ~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~------ 635 (740)
++++|.+++..+. ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.++++||+......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999996542 45899999999999999999999998 9999999999999999999999997532110
Q ss_pred -------------------C----C-CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 -------------------R----D-LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 -------------------~----~-~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
+ . ..++.++||||||+++|||++|+.||..........+.. .......++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~ 233 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-----NGTVPCLLDT 233 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-----cCCccccccc
Confidence 0 0 234678999999999999999999996432211111100 0000000000
Q ss_pred ------------------------------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 692 ------------------------------------NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 692 ------------------------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
....+........+.+++.+||+.||++|||++|+++ +++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0000111122346889999999999999999999987 55554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=299.01 Aligned_cols=234 Identities=26% Similarity=0.402 Sum_probs=186.5
Q ss_pred hcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++|...+.||+|+||.||++...+ +..||+|.+..... .....+|.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 4578889999999999999998753 36899999865432 2334578999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEE
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL---------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI 625 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 625 (740)
.++||||+++++|.+++.... ..++|..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999996432 24789999999999999999999988 999999999999999999999
Q ss_pred eecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHh
Q 040687 626 ADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 626 ~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
+|||+++.... ....+.++||||||+++|||+| |+.||.... ...+. ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~----~~~~ 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVL----KFVI 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHH----HHHh
Confidence 99998753211 1223668999999999999999 999986322 11111 1111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.. ...+.+......+.+++.+||+.+|++|||+.+|++.|++
T Consensus 236 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DG---------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11 1111122234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=306.36 Aligned_cols=222 Identities=23% Similarity=0.312 Sum_probs=178.0
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+.||+|+||.||+++.. +++.||+|.+...... ......+.+|++++.+++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 5889999998765422 223456788999999999999999999999999999999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 999998754 468999999999999999999997 67 99999999999999999999999998764211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||++||||+||+.||...... . .... +.......|.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~----~~~~--------i~~~~~~~p~~--~~~ 221 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-K----LFEL--------ILMEEIRFPRT--LSP 221 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-H----HHHH--------HhcCCCCCCCC--CCH
Confidence 122367899999999999999999999643211 0 1111 11112222222 234
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 704 KLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
++.+++.+||+.||++|+ ++.++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 678999999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.44 Aligned_cols=225 Identities=26% Similarity=0.379 Sum_probs=176.7
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHH---HhCCCCCcceEEeEEEeCCeEEEE
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVL---CNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
|+..+.||+|+||.||++... +++.||||.++..... ....+.+.+|++++ ++++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999975 4889999998765322 22334566676655 567899999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|..+++. ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999999865 35999999999999999999999998 99999999999999999999999998764211
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||++|+.||...... + .... +.......|.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~-~~~~--------i~~~~~~~p~ 222 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----E-VFDS--------IVNDEVRYPR 222 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----H-HHHH--------HHhCCCCCCC
Confidence 122356899999999999999999999743211 1 1111 1112222222
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
. ....+.+++.+||+.||++|| ++.++++
T Consensus 223 ~--~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 F--LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C--CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 2 234678999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.61 Aligned_cols=235 Identities=20% Similarity=0.273 Sum_probs=185.7
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (740)
++....++|+..+.||+|+||.||+++... ++.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 344456789999999999999999999754 789999998753322 223456889999999999999999999999999
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999999754 4888999999999999999999998 99999999999999999999999999865
Q ss_pred ccCC--------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch
Q 040687 634 CERD--------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA 687 (740)
Q Consensus 634 ~~~~--------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (740)
.... ..++.++||||||++||||++|+.||...... .. . ..
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~~-~--------~~ 258 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----GT-Y--------SK 258 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----HH-H--------HH
Confidence 3210 11356899999999999999999999643211 11 1 11
Q ss_pred hccc--ccCCCCCchhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 040687 688 IIDR--NVALPRNVEPLFKLADIAELAIRENPSE--LPTMSQVAT 728 (740)
Q Consensus 688 i~d~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 728 (740)
+++. .+..|........+.+++..|++.++.+ ||++.|+++
T Consensus 259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 2221 1223333333446778999999855543 899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.78 Aligned_cols=233 Identities=23% Similarity=0.342 Sum_probs=183.4
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 5688899999999999999997 458899999987543 2334568899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.++++.. .++++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 87 YCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999754 46899999999999999999999988 99999999999999999999999998753311
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++||||||+++|||++|+.||......... ..+...... .+.. +
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~---~~~~--~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMSKSNFQ---PPKL--K 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----eeeecCCCC---CCCC--c
Confidence 011245899999999999999999998532211100 000000000 0011 1
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
........+.+++.+||+.+|++||++++|++.|
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112334788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=301.39 Aligned_cols=234 Identities=29% Similarity=0.438 Sum_probs=186.5
Q ss_pred hcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++|+..+.||+|+||.||+++.. ++..||+|.+..... ....++|.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467889999999999999999863 467899999875432 2334679999999999999999999999999889
Q ss_pred EEEEEecCCCCChHHhHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL---------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996421 24788999999999999999999998 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVP 669 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 669 (740)
|||+++++.+||+|||++..... ...++.++||||||+++|||++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999998753211 1223568999999999999998 8888853211
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.+ ....+..... .+.+.....++.+|+.+||+.+|++||++.||++.|++
T Consensus 239 ---~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EE-VIYYVRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HH-HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 1112211111 11122234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.57 Aligned_cols=234 Identities=20% Similarity=0.311 Sum_probs=189.9
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.+...++|+.+++||+|+||.||+++-++ |..+|+|++++..+... +.+..+.|-.+|...++|+||+|+-.|.+.+.
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 34456889999999999999999999765 89999999998765443 45678999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+||||||+|+|++..+|... ..|+.....-++.+++.||+-||..+ ||||||||+|+|||..|++||+||||+.-.
T Consensus 216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999999754 57899988899999999999999999 999999999999999999999999997421
Q ss_pred cC--------------------------------------------------------------------CCCCCcccce
Q 040687 635 ER--------------------------------------------------------------------DLTTDMKSDV 646 (740)
Q Consensus 635 ~~--------------------------------------------------------------------~~~~~~ksDV 646 (740)
.. ...++..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 0011457899
Q ss_pred ehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc--ccCCCCCchhHHHHHHHHHHhhhcCCCCCCC--
Q 040687 647 HNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR--NVALPRNVEPLFKLADIAELAIRENPSELPT-- 722 (740)
Q Consensus 647 wSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-- 722 (740)
||+|+||||||.|-+||..+.. ... ...|+.. .+..|.+.+...+..+||.+|+. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp-~~T------------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETP-QET------------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCH-HHH------------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999975432 111 1122222 24455555555678899999999 9999965
Q ss_pred -HHHHHH
Q 040687 723 -MSQVAT 728 (740)
Q Consensus 723 -~~ev~~ 728 (740)
++||-+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 555543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.40 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=179.6
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------ 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (740)
..++|+..+.||+|+||.||+|+.. .++.||||++.... ....+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4567999999999999999999975 47899999885432 2345799999999999999999887532
Q ss_pred --CeEEEEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEe
Q 040687 553 --GERLLVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIA 626 (740)
Q Consensus 553 --~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~ 626 (740)
...++||||+++ +|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.+. .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 246789999975 78777642 3356899999999999999999999998 99999999999999664 79999
Q ss_pred ecCCCccccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc-
Q 040687 627 DFGLLTSCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK- 684 (740)
Q Consensus 627 DFGla~~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~- 684 (740)
|||+++.... ...++.++|||||||+||||+||+.||........+... ...+....
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i-~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI-IQVLGTPTE 292 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCCH
Confidence 9999864321 113467899999999999999999999754322222111 11000000
Q ss_pred ---------cchhcccc-----cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 040687 685 ---------AAAIIDRN-----VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVK 735 (740)
Q Consensus 685 ---------~~~i~d~~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~ 735 (740)
...+.-+. +....+.....++.+|+.+||+.||.+|||+.|+++ +++.+.+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00000000 000001112346789999999999999999999996 7776654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.32 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=187.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-----------------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcc
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-----------------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv 543 (740)
.++|+..++||+|+||.||+++..+ +..||+|.+..... .....+|.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 3568889999999999999998643 24689999876532 23456799999999999999999
Q ss_pred eEEeEEEeCCeEEEEEecCCCCChHHhHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL----------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 544 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
++++++......++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999899999999999999999997543 26899999999999999999999998 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh--CCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS--GRKAYDIEYV 668 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt--G~~p~~~~~~ 668 (740)
|||+++++.+||+|||+++.... ....+.++||||||+++|||++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999764211 1133678999999999999998 6777753221
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
..+........... +.....+.......++.+++.+||+.||++||++.||+++|++
T Consensus 240 -~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -QQVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111000 1111112222233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.50 Aligned_cols=227 Identities=24% Similarity=0.365 Sum_probs=178.0
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++.. +++.||+|.++..... ....+.+.+|+.++.++ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 4789999998865322 22345678899998877 899999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 9999998654 46899999999999999999999998 99999999999999999999999999864211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCC----chhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP----PGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++||||||+++|||+||+.||+..... ....++....+ .......|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~~~~p~~- 227 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQIRIPRS- 227 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCCCCCCCC-
Confidence 122356899999999999999999999632111 11112222222 2222333332
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCC------HHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPT------MSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt------~~ev~~ 728 (740)
...++.+++.+||+.||++||+ +.++++
T Consensus 228 -~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 228 -LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 2346779999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.84 Aligned_cols=231 Identities=19% Similarity=0.299 Sum_probs=183.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.. +++.||||++...... ......+.+|+++|.+++||||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999975 4889999999764322 223456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999998753211
Q ss_pred --------------------------------------------------------CCCCCcccceehhHHHHHHHHhCC
Q 040687 637 --------------------------------------------------------DLTTDMKSDVHNFGIVLLEILSGR 660 (740)
Q Consensus 637 --------------------------------------------------------~~~~~~ksDVwSfGvvl~ElltG~ 660 (740)
...++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 112356899999999999999999
Q ss_pred CCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 040687 661 KAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPT---MSQVAT 728 (740)
Q Consensus 661 ~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 728 (740)
.||...... +. ...+... ......+.......++.+++++|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~----~~-~~~i~~~------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQ----ET-YRKIINW------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHH----HH-HHHHHcC------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999743211 11 1111110 0112222222233467789999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.78 Aligned_cols=230 Identities=24% Similarity=0.366 Sum_probs=183.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc---hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII---HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||.||++... ++++||+|.+...... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999974 5899999988654321 1234578999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++++|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999999754 46889999999999999999999998 99999999999999999999999999753211
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
....+.++||||||+++|||++|+.||...... +...... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~---------~~~~ 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIA---------TQPT 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHh---------ccCC
Confidence 111356899999999999999999999643211 1011111 1111
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+.+......+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 11112233446789999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.35 Aligned_cols=222 Identities=23% Similarity=0.330 Sum_probs=174.2
Q ss_pred ceecccCceEEEEEEEeC-------------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 488 NELGRGSYGFVYKAVLVD-------------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-------------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
+.||+|+||.||+|++.+ ...|++|.+.... ......|.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998532 2358899876543 2334578899999999999999999999999889
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC-------EEEee
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG-------ARIAD 627 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~ki~D 627 (740)
.++||||+++++|..+++.....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999999866667999999999999999999999998 999999999999987664 89999
Q ss_pred cCCCccccC------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 628 FGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 628 FGla~~~~~------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
||++..... ...++.++||||||++||||++ |+.||...... + ... ..
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~-~~~-~~------- 222 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----E-KER-FY------- 222 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----H-HHH-HH-------
Confidence 998753321 1234668999999999999985 88887532211 0 000 00
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
....... .....++.+|+.+||+.||++||++.+|++.|
T Consensus 223 -~~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 -EGQCMLV--TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -hcCccCC--CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111111 11234678999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.38 Aligned_cols=225 Identities=24% Similarity=0.305 Sum_probs=177.2
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||+||++... +++.||+|.+....... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999975 58899999987644322 2345678899999999999999999999999999999999999999
Q ss_pred HHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 568 HDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 568 ~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988753 2346899999999999999999999998 99999999999999999999999999864321
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||..........+ + ...++......+ .....
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-----~----~~~~~~~~~~~~--~~~~~ 226 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-----L----KQRILNDSVTYP--DKFSP 226 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-----H----HHhhcccCCCCc--ccCCH
Confidence 12235689999999999999999999975332111100 0 011111112222 22344
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 704 KLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
.+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 678999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=312.41 Aligned_cols=226 Identities=26% Similarity=0.381 Sum_probs=190.1
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCe
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNI-RHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (740)
....++|...++||+|+||+|+++.++. ++.+|||.+++..+.+. ..+..+.|.+|+.-. +||.|++|+..+..+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445789999999999999999999864 78999999998765543 456678888888877 59999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+|+||||..+|++..+.+. ..+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|.+||+||||+++.
T Consensus 444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999996555543 46999999999999999999999999 999999999999999999999999998754
Q ss_pred c---------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 635 E---------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 635 ~---------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
. .+..|+..+|.|||||+|||||.|..||..+++++ ....|+...+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------~FdsI~~d~~ 585 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------VFDSIVNDEV 585 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------HHHHHhcCCC
Confidence 3 13456789999999999999999999998655321 2334555566
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
..|..... +...||++++++||++|.-+
T Consensus 586 ~yP~~ls~--ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSK--EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccH--HHHHHHHHHhccCcccccCC
Confidence 66665544 67799999999999999876
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.22 Aligned_cols=236 Identities=22% Similarity=0.348 Sum_probs=185.2
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
|++.+++++.....||+|+||.||++++. +++.|++|.+.... ....+.+.+|++++++++|+||+++++++...+.
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34556677777789999999999999965 47789999887543 2344678999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPL--NWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLL 631 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla 631 (740)
.++|+||+++++|.+++.....++ ++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999999998654555 88889999999999999999998 999999999999986 678999999987
Q ss_pred ccccC-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 632 TSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 632 ~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
..... ....+.++||||||+++|||++|+.||........ ..+. . ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~---~------~~ 226 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFK---V------GM 226 (268)
T ss_pred eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhh---h------hh
Confidence 53211 01135689999999999999999999964221110 0000 0 00
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+ .....++.+++.+||+.+|++||++.||+.
T Consensus 227 ~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 FKIHPEIP--ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hccCCCCC--cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111112 223346889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.39 Aligned_cols=227 Identities=23% Similarity=0.362 Sum_probs=179.4
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++.. +++.||+|.++...... ...+.+..|..++.++ +||||+++++++.+....+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999975 48899999998654322 2345688999999998 799999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 9999998654 46999999999999999999999998 99999999999999999999999998763210
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCC----chhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP----PGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++||||||+++|||+||+.||+..... ....++.... +.......|..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~p~~- 227 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQIRIPRS- 227 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCCCCCCC-
Confidence 122356899999999999999999999642111 1111222222 22223333332
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCC------HHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPT------MSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt------~~ev~~ 728 (740)
...++.+++.+||+.||.+||+ +.++++
T Consensus 228 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 -LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 2346789999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.99 Aligned_cols=227 Identities=24% Similarity=0.315 Sum_probs=179.6
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCC-CcceEEeEEEeCCeEEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHS-NIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 559 (740)
+|+..+.||+|+||.||+++..+ ++.||||.+...... ....+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999999754 778999998765322 23456788999999999765 5888999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999998753210
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||+||+.||...... . .... +.+.....+.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~----~~~~--------i~~~~~~~~~- 222 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-E----LFQS--------IMEHNVSYPK- 222 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-H----HHHH--------HHcCCCCCCC-
Confidence 122367899999999999999999999743211 1 1111 1122222222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTM-----SQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 728 (740)
....++.+++.+||+.||.+||+. .++.+
T Consensus 223 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 223 -SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 223467899999999999999986 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.27 Aligned_cols=237 Identities=29% Similarity=0.450 Sum_probs=188.6
Q ss_pred cCccccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM 552 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (740)
.+|+..+.||+|+||.||+++... ...||+|.++... .....+++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 458889999999999999998531 2368999877533 233456899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL 617 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 617 (740)
...+++|||+++|+|.+++.... ..++|.+++.++.|+++||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999996431 34889999999999999999999998 9999999999999
Q ss_pred CCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhH
Q 040687 618 DSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIV 673 (740)
Q Consensus 618 ~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 673 (740)
+.++.+||+|||+++.... ...++.++||||||++||||++ |..||.... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VE 243 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----HH
Confidence 9999999999999864321 1123568999999999999999 888886432 11
Q ss_pred HhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 674 EWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 674 ~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+ ....+... ...+.......++.+++.+||+.+|++||++.||++.|+++...
T Consensus 244 ~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 E-LFKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred H-HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1 11112111 11122223345788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.90 Aligned_cols=217 Identities=25% Similarity=0.336 Sum_probs=174.0
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++.. +++.||||.++..... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 4789999998765322 23345678899999876 699999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 9999998754 46899999999999999999999998 99999999999999999999999998764211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||...... . ....+ .......+.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~----~~~~i--------~~~~~~~~~~--~~~ 221 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-D----LFEAI--------LNDEVVYPTW--LSQ 221 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-H----HHHHH--------hcCCCCCCCC--CCH
Confidence 122356899999999999999999999743211 1 11111 1222222222 233
Q ss_pred HHHHHHHHhhhcCCCCCCCH
Q 040687 704 KLADIAELAIRENPSELPTM 723 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~ 723 (740)
++.+++.+||+.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 67899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.46 Aligned_cols=230 Identities=24% Similarity=0.352 Sum_probs=187.1
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||.++.. +++.+++|++..........+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999864 588999999876654455567899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 562 MPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
+++++|.+++... ...+++.++..++.|++++|.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999765 346899999999999999999999998 999999999999999999999999987643221
Q ss_pred ------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...+.++||||||+++|||++|+.||+..... +.. ..+...... +...
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~-~~~~~~~~~---------~~~~ 223 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----NLV-VKIVQGNYT---------PVVS 223 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----HHH-HHHHcCCCC---------CCcc
Confidence 12356899999999999999999999643211 111 111111111 1112
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
....++.+++.+||+.+|++||+++|+++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 233468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.44 Aligned_cols=228 Identities=23% Similarity=0.349 Sum_probs=173.9
Q ss_pred eecccCceEEEEEEEeC---CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 489 ELGRGSYGFVYKAVLVD---GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~---g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+||+|+||.||+|...+ ...+++|.+.... .......|.+|+++++.++|+||+++++.+......+|||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 69999999999998643 3568888876433 2233467899999999999999999999999999999999999999
Q ss_pred ChHHhHhCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 566 TLHDHLHGGLS----PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 566 sL~~~l~~~~~----~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+|.+++..... ..++...+.++.||++||+|||+.+ |+||||||+|||+++++++||+|||++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2468888999999999999999998 99999999999999999999999999753211
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
....+.++||||||+++|||++ |..||....... ............+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-----VLKQVVREQDIKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhhccCccCCC
Confidence 0122568999999999999999 788886432111 111111111111111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
+.. .......+.+++..|| .||++||+++||++.|
T Consensus 233 ~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 PQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred Ccc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111 1223345668999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=294.77 Aligned_cols=228 Identities=26% Similarity=0.366 Sum_probs=182.5
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|+..++||+|+||.||++.... +..+++|.+.... ......|.+|++++++++||||+++++++......++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 5677889999999999999754 7788999886543 234567899999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
++++|.+++.....++++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999999998765567999999999999999999999998 99999999999999999999999998754311
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++|||||||++|||++|+.||...... +...... .... .. .+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~-~~~~-----~~--~~ 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIA-KSEP-----PT--LA 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHh-hcCC-----CC--CC
Confidence 111345899999999999999999998643211 1111111 1110 01 11
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+.....++.+++++||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223347889999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.19 Aligned_cols=226 Identities=33% Similarity=0.478 Sum_probs=185.0
Q ss_pred ceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 488 NELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
+.||+|+||.||++...+ +..|++|.+....... ..+.+.+|++++++++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999754 7889999988654322 45789999999999999999999999999899999999999
Q ss_pred CCChHHhHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 564 RGTLHDHLHGG--------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 564 ~gsL~~~l~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+++|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875 367899999999999999999999988 9999999999999999999999999986543
Q ss_pred CC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 RD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. ...+.++||||||+++|||++ |+.||.... ...+ ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~----~~~~~~--------- 222 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEV----LEYLRK--------- 222 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-HHHH----HHHHHc---------
Confidence 31 123568999999999999999 699996442 1111 111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
....+.+.....++.+++.+||+.+|++||++.|+++.|+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111222233457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.82 Aligned_cols=247 Identities=18% Similarity=0.261 Sum_probs=186.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...++||+|+||.||+++.. +++.||+|.++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888999999999999999975 478899999875432 2233467889999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++ +|.+++......+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9975 899998766566899999999999999999999998 99999999999999999999999998753211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---ccc------hhc
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---KAA------AII 689 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~------~i~ 689 (740)
...++.++||||||+++|||+||+.||........+ ......+... ... ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-HLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhhcchhhhh
Confidence 112356899999999999999999999754322111 1111110000 000 000
Q ss_pred ccccCC-------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 690 DRNVAL-------PRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 690 d~~~~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
+..... ........++.+++.+||+.||.+|||+.|+++ +++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000000 000112336779999999999999999999997 666543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.76 Aligned_cols=229 Identities=28% Similarity=0.402 Sum_probs=186.4
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++..+ ++.+++|.+.... ..+++.+|++++++++|+||+++++++......++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 3678889999999999999999865 7899999987543 2578999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++++|.+++......+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999999866667999999999999999999999998 999999999999999999999999987643221
Q ss_pred -------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...+.++||||||+++|||++|+.||......... ..+.. .... ....+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~~~~-----~~~~--~~~~~ 222 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FMIPN-----KPPP--TLSDP 222 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hhhcc-----CCCC--CCCch
Confidence 12356899999999999999999999643211110 00000 0001 11111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.+++.+||+.||++||++.||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 222346889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.01 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=182.2
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||+++.. +++.||||+++.........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999975 588999999876543333456788999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 562 MPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 69999886433 46899999999999999999999998 99999999999999999999999998753210
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh--hC---ccchhcccc
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK--QG---KAAAIIDRN 692 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~--~~---~~~~i~d~~ 692 (740)
....+.++||||||+++|||+||+.||.................. .. ....+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 112356899999999999999999999754322111110000000 00 000000000
Q ss_pred cCC---------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VAL---------PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... ........++.+++++||+.||++|||+.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 001112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.91 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=181.4
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----eEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-----ERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 556 (740)
+|+..++||+|+||.||++... +++.||||++..........+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778889999999999999974 6899999998654322334567899999999999999999999998776 789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 5888888654 46899999999999999999999998 99999999999999999999999999864321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh-----------
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ----------- 682 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~----------- 682 (740)
...++.++||||||+++|||++|+.||........+ +........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL-DLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHHhhH
Confidence 012366899999999999999999999754321111 111000000
Q ss_pred CccchhcccccCC-------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 GKAAAIIDRNVAL-------PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ~~~~~i~d~~~~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+....... ....+...++.+|+.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000000 011122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=297.84 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=185.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||.||+++.. ++..+|+|.+..... .....++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46888999999999999999975 478899998865421 2334568899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++||||||+|||+++++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence 99999999999754 568999999999999999999997 46 99999999999999999999999998764321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc----------------
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK---------------- 684 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 684 (740)
....+.++||||||+++|||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 12235689999999999999999999864321 111110000000000
Q ss_pred --------cchhccc-ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 685 --------AAAIIDR-NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 685 --------~~~i~d~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
...+... ....+. .....++.+++.+||+.||++||+++||++ ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0000000 000111 112346889999999999999999999997 4544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=301.14 Aligned_cols=227 Identities=24% Similarity=0.323 Sum_probs=180.0
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+|+..+.||+|+||.||+++... ++.||||.+...... ......+..|..++..+ +|++|+++++++...+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999999754 789999998765422 22344577888888877 5899999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999998754 46899999999999999999999998 99999999999999999999999999864211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++|||||||++|||+||+.||..... ..+ .. .+.+.....|..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~----~~--------~i~~~~~~~p~~ 223 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DEL----FQ--------SIMEHNVAYPKS 223 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHH----HH--------HHHhCCCCCCCc
Confidence 12236789999999999999999999974321 111 11 122222223322
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTM-----SQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 728 (740)
...++.+++.+|++.||++|++. +++.+
T Consensus 224 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 224 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 33467899999999999999984 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=292.51 Aligned_cols=233 Identities=27% Similarity=0.403 Sum_probs=183.0
Q ss_pred ccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------
Q 040687 484 FKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ 553 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (740)
|...+.||+|+||.||++.+. .++.||||.+..........+++.+|+++|++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999864 2678999998765544455677999999999999999999999886542
Q ss_pred eEEEEEecCCCCChHHhHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 554 ERLLVYEFMPRGTLHDHLHGG-----LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
..++++||+++|+|.+++... ...+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887432 124789999999999999999999998 999999999999999999999999
Q ss_pred CCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 629 GLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 629 Gla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
|+++.... ....+.++||||||+++|||++ |+.||..... ..+. ..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~----~~~~~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIY----NYLIKGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHH----HHHHcCC
Confidence 99865421 1112568999999999999999 8888863321 1111 1111110
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
..+........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111123345788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.64 Aligned_cols=231 Identities=20% Similarity=0.270 Sum_probs=180.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||||.+....... .....+.+|+++|++++|+||+++++.+.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 48899999987543222 23456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc----
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE---- 635 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~---- 635 (740)
||+++|+|.+++... ..++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999999754 46888899999999999999999998 9999999999999999999999999874210
Q ss_pred ------------------------------------------------------------CCCCCCcccceehhHHHHHH
Q 040687 636 ------------------------------------------------------------RDLTTDMKSDVHNFGIVLLE 655 (740)
Q Consensus 636 ------------------------------------------------------------~~~~~~~ksDVwSfGvvl~E 655 (740)
....++.++|||||||+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 01123568999999999999
Q ss_pred HHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCC---CHHHHHH
Q 040687 656 ILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELP---TMSQVAT 728 (740)
Q Consensus 656 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~ev~~ 728 (740)
|++|+.||....... ...... .. ......+.......++.+++.+|+ .+|.+|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~~----~~~~i~-~~------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPAE----TQLKVI-NW------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHHH----HHHHHh-cc------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999997543111 100111 00 011122222223345667888876 5999999 8888886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.34 Aligned_cols=222 Identities=24% Similarity=0.329 Sum_probs=173.7
Q ss_pred ceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++..+ ++.||||.++..... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 788999998765322 22344566777777654 899999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 9999999754 46899999999999999999999998 99999999999999999999999999864311
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||...... .....+ .......+. ....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i--------~~~~~~~~~--~~~~ 221 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSI--------LNDRPHFPR--WISK 221 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHH--------HcCCCCCCC--CCCH
Confidence 122367899999999999999999999743211 111111 111122222 2233
Q ss_pred HHHHHHHHhhhcCCCCCCCHH-HHHH
Q 040687 704 KLADIAELAIRENPSELPTMS-QVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~-ev~~ 728 (740)
++.+++.+||+.||++||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 677999999999999999975 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.51 Aligned_cols=222 Identities=24% Similarity=0.318 Sum_probs=178.2
Q ss_pred ceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||+||+++... ++.||||.++..... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 789999998865422 23345678899999888 799999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 9999998754 46899999999999999999999998 99999999999999999999999998754211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++|||||||++|||++|+.||..... ......+ .......+. ....
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i--------~~~~~~~~~--~~~~ 221 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSI--------LEDEVRYPR--WLSK 221 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHH--------HcCCCCCCC--cCCH
Confidence 12336789999999999999999999964321 1111111 111222222 2234
Q ss_pred HHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 040687 704 KLADIAELAIRENPSELPTM-----SQVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 728 (740)
.+.+|+.+||+.||++||++ .++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 67899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=309.24 Aligned_cols=230 Identities=21% Similarity=0.288 Sum_probs=179.1
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.|+..++||+|+||+||+++.. +++.||+|.+...... ......+.+|++++++++||||+++++.+.+....+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999974 4789999998764321 2334578999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc-----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE----- 635 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~----- 635 (740)
|+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999999754 46888999999999999999999998 9999999999999999999999999864210
Q ss_pred ---------------------------------------------------------------CCCCCCcccceehhHHH
Q 040687 636 ---------------------------------------------------------------RDLTTDMKSDVHNFGIV 652 (740)
Q Consensus 636 ---------------------------------------------------------------~~~~~~~ksDVwSfGvv 652 (740)
....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 01123568999999999
Q ss_pred HHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 040687 653 LLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPT---MSQVAT 728 (740)
Q Consensus 653 l~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 728 (740)
||||++|+.||...... +.....+. .......|.......+..+++.+++ .+|++|++ +.|++.
T Consensus 238 l~elltG~~Pf~~~~~~----~~~~~i~~-------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPL----ETQMKVIN-------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHH----HHHHHHHc-------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999743211 10111110 0111222222223345667777766 49999987 887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=317.58 Aligned_cols=227 Identities=20% Similarity=0.233 Sum_probs=180.6
Q ss_pred CccccceecccCceEEEEEEEe-C-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-D-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.|...+.||+|+||.||++... + ++.||+|.+.... ......+.+|+.+|++++||||+++++++...+..+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888899999999999999863 3 5788998765433 2333567889999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 561 FMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
|+++|+|.++|+.. ..++++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999988642 246899999999999999999999998 99999999999999999999999999865322
Q ss_pred ----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 637 ----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 637 ----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...++.++||||||+++|||+||+.||..... .+ ....+..+ ...
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~-~~~~~~~~--------~~~ 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----RE-IMQQVLYG--------KYD 289 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHHHhC--------CCC
Confidence 11235689999999999999999999964321 11 11111111 111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.+.....++.+|+.+||+.||++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111222346889999999999999999999875
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.81 Aligned_cols=232 Identities=25% Similarity=0.343 Sum_probs=187.0
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
+.++|+..+.||+|+||.||++.+. ++..+|+|.+.... ....+.|.+|++++++++||||+++++++..+...++|
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 3567899999999999999999975 58899999986543 23456799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++......+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999999999876567999999999999999999999998 99999999999999999999999998643211
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
....+.++||||||+++|||++|+.||........+ ..+.... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~-------~ 225 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-----LKILKSE-------P 225 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-----HHHhcCC-------C
Confidence 111355899999999999999999999643211111 1111110 0
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.....++.+++.+||+.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 111112223346789999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.50 Aligned_cols=226 Identities=22% Similarity=0.266 Sum_probs=175.6
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||.||+++.. +++.||+|.+........ ..+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999975 489999999875433221 234567799999999999999999999999999999999999999
Q ss_pred HHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----------
Q 040687 568 HDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---------- 636 (740)
Q Consensus 568 ~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---------- 636 (740)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99886433 45899999999999999999999998 99999999999999999999999998764321
Q ss_pred ----------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHH
Q 040687 637 ----------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLA 706 (740)
Q Consensus 637 ----------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~ 706 (740)
...++.++|||||||++|||++|+.||..........+. ... .+......+. .....++.
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~-~~~--------~~~~~~~~~~-~~~~~~~~ 227 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL-KRR--------TLEDEVKFEH-QNFTEESK 227 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-HHH--------hhcccccccc-ccCCHHHH
Confidence 122367899999999999999999999643221111111 111 1111111111 12234678
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 040687 707 DIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 707 ~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+|+.+||+.||++||+++|+++
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHhccCHhhCCCCccchh
Confidence 9999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=309.02 Aligned_cols=235 Identities=19% Similarity=0.215 Sum_probs=177.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||.||++... .++.||||.... ..+.+|+++|++|+||||+++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 357999999999999999999974 488999996432 35688999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+. ++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 163 e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 163 PRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred ecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9995 7999998654 46899999999999999999999998 99999999999999999999999999853211
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCC------chhHHhhhhHHh----------
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP------PGIVEWALPLIK---------- 681 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~------~~~~~~~~~~~~---------- 681 (740)
...++.++||||||++||||+||+.||...... ............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 122366899999999999999999887432110 000010100000
Q ss_pred hCccchhc----ccccCCCC-------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 682 QGKAAAII----DRNVALPR-------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 682 ~~~~~~i~----d~~~~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+. ......+. ..+...++.+|+.+||+.||.+|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 00000000 0122346789999999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.92 Aligned_cols=223 Identities=22% Similarity=0.343 Sum_probs=174.6
Q ss_pred ceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 488 NELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+.||+|+||.||++.... ..+|++|.+.... ....++|.+|+.++++++||||+++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999998643 2348888875432 233467899999999999999999999999988999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC--------EEEeecCCC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG--------ARIADFGLL 631 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~ki~DFGla 631 (740)
||+++|+|.++++.....+++..++.++.||+.||+|||+.+ |+||||||+|||++.+.. +|++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999876667899999999999999999999998 999999999999987765 699999987
Q ss_pred ccccC------------------CCCCCcccceehhHHHHHHHHhCC-CCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 632 TSCER------------------DLTTDMKSDVHNFGIVLLEILSGR-KAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 632 ~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
..... ...++.++||||||+++|||++|. .||.... +... .. +...+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~----~~---------~~~~~ 221 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKK----LQ---------FYEDR 221 (258)
T ss_pred cccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHH----HH---------HHHcc
Confidence 53221 122466899999999999999985 5553211 1100 00 11112
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
...|.. ...++.+|+.+||+.||++||++++|++.|+
T Consensus 222 ~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPAP--KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCCC--CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 222221 2246889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.27 Aligned_cols=242 Identities=25% Similarity=0.327 Sum_probs=181.5
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----eEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-----ERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 556 (740)
.|...+.+|.|+||.||+|++.. ++.||||+.-.+. +---.|+++|++++|||||+|+-++.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 47778899999999999999754 7899999876543 12235999999999999999999887543 235
Q ss_pred EEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCCCc
Q 040687 557 LVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGLLT 632 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGla~ 632 (740)
|||||||. +|.++++. ....++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 99999873 2345777778889999999999999988 9999999999999976 899999999998
Q ss_pred cccCC---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH-------HhhCc
Q 040687 633 SCERD---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL-------IKQGK 684 (740)
Q Consensus 633 ~~~~~---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~-------~~~~~ 684 (740)
....+ ..|+.+.||||.|||+.||+-|+..|.++.....+++.+.-. +....
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 66442 234789999999999999999999998765444444322111 00000
Q ss_pred cc--hhcccccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 685 AA--AIIDRNVALP-----RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 685 ~~--~i~d~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.. +.-.+.+... .......+..+|+.++++.+|.+|.+..|++. .++++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00 1111111111 11122347889999999999999999999886 455444
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.05 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=187.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----C
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----G 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 553 (740)
....|...+.||+|+||.|..+... +++.||||++..........+.-.+|+.+|++++|+||+.+++..... .
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666788999999999999974 589999999885443344567789999999999999999999998752 4
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..|+|+|+| .-+|...++.+ ..|+......+..|+++||+|+|+.+ |+||||||+|+|++.+...||+|||||+.
T Consensus 100 DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 689999999 45999999865 35899999999999999999999999 99999999999999999999999999987
Q ss_pred ccC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchh----------HHhhhhH
Q 040687 634 CER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGI----------VEWALPL 679 (740)
Q Consensus 634 ~~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~----------~~~~~~~ 679 (740)
... ...++...||||.||||.||++|+..|.+.+.-.++ .+.....
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 742 123467899999999999999999999764322211 1111222
Q ss_pred HhhCccchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 680 IKQGKAAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 680 ~~~~~~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+........+..-...|. -+.......+|+++||..||.+|+|++|.++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 222222222221111111 1122335679999999999999999999886
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=293.67 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=183.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||++++. +++.||+|++..........+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 48899999987543222334568899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|+++++|..++... ..+++..++.++.|++++|+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99998888776543 46899999999999999999999988 999999999999999999999999997643211
Q ss_pred -------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh--Cccchhccc-----
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ--GKAAAIIDR----- 691 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~i~d~----- 691 (740)
..++.++||||||+++|||++|+.||........+.... ..... ....++.+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR-KTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCChHHhhhcccccccc
Confidence 123568999999999999999999997543222111100 00000 000000000
Q ss_pred ccCCCC----------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR----------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .......+.+|+.+||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 0112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.43 Aligned_cols=218 Identities=25% Similarity=0.301 Sum_probs=171.4
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHH-HHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELE-VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||+||+++.. +++.||||++....... ...+++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 58999999987643221 22345556655 56789999999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 9999999754 46899999999999999999999998 99999999999999999999999998764211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||..... .+ .... ++......+. ....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~-~~~~--------i~~~~~~~~~--~~~~ 221 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AE-MYDN--------ILNKPLRLKP--NISV 221 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----HH-HHHH--------HHcCCCCCCC--CCCH
Confidence 12236689999999999999999999964321 11 1111 1111222222 2234
Q ss_pred HHHHHHHHhhhcCCCCCCCHH
Q 040687 704 KLADIAELAIRENPSELPTMS 724 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~ 724 (740)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 678999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=292.58 Aligned_cols=232 Identities=26% Similarity=0.328 Sum_probs=179.4
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++. .+++.||+|.+.... .....++|.+|++++++++||||+++++++......++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3577888999999999999996 458899999986542 22344679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~ 151 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK 151 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence 99999997653 3788889999999999999999998 99999999999999999999999999754321
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
....+.++||||||+++|||++|+.||............ ... ...+.+...........
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQL-----LQCIVDEDPPVLPVGQF 225 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-HHH-----HHHHhccCCCCCCCCcC
Confidence 122366899999999999999999999643211110000 000 00111111110011122
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..++.+++.+||+.+|++||+++|+++
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 346789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.28 Aligned_cols=229 Identities=23% Similarity=0.358 Sum_probs=184.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..+|+..+.||+|+||.||+++.. +++.|++|.+..... .....+.+|+.++++++|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 357888999999999999999964 588999998876442 23467889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++.+. .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999999753 5899999999999999999999998 99999999999999999999999998753221
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||+++|||++|+.||........+. .... ......+.+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~----~~~~--------~~~~~~~~~ 239 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY----LIAT--------NGTPELQNP 239 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH----HHhc--------CCCCCCCCc
Confidence 1123568999999999999999999996443211110 1110 011111112
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+.+++.+||..+|++||++.||+.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 223346789999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.60 Aligned_cols=228 Identities=26% Similarity=0.407 Sum_probs=182.8
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..+.||+|+||.||++.. .++.||+|.++... ....|.+|+.++++++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4588889999999999999975 67889999886532 235789999999999999999999998764 57899999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCC
Confidence 99999999997543 35899999999999999999999988 99999999999999999999999998764321
Q ss_pred --------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 --------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 --------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
....+.++||||||+++|||++ |+.||..... .+ ....+.. ....+.....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~-~~~~~~~---------~~~~~~~~~~ 222 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KE-VKECVEK---------GYRMEPPEGC 222 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HH-HHHHHhC---------CCCCCCCCcC
Confidence 1223568999999999999998 9999864321 11 1111111 1111112233
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
...+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 4578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=287.71 Aligned_cols=229 Identities=20% Similarity=0.330 Sum_probs=183.6
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..++||+|+||.||+++.. +++.+|+|.++.... ....+.+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4777889999999999999975 588999998865432 23456788999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.+++.... ..+++...+.++.|+++||.|||+.+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999999986532 45889999999999999999999998 99999999999999999999999999764422
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||++|+.||+.... .. ....+..+... +.+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~-~~~~~~~~~~~---------~~~~ 222 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KN-LILKVCQGSYK---------PLPS 222 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HH-HHHHHhcCCCC---------CCCc
Confidence 11235689999999999999999999974321 11 11111111111 1111
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
.....+.+++.+||+.||++||++.+|+..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223467799999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=287.18 Aligned_cols=229 Identities=24% Similarity=0.387 Sum_probs=185.8
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||+++.. +++.||+|++..........+++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999974 588999999876543344556899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999997543 35799999999999999999999998 99999999999999999999999998754322
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||++++||+||+.||..... .+.....+ . ... .+.+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~~-~--------~~~-~~~~~ 223 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----KNLVLKII-R--------GSY-PPVSS 223 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----HHHHHHHh-c--------CCC-CCCcc
Confidence 12235689999999999999999999964321 11111111 1 111 11122
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+++.+||+.+|++||++.||++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 33447889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=299.18 Aligned_cols=221 Identities=25% Similarity=0.338 Sum_probs=174.9
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++.. +++.||+|.++..... ......+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 4889999998765321 22345677788888764 899999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 9999999754 46899999999999999999999998 99999999999999999999999998763210
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||..... .. ....+. ......+.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~----~~~~~~--------~~~~~~~~~--~~~ 221 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DE----LFESIR--------VDTPHYPRW--ITK 221 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HH----HHHHHH--------hCCCCCCCC--CCH
Confidence 12346689999999999999999999964321 11 111111 111122222 233
Q ss_pred HHHHHHHHhhhcCCCCCCCHH-HHH
Q 040687 704 KLADIAELAIRENPSELPTMS-QVA 727 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~-ev~ 727 (740)
++.+++.+||+.||++||++. ++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 677999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=298.70 Aligned_cols=222 Identities=24% Similarity=0.336 Sum_probs=175.1
Q ss_pred ceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHh-CCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCN-IRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++..+ ++.||||.++..... ......+..|..++.. ++||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999754 789999998765321 2234557778888876 4999999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 9999999754 46899999999999999999999998 99999999999999999999999998764210
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||..... ..+ ...+.. .....+.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~----~~~i~~--------~~~~~~~~--~~~ 221 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EEL----FQSIRM--------DNPCYPRW--LTR 221 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHH----HHHHHh--------CCCCCCcc--CCH
Confidence 12346789999999999999999999964321 111 111111 11112221 223
Q ss_pred HHHHHHHHhhhcCCCCCCCHH-HHHH
Q 040687 704 KLADIAELAIRENPSELPTMS-QVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~-ev~~ 728 (740)
++.+++.+||+.||++||++. ++..
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 677999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.40 Aligned_cols=233 Identities=26% Similarity=0.358 Sum_probs=186.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++++.+....+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 467889999999999999999975 478899999876542 24578999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++......++..++..++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999999776567999999999999999999999998 99999999999999999999999998653211
Q ss_pred ------------------CC---CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ------------------DL---TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ------------------~~---~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
.. ..+.++||||||+++|||+||+.||.......... .+...... ....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~~~~~~~~-----~~~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----LISKSNFP-----PPKL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhccCC-----Cccc
Confidence 11 34568999999999999999999996432111110 01111000 0011
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........++.+++++||+.+|.+||++.+|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=304.91 Aligned_cols=239 Identities=19% Similarity=0.260 Sum_probs=185.9
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
+.++....++|+..+.||+|+||.||+++.. +++.||+|.+...... ......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556689999999999999999999975 4789999998653322 2233457889999999999999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
....++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999999754 4788889999999999999999999 999999999999999999999999998
Q ss_pred ccccCC--------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 632 TSCERD--------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 632 ~~~~~~--------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
...... ..++.++|||||||+||||++|+.||..... ... ...+....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~-~~~i~~~~- 263 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGT-YSKIMNHK- 263 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHH-HHHHHcCC-
Confidence 543210 1145689999999999999999999974321 111 11111100
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSE--LPTMSQVAT 728 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 728 (740)
.....+........+.+++..|++.++.+ ||++.||++
T Consensus 264 -----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 264 -----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred -----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 11222333334446778999999844433 789998887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=292.83 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=185.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||+||++... +++.||+|.+..... ....+.|.+|++++++++||||+++++++.....++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 56888889999999999999975 488999998765432 2345679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++... .++++.....++.+++.+|.|||+ .+ ++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 99999999998753 468999999999999999999997 46 99999999999999999999999998754211
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc-cCCCCCc
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN-VALPRNV 699 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~-~~~~~~~ 699 (740)
....+.++||||||+++|||+||+.||+....+........... .....++... ...+ ..
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~ 236 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQEPPPRLP-SS 236 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH--HHHHHHhhccCCCCC-ch
Confidence 12235689999999999999999999975432211000000000 0011111111 1111 11
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
+...++.+|+.+||+.||++||++.|+++.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 234468899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.41 Aligned_cols=231 Identities=27% Similarity=0.376 Sum_probs=185.1
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.+.|+..++||+|+||.||+++... ++.|++|.+.... ....+.+.+|++++++++||||+++++.+..+...++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3668889999999999999999754 8899999987543 334567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|..++.+....+++..++.++.|++++|+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999999988765567999999999999999999999988 99999999999999999999999998653211
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...++.++||||||+++|||++|+.||...... +.. ..+.... .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~-~~~~~~~-----~~-- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVL-LKIAKSE-----PP-- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHH-HHHhcCC-----Cc--
Confidence 111255799999999999999999998643211 111 1111110 01
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+.+.....++.+++.+||+.||++||++.||++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11112223346789999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.32 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=183.5
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||.||++.+.+ ++.||+|++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999864 8899999987654333344678899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.++.... ..+++.+++.++.||+++|+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 99998888877543 45899999999999999999999998 99999999999999999999999998754321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh--Cccchhccc-----
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ--GKAAAIIDR----- 691 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~i~d~----- 691 (740)
....+.++||||||+++|||++|+.||..+........ ....... .......+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH-IIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH-HHHHhCCCchhhHHHhccchHhh
Confidence 11235689999999999999999999864322111000 0000000 000000000
Q ss_pred ccCCCC----------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR----------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .......+.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 1123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.46 Aligned_cols=227 Identities=30% Similarity=0.450 Sum_probs=179.3
Q ss_pred ceecccCceEEEEEEEeC-------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 488 NELGRGSYGFVYKAVLVD-------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+.||+|+||.||+++..+ ++.+|||.+..... .....+|.+|++++++++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 369999999999999743 25799998765421 2345679999999999999999999999999899999999
Q ss_pred cCCCCChHHhHhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-----CEEEeecC
Q 040687 561 FMPRGTLHDHLHGG------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-----GARIADFG 629 (740)
Q Consensus 561 y~~~gsL~~~l~~~------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~ki~DFG 629 (740)
|+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|||++++. .+||+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999642 134789999999999999999999988 99999999999999887 89999999
Q ss_pred CCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 630 LLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 630 la~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
++..... ....+.++||||||+++|||+| |+.||...... .. ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~----~~~~~~--- 228 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EV----LQHVTA--- 228 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HH----HHHHhc---
Confidence 8753211 1223668999999999999998 99999643211 11 111111
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.............+.+++.+||+.+|++||++++|++.|++
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111222334578899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.63 Aligned_cols=242 Identities=19% Similarity=0.242 Sum_probs=182.4
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|.||.||+++.. +++.||+|++............+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999975 588999999876543333345688899999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
++ ++|.+++......+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 97 5899888765567999999999999999999999998 99999999999999999999999998764321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC------ccchhccccc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG------KAAAIIDRNV 693 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~i~d~~~ 693 (740)
...++.++||||||+++|||+||+.|+..........+......... ......+...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 01235689999999999999999998643322111111111000000 0000000000
Q ss_pred --CCC-------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 --ALP-------RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 --~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+ .......++.+++++||+.||.+|||++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=289.00 Aligned_cols=221 Identities=23% Similarity=0.366 Sum_probs=175.0
Q ss_pred ceecccCceEEEEEEEeCCc-----------EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 488 NELGRGSYGFVYKAVLVDGR-----------QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~-----------~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
+.||+|+||.||++.+.+.. .+++|.+..... ....|.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36999999999999986533 578887765431 15789999999999999999999999988 7789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-------CEEEeecC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-------GARIADFG 629 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~ki~DFG 629 (740)
+||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999999876557899999999999999999999988 99999999999999888 79999999
Q ss_pred CCccccC-----------------C--CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 630 LLTSCER-----------------D--LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 630 la~~~~~-----------------~--~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
++..... . ...+.++||||||+++|||++ |..||.... ...... ...
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~----~~~-------- 220 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKER----FYQ-------- 220 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHH----HHh--------
Confidence 8765221 0 134668999999999999999 577775332 111110 000
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
.....+.+. ...+.+++.+||+.+|++||++.||++.|+
T Consensus 221 -~~~~~~~~~--~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -DQHRLPMPD--CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -cCCCCCCCC--chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111111 147889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=290.16 Aligned_cols=233 Identities=23% Similarity=0.325 Sum_probs=182.3
Q ss_pred CccccceecccCceEEEEEEEeC--CcEEEEEEecccc--------cchhcHHHHHHHHHHHHh-CCCCCcceEEeEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD--GRQVAVKRANAAT--------IIHTNIREFEMELEVLCN-IRHSNIVNLLGYCLE 551 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAiK~l~~~~--------~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 551 (740)
+|+..+.||+|+||.||++.+.. ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999865 6889999876432 112234567889998875 799999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 552 MGERLLVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
.+..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+ ++|+||||+|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998743 33468999999999999999999996 56 99999999999999999999999
Q ss_pred cCCCccccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch
Q 040687 628 FGLLTSCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA 687 (740)
Q Consensus 628 FGla~~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (740)
||++...... ...+.++||||||+++|||++|+.||...... . ....+..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~-~~~~~~~----- 227 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----S-LATKIVE----- 227 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----H-HHHHHhh-----
Confidence 9987643321 12356899999999999999999999633211 1 0111111
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
.............++.+++++||+.||++||++.|+.++|+
T Consensus 228 ---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 ---AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111123347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.84 Aligned_cols=240 Identities=26% Similarity=0.385 Sum_probs=188.8
Q ss_pred ccChhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeE
Q 040687 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGY 548 (740)
Q Consensus 471 ~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 548 (740)
.+...++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +|||+++++++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 4566777788899999999999999999999974 58899999886532 2235678899999999 89999999999
Q ss_pred EEeC-----CeEEEEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 549 CLEM-----GERLLVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 549 ~~~~-----~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
+... ...++||||+++++|.++++. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~ 164 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE 164 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence 8754 358999999999999998863 2346899999999999999999999988 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------C---------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHH
Q 040687 621 WGARIADFGLLTSCER-----------------D---------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVE 674 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------~---------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 674 (740)
+.+||+|||++..... + ...+.|+||||||+++|||++|+.||........+.
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~- 243 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF- 243 (291)
T ss_pred CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-
Confidence 9999999998653211 0 013578999999999999999999996432211111
Q ss_pred hhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 675 WALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 675 ~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+...... ......+....+.+++.+||+.+|++||++.|+++
T Consensus 244 ----~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 ----KIPRNPPP-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----HHhcCCCC-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111 11111223346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=299.79 Aligned_cols=218 Identities=26% Similarity=0.295 Sum_probs=171.2
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHH-HHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELE-VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++.. +++.||+|.+...... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 4889999998764322 123345666654 57889999999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..++...+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 9999988754 46888889999999999999999998 99999999999999999999999998764211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||..... .+ ... .+.......+. ....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~-~~~--------~i~~~~~~~~~--~~~~ 221 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQ-MYD--------NILHKPLQLPG--GKTV 221 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HH-HHH--------HHhcCCCCCCC--CCCH
Confidence 12236689999999999999999999964321 11 111 11222222222 2234
Q ss_pred HHHHHHHHhhhcCCCCCCCHH
Q 040687 704 KLADIAELAIRENPSELPTMS 724 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~ 724 (740)
.+.+++.+||+.||.+||+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 678999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=295.26 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=186.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...++||+|+||.||+++.. +++.||+|.++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 56888999999999999999975 478999999875432 2233467889999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|++ ++|.+++......+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 997 5999999776667899999999999999999999998 99999999999999999999999998754221
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh---hCccchhccc----
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK---QGKAAAIIDR---- 691 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---~~~~~~i~d~---- 691 (740)
....+.++||||||+++|||+||+.||....... ........+. ......+++.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhcccccc
Confidence 1123568999999999999999999997543211 1111111000 0000000000
Q ss_pred ccCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 692 NVALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 692 ~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
....+. .......+.+|+.+||+.||.+|||++|+++ +++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000010 1122346789999999999999999999997 554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.80 Aligned_cols=233 Identities=21% Similarity=0.247 Sum_probs=180.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.. +++.||+|.+...... ....+.|.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999975 4889999998753321 223456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999765567899999999999999999999999 999999999999999999999999997543210
Q ss_pred -------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 638 -------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 638 -------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
..++.++|||||||++|||++|+.||..... .+......... ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~-------~~ 226 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHK-------EH 226 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCC-------Cc
Confidence 1235689999999999999999999964321 11111111111 11
Q ss_pred cCCCC-CchhHHHHHHHHHHhhhcC--CCCCCCHHHHHH
Q 040687 693 VALPR-NVEPLFKLADIAELAIREN--PSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~-~~~~~~~l~~l~~~Cl~~d--P~~RPt~~ev~~ 728 (740)
...+. .......+.+++++|+..+ +..||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 11111 1123346778888877553 334889999886
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.55 Aligned_cols=230 Identities=26% Similarity=0.335 Sum_probs=183.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+.|+..+.||+|+||+||+++.. +++.||+|.+..... .....+++.+|++++++++||||+++++++.+....++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999975 588999998864432 2234467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||++ |+|.+++.....++++..+..++.|++.+|.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 9996 6888888655567999999999999999999999998 99999999999999999999999998754321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||+||+.||...... ..... +.... .... ...
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~~-~~~~~-------~~~~-~~~ 237 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH-IAQND-------SPTL-SSN 237 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHHH-HhcCC-------CCCC-Cch
Confidence 122466899999999999999999998643211 10001 11110 0011 112
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+++.+||+.+|++||++.+|+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 23457889999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=291.99 Aligned_cols=230 Identities=25% Similarity=0.402 Sum_probs=183.8
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.|+..+.||+|.||.||+|.+. +++.||+|.+..... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4677788999999999999874 478899998875432 23446799999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 999999999865 35899999999999999999999988 99999999999999999999999998754321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||+++|||+||+.||....... . ...+.. .........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~----~~~~~~---------~~~~~~~~~ 224 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-V----LFLIPK---------NSPPTLEGQ 224 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-H----Hhhhhc---------CCCCCCCcc
Confidence 1123568999999999999999999986322110 0 001111 111111122
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
....+.+++.+||+.+|++||+|.+|++ ++.+
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 3446889999999999999999999997 5543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=289.04 Aligned_cols=233 Identities=30% Similarity=0.468 Sum_probs=183.0
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|+..+.||+|+||+||+++... ++.+|+|.+..............+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999865 678999999877644444444566999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
++++|.++|. ....+++.+++.++.|+++||+|||+.+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999998 2346899999999999999999999998 99999999999999999999999999853110
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||+|+++|||++|+.||..... .+... ....... ...... .. ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~-~~~~~~~---~~~~~~-~~--~~~~ 228 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLE-IIEKILK---RPLPSS-SQ--QSRE 228 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHH-HHHHHHH---THHHHH-TT--SHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc-hhhhh-hhhhccc---cccccc-cc--ccch
Confidence 12346799999999999999999999974410 01111 1111110 000000 00 0011
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1257889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.00 Aligned_cols=231 Identities=23% Similarity=0.353 Sum_probs=196.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe-EEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE-RLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 559 (740)
++|...+++|+|+||.+++.+.+ +...+++|+++.........+..++|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999998864 57899999999887666666788999999999999999999999999887 99999
Q ss_pred ecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
+|+++|+|.+.+.... ..+++..+..++.||+.|+.|||+.. |+|||||+.||+++.+..+||.|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998765 56899999999999999999999888 99999999999999999999999999986654
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
+..|..|+|||||||++|||.+=+.+|+..+... ++ .++.... ..|.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-Li------------~ki~~~~-~~Pl 226 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-LI------------LKINRGL-YSPL 226 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-HH------------HHHhhcc-CCCC
Confidence 3445789999999999999999999997543211 11 1111111 2344
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
+.....++..|+..|++.+|..||++.+++..
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 44555688899999999999999999999973
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.04 Aligned_cols=231 Identities=21% Similarity=0.265 Sum_probs=181.2
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
|+..+.||+|+||+||++... +++.||+|.+........ ....+.+|+++|++++|+|++++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999974 588999999876543222 234578899999999999999999999999999999999
Q ss_pred CCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 9999999988653 246999999999999999999999998 99999999999999999999999998754321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++||||||+++|||++|+.||......... +.....+ .+..... ...
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~~~~--------~~~~~~~--~~~ 227 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVDRRV--------LETEEVY--SAK 227 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhh--------hcccccc--Ccc
Confidence 122366899999999999999999999743211111 1111111 1111111 112
Q ss_pred hHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
....+.+|+..||+.||++||+ +.+++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2346779999999999999999 667776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.03 Aligned_cols=230 Identities=24% Similarity=0.375 Sum_probs=182.3
Q ss_pred CccccceecccCceEEEEEEEeCCcEEEEEEecccccc----hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATII----HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
+|+..+.||+|+||+||++...+++.+|+|.++..... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36778899999999999999878899999988754321 22345689999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... .++++..+..++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999754 46889999999999999999999998 99999999999999999999999998754210
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
....+.++||||||+++|||++|+.||......... . .+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~-~~~~~--~----- 224 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM----F-YIGAH--R----- 224 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----H-Hhhhc--c-----
Confidence 111256899999999999999999999643211100 0 00000 0
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+.....++.+++++||+.+|++||++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001112223446789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.14 Aligned_cols=241 Identities=24% Similarity=0.258 Sum_probs=176.7
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC---CCCCcceEEeEEEeC-----C
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI---RHSNIVNLLGYCLEM-----G 553 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 553 (740)
+|+..+.||+|+||+||+++.. +++.||+|.++...........+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999975 488999999876433222334566788777765 799999999988642 4
Q ss_pred eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999997 48999887543 35899999999999999999999998 9999999999999999999999999986
Q ss_pred cccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccch--
Q 040687 633 SCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAAA-- 687 (740)
Q Consensus 633 ~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~-- 687 (740)
.... ...++.++|||||||++|||++|+.||........+.+ ....+.. .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH-HHHHhCCCChhhCcccc
Confidence 4321 12236789999999999999999999965432221111 1111000 00000
Q ss_pred -----hcccccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 688 -----IIDRNVAL---PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 688 -----i~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........ ....+....+.+++.+||+.||++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 001122346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=300.03 Aligned_cols=219 Identities=26% Similarity=0.301 Sum_probs=171.4
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHH-HHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELE-VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||+||+++.. +++.||+|++...... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999974 5889999998764321 223345666665 46779999999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 9999998754 46899999999999999999999998 99999999999999999999999999764211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||...... + ....+ +......+. ....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~-~~~~~--------~~~~~~~~~--~~~~ 221 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----E-MYDNI--------LHKPLVLRP--GASL 221 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----H-HHHHH--------HcCCccCCC--CCCH
Confidence 122367899999999999999999999643211 1 11111 111111111 2233
Q ss_pred HHHHHHHHhhhcCCCCCCCHHH
Q 040687 704 KLADIAELAIRENPSELPTMSQ 725 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~e 725 (740)
.+.+++++|++.+|.+||++++
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCC
Confidence 6778999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.40 Aligned_cols=240 Identities=25% Similarity=0.365 Sum_probs=186.7
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEE
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYC 549 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 549 (740)
+.++.+..+.++|+..+.||+|+||.||+++.. .++.+|+|.+.... ....++.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 456777888999999999999999999999974 47899999876432 2235688999999999 799999999988
Q ss_pred Ee-----CCeEEEEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 550 LE-----MGERLLVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 550 ~~-----~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
.. ....++||||+++++|.++++. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence 53 3468999999999999998753 2246889999999999999999999988 99999999999999999
Q ss_pred CEEEeecCCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHh
Q 040687 622 GARIADFGLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEW 675 (740)
Q Consensus 622 ~~ki~DFGla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~ 675 (740)
.+||+|||++..... ...++.++||||||+++|||++|+.||........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-- 239 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--
Confidence 999999998754321 0113568999999999999999999986432111110
Q ss_pred hhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 676 ALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 676 ~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
..... .......+ .....++.+++.+||+.||++||++.||++.
T Consensus 240 ---~~~~~-----~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ---KIPRN-----PPPTLHQP--ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---hcccc-----CCCcccCC--CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 00011111 1123367899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.09 Aligned_cols=222 Identities=24% Similarity=0.328 Sum_probs=176.3
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 559 (740)
+|+..+.||+|+||+||+++.. +++.||+|.+...... ....+.+..|..++..+. |++|+++++++...+..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999975 5889999998764322 223456788999998885 577888999999989999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999998764211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||+||+.||..... ..+ . ..++......|..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~----~--------~~i~~~~~~~p~~ 223 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DEL----F--------QSIMEHNVSYPKS 223 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHH----H--------HHHHhCCCCCCcc
Confidence 11235689999999999999999999974321 111 1 1112222222222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
...++.+++.+||+.+|.+|++.
T Consensus 224 --~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 224 --LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCHHHHHHHHHHcccCHhhCCCC
Confidence 23467799999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.99 Aligned_cols=233 Identities=21% Similarity=0.238 Sum_probs=181.0
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||+||+++... ++.+|+|.+.+.... ......|.+|+.++..++|+||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999754 778999998653322 223345888999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.++++.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999875567899999999999999999999998 99999999999999999999999998753211
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++|||||||+||||++|+.||..... .+.. ..+.... .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~----~~~~-~~i~~~~------~~ 226 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETY-GKIMNHK------ER 226 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH----HHHH-HHHhCCC------cc
Confidence 11235689999999999999999999974321 1111 1111110 01
Q ss_pred cCCCC-CchhHHHHHHHHHHhhhcCCC--CCCCHHHHHH
Q 040687 693 VALPR-NVEPLFKLADIAELAIRENPS--ELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~-~~~~~~~l~~l~~~Cl~~dP~--~RPt~~ev~~ 728 (740)
...|. ......++.+|+++|+..+++ .||+++|+++
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 11121 112334677899998865444 4789999886
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=322.37 Aligned_cols=240 Identities=21% Similarity=0.246 Sum_probs=187.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||.||+++.. .++.||||+++..... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999975 4889999998754322 123457999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 560 EFMPRGTLHDHLHGG----------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
||+++++|.+++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998631 124678888999999999999999998 9999999999999999999999999
Q ss_pred CCccccC---------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc
Q 040687 630 LLTSCER---------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP 670 (740)
Q Consensus 630 la~~~~~---------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 670 (740)
++..... ....+.++||||||+++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9865410 1122568999999999999999999996432111
Q ss_pred hhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHh
Q 040687 671 GIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELP-TMSQVATWLEQIVKD 736 (740)
Q Consensus 671 ~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~Le~l~~~ 736 (740)
.. ... .+.++ .......+....+.+++.+|++.||++|| +++++.+.|+.+++.
T Consensus 239 i~--------~~~---~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS--------YRD---VILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--------hhh---hccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 000 00011 01111112334678999999999999995 577888888887654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.30 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=186.5
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEE
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYC 549 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 549 (740)
.++.++..+.+.|+..+.||+|+||.||+++.. +++.+|+|.+.... ....++..|+.+++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 356677777888999999999999999999974 47899999876542 2345788999999998 799999999998
Q ss_pred Ee------CCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 550 LE------MGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 550 ~~------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
.. ....+++|||+++++|.+++.... ..+++..++.++.|++.+|.|||+.+ |+|+||||+||++++++.
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 63 357899999999999999997533 45888889999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh
Q 040687 623 ARIADFGLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 623 ~ki~DFGla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 676 (740)
+||+|||++..... ...++.++||||||+++|||++|+.||........+.
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 99999998753211 1224568999999999999999999996432111000
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+...............++.+++.+||+.||.+||++.||++
T Consensus 237 ----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ----------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000010110111123447889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.05 Aligned_cols=229 Identities=23% Similarity=0.341 Sum_probs=173.1
Q ss_pred eecccCceEEEEEEEeCC---cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 489 ELGRGSYGFVYKAVLVDG---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~g---~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+||+|+||.||+++..++ ..+++|.+..... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 699999999999986543 3466776654332 234568999999999999999999999999999999999999999
Q ss_pred ChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc-------
Q 040687 566 TLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE------- 635 (740)
Q Consensus 566 sL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~------- 635 (740)
+|.++++... ..+++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 34677788899999999999999998 9999999999999999999999999864210
Q ss_pred ------------CC-----------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 ------------RD-----------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ------------~~-----------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.+ ...+.++||||||+++|||++ ++.||..... .... ...+. +....+.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~---~~~~~-~~~~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVL---NHVIK-DQQVKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHH---HHHHh-hcccccCCC
Confidence 00 012468999999999999998 5778853221 1111 11121 122222222
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
.... .....+.+++..|| .+|++||+++||++.|.
T Consensus 233 ~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222 12346778999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.07 Aligned_cols=233 Identities=25% Similarity=0.400 Sum_probs=185.0
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|+..+.||+|+||+||+++.+ +.+.|++|.+..... .....+|.+|++++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 56888899999999999999964 246799998765331 12346799999999999999999999999998899
Q ss_pred EEEEecCCCCChHHhHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 556 LLVYEFMPRGTLHDHLHGGL--------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~--------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
++||||+++++|.++++... ..+++..++.++.|++++|+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997543 15899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccC----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 628 FGLLTSCER----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 628 FGla~~~~~----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
||++..... ....+.++||||||+++|||++ |..||..... ..+ .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~----~~~~~~~- 234 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEV----LNRLQAG- 234 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHH----HHHHHcC-
Confidence 998753211 1123567999999999999999 8889853221 111 1111111
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
....+........+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 -------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 -------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111222233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.17 Aligned_cols=222 Identities=22% Similarity=0.327 Sum_probs=175.3
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||+||+++.. +++.||+|.++...... ...+.+.+|+.++.++ +||||+++++++......+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 47899999998654322 2345688999999988 699999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 9999988654 46999999999999999999999998 99999999999999999999999998764210
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCC--chhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP--PGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++||||||++||||+||+.||+..... ....+.....+ .......|.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~p~~--~ 226 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEKPIRIPRF--L 226 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhCCCCCCCC--C
Confidence 123367999999999999999999999642211 11122222222 1222223322 2
Q ss_pred HHHHHHHHHHhhhcCCCCCCCH
Q 040687 702 LFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
...+.+++.+||+.||++||++
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCC
Confidence 2367799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.59 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=180.1
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----- 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 553 (740)
..++|+..+.||+|+||.||+++.. .++.||+|++............+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999974 4889999998765433344567889999999999999999999986543
Q ss_pred -eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 554 -ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 554 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47999999965 67777753 4788999999999999999999998 9999999999999999999999999986
Q ss_pred cccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh----------
Q 040687 633 SCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---------- 682 (740)
Q Consensus 633 ~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---------- 682 (740)
.... ...++.++||||||+++|||+||+.||........+.. .......
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK-VIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCcHHHHHHHH
Confidence 4321 12236689999999999999999999975432111100 0000000
Q ss_pred CccchhcccccC--------------CCC----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 GKAAAIIDRNVA--------------LPR----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ~~~~~i~d~~~~--------------~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
............ .+. ......++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000 000 0111246789999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.10 Aligned_cols=242 Identities=20% Similarity=0.292 Sum_probs=182.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++.. +++.||||.+..... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999975 588999999875432 1223457889999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++ +|.+++......+++.....++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9985 999999766567899999999999999999999998 99999999999999999999999998753210
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccchh------c
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAAAI------I 689 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i------~ 689 (740)
....+.++||||||+++|||++|+.||................+.. .....+ .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 1123568999999999999999999996443211111111111000 000000 0
Q ss_pred ccccCC--C-------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 DRNVAL--P-------RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 d~~~~~--~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...... + .......++.+++.+||+.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0 01111246779999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=284.54 Aligned_cols=229 Identities=24% Similarity=0.350 Sum_probs=182.4
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 560 (740)
+|+..+.||+|+||.||+++.. +++.||+|++..........+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999975 47889999987654434455678999999999999999999988764 346789999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++.... ..+++.+++.++.|++.+|+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999997643 45899999999999999999999998 99999999999999999999999998754321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||++++||++|+.||+.... .+.... +..+... +..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~-~~~~~~~---------~~~ 223 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSLVYR-IIEGKLP---------PMP 223 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHH-HHhcCCC---------CCc
Confidence 11225689999999999999999999964321 111111 1111110 111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 223347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.55 Aligned_cols=241 Identities=24% Similarity=0.272 Sum_probs=183.9
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccc---hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII---HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
+|+..+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 5889999999765432 22234578899999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||+ +++|.+++......+++..++.++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 89999999765447999999999999999999999999 999999999999999999999999987643211
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---------Cccch
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---------GKAAA 687 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~ 687 (740)
...+.++||||||+++|||++|..||........+ +........ .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL-GKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH-HHHHHHcCCCchhhhhhcccccc
Confidence 12356899999999999999997777643321111 111110000 00000
Q ss_pred hcccccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 688 IIDRNVALPR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 688 i~d~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........+. ......++.+++.+||+.||++||++.||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000010 1122357889999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.67 Aligned_cols=172 Identities=28% Similarity=0.325 Sum_probs=148.5
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
...+|+..+.||+|+||.||+++... ++.||+|..... ....|+.++++++||||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34579999999999999999999754 678999975432 235699999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
+||+. ++|.+++......+++.+++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99994 6999999876678999999999999999999999998 99999999999999999999999999863211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~ 663 (740)
...++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123467899999999999999955554
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.70 Aligned_cols=233 Identities=21% Similarity=0.238 Sum_probs=181.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|...+.||+|+||+||+++.. +++.||+|.+...... ......+.+|..++..++|+||+++++++.+.+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999975 4788999998753221 223455888999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++|+|.++++.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999865567899999999999999999999998 999999999999999999999999987543210
Q ss_pred -------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 638 -------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 638 -------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
..++.++||||||++||||++|+.||...... +. ...+... ..+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~-~~~i~~~------~~~ 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ET-YGKIMNH------EER 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----HH-HHHHHcC------CCc
Confidence 12356899999999999999999999643211 11 1111110 011
Q ss_pred cCCCCC-chhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 040687 693 VALPRN-VEPLFKLADIAELAIRENPSE--LPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~-~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 728 (740)
...+.. .....++.+++.+|+..++++ |++++++++
T Consensus 227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 112211 122346778999999865544 568888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=286.48 Aligned_cols=231 Identities=23% Similarity=0.307 Sum_probs=194.4
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+.|+.++.||+|.-|+||++++++ +..+|+|++.+..+. .........|-+||+.++||.++.|+..++.+...+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457788899999999999999876 588999999877654 334566788999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||++|+|+..++.+. +.++...+.-++.+|+-||+|||..+ ||+|||||+||||-++|.+.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999987654 45899999999999999999999999 99999999999999999999999998532110
Q ss_pred --------------------------------CCC-------------------------------------------CC
Q 040687 637 --------------------------------DLT-------------------------------------------TD 641 (740)
Q Consensus 637 --------------------------------~~~-------------------------------------------~~ 641 (740)
... .+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 02
Q ss_pred cccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCC
Q 040687 642 MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELP 721 (740)
Q Consensus 642 ~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 721 (740)
.++|+|.|||+||||+.|+.||...... ..+..|+...+.+|...+......+||++.|.+||.+|.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch-------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 3689999999999999999999876532 344566677777787776677888999999999999998
Q ss_pred C----HHHHHH
Q 040687 722 T----MSQVAT 728 (740)
Q Consensus 722 t----~~ev~~ 728 (740)
. +.||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 8 666654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.73 Aligned_cols=235 Identities=21% Similarity=0.262 Sum_probs=183.6
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
|+..+.||+|+||+||++... +++.||+|.+........ ....+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677788999999999999975 588999999876543222 234578899999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999986432 45899999999999999999999988 99999999999999999999999998764321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++||||||+++|||++|+.||.......... ........ .. ...+ ..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~--~~------~~~~--~~ 227 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE--VQ------EEYS--EK 227 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh--hh------hhcC--cc
Confidence 1223568999999999999999999997543221110 00011100 00 0111 12
Q ss_pred hHHHHHHHHHHhhhcCCCCCCC-----HHHHHH--HHHH
Q 040687 701 PLFKLADIAELAIRENPSELPT-----MSQVAT--WLEQ 732 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~--~Le~ 732 (740)
...++.+|+.+||+.||++||+ ++|+++ ++.+
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 2336779999999999999999 889887 5543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.09 Aligned_cols=232 Identities=27% Similarity=0.437 Sum_probs=184.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++.. .++.||+|.+.... .......+.+|++++++++|+||+++++.+......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35788889999999999999985 58999999886542 22345679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 561 FMPRGTLHDHLHGG--LSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
|+++++|.+++... ...+++..+..++.|++.+|.|||+. + |+||||||+|||+++++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999998764 23689999999999999999999974 6 99999999999999999999999998754311
Q ss_pred --------------C----------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 --------------D----------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 --------------~----------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
+ ...+.++||||||+++|||++|+.||..... ...... ...+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~---------~~~~~~~~ 226 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQ---------LSAIVDGD 226 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHH---------HHHHhhcC
Confidence 0 1125689999999999999999999964321 111110 01111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+...++.+++.+||+.+|++||++.+++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11112224457889999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.47 Aligned_cols=233 Identities=23% Similarity=0.358 Sum_probs=185.8
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++......++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36788999999999999999996 4689999999875432 23456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++.+. .+++.++..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999999753 5899999999999999999999998 99999999999999999999999998754321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||+++|||++|+.||........+ .... .........+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~----~~~~--------~~~~~~~~~~ 238 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIA--------TNGTPELQNP 238 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----eeec--------cCCCCCCCCc
Confidence 112356899999999999999999999643211110 0000 0011111112
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
......+.+++.+||+.+|++||++++|++ +++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 223346778999999999999999999997 5543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.70 Aligned_cols=235 Identities=22% Similarity=0.251 Sum_probs=177.6
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.+|...+.||+|+||.||+++... ++.||||.... ..+.+|+++|++|+|+|||++++++...+..+||||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999854 78899996322 346789999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+. ++|.+++......++|.+++.|+.||++||.|||+.+ ||||||||+||||+.++.+||+|||+++....
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 994 7999999766567999999999999999999999998 99999999999999999999999999864321
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC-CC--CchhHHhhhhHHhhCccc--hh----
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE-YV--PPGIVEWALPLIKQGKAA--AI---- 688 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~-~~--~~~~~~~~~~~~~~~~~~--~i---- 688 (740)
...++.++|||||||+||||++|..|+... .. .......+...+...... +.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 112366899999999999999987665321 11 111111111222111100 00
Q ss_pred -------------cccccCC--CCCc---hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 -------------IDRNVAL--PRNV---EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 -------------~d~~~~~--~~~~---~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+... +... .....+.+|+.+||+.||.+|||+.|+++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 0000 11225778999999999999999999987
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=284.75 Aligned_cols=231 Identities=26% Similarity=0.405 Sum_probs=186.3
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||++... +++.|++|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999975 588999999887654334567899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---- 637 (740)
+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999764 35889999999999999999999998 999999999999999999999999987543210
Q ss_pred ---------------------C---CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 638 ---------------------L---TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 638 ---------------------~---~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
. ..+.++||||||+++|||++|+.||......... ...... ....
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~~------~~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVGA------GHKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHhc------CCCC
Confidence 1 1466899999999999999999999643211111 110000 1122
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..|........+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22333323446779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.98 Aligned_cols=228 Identities=27% Similarity=0.401 Sum_probs=184.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||.|+||.||+++.. +++.||+|.+.... .......+.+|++++++++|+||+++++++.+....++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36788889999999999999975 48899999987543 22345678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|+++++|.++++.. ++++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999999764 6899999999999999999999998 999999999999999999999999987554321
Q ss_pred ------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...+.++||||||+++|||+||+.||..... .. ....+....... .+. .
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-~~----~~~~~~~~~~~~-------~~~-~ 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-MR----VLFLIPKNNPPS-------LEG-N 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-HH----HHHHhhhcCCCC-------Ccc-c
Confidence 1236789999999999999999999964321 11 111111111110 011 1
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+++.+||+.+|++||+++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 12346779999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.70 Aligned_cols=229 Identities=21% Similarity=0.351 Sum_probs=183.0
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--CCeEEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE--MGERLLVY 559 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 559 (740)
+|+..+.||+|+||.||++... +++.||+|++..........+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999864 57899999987655445556778999999999999999999998764 34679999
Q ss_pred ecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 560 EFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLH-----KDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH-----~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
||+++++|.+++... ..++++..++.++.|+++||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999653 357899999999999999999999 666 999999999999999999999999987
Q ss_pred ccccCC---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 632 TSCERD---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 632 ~~~~~~---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
...... ...+.++||||||+++|||++|+.||..... .. ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~----~~~~~~~~~~----- 227 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQ----LASKIKEGKF----- 227 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HH----HHHHHhcCCC-----
Confidence 654321 1125679999999999999999999975331 11 1111111111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+.+......+.+++.+||+.+|++||++.+|++
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1112233447889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=297.37 Aligned_cols=228 Identities=25% Similarity=0.372 Sum_probs=186.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
..|+..+.||+|+||.||||.... ++.||||.+..+.. +....++.+|+.+|++++++||.++++.+.....++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 347777889999999999999754 88999999987653 3456788999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
||.+|++.+.|+... .+++....-|..++..||.|||+++ .+|||||+.|||+..++.+|++|||.+-....
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999997653 4477777788999999999999999 99999999999999999999999998644332
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...|+.|+||||||++.+||.+|.+|+..... .++.-++-+..+...+.
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--------------mrvlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--------------MRVLFLIPKSAPPRLDG 233 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--------------ceEEEeccCCCCCcccc
Confidence 33567899999999999999999999964321 11122222222211222
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+++..||++||+.||+++++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 34446889999999999999999999987
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.62 Aligned_cols=220 Identities=24% Similarity=0.267 Sum_probs=170.3
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHH-HHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELE-VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||+++.. +++.||+|.+....... ....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 47789999987643221 22334555554 56789999999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..++......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 9999999754 45788888899999999999999998 99999999999999999999999999864211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||...... + ....+ .......+ .....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~-~~~~i--------~~~~~~~~--~~~~~ 221 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----E-MYDNI--------LNKPLQLK--PNITN 221 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----H-HHHHH--------HhCCcCCC--CCCCH
Confidence 122356899999999999999999999643211 1 11111 11111111 12234
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHH
Q 040687 704 KLADIAELAIRENPSELPTMSQV 726 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RPt~~ev 726 (740)
.+.+++.+||+.||.+||++.+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCC
Confidence 67799999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.30 Aligned_cols=231 Identities=19% Similarity=0.301 Sum_probs=180.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.. +++.||||.++..... ......+.+|+.++.+++||||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 4889999998754322 233456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999998753210
Q ss_pred -----------------------------------------------------CCCCCcccceehhHHHHHHHHhCCCCC
Q 040687 637 -----------------------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 637 -----------------------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~ 663 (740)
...++.++|||||||+||||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 122356899999999999999999999
Q ss_pred CCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 040687 664 DIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPT---MSQVAT 728 (740)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 728 (740)
...... .. ...+... ...+..|.......++.+|+.+++. ||.+|++ +.|+++
T Consensus 237 ~~~~~~-~~----~~~i~~~------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQ-ET----YRKVMNW------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHH-HH----HHHHHcC------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 643211 11 1111110 1112222222223466788888764 9999985 667665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=324.49 Aligned_cols=237 Identities=21% Similarity=0.308 Sum_probs=184.3
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--Ce
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GE 554 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 554 (740)
+...++|...++||+|+||+||+++... +..||+|.+............|..|+.+|++|+|||||++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445689999999999999999999754 77899999876554445567799999999999999999999988654 56
Q ss_pred EEEEEecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCEEECC--------
Q 040687 555 RLLVYEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAA----PPIIHRDVKTLNILLDS-------- 619 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~----~~iiHrDlk~~NILl~~-------- 619 (740)
+||||||+++++|.++|... ...+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999653 2468999999999999999999998542 34999999999999964
Q ss_pred ---------CCCEEEeecCCCccccC----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCC
Q 040687 620 ---------DWGARIADFGLLTSCER----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYV 668 (740)
Q Consensus 620 ---------~~~~ki~DFGla~~~~~----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~ 668 (740)
...+||+|||++..... ...++.++||||||||||||+||+.||.....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 33589999998764321 11246789999999999999999999964321
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... ....+.. ....+. .....++.+||..||+.+|.+||++.|++.
T Consensus 249 ~~q----li~~lk~---------~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQ----LISELKR---------GPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHH----HHHHHhc---------CCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 1111111 111111 112346889999999999999999999985
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.52 Aligned_cols=242 Identities=19% Similarity=0.243 Sum_probs=183.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (740)
++|+..+.||+|.||.||+++.. +++.+++|.++...........+.+|++++++++||||+++++++... ...+||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999985 488999999976544333345678899999999999999999998877 789999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||++ ++|.+++......+++.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99997 4999999766567999999999999999999999998 999999999999999999999999987643221
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-----------hh---
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI-----------KQ--- 682 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~-----------~~--- 682 (740)
...+.++||||||+++|||++|+.||........+.. ..... ..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK-IFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCchHHHHHhhccch
Confidence 1125689999999999999999999964332111110 00000 00
Q ss_pred ---CccchhcccccCCCCCch-hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 ---GKAAAIIDRNVALPRNVE-PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ---~~~~~i~d~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..........+....... ....+.+++++||+.||++||+++|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000100 2346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=283.44 Aligned_cols=229 Identities=27% Similarity=0.400 Sum_probs=184.3
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|...+.||+|+||.||++... +++.+|+|++..........+.+.+|++++++++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999974 588999999876654445567899999999999999999999999988999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCCCccccC---
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGLLTSCER--- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGla~~~~~--- 636 (740)
+++++|.+++.... ..+++..+..++.|++++|+|||+.+ ++|+||||+||+++++ ..+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997643 45899999999999999999999998 9999999999999865 4689999998764321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||++|+.||.....+. . ..... .... .+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~---~~~~~-~~~~---------~~~~~ 223 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-L---VLKIM-SGTF---------APISD 223 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-H---HHHHH-hcCC---------CCCCC
Confidence 1123568999999999999999999996443211 1 11111 1111 11111
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 23346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=284.78 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=184.2
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC-cceEEeEEEeCC-----
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN-IVNLLGYCLEMG----- 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~----- 553 (740)
...|...++||+|.||+||+|+. .+|+.||+|+++.....+.-.....+|+.+|++|+|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577778899999999999996 45899999999876532122345688999999999999 999999998877
Q ss_pred -eEEEEEecCCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 554 -ERLLVYEFMPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 554 -~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
..+||+||+.. +|.+++.... ..++...+..++.||++||+|||+++ |+||||||.||||++++.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999965 9999998655 34777889999999999999999999 9999999999999999999999999
Q ss_pred CCccccC----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh---hCc
Q 040687 630 LLTSCER----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK---QGK 684 (740)
Q Consensus 630 la~~~~~----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---~~~ 684 (740)
+|+...- ...++...||||+|+++.||++++.-|....+...+.. +...+. +..
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~-If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR-IFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH-HHHHcCCCCccC
Confidence 9975541 22346789999999999999999988876544222211 111110 011
Q ss_pred cch---hcccccCCCCC----------chhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 685 AAA---IIDRNVALPRN----------VEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 685 ~~~---i~d~~~~~~~~----------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
... ..+.....+.. .....+..+++.+|++.+|.+|.+++..++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 11111111110 0001256689999999999999999998873
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=286.73 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=186.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (740)
++|...++||+|.+|.||++... +++.+|+|.+..... .....++.+|++++++++||||+++++++.+. ...+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46888899999999999999985 478999999875432 23456799999999999999999999998654 468999
Q ss_pred EecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
|||+++++|.+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 2345899999999999999999999998 9999999999999999999999999875322
Q ss_pred C-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 636 R-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 636 ~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
. ...++.++||||||+++|||++|+.||+....+..........+....... +... .+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~ 233 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE-LKDE--PG 233 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh-hccC--CC
Confidence 1 123366899999999999999999999755321111111111111111111 1100 11
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
........+.+++.+||+.+|++|||+.||++ ++.+.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 11223457889999999999999999999998 55443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=287.48 Aligned_cols=227 Identities=24% Similarity=0.381 Sum_probs=183.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
..|+..++||+|+||.||++... .++.||||.+..... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 34777888999999999999975 488999998875432 2345679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.+++.. .++++.+...++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 9999999999975 35899999999999999999999988 99999999999999999999999998754321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||+||+.||...... ... ..+ ..........
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~----~~~---------~~~~~~~~~~ 223 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-RVL----FLI---------PKNNPPTLTG 223 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-hHh----hhh---------hcCCCCCCch
Confidence 112356899999999999999999999643211 000 001 0011111122
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 34557889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.37 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=182.5
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------ 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (740)
..++|...+.||+|+||.||++... +++.||||++..........+.+.+|+++|++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567999999999999999999974 578999999876443333445688999999999999999999987543
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
...++++|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccce
Confidence 3578999998 7799988864 35899999999999999999999998 9999999999999999999999999986
Q ss_pred cccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh----------hHHhhC
Q 040687 633 SCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL----------PLIKQG 683 (740)
Q Consensus 633 ~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~----------~~~~~~ 683 (740)
..... ..++.++||||||+++|||++|+.||........+..... ..+...
T Consensus 167 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred ecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 53221 2346689999999999999999999965332111111000 000000
Q ss_pred ccchhcccccCCCCC------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 684 KAAAIIDRNVALPRN------VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 684 ~~~~i~d~~~~~~~~------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.....+......+.. ......+.+|+.+||+.||++|||+.|+++ ++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 000000000000100 011224679999999999999999999996 4543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.43 Aligned_cols=232 Identities=25% Similarity=0.359 Sum_probs=182.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. +++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 356888889999999999999974 58899999987543 233456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999998754 46899999999999999999999998 99999999999999999999999998743211
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
...++.++|||||||++|||++|+.||........+ ......... .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-----~~~~~~~~~---~~~~-- 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----FLMTKSNFQ---PPKL-- 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-----HhhhccCCC---CCcc--
Confidence 112356899999999999999999998543211111 001011000 0000
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.........+.+++.+||+.+|++||++++|++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 011122336779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.25 Aligned_cols=242 Identities=21% Similarity=0.283 Sum_probs=180.7
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------ 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (740)
..++|...+.||+|+||.||++... .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 488999999876543334456788999999999999999999988643
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999965 77777753 4889999999999999999999998 9999999999999999999999999986
Q ss_pred cccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh-------HHh--hC
Q 040687 633 SCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP-------LIK--QG 683 (740)
Q Consensus 633 ~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~-------~~~--~~ 683 (740)
.... ...++.++||||||+++|||++|+.||........+...... ... ..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 5322 112366899999999999999999999754311111000000 000 00
Q ss_pred ccchhcccccC--------------CC----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAIIDRNVA--------------LP----RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i~d~~~~--------------~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.... .+ .......++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000000000 00 01112346789999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=288.94 Aligned_cols=244 Identities=22% Similarity=0.244 Sum_probs=182.1
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
++++|...+.||+|+||.||++... +++.||+|++..... ......+.+|++++++++|+||+++++++......++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4578999999999999999999874 588999999875432 22234678899999999999999999999998999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+. ++|.+++......+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 99995 7888887655556889999999999999999999998 99999999999999999999999998754211
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh-------------hC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK-------------QG 683 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-------------~~ 683 (740)
....+.++||||||+++|||+||+.||+...............+. ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 011355789999999999999999999743321111111100000 00
Q ss_pred ccchhcccccC----C-CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAIIDRNVA----L-PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i~d~~~~----~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........... . .........+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000 0 000112346779999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=286.57 Aligned_cols=232 Identities=27% Similarity=0.375 Sum_probs=184.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCC---
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMG--- 553 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--- 553 (740)
.++++|+..+.||+|+||.||++... +++.+++|.+.... ....+|.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45788999999999999999999985 47899999887543 2346789999999999 7999999999997654
Q ss_pred ---eEEEEEecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 554 ---ERLLVYEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 554 ---~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
..++||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECC
Confidence 489999999999999998643 256899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh
Q 040687 628 FGLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 628 FGla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
||++..... ...++.++||||||++||||+||+.||........+ ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~ 231 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-----FKIP 231 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-----HHhh
Confidence 998743211 112356899999999999999999999632211111 0111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... .............+.+++.+||+.||++|||+.||++
T Consensus 232 ~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 1111122223457889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=288.21 Aligned_cols=236 Identities=27% Similarity=0.416 Sum_probs=180.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHH-HHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEV-LCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||||+++..... ....++..|+.+ ++.++||||+++++++......++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 46888899999999999999975 5899999998765432 223456667665 56679999999999999999999999
Q ss_pred ecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 560 EFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 560 Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
||++ ++|.+++.. ....+++..++.++.||+.||+|||+. + ++||||||+|||+++++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 688888754 224689999999999999999999986 6 9999999999999999999999999876432
Q ss_pred CC------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 RD------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~~------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. ...+.++||||||+++|||++|+.||....... +.....+ ....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~-~~~~------ 225 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---QQLKQVV-EEPS------ 225 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---HHHHHHH-hcCC------
Confidence 10 123568999999999999999999996322111 1111111 1100
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
...+. .....++.+++.+||+.+|++||++.+|++ ++++..
T Consensus 226 -~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 -PQLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -CCCCc-cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 11111 112346889999999999999999999997 555443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.01 Aligned_cols=241 Identities=22% Similarity=0.323 Sum_probs=181.9
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||+++.. +++.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 588999999876543333446789999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 68999886532 46899999999999999999999998 99999999999999999999999998753211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC------ccchhcccc
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG------KAAAIIDRN 692 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~i~d~~ 692 (740)
....+.++||||||+++|||+||+.||........+.... ...... ....+.+..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF-RTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-HHhCCCChhhhhhhhHHHHHH
Confidence 0112567999999999999999999996543222211111 000000 000000000
Q ss_pred cCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+. ......++.+++.+||+.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000 0111235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=283.05 Aligned_cols=229 Identities=25% Similarity=0.376 Sum_probs=182.5
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEeccccc---chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI---IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
+|+..+.||+|+||.||+|... +++.|++|.+..... .++..+.+.+|++++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999986 689999998865432 123456799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... ..+++..+..++.|++++|+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999999754 46899999999999999999999998 99999999999999999999999998753221
Q ss_pred ------------------CCC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 ------------------DLT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 ------------------~~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
... .+.++|+||||+++|||++|+.||...... +........... ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~-------~~~-- 223 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVFKIGRSKEL-------PPI-- 223 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHHHHHhcccC-------CCc--
Confidence 011 456899999999999999999999643211 111111100000 111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+......+.+++++||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122346789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=285.11 Aligned_cols=234 Identities=28% Similarity=0.424 Sum_probs=187.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||++... +++.||+|++..... ....+++.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 35777889999999999999985 588999999876543 2445679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++++|.+++......++......++.|++++|+|||+ .+ ++|+||||+||++++++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999999998665678999999999999999999999 77 99999999999999999999999998753311
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCC-chhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP-PGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||++|+.||.....+ ....+...... .. .....+..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~- 227 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NE-------PPPRLPSG- 227 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cC-------CCCCCChh-
Confidence 123467899999999999999999999654221 12222111111 11 01111111
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+++.+||..||++||++.|++.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13446889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.66 Aligned_cols=241 Identities=21% Similarity=0.285 Sum_probs=180.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------ 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (740)
..++|...+.||+|+||.||++... .++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999964 488999999876543334456788999999999999999999987543
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 78887753 4889999999999999999999998 9999999999999999999999999986
Q ss_pred cccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh----------h
Q 040687 633 SCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK----------Q 682 (740)
Q Consensus 633 ~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~----------~ 682 (740)
.... ...++.++||||||++||||++|+.||........+.. ....+. .
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK-VIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHhhh
Confidence 4322 11235689999999999999999999965322111110 000000 0
Q ss_pred Cccchhcccc--------------cCCCC----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 GKAAAIIDRN--------------VALPR----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ~~~~~i~d~~--------------~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......++.+ ...+. ......++.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 00010 1112236779999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.15 Aligned_cols=230 Identities=23% Similarity=0.361 Sum_probs=184.7
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
...+|+..+.||.|.||.||++.. .+++.|++|.+.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 345699999999999999999986 458999999987543 23346789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
+||+++++|.+++... .+++.+++.++.|++++|+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 95 MEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999999999754 5899999999999999999999998 99999999999999999999999998653221
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
....+.++|||||||++|||++|+.||....... ... .+.... ......
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~----~~~-~~~~~~-------~~~~~~ 237 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALY-LIATNG-------TPELQN 237 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH-HHHhcC-------CcccCC
Confidence 1123568999999999999999999996432111 111 111110 001111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+......+.+++++||+.||++||++.+|+.
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2223346779999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=284.67 Aligned_cols=233 Identities=27% Similarity=0.422 Sum_probs=181.5
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccch--------hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH--------TNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (740)
+|...+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|++++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 58899999886432111 12346888999999999999999999999999
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++||||+++++|.++++.. ..+++..+..++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999765 57899999999999999999999988 99999999999999999999999998754
Q ss_pred ccC-----------------------C--CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 634 CER-----------------------D--LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 634 ~~~-----------------------~--~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
... . ...+.++||||||+++|||++|+.||........+ .... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~-~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM----FKLG-NKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH----HHhh-ccccCCc
Confidence 321 0 11366899999999999999999999633211111 0100 0111111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+... ...+....+.+++.+||+.+|++||++.+|++
T Consensus 233 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 233 IPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 11123457889999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.31 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=184.8
Q ss_pred cccceecccCceEEEEEEEe-CCcEEEEEEecccccch--hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe--EEEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH--TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE--RLLVY 559 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 559 (740)
+...+||+|+|-+||||.+. +|..||--.++...+.+ .....|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44557999999999999974 37778755444433322 334789999999999999999999999987654 78999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~-- 636 (740)
|+|..|+|..|+++. ..++.+.+.+|++||++||.|||++. |||||||||=+||+|+. .+.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999865 46889999999999999999999975 88999999999999985 57899999999865432
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
+..|++..||||||+-|+||+|+.+||..-..+..+...+..-++..-+..+-|+
T Consensus 201 aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP--------- 271 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP--------- 271 (632)
T ss_pred cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH---------
Confidence 2446889999999999999999999998665555555444443333323322222
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
++.+||.+|+.. .++|||+.|++.
T Consensus 272 ---evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ---EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---HHHHHHHHHhcC-chhccCHHHHhh
Confidence 677999999999 899999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=291.23 Aligned_cols=234 Identities=21% Similarity=0.281 Sum_probs=183.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||++.... ++.|++|.+...... ......+.+|++++++++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999999754 789999998765422 223457889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc----
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE---- 635 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~---- 635 (740)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999754 46899999999999999999999988 9999999999999999999999999875210
Q ss_pred ----------------------------C----CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC
Q 040687 636 ----------------------------R----DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG 683 (740)
Q Consensus 636 ----------------------------~----~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 683 (740)
. ....+.++||||||+++|||++|+.||..... . + .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~---~-~~~~~~~- 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-E---E-LFGQVIS- 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H---H-HHHHHHh-
Confidence 0 11235689999999999999999999964321 1 1 1111111
Q ss_pred ccchhcccccCCCCC-chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 684 KAAAIIDRNVALPRN-VEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 684 ~~~~i~d~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.....+.. ......+.+++.+||+.||++||++.++.+.|+.
T Consensus 231 -------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 -------DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -------cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111 1233467899999999999999997666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=282.19 Aligned_cols=228 Identities=33% Similarity=0.485 Sum_probs=183.2
Q ss_pred cccceecccCceEEEEEEEeC-----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~-----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+..+.||+|+||.||+++..+ +..||+|.+..... ....+.+.+|++++.+++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999754 37899999876542 224578999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSP-LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~-l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||+++++|.+++...... +++..+..++.|++.+|+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765444 899999999999999999999998 99999999999999999999999999854321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||++++||++ |+.||..... ..+ ...+.... ..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~----~~~~~~~~---------~~ 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEV----LEYLKKGY---------RL 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHhcCC---------CC
Confidence 1223568999999999999999 8888864211 111 11111111 11
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
+.......++.+++.+||+.||++|||+.|+++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11222345788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=287.73 Aligned_cols=241 Identities=23% Similarity=0.308 Sum_probs=185.8
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|.||.||++++. +++.||+|++............+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999974 589999999876554344456799999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---- 637 (740)
+ +++|.+++.....++++.+++.++.||+++|+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999999766677999999999999999999999998 999999999999999999999999987643221
Q ss_pred -------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc------cchhcc-c
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK------AAAIID-R 691 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~i~d-~ 691 (740)
...+.++||||||+++|||+||+.||...... .............. ..+..+ .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 11356899999999999999998777543221 11111111110000 000000 0
Q ss_pred ccCCC---------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALP---------RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+ ...+....+.+++++||+.+|++||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 00122357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.70 Aligned_cols=242 Identities=22% Similarity=0.248 Sum_probs=183.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|.||.||++... +++.||+|+++...........+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 47899999987654334445679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|++++.|..++.. ...+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9998666665543 356899999999999999999999998 999999999999999999999999986543221
Q ss_pred -------------------C-CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh------------hC--
Q 040687 638 -------------------L-TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK------------QG-- 683 (740)
Q Consensus 638 -------------------~-~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~------------~~-- 683 (740)
. ..+.++||||||+++|||++|+.||........+.. ...... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHhhhcccCccc
Confidence 1 346789999999999999999999974422111111 000000 00
Q ss_pred ---ccchhccccc-CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 ---KAAAIIDRNV-ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ---~~~~i~d~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+..+... ....+.....++.+++++||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 00001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=283.49 Aligned_cols=229 Identities=26% Similarity=0.393 Sum_probs=176.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc---hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII---HTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (740)
.+|+..+.||+|+||.||++... .++.|++|++...... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999975 4889999988654321 12345688999999999999999999988753 567
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999999754 35899999999999999999999988 9999999999999999999999999875332
Q ss_pred C------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 R------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ....+.++||||||+++|||++|+.||........+ ...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----~~~~~~-----~~-- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----FKIATQ-----PT-- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----HHHhcC-----CC--
Confidence 1 111256899999999999999999999643211111 000000 00
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .....+.+++ .||..+|++||+++||+.
T Consensus 227 ~~~~~~--~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQLPS--HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCch--hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111 1223455666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=290.35 Aligned_cols=231 Identities=26% Similarity=0.334 Sum_probs=183.3
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.|+..+.||+|+||.||+++.. ++..||+|++..... .......+.+|++++++++|||++++++++.+....+||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3778889999999999999974 588999999865422 12334578999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|++ |+|.+++.....++++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence 996 5888888765667999999999999999999999998 99999999999999999999999998653321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||+++|||++|+.||........ . ..+ ............
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~-~~~--------~~~~~~~~~~~~ 248 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----L-YHI--------AQNESPTLQSNE 248 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----H-HHH--------HhccCCCCCCcc
Confidence 12346789999999999999999999864321110 0 111 111111111222
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
....+.+++.+||+.+|.+||++.+|++.+
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 334688999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=292.03 Aligned_cols=231 Identities=23% Similarity=0.312 Sum_probs=187.1
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||++...+ ++.||+|.+....... ...+.+.+|++++++++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468888999999999999999764 8999999987654332 24567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||+++++|.+++.... ..+++..+..++.|++++|+|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997543 46899999999999999999999998 99999999999999999999999998653211
Q ss_pred ------------------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCC
Q 040687 637 ------------------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYV 668 (740)
Q Consensus 637 ------------------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~ 668 (740)
....+.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 01125589999999999999999999964432
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPT----MSQVAT 728 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~ev~~ 728 (740)
... ...+.+.....+........+.+++.+||+.||++||+ ++|++.
T Consensus 238 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET-------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH-------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111 11122223333333224457889999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=280.90 Aligned_cols=233 Identities=25% Similarity=0.418 Sum_probs=185.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||+||++... ++..+++|++....... ..+.+.+|++++++++|+||+++++.+......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46888999999999999999964 57899999987654332 55789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 561 FMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|+++++|.++++... ..+++.....++.|++.+|+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999997542 46899999999999999999999998 99999999999999999999999998643221
Q ss_pred -----------------------CC-CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DL-TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~-~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
.. ..+.++||||||+++|||++|+.||........+.+ ... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~----~~~-~~-----~~~ 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML----TLQ-ND-----PPS 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH----Hhc-CC-----CCC
Confidence 01 235689999999999999999999964432211111 111 00 011
Q ss_pred cCCCC-CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPR-NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..... .......+.+++.+||+.||++||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1133456789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=283.36 Aligned_cols=227 Identities=26% Similarity=0.413 Sum_probs=180.6
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-------hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-------TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
|...+.||+|+||.||+|... +++.+|+|.+....... ...+.+.+|++++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566778999999999999974 47899999886543211 1235688999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++... ..+++..+..++.|++.+|+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999754 56899999999999999999999998 9999999999999999999999999876443
Q ss_pred C---------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 636 R---------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 636 ~---------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
. ....+.++||||||+++|||++|+.||........+ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~-------- 224 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-----FKI-------- 224 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-----HHH--------
Confidence 1 011245899999999999999999999743211110 000
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. ......+......+.+++++||+.||++||++.||++
T Consensus 225 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 0011111223347789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=292.09 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=184.5
Q ss_pred ceeccc--CceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRG--SYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G--~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
.+||+| +|++||+++.. +++.||+|.+..........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357776 99999999974 689999999876543334456789999999999999999999999999999999999999
Q ss_pred CChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc--------
Q 040687 565 GTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE-------- 635 (740)
Q Consensus 565 gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~-------- 635 (740)
++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+|++||+.+....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987543 35899999999999999999999988 9999999999999999999999997421100
Q ss_pred ----------------C------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh---------------
Q 040687 636 ----------------R------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP--------------- 678 (740)
Q Consensus 636 ----------------~------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~--------------- 678 (740)
. ...++.++||||||+++|||++|+.||........+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0 012357899999999999999999999643221111110000
Q ss_pred -HH----------------hhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 040687 679 -LI----------------KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKD 736 (740)
Q Consensus 679 -~~----------------~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~ 736 (740)
.. .......+.+.....+........+.+|+++||+.||++|||++|+++ +++.+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 00 000000111111222223334567889999999999999999999986 77776654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=283.48 Aligned_cols=227 Identities=25% Similarity=0.409 Sum_probs=181.9
Q ss_pred CccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC---CCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR---HSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 558 (740)
.|+..+.||+|+||.||++.. .+++.||+|.+..... .....++.+|+.++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999997 4588999999875432 234567889999999996 99999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... .+++...+.++.|++++|.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999999754 6899999999999999999999998 99999999999999999999999998754321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
....+.++||||||+++|||++|+.||......... ..+.... ....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-----~~~~~~~-------~~~~~ 223 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-----MLIPKSK-------PPRLE 223 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-----hccccCC-------CCCCC
Confidence 112356899999999999999999999643211100 0000000 00111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. .....++.+++.+||+.||++||++.|++.
T Consensus 224 ~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 D-NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c-ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 113447889999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=280.75 Aligned_cols=235 Identities=26% Similarity=0.387 Sum_probs=188.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++..+ ++.|++|++...... ...+.|.+|++++.+++|+||+++++++......++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 468888999999999999999864 899999998765432 345789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
|+++++|.+++... .++++..++.++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999999754 578999999999999999999999 88 999999999999999999999999987643221
Q ss_pred -------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...+.++||||||+++|||+||+.||..... ....+. ...+. .. ...+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~-~~~~~--------~~-~~~~~~ 224 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFEL-MQAIC--------DG-PPPSLP 224 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHH-HHHHh--------cC-CCCCCC
Confidence 1225689999999999999999999965432 111111 11111 11 111111
Q ss_pred ch-hHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 699 VE-PLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 699 ~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.. ....+.+++++||+.+|++||++.|+++ ++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 12 3457889999999999999999999997 4443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=285.16 Aligned_cols=237 Identities=27% Similarity=0.399 Sum_probs=189.9
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
...+++|+..+.||+|.||.||++.+. +++.|++|.+..... ....+.+|++++++++|+|++++++.+......+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 346677888899999999999999986 588999999875432 4567899999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+|+||+++++|.+++......+++..++.++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999999876447999999999999999999999988 99999999999999999999999997643211
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||+++|||++|+.||....... ... .+..... ...
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~-~~~~~~~-------~~~ 236 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALF-LITTKGI-------PPL 236 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHH-HHHhcCC-------CCC
Confidence 1223678999999999999999999986432111 000 1111100 111
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
+........+.+++.+||+.+|.+||++.+|+. ++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 111113347889999999999999999999986 5444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=290.06 Aligned_cols=171 Identities=25% Similarity=0.394 Sum_probs=141.5
Q ss_pred cceecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--CCeEEEEEec
Q 040687 487 FNELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE--MGERLLVYEF 561 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey 561 (740)
.++||+|+||.||+++.. +++.||+|.+..... ...+.+|+++|++++||||+++++++.. ....++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999964 367899999865432 2457889999999999999999998865 3468899999
Q ss_pred CCCCChHHhHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCCEEEeecC
Q 040687 562 MPRGTLHDHLHGG--------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL----DSDWGARIADFG 629 (740)
Q Consensus 562 ~~~gsL~~~l~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DFG 629 (740)
+. ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 96 4888887532 125889999999999999999999998 9999999999999 456789999999
Q ss_pred CCccccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCC
Q 040687 630 LLTSCER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDI 665 (740)
Q Consensus 630 la~~~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~ 665 (740)
+++.... ...++.++|||||||++|||++|+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9864321 01235689999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=281.05 Aligned_cols=243 Identities=20% Similarity=0.291 Sum_probs=198.5
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
.++....++++....+-+|.||.||+|.|++ .+.|-+|.++... ++-+...|..|.-.|..+.|||+..+.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4455556778888889999999999997754 3557778776543 23345678999999999999999999999
Q ss_pred EEeC-CeEEEEEecCCCCChHHhHh-----CC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 549 CLEM-GERLLVYEFMPRGTLHDHLH-----GG--LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 549 ~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
+.+. ..++.+|.++.-|+|..||. +. ...++-.+...++.|++.||+|||+++ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9875 46788999999999999997 22 235778889999999999999999999 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 676 (740)
.++||+|=-|++..-. +..++..+|||||||+||||+| |+.||-.-+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--------- 503 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--------- 503 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC---------
Confidence 9999999999875432 2234678999999999999999 999995211
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.-+....+.+..++..+..++.+++.+|.-||..+|++||+++|++.-|.++..
T Consensus 504 -----PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 504 -----PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -----HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 112334455566667777888899999999999999999999999999988754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.88 Aligned_cols=221 Identities=23% Similarity=0.260 Sum_probs=172.2
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhC---CCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNI---RHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
||+|+||+||+++.. +++.||||++...... ......+..|..++.++ +||||++++.++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 4889999998754322 12334566777777765 699999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 9999999754 46899999999999999999999998 99999999999999999999999999754211
Q ss_pred --------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhH
Q 040687 637 --------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702 (740)
Q Consensus 637 --------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~ 702 (740)
...++.++|||||||+||||+||+.||...... .....+.. .....+.. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~--------~~~~~~~~-~~~ 222 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAF--------GKVRFPKN-VLS 222 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHc--------CCCCCCCc-cCC
Confidence 112467899999999999999999999643211 11111111 11222221 123
Q ss_pred HHHHHHHHHhhhcCCCCCC----CHHHHHH
Q 040687 703 FKLADIAELAIRENPSELP----TMSQVAT 728 (740)
Q Consensus 703 ~~l~~l~~~Cl~~dP~~RP----t~~ev~~ 728 (740)
.++.+++++||+.||++|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3677899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=289.14 Aligned_cols=227 Identities=26% Similarity=0.388 Sum_probs=180.2
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.|.....||+|+||.||++... ++..||||++.... ....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3444567999999999999974 58899999986543 23446789999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 101 ~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 101 LEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999999998653 5899999999999999999999998 99999999999999999999999998754321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||+++|||++|+.||....... . ...+. ..+...... ...
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~----~~~~~-----~~~~~~~~~--~~~ 243 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-A----MRRIR-----DNLPPRVKD--SHK 243 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H----HHHHH-----hcCCCcccc--ccc
Confidence 1123678999999999999999999996432111 0 11111 111111111 112
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2336778999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=299.59 Aligned_cols=236 Identities=21% Similarity=0.249 Sum_probs=178.6
Q ss_pred hcCccccceecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
..+|...+.||+|+||.||++... .++.||+|.+... +.+.+|+++|++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 357999999999999999999853 3578999987542 245689999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+. ++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 164 v~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 999995 689999843 357999999999999999999999998 99999999999999999999999999854321
Q ss_pred ----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchh--HHhhhhHHhhCc--------
Q 040687 637 ----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGI--VEWALPLIKQGK-------- 684 (740)
Q Consensus 637 ----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~--~~~~~~~~~~~~-------- 684 (740)
...++.++|||||||+||||++|+.||......... ...+...+....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 112356899999999999999999999654322111 011111110000
Q ss_pred ---------cchhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 ---------AAAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ---------~~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+....+. ......++.+++++||+.||++||++.|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000011110 0112346778999999999999999999987
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=287.25 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=180.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCe-----
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGE----- 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 554 (740)
++|+..+.||+|+||.||++... +++.||||.+............+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 5889999988765432333467889999999995 6999999999887655
Q ss_pred EEEEEecCCCCChHHhHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecC
Q 040687 555 RLLVYEFMPRGTLHDHLHGG----LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFG 629 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFG 629 (740)
.|+||||+++ +|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 899888643 235899999999999999999999998 999999999999998 8899999999
Q ss_pred CCccccC----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc---
Q 040687 630 LLTSCER----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK--- 684 (740)
Q Consensus 630 la~~~~~----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 684 (740)
++..... ....+.++||||||+++|||++|+.||........+... ...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI-FKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHHhCCCChhh
Confidence 8764211 122367899999999999999999999653322111110 00000000
Q ss_pred cchhcccc-----cC-CC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 AAAIIDRN-----VA-LP-----RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ~~~i~d~~-----~~-~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.. .. .+ .......++.+++.+||+.||.+||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 00 00 00123346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=281.66 Aligned_cols=229 Identities=22% Similarity=0.388 Sum_probs=183.3
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||++... ++..+|+|.+..........+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999975 488999999876543334456788999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC---
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER--- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~--- 636 (740)
+++++|.+++.... ..+++..++.++.|++++|.|||+.+ ++|+||||+||+++++. .+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997543 35899999999999999999999998 99999999999999885 469999998754322
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||+++|||++|+.||.... ..+...... .. ... +..
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~--------~~~-~~~ 223 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKIC-QG--------YFA-PIS 223 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh-cc--------cCC-CCC
Confidence 1123568999999999999999999996432 111111111 11 110 111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.+++.+||+.+|++||++.||+.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 222346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=287.98 Aligned_cols=245 Identities=24% Similarity=0.300 Sum_probs=185.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC----
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG---- 553 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 553 (740)
...++|+..+.||+|+||.||+|... +++.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999985 4889999998765433334457889999999999999999999987654
Q ss_pred ------eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 554 ------ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 554 ------~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
..+||+||+++ +|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 888888766567999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccC-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 628 FGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 628 FGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
||++..... ....+.++||||||+++|||++|+.||........+ +..........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCC
Confidence 998764321 111356899999999999999999999754321111 11111100000
Q ss_pred ---cchh--------cccccCC-----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 ---AAAI--------IDRNVAL-----PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ---~~~i--------~d~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+ .+..... .........+.+++..||+.||++||++++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000000 001112347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=284.26 Aligned_cols=228 Identities=26% Similarity=0.350 Sum_probs=184.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||++... +++.||+|.+...... ......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999975 4899999998754322 234467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||+|+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 999999999999765 57899999999999999999999988 999999999999999999999999998654221
Q ss_pred ----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 638 ----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 638 ----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...+.++||||||+++|||++|+.||..... ...... +.......+...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~--------~~~~~~~~~~~~-- 221 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEK--------ILEGKVRFPSFF-- 221 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------HhcCCccCCccC--
Confidence 1235689999999999999999999964321 111111 112222223222
Q ss_pred HHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
...+.+++.+||+.||.+|| +++|++.
T Consensus 222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 34778999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=277.22 Aligned_cols=230 Identities=26% Similarity=0.341 Sum_probs=186.6
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLVY 559 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 559 (740)
+|+..+.||+|+||.||++... +++.|++|.+..........+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999986 588999999876654334567899999999999999999999999988 8899999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL- 638 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~- 638 (740)
||+++++|.+++.... .+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997654 7999999999999999999999988 9999999999999999999999999865443221
Q ss_pred ----------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 639 ----------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 639 ----------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
..+.++||||||+++|||++|+.||....... ..... +........
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~---------~~~~~~~~~ 224 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYK---------IGSSGEPPE 224 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHh---------ccccCCCcC
Confidence 13568999999999999999999997543111 11111 111011111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+......+.+++.+|++.||++||++.|++.
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11222457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=269.61 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=194.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh------cHHHHHHHHHHHHhC-CCCCcceEEeEEEeC
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT------NIREFEMELEVLCNI-RHSNIVNLLGYCLEM 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~------~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (740)
-++|...+.||+|..+.|-+...+ .+.++|+|++........ -.++-.+|+.||+++ .||||+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777888999999999888764 488899998875432111 133467899999998 699999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
...++|+|.|+.|.|.|+|.+. -.+++++..+|+.|+.+|++|||... ||||||||+|||+|++.++||+|||++.
T Consensus 96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceee
Confidence 9999999999999999999865 46899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCC--------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 633 SCERD--------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 633 ~~~~~--------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
.+++. ..|+...|+|+.||+||-|+.|..||.... .+ ..+..+.+++.
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---Qm--lMLR~ImeGky- 245 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QM--LMLRMIMEGKY- 245 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HH--HHHHHHHhccc-
Confidence 66542 234568999999999999999999995211 11 12223333322
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKD 736 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~ 736 (740)
....|.+.+..+++.+|+.+||+.||.+|.|.+|.+. ++.+++..
T Consensus 246 -----qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 246 -----QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred -----ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 2344556677778999999999999999999999997 55555443
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=279.75 Aligned_cols=229 Identities=23% Similarity=0.332 Sum_probs=177.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc---hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII---HTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (740)
++|+..+.||+|+||.||++... +++.||||.+...... ....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999975 4889999988643211 12345788999999999999999999988764 467
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++... ..+++...++++.|++.+|+|||+.+ ++|+||||+|||+++++.+||+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999999754 45889999999999999999999998 9999999999999999999999999875321
Q ss_pred C------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 R------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ....+.++||||||+++|||++|+.||........ ... . ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~-~--------~~~ 224 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----IFK-I--------ATQ 224 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----HHH-H--------hcC
Confidence 1 11235689999999999999999999963211110 000 1 000
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+......+.+++.+|+. +|++||+++||++
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111122233467789999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=282.22 Aligned_cols=226 Identities=26% Similarity=0.401 Sum_probs=181.8
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
-|+..++||+|+||.||++... +++.||||.+..... ....+.|.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3677888999999999999874 578999998765432 23446789999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 9999999999753 5899999999999999999999988 99999999999999999999999998754321
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
....+.++||||||+++|||++|+.||..... ... ...+.... .......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~----~~~~~~~~---------~~~~~~~ 224 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKV----LFLIPKNN---------PPTLEGN 224 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHH----HHHHhcCC---------CCCCCcc
Confidence 11225689999999999999999999963221 100 11111110 1111122
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...++.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3346789999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=287.93 Aligned_cols=233 Identities=21% Similarity=0.319 Sum_probs=195.7
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.-|.+.+.||+|-|..|-+++. ..|+.||||++.+..+.......+.+|++.|+-++|||||+|+.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3467778899999999999985 579999999998877655555678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEEEeecCCCccccCCC-
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGARIADFGLLTSCERDL- 638 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGla~~~~~~~- 638 (740)
+=.+|+|+|||-.+...+.+....+++.||+.+|.|+|... +|||||||+||.+- .-+.+||.|||++-.+....
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999888888999999999999999999999988 99999999998775 45789999999976554321
Q ss_pred --------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 639 --------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 639 --------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
+..+++||||+|||||.|+.|+.||+...+. +.+..|+|-.+..|.-
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------ETLTmImDCKYtvPsh 241 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------ETLTMIMDCKYTVPSH 241 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-------------hhhhhhhcccccCchh
Confidence 2246899999999999999999999753321 2334456666655543
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
. ..+..+||..||..||++|-+.+||+. ||+.
T Consensus 242 v--S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 242 V--SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred h--hHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 2 336779999999999999999999986 6543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=295.38 Aligned_cols=230 Identities=23% Similarity=0.340 Sum_probs=196.5
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
-...|...+.||+|.|++|.+++.. .+..||||.+.+........+.+.+|+++|..|+|||||+|+.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467889999999999999999974 489999999988776666666799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||+.+|.+++||.++. .+...+...+..|+.++++|||++. |+|||||++||||+.++++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999998664 4555888899999999999999999 999999999999999999999999998655431
Q ss_pred --------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
.+..+++|+||+|++||-|+.|..||+....+ .-..+++-.+++.|.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------~Lr~rvl~gk~rIp~ 276 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------ELRPRVLRGKYRIPF 276 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------cccchheeeeecccc
Confidence 12257899999999999999999999865422 122344556666676
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.... +..+|+++++-++|.+|+++++|.+
T Consensus 277 ~ms~--dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 277 YMSC--DCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeec--hhHHHHHHhhccCccccCCHHHhhh
Confidence 5555 4558999999999999999999986
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.94 Aligned_cols=232 Identities=24% Similarity=0.353 Sum_probs=182.2
Q ss_pred CccccceecccCceEEEEEEE-eCCcEEEEEEecccccc----hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATII----HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
+|+..+.||+|+||.||+++. .+++.||+|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 45889999998753311 1134678999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~ 636 (740)
||||+++++|.+++... .++++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999999754 46899999999999999999999998 99999999999998775 599999998754321
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
....+.++||||||+++|||++|+.||......... .... ++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~---------~~~~~ 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIF---------KIASA 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-HHHH---------HHhcc
Confidence 122356899999999999999999999643221111 1000 00001
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+.....++.+++.+||+.+|++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1111122233347889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=284.28 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=182.7
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEEEe
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLVYE 560 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 560 (740)
|+..++||+|+||.||+++..+ ++.+|+|++............+.+|++++++++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667889999999999999764 88999999986542233446788999999999999999999999988 78999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|+++ +|.+++......+++..++.++.|+++||+|||+.+ ++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 999998766567999999999999999999999998 999999999999999999999999987543221
Q ss_pred --------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccchh------
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAAAI------ 688 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i------ 688 (740)
...+.++||||||+++|||+||+.||+....... .......... .....+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchhh
Confidence 1235689999999999999999999975432211 1111111000 000000
Q ss_pred --cccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 --IDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 --~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+. .......+.+++++||+.+|.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 0011446789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=279.75 Aligned_cols=229 Identities=23% Similarity=0.290 Sum_probs=184.5
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+|+..+.||+|+||.||+++.. .++.||+|.+....... ...+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 48899999987654322 345789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--- 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--- 637 (740)
|+++++|.+++... .++++.++..++.|++++|.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 99999999999765 57899999999999999999999998 999999999999999999999999987543221
Q ss_pred -----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...+.++||||||+++|||++|+.||...... ..+........ .....+ ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~~--~~ 224 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET--------ADVLYP--AT 224 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc--------ccccCc--cc
Confidence 12367899999999999999999999754321 11111111110 111111 22
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTM--SQVA 727 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~--~ev~ 727 (740)
....+.+++.+||+.||.+||++ +|++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 23578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=282.50 Aligned_cols=237 Identities=24% Similarity=0.266 Sum_probs=178.7
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeC--CeEEEEE
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEM--GERLLVY 559 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 559 (740)
|+..++||+|.||.||+++.. +++.||+|+++..... .......+|+.++.++. |+|++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 566788999999999999974 5889999998764322 22234567999999985 99999999999987 8899999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||++ ++|.+++......++|.++..++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9997 5999998765567999999999999999999999998 999999999999999 9999999998764321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch---hcc----c
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA---IID----R 691 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---i~d----~ 691 (740)
....+.++|||||||++|||++|+.||...... ............ ...+ ... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGT-PDAEVLKKFRKSRHM 232 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCC-CCHHHHHhhcccccc
Confidence 112356899999999999999999999654321 111111111100 0000 000 0
Q ss_pred ccCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .......+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000110 1123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=281.12 Aligned_cols=224 Identities=25% Similarity=0.339 Sum_probs=178.1
Q ss_pred ecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||.||+++..+ ++.+++|.+...... +.....+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 899999998765431 23456789999999999999999999999999999999999999999
Q ss_pred HHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----------
Q 040687 568 HDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---------- 637 (740)
Q Consensus 568 ~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---------- 637 (740)
.++++... .+++..+++++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997643 7899999999999999999999998 999999999999999999999999987543211
Q ss_pred -------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...+.++||||||+++|||++|+.||...... +. ...+ .......+..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~-~~~~--------~~~~~~~~~~ 223 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EI-FQNI--------LNGKIEWPED 223 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HH-HHHH--------hcCCcCCCcc
Confidence 11245899999999999999999999643211 11 1111 1111222222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
......+.+++.+||+.+|++||++.++.+.|
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 21245788999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=287.30 Aligned_cols=170 Identities=25% Similarity=0.394 Sum_probs=141.0
Q ss_pred ceecccCceEEEEEEEeC---CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--CCeEEEEEecC
Q 040687 488 NELGRGSYGFVYKAVLVD---GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE--MGERLLVYEFM 562 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~---g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~ 562 (740)
.+||+|+||+||+++..+ +..||+|.+.... ....+.+|+++|++++||||+++++++.. +...++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999999753 5789999886543 22467889999999999999999999854 45789999999
Q ss_pred CCCChHHhHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCCEEEeecCC
Q 040687 563 PRGTLHDHLHGG--------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL----DSDWGARIADFGL 630 (740)
Q Consensus 563 ~~gsL~~~l~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DFGl 630 (740)
++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 888877421 124889999999999999999999998 9999999999999 5667899999999
Q ss_pred CccccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCC
Q 040687 631 LTSCER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDI 665 (740)
Q Consensus 631 a~~~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~ 665 (740)
++.... ...++.++||||||+++|||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 864321 01235689999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=283.88 Aligned_cols=241 Identities=22% Similarity=0.267 Sum_probs=181.4
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|+..++||+|.+|.||++... +++.||+|++............+.+|++++++++|||++++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999974 6899999998765433334467889999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 563 PRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 563 ~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+ ++|.+++.... ..+++..++.++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 69999987543 36899999999999999999999988 99999999999999999999999998754321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC--------ccchhccc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG--------KAAAIIDR 691 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~i~d~ 691 (740)
....+.++||||||+++|||+||+.||........+.+......... ........
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 01125689999999999999999999964322111111000000000 00000000
Q ss_pred c--cCC----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 N--VAL----PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~--~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ... .........+.+++.+||+.||++||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000 001122246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=272.99 Aligned_cols=229 Identities=30% Similarity=0.436 Sum_probs=186.0
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.|+..+.||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677889999999999999985 588999999876542 3557899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---- 637 (740)
+++++|.+++......+++..+..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 9999999999876567999999999999999999999988 999999999999999999999999987654332
Q ss_pred ----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 638 ----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 638 ----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...+.++||||||+++|||++|+.||......... ....... ....+.....
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~-------~~~~~~~~~~ 223 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----FKIATNG-------PPGLRNPEKW 223 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHHhcC-------CCCcCccccc
Confidence 12366899999999999999999999643211110 0111110 1111112212
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=305.30 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=179.2
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC------CCcceEEe
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH------SNIVNLLG 547 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g 547 (740)
+++...+++|+..++||+|+||+||+++.. .++.||||+++... ...+++..|++++.+++| .+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 344456788999999999999999999975 47889999986432 223456778888877755 45888998
Q ss_pred EEEeC-CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCC----
Q 040687 548 YCLEM-GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDW---- 621 (740)
Q Consensus 548 ~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~---- 621 (740)
++... ...+||||++ +++|.+++... ..+++.++..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 88764 4788999988 77999998754 4699999999999999999999974 7 99999999999998765
Q ss_pred ------------CEEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCch
Q 040687 622 ------------GARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG 671 (740)
Q Consensus 622 ------------~~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 671 (740)
.+||+|||++..... ...++.++|||||||+||||+||+.||+.......
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998643211 22346789999999999999999999975432111
Q ss_pred hHHhhhhHH-------h----hCccchhccccc--------------CC---CCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 040687 672 IVEWALPLI-------K----QGKAAAIIDRNV--------------AL---PRNVEPLFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 672 ~~~~~~~~~-------~----~~~~~~i~d~~~--------------~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
+ ......+ . ......+.+... .. .........+.+|+.+||+.||++|||+
T Consensus 354 ~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 354 L-HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred H-HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 1 0000000 0 000000000000 00 0000112356799999999999999999
Q ss_pred HHHHH--HHHHHH
Q 040687 724 SQVAT--WLEQIV 734 (740)
Q Consensus 724 ~ev~~--~Le~l~ 734 (740)
+|+++ +|.+..
T Consensus 433 ~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 433 RQMTTHPYVLKYY 445 (467)
T ss_pred HHHhcCccccccC
Confidence 99997 666543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=285.08 Aligned_cols=242 Identities=26% Similarity=0.331 Sum_probs=181.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 557 (740)
.++|+..+.||+|+||.||++... +++.||+|.++...........+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999975 489999999875443222234567899999999999999999998765 46899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||++ ++|.+++......+++.++..++.||++||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 4899988765567999999999999999999999999 99999999999999999999999998754321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh---c---
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI---I--- 689 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i---~--- 689 (740)
....+.++||||||+++|||++|+.||....... .......... .....+ +
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~ 239 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLG-TPNESIWPGFSDL 239 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC-CCChhhchhhhcc
Confidence 1123568999999999999999999996432211 1111111000 000000 0
Q ss_pred --ccccCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 --DRNVALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 --d~~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+. ......++.+++.+||+.||++||+++|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0011345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=281.31 Aligned_cols=240 Identities=22% Similarity=0.336 Sum_probs=182.2
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..++||+|+||.||+++.. +++.||||.++.... ......+.+|++++++++|+||+++++++...+..+|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5788899999999999999985 488999999876542 23345678899999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 562 MPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 8999886543 46899999999999999999999998 99999999999999999999999998753211
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh---hCccchhc---cc
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK---QGKAAAII---DR 691 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---~~~~~~i~---d~ 691 (740)
...++.++||||||+++|||++|+.||.....+..+.. ...... ......+. +.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK-IFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCCCChhhHHHHhcCchh
Confidence 11235689999999999999999999975433221111 110000 00000000 00
Q ss_pred ccCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .......+.+++.+|++.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=282.37 Aligned_cols=229 Identities=24% Similarity=0.371 Sum_probs=183.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|...+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++++++||||+++++.+......++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 367888999999999999999864 57889999986443 233467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999999754 4889999999999999999999998 99999999999999999999999998643211
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
....+.++||||||+++|||++|+.||........+. ... .......+..
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----~~~--------~~~~~~~~~~ 238 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIA--------TNGTPELQNP 238 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee----ehh--------cCCCCCCCCc
Confidence 1223568999999999999999999996432211100 000 0111111112
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+.+++++||+.+|++||++.+++.
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222346779999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=279.61 Aligned_cols=227 Identities=25% Similarity=0.392 Sum_probs=180.9
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.|...+.||+|+||.||++... +++.+++|++.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3555678999999999999964 58899999886433 23345689999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++++|.+++.. .++++.++..++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 999999999976 46899999999999999999999998 99999999999999999999999998653221
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++||||||+++|||++|+.||..... .+. ...+.... .+.. .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~-~~~~~~~~-----~~~~--~~~~~ 240 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQA-MKRIRDNL-----PPKL--KNLHK 240 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHH-HHHHHhcC-----CCCC--ccccc
Confidence 11246789999999999999999999864321 111 11111111 0111 11112
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 3347889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.10 Aligned_cols=237 Identities=26% Similarity=0.395 Sum_probs=179.7
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 560 (740)
+|...++||+|+||.||+++.. +++.||+|.+...... .....+.+|+.++.++. |+||+++++++......+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4566778999999999999975 4889999998754432 34467899999999996 9999999999999889999999
Q ss_pred cCCCCChHHhH---hC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 561 FMPRGTLHDHL---HG-GLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 561 y~~~gsL~~~l---~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
|++. +|.++. .. ....+++.....++.|++.||+|||+. + ++||||||+|||+++++.+||+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 555433 22 225689999999999999999999975 6 9999999999999999999999999875321
Q ss_pred C---------------------C--CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 636 R---------------------D--LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 636 ~---------------------~--~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
. . ..++.++||||||+++|||++|+.||.... ...+....... .. .+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~-~~-----~~~ 230 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVK-GD-----PPI 230 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcC-CC-----CCc
Confidence 1 0 134678999999999999999999996432 11111111110 00 011
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
...........++.+|+.+||+.||++||++++|+. ++++.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 111112234457889999999999999999999997 45443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=290.21 Aligned_cols=247 Identities=20% Similarity=0.282 Sum_probs=183.8
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------ 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (740)
..++|+..+.||+|+||.||+++.. +++.||||++............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3477999999999999999999974 589999999865433233445678899999999999999999988644
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
...++||||+. ++|.+++... ++...+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 24799999996 5899888643 889999999999999999999998 9999999999999999999999999986
Q ss_pred cccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh--------------
Q 040687 633 SCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP-------------- 678 (740)
Q Consensus 633 ~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~-------------- 678 (740)
..... ...+.++||||||+++|||++|+.||........... ...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK-IIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHHhh
Confidence 43221 1235689999999999999999999964322111100 000
Q ss_pred -----HHhhCc------cchhcccccCCCC----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 679 -----LIKQGK------AAAIIDRNVALPR----NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 679 -----~~~~~~------~~~i~d~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
...... ..++......... ......++.+++.+||+.||++||++.|++. +|+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 000000 0011111000000 1123446789999999999999999999996 665443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=273.58 Aligned_cols=229 Identities=24% Similarity=0.400 Sum_probs=186.9
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|+||.||++... +++.|++|++..........+++.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999975 488999999877654445567899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 562 MPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
+++++|.+++.... ..+++.++..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997653 67999999999999999999999998 99999999999999999999999998754322
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
....+.++||||||++++||++|+.||+..... .+ ........ ..+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~----~~~~~~~~---------~~~~ 223 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-EL----ALKILKGQ---------YPPI 223 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-HH----HHHHhcCC---------CCCC
Confidence 122357899999999999999999999643211 11 11111111 1111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+......+.+++++||..+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1133347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.77 Aligned_cols=226 Identities=24% Similarity=0.365 Sum_probs=179.4
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|....+||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 444557999999999999974 58899999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------ 636 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------ 636 (740)
++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 99999998865 35899999999999999999999998 99999999999999999999999998753221
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
....+.++||||||+++|||++|+.||....... . ...+..... ... ......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~----~~~~~~~~~-----~~~--~~~~~~ 243 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-A----MKRLRDSPP-----PKL--KNAHKI 243 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H----HHHHhccCC-----CCc--cccCCC
Confidence 1123668999999999999999999996432111 1 111111100 001 111122
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.+++.+||+.+|++||++++|++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 346789999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=283.60 Aligned_cols=230 Identities=26% Similarity=0.321 Sum_probs=181.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+.|+..+.||+|+||.||+++.. +++.+|+|.+..... .....+++.+|++++++++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999975 478899998864321 2233467889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+. ++|.+++.....++++.++..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 9996 6898888655567899999999999999999999988 99999999999999999999999998764221
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||++|+.||...... +... .+.... .......
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~-~~~~~~--------~~~~~~~ 237 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY-HIAQNE--------SPALQSG 237 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----HHHH-HHhhcC--------CCCcCcc
Confidence 122466899999999999999999998532111 0000 111111 1111111
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+|+.+||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 23346789999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.00 Aligned_cols=228 Identities=25% Similarity=0.320 Sum_probs=181.2
Q ss_pred ecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||.||+++... ++.||+|.+...... ....+.+.+|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999854 889999998765432 23346799999999999999999999999999999999999999999
Q ss_pred HHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----------
Q 040687 568 HDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---------- 637 (740)
Q Consensus 568 ~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---------- 637 (740)
.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence 9999764 45899999999999999999999988 999999999999999999999999997654321
Q ss_pred ----------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHH
Q 040687 638 ----------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707 (740)
Q Consensus 638 ----------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~ 707 (740)
...+.++|+||||+++|||++|+.||.....+. .+.. ..+.+.....+.+.....++.+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~---------~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIY---------NDILKGNGKLEFPNYIDKAAKD 225 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHH---------HHHhccCCCCCCCcccCHHHHH
Confidence 123568999999999999999999997543211 1111 1111111111122222457889
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHH--HHHH
Q 040687 708 IAELAIRENPSELPT-----MSQVAT--WLEQ 732 (740)
Q Consensus 708 l~~~Cl~~dP~~RPt-----~~ev~~--~Le~ 732 (740)
++.+||+.+|++||+ ++|+++ ++..
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 999999999999999 788876 5544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=281.72 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=182.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|.||.||+++.. +++.||+|++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999975 58899999987654333344678899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccC--
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCER-- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~-- 636 (740)
|++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++ +..+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 58888886443 23688888899999999999999998 999999999999985 55799999998754211
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc-------
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII------- 689 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~------- 689 (740)
....+.++||||||+++|||+||+.||........+.+ ...... .......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFRILG-TPNEETWPGVTSLP 235 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhC-CCChhhccccccch
Confidence 01235689999999999999999999965432211111 000000 0000000
Q ss_pred c-----cccCCC----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 690 D-----RNVALP----RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 690 d-----~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
+ +..... .......++.+++.+|++.+|++||++.++++ +++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 000000 01112335778999999999999999999987 55443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=282.37 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=179.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (740)
.++|+..++||+|+||.||+++.. +++.||||++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356899999999999999999975 5889999988654332333345678999999999999999999987653
Q ss_pred --eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 554 --ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 554 --~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
..++||||+. ++|.+++......+++.+++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 4898888766557899999999999999999999998 999999999999999999999999987
Q ss_pred ccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 632 TSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 632 ~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
..... ....+.++||||||+++|||+||+.||....... ..+...... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~~~~~~-~~~~ 244 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLISQLC-GSIT 244 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCCC
Confidence 53311 0113568999999999999999999996543211 111100000 0000
Q ss_pred chhc--------ccccCCCCC-----------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 AAII--------DRNVALPRN-----------VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 ~~i~--------d~~~~~~~~-----------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.++. ......+.. ......+.+++.+||+.||++||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000000100 001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=286.62 Aligned_cols=231 Identities=24% Similarity=0.286 Sum_probs=192.5
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 556 (740)
..+.|+..++||+|.||.||+++.+. |+.+|+|.+.+...... ....+.+|+++|++|. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999999865 99999999987654322 3467899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC----CCEEEeecCCCc
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD----WGARIADFGLLT 632 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~ki~DFGla~ 632 (740)
||||++.+|.|.+.+... .+++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999999766 3999999999999999999999998 9999999999999654 479999999987
Q ss_pred cccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 633 SCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 633 ~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
.... ...++.++||||.||++|.|++|..||..+....... .++...
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~~~ 254 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILRGD 254 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHcCC
Confidence 6543 2345779999999999999999999997654322111 222222
Q ss_pred --cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 --VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 --~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+..+..........++++.++..||.+|+++.++++
T Consensus 255 ~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 233344455667889999999999999999999997
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=274.67 Aligned_cols=229 Identities=24% Similarity=0.376 Sum_probs=185.4
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..++||+|+||.||+++.. +++.+++|++...........++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999864 578999999876554444556788999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 562 MPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
+++++|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||+++++..+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998652 246899999999999999999999998 99999999999999999999999998764432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++|+||||+++|||++|+.||.....+ .+ ...+..... .+...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~----~~~~~~~~~---------~~~~~ 223 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DL----RYKVQRGKY---------PPIPP 223 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHhcCCC---------CCCch
Confidence 112356899999999999999999999643211 11 111111111 11122
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 33457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=282.94 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=178.4
Q ss_pred CccccceecccCceEEEEEEEe---CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV---DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 556 (740)
+|+..++||+|+||.||+++.. +++.||+|.+..... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999975 478999999886431 112235678899999999999999999999988 7899
Q ss_pred EEEecCCCCChHHhHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC----CCCEEEeec
Q 040687 557 LVYEFMPRGTLHDHLHGGL----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS----DWGARIADF 628 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~ki~DF 628 (740)
+||||+++ +|.+++.... ..++...++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7777764321 26889999999999999999999998 999999999999999 999999999
Q ss_pred CCCccccCC-------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCch--------hHHh
Q 040687 629 GLLTSCERD-------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG--------IVEW 675 (740)
Q Consensus 629 Gla~~~~~~-------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~--------~~~~ 675 (740)
|++...... ...+.++||||||++||||++|+.||........ ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 987643211 1235689999999999999999999975432210 0000
Q ss_pred hhhHHhh------------Cccchhccc--ccCCCC-C--------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 676 ALPLIKQ------------GKAAAIIDR--NVALPR-N--------VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 676 ~~~~~~~------------~~~~~i~d~--~~~~~~-~--------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.. .......+. ....+. . .....++.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000000000 001110 0 022346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=278.53 Aligned_cols=231 Identities=26% Similarity=0.330 Sum_probs=181.1
Q ss_pred CccccceecccCceEEEEEEEe----CCcEEEEEEecccccch--hcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIH--TNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (740)
+|+..+.||+|+||.||+++.. +++.||+|++....... ...+.+.+|+++++++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4777889999999999999863 68899999987543211 2345688999999999 599999999999988899
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++... ..+++..+..++.|++++|.|||+.+ ++||||||+|||+++++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999754 46889999999999999999999988 9999999999999999999999999876532
Q ss_pred CC------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 RD------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~~------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. ...+.++||||||+++|||++|+.||..........+.... +...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------~~~~ 227 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---------ILKS 227 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH---------hhcc
Confidence 21 12346899999999999999999999643222222111111 1111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
....+ ......+.+++++||+.||++|| +.++++.
T Consensus 228 ~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 EPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11112 22334678999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=283.51 Aligned_cols=242 Identities=20% Similarity=0.223 Sum_probs=178.2
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
+.+|.|+++.||+++. +++.||||+++.........+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555555544 689999999876544445667899999999999999999999999999999999999999999
Q ss_pred HHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----------
Q 040687 568 HDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---------- 636 (740)
Q Consensus 568 ~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---------- 636 (740)
.+++.... ..+++.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+||+.+.....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99997542 45889999999999999999999998 99999999999999999999999997642210
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH----hhCc-------c
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI----KQGK-------A 685 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~----~~~~-------~ 685 (740)
...++.++||||||+++|||++|+.||........+.+...... .... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 01245689999999999999999999974322222211110000 0000 0
Q ss_pred ch----hcccc----cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 686 AA----IIDRN----VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 686 ~~----i~d~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
.. ..+.. ...+.......++.+++.+||+.||++|||++|+++ ++..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00 00000 011111222346789999999999999999999997 55554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.64 Aligned_cols=228 Identities=26% Similarity=0.354 Sum_probs=180.1
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
|...++||+|+||+||+++.. +++.|++|++...... ......+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999974 5889999998754322 22345788999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+. ++|.+++.....++++.+++.++.||+.+|.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcc
Confidence 96 6888888766667999999999999999999999998 99999999999999999999999998653211
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
....+.++||||||+++|||++|+.||....... ...... ...... . .....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~-----~---~~~~~ 245 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIA-QNDSPT-----L---QSNEW 245 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHH-hcCCCC-----C---Ccccc
Confidence 1224568999999999999999999986432111 111111 111110 0 11122
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.+++.+||+.+|.+||++.+++.
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 235779999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=290.42 Aligned_cols=178 Identities=29% Similarity=0.419 Sum_probs=154.8
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCC-C-----CCcceEEeEEEeCCeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIR-H-----SNIVNLLGYCLEMGER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~ 555 (740)
+|...+.||+|+||.|-|+.... ++.||||+++... ...++-..|+.+|.+|+ | -|+|++++++..+++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 68889999999999999999754 8999999998754 34456678999999997 4 4899999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC--CCEEEeecCCCc
Q 040687 556 LLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD--WGARIADFGLLT 632 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~ki~DFGla~ 632 (740)
+||+|.++ -+|+++|+.+. ..++...+..|+.||+.+|.+||+.+ |||.||||+||||.+. ..+||+|||.+.
T Consensus 264 ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999995 49999998654 56999999999999999999999999 9999999999999754 469999999986
Q ss_pred cccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 040687 633 SCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEY 667 (740)
Q Consensus 633 ~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~ 667 (740)
...+ ...++++.||||||||+.||+||.+.|.++.
T Consensus 340 ~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 5443 3456889999999999999999988886553
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=280.74 Aligned_cols=231 Identities=26% Similarity=0.410 Sum_probs=179.1
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||++++.+ ++.||||.++..... ....++..|+.++.++. ||||+++++++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 568888999999999999999865 889999998754322 23456777888777775 999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
||++ ++|.+++.....++++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9985 47887776545579999999999999999999997 46 999999999999999999999999987543210
Q ss_pred -----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 638 -----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 638 -----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...+.++||||||+++|||++|+.||....... + ....+.... ...
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~-~~~~~~~~~-------~~~ 238 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---E-VLTKILQEE-------PPS 238 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---H-HHHHHhcCC-------CCC
Confidence 113568999999999999999999996321111 1 111111111 111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+.......++.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111123457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.07 Aligned_cols=240 Identities=25% Similarity=0.304 Sum_probs=178.5
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhC---CCCCcceEEeEEEeCCe-----
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNI---RHSNIVNLLGYCLEMGE----- 554 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 554 (740)
|+..+.||+|+||.||+++... ++.||+|+++...........+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999865 89999999875543223345677888877766 69999999999988776
Q ss_pred EEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.+++|||++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+|||+++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 48999887543 35899999999999999999999998 99999999999999999999999998765
Q ss_pred ccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh-Ccc-------
Q 040687 634 CERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ-GKA------- 685 (740)
Q Consensus 634 ~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-~~~------- 685 (740)
.... ...+.++||||||+++|||++|+.||........+... ...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI-FDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH-HHHcCCCChHhcCCCcc
Confidence 4221 22356899999999999999999998754322222111 110000 000
Q ss_pred --chhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 --AAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 --~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..........+. ..+....+.+++.+||+.||++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 0122346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=287.49 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=185.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----Ce
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----GE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (740)
.++|...+.||+|+||+||+++.. +++.||||.+............+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999974 588999999875432233445678899999999999999999988654 24
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+|||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6999998754 46999999999999999999999998 999999999999999999999999987643
Q ss_pred cCC----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH-----------Hh
Q 040687 635 ERD----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL-----------IK 681 (740)
Q Consensus 635 ~~~----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~-----------~~ 681 (740)
... ...+.++||||||+++|||++|+.||....... ........ +.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcC
Confidence 211 123568999999999999999999996432111 00000000 00
Q ss_pred hCccchhcccccCCC------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 682 QGKAAAIIDRNVALP------RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.......++.....+ .......++.+++++||+.+|++||+++|+++ +|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000000000 01123456789999999999999999999997 466653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=288.79 Aligned_cols=230 Identities=28% Similarity=0.356 Sum_probs=187.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccc-cchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAAT-IIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+-|..++.||.|+||.||.++.. +.+.||||++.... .+.....++++|+.+|.+|+|||++.+-|++......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34888899999999999999974 57889999987543 22345678999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||| -|+-.|+|.-+.+++-..++..|..+.+.||+|||+.. .||||||+.||||++.+.+||+|||.|....+
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 999 56888888767788999999999999999999999999 99999999999999999999999998754432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...|+-|+||||+|++..||.-.++|+.... ... ++-.|.+++. +.+ ...
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----AMS-ALYHIAQNes-----PtL---qs~ 248 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMS-ALYHIAQNES-----PTL---QSN 248 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----HHH-HHHHHHhcCC-----CCC---CCc
Confidence 3456789999999999999999999975321 111 1112222111 111 134
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+....+..++..||++-|.+|||.++++.
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 55667889999999999999999999876
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=270.82 Aligned_cols=228 Identities=28% Similarity=0.430 Sum_probs=185.3
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|+..+.||+|.||.||+++.. +++.|++|.+............+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999875 478999999987654445567899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---- 637 (740)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 9999999999765 57899999999999999999999998 999999999999999999999999987644321
Q ss_pred -----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...+.++||||||+++|||++|+.||......... ...... .....+ ..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~-------~~~~~~--~~ 222 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-----FRIVQD-------DHPPLP--EG 222 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHhcc-------CCCCCC--CC
Confidence 11356899999999999999999999643211000 011100 111111 12
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.+++.+||+.+|++||++.|++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=277.88 Aligned_cols=224 Identities=23% Similarity=0.251 Sum_probs=170.8
Q ss_pred eecccCceEEEEEEEe-CCcEEEEEEecccccchhc-HHHHHHHHHHHH---hCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 489 ELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTN-IREFEMELEVLC---NIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~-~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
.||+|+||.||++... +++.+|+|.+......... ...+.+|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 4889999988765432222 223445544443 3479999999999999899999999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-------
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------- 636 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------- 636 (740)
+++|.+++..+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcC
Confidence 99999998754 46999999999999999999999998 99999999999999999999999998753211
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
....+.++||||||+++|||++|+.||........ ....... .......+ .....
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~--------~~~~~~~~--~~~~~ 224 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMT--------LTVNVELP--DSFSP 224 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHh--------hcCCcCCc--cccCH
Confidence 12236689999999999999999999974332111 0000000 00011111 22334
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 704 KLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
++.+++.+||+.||++|| +++|+++
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 778999999999999999 5988887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=282.63 Aligned_cols=243 Identities=24% Similarity=0.299 Sum_probs=180.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (740)
.++|+..++||+|+||.||+++.. +++.+|||++............+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 5889999998765432333356789999999999999999999875433
Q ss_pred --eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 554 --ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 554 --~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
..++|+||+.. +|.+.+......+++.++..++.|++++|+|||+.+ |+|+||||+|||+++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999965 788888765567999999999999999999999998 999999999999999999999999987
Q ss_pred ccccC---------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh
Q 040687 632 TSCER---------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP 678 (740)
Q Consensus 632 ~~~~~---------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 678 (740)
..... ....+.++||||||+++|||++|+.||......... +....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~-~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL-HLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH
Confidence 53211 112356899999999999999999999643321111 11111
Q ss_pred HHhh---------Cccchhccccc--CCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 679 LIKQ---------GKAAAIIDRNV--ALPR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 679 ~~~~---------~~~~~i~d~~~--~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.... ..+....+... ..+. .......+.+++.+||+.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 00000000000 0000 0112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=275.85 Aligned_cols=227 Identities=26% Similarity=0.395 Sum_probs=190.9
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
-|..+.+||+|+||.|||+..+. |..||||.+... .+.+++.+|+.||++.+.|++|+++|.+.....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 47778899999999999999754 899999998764 4668999999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
|--|+..|.++.++++|++.++..+..+.++||+|||... -||||||+.||||+-++.+||+|||.|-.+..
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999999988899999999999999999999999988 89999999999999999999999998754432
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...|+.+.||||+|++..||.-|++||.+-.. . +.-+.-..++...+..+++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------M--RAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----------M--RAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------c--ceeEeccCCCCCCCCChHh
Confidence 33457899999999999999999999963210 0 0000111112222333556
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...++.++++.||-++|++|-|+.++++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 6778899999999999999999998876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=277.34 Aligned_cols=235 Identities=23% Similarity=0.298 Sum_probs=182.5
Q ss_pred CccccceecccCceEEEEEEEe----CCcEEEEEEecccccc--hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATII--HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (740)
+|+..+.||+|+||.||+++.. +++.||||.++..... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 4688999998754321 12345688999999999 699999999999988899
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++... ..+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999998754 46899999999999999999999988 9999999999999999999999999875422
Q ss_pred CC----------------------C--CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 RD----------------------L--TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~~----------------------~--~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. . ..+.++||||||+++|||+||+.||..........+.. . .+...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~--------~~~~~ 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS-R--------RILKS 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH-H--------HHHcc
Confidence 10 0 13568999999999999999999996432211111111 1 11111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
....+. .....+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 ~~~~~~--~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPK--TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCc--ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 112222 223467899999999999999998888766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=277.19 Aligned_cols=240 Identities=24% Similarity=0.331 Sum_probs=183.3
Q ss_pred ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|+..+.||+|++|.||+++.. +++.+++|++............+.+|++++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999974 5889999998765543344567889999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-----
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD----- 637 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~----- 637 (740)
++ +|.+++......+++..++.++.|++++|.|||+.+ |+|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 75 999998776567999999999999999999999998 999999999999999999999999986433221
Q ss_pred -----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccchhcc----ccc
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAAAIID----RNV 693 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i~d----~~~ 693 (740)
...+.++||||||+++|||+||+.||........+.. ....+.. .......+ ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCchHhcccchhhhhhhhh
Confidence 1346789999999999999999999965432111110 0000000 00000000 000
Q ss_pred CC------C---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 AL------P---RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~~------~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. + ...+...++.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0 01123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=286.29 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=185.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 555 (740)
.++|+..+.||+|+||.||++... +++.||+|++..........+.+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999975 58999999987654333345678889999999999999999988763 3468
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 6999998754 45899999999999999999999998 9999999999999999999999999875431
Q ss_pred C--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh----------hH
Q 040687 636 R--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL----------PL 679 (740)
Q Consensus 636 ~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~----------~~ 679 (740)
. ...++.++||||||+++|||++|+.||........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 1 01235689999999999999999999965432211110000 00
Q ss_pred HhhCccchhccc---ccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 680 IKQGKAAAIIDR---NVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 680 ~~~~~~~~i~d~---~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
.....+.+..+. ....+. ......++.+++++||+.+|++||++.+++. ++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 000011111110 001100 0123457889999999999999999999987 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=285.56 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=182.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (740)
.++|...+.||+|+||.||+|+.. +++.||||++............+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999974 589999999875433233345688999999999999999999998754 2
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++|+||+.. +|.+++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46999999964 7877763 25899999999999999999999998 99999999999999999999999998764
Q ss_pred ccC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh-----------HHhhC
Q 040687 634 CER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP-----------LIKQG 683 (740)
Q Consensus 634 ~~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~-----------~~~~~ 683 (740)
... ...++.++||||||+++|||++|+.||........+.. ... .....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ-ILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHHhccc
Confidence 321 12246689999999999999999999975322111110 000 00000
Q ss_pred ccchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 684 KAAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 684 ~~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.....+......+. ......++.+++++||+.||++||++.|++. +++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000000000 0112336779999999999999999999995 566654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.05 Aligned_cols=225 Identities=23% Similarity=0.290 Sum_probs=175.8
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||+||++... +++.||+|.+....... .....+.+|+++|++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 58899999987543222 2345678899999999999999999999999999999999999999
Q ss_pred HHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----------
Q 040687 568 HDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---------- 636 (740)
Q Consensus 568 ~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---------- 636 (740)
.+++.... ..+++.+++.++.|++++|.|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99997543 36899999999999999999999998 99999999999999999999999998754321
Q ss_pred ----------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHH
Q 040687 637 ----------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLA 706 (740)
Q Consensus 637 ----------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~ 706 (740)
....+.++||||||+++|||++|+.||.......... .+... +.......+ ......+.
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~----~~~~~~~~~--~~~~~~~~ 226 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-----ELKRR----TLEMAVEYP--DKFSPEAK 226 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-----HHHhc----cccccccCC--ccCCHHHH
Confidence 1123568999999999999999999996433211110 01110 111111111 12234678
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 707 DIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 707 ~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
+++.+||+.||++|| ++.+++.
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHh
Confidence 999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=284.64 Aligned_cols=248 Identities=27% Similarity=0.347 Sum_probs=184.0
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC--CeE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM--GER 555 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 555 (740)
..++|+..+.||+|+||.||++.+. +++.+|+|++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999975 478999998865332233445678899999999 999999999998654 368
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||++ ++|.+++... .++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999998764 6899999999999999999999998 9999999999999999999999999875332
Q ss_pred C---------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh----------hh
Q 040687 636 R---------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA----------LP 678 (740)
Q Consensus 636 ~---------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~----------~~ 678 (740)
. ....+.++||||||+++|||+||+.||............. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 1 0112568999999999999999999996432211110000 00
Q ss_pred HHhhCccchhcc----cccCC--CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 679 LIKQGKAAAIID----RNVAL--PRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 679 ~~~~~~~~~i~d----~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
.+.......+++ ..... ....+...++.+++.+||+.||++||++.+++. +++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000011111 00000 001113447889999999999999999999997 45554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=284.55 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=187.2
Q ss_pred cccChhHHHHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 470 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 470 ~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
+.....++...+++|...+.||+|+||.||++.. .+++.||+|++..........+.+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3344566777889999999999999999999986 458899999987643223334668899999999999999999998
Q ss_pred EEeC------CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 549 CLEM------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 549 ~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
+... ...++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 8643 3467888887 78999888653 5899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh-------
Q 040687 623 ARIADFGLLTSCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA------- 676 (740)
Q Consensus 623 ~ki~DFGla~~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~------- 676 (740)
+||+|||++...... ...+.|+||||||+++|||++|+.||........+....
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 159 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred EEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999997643221 223568999999999999999999996432211111100
Q ss_pred ---hhHHhhCccchh---cccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 677 ---LPLIKQGKAAAI---IDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 677 ---~~~~~~~~~~~i---~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+........ +........ ......++.+++.+|++.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000000000 000000000 0112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=283.62 Aligned_cols=229 Identities=22% Similarity=0.322 Sum_probs=187.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 559 (740)
...|+..++||+|+...||++...+.+.+|+|++.......+....|.+|+.+|.+|+ |.+||+|++|...++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3468889999999999999999888889999988777666667788999999999995 999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCC-HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC
Q 040687 560 EFMPRGTLHDHLHGGLSPLN-WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~-~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 638 (740)
||=+ -+|..+|+.....+. | .+..+..||+.++.++|.++ |||-||||.|.|+-. |.+||+|||+|..+..+.
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 9874 499999987655444 5 67789999999999999999 999999999999965 579999999986554311
Q ss_pred C----------------------------------CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 639 T----------------------------------TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 639 ~----------------------------------~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
+ ...+|||||+|||||+|+.|+.||..- . . ...+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~----n--~~aK 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------I----N--QIAK 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------H----H--HHHH
Confidence 1 145899999999999999999999521 1 0 1134
Q ss_pred cchhcccccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 AAAIIDRNVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ~~~i~d~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+..|.|+....+. -.+ ..++.++|+.||++||++||++.|+++
T Consensus 582 l~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 5667777553333 222 223889999999999999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=291.85 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=194.1
Q ss_pred cccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------eEEE
Q 040687 485 KEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ERLL 557 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 557 (740)
...+.||+|+||.||+++. ..|+.||||.++... .....+.+.+|+++|++|+|+|||++++.-++.. ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456799999999999995 459999999998755 2345567899999999999999999999876543 5789
Q ss_pred EEecCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CCC--CEEEeecCCC
Q 040687 558 VYEFMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD--SDW--GARIADFGLL 631 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~--~~ki~DFGla 631 (740)
|||||++|+|+..|.+.. ..|++.+.+.+..+++.||.|||+.+ |+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998643 35999999999999999999999999 99999999999993 333 4699999999
Q ss_pred ccccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch---
Q 040687 632 TSCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA--- 687 (740)
Q Consensus 632 ~~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 687 (740)
+..++ +..++..+|.|||||++||++||..||-....+.+..+.++..+.+..-..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 87654 245577899999999999999999999766666554444444333221111
Q ss_pred -------hcccccCCCCC----chhHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHhccC
Q 040687 688 -------IIDRNVALPRN----VEPLFKLADIAELAIRENPSELP--TMSQVATWLEQIVKDGLI 739 (740)
Q Consensus 688 -------i~d~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RP--t~~ev~~~Le~l~~~~~~ 739 (740)
.++....+|.+ ......+-..+..++..+|.+|- .+.+....+..+++...+
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv 316 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV 316 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence 11111122222 12234566788899999999998 888888888888776544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=267.64 Aligned_cols=231 Identities=22% Similarity=0.305 Sum_probs=188.2
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+++|+..++||+|.|+.||+... ..|+.+|+|.++...+.....+++.+|+.|-+.|+||||++|+....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45678888999999999999886 45899999999988887778889999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD---WGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DFGla~~~~~ 636 (740)
|+|.+++|..-+-.+ ...++...-..+.||+++|.|+|..+ |||||+||+|+||.+. --+|++|||+|..+..
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999998766433 34677788889999999999999999 9999999999999543 3489999999876543
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC-
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL- 695 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~- 695 (740)
...++..+|||+-||+||-|+.|..||.++.... .+ +.|+...+.+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-----ly--------e~I~~g~yd~~ 232 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LY--------EQIKAGAYDYP 232 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-----HH--------HHHhccccCCC
Confidence 2234568999999999999999999997543211 11 2233333333
Q ss_pred -CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 -PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 -~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
|......++..+|+++||..||.+|.|+.|.+.
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 334444456779999999999999999998875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=298.76 Aligned_cols=244 Identities=19% Similarity=0.220 Sum_probs=167.9
Q ss_pred HhhcCccccceecccCceEEEEEEEeC--CcEEEEEEe--------------ccc-ccchhcHHHHHHHHHHHHhCCCCC
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVD--GRQVAVKRA--------------NAA-TIIHTNIREFEMELEVLCNIRHSN 541 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAiK~l--------------~~~-~~~~~~~~~~~~E~~~l~~l~H~n 541 (740)
...++|+..++||+|+||+||++.++. +...++|.+ .+. .........|.+|+++|++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987643 222222211 000 001122356889999999999999
Q ss_pred cceEEeEEEeCCeEEEEEecCCCCChHHhHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 040687 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL 617 (740)
Q Consensus 542 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 617 (740)
|+++++++...+..|+|+|++. ++|.+++.... ......+...|+.||+.||+|||+.+ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 58888875432 12345667789999999999999998 9999999999999
Q ss_pred CCCCCEEEeecCCCccccCC----------------------CCCCcccceehhHHHHHHHHhCCCC-CCCCCCCchhHH
Q 040687 618 DSDWGARIADFGLLTSCERD----------------------LTTDMKSDVHNFGIVLLEILSGRKA-YDIEYVPPGIVE 674 (740)
Q Consensus 618 ~~~~~~ki~DFGla~~~~~~----------------------~~~~~ksDVwSfGvvl~ElltG~~p-~~~~~~~~~~~~ 674 (740)
+.++.+||+|||++...... ..++.++|||||||+||||++|+.+ +....... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~--~~ 378 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP--GK 378 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH--HH
Confidence 99999999999998654221 1235689999999999999998754 43221110 01
Q ss_pred hhhhHHhh-----C-------ccchhcccc-c-----CCC---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 675 WALPLIKQ-----G-------KAAAIIDRN-V-----ALP---RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 675 ~~~~~~~~-----~-------~~~~i~d~~-~-----~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.. . ++...++.. + ..+ ........+.+++.+||+.||++||++.|++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111100 0 000000000 0 000 00011235667899999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=275.87 Aligned_cols=238 Identities=17% Similarity=0.175 Sum_probs=168.8
Q ss_pred cCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhc---------HHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTN---------IREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
++|+..++||+|+||.||+|+..+ +..+|+|........... ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999754 345666653322110000 1122334455667799999999997
Q ss_pred EEeCC----eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEE
Q 040687 549 CLEMG----ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR 624 (740)
Q Consensus 549 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 624 (740)
+.... ..++++|++.. ++.+.+... ...++..+..|+.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 76543 34778887743 677666542 34678889999999999999999998 99999999999999999999
Q ss_pred EeecCCCccccC----------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh
Q 040687 625 IADFGLLTSCER----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 625 i~DFGla~~~~~----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 676 (740)
|+|||+++.... ...++.++||||||++||||++|+.||.............
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999864311 1123668999999999999999999997543222221111
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
. .+....+.......+. ....+.+++..||+.+|++||++.+|.+.|+
T Consensus 247 ~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 K----CDFIKRLHEGKIKIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H----HHHHHHhhhhhhccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 0111112222222222 2346889999999999999999999998763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=275.92 Aligned_cols=239 Identities=25% Similarity=0.326 Sum_probs=179.7
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
|+..+.||+|+||+||+|+..+ ++.|+||++...... .......+|+..+++++ |+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 5667889999999999999864 788999998764321 22234567999999999 99999999999999999999999
Q ss_pred CCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 562 MPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
+ +++|.+++.... ..+++.+++.++.|++++|.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9 889999997654 46899999999999999999999998 99999999999999999999999998754322
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH---------hhCccchhcc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI---------KQGKAAAIID 690 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~i~d 690 (740)
....+.++||||||+++|||++|+.||........+.. ....+ ........++
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK-ICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH-HHHhcCCCChhhhhhHhhhhcccc
Confidence 11135689999999999999999999965432111110 00000 0000000000
Q ss_pred cccCC--CC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RNVAL--PR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..... +. .......+.+++++||+.||++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 00 0011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=269.28 Aligned_cols=229 Identities=24% Similarity=0.340 Sum_probs=178.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccc---cchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAAT---IIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (740)
++|+..+.||+|+||.||+++.. +++.||+|.+.... ........|.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999974 48899999875421 1123446789999999999999999999998764 468
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++|+||+++++|.+++... ..+++...+.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999999754 35889999999999999999999998 9999999999999999999999999886432
Q ss_pred C------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 R------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ....+.++||||||+++|||++|+.||........ ... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~---------~~~~ 224 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----IFK---------IATQ 224 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----HHH---------HHcC
Confidence 1 01125689999999999999999999964321110 111 1111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+......+.+++.+||+ +|..||+..+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111122333467899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.04 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=184.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCe
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGE 554 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 554 (740)
+...+++|+..+.||+|+||.||++... +++.||||++..........+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999965 68899999886543333345678899999999999999999999876 457
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++|+||+ +++|.++++.. ++++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 89999999 56999988753 5788888999999999999999998 999999999999999999999999987543
Q ss_pred cC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH-----------HhhCc
Q 040687 635 ER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL-----------IKQGK 684 (740)
Q Consensus 635 ~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~-----------~~~~~ 684 (740)
.. ...++.++||||||+++|||+||+.||........+ ...... +....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred CCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhccchh
Confidence 21 023467899999999999999999999643211110 000000 00000
Q ss_pred cchhcc---cccCCCCC---chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 AAAIID---RNVALPRN---VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ~~~i~d---~~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+++. .....+.. .....++.+++++||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00011110 112357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=271.04 Aligned_cols=226 Identities=20% Similarity=0.245 Sum_probs=171.6
Q ss_pred ceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHH-hCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLC-NIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.||+|+||.||++... +++.||+|.+...... ......+..|..++. ..+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999974 4889999998754321 122334556655544 55899999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTP 157 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCc
Confidence 9999999754 46899999999999999999999998 99999999999999999999999998754221
Q ss_pred ---------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHH
Q 040687 637 ---------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707 (740)
Q Consensus 637 ---------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~ 707 (740)
...++.++||||||+++|||+||+.||...... . ....+...... ............+.+
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~------~~~~~~~~~~~~~~~ 226 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-A----VFDNILSRRIN------WPEEVKEFCSPEAVD 226 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-H----HHHHHHhcccC------CCCcccccCCHHHHH
Confidence 122467899999999999999999999643211 1 11111111110 011111123457889
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 040687 708 IAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 708 l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
++.+||+.+|++||++.++.+
T Consensus 227 ~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 227 LINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHccCCHHHccCCCcHHH
Confidence 999999999999997654444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.49 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=182.6
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|+..+.||+|.||.||+++..+ ++.||+|.+..........+.+.+|++++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999864 899999998875433334567889999999999999999999999999999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-----
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD----- 637 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~----- 637 (740)
+ ++|.+++......+++..++.++.|++++|+|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 8 5999999876457999999999999999999999998 999999999999999999999999987543211
Q ss_pred -----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh-----------hCc-cchh
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK-----------QGK-AAAI 688 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~-~~~i 688 (740)
...+.++||||||+++|||++|+.||..+.....+ ........ ... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL-FKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHHHhCCCcHHHHHhhccccccccc
Confidence 13356899999999999999999999654321111 11100000 000 0000
Q ss_pred cccccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNVAL---PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....... .........+.+++++||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000111346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=288.68 Aligned_cols=223 Identities=27% Similarity=0.416 Sum_probs=182.1
Q ss_pred eecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 489 ELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
+||+|.||+||-|++.+ ...+|||.+.... ....+-+..|+.+-++|+|+|||+++|.+.+.+.+-|.||.+|+|+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999999765 5678999887554 23345678899999999999999999999999999999999999999
Q ss_pred HHhHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEEEeecCCCccccC--------
Q 040687 568 HDHLHGGLSPL--NWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 568 ~~~l~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGla~~~~~-------- 636 (740)
.+.|+..-.++ .+.++--+..||++||.|||+.. |||||||-+|||++ -.+.+||+|||.++.+..
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99999887787 78888889999999999999999 99999999999996 578899999998765432
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...|...+|||||||++.||.||++||..-..+.. .+.+-+ +.. .-.|.+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkVG----myK--vHP~iPeel 804 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKVG----MYK--VHPPIPEEL 804 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhhc----cee--cCCCCcHHH
Confidence 12235689999999999999999999964433321 111111 111 223445555
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.++...+|.+|+.+||.+||++.+++.
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 667789999999999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=282.61 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=187.8
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----eEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-----ERL 556 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 556 (740)
+|...+.||+|+||.||+++... ++.||||++..........+.+.+|++++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788899999999999999754 889999998765432344567999999999999999999999988765 789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||++ ++|.+++.... ++++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 58999987653 7999999999999999999999998 99999999999999999999999998764322
Q ss_pred CC-------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-----------
Q 040687 637 DL-------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI----------- 680 (740)
Q Consensus 637 ~~-------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~----------- 680 (740)
.. ..+.++||||||+++|||++|+.||........+ .......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-NLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHhcCCCChhHhhhc
Confidence 11 3356899999999999999999999654321110 0000000
Q ss_pred hhCccchhcc---cccCCC---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 040687 681 KQGKAAAIID---RNVALP---RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKD 736 (740)
Q Consensus 681 ~~~~~~~i~d---~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~ 736 (740)
........+. .....+ ........+.+++++||+.+|++||++.+++. +|+++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000 000000 01112346789999999999999999999998 67766543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.99 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=181.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----e
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-----E 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 554 (740)
+++|+..++||+|+||.||+++.. +++.||||.+..... ......+.+|+.++++++|+||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 468999999999999999999864 588999999864321 233456889999999999999999999876543 5
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++|+||+++ +|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 7999999974 898888653 5899999999999999999999998 999999999999999999999999987543
Q ss_pred cC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccc
Q 040687 635 ER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAA 686 (740)
Q Consensus 635 ~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 686 (740)
.. ....+.++||||||+++|||++|+.||......... ......+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHH
Confidence 21 112356899999999999999999999643211111 000000000 0000
Q ss_pred hhcc-----------cccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 687 AIID-----------RNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 687 ~i~d-----------~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
.+.+ .....+. ......++.+++.+||+.+|++||++.|+++ +|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 0000000 0112346789999999999999999999997 45544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=273.27 Aligned_cols=223 Identities=24% Similarity=0.387 Sum_probs=177.1
Q ss_pred cceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 487 FNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
..+||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+|++++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 457999999999999874 58899999876433 233456899999999999999999999999999999999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------- 636 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------- 636 (740)
+|.+++... .+++.....++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 999988643 5899999999999999999999998 99999999999999999999999998653321
Q ss_pred ------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHH
Q 040687 637 ------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFK 704 (740)
Q Consensus 637 ------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~ 704 (740)
....+.++||||||+++|||++|+.||....... ....+... +..... ........
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-----~~~~~~~~-----~~~~~~--~~~~~~~~ 245 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDN-----LPPKLK--NLHKVSPS 245 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhh-----CCcccC--CcccCCHH
Confidence 1122568999999999999999999986432111 11111111 111111 11112336
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 705 LADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 705 l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.+++.+||+.+|.+||++.+++.
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=270.90 Aligned_cols=224 Identities=21% Similarity=0.246 Sum_probs=171.4
Q ss_pred eecccCceEEEEEEEe-CCcEEEEEEecccccchh-cHHHHHHHHH---HHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 489 ELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-NIREFEMELE---VLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
.||+|+||.||++... +++.||+|.+........ ....+.+|.. .++..+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999974 488999999876433211 1223444544 3445689999999999999999999999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-------
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------- 636 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------- 636 (740)
+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcC
Confidence 99999998754 46999999999999999999999988 99999999999999999999999998753321
Q ss_pred -------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHH
Q 040687 637 -------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703 (740)
Q Consensus 637 -------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~ 703 (740)
...++.++||||||+++|||++|+.||........ ....... .......+. ....
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~--------~~~~~~~~~--~~s~ 224 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMT--------LTMAVELPD--SFSP 224 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHh--------hccCCCCCC--cCCH
Confidence 11246789999999999999999999975321111 0000000 001111221 2234
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 704 KLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 704 ~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
++.+++.+|++.+|.+|| ++.++++
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 788999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=281.07 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=184.7
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----- 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 553 (740)
..++|+..+.||+|+||.||++... +++.||||++............+.+|+++|++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999864 5889999998654322233456889999999999999999999887543
Q ss_pred -eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 554 -ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 554 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999999 6799988864 35899999999999999999999998 9999999999999999999999999886
Q ss_pred cccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh----------hhHHhhC
Q 040687 633 SCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA----------LPLIKQG 683 (740)
Q Consensus 633 ~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~----------~~~~~~~ 683 (740)
..... ...+.++||||||+++|||++|+.||........+.+.. ...+...
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred ccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 43221 123568999999999999999999997432211111100 0000000
Q ss_pred ccchhcccccCCC------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 684 KAAAIIDRNVALP------RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 684 ~~~~i~d~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.....+....... ........+.+++.+|++.||++||++.+++. +++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0000000000000 01122335779999999999999999999995 666553
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=273.29 Aligned_cols=228 Identities=24% Similarity=0.349 Sum_probs=183.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 558 (740)
++|...+.||+|+||.||+++.. +++.||+|.+...... ....+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 5899999998764322 233467899999999998 99999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999764 46999999999999999999999998 999999999999999999999999987543211
Q ss_pred ----------------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh
Q 040687 638 ----------------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 638 ----------------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 677 (740)
...+.++||||||++++||++|+.||....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~- 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-----T- 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----H-
Confidence 112458999999999999999999997432100 0
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTM----SQVAT 728 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~ev~~ 728 (740)
...+.+.....+. .....+.+++++||+.+|++||++ +|++.
T Consensus 231 -------~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 -------FQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------HHHHHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0111112222222 223468899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=278.78 Aligned_cols=241 Identities=24% Similarity=0.281 Sum_probs=179.3
Q ss_pred cCccc-cceecccCceEEEEEEEe-CCcEEEEEEecccccchh------------cHHHHHHHHHHHHhCCCCCcceEEe
Q 040687 482 NGFKE-FNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT------------NIREFEMELEVLCNIRHSNIVNLLG 547 (740)
Q Consensus 482 ~~~~~-~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~------------~~~~~~~E~~~l~~l~H~niv~l~g 547 (740)
++|.. .+.||+|+||.||++... +++.||||.+........ ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 467999999999999975 588999998865432210 0125789999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
++...+..++||||++ ++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 6999998653 46899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccC------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCch
Q 040687 628 FGLLTSCER------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG 671 (740)
Q Consensus 628 FGla~~~~~------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 671 (740)
||++..... ....+.++||||||+++|||+||+.||........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998764330 01235689999999999999999999975432211
Q ss_pred hHHhhhhHHhhCc---cchhcc-----c-ccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 672 IVEWALPLIKQGK---AAAIID-----R-NVALPR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 672 ~~~~~~~~~~~~~---~~~i~d-----~-~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+ ..+........ .....+ + ....+. ......++.+++.+||+.+|++||+++|++.
T Consensus 243 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 L-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 11111110000 000000 0 000000 0112346789999999999999999999986
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=266.67 Aligned_cols=230 Identities=20% Similarity=0.222 Sum_probs=173.5
Q ss_pred HHHHhhcCcccccee--cccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 476 ELKDATNGFKEFNEL--GRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 476 ~l~~~~~~~~~~~~L--G~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
+.....++|+..+.+ |+|+||.||+++.. +++.+|+|.+...... .. |+.....+ +||||+++++.+..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-----~~--e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-----AI--EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-----hh--hHHHHHHhhcCCCEEEEEEEEec
Confidence 334444566666666 99999999999964 5788999988654321 11 22222222 79999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGL 630 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGl 630 (740)
.+..++||||+++++|.+++.... .+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999997653 7999999999999999999999998 99999999999999998 999999998
Q ss_pred CccccC-----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc-hhHHhhhhHHhhCccchhcccc
Q 040687 631 LTSCER-----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP-GIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 631 a~~~~~-----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
+..... ...++.++||||||+++|||++|+.||....... .... +.. .....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~-----~~~~~ 226 (267)
T PHA03390 157 CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES-----LLK-----RQQKK 226 (267)
T ss_pred ceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH-----HHH-----hhccc
Confidence 754321 1233668999999999999999999997432211 1111 100 00111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPT-MSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 728 (740)
...+ ......+.+++.+||+.+|.+||+ ++|+++
T Consensus 227 ~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 LPFI--KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCcc--cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111 123346789999999999999995 688875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=281.72 Aligned_cols=246 Identities=23% Similarity=0.362 Sum_probs=184.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe----
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE---- 554 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 554 (740)
..++|+..+.||+|+||.||+++.. +++.||||++............+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999985 47899999987543323344667889999999999999999988766554
Q ss_pred --EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 555 --RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 555 --~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
.++|+||+ +++|.+++.. ..+++..+..++.|++++|+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 5699999875 36999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-----------hh
Q 040687 633 SCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI-----------KQ 682 (740)
Q Consensus 633 ~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~-----------~~ 682 (740)
..... ...+.++||||||+++|||+||+.||........+ ....... ..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 167 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL-KRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCHHHHhhccc
Confidence 54221 12357899999999999999999999643221111 1000000 00
Q ss_pred CccchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 683 GKAAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 683 ~~~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
......+........ ......++.+++.+||+.||++|||+.||+. ++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 000000000000000 0112347889999999999999999999986 4544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=273.42 Aligned_cols=245 Identities=24% Similarity=0.317 Sum_probs=179.1
Q ss_pred CccccceecccCceEEEEEEEe-C--CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC----Ce
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-D--GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM----GE 554 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~--g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 554 (740)
+|+..+.||+|+||.||+++.. . +..||||++..........+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999974 3 67899999875432233356788999999999 599999999976432 35
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999986 6999998654 46899999999999999999999998 999999999999999999999999987532
Q ss_pred cC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH---------
Q 040687 635 ER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL--------- 679 (740)
Q Consensus 635 ~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~--------- 679 (740)
.. ....+.++||||||+++|||++|+.||....... ........
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 11 0123568999999999999999999996533211 11111100
Q ss_pred --HhhCccchhccc-----ccCCC-CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 680 --IKQGKAAAIIDR-----NVALP-RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 680 --~~~~~~~~i~d~-----~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
+........+.. ....+ ........+.+++.+||+.||++||++.|++. +|.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000000000000 00000 01112346889999999999999999999986 55544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=298.93 Aligned_cols=232 Identities=25% Similarity=0.373 Sum_probs=174.8
Q ss_pred HHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC----
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM---- 552 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---- 552 (740)
..-.++|++.+.||+|+||.|||++. -||+.+|||++.... +.+..+.+.+|+.+|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 34556799999999999999999996 489999999998776 556667899999999999999999997654210
Q ss_pred --------------------------------------------------------------------------------
Q 040687 553 -------------------------------------------------------------------------------- 552 (740)
Q Consensus 553 -------------------------------------------------------------------------------- 552 (740)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 040687 553 -----------------------------------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597 (740)
Q Consensus 553 -----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yL 597 (740)
..+||-||||+.-+|+++++.+...-.-...++++.+|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 013677899988778888776532224677889999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc---C-------------------------------------C
Q 040687 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE---R-------------------------------------D 637 (740)
Q Consensus 598 H~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~---~-------------------------------------~ 637 (740)
|+++ ||||||||.||+||++..+||+|||+|.... . .
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999987521 0 0
Q ss_pred --CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC--CCchhHHHHHHHHHHhh
Q 040687 638 --LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP--RNVEPLFKLADIAELAI 713 (740)
Q Consensus 638 --~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~--~~~~~~~~l~~l~~~Cl 713 (740)
..++.|+|+||+||||+||+. ||...-+.. .++..++ +..++.+ ...+....-+.+|++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa----~iL~~LR--------~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA----SILTNLR--------KGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHH----HHHHhcc--------cCCCCCCcccccccchHHHHHHHHHh
Confidence 135679999999999999995 464221100 0111111 2222222 11222234458999999
Q ss_pred hcCCCCCCCHHHHHH
Q 040687 714 RENPSELPTMSQVAT 728 (740)
Q Consensus 714 ~~dP~~RPt~~ev~~ 728 (740)
+.||++|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999885
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=255.92 Aligned_cols=230 Identities=23% Similarity=0.364 Sum_probs=178.8
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++.+..||.|..|.|++.+.+. |...|||.+....- +++.+.++..+.++.+- +.|+||+-+|||..+...++-||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3445579999999999999755 88999999987543 34456677777777655 489999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
|. ..+..+|+.-..++++..+-++...+.+||.||.++. .|||||+||+|||+|+.+++|++|||++-.+.+
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 94 4677777766678999999999999999999998754 399999999999999999999999998643221
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...|+.++||||||+.|+||.||+.||.....+-.. +..+.+++ ...++..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----ltkvln~e-------PP~L~~~ 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----LTKVLNEE-------PPLLPGH 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----HHHHHhcC-------CCCCCcc
Confidence 234577899999999999999999999865433222 11221111 1222333
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+.+++..||++|+.+||...++++
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 334457789999999999999999887764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=261.32 Aligned_cols=217 Identities=27% Similarity=0.354 Sum_probs=175.5
Q ss_pred ecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
||+|+||.||++... +++.+++|.+....... .....+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 48899999987654322 2456789999999999999999999999999999999999999999
Q ss_pred HHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----------
Q 040687 568 HDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---------- 637 (740)
Q Consensus 568 ~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---------- 637 (740)
.+++... ..+++..+..++.|++++|.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 9999765 36899999999999999999999988 999999999999999999999999987543221
Q ss_pred -----------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHH
Q 040687 638 -----------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLA 706 (740)
Q Consensus 638 -----------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~ 706 (740)
...+.++|+||||+++|||++|+.||..... ... .. .+.......+.. ....+.
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~----~~--------~~~~~~~~~~~~--~~~~l~ 221 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEI----YE--------KILKDPLRFPEF--LSPEAR 221 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHH----HH--------HHhcCCCCCCCC--CCHHHH
Confidence 1124689999999999999999999964331 111 11 111112222222 234778
Q ss_pred HHHHHhhhcCCCCCCCHHH
Q 040687 707 DIAELAIRENPSELPTMSQ 725 (740)
Q Consensus 707 ~l~~~Cl~~dP~~RPt~~e 725 (740)
+++++||..||++||++++
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=264.60 Aligned_cols=228 Identities=22% Similarity=0.288 Sum_probs=174.5
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccc---cchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAAT---IIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
+|...++||+|+||.||+++... +..+++|.++... .......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998754 4445566554322 2222334677899999999999999999999998899999
Q ss_pred EecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
|||+++++|.+++.. ....+++.+++.++.|+++||.|||+.+ ++|+||||+||++++ ..+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 2346899999999999999999999998 999999999999986 469999999875432
Q ss_pred C---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 636 R---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 636 ~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
. ....+.++||||||+++|||++|..||.... ..+.... +.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~-~~~~~---------~ 222 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLR-IVEGP---------T 222 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHH-HHcCC---------C
Confidence 1 1122558999999999999999999996322 1111111 11110 0
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.....++.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112233347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=274.27 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=177.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--------
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-------- 552 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 552 (740)
.+|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 67899999999999999999975 488999998865442 3456789999999999999999999776543
Q ss_pred ------CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEE
Q 040687 553 ------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARI 625 (740)
Q Consensus 553 ------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki 625 (740)
...++||||++ ++|.+++... .+++.....++.||++||.|||+.+ |+||||||+|||++. +..+||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 5999988653 5899999999999999999999998 999999999999974 567899
Q ss_pred eecCCCccccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh--h
Q 040687 626 ADFGLLTSCER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL--P 678 (740)
Q Consensus 626 ~DFGla~~~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~--~ 678 (740)
+|||++..... ....+.++||||||+++|||++|+.||.............. +
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99998754211 11235689999999999999999999964322111110000 0
Q ss_pred HHhh---Cc----cchhcc---cccCCC---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 679 LIKQ---GK----AAAIID---RNVALP---RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 679 ~~~~---~~----~~~i~d---~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
.... .. ...... .....+ .......++.+++.+||+.||++||++.|++. +|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 0000 00 000000 000000 00112346779999999999999999999985 554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=277.63 Aligned_cols=229 Identities=26% Similarity=0.365 Sum_probs=182.9
Q ss_pred CccccceecccCceEEEEEEEeCCc-EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGR-QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~-~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.+.++-.||.|+||.|||++.++.. ..|-|.+.... .....+|+-|++||+..+||+||+|++.+...+.+||+.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3556667999999999999976533 44666665433 45677899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc------
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE------ 635 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~------ 635 (740)
|.+|.....+-.-...|+..++..++.|++.+|.|||++. |||||||+.|||++-+|.++|+|||.+....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 9999999888766678999999999999999999999999 9999999999999999999999999864221
Q ss_pred --------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 636 --------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 636 --------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
.+..|+.|+||||||++|.||..+.+|-..- +... ++-.+...+.. . +
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel----npMR-VllKiaKSePP-----T--L 255 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMR-VLLKIAKSEPP-----T--L 255 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----chHH-HHHHHhhcCCC-----c--c
Confidence 1455688999999999999999999997522 1111 11122111111 1 1
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
-.+......+.+++.+||..||..||++.++++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 122334446779999999999999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=264.93 Aligned_cols=236 Identities=25% Similarity=0.310 Sum_probs=183.4
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhc-----HHHHHHHHHHHHhCCCCCcceEEeEEE-eCCe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTN-----IREFEMELEVLCNIRHSNIVNLLGYCL-EMGE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~ 554 (740)
++|-.++.||+|+|..|||+.+ ...+.||+|+-......... .+...+|..|-+.|+||.||++++|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5677788899999999999995 45889999986544322221 233567899999999999999999986 4567
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGLL 631 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGla 631 (740)
++-|+||+++.+|.-||+.+ +.++++++..|+.||+.+|.||.+. .|||||-||||.||||.+ .+.+||.||||+
T Consensus 543 FCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 88999999999999999865 4689999999999999999999987 488999999999999954 578999999999
Q ss_pred ccccCCC--------------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH
Q 040687 632 TSCERDL--------------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL 679 (740)
Q Consensus 632 ~~~~~~~--------------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~ 679 (740)
+.++.+. ..+.|+||||.|||+|..+.|++||..+.....+.+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq----- 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ----- 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-----
Confidence 8765421 125699999999999999999999975543333222
Q ss_pred HhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 680 IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 680 ~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.. ...+.+|..+....+...+|++||+..-++|.+..++..
T Consensus 696 --eNTIlk--AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 --ENTILK--ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --hhchhc--ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111 122344444444446668999999999999998887764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-31 Score=256.67 Aligned_cols=233 Identities=25% Similarity=0.412 Sum_probs=175.3
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHH-hCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLC-NIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+++.+..||.|+||+|+|-..+. |+..|||+++.... +...++++.|.+... .-+.||||+++|.+..++.-||-||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 44556689999999999998754 89999999987665 445578888887655 4578999999999999999999999
Q ss_pred cCCCCChHHhH---hC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc-
Q 040687 561 FMPRGTLHDHL---HG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE- 635 (740)
Q Consensus 561 y~~~gsL~~~l---~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~- 635 (740)
+|. -+|..+- .. ....+++..+-.|..-.++||.||.+.- .|||||+||+|||||..+.+||+|||++-.+.
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 4665443 21 2245888888889999999999997654 39999999999999999999999999853211
Q ss_pred --------------------C-CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 636 --------------------R-DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 636 --------------------~-~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
. ...++.+|||||+|++|||+.||+.||..-. ++.+..-... .++...+ .
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---svfeql~~Vv-~gdpp~l-----~ 291 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SVFEQLCQVV-IGDPPIL-----L 291 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---HHHHHHHHHH-cCCCCee-----c
Confidence 1 2236789999999999999999999996311 1222111111 1111111 1
Q ss_pred CCC-CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPR-NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+. ..+....+.+++..|+.+|-++||...++.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 2334557889999999999999999999876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=255.78 Aligned_cols=202 Identities=19% Similarity=0.240 Sum_probs=160.0
Q ss_pred cCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCChHHhH
Q 040687 493 GSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL 571 (740)
Q Consensus 493 G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l 571 (740)
|.|+.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+....++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999974 58899999986542 3345556666678999999999999999999999999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------------
Q 040687 572 HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--------------- 636 (740)
Q Consensus 572 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--------------- 636 (740)
... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++.....
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 754 35899999999999999999999998 99999999999999999999999997543221
Q ss_pred ---CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhh
Q 040687 637 ---DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAI 713 (740)
Q Consensus 637 ---~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl 713 (740)
....+.++||||||+++|||++|+.|+..... . + .. ......|. .....+.+++.+|+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~--------~-----~~--~~~~~~~~--~~~~~~~~li~~~l 213 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPS--G--------I-----NT--HTTLNIPE--WVSEEARSLLQQLL 213 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--h--------c-----cc--ccccCCcc--cCCHHHHHHHHHHc
Confidence 12235689999999999999999988752210 0 0 00 00111121 22346789999999
Q ss_pred hcCCCCCCCHH
Q 040687 714 RENPSELPTMS 724 (740)
Q Consensus 714 ~~dP~~RPt~~ 724 (740)
+.||++||++.
T Consensus 214 ~~dp~~R~~~~ 224 (237)
T cd05576 214 QFNPTERLGAG 224 (237)
T ss_pred cCCHHHhcCCC
Confidence 99999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=231.64 Aligned_cols=242 Identities=21% Similarity=0.275 Sum_probs=185.1
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+|...++||+|.||+|||++.++ ++.||+|+++.....+.-.....+|+-+|+.++|+|||+++++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677889999999999999654 78899999987664444456789999999999999999999999988899999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---- 637 (740)
+. -+|..|..+-+..++......++.|+++||.|+|++. +.||||||.|.||+.+++.|++|||+++.+.-.
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 95 4999998877778999999999999999999999999 999999999999999999999999998754321
Q ss_pred ------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhH--HhhCccc---hhccccc
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPL--IKQGKAA---AIIDRNV 693 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~--~~~~~~~---~i~d~~~ 693 (740)
.-+++..|+||-|+++.|+.. |++.|...+..+.+...+... ..++... .+.|...
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 123678899999999999998 777776655444433221111 1111111 1111111
Q ss_pred C--CCCCch---hH----HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 A--LPRNVE---PL----FKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~--~~~~~~---~~----~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. .|.... .. ..=.+|+++.+.-+|.+|.++++.++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1 111111 11 12237899999999999999988765
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.48 Aligned_cols=228 Identities=22% Similarity=0.274 Sum_probs=184.1
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.+.|+..++||+|+||.||-.+.++ |+.+|.|++.++.+.+. ...-.++|-.||.+++.+.||.|--.++.++.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3678999999999999999998754 89999999987765433 234478999999999999999999889999999999
Q ss_pred EecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 559 YEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
+..|.+|+|.-||.+.. ..+++..++-++.+|+-||++||+.. ||+|||||+|||||+.++++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999997654 45899999999999999999999999 99999999999999999999999999876543
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc-chhcccccCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA-AAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~i~d~~~~~~ 696 (740)
+..|+...|.||+||+||||+.|+.||....+. .+..++ +.++......+
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------vk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------VKREEVDRRTLEDPEEYS 410 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------hhHHHHHHHHhcchhhcc
Confidence 334677899999999999999999999643211 111111 11222222223
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
....++...|.+..|++||++|.-.
T Consensus 411 --~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 --DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --cccCHHHHHHHHHHHccCHHHhccC
Confidence 2333466789999999999999653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=272.71 Aligned_cols=239 Identities=21% Similarity=0.260 Sum_probs=167.7
Q ss_pred hhcCccccceecccCceEEEEEEE-----------------eCCcEEEEEEecccccchhcHH--------------HHH
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-----------------VDGRQVAVKRANAATIIHTNIR--------------EFE 528 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAiK~l~~~~~~~~~~~--------------~~~ 528 (740)
..++|+..++||+|+||.||+|.+ .+++.||||++..... ...+ .+.
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~--~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ--GVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch--hhHHHHHhhhhhhhcccchhH
Confidence 467899999999999999999974 2356799999865321 1112 244
Q ss_pred HHHHHHHhCCCCCc-----ceEEeEEEe--------CCeEEEEEecCCCCChHHhHhCCC--------------------
Q 040687 529 MELEVLCNIRHSNI-----VNLLGYCLE--------MGERLLVYEFMPRGTLHDHLHGGL-------------------- 575 (740)
Q Consensus 529 ~E~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~-------------------- 575 (740)
.|+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++|+...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888877654 778888764 356899999999999999987421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-----------C--
Q 040687 576 ---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-----------T-- 639 (740)
Q Consensus 576 ---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~-----------~-- 639 (740)
..++|..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 12467888999999999999999998 9999999999999999999999999985421100 0
Q ss_pred -------------------------------CCcccceehhHHHHHHHHhCCC-CCCCCC-CCchhHH--hhhhHHhhCc
Q 040687 640 -------------------------------TDMKSDVHNFGIVLLEILSGRK-AYDIEY-VPPGIVE--WALPLIKQGK 684 (740)
Q Consensus 640 -------------------------------~~~ksDVwSfGvvl~ElltG~~-p~~~~~-~~~~~~~--~~~~~~~~~~ 684 (740)
...+.||||+||+||||+++.. ||.... ....+.+ .....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~----- 452 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR----- 452 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH-----
Confidence 0124699999999999999875 664211 0001000 00000
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENP---SELPTMSQVAT 728 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~ev~~ 728 (740)
...+....+.++..........+|+.+++..+| .+|+|++|+++
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 011111122222222223466789999999766 68999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=272.51 Aligned_cols=220 Identities=23% Similarity=0.297 Sum_probs=176.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
++.|.....+|.|+|+.|-++... +++..++|++.... .+-.+|+.++.+. +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 567888888999999999999864 47889999987652 2334577666655 799999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-CCCCCEEEeecCCCccccCC
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL-DSDWGARIADFGLLTSCERD 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~ki~DFGla~~~~~~ 637 (740)
||++.++-|.+.+.... ....++..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++....+
T Consensus 395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999999887543 333778889999999999999999 9999999999999 59999999999998766543
Q ss_pred ------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC-CC
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP-RN 698 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~-~~ 698 (740)
..+|+.+|+||||++||||++|+.||..... + ..... ++..+ ..
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~--~--~ei~~-------------~i~~~~~s 532 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA--G--IEIHT-------------RIQMPKFS 532 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc--h--HHHHH-------------hhcCCccc
Confidence 3357899999999999999999999964321 1 01111 11111 12
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........+|+..||+.||.+||+|.++..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 233346679999999999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=250.62 Aligned_cols=180 Identities=26% Similarity=0.372 Sum_probs=151.1
Q ss_pred cCccccceecccCceEEEEEEEeC-----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 555 (740)
..|+....||+|.||.|||+.-.+ ...+|||+++.......-.....+|+.+++.|+||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888899999999999996432 3379999998663211112456889999999999999999999887 6789
Q ss_pred EEEEecCCCCChHHhHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC----CCEEEee
Q 040687 556 LLVYEFMPRGTLHDHLHGGL----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD----WGARIAD 627 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~ki~D 627 (740)
+|++||.++ +|.+.++-+. ..++-..+.+|..||+.|+.|||+.- |+||||||.|||+..+ +.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 8988886432 45888999999999999999999999 9999999999999877 8999999
Q ss_pred cCCCccccCC-------------------------CCCCcccceehhHHHHHHHHhCCCCCCC
Q 040687 628 FGLLTSCERD-------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDI 665 (740)
Q Consensus 628 FGla~~~~~~-------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~ 665 (740)
||+++.+... ..+|.+.|||+.|||+.||+|-++.|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999876542 2347889999999999999998888864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=295.73 Aligned_cols=230 Identities=27% Similarity=0.396 Sum_probs=182.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+-++.....||.|.||.||-+... +|+..|+|.++......+..+.+.+|+.+|..|+|||+|+++|+..+++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345566678999999999999964 5888999988766544555677899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCCC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 639 (740)
|||++|+|.+.+... ...++.....+..|++.|++|||+++ ||||||||.||||+.++.+|..|||.|..+..+..
T Consensus 1314 EyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999754 23566666678899999999999999 99999999999999999999999999876543211
Q ss_pred ----------------------------CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-hhCccchhcc
Q 040687 640 ----------------------------TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI-KQGKAAAIID 690 (740)
Q Consensus 640 ----------------------------~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~i~d 690 (740)
..-+.||||+|||++||+||++||..-+. +|+.... ..+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V~~g------- 1457 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHVAAG------- 1457 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHHhcc-------
Confidence 01268999999999999999999964332 2333221 111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....|.. ...+=.+++.+||+.||++|.++.|+++
T Consensus 1458 h~Pq~P~~--ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 HKPQIPER--LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCCCchh--hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 12223332 2334558999999999999999887775
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=284.08 Aligned_cols=147 Identities=27% Similarity=0.408 Sum_probs=131.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|...++||+|+||.||++... +++.||||+++...... .....+.+|+.++..++||||++++.++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999986 58899999987543222 23456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
||+++++|.++++.. ..+++..++.|+.||+.||+|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999753 46889999999999999999999998 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=251.28 Aligned_cols=223 Identities=24% Similarity=0.319 Sum_probs=183.2
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|..+++||+|.||+|.+.+- ..++.+|||++++..+... ....-..|-++|+..+||.+..|--.+..++++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 47899999999999999999985 4589999999998766544 344467899999999999999988888888999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc---
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE--- 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~--- 635 (740)
|||..+|.|.-||... ..+++....-+-..|..||.|||+.. ||.||||.+|.|||.++.+||+||||+++-.
T Consensus 247 MeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999999999999754 45777777778999999999999998 9999999999999999999999999976432
Q ss_pred ------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 636 ------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 636 ------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
++..+...+|.|.+||+||||+.|+.||...+... ...-|+-..+++|.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-------------LFeLIl~ed~kFPr 389 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-------------LFELILMEDLKFPR 389 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-------------HHHHHHhhhccCCc
Confidence 23445678999999999999999999996433211 12233444566666
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCC
Q 040687 698 NVEPLFKLADIAELAIRENPSELPT 722 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt 722 (740)
.... +...|+...|.+||++|.-
T Consensus 390 ~ls~--eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 390 TLSP--EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred cCCH--HHHHHHHHHhhcChHhhcC
Confidence 5444 5568999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=246.87 Aligned_cols=218 Identities=28% Similarity=0.349 Sum_probs=175.0
Q ss_pred CceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCChHHhHh
Q 040687 494 SYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH 572 (740)
Q Consensus 494 ~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~ 572 (740)
+||.||+++..+ ++.+++|++........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999864 89999999876543221 5789999999999999999999999999999999999999999999997
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC---------------
Q 040687 573 GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--------------- 637 (740)
Q Consensus 573 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~--------------- 637 (740)
... .+++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 643 3899999999999999999999998 999999999999999999999999997654331
Q ss_pred -----CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch-hHHHHHHHHHH
Q 040687 638 -----LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE-PLFKLADIAEL 711 (740)
Q Consensus 638 -----~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~-~~~~l~~l~~~ 711 (740)
...+.++||||||++++||++|+.||........+. ..+.. .......... ...++.+++.+
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~----~~~~~--------~~~~~~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF----KKIGK--------PKPPFPPPEWKISPEAKDLIRK 223 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH----HHHhc--------cCCCCccccccCCHHHHHHHHH
Confidence 223568999999999999999999996532211111 11111 1111111110 33578899999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 040687 712 AIRENPSELPTMSQVAT 728 (740)
Q Consensus 712 Cl~~dP~~RPt~~ev~~ 728 (740)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=249.02 Aligned_cols=235 Identities=23% Similarity=0.305 Sum_probs=183.1
Q ss_pred ceecccCceEEEEEE-EeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~-~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
+.||+|+|+.|--++ +..+.++|||++.+.. -..+....+|++++.+. .|+||+.|+.++++++.+|||||-|.+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 359999999999888 4679999999987653 23456789999999988 5999999999999999999999999999
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC---EEEeecCCCcccc-------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG---ARIADFGLLTSCE------- 635 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DFGla~~~~------- 635 (740)
.|..+|+++ .-+++.++.++..+||.||.|||.++ |.||||||+|||-.+... +||+||.|..-..
T Consensus 162 plLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 162 PLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred hHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999999865 46899999999999999999999999 999999999999976654 8999998753211
Q ss_pred --------------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc-hhHH-hhhhHHhhCccch
Q 040687 636 --------------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP-GIVE-WALPLIKQGKAAA 687 (740)
Q Consensus 636 --------------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~-~~~~-~~~~~~~~~~~~~ 687 (740)
+...|+.+.|.||+|||||-|++|..||...-... +-.+ .+-+.-.+..++.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 12234678999999999999999999997532111 0000 0001111222344
Q ss_pred hcccccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 688 IIDRNVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 688 i~d~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
|-+..+.+|. +.....+..+++...+..|+.+|.++.+++.
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 4455555554 2333446678999999999999999999886
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-30 Score=250.39 Aligned_cols=239 Identities=22% Similarity=0.317 Sum_probs=179.5
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--------C
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--------G 553 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 553 (740)
.|....+||+|.||+||+++..+ ++.||+|+.-.+...........+|+.+|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 46667789999999999999754 78889987544322122234568899999999999999999888542 3
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.+|||++++++ +|.-.|.+....++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 48999999987 999999887778999999999999999999999998 99999999999999999999999999965
Q ss_pred ccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhH--H--------hhh
Q 040687 634 CER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIV--E--------WAL 677 (740)
Q Consensus 634 ~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~--~--------~~~ 677 (740)
+.. +..++.+.|||.-||+|.||+|+.+.++.+.+...+. . .++
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 432 2234678999999999999999999887654433221 1 111
Q ss_pred hHHhhCccchhc-------------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 678 PLIKQGKAAAII-------------DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 678 ~~~~~~~~~~i~-------------d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+....-.+.+-+ ..+.+ |.-. ..+..+|+..++..||.+||+..+++.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~k-p~~k--d~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLK-PYVK--DDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcc-cccC--ChhHHHHHHHHhccCcccCcchHhhhc
Confidence 111111111111 11111 1111 114568999999999999999998875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=275.54 Aligned_cols=234 Identities=19% Similarity=0.212 Sum_probs=152.3
Q ss_pred hhcCccccceecccCceEEEEEEEeC-----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeE------
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY------ 548 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------ 548 (740)
..++|...++||+|+||.||+|++.+ +..||||++.... ....+.+| .+.+..+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 45789999999999999999999754 6899999876432 11112222 1222223333222211
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPL-------------------NWSLRLKISMQAAKGLEYLHKDAAPPIIHRD 609 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l-------------------~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrD 609 (740)
.......+|||||+++++|.++++....+. ....+..++.||++||+|||+.+ |+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence 234567899999999999999987543111 12345579999999999999998 99999
Q ss_pred CCCCCEEECC-CCCEEEeecCCCccccCC--------------------------------------------CCCCccc
Q 040687 610 VKTLNILLDS-DWGARIADFGLLTSCERD--------------------------------------------LTTDMKS 644 (740)
Q Consensus 610 lk~~NILl~~-~~~~ki~DFGla~~~~~~--------------------------------------------~~~~~ks 644 (740)
|||+|||+++ ++.+||+|||+++..... ..++.|+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 578999999998643210 0112356
Q ss_pred ceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc-----cchhcccccCCC------CCchhHHHHHHHHHHhh
Q 040687 645 DVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK-----AAAIIDRNVALP------RNVEPLFKLADIAELAI 713 (740)
Q Consensus 645 DVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~i~d~~~~~~------~~~~~~~~l~~l~~~Cl 713 (740)
|||||||+||||+++..+++.+ +.. ....+.... ....+....... ..........+|+.+||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~-----~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN-----LIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH-----HHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999987765421 111 001111000 001111110000 00000113458999999
Q ss_pred hcCCCCCCCHHHHHH
Q 040687 714 RENPSELPTMSQVAT 728 (740)
Q Consensus 714 ~~dP~~RPt~~ev~~ 728 (740)
+.||++|||++|+++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999987
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=244.16 Aligned_cols=229 Identities=21% Similarity=0.268 Sum_probs=178.6
Q ss_pred hcCcccc-ceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeC----C
Q 040687 481 TNGFKEF-NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEM----G 553 (740)
Q Consensus 481 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~ 553 (740)
+++|+.. ++||-|-.|.|-....+ .++.+|+|.+... ....+|+++--.. .|||||+++++++.. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4445433 46999999999988864 4889999988643 3446677764444 699999999998653 4
Q ss_pred eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecC
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFG 629 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFG 629 (740)
.+++|||.|++|.|+..+.++. ..++++++-.|+.||..|+.|||+.. |.||||||+|+|... +-.+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6789999999999999997654 46999999999999999999999999 999999999999964 4568999999
Q ss_pred CCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 630 LLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 630 la~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
+|+...+ ..+++...|+||+||+||-|+.|..||..+.. . .+..+...+|.
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~--------aispgMk~rI~ 280 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-L--------AISPGMKRRIR 280 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-c--------cCChhHHhHhh
Confidence 9987553 12345678999999999999999999964321 1 11222333444
Q ss_pred ccccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 DRNVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 d~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.+|. +....+...++|+..|+.+|.+|.|+.|+..
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 55555554 3444556778999999999999999999886
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=281.75 Aligned_cols=238 Identities=21% Similarity=0.277 Sum_probs=192.3
Q ss_pred ChhHHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEE
Q 040687 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCL 550 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (740)
...++....++|...+.||+|+||.|..++.+. ++.+|+|++++-.+.+. ...-|..|-.+|..-+.+-|+.|+-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 456777778999999999999999999999865 78899999987544432 3345788889999889999999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
+..++|||||||+||+|...|.+.. +++...+.-++..|+.||.-||+.+ +|||||||+|||||..|++||+|||.
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999999998664 7888888889999999999999999 99999999999999999999999997
Q ss_pred CccccC--------------------------C-CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC
Q 040687 631 LTSCER--------------------------D-LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG 683 (740)
Q Consensus 631 a~~~~~--------------------------~-~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 683 (740)
+..+.. + ..|...+|.||+||++|||+.|..||..+ ++++.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveT-------- 289 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVET-------- 289 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHH--------
Confidence 654432 1 34567899999999999999999999632 23332
Q ss_pred ccchhccc--ccCCCCCchhHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 040687 684 KAAAIIDR--NVALPRNVEPLFKLADIAELAIRENPSELPT---MSQVAT 728 (740)
Q Consensus 684 ~~~~i~d~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 728 (740)
...|++. .+.+|...+..++..+||++.+. +|+.|.. +++|-.
T Consensus 290 -Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 290 -YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 2223332 45566555566677889988775 5666766 777754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=253.71 Aligned_cols=223 Identities=26% Similarity=0.343 Sum_probs=180.7
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHH-HHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIRE-FEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~-~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
..+|+.+.+||+|+||.|.++..+. .+.+|||++++..+.+.+.-+ -+.|-++|+-. +-|.+++|+.++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3468889999999999999998654 567999999988766554222 45677777765 57889999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+.+|+|..+++.- ..+.+..+.-+|.+||-||-|||+++ ||+||||.+|||||.++.+||+|||++++..-
T Consensus 428 VMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999999999743 46778888899999999999999999 99999999999999999999999999875322
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...|...+|.|||||+||||+.|+.||+.++++. ....|.+..+..|
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------------lF~aI~ehnvsyP 570 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------------LFQAIMEHNVSYP 570 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------------HHHHHHHccCcCc
Confidence 2234568899999999999999999998765322 2344555666666
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCC
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPT 722 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt 722 (740)
..... +...|.+..+...|.+|.-
T Consensus 571 KslSk--EAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 571 KSLSK--EAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccccH--HHHHHHHHHhhcCCccccC
Confidence 54333 5567888999999999843
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=255.43 Aligned_cols=223 Identities=22% Similarity=0.286 Sum_probs=181.3
Q ss_pred cceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 487 FNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
.+.||+|.||+||-|+.+ .|+.||||.+.+..+..+....+.+|+.||++++||.||.|--.|+..+..+.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 367999999999999974 5999999999988887777788999999999999999999999999999999999999 56
Q ss_pred ChHHhH-hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CCEEEeecCCCccccC-----
Q 040687 566 TLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD---WGARIADFGLLTSCER----- 636 (740)
Q Consensus 566 sL~~~l-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DFGla~~~~~----- 636 (740)
++.+.+ ......|+.....-+..||+.||.|||.++ |+|.||||+||||.+. -++||+|||+|+...+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 777665 444567999888889999999999999999 9999999999999653 4699999999987654
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC--CCc
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP--RNV 699 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~--~~~ 699 (740)
+..++..-|+||.||++|--++|..||..+.+ +.+ +|-+.....| .+.
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---Ind------------QIQNAaFMyPp~PW~ 789 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---IND------------QIQNAAFMYPPNPWS 789 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhH------------HhhccccccCCCchh
Confidence 23346678999999999999999999964321 111 1111112122 233
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+......+||...|+..-.+|-+.++-+.
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 44456779999999999999999887664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=244.17 Aligned_cols=239 Identities=20% Similarity=0.264 Sum_probs=182.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCC--CC----cceEEeEEEeCC
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SN----IVNLLGYCLEMG 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~g~~~~~~ 553 (740)
+++|.....+|+|.||.|-...... +..||||+++... ...++-+-|+++|.+|.+ |+ +|.+.+++.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 6789999999999999999998754 6899999987543 334556789999999943 33 788888899999
Q ss_pred eEEEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-------------
Q 040687 554 ERLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS------------- 619 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~------------- 619 (740)
+.+||+|.| +-++.|+|.++ ..+++...+..|+.|+.++++|||+.. ++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999 56999999874 467899999999999999999999999 999999999999943
Q ss_pred -------CCCEEEeecCCCccccCCC------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHH
Q 040687 620 -------DWGARIADFGLLTSCERDL------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVE 674 (740)
Q Consensus 620 -------~~~~ki~DFGla~~~~~~~------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 674 (740)
+..+||+|||-|+...+.. ..+.++||||+||||.||.||...|+..+..+.+..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 3358999999987654432 236799999999999999999999986553333211
Q ss_pred hhhhHHhhCccch-----------------------------hccccc----CCCCCchhHHHHHHHHHHhhhcCCCCCC
Q 040687 675 WALPLIKQGKAAA-----------------------------IIDRNV----ALPRNVEPLFKLADIAELAIRENPSELP 721 (740)
Q Consensus 675 ~~~~~~~~~~~~~-----------------------------i~d~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 721 (740)
...+-+..... +.+... .+.....+..+|++|+++||..||.+|+
T Consensus 321 --MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 321 --MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred --HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 01110000000 000000 0112234556899999999999999999
Q ss_pred CHHHHHH
Q 040687 722 TMSQVAT 728 (740)
Q Consensus 722 t~~ev~~ 728 (740)
|+.|++.
T Consensus 399 Tl~EAL~ 405 (415)
T KOG0671|consen 399 TLREALS 405 (415)
T ss_pred cHHHHhc
Confidence 9999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=259.75 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=194.5
Q ss_pred ccChhHHHHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeE
Q 040687 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGY 548 (740)
Q Consensus 471 ~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 548 (740)
...++.+...++.|++.+.||+|.+|.||+++. ++++.+|+|++.... ....+...|.++|+.. +|||++.++|+
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345666777888899999999999999999995 458889999887653 3346778899999887 79999999999
Q ss_pred EEeC-----CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 549 CLEM-----GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 549 ~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
+... +++|||||||.+|+.-|++++-. ..+.|..+..|+..+++||.+||... +||||||=.||||+.++.
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCc
Confidence 9753 58999999999999999997643 45899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh
Q 040687 623 ARIADFGLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 623 ~ki~DFGla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 676 (740)
+|+.|||++..+.. +.+++..+|+||+|++..||--|.+|+-+.-
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH--------- 232 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH--------- 232 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc---------
Confidence 99999998754432 3345678999999999999999999984221
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+. .-.+.-.-++...+-.+.....++.++|..||..|-.+||++.++++
T Consensus 233 -Pm--raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 -PM--RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hh--hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 00111111233333445667778999999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=221.31 Aligned_cols=188 Identities=28% Similarity=0.427 Sum_probs=154.4
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHh-CCCCCcceEEeEEEeC
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCN-IRHSNIVNLLGYCLEM 552 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~ 552 (740)
+.++.+.+.+.....||+|++|.|-+-++. +|...|+|+++...- .+..+...+|+.+..+ ...|.+|.|+|...+.
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 335566677777888999999999988874 589999999986543 3445678888887654 5799999999999999
Q ss_pred CeEEEEEecCCCCChHHhHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 553 GERLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
...++.||.|.- +|..+-+ .+...+++..+-+|+..+.+||.|||++-. +||||+||+||||+.++++||+|||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccc
Confidence 999999999954 7766543 233568888899999999999999999754 9999999999999999999999999
Q ss_pred CCccccC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 040687 630 LLTSCER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE 666 (740)
Q Consensus 630 la~~~~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~ 666 (740)
++-.+.+ +..|+.||||||+|+++.||.+++.||+.-
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 8632211 234678999999999999999999999743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=222.19 Aligned_cols=190 Identities=35% Similarity=0.531 Sum_probs=166.7
Q ss_pred ecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCChH
Q 040687 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLH 568 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 568 (740)
||+|.+|.||+++..+ ++.+++|++....... ..+.+.+|++.+++++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999865 8999999988654211 3467999999999999999999999999989999999999999999
Q ss_pred HhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccCC----------
Q 040687 569 DHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCERD---------- 637 (740)
Q Consensus 569 ~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~~---------- 637 (740)
+++......+++..+..++.+++++|+|||+.+ ++|+||+|.||+++. +..++|+||+.+......
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 999765456899999999999999999999998 999999999999999 899999999987644321
Q ss_pred -----------C-CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHH
Q 040687 638 -----------L-TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705 (740)
Q Consensus 638 -----------~-~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l 705 (740)
. ..+.++|+|++|++++|| ..+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~~~ 190 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------PEL 190 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------HHH
Confidence 1 335789999999999999 367
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 706 ADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 706 ~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
.+++..|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=233.08 Aligned_cols=241 Identities=20% Similarity=0.325 Sum_probs=177.1
Q ss_pred ccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----eEEE
Q 040687 484 FKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-----ERLL 557 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l 557 (740)
.+..+.||.|+||.||..++ ++|+.||+|++......-...+.+.+|+++|..++|.|++.+++...-.. +.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34456799999999999987 56999999998754433344577899999999999999999998765442 5688
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 637 (740)
|+|+|. .+|...+-+. .+++...+.-+..||++||+|||+.+ |.||||||.|.|++++...||+||||++..+.+
T Consensus 135 ~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 999995 4888887654 46888888889999999999999999 999999999999999999999999999865432
Q ss_pred -----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchh--HH--------hhhhHHhhCc
Q 040687 638 -----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGI--VE--------WALPLIKQGK 684 (740)
Q Consensus 638 -----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~--~~--------~~~~~~~~~~ 684 (740)
..++...||||.|+++.||+-.+..|+....-..+ +. ......-++-
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 23467899999999999999888888643221111 00 0111111122
Q ss_pred cchhcccccCCC---------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 685 AAAIIDRNVALP---------RNVEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 685 ~~~i~d~~~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
...++....+.| .......+-..+...++..||++|.+.++.+..
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 222332222222 112223355578888999999999998887653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=221.08 Aligned_cols=236 Identities=19% Similarity=0.304 Sum_probs=179.7
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCC--eEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMG--ERL 556 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 556 (740)
.++|+..+++|+|.|++||.|.. .+.++++||.+++.. .+.+.+|+.||..|. ||||++|++...++. .+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46799999999999999999994 567899999998643 367899999999997 999999999987764 467
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCCCcccc
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGLLTSCE 635 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGla~~~~ 635 (740)
||+||+.+-+....- ..|+-.++..++.++++||.|+|+.+ |.|||+||.|++||.. -..+|+|+|||....
T Consensus 112 LiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999999998876654 24777788889999999999999999 9999999999999965 468999999998766
Q ss_pred CCCC---------------------CCcccceehhHHHHHHHHhCCCCCCC-CCCCchhHHhhhh--------HHh----
Q 040687 636 RDLT---------------------TDMKSDVHNFGIVLLEILSGRKAYDI-EYVPPGIVEWALP--------LIK---- 681 (740)
Q Consensus 636 ~~~~---------------------~~~ksDVwSfGvvl~ElltG~~p~~~-~~~~~~~~~~~~~--------~~~---- 681 (740)
.... ++..-|+|||||+|.+|+..+.||.. ....+.++..+.- .+.
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 5332 35578999999999999999999853 3333444432211 110
Q ss_pred --hCccchhcccccCC-------CCCch-hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 682 --QGKAAAIIDRNVAL-------PRNVE-PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 682 --~~~~~~i~d~~~~~-------~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+...++....+. +.... ...+..+++.+.|+.|-.+|||++|...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111222221111 11111 1246789999999999999999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=230.18 Aligned_cols=228 Identities=21% Similarity=0.328 Sum_probs=185.0
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhc-HHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN-IREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~-~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
.++|.++++||+|+|.+|.+++++. .+.+|+|+++++...... ..=...|-.++.+- +||.+|.|+.++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3679999999999999999999854 678999999877554332 22245677777765 79999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
|.||+++|+|.-++... ..|++..+.-+...|..+|.|||+.+ ||.||||.+|+|||.++.+|+.|+|++++...
T Consensus 329 vieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999999888754 46889998889999999999999999 99999999999999999999999999875432
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC---CCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE---YVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~---~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...|...+|.|++||+|+||+.|+.||+.- ..+.+..++. ++-|+++.+
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl--------fqvilekqi 476 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL--------FQVILEKQI 476 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH--------HHHHhhhcc
Confidence 223456899999999999999999999852 2233333332 234566777
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCC
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPT 722 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 722 (740)
+.|+.... +...+++.-|.+||++|.-
T Consensus 477 riprslsv--kas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 RIPRSLSV--KASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccceeeh--hhHHHHHHhhcCCcHHhcC
Confidence 88876654 4557899999999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=253.31 Aligned_cols=218 Identities=26% Similarity=0.343 Sum_probs=165.6
Q ss_pred ccccceecccCceE-EEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGF-VYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~-Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
|...+.+|.|+.|+ ||+|.. +++.||||++-.. ...-..+|+..|+.= +|||||++++...++...||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 55566789998874 699988 7789999998643 234557899999876 699999999999999999999999
Q ss_pred CCCCChHHhHhCCC-C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---C--CCEEEeecCCCcc
Q 040687 562 MPRGTLHDHLHGGL-S--PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---D--WGARIADFGLLTS 633 (740)
Q Consensus 562 ~~~gsL~~~l~~~~-~--~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~--~~~ki~DFGla~~ 633 (740)
|. -+|+|++.... . ...-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 95 59999998741 1 1111345678899999999999988 999999999999976 2 5699999999876
Q ss_pred ccCCC------------------------CCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 634 CERDL------------------------TTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 634 ~~~~~------------------------~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
...+. ..+..+||||+|||+|+.+| |+.||......+ ..|
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------------~NI 725 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------------ANI 725 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------------hhh
Confidence 64321 12457899999999999999 699997543211 011
Q ss_pred ccccc---CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNV---ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.... .+....++ +..+||.+|++++|..||++.+|+.
T Consensus 726 l~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 726 LTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111 11122222 5568999999999999999999974
|
|
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=228.41 Aligned_cols=259 Identities=17% Similarity=0.261 Sum_probs=196.2
Q ss_pred eEEEccCCCCCCCCCCCCCCC-CccccCC-------CceEEeccCCeEeEEecCCCceEeccCCCC--CCCCc-------
Q 040687 24 DVICWAKNSSSPSSSFLSANS-ASFSNIP-------SMAVLSGGEGLLCGILANTSQAFCWSSNSS--PGNTT------- 86 (740)
Q Consensus 24 ~v~cwg~n~~gqlg~~~~~~~-~~~~~v~-------~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~--~g~g~------- 86 (740)
.|+|||+|..+|||-|.-++. ..|...| .+..+++|..|+.+|..++. +|.||.|.. +|.-+
T Consensus 69 ~v~~~Gsn~~~eLGlg~de~~~~~P~~~~~~~~d~~~i~~~acGg~hsl~ld~Dg~-lyswG~N~~G~Lgr~~~~~~~~~ 147 (476)
T COG5184 69 SVYSWGSNGMNELGLGNDETKVDRPQLNPFGRIDKASIIKIACGGNHSLGLDHDGN-LYSWGDNDDGALGRDIHKDICDQ 147 (476)
T ss_pred eeEEEecCcceeeccCCchhcccCceecCcccccceeeEEeecCCceEEeecCCCC-EEEeccCcccccccccccccccc
Confidence 789999999999996654433 5555553 34689999999999988854 999999976 22222
Q ss_pred ------------cccc-cccc------CCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccc--
Q 040687 87 ------------DLVP-SVYK------NTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLF-- 145 (740)
Q Consensus 87 ------------~~~~-~~~~------~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~-- 145 (740)
...| .+.. ...+++|++|+.+++++. .+|.||-| |.+-.+.++.+..
T Consensus 148 ~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~cg~e~svil~-------~~G~V~~~-----gt~r~~e~~~g~~~~ 215 (476)
T COG5184 148 NNDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLACGWEISVILT-------ADGRVYSW-----GTFRCGELGQGSYKN 215 (476)
T ss_pred cccccccchhhcccCCceeeccccccCChheEEeecCCceEEEEc-------cCCcEEEe-----cCccccccccccccc
Confidence 1234 2222 126999999999999999 89999999 6655455554411
Q ss_pred --------cccccceeeEEEEEecCCeeeeeeeCCeEEEecCCCCCC---------------CccCCCCcEEEEeeCCce
Q 040687 146 --------YDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDSESL---------------GVFNVTESFKVLASGKSS 202 (740)
Q Consensus 146 --------~~~~~~~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~~---------------~~~~~~~~~~~iaaG~~h 202 (740)
.....|...+.++|+|.+|.-+|+.+|++|-||+|..+. +.......+..|++|.+|
T Consensus 216 s~k~~~~~~p~~v~~~~i~qla~G~dh~i~lt~~G~vy~~Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h 295 (476)
T COG5184 216 SQKTSIQFTPLKVPKKAIVQLAAGADHLIALTNEGKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDH 295 (476)
T ss_pred cccceeeeeeeecCchheeeeccCCceEEEEecCCcEEEecCCcccccCCchhhhcccccccCChhhhhhhhhcccCcce
Confidence 111222235899999999999999999999999997751 111112235679999999
Q ss_pred eeeeecCCCcEEEeecCCCCCCCCC-------------------cccEEEEecccceeeeeeecCCcEEecCCCCCCCCC
Q 040687 203 LCGISELSGEVKCWGNNDFVSVPPV-------------------GIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVP 263 (740)
Q Consensus 203 ~Cai~~~~g~v~CWG~n~~g~~~~~-------------------~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~ 263 (740)
+-|| +.+|.+++||-|.+||.... +..+.++++|+.|+-.|+ .||.++-||++..+|+.
T Consensus 296 ~~al-~~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~~~~~~i~~is~ge~H~l~L~-~~G~l~a~Gr~~~~qlg 373 (476)
T COG5184 296 SLAL-DEDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGVTICSISAGESHSLILR-KDGTLYAFGRGDRGQLG 373 (476)
T ss_pred EEEE-cCCCeEEEeccchhcccccCcccccceeeccccccccCCCceEEEEecCcceEEEEe-cCceEEEecCCcccccc
Confidence 9999 66999999999999993211 134789999999999999 89999999999999852
Q ss_pred CC----------------CceEEEEecCceeeEEEeCCceeecccccCCCC
Q 040687 264 KN----------------SGFMAIASSDFTTCGIRENDLVLDCWFANVSSP 298 (740)
Q Consensus 264 ~~----------------~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~ 298 (740)
.. ..|..+++|..|+-+.+ .+++|++||+|..++
T Consensus 374 ~~~~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~~t-~~gsvy~wG~ge~gn 423 (476)
T COG5184 374 IQEEITIDVSTPTKLSVAIKLEQVACGTHHNIART-DDGSVYSWGWGEHGN 423 (476)
T ss_pred CcccceeecCCccccccccceEEEEecCccceeec-cCCceEEecCchhhh
Confidence 22 24999999999999887 777999999986654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-27 Score=245.77 Aligned_cols=236 Identities=23% Similarity=0.312 Sum_probs=183.4
Q ss_pred cCccccceecccCceEEEEEEEeCCc-EEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGR-QVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~-~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.+++....||-|+||.|-+.+....+ .+|+|.+++.-+... +......|-.||...+.|.||+|+..+.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556667999999999999875543 489998887654433 3456889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL- 638 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~- 638 (740)
|-|-+|.|...|+.+ ..++..+..-++.-+++|++|||+++ ||+|||||+|.|||.++-+||.|||+|+......
T Consensus 500 EaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999999865 46777778888999999999999999 9999999999999999999999999998765432
Q ss_pred -------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 639 -------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 639 -------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
..+..+|.||+|+++|||+||++||...+ +.-....++.-+. .+.+|.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-pmktYn~ILkGid----------~i~~Pr-- 642 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-PMKTYNLILKGID----------KIEFPR-- 642 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-hHHHHHHHHhhhh----------hhhccc--
Confidence 23568999999999999999999997543 1111111111111 112222
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH--HHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPT-----MSQVAT--WLEQIV 734 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~--~Le~l~ 734 (740)
.......+|+++..+.+|.+|.- +.||-+ |++.+-
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 22224558999999999999976 566654 555443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=237.93 Aligned_cols=186 Identities=24% Similarity=0.334 Sum_probs=156.1
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
-+....-|..++.||-|+||+|-+++..| ...+|+|.|++...... +....+.|-.||..-+.+-||+|+-.|.+++.
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 33334568888899999999999999766 56789999987764433 34557889999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+|+||||+++|++..+|... .-+.+..+.-++.++.-++++.|..+ +|||||||+|||||.++.+||.||||+.-+
T Consensus 704 LYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999999998754 35777777778889999999999999 999999999999999999999999997532
Q ss_pred cC---------------------------------------------------------------CCCCCcccceehhHH
Q 040687 635 ER---------------------------------------------------------------DLTTDMKSDVHNFGI 651 (740)
Q Consensus 635 ~~---------------------------------------------------------------~~~~~~ksDVwSfGv 651 (740)
.. ...++..+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 10 001145689999999
Q ss_pred HHHHHHhCCCCCCCC
Q 040687 652 VLLEILSGRKAYDIE 666 (740)
Q Consensus 652 vl~ElltG~~p~~~~ 666 (740)
|||||+.|+.||..+
T Consensus 860 il~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLAD 874 (1034)
T ss_pred HHHHHhhCCCCccCC
Confidence 999999999999643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=217.17 Aligned_cols=178 Identities=33% Similarity=0.426 Sum_probs=155.0
Q ss_pred ccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
|+..+.||+|+++.||++...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4566789999999999999865 889999998865432 24568999999999999999999999999889999999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-----
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD----- 637 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~----- 637 (740)
++++|.+++......+++.....++.+++++|.|||+.+ ++|+||+|+||+++.+..++|+|||++......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 999999999865433899999999999999999999998 999999999999999999999999987654322
Q ss_pred ------------------CCCCcccceehhHHHHHHHHhCCCCCCC
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILSGRKAYDI 665 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~ 665 (740)
...+.++|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1124589999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=218.31 Aligned_cols=241 Identities=21% Similarity=0.324 Sum_probs=179.8
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeE-EEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGY-CLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~l 557 (740)
.+.|.+.+.||+|.||.+-+++.+. .+.+++|.+.... ...++|.+|...--.| .|.||+.-+.. +...+.+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 3668899999999999999999865 6789999887654 4568899998876666 58999987765 455678889
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CCCCEEEeecCCCcccc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD--SDWGARIADFGLLTSCE 635 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~ki~DFGla~~~~ 635 (740)
++||+|.|+|.+-+.. ..+.+....+++.|++.||.|+|++. +||||||.+||||- +...+||+|||+.+...
T Consensus 100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999988865 34778888999999999999999999 99999999999993 34579999999976443
Q ss_pred C-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC-CCCchhHHhhhhHHhhCccchhccc
Q 040687 636 R-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE-YVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ....+..+|||.||++++.++||+.||+.. ...+.+++|....- +...
T Consensus 175 ~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--rk~~----- 247 (378)
T KOG1345|consen 175 TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--RKNP----- 247 (378)
T ss_pred ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--ccCc-----
Confidence 2 111245789999999999999999999853 22344544432211 1111
Q ss_pred ccCCCCC-chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 692 NVALPRN-VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 692 ~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
+.|.. ....+.+.++.++-+..+|++|--..++.++-.....+.+
T Consensus 248 --~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 248 --ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred --cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 11211 1112356678888899999999777777665555444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=215.78 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=172.8
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------e
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------E 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 554 (740)
.+|..++.++.|.- .|--+.+ ..+++||||++..........+...+|..++..++|+|+++++.+++-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888877 5555543 34889999998766433445567789999999999999999999987543 5
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.|+|||||. .+|...++. .++-..+..|..|+..|++|||+.+ |+||||||+||++..+..+||.|||+|+..
T Consensus 96 ~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 799999994 599988873 3777888999999999999999999 999999999999999999999999998754
Q ss_pred cCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCc--------------hhHHhhhhH-
Q 040687 635 ERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP--------------GIVEWALPL- 679 (740)
Q Consensus 635 ~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~--------------~~~~~~~~~- 679 (740)
..+ ..+.+++||||.||++.||++|+.-|.....-. .+.+...+.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 321 224678999999999999999998886432111 111111110
Q ss_pred ---Hh------hCccchhccccc-C--CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 680 ---IK------QGKAAAIIDRNV-A--LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 680 ---~~------~~~~~~i~d~~~-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. .-...+.+.... . ...+........+++.+||..||++|.++++++.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 000111111110 0 0111112234568999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=230.31 Aligned_cols=178 Identities=24% Similarity=0.368 Sum_probs=150.7
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh------cHHHHHHHHHHHHhCC---CCCcceEEeEEEeC
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT------NIREFEMELEVLCNIR---HSNIVNLLGYCLEM 552 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~------~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 552 (740)
.|+..+++|+|+||.|+++.++. ...|+||.+.++.+... ..-..-.|++||.+|+ |+||++++++++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 57888999999999999999865 66899999887654322 1223567999999997 99999999999999
Q ss_pred CeEEEEEecC-CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 553 GERLLVYEFM-PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 553 ~~~~lV~Ey~-~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
+.+||+||-. ++-+|++++.-+ ..+++.+...|..||+.|+++||+++ |||||||-+||.++.++-+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 9999999976 456899999754 56999999999999999999999999 999999999999999999999999987
Q ss_pred ccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCC
Q 040687 632 TSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYD 664 (740)
Q Consensus 632 ~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~ 664 (740)
..... +.+....-|||++|++||-++...-||.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 54322 1222456899999999999998888874
|
|
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-22 Score=213.23 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=189.2
Q ss_pred eeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCC----------------CCCCCccccCCC---------ceEEec
Q 040687 4 ISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFL----------------SANSASFSNIPS---------MAVLSG 58 (740)
Q Consensus 4 ~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~----------------~~~~~~~~~v~~---------~~~i~~ 58 (740)
+.++.|| .|+-+|..|| .||.||.|..|+||.-. .....+|..||. +..|++
T Consensus 107 ~~~acGg-~hsl~ld~Dg--~lyswG~N~~G~Lgr~~~~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~c 183 (476)
T COG5184 107 IKIACGG-NHSLGLDHDG--NLYSWGDNDDGALGRDIHKDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLAC 183 (476)
T ss_pred EEeecCC-ceEEeecCCC--CEEEeccCcccccccccccccccccccccccchhhcccCCceeeccccccCChheEEeec
Confidence 4466676 8999999999 99999999999999554 112367777754 689999
Q ss_pred cCCeEeEEecCCCceEeccCCCC--CCCC--cc-------ccccccc-CCceEEEeeCCCeeeeEEccccccCCCceeee
Q 040687 59 GEGLLCGILANTSQAFCWSSNSS--PGNT--TD-------LVPSVYK-NTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDC 126 (740)
Q Consensus 59 G~~~~Cal~~~~~~~~cWg~~~~--~g~g--~~-------~~~~~~~-~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~c 126 (740)
|+.++++|.+++ .+|-||.+-. ++.| +. ..| +.. -..+.+||+|.+|.-++. .+|++|-
T Consensus 184 g~e~svil~~~G-~V~~~gt~r~~e~~~g~~~~s~k~~~~~~p-~~v~~~~i~qla~G~dh~i~lt-------~~G~vy~ 254 (476)
T COG5184 184 GWEISVILTADG-RVYSWGTFRCGELGQGSYKNSQKTSIQFTP-LKVPKKAIVQLAAGADHLIALT-------NEGKVYG 254 (476)
T ss_pred CCceEEEEccCC-cEEEecCccccccccccccccccceeeeee-eecCchheeeeccCCceEEEEe-------cCCcEEE
Confidence 999999999987 5999999642 2223 11 233 212 247999999999999999 8899999
Q ss_pred cccccCCCCccCcccccccccccccee--------eEEEEEecCCeeeeeeeCCeEEEecCCCCCCCccC----------
Q 040687 127 WDIVRKGNNTLSSVQTNLFYDEYVSTI--------VLKDVISGDGFSCGGVRDGGIVCWGPDSESLGVFN---------- 188 (740)
Q Consensus 127 W~~~~~G~n~~gqlg~~~~~~~~~~~~--------~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~~~~~~---------- 188 (740)
| |+|-.||||...+.+....+. .+..|++|.+|+-||.++|.+++||.|-++.-..+
T Consensus 255 ~-----Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al~~~G~i~a~G~n~fgqlg~~~~~~~~a~~t 329 (476)
T COG5184 255 W-----GSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLALDEDGEIYAWGVNIFGQLGAGSDGEIGALTT 329 (476)
T ss_pred e-----cCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEEcCCCeEEEeccchhcccccCcccccceeec
Confidence 9 999999999886554332222 26779999999999999999999999977521111
Q ss_pred --------CCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCC-----------CCC----cccEEEEecccceeeeee
Q 040687 189 --------VTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSV-----------PPV----GIRFVSLAAGANHFCGIR 245 (740)
Q Consensus 189 --------~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~-----------~~~----~~~~~~la~G~~h~C~l~ 245 (740)
..-.+.+|++|..|+-+|+. +|.|+-||+++.+|. .|. ...+.++++|..|+=+.+
T Consensus 330 k~~~~~~~~~~~i~~is~ge~H~l~L~~-~G~l~a~Gr~~~~qlg~~~~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~~t 408 (476)
T COG5184 330 KPNYKQLLSGVTICSISAGESHSLILRK-DGTLYAFGRGDRGQLGIQEEITIDVSTPTKLSVAIKLEQVACGTHHNIART 408 (476)
T ss_pred cccccccCCCceEEEEecCcceEEEEec-CceEEEecCCccccccCcccceeecCCccccccccceEEEEecCccceeec
Confidence 11137899999999999955 999999999999991 111 135999999999999998
Q ss_pred ecCCcEEecCCCCCCCCC
Q 040687 246 EDNHGVECWGSFNYSSVP 263 (740)
Q Consensus 246 ~~~g~v~CWG~~~~g~~~ 263 (740)
.+++|++||.++++++.
T Consensus 409 -~~gsvy~wG~ge~gnlG 425 (476)
T COG5184 409 -DDGSVYSWGWGEHGNLG 425 (476)
T ss_pred -cCCceEEecCchhhhcc
Confidence 89999999999988864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=219.05 Aligned_cols=183 Identities=22% Similarity=0.259 Sum_probs=152.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC------CCCcceEEeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR------HSNIVNLLGYC 549 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~ 549 (740)
-+...+.|......|+|-|++|-+|... .+..||||++.....+. +.=+.|++||.+|+ .-|.++|+..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3344567888888999999999999964 48899999998765432 45578999999995 35899999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEe
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGG--LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIA 626 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~ 626 (740)
...++++||+|-+ ..+|.+.|..- ...|....+..++.|+..||..|-..+ |+|.||||.|||+++.- .+||+
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 9999999999988 45999999743 234778888899999999999999998 99999999999999765 57999
Q ss_pred ecCCCccccC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 040687 627 DFGLLTSCER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE 666 (740)
Q Consensus 627 DFGla~~~~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~ 666 (740)
|||.|-.... ...|+...|+||.||.||||.||+..|.+.
T Consensus 580 DfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 580 DFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 9998755433 345577899999999999999999888653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=206.93 Aligned_cols=131 Identities=27% Similarity=0.360 Sum_probs=110.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-----C---CCcceEEeEEEeC
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-----H---SNIVNLLGYCLEM 552 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~ 552 (740)
.+|...++||-|-|.+||++.+. ..+.||+|+.+... ...+..+.||++|++++ | .+||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 56889999999999999999964 47899999987543 23345789999999883 3 4699999999865
Q ss_pred ----CeEEEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 040687 553 ----GERLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD 618 (740)
Q Consensus 553 ----~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 618 (740)
.+.+||+|++ +-+|..+|... ..-++...+..|+.||+.||.|||.+. .|||-||||+||||-
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4789999999 66888888644 356899999999999999999999987 399999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=212.93 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=180.7
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
+....+.|...++||+|.|++||++.+. ..+.||+|.+.... ......+|+++|..+ -+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 4445577999999999999999999964 36789999987653 335689999999999 59999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGL 630 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGl 630 (740)
++...+|+||+++-+..+++.+ ++..++..+...+.+||+|+|+++ ||||||||+|+|.+.. +.-.|.||||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999999999864 778899999999999999999999 9999999999999864 5679999999
Q ss_pred CccccCC------------------------------------------------------------------CCCCccc
Q 040687 631 LTSCERD------------------------------------------------------------------LTTDMKS 644 (740)
Q Consensus 631 a~~~~~~------------------------------------------------------------------~~~~~ks 644 (740)
|...... ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 8521100 0004579
Q ss_pred ceehhHHHHHHHHhCCCCCCCCCCC-chhHHhhhhH---------HhhCc--------cchhcccc----------c-C-
Q 040687 645 DVHNFGIVLLEILSGRKAYDIEYVP-PGIVEWALPL---------IKQGK--------AAAIIDRN----------V-A- 694 (740)
Q Consensus 645 DVwSfGvvl~ElltG~~p~~~~~~~-~~~~~~~~~~---------~~~~~--------~~~i~d~~----------~-~- 694 (740)
||||-|||++-+++++.||.....+ ..+.+.+... ...+. +..+.+.+ + .
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999999654322 2232211100 00011 00000000 0 0
Q ss_pred ------C-CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 ------L-PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ------~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. .........+++|+.+|++.||.+|.|++|.++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 001112236789999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=227.49 Aligned_cols=234 Identities=26% Similarity=0.359 Sum_probs=182.8
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
.+.++|....++|+|.||.|||++.. .++..|+|.++... ...++-..+|+-+++.-+|||||-++|-+...+..++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 45678999999999999999999974 58899999988765 2455667889999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
.|||+.+|+|++.-+-. .++++.+.-.+++...+||+|||+.+ -+|||||=.|||+++.+.+|++|||.+-.+..
T Consensus 90 cMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999999987643 57889999999999999999999999 78999999999999999999999998643321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...+.+++|||+.|+...|+---..|...-- + ..++-++...... .+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-p----mr~l~LmTkS~~q-----pp 235 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-P----MRALFLMTKSGFQ-----PP 235 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-h----HHHHHHhhccCCC-----CC
Confidence 2334679999999999999977666642110 0 0111111111111 11
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.........+.+.++++.++..+|++||+.+.++.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11122334446779999999999999999987765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=248.52 Aligned_cols=173 Identities=17% Similarity=0.230 Sum_probs=125.9
Q ss_pred hCCC-CCcceEEeEE-------EeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 040687 536 NIRH-SNIVNLLGYC-------LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607 (740)
Q Consensus 536 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 607 (740)
+++| +||+++++++ .+...+++++||+ .++|+++|+.....+++.+++.++.||++||+|||+++ |||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4455 6888888877 2334577889988 55999999866567999999999999999999999999 999
Q ss_pred cCCCCCCEEEC-------------------CCCCEEEeecCCCcccc---------------------------------
Q 040687 608 RDVKTLNILLD-------------------SDWGARIADFGLLTSCE--------------------------------- 635 (740)
Q Consensus 608 rDlk~~NILl~-------------------~~~~~ki~DFGla~~~~--------------------------------- 635 (740)
|||||+||||+ .+..+||+|||+++...
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999995 35567888888775311
Q ss_pred ----CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHH
Q 040687 636 ----RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAEL 711 (740)
Q Consensus 636 ----~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~ 711 (740)
....++.++|||||||+||||++|..|+.... .. ...+.. ..+. +.......+...++.+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~-~~~~~~----~~~~-----~~~~~~~~~~~~~~~~ 247 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RT-MSSLRH----RVLP-----PQILLNWPKEASFCLW 247 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HH-HHHHHH----hhcC-----hhhhhcCHHHHHHHHH
Confidence 01224679999999999999999988864211 00 001110 0111 1111112245688999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 040687 712 AIRENPSELPTMSQVAT 728 (740)
Q Consensus 712 Cl~~dP~~RPt~~ev~~ 728 (740)
||+++|.+||+|.||++
T Consensus 248 ~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hCCCChhhCcChHHHhh
Confidence 99999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=206.37 Aligned_cols=142 Identities=25% Similarity=0.252 Sum_probs=113.8
Q ss_pred HhhcCccccceecccCceEEEEEEEe--CCcEEEEEEeccccc---chhcHHHHHHHHHHHHhCCCCCcce-EEeEEEeC
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV--DGRQVAVKRANAATI---IHTNIREFEMELEVLCNIRHSNIVN-LLGYCLEM 552 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAiK~l~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~ 552 (740)
...++|...+.||+|+||+||+|.+. +++.||||++..... .....+.|.+|+++|++++|+|++. ++.+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34577999999999999999999874 477789998753311 1223456999999999999999985 4432
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEECCCCCEEEeecCCC
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDV-KTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~ki~DFGla 631 (740)
+..+|||||+++++|... .. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 467999999999999732 11 11 1467889999999999998 999999 999999999999999999998
Q ss_pred cccc
Q 040687 632 TSCE 635 (740)
Q Consensus 632 ~~~~ 635 (740)
+...
T Consensus 160 ~~~~ 163 (365)
T PRK09188 160 SVFR 163 (365)
T ss_pred eecc
Confidence 7543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-22 Score=198.31 Aligned_cols=235 Identities=21% Similarity=0.379 Sum_probs=176.8
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
+....+|.+.-.|+.|+|+|. |..++.|+++.........++|..|.-.|+-+.||||+.++|.|.....+.++..|||
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344557888889999999994 4556778887665444455789999999999999999999999999999999999999
Q ss_pred CCChHHhHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe-cCCCCCCEEECCCCCEEEe--e--cCCCc---cc
Q 040687 564 RGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPIIH-RDVKTLNILLDSDWGARIA--D--FGLLT---SC 634 (740)
Q Consensus 564 ~gsL~~~l~~~~~-~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH-rDlk~~NILl~~~~~~ki~--D--FGla~---~~ 634 (740)
.|+|+..||+... .++-.+..+++.+||+||+|||+.. |+|- --|.+..+++|++.++||+ | |.+-. .+
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAY 348 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeeecccccc
Confidence 9999999997653 3688899999999999999999975 2444 4689999999999999885 3 22210 00
Q ss_pred c------C------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhH
Q 040687 635 E------R------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702 (740)
Q Consensus 635 ~------~------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~ 702 (740)
. + ....-...|+|||.++||||.|...||..-. + .+.- ..+.-+.++...++...
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls-p---mecg---------mkialeglrv~ippgis 415 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS-P---MECG---------MKIALEGLRVHIPPGIS 415 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC-c---hhhh---------hhhhhccccccCCCCcc
Confidence 0 0 0011246899999999999999999996321 0 0100 01111222333333444
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 703 FKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 703 ~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
..+.+||.-|...||.+||.+..|+-.||++.
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 57889999999999999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=187.60 Aligned_cols=155 Identities=23% Similarity=0.195 Sum_probs=114.1
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-------- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-------- 636 (740)
|+|.++++....+++|.+++.|+.||++||+|||+.+ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~ 69 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPY 69 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccCCCccc
Confidence 7899999876667999999999999999999999876 999999999999999 998764321
Q ss_pred --------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhH--HHHH
Q 040687 637 --------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL--FKLA 706 (740)
Q Consensus 637 --------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~--~~l~ 706 (740)
...++.|+||||||+++|||+||+.||.................. .. +.. ..+...... .++.
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~--~~~-~~~~~~~~~~~~~~~ 142 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP----AD--DPR-DRSNLESVSAARSFA 142 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc----cC--Ccc-ccccHHHHHhhhhHH
Confidence 233467999999999999999999999643322221111111110 00 000 001111112 2588
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 707 DIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 707 ~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
+++.+||+.||++||++.|+++.+..+..+.
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 9999999999999999999999988877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=186.68 Aligned_cols=140 Identities=20% Similarity=0.218 Sum_probs=109.0
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchhc-------HHH-----------------HHHHHHHHHhCCCCCcc
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN-------IRE-----------------FEMELEVLCNIRHSNIV 543 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~-------~~~-----------------~~~E~~~l~~l~H~niv 543 (740)
..||+|+||.||+|...+|++||||+++........ ... ..+|+++|.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999998765321111 011 24599999999887764
Q ss_pred eEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEECCCCC
Q 040687 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL-HKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 544 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
....+.. ...+|||||+++++|...+... .+++..+...++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 4333222 2348999999988776553222 4689999999999999999999 6888 99999999999998 478
Q ss_pred EEEeecCCCccc
Q 040687 623 ARIADFGLLTSC 634 (740)
Q Consensus 623 ~ki~DFGla~~~ 634 (740)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-19 Score=192.59 Aligned_cols=238 Identities=20% Similarity=0.263 Sum_probs=176.3
Q ss_pred CccccceecccCceEEEEEEEeCC--cEEEEEEecccccchhcHHHHHHHHHHHHhCCC----CCcceEEeEE-EeCCeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDG--RQVAVKRANAATIIHTNIREFEMELEVLCNIRH----SNIVNLLGYC-LEMGER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g--~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~ 555 (740)
+|+..++||+|+||.||++..... ..+|+|........ ....+..|..+|..+.+ +++.++++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~--~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS--KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC--CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999997553 47888876654321 11267889999998873 6889999888 467788
Q ss_pred EEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-----CCEEEeecC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-----WGARIADFG 629 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~ki~DFG 629 (740)
++||+.+ +.+|.++..... ..++..+.++|+.|++.+|++||+.+ +|||||||.|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999988 779999885444 67999999999999999999999999 9999999999999765 469999999
Q ss_pred CCc--cccC----------C-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh
Q 040687 630 LLT--SCER----------D-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP 678 (740)
Q Consensus 630 la~--~~~~----------~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 678 (740)
+++ .... . ...+.+.|+||++.++.|++.|..||..........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~----- 247 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS----- 247 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH-----
Confidence 998 3110 0 001357899999999999999999996433222111
Q ss_pred HHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 679 ~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+........... .......++.+++..+-..+..++|....+...|+++...
T Consensus 248 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111111111111 1111223555666666678999999999999998887665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=179.25 Aligned_cols=235 Identities=20% Similarity=0.256 Sum_probs=177.2
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC-CCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-SNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV 558 (740)
..+|..+++||+|+||.+|.|.. .+|++||||.-.... ....+.-|..+...|+| ..|..+.-|..+...-.||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 46799999999999999999995 569999999765433 22456778899988876 5677777777888888999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGla~~~~ 635 (740)
||++ +.+|.+.+.-....++.++.+.++-|++.-++|+|.++ +|||||||+|.|..- ...+.++|||||+.+-
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9998 77999998766667999999999999999999999999 999999999999964 4568999999997653
Q ss_pred CCCC----------------------------CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch
Q 040687 636 RDLT----------------------------TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA 687 (740)
Q Consensus 636 ~~~~----------------------------~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (740)
+..+ .+.+-|+-|+|.+|.+..-|..||+.-. +.-+.++.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk----------a~tk~QKyEk 235 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK----------AATKKQKYEK 235 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc----------hhhHHHHHHH
Confidence 3110 1346799999999999999999997532 1122333444
Q ss_pred hcccccCCCCC---chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 688 IIDRNVALPRN---VEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 688 i~d~~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
|.+.....+.+ ...+.++...+.-|=..--++-|+..-+-+.+.-+
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 44444433321 12234666777888877777888876665554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=179.35 Aligned_cols=142 Identities=22% Similarity=0.234 Sum_probs=112.3
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhc------------------------HHHHHHHHHHHHhCCCCCc
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN------------------------IREFEMELEVLCNIRHSNI 542 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~------------------------~~~~~~E~~~l~~l~H~ni 542 (740)
...||+|+||.||+|+..+|+.||||+++........ ...+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999998865311000 1124678999999999987
Q ss_pred ceEEeEEEeCCeEEEEEecCCCCChHHh-HhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCC
Q 040687 543 VNLLGYCLEMGERLLVYEFMPRGTLHDH-LHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 543 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~ 620 (740)
.....+... ..+|||||++++++... +.. ..++..+...++.|++.+|.|||+ .+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 554444333 34899999998865443 432 357888999999999999999999 88 99999999999999 7
Q ss_pred CCEEEeecCCCccccC
Q 040687 621 WGARIADFGLLTSCER 636 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~ 636 (740)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=183.17 Aligned_cols=164 Identities=14% Similarity=0.162 Sum_probs=130.7
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhc-HH------HHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN-IR------EFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~-~~------~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..++|+..+.||.|+||.||+... ++..+|||.+.......+. .. .|.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999655 5778999999765422221 11 268999999999999999999886643
Q ss_pred --------CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEE
Q 040687 553 --------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR 624 (740)
Q Consensus 553 --------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 624 (740)
...+|||||+++.+|.++.. ++. ....+++.+|..+|+.+ ++||||||+||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence 35789999999999988742 222 24568999999999999 99999999999999988 99
Q ss_pred EeecCCCccccCC---------CCCCcccceehhHHHHHHHH
Q 040687 625 IADFGLLTSCERD---------LTTDMKSDVHNFGIVLLEIL 657 (740)
Q Consensus 625 i~DFGla~~~~~~---------~~~~~ksDVwSfGvvl~Ell 657 (740)
|+|||.......+ ..++.+.|+||||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence 9999987655432 12357999999999886554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=199.13 Aligned_cols=198 Identities=27% Similarity=0.415 Sum_probs=154.2
Q ss_pred HHhCCCCCcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 534 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
|+.+.|.|+.+|+|.+.+....++|.+|++.|+|+|.+......++|.....+..+|++||+|||+... ..|..|+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeeccc
Confidence 457899999999999999999999999999999999999877789999999999999999999997651 399999999
Q ss_pred CEEECCCCCEEEeecCCCccccC---------------------------CC---CCCcccceehhHHHHHHHHhCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER---------------------------DL---TTDMKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~---------------------------~~---~~~~ksDVwSfGvvl~ElltG~~p~ 663 (740)
|+++|..+.+||+|||+...... .. ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999998655421 00 1256799999999999999999999
Q ss_pred CCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 664 DIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
+.........+.+.. ++. .....+.+.+.. ..+...++..+++.||..+|.+||++++|-..++.+.+.+
T Consensus 159 ~~~~~~~~~~eii~~-~~~-~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILR-VKK-GGSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHH-HHh-cCCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 875433332222222 222 011111111111 1133336889999999999999999999999988877643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-18 Score=181.05 Aligned_cols=235 Identities=30% Similarity=0.406 Sum_probs=179.0
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCC-CcceEEeEEEeCCeEEEEEec
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHS-NIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 561 (740)
|...+.||.|.|+.||++... ..+++|.+........ ....|.+|+.+++++.|+ +++++..++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 7899999887654332 467899999999999988 799999999777778999999
Q ss_pred CCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC--
Q 040687 562 MPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER-- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~-- 636 (740)
+.+++|.+++.... ..+.......+..|++.++.|+|+.+ ++||||||+|||++... .+++.|||++.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999998776543 26889999999999999999999999 99999999999999988 799999998752211
Q ss_pred -------------------------C---CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 637 -------------------------D---LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 637 -------------------------~---~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
. .......|+||+|++++++++|..||...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc--
Confidence 1 23456789999999999999999997644321 0011111111111111
Q ss_pred cccccCCCCC----chhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 689 IDRNVALPRN----VEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 689 ~d~~~~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
....+.. ......+.+++..++..+|.+|.++.+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000111 1122467789999999999999998877653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-18 Score=177.24 Aligned_cols=237 Identities=18% Similarity=0.230 Sum_probs=177.9
Q ss_pred cCccccceecccCceEEEEEE-EeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 559 (740)
-+|+..++||+|+||..+.|+ +-++++||||.-..+. ...++..|.+..+.|. -+.|...+-+-.+..+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 469999999999999999999 4679999999654332 3346777888888774 588888887777777788999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-----CCEEEeecCCCccc
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-----WGARIADFGLLTSC 634 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~ki~DFGla~~~ 634 (740)
|++ +-+|.|+..-....++.++...||.|+..-|+|+|++. +|.|||||+|.||... ..+.|+|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 998 77999988766567999999999999999999999999 9999999999999643 45899999999876
Q ss_pred cCCCC----------------------------CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 635 ERDLT----------------------------TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 635 ~~~~~----------------------------~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
.+..+ .+.+-|.-|+|-|+++.|-|..||+.-..+.+ .. +.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~--------kYe 249 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KE--------KYE 249 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HH--------HHH
Confidence 54211 13467999999999999999999986433221 11 112
Q ss_pred hhcccccCCCCC---chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 687 AIIDRNVALPRN---VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 687 ~i~d~~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.|=+..-..|.+ ...+++++.-++-.=+.+-.+-|+.+-+...+..++++
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 222222111111 11234566666667777888889998888877776653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6e-18 Score=169.82 Aligned_cols=137 Identities=20% Similarity=0.154 Sum_probs=106.8
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-----CCCCcceEEeEEEeCC---e-
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-----RHSNIVNLLGYCLEMG---E- 554 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~- 554 (740)
++..+.||+|+|+.||. .++....+||++..... ...+++.+|+.+++++ +||||++++|+++++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 44567899999999996 43333347998765432 2346799999999999 6799999999998863 3
Q ss_pred EEEEEec--CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEECC----CCCEEEee
Q 040687 555 RLLVYEF--MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL-EYLHKDAAPPIIHRDVKTLNILLDS----DWGARIAD 627 (740)
Q Consensus 555 ~~lV~Ey--~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~ki~D 627 (740)
..+|+|| ++.++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 3478999 6689999999764 35554 35677888888 9999999 999999999999974 34799999
Q ss_pred cCCC
Q 040687 628 FGLL 631 (740)
Q Consensus 628 FGla 631 (740)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-17 Score=168.70 Aligned_cols=136 Identities=21% Similarity=0.282 Sum_probs=114.8
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchh------cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT------NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
+.||+|++|.||+|.+ ++..|++|.......... ....+.+|++++.+++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899998654332111 124578899999999999988877777777788999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 78899999999999999998 99999999999999 78899999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-18 Score=165.66 Aligned_cols=164 Identities=16% Similarity=0.126 Sum_probs=126.6
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEecccccchh--cHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEec
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT--NIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.....|++|.||+||.+.. ++.+++.+.+........ ....|.+|+++|++|+ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456799999999997765 678888888776543111 1225789999999995 5889999886 346899999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEECCCCCEEEeecCCCccccCCCC-
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDV-KTLNILLDSDWGARIADFGLLTSCERDLT- 639 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~ki~DFGla~~~~~~~~- 639 (740)
+++.+|.+.+.. ....+..|++++|+|+|+.+ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998765421 11357789999999999999 999999 79999999999999999999875433210
Q ss_pred ------------------C-------------C----cccceehhHHHHHHHHhCCCCCC
Q 040687 640 ------------------T-------------D----MKSDVHNFGIVLLEILSGRKAYD 664 (740)
Q Consensus 640 ------------------~-------------~----~ksDVwSfGvvl~ElltG~~p~~ 664 (740)
+ . ...+.++-|..+|.++|+..+.-
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 13578889999999999887764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.7e-17 Score=185.62 Aligned_cols=140 Identities=20% Similarity=0.251 Sum_probs=113.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccch------hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH------TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
...|...+.||+|+||+||++.+... .+++|+........ ...+.+.+|++++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556778999999999999987544 34444322211111 123468899999999999999988888877778
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+|||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999999885 35678999999999999998 9999999999999 6778999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-18 Score=197.92 Aligned_cols=238 Identities=21% Similarity=0.228 Sum_probs=165.5
Q ss_pred cccceecccCceEEEEEEEe-CCcEEEEEEecc---cccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLV-DGRQVAVKRANA---ATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~---~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.....+|.|++|.|+..... +.+..+.|..+. ...... ....+..|.-+-.+|+|+|++..+....+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 44567999999988877643 344445444331 111111 1223677888888999999988887777766666669
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||++. +|..++... ..+...++-.+..|+.+|++|||+.+ |.|||||++|++++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999999764 35788888999999999999999999 99999999999999999999999998643211
Q ss_pred ----------------------CCC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 ----------------------DLT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 ----------------------~~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
... .....||||.|+++..|++|+.||......++.. .......-..+...
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~~~~~~~~~~-- 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNYSDQRNIFEG-- 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhccccccccccC--
Confidence 011 1346899999999999999999997532211100 00000000000000
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
......+...+...+|.++|+.||.+|-|+++|++ |++++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00111223345668999999999999999999997 66654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=162.57 Aligned_cols=133 Identities=21% Similarity=0.326 Sum_probs=108.4
Q ss_pred eecccCceEEEEEEEeCCcEEEEEEecccccch------hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH------TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
.||+|+||.||++.+ ++..|++|......... .....+.+|++++.+++|+++.....++......+|||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 67889999865432211 12356788999999999887665555556666778999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
++++|.+++..... .++.+++++|.+||+.+ ++|+|++|+|||++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998864311 78999999999999998 99999999999999 789999999998664
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.1e-17 Score=161.67 Aligned_cols=146 Identities=21% Similarity=0.167 Sum_probs=112.8
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccch--------------------hcHHHHHHHHHHHH
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH--------------------TNIREFEMELEVLC 535 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~--------------------~~~~~~~~E~~~l~ 535 (740)
++......|...+.||+|+||.||++...+++.||||+++...... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333333477788999999999999998889999999866432100 01123678999999
Q ss_pred hCCCC--CcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 536 NIRHS--NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 536 ~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
++.|+ .+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 99887 45555542 456899999999999776431 234578899999999999988 999999999
Q ss_pred CEEECCCCCEEEeecCCCcccc
Q 040687 614 NILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~ 635 (740)
|||+++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=163.59 Aligned_cols=146 Identities=18% Similarity=0.154 Sum_probs=112.8
Q ss_pred CccccceecccCceEEEEEE--EeCCcEEEEEEecccccchh----------------------cHHHHHHHHHHHHhCC
Q 040687 483 GFKEFNELGRGSYGFVYKAV--LVDGRQVAVKRANAATIIHT----------------------NIREFEMELEVLCNIR 538 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~--~~~g~~vAiK~l~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 538 (740)
.|...+.||+|+||.||+|. ..+++.||||+++....... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 46799999999875431100 0123578999999997
Q ss_pred CC--CcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 040687 539 HS--NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616 (740)
Q Consensus 539 H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 616 (740)
+. .+.+++.+ ...+|||||+++.+|...+... ..+...+...++.|++.+|+|||+.+ .|+||||||+|||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 53 34555543 2358999999998887765322 34566667889999999999999876 3999999999999
Q ss_pred ECCCCCEEEeecCCCccccC
Q 040687 617 LDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 617 l~~~~~~ki~DFGla~~~~~ 636 (740)
++ +++++|+|||++.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999875443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=189.47 Aligned_cols=226 Identities=20% Similarity=0.236 Sum_probs=162.1
Q ss_pred CccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHH--HHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEV--LCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++...+.||++.|=+|.+++.++|. |+||.+-+..- .-..+.|.++++- +..++|||.+.+.-+-....--|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p-~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDP-TISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCC-CCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677788999999999999988777 89998765431 1233444443333 556699999998877666666788888
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc--ccC--
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS--CER-- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~--~~~-- 636 (740)
|..+ +|+|.|..+ .-+...+..-|+.|++.||..+|+.+ |.|+|||.+||||++=.-+.|+||---+. +++
T Consensus 102 yvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9966 999999754 34677888889999999999999999 99999999999999988899999963210 000
Q ss_pred ----------------------------------C-CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHH
Q 040687 637 ----------------------------------D-LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLI 680 (740)
Q Consensus 637 ----------------------------------~-~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~ 680 (740)
+ ...+.+-||||.||++.||++ |++||... ++.. +...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~a--Yr~~ 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLA--YRSG 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHh--Hhcc
Confidence 0 012567899999999999999 89888521 0100 0000
Q ss_pred hhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
.....+.+++. +. + ..+..++..|++.||++|.++++.++.
T Consensus 251 ~~~~~e~~Le~-Ie-----d--~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEK-IE-----D--VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHh-Cc-----C--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 01111111111 10 0 145689999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-17 Score=182.17 Aligned_cols=212 Identities=23% Similarity=0.278 Sum_probs=165.0
Q ss_pred eecccCceEEEEEEE----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEecCC
Q 040687 489 ELGRGSYGFVYKAVL----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
.+|+|.||.|++.+. ..+..+|+|.+++.............|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999997663 23677899988876543333335667889999997 9999999999999999999999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-----
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL----- 638 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~----- 638 (740)
+|+|..++... ..++......+...+|-+++++|+.+ |+|||+|++||+++.+|.+|+.|||++++.....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGT 156 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhcccc
Confidence 99999998755 34566666667788999999999999 9999999999999999999999999987543321
Q ss_pred ----------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHH
Q 040687 639 ----------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADI 708 (740)
Q Consensus 639 ----------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l 708 (740)
......|.||||++++||+||..||.. + ....|+...+.+|.. .......+
T Consensus 157 ~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~--------~---------~~~~Il~~~~~~p~~--l~~~a~~~ 217 (612)
T KOG0603|consen 157 YEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG--------D---------TMKRILKAELEMPRE--LSAEARSL 217 (612)
T ss_pred hhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch--------H---------HHHHHhhhccCCchh--hhHHHHHH
Confidence 135689999999999999999999963 1 112233333444433 33355578
Q ss_pred HHHhhhcCCCCCCCH
Q 040687 709 AELAIRENPSELPTM 723 (740)
Q Consensus 709 ~~~Cl~~dP~~RPt~ 723 (740)
+..++..+|..|--.
T Consensus 218 ~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHhhCHHHHhcc
Confidence 888889999888654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=150.05 Aligned_cols=139 Identities=22% Similarity=0.227 Sum_probs=100.9
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHH----------------------HHHHHHHHHhCCCC--Cc
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE----------------------FEMELEVLCNIRHS--NI 542 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~----------------------~~~E~~~l~~l~H~--ni 542 (740)
.+.||+|+||+||++...+++.||||+++........... ...|.+.+.++++. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888999999988754321111111 14566777777544 35
Q ss_pred ceEEeEEEeCCeEEEEEecCCCCChHHh-HhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCC
Q 040687 543 VNLLGYCLEMGERLLVYEFMPRGTLHDH-LHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 543 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~ 620 (740)
.+.+++ ...+|||||++++.+... +.... .. .+...++.+++.++.++|. .+ |+||||||+|||++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 555543 246899999999554322 21110 11 5677899999999999998 77 99999999999999 8
Q ss_pred CCEEEeecCCCccccC
Q 040687 621 WGARIADFGLLTSCER 636 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~ 636 (740)
+.++|+|||++.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 8999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=156.32 Aligned_cols=215 Identities=21% Similarity=0.329 Sum_probs=136.6
Q ss_pred CccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCC----------CCcceEEeEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRH----------SNIVNLLGYCL 550 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~ 550 (740)
.+...+.||.|.|+.||.+++.+ ++++|+|.+...... ....+++++|......+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35667789999999999999865 899999987654422 2346677777766555433 12222222211
Q ss_pred ---------eC---C-----eEEEEEecCCCCChHHhHh---CCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 040687 551 ---------EM---G-----ERLLVYEFMPRGTLHDHLH---GGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607 (740)
Q Consensus 551 ---------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 607 (740)
.. . ..+++|+-+ .++|.+++. ... ..+....++.+..|+.+-+++||+++ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 236778877 568988764 111 12445566778899999999999999 999
Q ss_pred cCCCCCCEEECCCCCEEEeecCCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCC
Q 040687 608 RDVKTLNILLDSDWGARIADFGLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRK 661 (740)
Q Consensus 608 rDlk~~NILl~~~~~~ki~DFGla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~ 661 (740)
+||||+|+|++.++.++|+||+....... ...++.+.|.|++|+++|.|++++.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999999986432111 1123668899999999999999999
Q ss_pred CCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCC
Q 040687 662 AYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSEL 720 (740)
Q Consensus 662 p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 720 (740)
||+...... ..++ .+..-.+.++.+..||..+|++||.+|
T Consensus 249 Pf~~~~~~~-~~~~------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEA-DPEW------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGS-TSGG------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccc-cccc------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 997432110 0000 111111445578899999999999988
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.5e-15 Score=139.58 Aligned_cols=135 Identities=21% Similarity=0.149 Sum_probs=114.4
Q ss_pred ccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC--CCcceEEeEEEeCCeEEEEEecCC
Q 040687 486 EFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
+.+.|++|.++.||++...+ ..+++|....... ...+.+|+.++++++| .++++++.+....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35679999999999999754 7899998765431 3578999999999976 589999998888788999999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
+..+..+ +......++.+++++|++||....+.++|+||+|+|||++++..+++.||+++..
T Consensus 77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 5566778899999999999986545699999999999999989999999999753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=176.70 Aligned_cols=179 Identities=27% Similarity=0.346 Sum_probs=134.2
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC---CCCcceEEeEEE
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR---HSNIVNLLGYCL 550 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~ 550 (740)
..+.+.-.+.|.+.+.||+|+||+||+|...+++.||+|.-+..... +|.--.+++.||+ -+-|..+.....
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 34455556778899999999999999999888999999986655422 2333344555555 223344444444
Q ss_pred eCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-------CCCE
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-------DWGA 623 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-------~~~~ 623 (740)
..+.-+||+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||..+ |||+||||+|.||.. ...+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 5566789999999999999998 4467999999999999999999999999 999999999999942 3458
Q ss_pred EEeecCCCcccc---C--------------------CCCCCcccceehhHHHHHHHHhCCC
Q 040687 624 RIADFGLLTSCE---R--------------------DLTTDMKSDVHNFGIVLLEILSGRK 661 (740)
Q Consensus 624 ki~DFGla~~~~---~--------------------~~~~~~ksDVwSfGvvl~ElltG~~ 661 (740)
+|+|||-+-.+. + ....+.+.|.|.|.-+++-||-|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999864322 1 1222556777777777777777763
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-14 Score=140.94 Aligned_cols=259 Identities=14% Similarity=0.196 Sum_probs=181.4
Q ss_pred EEecCCc-eEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCCCc-----eEEeccCCeEeEEecCCCceEeccCC
Q 040687 6 ASFGQNS-FFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSM-----AVLSGGEGLLCGILANTSQAFCWSSN 79 (740)
Q Consensus 6 ~~~g~~~-~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~~~-----~~i~~G~~~~Cal~~~~~~~~cWg~~ 79 (740)
++.|-.. |.-+|.-++ ..|-||+|..||||.+....+..|+-|+.+ ...++|..||.+|... ++++.+|+|
T Consensus 61 VasG~~aaH~vli~meg--k~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~ltdt-G~v~afGeN 137 (443)
T KOG1427|consen 61 VASGCAAAHCVLIDMEG--KCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVLTDT-GQVLAFGEN 137 (443)
T ss_pred EecccchhhEEEEeccc--ceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEEecC-CcEEEeccc
Confidence 3444433 444566788 899999999999999988889999988755 5678999999999655 569999999
Q ss_pred CC--CCCCcc-----ccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccc------
Q 040687 80 SS--PGNTTD-----LVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLF------ 145 (740)
Q Consensus 80 ~~--~g~g~~-----~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~------ 145 (740)
-+ +|-|.. ..| .-+.++.++.|++|.+|+--|. ..+.+... |.-.+||||+++-
T Consensus 138 K~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l~-------~~~si~t~-----glp~ygqlgh~td~~~~~~ 205 (443)
T KOG1427|consen 138 KYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWLS-------STESILTA-----GLPQYGQLGHGTDNEFNMK 205 (443)
T ss_pred ccccccccccccccccCCCccccCccceeeccccceEEEee-------cccceeec-----CCccccccccCcchhhccc
Confidence 87 333322 112 3456789999999999999988 67889999 8889999998731
Q ss_pred --------cccccc-------eeeEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCccC---------------CCCcEE
Q 040687 146 --------YDEYVS-------TIVLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGVFN---------------VTESFK 194 (740)
Q Consensus 146 --------~~~~~~-------~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~~~---------------~~~~~~ 194 (740)
..++.| ...++.+|+|..|+-|+.++++||-||-+.+| ++-.. .+..-.
T Consensus 206 ~~~~~~~~e~~pr~~~i~~~dgvqiv~~acg~nhtvavd~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~ 285 (443)
T KOG1427|consen 206 DSSVRLAYEAQPRPKAIASLDGVQIVKVACGTNHTVAVDKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPP 285 (443)
T ss_pred cccceeeeecCCCccccccccceeeEEEeccCcceeeecCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCc
Confidence 111111 12378999999999999999999999977665 11100 111233
Q ss_pred EEeeCCceeeeeecCCCcEEEeecCCCCCCC-----CC----cccEEEEecccceeeeeeecCCcEEecCCCCCCC----
Q 040687 195 VLASGKSSLCGISELSGEVKCWGNNDFVSVP-----PV----GIRFVSLAAGANHFCGIREDNHGVECWGSFNYSS---- 261 (740)
Q Consensus 195 ~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~~-----~~----~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~---- 261 (740)
++-+|...+..+. .-|.++-||.+...... |. +-+..-+-.|..| |.+. .|.+..-||...++.
T Consensus 286 ~~~~g~t~Sl~v~-e~G~Lf~~g~~k~~ge~~mypkP~~dlsgwnl~~~~~~~~h-~~v~-ad~s~i~wg~~~~g~~lgg 362 (443)
T KOG1427|consen 286 NAILGYTGSLNVA-EGGQLFMWGKIKNNGEDWMYPKPMMDLSGWNLRWMDSGSMH-HFVG-ADSSCISWGHAQYGELLGG 362 (443)
T ss_pred ceeeecccceeec-ccceeEEeeccccCcccccCCCchhhcCCccCCCcCcccee-eeec-ccccccccccccccccccC
Confidence 6677877777774 47999999988543311 11 1223445555444 6666 788899999544432
Q ss_pred --------CCCC------CceEEEEecCceeeEEE
Q 040687 262 --------VPKN------SGFMAIASSDFTTCGIR 282 (740)
Q Consensus 262 --------~~~~------~~~~~i~ag~~~~Cg~~ 282 (740)
.|+. ..+..++.|..|+.-|.
T Consensus 363 p~~Qkss~~Pk~v~~l~~i~v~~VamGysHs~viv 397 (443)
T KOG1427|consen 363 PNGQKSSAAPKKVDMLEGIHVMGVAMGYSHSMVIV 397 (443)
T ss_pred ccccccccCccccchhcceeccceeeccceEEEEE
Confidence 1222 24677889999988776
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.9e-15 Score=151.50 Aligned_cols=168 Identities=23% Similarity=0.248 Sum_probs=118.5
Q ss_pred CCCCcceEEeEEEeC---------------------------CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHH
Q 040687 538 RHSNIVNLLGYCLEM---------------------------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590 (740)
Q Consensus 538 ~H~niv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~i 590 (740)
+|||||+++++|.+. ...||||.-.+. +|++||-.+ ..+.....-|..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 599999999988652 135889987755 999999654 35666777789999
Q ss_pred HHHHHHHHhCCCCCeEecCCCCCCEEE--CCCC--CEEEeecCCCccccC---CCC------------------------
Q 040687 591 AKGLEYLHKDAAPPIIHRDVKTLNILL--DSDW--GARIADFGLLTSCER---DLT------------------------ 639 (740)
Q Consensus 591 a~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~--~~ki~DFGla~~~~~---~~~------------------------ 639 (740)
++|+.|||.++ |.|||+|++|||| |+|. ...|+|||.+..-+. ...
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 9999999999999 3333 478999997532211 000
Q ss_pred ------CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhh
Q 040687 640 ------TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAI 713 (740)
Q Consensus 640 ------~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl 713 (740)
.-.|.|.|+.|.+.||+++..-||....+- .+.. ....+.++ ..+| ......+.+++...|
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~---r~Yqe~qL-------Palp--~~vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDT---RTYQESQL-------PALP--SRVPPVARQLVFDLL 494 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eech---hhhhhhhC-------CCCc--ccCChHHHHHHHHHh
Confidence 024899999999999999999999642210 0000 00111111 1122 223335678999999
Q ss_pred hcCCCCCCCHH
Q 040687 714 RENPSELPTMS 724 (740)
Q Consensus 714 ~~dP~~RPt~~ 724 (740)
++||++||+..
T Consensus 495 ~r~pskRvsp~ 505 (598)
T KOG4158|consen 495 KRDPSKRVSPN 505 (598)
T ss_pred cCCccccCCcc
Confidence 99999999854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.2e-14 Score=145.59 Aligned_cols=138 Identities=15% Similarity=0.141 Sum_probs=107.2
Q ss_pred ceec-ccCceEEEEEEEeCCcEEEEEEeccccc----c-------hhcHHHHHHHHHHHHhCCCCCc--ceEEeEEEeCC
Q 040687 488 NELG-RGSYGFVYKAVLVDGRQVAVKRANAATI----I-------HTNIREFEMELEVLCNIRHSNI--VNLLGYCLEMG 553 (740)
Q Consensus 488 ~~LG-~G~fG~Vy~~~~~~g~~vAiK~l~~~~~----~-------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 553 (740)
..|| .|+.|+||+... ++..++||++..... . ......+.+|++++.+|+|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 888999999887 467899998864221 0 1123457889999999998875 77787754432
Q ss_pred ----eEEEEEecCCC-CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 554 ----ERLLVYEFMPR-GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 554 ----~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
..+|||||+++ .+|.+++... +++.. ...+|+.+|.+||+.+ |+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 6999998653 35543 3568999999999999 999999999999999889999999
Q ss_pred CCCcccc
Q 040687 629 GLLTSCE 635 (740)
Q Consensus 629 Gla~~~~ 635 (740)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9987643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.6e-13 Score=147.43 Aligned_cols=143 Identities=23% Similarity=0.221 Sum_probs=102.8
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccch--h------------------------------------cHHHHHH
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH--T------------------------------------NIREFEM 529 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~--~------------------------------------~~~~~~~ 529 (740)
+.||+|++|.||+|++.+|+.||||+.++..... . ..-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986542100 0 0013566
Q ss_pred HHHHHHhCC----CCCcceEEeEEE-eCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 040687 530 ELEVLCNIR----HSNIVNLLGYCL-EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK-GLEYLHKDAAP 603 (740)
Q Consensus 530 E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~-gL~yLH~~~~~ 603 (740)
|.+.+.+++ |.+-+.+-.++. ..+..+|||||+++++|.+++....... .+..++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC--
Confidence 776666652 333333333332 2346789999999999988765322222 23456676666 478899888
Q ss_pred CeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 604 ~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
++|+|+||.||++++++.+++.|||++.....
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=157.54 Aligned_cols=186 Identities=25% Similarity=0.342 Sum_probs=124.4
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+.++.|-.|+||.||..+++. .+.+|+| +++..... ++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil------Rn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL------RN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh------hc---cccccCCccee---------------
Confidence 34689999999999999999998764 5678884 44322111 11 23233334333
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|+=.+.++.. .+++. +++.+++|||+++ |+|||+||+|.||+.-+.+|+.||||.+....
T Consensus 136 ------gDc~tllk~~-g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ------GDCATLLKNI-GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ------chhhhhcccC-CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4545555432 22322 2277899999999 99999999999999999999999998653221
Q ss_pred ----------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh
Q 040687 637 ----------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682 (740)
Q Consensus 637 ----------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 682 (740)
...|...+|+|++|+|+||.+-|+.||+.+.. +.+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg-------- 268 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFG-------- 268 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHh--------
Confidence 11124579999999999999999999986532 21211
Q ss_pred CccchhcccccCCCC-CchhHHHHHHHHHHhhhcCCCCCC
Q 040687 683 GKAAAIIDRNVALPR-NVEPLFKLADIAELAIRENPSELP 721 (740)
Q Consensus 683 ~~~~~i~d~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RP 721 (740)
.++...+..+. .+....+..+++.+.|+.+|.+|-
T Consensus 269 ----~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 ----QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11111121121 233344677999999999999994
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.2e-11 Score=121.83 Aligned_cols=198 Identities=17% Similarity=0.235 Sum_probs=143.8
Q ss_pred cCCceEEEeeC--CCeeeeEEccccccCCCceeeecccccCCCCccCcccccccccccccee-------eEEEEEecCCe
Q 040687 94 KNTAYSRIAAG--TNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTI-------VLKDVISGDGF 164 (740)
Q Consensus 94 ~~~~~~~is~G--~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~~~-------~~~~ia~G~~~ 164 (740)
.+..++-|++| ..|+-.|. -+|+.|-| |+|..||||.+.....-.|+. .+++-|+|..|
T Consensus 54 ~gv~iR~VasG~~aaH~vli~-------megk~~~w-----GRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnH 121 (443)
T KOG1427|consen 54 VGVNIRFVASGCAAAHCVLID-------MEGKCYTW-----GRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNH 121 (443)
T ss_pred ccceEEEEecccchhhEEEEe-------cccceeec-----ccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCc
Confidence 45567778877 46777777 78999999 999999999985444333332 27788999999
Q ss_pred eeeeeeCCeEEEecCCCCC-CCc---------cC----CCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCC-------
Q 040687 165 SCGGVRDGGIVCWGPDSES-LGV---------FN----VTESFKVLASGKSSLCGISELSGEVKCWGNNDFVS------- 223 (740)
Q Consensus 165 ~C~l~~~g~v~CwG~~~~~-~~~---------~~----~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~------- 223 (740)
+..|+.+|+|+.+|.|.+| .++ .| .+..+..|++|..++.-| +..+.+.-.|-..+||
T Consensus 122 Tl~ltdtG~v~afGeNK~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l-~~~~si~t~glp~ygqlgh~td~ 200 (443)
T KOG1427|consen 122 TLVLTDTGQVLAFGENKYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWL-SSTESILTAGLPQYGQLGHGTDN 200 (443)
T ss_pred EEEEecCCcEEEecccccccccccccccccccCCCccccCccceeeccccceEEEe-ecccceeecCCccccccccCcch
Confidence 9999999999999999875 111 11 245688999999999987 6689999999999988
Q ss_pred ---------------C-------CCCcccEEEEecccceeeeeeecCCcEEecCCCCCCCCC----CC------------
Q 040687 224 ---------------V-------PPVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVP----KN------------ 265 (740)
Q Consensus 224 ---------------~-------~~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~----~~------------ 265 (740)
. ...+.+.+.+|+|.+||.||. ++..||-||-+.||.+. ++
T Consensus 201 ~~~~~~~~~~~~~e~~pr~~~i~~~dgvqiv~~acg~nhtvavd-~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~ 279 (443)
T KOG1427|consen 201 EFNMKDSSVRLAYEAQPRPKAIASLDGVQIVKVACGTNHTVAVD-KNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDR 279 (443)
T ss_pred hhccccccceeeeecCCCccccccccceeeEEEeccCcceeeec-CCccEEEeccccccccccccchhhHHHHHHHHhcC
Confidence 0 112356889999999999998 99999999988888642 11
Q ss_pred --CceEEEEecCceeeEEEeCCceeecccccCCCC--CCCCCCcc
Q 040687 266 --SGFMAIASSDFTTCGIRENDLVLDCWFANVSSP--TDFDPPLE 306 (740)
Q Consensus 266 --~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~--~~~~~p~~ 306 (740)
..-..+-+|...+-.+ ..-+.|+-||.+..+. .-++-|+.
T Consensus 280 ~~rg~~~~~~g~t~Sl~v-~e~G~Lf~~g~~k~~ge~~mypkP~~ 323 (443)
T KOG1427|consen 280 NNRGPPNAILGYTGSLNV-AEGGQLFMWGKIKNNGEDWMYPKPMM 323 (443)
T ss_pred CCCCCcceeeecccceee-cccceeEEeeccccCcccccCCCchh
Confidence 1122333343333323 3677899999874322 23445554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.6e-12 Score=140.74 Aligned_cols=147 Identities=21% Similarity=0.216 Sum_probs=95.0
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc--------------------------------hhcH----
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII--------------------------------HTNI---- 524 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~--------------------------------~~~~---- 524 (740)
..|+. +.||+|++|.||+|++++ |+.||||+.++.... .+..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999988 999999998754210 0001
Q ss_pred --HHHHHHHHHHHhCC----CCCcceEEeEEEe-CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHH-HHHH
Q 040687 525 --REFEMELEVLCNIR----HSNIVNLLGYCLE-MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK-GLEY 596 (740)
Q Consensus 525 --~~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~-gL~y 596 (740)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++++.|.++-.-.....+... ++...++ -+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence 12455555555552 4444443333332 3567899999999999875321111122221 2222111 1233
Q ss_pred HHhCCCCCeEecCCCCCCEEECCCC----CEEEeecCCCcccc
Q 040687 597 LHKDAAPPIIHRDVKTLNILLDSDW----GARIADFGLLTSCE 635 (740)
Q Consensus 597 LH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DFGla~~~~ 635 (740)
++..+ ++|+|+||.||+++.++ .+++.|||++....
T Consensus 276 if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 44567 99999999999999988 99999999976543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-13 Score=158.39 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=171.0
Q ss_pred hcCccccceecccCceEEEEEEEeC--CcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD--GRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 557 (740)
...|...+.||+|+|+.|-...... ...+|+|.+...............|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3457777789999999998887633 456777766654422223334455777777776 9999999999999999999
Q ss_pred EEecCCCCChHHhH-hCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccc
Q 040687 558 VYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLH-KDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSC 634 (740)
Q Consensus 558 V~Ey~~~gsL~~~l-~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~ 634 (740)
++||..++++.+.+ +......+......+..|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999998 554435666677788999999999999 888 99999999999999999 9999999998654
Q ss_pred cC-C-------------C------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 635 ER-D-------------L------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 635 ~~-~-------------~------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
.. + . ......|+||.|+++.-+++|..|++...... +.....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------------~~~~~~ 243 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------------GRYSSW 243 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc------------ccceee
Confidence 43 1 0 11347899999999999999999987433221 111111
Q ss_pred ccccc--CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 IDRNV--ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ~d~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+... .............++..+++..+|+.|.+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11110 11111222235668888999999999999888764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.8e-13 Score=144.27 Aligned_cols=149 Identities=27% Similarity=0.359 Sum_probs=107.8
Q ss_pred eEEEEEecCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
..||.|+++...+|.++|..+. ...++...+.++.|++.+++| ++ .+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4789999999999999996443 457899999999999999999 66 899999999999999999999999997
Q ss_pred ccccCC---------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhC
Q 040687 632 TSCERD---------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQG 683 (740)
Q Consensus 632 ~~~~~~---------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 683 (740)
...... ..++.|+||||+|++|+||++ =..++... .+..-++.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------~t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------ATLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------HhhhhhhcC
Confidence 554332 224679999999999999998 33333210 011111111
Q ss_pred ccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHH
Q 040687 684 KAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQ 725 (740)
Q Consensus 684 ~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 725 (740)
.+. +......+ +=+.|++.++.+.|.+||++.+
T Consensus 476 ~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 476 IIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred CCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 111 11111112 2247999999999999994433
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.2e-11 Score=118.31 Aligned_cols=131 Identities=21% Similarity=0.147 Sum_probs=97.5
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-ceEEeEEEeCCeEEEEEecCCCC
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-VNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
.+.|+.|.++.||+.+.. ++.+++|....... ....+.+|+++++.+.+.++ .+++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 456899999999999864 77899998754421 12356789999998865554 4555543 33457999999998
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA--APPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
++.+.. . ....+..++++.|+.||... ...++|+|++|.||+++ +..++++||+.+..
T Consensus 77 ~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 876431 1 11245678999999999876 22369999999999999 66899999999753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.9e-12 Score=127.96 Aligned_cols=178 Identities=22% Similarity=0.296 Sum_probs=122.2
Q ss_pred HHHhCCCCCcceEEeEEEeCC-----eEEEEEecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 040687 533 VLCNIRHSNIVNLLGYCLEMG-----ERLLVYEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604 (740)
Q Consensus 533 ~l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 604 (740)
-|-.+.|.|||+++.|+.+.. +..+++|||+.|+|..+|++. ...+......+|+.||..||.|||+.. ||
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 344567999999999987653 468899999999999999753 245777888899999999999999975 88
Q ss_pred eEecCCCCCCEEECCCCCEEEeecCC---------CccccC----------------CCCCCcccceehhHHHHHHHHhC
Q 040687 605 IIHRDVKTLNILLDSDWGARIADFGL---------LTSCER----------------DLTTDMKSDVHNFGIVLLEILSG 659 (740)
Q Consensus 605 iiHrDlk~~NILl~~~~~~ki~DFGl---------a~~~~~----------------~~~~~~ksDVwSfGvvl~ElltG 659 (740)
|+|.++.-+.|++..++.+||.---- .+..+. ....+..+|||+||+-.+||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999998888743211 000000 11124589999999999999877
Q ss_pred CCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 660 RKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 660 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..--.... ..-.++ .....++ +....... ..++.+|++..|..||+|++++.
T Consensus 279 Eiq~tnse-S~~~~e--------e~ia~~i---~~len~lq-----r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSE-SKVEVE--------ENIANVI---IGLENGLQ-----RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCc-ceeehh--------hhhhhhe---eeccCccc-----cCcCcccccCCCCCCcchhhhhc
Confidence 64311110 000000 0011100 01111111 25888999999999999998864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-10 Score=115.03 Aligned_cols=143 Identities=21% Similarity=0.311 Sum_probs=112.1
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC--CCcceEEeEEEeCC---eEEEEEecC
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNLLGYCLEMG---ERLLVYEFM 562 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~ 562 (740)
+.|+.|.++.||+....+|+.+++|........ ....++.+|.++++.+++ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999999876789999987654321 134578999999999976 44677888776542 568999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA----------------------------------------- 601 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~----------------------------------------- 601 (740)
++.+|.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888876542 34777888888999999999998531
Q ss_pred ------------CCCeEecCCCCCCEEECC--CCCEEEeecCCCcc
Q 040687 602 ------------APPIIHRDVKTLNILLDS--DWGARIADFGLLTS 633 (740)
Q Consensus 602 ------------~~~iiHrDlk~~NILl~~--~~~~ki~DFGla~~ 633 (740)
...++|+|+++.|||++. +..+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135899999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.5e-10 Score=109.10 Aligned_cols=138 Identities=15% Similarity=0.122 Sum_probs=99.5
Q ss_pred ceecccCceEEEEEEEeC-------CcEEEEEEecccccc-------------------hhc-HHHHH----HHHHHHHh
Q 040687 488 NELGRGSYGFVYKAVLVD-------GRQVAVKRANAATII-------------------HTN-IREFE----MELEVLCN 536 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-------g~~vAiK~l~~~~~~-------------------~~~-~~~~~----~E~~~l~~ 536 (740)
..||.|.-+.||.|...+ +..+|||..+..... ..+ .+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998643 478999987643210 001 12233 89999999
Q ss_pred CCC--CCcceEEeEEEeCCeEEEEEecCCCCChHH-hHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCC
Q 040687 537 IRH--SNIVNLLGYCLEMGERLLVYEFMPRGTLHD-HLHGGLSPLNWSLRLKISMQAAKGLEYL-HKDAAPPIIHRDVKT 612 (740)
Q Consensus 537 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~iiHrDlk~ 612 (740)
+.. -++.+++.+ ...+|||||+.+..+.. .|++ ..++..+...+..+++..|.+| |..+ +||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 853 567777765 45679999997654422 2322 1345556677889999999999 7888 99999999
Q ss_pred CCEEECCCCCEEEeecCCCcccc
Q 040687 613 LNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 613 ~NILl~~~~~~ki~DFGla~~~~ 635 (740)
.|||+++ +.+.|+|||.+-...
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 679999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.6e-10 Score=105.54 Aligned_cols=144 Identities=24% Similarity=0.340 Sum_probs=105.7
Q ss_pred eecccCceEEEEEEEeCCcEEEEEEecccccchhc------HHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecC
Q 040687 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN------IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 562 (740)
.+.+|+-..+|.+.+. +.++.+|.=.++...... ...-.+|+.+|++++---|.--.=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4788999999999764 445666643332222221 234678999999886544433333555667778999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCCCCCc
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM 642 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 642 (740)
++-.|.+.|... ...++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+....... +.
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~E--d~ 147 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVE--DK 147 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHH--hh
Confidence 999999999754 2556777777888899999 99999999999998775 9999999987554433 66
Q ss_pred cccee
Q 040687 643 KSDVH 647 (740)
Q Consensus 643 ksDVw 647 (740)
..|+|
T Consensus 148 aVDl~ 152 (204)
T COG3642 148 AVDLH 152 (204)
T ss_pred hchHH
Confidence 78887
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-10 Score=128.95 Aligned_cols=227 Identities=22% Similarity=0.250 Sum_probs=161.6
Q ss_pred ccccceecc--cCceEEEEEEE---eCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 484 FKEFNELGR--GSYGFVYKAVL---VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 484 ~~~~~~LG~--G~fG~Vy~~~~---~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
|...+.+|+ |.+|.||.+.. .++..+|+|+-+...........-.+|+...+++ .|+|.++.+..++..+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 556677999 99999999986 3478899997443322112223345677777777 49999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCCCc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK----GLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGLLT 632 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGla~ 632 (740)
-+|++. .+|.++.+.....++...++.+..+... ||.++|+.. ++|-|+||.||++..+ ...++.|||+..
T Consensus 196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeE
Confidence 999985 7999998876555667777777777777 999999988 9999999999999999 789999999865
Q ss_pred cccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch
Q 040687 633 SCER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA 687 (740)
Q Consensus 633 ~~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (740)
.+.. +..++.++|+|++|.+.+|-.++..+....+... | ..+++..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----W--~~~r~~~--- 342 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----W--SQLRQGY--- 342 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC----c--ccccccc---
Confidence 4432 1123568999999999999999877654332111 0 0000100
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+....-.....++...+..+++.+|..|++...+..
T Consensus 343 -----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 -----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 010111111224445888899999999998877654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-09 Score=101.53 Aligned_cols=157 Identities=20% Similarity=0.226 Sum_probs=109.1
Q ss_pred ccceecccCceEEEEEEEeCCcEEEEEEecccccchh------cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 486 EFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT------NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
....|-+|+-+.|+++.+ .|+...||.-..+..... ..+.-++|+++|.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456788999999999987 567767764222221111 2345788999999886444333233444555566899
Q ss_pred ecCCC-CChHHhHhCCCCCCCHHH-HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---CEEEeecCCCccc
Q 040687 560 EFMPR-GTLHDHLHGGLSPLNWSL-RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW---GARIADFGLLTSC 634 (740)
Q Consensus 560 Ey~~~-gsL~~~l~~~~~~l~~~~-~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki~DFGla~~~ 634 (740)
||+++ -++.+++...-..-...+ ...++.+|-+-+.-||... |||+||..+||+|..++ .+.++||||+...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99976 478888865432222233 3678889999999999999 99999999999996654 4689999998654
Q ss_pred cCCCCCCcccceeh
Q 040687 635 ERDLTTDMKSDVHN 648 (740)
Q Consensus 635 ~~~~~~~~ksDVwS 648 (740)
.... +..+|+|=
T Consensus 167 ~~~E--DKgVDLYV 178 (229)
T KOG3087|consen 167 RLPE--DKGVDLYV 178 (229)
T ss_pred cCcc--cccceeee
Confidence 3333 56788884
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=128.99 Aligned_cols=242 Identities=18% Similarity=0.194 Sum_probs=170.0
Q ss_pred ccChhH-HHHhhcCccccceecccCceEEEEEEEe--CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEE
Q 040687 471 VFRLSE-LKDATNGFKEFNELGRGSYGFVYKAVLV--DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLL 546 (740)
Q Consensus 471 ~~~~~~-l~~~~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 546 (740)
+|...+ ....+.+|.++..||.+.|+.|++...+ ++..+++|.+............-..|+.+...+ .|.|++++.
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 4455678999999999999999997753 477899998776543222222224566665555 588999888
Q ss_pred eEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEE
Q 040687 547 GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARI 625 (740)
Q Consensus 547 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki 625 (740)
..+......|+=.||++++++...+.- ...++...++++..|++.++.++|+.. ++|+|+||+||++.++ +.-++
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhc
Confidence 777777778899999999998877632 235778888999999999999999888 9999999999999986 78899
Q ss_pred eecCCCcccc--------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 626 ADFGLLTSCE--------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 626 ~DFGla~~~~--------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
.||+.+..+. ++...-.|.|++|||.-+.|.+++..--. . . ...
T Consensus 409 ~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~-----~----------~~~ 472 (524)
T KOG0601|consen 409 GDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-S-----G----------VQS 472 (524)
T ss_pred cccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCc-c-----c----------ccc
Confidence 9999874211 11222458999999999999998764321 1 0 011
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
..+......... ....++..+.+.+..+++..||.+.++....+...
T Consensus 473 ~~i~~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 LTIRSGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred eeeecccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111111111111 11135567888899999999999988876555443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-08 Score=113.36 Aligned_cols=147 Identities=20% Similarity=0.224 Sum_probs=114.4
Q ss_pred eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHH
Q 040687 504 VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR 583 (740)
Q Consensus 504 ~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~ 583 (740)
.++.+|.|...+.... .......+-++.|+.|+||||++++...+..+..|||+|-+. -|..++.+ +.-...
T Consensus 35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHH
Confidence 4577888877665442 223446677888999999999999999999999999999884 57777764 334555
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC-----------CC--------Cccc
Q 040687 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-----------TT--------DMKS 644 (740)
Q Consensus 584 ~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~-----------~~--------~~ks 644 (740)
-..+.||+.||.|||+++. ++|.+|.-..|++++.+..||.+|-++....... .. +...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s~ 184 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWSI 184 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccch
Confidence 5678999999999997663 9999999999999999999999998764332211 00 1234
Q ss_pred ceehhHHHHHHHHhCC
Q 040687 645 DVHNFGIVLLEILSGR 660 (740)
Q Consensus 645 DVwSfGvvl~ElltG~ 660 (740)
|.|-||++++|++.|.
T Consensus 185 D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhHHHHHHHHhCcc
Confidence 9999999999999993
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3e-08 Score=111.13 Aligned_cols=251 Identities=16% Similarity=0.196 Sum_probs=161.4
Q ss_pred ceEEEccCCCCCCCCCCCCCCCCccccCCC-------ceEEeccCCeEeEEecCCCceEeccCCCC--CCCC--cc-ccc
Q 040687 23 QDVICWAKNSSSPSSSFLSANSASFSNIPS-------MAVLSGGEGLLCGILANTSQAFCWSSNSS--PGNT--TD-LVP 90 (740)
Q Consensus 23 ~~v~cwg~n~~gqlg~~~~~~~~~~~~v~~-------~~~i~~G~~~~Cal~~~~~~~~cWg~~~~--~g~g--~~-~~~ 90 (740)
..|+-||.|.+..||.|+..+...|..|.- +..+..+..|.--+...+ ++|.-|-+.. +|.| |. .+|
T Consensus 142 ndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl~~kg-qvY~cGhG~GGRlG~gdeq~~~iP 220 (1267)
T KOG0783|consen 142 NDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFLTEKG-QVYVCGHGAGGRLGFGDEQYNFIP 220 (1267)
T ss_pred cceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEecCCC-cEEEeccCCCCccCcCcccccccc
Confidence 389999999999999998888888887731 257788888888886553 5988876543 4444 22 566
Q ss_pred -cc--ccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccccc-cc---------ee-eEE
Q 040687 91 -SV--YKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEY-VS---------TI-VLK 156 (740)
Q Consensus 91 -~~--~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~-~~---------~~-~~~ 156 (740)
+| +.+..+.+||+-..|+.+|+ .+|.||-| |.|..+|||..+..... .| +. .+.
T Consensus 221 krV~gL~gh~~~qisvs~~HslvLT-------~~g~Vys~-----GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iI 288 (1267)
T KOG0783|consen 221 KRVPGLIGHKVIQISVSHTHSLVLT-------KFGSVYSW-----GLNGSHQLGLSNDELKKDDPIQITARRIKGFKQII 288 (1267)
T ss_pred cccccccccceEEEEeecceeEEEe-------ecceEEEe-----ecCcccccCCcCchhhcCchhhhhhHhhcchhhhh
Confidence 33 34679999999999999999 89999999 99999999965322211 11 11 267
Q ss_pred EEEecCCeeeeeeeCCeEEEecCCCCCCCccCC-------------CCcEEEEee-CCceeeeeecCCCcEEEeecCCCC
Q 040687 157 DVISGDGFSCGGVRDGGIVCWGPDSESLGVFNV-------------TESFKVLAS-GKSSLCGISELSGEVKCWGNNDFV 222 (740)
Q Consensus 157 ~ia~G~~~~C~l~~~g~v~CwG~~~~~~~~~~~-------------~~~~~~iaa-G~~h~Cai~~~~g~v~CWG~n~~g 222 (740)
.|+||+.|+-+-+ +..||-||-|..+.+..+. ...+.-++| -+..+|-+ . ++.++|.-+-..-
T Consensus 289 gvaAg~~hsVawt-~~~VY~wGlN~GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~-~-~~~i~~~ady~~~ 365 (1267)
T KOG0783|consen 289 GVAAGKSHSVAWT-DTDVYSWGLNNGQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLL-Q-NNSIIAFADYNQV 365 (1267)
T ss_pred hhhcccceeeeee-cceEEEecccCceecCCCCCceeecchhhcccccceEEEEecCccEEEEe-c-CCcEEEEecccce
Confidence 8999999999864 5579999998775443221 122344444 44456655 5 7889998753211
Q ss_pred CCCCCcc-----------------cEEEEecccceeeeeeecCCcEEecCCCCCCC------CCCCCceEEEEecCceee
Q 040687 223 SVPPVGI-----------------RFVSLAAGANHFCGIREDNHGVECWGSFNYSS------VPKNSGFMAIASSDFTTC 279 (740)
Q Consensus 223 ~~~~~~~-----------------~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~------~~~~~~~~~i~ag~~~~C 279 (740)
-.++... .+....|-..---+++ +-|.|+||=.++... ++.-.....|+--.+-.
T Consensus 366 k~~~n~~~lks~~V~gg~l~~~~~~~~k~~a~~~kll~lt-e~g~Vy~w~s~ns~~~~c~ftp~r~~~isdIa~~~N~~- 443 (1267)
T KOG0783|consen 366 KLPFNVDFLKSLKVTGGPLSLTRFNVRKLLASENKLLVLT-ELGEVYEWDSKNSTRTSCKFTPLRIFEISDIAWTANSL- 443 (1267)
T ss_pred ecCcchhccceeEEecCccchhhhhhhhcchhhhheeeec-cCCeEEEEecCCCceeeeecccceeeehhhhhhccceE-
Confidence 1111111 1223333334445556 899999999665542 22223334444333332
Q ss_pred EEEeCCceeeccccc
Q 040687 280 GIRENDLVLDCWFAN 294 (740)
Q Consensus 280 g~~~~~~~~~cWG~n 294 (740)
-+.+.|+ ||-++
T Consensus 444 ~~~t~dG---c~~Rg 455 (1267)
T KOG0783|consen 444 ILCTRDG---CWKRG 455 (1267)
T ss_pred EEEecCc---ceehh
Confidence 2335777 88665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.3e-07 Score=98.74 Aligned_cols=133 Identities=14% Similarity=0.131 Sum_probs=97.2
Q ss_pred EEEEEEEeCCcEEEEEEecccccch---------hcHHHHHHHHHHHHhCCCC--CcceEEeEEEeC-----CeEEEEEe
Q 040687 497 FVYKAVLVDGRQVAVKRANAATIIH---------TNIREFEMELEVLCNIRHS--NIVNLLGYCLEM-----GERLLVYE 560 (740)
Q Consensus 497 ~Vy~~~~~~g~~vAiK~l~~~~~~~---------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~-----~~~~lV~E 560 (740)
.|.+..+ +|+.+.||+........ .-...+.+|...+.++... ..+.++++.+.. ..-+||||
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4666655 67889999765433110 0011478899999888433 344556665432 35689999
Q ss_pred cCCCC-ChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-------CCCEEEeecCCC
Q 040687 561 FMPRG-TLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-------DWGARIADFGLL 631 (740)
Q Consensus 561 y~~~g-sL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-------~~~~ki~DFGla 631 (740)
++++- +|.+++... ..+.+...+..++.++++.+.-||..+ |+|+|++++|||++. +..+.++||+.+
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99886 899998532 234566677789999999999999999 999999999999985 468999999988
Q ss_pred cc
Q 040687 632 TS 633 (740)
Q Consensus 632 ~~ 633 (740)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 54
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.1e-09 Score=69.64 Aligned_cols=29 Identities=34% Similarity=0.864 Sum_probs=14.8
Q ss_pred EEEeeCCceeeeeecCCCcEEEeecCCCCC
Q 040687 194 KVLASGKSSLCGISELSGEVKCWGNNDFVS 223 (740)
Q Consensus 194 ~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~ 223 (740)
++||+|.+|+|+|++ ||+|+|||.|.+||
T Consensus 2 ~~ia~G~~ht~al~~-~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 2 VQIACGGYHTCALTS-DGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEESSEEEEEE--TTEEEEEE--TTST
T ss_pred EEEEecCCEEEEEEc-CCCEEEEcCCcCCC
Confidence 455666666666532 56666666555554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.1e-07 Score=101.26 Aligned_cols=162 Identities=22% Similarity=0.296 Sum_probs=126.0
Q ss_pred eEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCeEEEEEecCCC-CChHH
Q 040687 496 GFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MGERLLVYEFMPR-GTLHD 569 (740)
Q Consensus 496 G~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~ 569 (740)
.+.||+.. .||..|.+||+........ ..-..-++.++++.|.|+|.|..++.. ...+.|||+|.|+ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 46789885 5799999999954332111 122345788999999999999988873 3468899999986 57777
Q ss_pred hHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 570 HLHGGL--------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 570 ~l~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+-.... ..+++..++.++.|+..||.++|+.+ +.-+-|.+++||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 653211 23577899999999999999999999 8889999999999999999999888876665
Q ss_pred CCCCC----CcccceehhHHHHHHHHhCCCC
Q 040687 636 RDLTT----DMKSDVHNFGIVLLEILSGRKA 662 (740)
Q Consensus 636 ~~~~~----~~ksDVwSfGvvl~ElltG~~p 662 (740)
.+... -.+-|.=-||.+++-|.||..-
T Consensus 445 ~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEPLESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcchhHHhhhhHHHHHHHHHHHhhcccc
Confidence 54422 2467888999999999999654
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.6e-09 Score=70.13 Aligned_cols=30 Identities=37% Similarity=0.851 Sum_probs=25.1
Q ss_pred EEEEecccceeeeeeecCCcEEecCCCCCCC
Q 040687 231 FVSLAAGANHFCGIREDNHGVECWGSFNYSS 261 (740)
Q Consensus 231 ~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~ 261 (740)
+++|++|.+|+|+|+ +||+|+|||.|++||
T Consensus 1 V~~ia~G~~ht~al~-~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALT-SDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE--TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEE-cCCCEEEEcCCcCCC
Confidence 578999999999999 899999999999987
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.5e-08 Score=107.19 Aligned_cols=169 Identities=18% Similarity=0.284 Sum_probs=118.0
Q ss_pred ceEeccCCCC--CCCC--cc-ccc-ccc----cCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccc
Q 040687 72 QAFCWSSNSS--PGNT--TD-LVP-SVY----KNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQ 141 (740)
Q Consensus 72 ~~~cWg~~~~--~g~g--~~-~~~-~~~----~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg 141 (740)
.+|-||.|.. +|.| +. ..| +|. .+.-+.+|+.+..|+-.+. .-|.||.. |-+..|.||
T Consensus 143 dvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl~-------~kgqvY~c-----GhG~GGRlG 210 (1267)
T KOG0783|consen 143 DVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFLT-------EKGQVYVC-----GHGAGGRLG 210 (1267)
T ss_pred ceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEec-------CCCcEEEe-----ccCCCCccC
Confidence 5999999965 4444 33 344 332 1335678999999999998 67899999 666677777
Q ss_pred ccc----cccccccee---eEEEEEecCCeeeeeeeCCeEEEecCCCC-CCCccCCC-----------------CcEEEE
Q 040687 142 TNL----FYDEYVSTI---VLKDVISGDGFSCGGVRDGGIVCWGPDSE-SLGVFNVT-----------------ESFKVL 196 (740)
Q Consensus 142 ~~~----~~~~~~~~~---~~~~ia~G~~~~C~l~~~g~v~CwG~~~~-~~~~~~~~-----------------~~~~~i 196 (740)
.|. +.+...+++ .+.+||+-..|+-+|+.+|.|+-||-|.. +++..+.. ..+..+
T Consensus 211 ~gdeq~~~iPkrV~gL~gh~~~qisvs~~HslvLT~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgv 290 (1267)
T KOG0783|consen 211 FGDEQYNFIPKRVPGLIGHKVIQISVSHTHSLVLTKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGV 290 (1267)
T ss_pred cCcccccccccccccccccceEEEEeecceeEEEeecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhh
Confidence 663 222223332 38999999999999999999999999866 33333321 135689
Q ss_pred eeCCceeeeeecCCCcEEEeecCCCCC----------CCC-----CcccEEEEecccceeeeeeecCCcEEecCC
Q 040687 197 ASGKSSLCGISELSGEVKCWGNNDFVS----------VPP-----VGIRFVSLAAGANHFCGIREDNHGVECWGS 256 (740)
Q Consensus 197 aaG~~h~Cai~~~~g~v~CWG~n~~g~----------~~~-----~~~~~~~la~G~~h~C~l~~~~g~v~CWG~ 256 (740)
+||..|+-|. . +-.||-||-|. || .+| ....+..++|-..-|-.++ .++.++|.-+
T Consensus 291 aAg~~hsVaw-t-~~~VY~wGlN~-GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~-~~~~i~~~ad 361 (1267)
T KOG0783|consen 291 AAGKSHSVAW-T-DTDVYSWGLNN-GQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLL-QNNSIIAFAD 361 (1267)
T ss_pred hcccceeeee-e-cceEEEecccC-ceecCCCCCceeecchhhcccccceEEEEecCccEEEEe-cCCcEEEEec
Confidence 9999999999 4 68899999874 45 122 1234666666555443444 4889999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.6e-08 Score=95.29 Aligned_cols=128 Identities=23% Similarity=0.255 Sum_probs=83.1
Q ss_pred EEEEEEEeCCcEEEEEEecccccc-------------------h-----hcHHHHHHHHHHHHhCCCC--CcceEEeEEE
Q 040687 497 FVYKAVLVDGRQVAVKRANAATII-------------------H-----TNIREFEMELEVLCNIRHS--NIVNLLGYCL 550 (740)
Q Consensus 497 ~Vy~~~~~~g~~vAiK~l~~~~~~-------------------~-----~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 550 (740)
.||.|...++..+|||..+..... . .......+|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999989999999986642100 0 0122467899999999765 577777552
Q ss_pred eCCeEEEEEecCC--CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 551 EMGERLLVYEFMP--RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY-LHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 551 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~y-LH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
...|||||++ +..+....... ++..+...+..++++.+.. +|..+ |||+||.+.|||++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 3469999998 54444333221 1133445677778776666 47888 9999999999999988 999999
Q ss_pred cCCCcccc
Q 040687 628 FGLLTSCE 635 (740)
Q Consensus 628 FGla~~~~ 635 (740)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.1e-09 Score=120.02 Aligned_cols=228 Identities=22% Similarity=0.282 Sum_probs=154.2
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchh-cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHT-NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
..+.|...+.+-++.|+.++..+-.. +...++|.......... ..+....+-.++-..+||-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44677777888999999999876422 43445554433322222 23344444445444566777766555555678899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc--
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE-- 635 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~-- 635 (740)
|++|..+++|...|++.. ..+..........+...++|||... ++|||+||.|+|+..++..+++||++.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999998653 3444444455666788999999876 8999999999999999999999998432110
Q ss_pred -------------------C---------C----------------------CCCCcccceehhHHHHHHHHhCCCCCCC
Q 040687 636 -------------------R---------D----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDI 665 (740)
Q Consensus 636 -------------------~---------~----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~ 665 (740)
. + .......|.|++|+.++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 0002367999999999999999999975
Q ss_pred CCCCchhHHhhhhHHhhCccchhcccccCCCC-CchhHHHHHHHHHHhhhcCCCCCCCHH
Q 040687 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPR-NVEPLFKLADIAELAIRENPSELPTMS 724 (740)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 724 (740)
.... ..+..++...+..+. +.+...+..+++...+..+|.+|-.+.
T Consensus 1038 ~tpq-------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ-------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchh-------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4321 122334444444443 223334566888899999999997765
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.4e-07 Score=105.71 Aligned_cols=192 Identities=19% Similarity=0.231 Sum_probs=120.3
Q ss_pred eccCCeEeEEecCCCceEeccCCCCCCCCcccccccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCc
Q 040687 57 SGGEGLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNT 136 (740)
Q Consensus 57 ~~G~~~~Cal~~~~~~~~cWg~~~~~g~g~~~~~~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~ 136 (740)
..|.+|+-++.+.++.+|-.|...---|-....-.-+.+.-++++|.|..|.||+. .+|.+|.| |-|.
T Consensus 574 v~~s~~VY~~vSenGkifM~G~~tm~~n~SSqmln~L~~~~isslAlGKsH~~av~-------rNG~l~T~-----GlNN 641 (3738)
T KOG1428|consen 574 VCASGHVYGYVSENGKIFMGGLHTMRVNVSSQMLNGLDNVMISSLALGKSHGVAVT-------RNGHLFTW-----GLNN 641 (3738)
T ss_pred EeeeeEEEEEEccCCeEEeecceeEEecchHHHhhccccceeehhhccccceeEEE-------eCCeEEEE-----ecCC
Confidence 34567888887766667766653210000000001123456889999999999999 78999999 8888
Q ss_pred cCcccccc----cc-cc---------cccee-e----------EEEEEecCCeeeeeee--CCeEEEecCCCCC------
Q 040687 137 LSSVQTNL----FY-DE---------YVSTI-V----------LKDVISGDGFSCGGVR--DGGIVCWGPDSES------ 183 (740)
Q Consensus 137 ~gqlg~~~----~~-~~---------~~~~~-~----------~~~ia~G~~~~C~l~~--~g~v~CwG~~~~~------ 183 (740)
.+|.|.-. .. .+ .+++. . .-..-+|.+-+|+-.- .|++-=-|.+.++
T Consensus 642 ~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~GES~C~~CG~ 721 (3738)
T KOG1428|consen 642 MNQCGRVESTSTTSSPRHSGRQEYQICPIGEHTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGVGESTCLRCGL 721 (3738)
T ss_pred cccccccccccccCCcccccceeecccCCccceeecCCcchhhhcccccccccccccCCCCCCcccccCCCcccceeccc
Confidence 88888421 00 00 11110 0 1123344444454321 2222111222211
Q ss_pred --------------------------------------CCccCCCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCC--
Q 040687 184 --------------------------------------LGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVS-- 223 (740)
Q Consensus 184 --------------------------------------~~~~~~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~-- 223 (740)
....|-..++++|++|..|+-.+ .+|++|+-+|.|-+||
T Consensus 722 Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~~HPs~V~~sq~~Hdvkv~sVSCG~~HtVlL-~sd~~VfTFG~~~HGQLG 800 (3738)
T KOG1428|consen 722 CRPCGEVTEPAQPGRAQHVQFSSTAAPQRSTLHPSRVILSQGPHDVKVSSVSCGNFHTVLL-ASDRRVFTFGSNCHGQLG 800 (3738)
T ss_pred cccccCcCCcCCCCHHHhheecccccccccccCchheeeccCCcceeEEEEeccCceEEEE-ecCCcEEEecCCcccccC
Confidence 00011123588999999999987 6699999999999999
Q ss_pred -------------CCCCcccEEEEecccceeeeeeecCCcEEecCCCCCCCC
Q 040687 224 -------------VPPVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSV 262 (740)
Q Consensus 224 -------------~~~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~ 262 (740)
..|.++..++++||.+||-... .||+|..+|.-..||+
T Consensus 801 ~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~l~~-~DGsVFTFGaF~KGQL 851 (3738)
T KOG1428|consen 801 VGDTLSKNTPQQVILPSDTVIVQVAAGSNHTILRA-NDGSVFTFGAFGKGQL 851 (3738)
T ss_pred cCccccCCCcceEEcCCCCceEEEecCCCceEEEe-cCCcEEEeccccCccc
Confidence 2344567899999999998877 9999999998888885
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.9e-06 Score=96.74 Aligned_cols=68 Identities=19% Similarity=0.210 Sum_probs=57.4
Q ss_pred ccEEEEecccceeeeeeecCCcEEecCCCCCCCC----------------CCCCceEEEEecCceeeEEEeCCceeeccc
Q 040687 229 IRFVSLAAGANHFCGIREDNHGVECWGSFNYSSV----------------PKNSGFMAIASSDFTTCGIRENDLVLDCWF 292 (740)
Q Consensus 229 ~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~----------------~~~~~~~~i~ag~~~~Cg~~~~~~~~~cWG 292 (740)
..+++++.|.+|+-.|. +|+.|+.+|.|.+||+ |.++..++++||++||- ++..|++|+.+|
T Consensus 767 vkv~sVSCG~~HtVlL~-sd~~VfTFG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~-l~~~DGsVFTFG 844 (3738)
T KOG1428|consen 767 VKVSSVSCGNFHTVLLA-SDRRVFTFGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTI-LRANDGSVFTFG 844 (3738)
T ss_pred eeEEEEeccCceEEEEe-cCCcEEEecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceE-EEecCCcEEEec
Confidence 46899999999999997 9999999999999984 44456899999999985 556999999998
Q ss_pred ccCCCC
Q 040687 293 ANVSSP 298 (740)
Q Consensus 293 ~n~~~~ 298 (740)
.-..++
T Consensus 845 aF~KGQ 850 (3738)
T KOG1428|consen 845 AFGKGQ 850 (3738)
T ss_pred cccCcc
Confidence 754444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=88.24 Aligned_cols=107 Identities=23% Similarity=0.220 Sum_probs=85.4
Q ss_pred HHHHHHHHHHHhCC--CCCcceEEeEEEeCC----eEEEEEecCCCC-ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 040687 525 REFEMELEVLCNIR--HSNIVNLLGYCLEMG----ERLLVYEFMPRG-TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597 (740)
Q Consensus 525 ~~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yL 597 (740)
....+|...+.+|. .-...+.+++.+... .-+||+|++++- +|.+++..... ++......++.++++.+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45778888888774 334567777766542 458999999884 79999875322 55667788999999999999
Q ss_pred HhCCCCCeEecCCCCCCEEECCCC---CEEEeecCCCcccc
Q 040687 598 HKDAAPPIIHRDVKTLNILLDSDW---GARIADFGLLTSCE 635 (740)
Q Consensus 598 H~~~~~~iiHrDlk~~NILl~~~~---~~ki~DFGla~~~~ 635 (740)
|..+ |+|+|+++.|||++.+. .+.++||+.++...
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 99999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2e-06 Score=87.45 Aligned_cols=137 Identities=20% Similarity=0.183 Sum_probs=96.0
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccc--------------------hhcHHHHHHHHHHHHhCCCC--C
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATII--------------------HTNIREFEMELEVLCNIRHS--N 541 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~--------------------~~~~~~~~~E~~~l~~l~H~--n 541 (740)
....++||-|.-+.||.+...++.++|||.=+....+ ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3455789999999999999999999999964322110 01123467899999999755 7
Q ss_pred cceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 542 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
+.+.+++ +.-.+||||+++-.|...-- ..-.... |...|++-+.-+-..+ |||+|+.+-|||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 7777765 45679999998866644321 1122333 3334444444444566 99999999999999999
Q ss_pred CEEEeecCCCcc
Q 040687 622 GARIADFGLLTS 633 (740)
Q Consensus 622 ~~ki~DFGla~~ 633 (740)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-05 Score=79.22 Aligned_cols=140 Identities=16% Similarity=0.074 Sum_probs=102.1
Q ss_pred ecccCceEEEEEEEeCCcEEEEEEeccccc---c-hhcHHHHHHHHHHHHhCCC--CCcceEEeEEEeC----CeEEEEE
Q 040687 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATI---I-HTNIREFEMELEVLCNIRH--SNIVNLLGYCLEM----GERLLVY 559 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~---~-~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~----~~~~lV~ 559 (740)
-++|+-+-|++-.+ +|..+-+|+-..... . .-....|.+|+..|.+|.. -.+.+.+...... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46688888998766 445788887552211 0 1235679999999998853 3355555222221 2468999
Q ss_pred ecCCC-CChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC--EEEeecCCCcc
Q 040687 560 EFMPR-GTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG--ARIADFGLLTS 633 (740)
Q Consensus 560 Ey~~~-gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~ki~DFGla~~ 633 (740)
|-+++ -+|.+++.+.. .+.+..++..+..++++.+.-||..+ +.|+|+-+.|||++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 48999886532 35677888899999999999999999 999999999999986666 99999976543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-06 Score=96.26 Aligned_cols=142 Identities=20% Similarity=0.212 Sum_probs=94.8
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccc--------------------hh------------------cHHHHHH
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATII--------------------HT------------------NIREFEM 529 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~--------------------~~------------------~~~~~~~ 529 (740)
+.|+.++-|.||+|++++|+.||||+.++.... .. ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 468999999999999999999999987753210 00 0112455
Q ss_pred HHHHHHhCC-----CCCcceEEeEE-EeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 040687 530 ELEVLCNIR-----HSNIVNLLGYC-LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKG-LEYLHKDAA 602 (740)
Q Consensus 530 E~~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~g-L~yLH~~~~ 602 (740)
|..-+.+++ .+++ ++=.++ +-.+...|+|||++|-.+.+...-....++-+.+ +..+++. +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHHhcC-
Confidence 666665552 2333 222233 2346778999999999898885333234553333 3333322 23333456
Q ss_pred CCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
++|.|..|.||+++.++.+.+.|||+.....+
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999765543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=78.67 Aligned_cols=138 Identities=14% Similarity=0.172 Sum_probs=85.4
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC--cceEEeEEEeCCeEEEEEecCCCC
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN--IVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
.+|++|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+.+....+...+|||++++.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46999999999983 35567788775422 2245688999999886433 467788877777788999999886
Q ss_pred C-hHHh---------------------HhCCC-CCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEecC
Q 040687 566 T-LHDH---------------------LHGGL-SPLNWSLRLK-ISM----------QAAK-GLEYLHKD-AAPPIIHRD 609 (740)
Q Consensus 566 s-L~~~---------------------l~~~~-~~l~~~~~~~-ia~----------~ia~-gL~yLH~~-~~~~iiHrD 609 (740)
+ +... ||.-. .......... +.. .+.+ ..++|... ..+.++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 2111 12110 0111111000 000 0111 12233221 123578999
Q ss_pred CCCCCEEECCCCCEEEeecCCCcc
Q 040687 610 VKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 610 lk~~NILl~~~~~~ki~DFGla~~ 633 (740)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=2e-05 Score=78.01 Aligned_cols=102 Identities=24% Similarity=0.255 Sum_probs=81.6
Q ss_pred HHHHHHHHhCCC-CCcceEEeEEEeCCeEEEEEecCCCCChHHhHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 040687 528 EMELEVLCNIRH-SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG--GLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604 (740)
Q Consensus 528 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 604 (740)
.+|..+|+.+++ +++.+++|+|- .++|+||...+++...-.. .....+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888976 69999999993 3679999987766422100 1123689999999999999999999865555
Q ss_pred eEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 605 IIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 605 iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
+.-.|++++|+-+++++.+|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.0001 Score=73.66 Aligned_cols=139 Identities=17% Similarity=0.232 Sum_probs=91.2
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchh-cHHH------HHHHHHHHHhCCC---CCcceEEeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT-NIRE------FEMELEVLCNIRH---SNIVNLLGYCL 550 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~-~~~~------~~~E~~~l~~l~H---~niv~l~g~~~ 550 (740)
.++|+..+.+-......|.+-.. +++.+.+|..+......+ .... ..+++..+.+++- -....++-+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45677777777776666666654 678899998765432211 1111 2334444444432 22333333333
Q ss_pred eC-----CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEE
Q 040687 551 EM-----GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI 625 (740)
Q Consensus 551 ~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 625 (740)
.. ...+|||||+++-.|.++.. ++. .++..++..|.-||..+ ++|+|+.|.|++++++ .+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEE
Confidence 22 34578999999988877643 222 24566778899999999 9999999999999865 4999
Q ss_pred eecCCCcc
Q 040687 626 ADFGLLTS 633 (740)
Q Consensus 626 ~DFGla~~ 633 (740)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=6e-05 Score=76.63 Aligned_cols=142 Identities=25% Similarity=0.260 Sum_probs=85.0
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC--CcceEEeEEEeC---CeEEEEEec
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS--NIVNLLGYCLEM---GERLLVYEF 561 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~Ey 561 (740)
.+.|+.|....||+....+ +.+++|..... .....+.+|..+++.|... .+.+++.+.... ...+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 4578999999999999866 68999986553 2335677888888888533 356777655433 357899999
Q ss_pred CCCCChHH----------------hH---hCC---CCCCCHHH---------HHHH------------HHHHHH-HHHHH
Q 040687 562 MPRGTLHD----------------HL---HGG---LSPLNWSL---------RLKI------------SMQAAK-GLEYL 597 (740)
Q Consensus 562 ~~~gsL~~----------------~l---~~~---~~~l~~~~---------~~~i------------a~~ia~-gL~yL 597 (740)
+++..+.+ .| +.. ..++.+.. .... ...+.+ .++.+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99887777 11 111 11111111 0000 112222 33333
Q ss_pred Hh----CCCCCeEecCCCCCCEEEC-CCCCEEEeecCCCcc
Q 040687 598 HK----DAAPPIIHRDVKTLNILLD-SDWGARIADFGLLTS 633 (740)
Q Consensus 598 H~----~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGla~~ 633 (740)
+. .....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 32 1334599999999999999 556668999988643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.9e-06 Score=63.08 Aligned_cols=45 Identities=16% Similarity=0.271 Sum_probs=38.4
Q ss_pred CCcceEEEccCCCCCCCC-CCCCCCCCccccCC-----CceEEeccCCeEeEE
Q 040687 20 SGKQDVICWAKNSSSPSS-SFLSANSASFSNIP-----SMAVLSGGEGLLCGI 66 (740)
Q Consensus 20 ~g~~~v~cwg~n~~gqlg-~~~~~~~~~~~~v~-----~~~~i~~G~~~~Cal 66 (740)
|| .||+||.|.+|||| .++..+...|..|+ .+..|++|+.|+.+|
T Consensus 1 dG--~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DG--RVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TS--EEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CC--cEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 46 99999999999999 77777778888773 368999999999986
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00011 Score=78.69 Aligned_cols=239 Identities=17% Similarity=0.179 Sum_probs=137.3
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE------eCC-eEE
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL------EMG-ERL 556 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~------~~~-~~~ 556 (740)
...+.||+|+.+.+|----. +..|| |+........+ .+-+..|.+. .||-+-.-+.+-. ++. ..-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchh-hchhh-eeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34567999999999853211 22233 55544331111 1123334443 5654433121111 112 234
Q ss_pred EEEecCCCC-ChHHhHh-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC-
Q 040687 557 LVYEFMPRG-TLHDHLH-----GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG- 629 (740)
Q Consensus 557 lV~Ey~~~g-sL~~~l~-----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG- 629 (740)
++|..+++. -..++++ .+....+|..+++.+..+|.+.+-||..+ .+-+|+.++|+|+.++..+.+.|-.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 566666543 2233332 12234799999999999999999999999 8889999999999999999887632
Q ss_pred --C-------------CccccCC---------CCCCcccceehhHHHHHHHHhC-CCCCCCCC---CCchhHHhhhhHHh
Q 040687 630 --L-------------LTSCERD---------LTTDMKSDVHNFGIVLLEILSG-RKAYDIEY---VPPGIVEWALPLIK 681 (740)
Q Consensus 630 --l-------------a~~~~~~---------~~~~~ksDVwSfGvvl~ElltG-~~p~~~~~---~~~~~~~~~~~~~~ 681 (740)
+ +.....+ ...+..+|-|.++|++++|+.| +.||..-. ...+-.| ..|.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia 240 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIA 240 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhh
Confidence 2 1111111 1125689999999999999994 99997531 1111111 0111
Q ss_pred hCccchhccccc-CCCCCch-----hHHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHh
Q 040687 682 QGKAAAIIDRNV-ALPRNVE-----PLFKLADIAELAIRE--NPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 682 ~~~~~~i~d~~~-~~~~~~~-----~~~~l~~l~~~Cl~~--dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.+...-+.+. ..|.+.+ ....+.-|..+|+.. ++.-||+.+--+..|..+.++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 222211111111 1111111 122455788889875 466899999988888776543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00012 Score=75.57 Aligned_cols=138 Identities=20% Similarity=0.191 Sum_probs=84.9
Q ss_pred ecccCc-eEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEecCCCCCh
Q 040687 490 LGRGSY-GFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYEFMPRGTL 567 (740)
Q Consensus 490 LG~G~f-G~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 567 (740)
|-.|.+ ..||+.... +..+.+|+..... ..+..+|+++++.+. +--+.+++.+....+..++|||++++.+|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444544 789998764 4778888875432 235677888888873 44566888887766678999999998776
Q ss_pred HHhH-------------------hCCC---CCCC--HHHHHHHHH--------------------HHHHHHHHHHh----
Q 040687 568 HDHL-------------------HGGL---SPLN--WSLRLKISM--------------------QAAKGLEYLHK---- 599 (740)
Q Consensus 568 ~~~l-------------------~~~~---~~l~--~~~~~~ia~--------------------~ia~gL~yLH~---- 599 (740)
.+.. |.-. .++. ....+.... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6431 1110 0111 001110000 01111222211
Q ss_pred CCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 600 ~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
...+.++|+|+.|.|||++++....|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1234599999999999999987789999998743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00012 Score=89.04 Aligned_cols=79 Identities=14% Similarity=0.378 Sum_probs=58.0
Q ss_pred cceecccCceEEEEEEEeCC---cEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCc--ceEEeEEEeC---CeEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDG---RQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNI--VNLLGYCLEM---GERLL 557 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g---~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~l 557 (740)
.++|+.|.+..+|+..+.++ ..+++|+...... ......+.+|.++|+.|. |.++ .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 56789999999999877553 4677887644321 122346889999999995 6665 8888888764 46789
Q ss_pred EEecCCCCC
Q 040687 558 VYEFMPRGT 566 (740)
Q Consensus 558 V~Ey~~~gs 566 (740)
||||+++-.
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.8e-05 Score=84.70 Aligned_cols=142 Identities=19% Similarity=0.134 Sum_probs=91.6
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccc-----------------------------hh------cHHHHHHHHH
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATII-----------------------------HT------NIREFEMELE 532 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~-----------------------------~~------~~~~~~~E~~ 532 (740)
+.|+.-+.|.||+|++++|+.||||.-++.... ++ ..-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 469999999999999999999999975532100 00 0113566665
Q ss_pred HHHhC----CCCC------cceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 040687 533 VLCNI----RHSN------IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602 (740)
Q Consensus 533 ~l~~l----~H~n------iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~ 602 (740)
-..++ +|-+ |.+++- .-...+.|+||||+|..+.|...-....++...+.+-+.++..-+- -..+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qI--f~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQI--FKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHH--HhcC-
Confidence 44443 4555 333322 1234678999999998776553222234665555444444332222 2335
Q ss_pred CCeEecCCCCCCEEECC----CCCEEEeecCCCccccC
Q 040687 603 PPIIHRDVKTLNILLDS----DWGARIADFGLLTSCER 636 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~----~~~~ki~DFGla~~~~~ 636 (740)
++|.|-.|-|||+.. +..+.+-|||+......
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999765543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00013 Score=73.66 Aligned_cols=153 Identities=23% Similarity=0.234 Sum_probs=99.0
Q ss_pred ChhHHHHhhcCccccc---eecccCceEEEEEEEeCCcEEEEEEecccccchhc-----------------HHH-----H
Q 040687 473 RLSELKDATNGFKEFN---ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN-----------------IRE-----F 527 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~---~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~-----------------~~~-----~ 527 (740)
++..+....++..... .|.+|.-..||+|...++..+|+|+.+.....-.. .+. .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444444433 45678888999999888999999998754321111 111 2
Q ss_pred HHHHHHHHhCC--CCCcceEEeEEEeCCeEEEEEecCCCCCh-HHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCC
Q 040687 528 EMELEVLCNIR--HSNIVNLLGYCLEMGERLLVYEFMPRGTL-HDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAP 603 (740)
Q Consensus 528 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~ 603 (740)
.+|..-|.++. +-.+.+-+++. .-.|||||+....+ .-.|.. -++...+...+..++++.|.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 45677777663 44455555442 34699999965411 111111 123333566677788888888876 56
Q ss_pred CeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 604 ~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+||.||..-|||+. ++.+.|+||+-|....
T Consensus 188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999876544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00046 Score=68.73 Aligned_cols=135 Identities=21% Similarity=0.204 Sum_probs=94.4
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEecccc--------------cchhcHHHHHHHHHHHHhCC------CCCcce
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAAT--------------IIHTNIREFEMELEVLCNIR------HSNIVN 544 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~--------------~~~~~~~~~~~E~~~l~~l~------H~niv~ 544 (740)
+....||+|+.-.||. +++.....||+..... ......+++.+|+....++. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3445799999999996 3455667888877654 11122456777777666665 889999
Q ss_pred EEeEEEeCCeEEEEEecCCC------CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 040687 545 LLGYCLEMGERLLVYEFMPR------GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD 618 (740)
Q Consensus 545 l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 618 (740)
++|+.+.+.-.-+|+|.+.+ -+|.+++.+. .++. ....... +-..||-+.. |+.+||+|.||++.
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 99999988878888887643 3688898654 3555 3333333 3456777777 99999999999995
Q ss_pred CC---C-CEEEee-cCC
Q 040687 619 SD---W-GARIAD-FGL 630 (740)
Q Consensus 619 ~~---~-~~ki~D-FGl 630 (740)
.. . .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 43 2 577887 554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0005 Score=68.03 Aligned_cols=127 Identities=30% Similarity=0.453 Sum_probs=91.7
Q ss_pred cCccccceecccCc-eEEEEEEEeCCcEEEEEEecccc----------cch---------hcHHHHHHHHHHHHhCC---
Q 040687 482 NGFKEFNELGRGSY-GFVYKAVLVDGRQVAVKRANAAT----------IIH---------TNIREFEMELEVLCNIR--- 538 (740)
Q Consensus 482 ~~~~~~~~LG~G~f-G~Vy~~~~~~g~~vAiK~l~~~~----------~~~---------~~~~~~~~E~~~l~~l~--- 538 (740)
.+++..+.||.|.. |.|||.+. +|+.+|+|.++.-. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999997 67899999933210 000 11235889999988885
Q ss_pred CCCc--ceEEeEEEeC------------------CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 040687 539 HSNI--VNLLGYCLEM------------------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598 (740)
Q Consensus 539 H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH 598 (740)
+.++ |+.+||..-. ..+-||.||++... .+. .+-+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHH
Confidence 4566 8999987422 12357777776533 122 233556778889999
Q ss_pred hCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 599 ~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 999 999999999986 4689999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0061 Score=67.25 Aligned_cols=77 Identities=19% Similarity=0.247 Sum_probs=54.5
Q ss_pred ceecccCceEEEEEEEeCC-cEEEEEEeccccc-----chhcHHHHHHHHHHHHhCC---CCCcceEEeEEEeCCeEEEE
Q 040687 488 NELGRGSYGFVYKAVLVDG-RQVAVKRANAATI-----IHTNIREFEMELEVLCNIR---HSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g-~~vAiK~l~~~~~-----~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 558 (740)
+.||.|.+..||+....+| +.|.||....... .......+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 5899998542210 0113355677888888762 3567888877 33557899
Q ss_pred EecCCCCC
Q 040687 559 YEFMPRGT 566 (740)
Q Consensus 559 ~Ey~~~gs 566 (740)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=97.72 E-value=3.3e-05 Score=58.88 Aligned_cols=43 Identities=21% Similarity=0.224 Sum_probs=33.5
Q ss_pred CceeeecccccCCCCccCccc-ccccccccccee-------eEEEEEecCCeeeee
Q 040687 121 LGTVDCWDIVRKGNNTLSSVQ-TNLFYDEYVSTI-------VLKDVISGDGFSCGG 168 (740)
Q Consensus 121 ~g~v~cW~~~~~G~n~~gqlg-~~~~~~~~~~~~-------~~~~ia~G~~~~C~l 168 (740)
||+||.| |.|.+|||| .+.......|.. .+++|++|..|+.+|
T Consensus 1 dG~vy~w-----G~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSW-----GSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEE-----EEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEE-----ECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 5899999 999999999 554444444443 389999999999875
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=1.8e-05 Score=89.61 Aligned_cols=128 Identities=16% Similarity=0.258 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC------------------------------C
Q 040687 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER------------------------------D 637 (740)
Q Consensus 588 ~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~------------------------------~ 637 (740)
.+++.||.|+|... .+||+.|.|++|.++..+..||+.|+.+-.... .
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999865 499999999999999999999999987532221 1
Q ss_pred CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcC
Q 040687 638 LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIREN 716 (740)
Q Consensus 638 ~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~d 716 (740)
...+.++|+||+|+++|-+.. |+..+......... . ...-.+.--......+...++.+=+.+.+..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~---~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY---S--------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh---h--------hhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence 112568999999999999985 55555432211110 0 00001111111112334457888899999999
Q ss_pred CCCCCCHHHHHH
Q 040687 717 PSELPTMSQVAT 728 (740)
Q Consensus 717 P~~RPt~~ev~~ 728 (740)
+..||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998777654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00086 Score=71.50 Aligned_cols=79 Identities=11% Similarity=0.103 Sum_probs=57.5
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC---CCcceEEeEEEeC---CeEEE
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH---SNIVNLLGYCLEM---GERLL 557 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~l 557 (740)
....+.|+.|..+.||+-...++ .+.+|..+.. .....|.+|.+.|+.|.- -.+.++++++... +..+|
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 44556799999999999876555 4666764321 122578999999998853 4688889887643 56899
Q ss_pred EEecCCCCCh
Q 040687 558 VYEFMPRGTL 567 (740)
Q Consensus 558 V~Ey~~~gsL 567 (740)
|||++++.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0019 Score=66.08 Aligned_cols=155 Identities=20% Similarity=0.187 Sum_probs=90.5
Q ss_pred cceecccCceEEEEEEEeC--CcEEEEEEecccccchhcHHHHHHHHHHHHhCCC-CCcceEEeEEEeCCeEEEEEecCC
Q 040687 487 FNELGRGSYGFVYKAVLVD--GRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-SNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~--g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
.+.|..|-...+|+....+ ++.|.+|....... ...+..+|+.+++.+.. .-..+++.... ..+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence 3567788888999988764 67888997654321 11233478888888843 33445554432 247999998
Q ss_pred CCChHHh-----------------HhCCCCC----------C-CHHHHHHHHH----------------------HHHHH
Q 040687 564 RGTLHDH-----------------LHGGLSP----------L-NWSLRLKISM----------------------QAAKG 593 (740)
Q Consensus 564 ~gsL~~~-----------------l~~~~~~----------l-~~~~~~~ia~----------------------~ia~g 593 (740)
+-++... +|..... . -|..+..+.. .+.+-
T Consensus 76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 155 (235)
T cd05157 76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE 155 (235)
T ss_pred CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence 8765311 1111111 1 1222111111 11111
Q ss_pred HHHH----HhC-CCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHH
Q 040687 594 LEYL----HKD-AAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEIL 657 (740)
Q Consensus 594 L~yL----H~~-~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~Ell 657 (740)
+..| ... ....++|+|+.+.|||+++ +..+.|+||-.|.... =.|=++.++.|+.
T Consensus 156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~---------~~~Dla~~~~e~~ 216 (235)
T cd05157 156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY---------RAFDIANHFNEWA 216 (235)
T ss_pred HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc---------hheeHHHHHHHHc
Confidence 1222 111 2235999999999999998 5789999998774332 1445788888864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00075 Score=64.78 Aligned_cols=130 Identities=22% Similarity=0.258 Sum_probs=86.1
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-ceEEeEEEeCCeEEEEEecCC
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-VNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~ 563 (740)
...+.|++|.++.||++.+. +..+|+|.-+.+ .....+..|+++|..++-.++ .+++.|- +-++.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 34567999999999999984 458899876543 345789999999999986665 3555553 3346699998
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCEEECCCCCEEEeecCCCccc
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVK-TLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk-~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+-.|.+.-... +-.+++. +++.-.-|...+ |-|..|. |...+|.++..+.|+||--|+..
T Consensus 96 G~~L~~~~~~~----~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIGG----DRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhcc----cHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88887765431 2233333 333322233345 7777765 34444444458999999988643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00066 Score=69.75 Aligned_cols=73 Identities=16% Similarity=0.165 Sum_probs=44.9
Q ss_pred ceecccCce-EEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC---CcceEEeEEEeC---CeEEEEEe
Q 040687 488 NELGRGSYG-FVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS---NIVNLLGYCLEM---GERLLVYE 560 (740)
Q Consensus 488 ~~LG~G~fG-~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E 560 (740)
+.|+.|+.. .||+. +..+.+|..... .....+.+|.++|..|... .+.+.+...... ...++|||
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 457766665 58875 235677764432 1234788899999887532 344555443332 23588999
Q ss_pred cCCCCChH
Q 040687 561 FMPRGTLH 568 (740)
Q Consensus 561 y~~~gsL~ 568 (740)
++++.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99887663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=4.4e-05 Score=85.53 Aligned_cols=177 Identities=18% Similarity=0.148 Sum_probs=120.0
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC-cceEEeEEE
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN-IVNLLGYCL 550 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~ 550 (740)
|..-.+++.+.-+...+.+++++++++||.+-...+....|.+.. . .+..-++++|.+++||| .++.++-+.
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~--l~~rl~~eLLdK~n~P~~~v~~~~d~~ 304 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----T--LSRRLAIELLDKVNNPNPVVRYLEDYD 304 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----c--hhhHHHHHHHHHccCCCCcccccccCC
Confidence 333445566666777778999999999998743333333443322 1 34566899999999999 777777777
Q ss_pred eCCeEEEEEecCCCC-ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 551 EMGERLLVYEFMPRG-TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
.+...+++++|+..+ +-.+........+...+...+...-+++++|||+.. =+||| |||..+ ...|..||+
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence 777889999999877 221111111112344445566777788999999875 58999 887766 578999999
Q ss_pred CCccccCC--------------------CCCCcccceehhHHHHHHHHhCCCCC
Q 040687 630 LLTSCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 630 la~~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~ 663 (740)
.+..+.+. ..+..+-|+|+.++--.+|--|..|-
T Consensus 377 v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 377 VPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 87655442 12245789999998666666666654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.034 Score=60.21 Aligned_cols=81 Identities=17% Similarity=0.243 Sum_probs=50.5
Q ss_pred eecccCceEEEEEEEeCC-cEEEEEEecccccc-----hhcHHHHHHHHHHHHhCC--CC-CcceEEeEEEeCCeEEEEE
Q 040687 489 ELGRGSYGFVYKAVLVDG-RQVAVKRANAATII-----HTNIREFEMELEVLCNIR--HS-NIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~g-~~vAiK~l~~~~~~-----~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 559 (740)
+||.|..-.||++...++ +.|+||....-... .-....-.-|.+.|+... -| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 68999975422110 112233445677776552 23 46666554 445667999
Q ss_pred ecCCCC-ChHHhH
Q 040687 560 EFMPRG-TLHDHL 571 (740)
Q Consensus 560 Ey~~~g-sL~~~l 571 (740)
|+++.. .|++.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0037 Score=65.07 Aligned_cols=136 Identities=13% Similarity=0.151 Sum_probs=77.9
Q ss_pred ecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-ceEEeEEEeCCeEEEEEecCCCCChH
Q 040687 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-VNLLGYCLEMGERLLVYEFMPRGTLH 568 (740)
Q Consensus 490 LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~ 568 (740)
+..|-...+|+.. .+++.+.+|....... ....+..+|.++++.+....+ .+++.... .++||||+++..+.
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 5567778899887 4567888887543221 110135778889988854333 44554432 36899999886653
Q ss_pred Hh-----------------HhCCC---CCCCHHHHH-HHHHH---------HHHHHHHHHhC-----CCCCeEecCCCCC
Q 040687 569 DH-----------------LHGGL---SPLNWSLRL-KISMQ---------AAKGLEYLHKD-----AAPPIIHRDVKTL 613 (740)
Q Consensus 569 ~~-----------------l~~~~---~~l~~~~~~-~ia~~---------ia~gL~yLH~~-----~~~~iiHrDlk~~ 613 (740)
.. ||... .+++....+ .+..+ +.+-+..+-.. ..+.++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 12211 122222211 11111 11112222221 1235899999999
Q ss_pred CEEECCCCCEEEeecCCCcc
Q 040687 614 NILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~ 633 (740)
|||+++++ ++|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999988743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0033 Score=66.85 Aligned_cols=141 Identities=18% Similarity=0.181 Sum_probs=85.5
Q ss_pred ccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC--CcceEEeE------EEeCCeEEE
Q 040687 486 EFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS--NIVNLLGY------CLEMGERLL 557 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~l 557 (740)
..+.|..|....+|+.... +..+++|+.... ...+...|++++..|.+. .+.+++.. ....+..++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEKV-----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred heecccCccccceEEEEeC-CCcEEEEEcCCC-----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 3456777877899998764 457888887541 224566788888877433 24455432 122345689
Q ss_pred EEecCCCCChHH--------------hHhCC----C------CCCCHHHHHH----------HHHHHHHHHHHHHhC---
Q 040687 558 VYEFMPRGTLHD--------------HLHGG----L------SPLNWSLRLK----------ISMQAAKGLEYLHKD--- 600 (740)
Q Consensus 558 V~Ey~~~gsL~~--------------~l~~~----~------~~l~~~~~~~----------ia~~ia~gL~yLH~~--- 600 (740)
|++|+++..+.. .||.. . ....|..... ....+.+.+.++...
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999998866421 01110 0 1123332211 112234455555531
Q ss_pred -CCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 601 -AAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 601 -~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
....++|+|+.|.|||++++..+.|.||..+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 12349999999999999998778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.025 Score=60.90 Aligned_cols=140 Identities=14% Similarity=0.173 Sum_probs=76.5
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC--CcceEEe------EEEeCCeEEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS--NIVNLLG------YCLEMGERLLV 558 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV 558 (740)
.+.|..|....+|+....++ .+.+|+.+. . .......|++++..|... .+.+.+. +....+..+++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER--L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc--C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 34567777789999887555 688887751 1 112333455555555321 2334332 11234567899
Q ss_pred EecCCCCChH-----------Hh---HhCCC----------CCCCH-HHHHHH------------H-HHHHHHHHHHHhC
Q 040687 559 YEFMPRGTLH-----------DH---LHGGL----------SPLNW-SLRLKI------------S-MQAAKGLEYLHKD 600 (740)
Q Consensus 559 ~Ey~~~gsL~-----------~~---l~~~~----------~~l~~-~~~~~i------------a-~~ia~gL~yLH~~ 600 (740)
+||+++..+. +. +|... ..+.| .....- . ..+..-++.+...
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 9999886431 11 11110 01222 221111 1 1111222333211
Q ss_pred ----CCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 601 ----AAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 601 ----~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
-...++|+|+.+.|||++.+...-|+||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12359999999999999977666899999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0083 Score=64.05 Aligned_cols=154 Identities=25% Similarity=0.280 Sum_probs=90.6
Q ss_pred ceecccCceEEEEEEEeC-------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC-cceEEeEEEeCCeEEEEE
Q 040687 488 NELGRGSYGFVYKAVLVD-------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN-IVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~-------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 559 (740)
+.|..|-.-.+|+....+ ++.+++|+..... ....+..+|.+++..+.... ..++++++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 456667677899888654 4788999865432 12234577888888875332 3455655532 3689
Q ss_pred ecCCCCChHHh-----------------HhCCCCC----------CCHHHHHH--------------------------H
Q 040687 560 EFMPRGTLHDH-----------------LHGGLSP----------LNWSLRLK--------------------------I 586 (740)
Q Consensus 560 Ey~~~gsL~~~-----------------l~~~~~~----------l~~~~~~~--------------------------i 586 (740)
||+++..+... ||..... .-|..+.+ +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99988765421 1211100 11111111 1
Q ss_pred HHHHHHHHHHHHh------CCCCCeEecCCCCCCEEECCC----CCEEEeecCCCccccCCCCCCcccceehhHHHHHHH
Q 040687 587 SMQAAKGLEYLHK------DAAPPIIHRDVKTLNILLDSD----WGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEI 656 (740)
Q Consensus 587 a~~ia~gL~yLH~------~~~~~iiHrDlk~~NILl~~~----~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~El 656 (740)
...+.+-+++|-. .....++|+|+.+.|||++++ ..++++||..+... .. .|=++.++.|+
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~------~p---~~DlA~~~~e~ 227 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN------YR---GFDIANHFCEW 227 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC------Cc---HHHHHHHHHHH
Confidence 1122233444432 133469999999999999985 78999999987533 22 23457777776
Q ss_pred H
Q 040687 657 L 657 (740)
Q Consensus 657 l 657 (740)
.
T Consensus 228 ~ 228 (302)
T cd05156 228 M 228 (302)
T ss_pred H
Confidence 5
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0021 Score=70.95 Aligned_cols=165 Identities=20% Similarity=0.203 Sum_probs=89.2
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEeEEEeC-CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 040687 524 IREFEMELEVLCNIRHSNIVNLLGYCLEM-GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602 (740)
Q Consensus 524 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~ 602 (740)
..++.-...+++.+.|+|+..++.+.... ....+|+|++ +.+|+|++..+. +--.. ..+ | +
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s------~~~------~--~- 87 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES------LLA------H--G- 87 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh------hcc------c--c-
Confidence 35667778899999999999999887654 3467889998 669999987653 11111 011 1 1
Q ss_pred CCeEecCCCCCCEEECCCCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh
Q 040687 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 682 (740)
+.|- ||+ +++| -++... ......|+||||+|.++.|+.-|...+..-.. ....+........
T Consensus 88 --~~~~-----~~~-------~~td-~~~t~~--~~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~-s~~l~~i~k~~~~ 149 (725)
T KOG1093|consen 88 --VLHL-----NII-------YITD-HFLTKY--PSPIGPKSDVWSLGFIILELYLGISLEAELTE-SEYLEILLKYYTD 149 (725)
T ss_pred --ccee-----hhh-------hccc-cccccC--CCCCCcchhhhhHHHHHHHHHHhhHHHHHHHH-HHHHHHHHHhccC
Confidence 3322 222 2222 111111 11223699999999999999998866532110 0011100000000
Q ss_pred C-ccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040687 683 G-KAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVA 727 (740)
Q Consensus 683 ~-~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 727 (740)
. ....+.... ....++...+.++.+.|+-..|..||...+..
T Consensus 150 d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 150 DQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred chhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 0 000000000 01112333566788889999998888655443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.037 Score=59.29 Aligned_cols=141 Identities=18% Similarity=0.232 Sum_probs=81.7
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC--CcceEEeEE------EeCCeEEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS--NIVNLLGYC------LEMGERLLV 558 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV 558 (740)
.+.++.|....+|+....++ .+.+|+..... ...+...|++++..|... .+.+++... ...+..++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 45577777789999876444 57788765421 123445667777776422 244444421 123567899
Q ss_pred EecCCCCChH-----------H---hHhCCCC-----------CCCHHHHHH------------HHHHHHHHHHHHHh--
Q 040687 559 YEFMPRGTLH-----------D---HLHGGLS-----------PLNWSLRLK------------ISMQAAKGLEYLHK-- 599 (740)
Q Consensus 559 ~Ey~~~gsL~-----------~---~l~~~~~-----------~l~~~~~~~------------ia~~ia~gL~yLH~-- 599 (740)
+||+++..+. . .+|.... .-.|..... ....+.+.++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999875431 1 1121000 012222111 11223345666643
Q ss_pred --CCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 600 --DAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 600 --~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
.....++|+|+.+.||+++.+....|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123459999999999999988777899999863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.16 Score=56.02 Aligned_cols=82 Identities=17% Similarity=0.191 Sum_probs=52.1
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEeccccc--ch---hcHHHHHHHHHHHHhCC---CCCcceEEeEEEeCCeEEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATI--IH---TNIREFEMELEVLCNIR---HSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~--~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 558 (740)
.+.||.|..-.||+... +++.+.||.-..... .. .....-..|.+.|+.+. ..++.+++.++. +.-+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 45789999999999876 456799997652211 00 11222334466665543 357888988877 346788
Q ss_pred EecCCC--CChHHhH
Q 040687 559 YEFMPR--GTLHDHL 571 (740)
Q Consensus 559 ~Ey~~~--gsL~~~l 571 (740)
|||++. -.|.+.|
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.007 Score=72.80 Aligned_cols=175 Identities=21% Similarity=0.242 Sum_probs=119.3
Q ss_pred HHHHHHHHHhCCCCCcceEEeEEEeCCeE----EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 040687 527 FEMELEVLCNIRHSNIVNLLGYCLEMGER----LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602 (740)
Q Consensus 527 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~ 602 (740)
-..|.+.+.++.|+|+++++.|-.++... .+..||++.-++...+..- ..++....+.+..++.+||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 45577778889999999999998765332 3445788888888887643 46788888889999999999999986
Q ss_pred CCeEecCCCCC---CEEECCCCCEEEe--ecCCCccccCCC----------------------CCCcccceehhHHHHHH
Q 040687 603 PPIIHRDVKTL---NILLDSDWGARIA--DFGLLTSCERDL----------------------TTDMKSDVHNFGIVLLE 655 (740)
Q Consensus 603 ~~iiHrDlk~~---NILl~~~~~~ki~--DFGla~~~~~~~----------------------~~~~ksDVwSfGvvl~E 655 (740)
..|.-+..+ +...+.++...++ ||+......... ....+.|+|.+|.++..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 555555554 5555667777777 888765443210 01224699999999999
Q ss_pred HHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040687 656 ILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATW 729 (740)
Q Consensus 656 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 729 (740)
+..+..+-.... ....+++.... ..+.+...+|+..++++|+...+++..
T Consensus 385 ~~~~~~i~~~~~----------------~~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 385 LSQGEDISEKSA----------------VPVSLLDVLST--------SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hhhcCccccccc----------------chhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 988765432110 01111111110 035578889999999999999888863
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.031 Score=59.13 Aligned_cols=140 Identities=21% Similarity=0.289 Sum_probs=74.0
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC---CCCcceEEeEEEeCCeEEEEEe
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR---HSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E 560 (740)
.+..+.|+-|....+|+.. .+++.+-||.-... ....|..|.+-|+.|. --.+.+.+++....+..+||+|
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 4556678999999999977 56788999976522 2246788888888873 4457788998877777899999
Q ss_pred cCCCCC--------hHH---hHhC-CC-C-------------------CCCHHHHH-----HHHHHHHH-----------
Q 040687 561 FMPRGT--------LHD---HLHG-GL-S-------------------PLNWSLRL-----KISMQAAK----------- 592 (740)
Q Consensus 561 y~~~gs--------L~~---~l~~-~~-~-------------------~l~~~~~~-----~ia~~ia~----------- 592 (740)
|++.+. |.. .||. .. . .-+|.+.. ....+.+.
T Consensus 93 ~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~ 172 (288)
T PF03881_consen 93 FLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELER 172 (288)
T ss_dssp --------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHH
T ss_pred eecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHH
Confidence 998761 111 1222 10 0 12454322 11111111
Q ss_pred HHHH----HHh-CCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 593 GLEY----LHK-DAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 593 gL~y----LH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
-++- |+. .-.|..+|+||-+.|++.+.++.+.|.|=.
T Consensus 173 l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 173 LVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 1111 221 125679999999999999999889999864
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.052 Score=57.98 Aligned_cols=129 Identities=16% Similarity=0.266 Sum_probs=75.7
Q ss_pred CcEEEEEEecccccchhcHHHHHHHHHHHHhCCC--CCcceEEeEEEeCC--eEEEEEecCCCCChHH------------
Q 040687 506 GRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNLLGYCLEMG--ERLLVYEFMPRGTLHD------------ 569 (740)
Q Consensus 506 g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~------------ 569 (740)
+++++++ ...............+|..+|+.+.- --+.+.+++|.+.. ..|.||+|.++..+.+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6677777 22111112233456778888887743 34556677777665 6799999998732222
Q ss_pred ------hHh---CC----C-----------CC-CCHHHHHHH--------HHHHHHHHHHHHhCC-----CCCeEecCCC
Q 040687 570 ------HLH---GG----L-----------SP-LNWSLRLKI--------SMQAAKGLEYLHKDA-----APPIIHRDVK 611 (740)
Q Consensus 570 ------~l~---~~----~-----------~~-l~~~~~~~i--------a~~ia~gL~yLH~~~-----~~~iiHrDlk 611 (740)
+|. +- . .+ ..|...++. .-...+-..||+... .+.++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 221 00 0 00 112221110 111223345555443 2479999999
Q ss_pred CCCEEECCCCCEEEeecCCCcccc
Q 040687 612 TLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 612 ~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+.|++++.+..+=|.||+++....
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCC
Confidence 999999999889999999986553
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0047 Score=64.73 Aligned_cols=133 Identities=15% Similarity=0.123 Sum_probs=90.0
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchh--------------------cHHHHHHHHHHHHhCC-CC-C
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT--------------------NIREFEMELEVLCNIR-HS-N 541 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~--------------------~~~~~~~E~~~l~~l~-H~-n 541 (740)
++..++||-|.-+.+|.+...+|++.++|.-+....+-. .+-...+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567789999999999999998899999985332211000 1123467888888884 32 3
Q ss_pred cceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 542 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
+.+.+++ ...++|||++.+-.|...-+- .+...+..- +..-+--|-..+ +||+|..--||+++++.
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly~~---lm~~Iv~la~~G---lIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPTLYDD---LMGLIVRLANHG---LIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHHHHHH---HHHHHHHHHHcC---ceecccchheeEEecCC
Confidence 4455544 456789999988777654322 222332222 222233455567 99999999999999999
Q ss_pred CEEEeecCC
Q 040687 622 GARIADFGL 630 (740)
Q Consensus 622 ~~ki~DFGl 630 (740)
.++++||--
T Consensus 240 ~i~vIDFPQ 248 (465)
T KOG2268|consen 240 KIVVIDFPQ 248 (465)
T ss_pred CEEEeechH
Confidence 999999974
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.15 Score=56.07 Aligned_cols=76 Identities=18% Similarity=0.226 Sum_probs=49.5
Q ss_pred cceecccCceEEEEEEEeC-CcEEEEEEecccccc----hhcHHHHHHHHHHHHhCC---CCCcceEEeEEEeCCeEEEE
Q 040687 487 FNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII----HTNIREFEMELEVLCNIR---HSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 558 (740)
.+.||.|.-..||++.+.+ ++.|+||....-... .-....-.-|.+.|+.+. -.++.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4579999999999999843 578999964422111 122344556777777552 2356667655 44456789
Q ss_pred EecCCC
Q 040687 559 YEFMPR 564 (740)
Q Consensus 559 ~Ey~~~ 564 (740)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.05 Score=57.34 Aligned_cols=32 Identities=22% Similarity=0.323 Sum_probs=26.4
Q ss_pred CCeEecCCCCCCEEECCCCC-EEEeecCCCccc
Q 040687 603 PPIIHRDVKTLNILLDSDWG-ARIADFGLLTSC 634 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~~~~-~ki~DFGla~~~ 634 (740)
+.++|+|+.+.|||+++++. .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 569999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.064 Score=58.48 Aligned_cols=153 Identities=19% Similarity=0.191 Sum_probs=86.9
Q ss_pred eecccCceEEEEEEEeC-----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-ceEEeEEEeCCeEEEEEecC
Q 040687 489 ELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-VNLLGYCLEMGERLLVYEFM 562 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~-----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~ 562 (740)
.|-.|-.-.+|+..+.+ ++.|.+|...... ...-+-.+|..+++.+...++ .++++.+.. . .|+||+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 45456667888877532 3678888775532 111233678888888854433 355665532 2 579999
Q ss_pred CCCChHHh-----------------HhCCCC-----CCCHHHHHHHHHH-----------------HHHHHHHHH----h
Q 040687 563 PRGTLHDH-----------------LHGGLS-----PLNWSLRLKISMQ-----------------AAKGLEYLH----K 599 (740)
Q Consensus 563 ~~gsL~~~-----------------l~~~~~-----~l~~~~~~~ia~~-----------------ia~gL~yLH----~ 599 (740)
++-+|... +|.... +..|.+..++..+ +..-+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665321 122110 1123333233211 111222222 1
Q ss_pred -CCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHH
Q 040687 600 -DAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEIL 657 (740)
Q Consensus 600 -~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~Ell 657 (740)
.....++|+|+++.|||+++ +..++++||..+.... =.|-+|..+.|..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~---------~~~Dia~~~~e~~ 246 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP---------VAYDIANHFCEMA 246 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc---------hHHHHHHHHHHHH
Confidence 11235899999999999986 4679999998874322 1345677777743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.14 Score=54.75 Aligned_cols=29 Identities=31% Similarity=0.347 Sum_probs=25.1
Q ss_pred CCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 603 PPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..++|+|+.+.|||++. ..+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 578999999753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.15 Score=54.66 Aligned_cols=140 Identities=22% Similarity=0.229 Sum_probs=90.6
Q ss_pred eecccCceEEEEEEEeCCcEEEEEEecccccchh-------------------cHH----H-HHHHHHHHHhCCCCCcce
Q 040687 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT-------------------NIR----E-FEMELEVLCNIRHSNIVN 544 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~-------------------~~~----~-~~~E~~~l~~l~H~niv~ 544 (740)
.|..|.-.-||.+.-.+|..+|||+.+...+.-. +.+ - ..+|++-|.+|+..-|.-
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 4677888899999998999999998775432110 111 1 246777788876443321
Q ss_pred EEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEE
Q 040687 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR 624 (740)
Q Consensus 545 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 624 (740)
---... ..-.|||+|+.. +=.-.-.-....++...+..+-.|+++-|.-|...+. +||.||.--|+|+ .++.+.
T Consensus 231 PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly-hdG~ly 304 (520)
T KOG2270|consen 231 PEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY-HDGKLY 304 (520)
T ss_pred CCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE-ECCEEE
Confidence 110111 134699999953 2211111112346666777777888888888866553 9999999999988 456899
Q ss_pred EeecCCCccc
Q 040687 625 IADFGLLTSC 634 (740)
Q Consensus 625 i~DFGla~~~ 634 (740)
|+|.+-+-..
T Consensus 305 iIDVSQSVE~ 314 (520)
T KOG2270|consen 305 IIDVSQSVEH 314 (520)
T ss_pred EEEccccccC
Confidence 9999876543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 740 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-100
Identities = 111/320 (34%), Positives = 163/320 (50%), Gaps = 38/320 (11%)
Query: 446 KHELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVD 505
K+ T++I D+L P + L +L++ATN F +G G +G VYK VL D
Sbjct: 4 KYSKATNSINDALSSSYL-VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 506 GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRG 565
G +VA+KR + I EFE E+E L RH ++V+L+G+C E E +L+Y++M G
Sbjct: 63 GAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 566 TLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622
L HL+G ++W RL+I + AA+GL YLH IIHRDVK++NILLD ++
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177
Query: 623 ARIADFGLL-TSCERDLT-----------------------TDMKSDVHNFGIVLLEILS 658
+I DFG+ E D T T+ KSDV++FG+VL E+L
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSDVYSFGVVLFEVLC 236
Query: 659 GRKAYDIEYVPPG---IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRE 715
R A +P + EWA+ G+ I+D N+A E L K D A +
Sbjct: 237 ARSAIVQS-LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 716 NPSELPTMSQVATWLEQIVK 735
+ + P+M V LE ++
Sbjct: 296 SSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 1e-99
Identities = 100/294 (34%), Positives = 157/294 (53%), Gaps = 30/294 (10%)
Query: 467 GMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIRE 526
G + F L EL+ A++ F N LGRG +G VYK L DG VAVKR +
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQ 73
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG---GLSPLNWSLR 583
F+ E+E++ H N++ L G+C+ ERLLVY +M G++ L PL+W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT 640
+I++ +A+GL YLH P IIHRDVK NILLD ++ A + DFGL + + +TT
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 641 DM-------------------KSDVHNFGIVLLEILSGRKAYDIEYVPPG----IVEWAL 677
+ K+DV +G++LLE+++G++A+D+ + +++W
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731
L+K+ K A++D ++ E + +L +A L + +P E P MS+V LE
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 287 bits (738), Expect = 9e-92
Identities = 91/304 (29%), Positives = 149/304 (49%), Gaps = 50/304 (16%)
Query: 470 QVFRLSELKDATNGFKE------FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN 523
F ELK+ TN F E N++G G +G VYK + + VAVK+ A I T
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 524 --IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG--GLSPLN 579
++F+ E++V+ +H N+V LLG+ + + LVY +MP G+L D L G PL+
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERD 637
W +R KI+ AA G+ +LH++ IHRD+K+ NILLD + A+I+DFGL +
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 638 ----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEW 675
+T KSD+++FG+VLLEI++G A D P +++
Sbjct: 189 TVMTSRIVGTTAYMAPEALRGEITP--KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 676 ALPLIKQGKA-AAIIDRNVALPR----NVEPLFKLADIAELAIRENPSELPTMSQVATWL 730
+ + K ID + + + + +A + E ++ P + +V L
Sbjct: 247 KEEIEDEEKTIEDYID-----KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 731 EQIV 734
+++
Sbjct: 302 QEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 8e-64
Identities = 68/311 (21%), Positives = 116/311 (37%), Gaps = 53/311 (17%)
Query: 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMEL 531
L + + RG +G V+KA + VAVK + E E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ---DKQSWQNEYEV 69
Query: 532 EVLCNIRHSNIVNLLGYCLE----MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKIS 587
L ++H NI+ +G + L+ F +G+L D L + ++W+ I+
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIA 127
Query: 588 MQAAKGLEYLHKDAA-------PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT 640
A+GL YLH+D P I HRD+K+ N+LL ++ A IADFGL E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 641 ----------------------------DMKSDVHNFGIVLLEILSGRKAYDI---EYVP 669
++ D++ G+VL E+ S A D EY+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 670 PGIVE-WALPLIKQGKAAAIIDRNV-ALPRNVEPLFKLADIAELAIR---ENPSELPTMS 724
P E P ++ + + + L + +A + E + +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 725 QVATWLEQIVK 735
V + Q+ +
Sbjct: 308 CVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-58
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 46/278 (16%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
++G GS+G V++A G VAVK + EF E+ ++ +RH NIV +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ +V E++ RG+L+ LH G L+ RL ++ AKG+ YLH PPI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM----------------------- 642
+HR++K+ N+L+D + ++ DFGL S + T
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGL--SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV--ALPRNVE 700
KSDV++FG++L E+ + ++ + P + AA+ + +PRN+
Sbjct: 219 KSDVYSFGVILWELATLQQPWG-NLNPAQV------------VAAVGFKCKRLEIPRNLN 265
Query: 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738
P ++A I E P + P+ + + L ++K +
Sbjct: 266 P--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-54
Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 40/274 (14%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+ +GRG++G V KA + VA+K+ + + + F +EL L + H NIV
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIV 64
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHG--GLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L G CL LV E+ G+L++ LHG L + + +Q ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 602 APPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCERDLTT------------------DM 642
+IHRD+K N+LL + +I DFG + +T
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702
K DV ++GI+L E+++ RK +D P + WA + G + +N+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGTRPPL-------IKNLPK- 231
Query: 703 FKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
+ + ++PS+ P+M ++ + +++
Sbjct: 232 -PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 49/272 (18%), Positives = 104/272 (38%), Gaps = 45/272 (16%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+L G ++K G + VK R+F E L H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 548 YCLE-MGERL-LVYEFMPRGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPP 604
C L+ +MP G+L++ LH G + ++ S +K ++ A+G+ +LH P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPL 133
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM---------------------K 643
I + + ++++D D ARI+ + M
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADV--KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRS 191
Query: 644 SDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN--VALPRNVEP 701
+D+ +F ++L E+++ + + I + +P + P
Sbjct: 192 ADMWSFAVLLWELVTREVPFA-DLSNMEI------------GMKVALEGLRPTIPPGISP 238
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLEQI 733
++ + ++ + E+P++ P + LE++
Sbjct: 239 --HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 73/279 (26%), Positives = 130/279 (46%), Gaps = 49/279 (17%)
Query: 488 NELGRGSYGFVYKAVLV-DGRQVAVKR-----ANAATIIHTNIREFEMELEVLCNIRHSN 541
++G+G +G V+K LV D VA+K + T + +EF+ E+ ++ N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
IV L G +V EF+P G L+ L P+ WS++L++ + A G+EY+ +
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQ 141
Query: 602 APPIIHRDVKTLNILLDSDWG-----ARIADFGLLTSCERDLTT---------------- 640
PPI+HRD+++ NI L S A++ADFGL S + +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL--SQQSVHSVSGLLGNFQWMAPETIG 199
Query: 641 ------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
K+D ++F ++L IL+G + + G +++ + ++G I
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF--DEYSYGKIKFINMIREEGLRPTI------ 251
Query: 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
P + P +L ++ EL +P + P S + L ++
Sbjct: 252 -PEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 53/279 (18%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
+G G +G VY+A G +VAVK R + I I E ++ ++H NI+ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
G CL+ LV EF G L+ L G + + + ++Q A+G+ YLH +A PI
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 606 IHRDVKTLNILLD--------SDWGARIADFGLLTSCERDLTTDM--------------- 642
IHRD+K+ NIL+ S+ +I DFGL + E TT M
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGL--AREWHRTTKMSAAGAYAWMAPEVIR 187
Query: 643 ------KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV--A 694
SDV ++G++L E+L+G + + V A + +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAV-----------AYGVAMNKLALP 234
Query: 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
+P A + E +P P+ + + L I
Sbjct: 235 IPSTCPE--PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 9e-52
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 43/276 (15%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+G GS+G VYK VAVK N ++ F+ E+ VL RH NI+ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
Y +L +V ++ +L+ HLH + + I+ Q A+G++YLH A II
Sbjct: 88 YS--TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 607 HRDVKTLNILLDSDWGARIADFGL-----LTSCERDLTT--------------------- 640
HRD+K+ NI L D +I DFGL S
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 641 DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
+SDV+ FGIVL E+++G+ Y + + + + + + N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEM--VGRGSLSPDLSK----VRSNCP 255
Query: 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
++ + +++ E P+ ++ +E++ ++
Sbjct: 256 K--RMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-51
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 54/283 (19%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+G+G +G VY +VA++ + ++ F+ E+ RH N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
C+ ++ TL+ + L+ + +I+ + KG+ YLH A I+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 608 RDVKTLNILLDSDWGARIADFGL----LTSCERDLTTDM--------------------- 642
+D+K+ N+ D + I DFGL +
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 643 ----------KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692
SDV G + E+ + + + P + W + G +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEAIIWQ---MGTGMKPNLSQIG 267
Query: 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
+ + +++DI E PT +++ LE++ K
Sbjct: 268 M--GK------EISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 65/324 (20%), Positives = 108/324 (33%), Gaps = 68/324 (20%)
Query: 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMEL 531
SE + K +GRG YG VYK L D R VAVK + N + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF-----ANRQNFINEK 56
Query: 532 EV--LCNIRHSNIVNLLGYCLEMG-----ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRL 584
+ + + H NI + + E LLV E+ P G+L +L +W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSC 114
Query: 585 KISMQAAKGLEYLHKDAA------PPIIHRDVKTLNILLDSDWGARIADFGL-------- 630
+++ +GL YLH + P I HRD+ + N+L+ +D I+DFGL
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 631 ----------------------------LTSCERDLTTDMKSDVHNFGIVLLEILSGRKA 662
+ + + D++ G++ EI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 663 YDI-----EYVPPGIVE-WALPLIKQGKAAAIIDR-----NVALPRNVEPLFKLADIAEL 711
EY E P + + ++ A N + L + E
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 712 AIRENPSELPTMSQVATWLEQIVK 735
++ T + +++
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMM 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-48
Identities = 68/299 (22%), Positives = 118/299 (39%), Gaps = 65/299 (21%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEV--LCNIRHSNIVNL 545
+G+G YG V++ G VAVK + + + E E+ +RH NI+
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 546 LGYCL----EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
+ + + L+ + G+L+D+L + L+ L+I + A GL +LH +
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 602 A-----PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-------------- 642
P I HRD+K+ NIL+ + IAD GL + +T+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL--AVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 643 -------------------KSDVHNFGIVLLEILSGRKAYDI--EYVPP--GIVEWALPL 679
+ D+ FG+VL E+ + I +Y PP +V P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND-PS 242
Query: 680 IKQGKAAAIIDRN-VALPRNVEPLFKLADIAELAIRE----NPSELPTMSQVATWLEQI 733
+ + +D+ +P L +A+L ++E NPS T ++ L +I
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL-MKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 6e-47
Identities = 63/299 (21%), Positives = 117/299 (39%), Gaps = 59/299 (19%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEV--LCNIRHSNIVNL 545
++G+G YG V+ G +VAVK T + E E+ +RH NI+
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 546 LGYCLEMGER----LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
+ ++ L+ ++ G+L+D+L + L+ LK++ + GL +LH +
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 602 A-----PPIIHRDVKTLNILLDSDWGARIADFGL-------------------------- 630
P I HRD+K+ NIL+ + IAD GL
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 631 -----LTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYDI--EYVPP-GIVEWALPLIKQ 682
+ + + +D+++FG++L E+ + I EY P + + P +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 683 GKAAAIIDRN-VALPRNVEPLFKLADIAELAIRE----NPSELPTMSQVATWLEQIVKD 736
+ I + + P L + +L + E NP+ T +V L ++ +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKL-MTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-46
Identities = 71/349 (20%), Positives = 130/349 (37%), Gaps = 71/349 (20%)
Query: 441 KSCIGKHELDTDAIADSLP-HPASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVY 499
+ I + D I D S P + Q + +E +G+G +G V+
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIV-----LQE--SIGKGRFGEVW 59
Query: 500 KAVLVDGRQVAVKRANAATIIHTNIREFEMELEV--LCNIRHSNIVNLLGYCLEMG---- 553
+ G +VAVK R + E E+ +RH NI+ + +
Sbjct: 60 RGKW-RGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113
Query: 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA-----PPIIHR 608
+ LV ++ G+L D+L+ + +K+++ A GL +LH + P I HR
Sbjct: 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-------------------------- 642
D+K+ NIL+ + IAD GL + D TD
Sbjct: 172 DLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 643 -------KSDVHNFGIVLLEILSGRKAYDI--EYVPP-GIVEWALPLIKQGKAAAIIDRN 692
++D++ G+V EI I +Y P + + P +++ + +
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 693 -VALPRNVEPLFKLADIAELAIRE----NPSELPTMSQVATWLEQIVKD 736
+P + L +A++ +RE N + T ++ L Q+ +
Sbjct: 290 RPNIPNRWQSCEALRVMAKI-MRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 67/301 (22%), Positives = 108/301 (35%), Gaps = 60/301 (19%)
Query: 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEME 530
FR S+L E LG+G +G K G + +K R F E
Sbjct: 7 FRPSDLI-----HGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKE 57
Query: 531 LEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590
++V+ + H N++ +G + + E++ GTL + S WS R+ +
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT------- 640
A G+ YLH IIHRD+ + N L+ + +ADFGL + +
Sbjct: 118 ASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 641 -------------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEW 675
D K DV +FGIVL EI+ A P +++
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMDF 232
Query: 676 ALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
L ++ + P N P I +P + P+ ++ WLE +
Sbjct: 233 GL-NVRGF-------LDRYCPPNCPP--SFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 736 D 736
Sbjct: 283 H 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 63/275 (22%), Positives = 102/275 (37%), Gaps = 43/275 (15%)
Query: 478 KDATNGFKEFNE-LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLC 535
F +F+ +GRGS+ VYK + +VA + + + F+ E E+L
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 80
Query: 536 NIRHSNIVNLLGYCLEMGE---RLLVY-EFMPRGTLHDHL--HGGLSPLNWSLRLKISMQ 589
++H NIV + +++ E M GTL +L + + Q
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQ 137
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCERDLTTDM------ 642
KGL++LH PPIIHRD+K NI + G +I D GL T +
Sbjct: 138 ILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 196
Query: 643 ------------KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690
DV+ FG+ +LE+ + Y E +
Sbjct: 197 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYS-ECQNAA----QIYRRVTSG-----V 246
Query: 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQ 725
+ + + P K +I E IR+N E ++
Sbjct: 247 KPASFDKVAIPEVK--EIIEGCIRQNKDERYSIKD 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 64/274 (23%), Positives = 100/274 (36%), Gaps = 45/274 (16%)
Query: 489 ELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
++GRG++G V+ L D VAVK +F E +L H NIV L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL-KAKFLQEARILKQYSHPNIVRLIG 179
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
C + +V E + G L + L L++ AA G+EYL IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIH 236
Query: 608 RDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-----------------------KS 644
RD+ N L+ +I+DFG+ + +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 645 DVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQGKAAAIIDRNVALPRNVEPL 702
DV +FGI+L E S G Y P + + +++G + P
Sbjct: 297 DVWSFGILLWETFSLGASPY------PNLSNQQTREFVEKGG---RLPC----PELCPD- 342
Query: 703 FKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
+ + E P + P+ S + L+ I K
Sbjct: 343 -AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 66/293 (22%), Positives = 108/293 (36%), Gaps = 66/293 (22%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
LG+G +G V +A L VAVK A I ++I EF E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 544 NLLGYCLEMGER------LLVYEFMPRGTLHDHL-----HGGLSPLNWSLRLKISMQAAK 592
L+G L + +++ FM G LH L L ++ + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD---------- 641
G+EYL ++ IHRD+ N +L D +ADFGL R + + D
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGL----SRKIYSGDYYRQGCASKL 201
Query: 642 ----M------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQG 683
+ SDV FG+ + EI++ G+ Y GI + G
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY------AGIENAEIYNYLIGG 255
Query: 684 KAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
+ + P ++ D+ +P + P+ + + LE I+
Sbjct: 256 N---RLKQ----PPECME--EVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 54/293 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-----DGRQVAVK--RANAATIIHTNIREFEMELEVLCN 536
K +LG G +G V G QVAVK + + +I + + E+E+L N
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG---NHIADLKKEIEILRN 79
Query: 537 IRHSNIVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
+ H NIV G C E G L+ EF+P G+L ++L + +N +LK ++Q KG+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------------ 642
+YL +HRD+ N+L++S+ +I DFGL + + TD
Sbjct: 140 DYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL----TKAIETDKEYYTVKDDRDSP 192
Query: 643 ----------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKA 685
SDV +FG+ L E+L+ + ++ + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 686 AAIIDRNVALPRNVEPLFKLADIAELAIR---ENPSELPTMSQVATWLEQIVK 735
+ LP P ++ +L + PS + + E ++K
Sbjct: 253 VNTLKEGKRLPC---PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 77/301 (25%), Positives = 125/301 (41%), Gaps = 80/301 (26%)
Query: 488 NELGRGSYGFVYKAVLVDGR--------QVAVK--RANAATIIHTNIREFEMELEVLCNI 537
LG G++G V A V VAVK + +A ++ + E+E++ I
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMI 97
Query: 538 -RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWS 581
+H NI+NLLG C + G ++ E+ +G L ++L + +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 582 LRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
+ + Q A+G+EYL A+ IHRD+ N+L+ + +IADFGL RD+
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL----ARDINNI 210
Query: 642 ---------------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI- 672
+SDV +FG+++ EI + G Y PGI
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------PGIP 264
Query: 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732
VE L+K+G +D+ P N +L + PS+ PT Q+ L++
Sbjct: 265 VEELFKLLKEGH---RMDK----PANCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 733 I 733
I
Sbjct: 316 I 316
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 82/301 (27%)
Query: 488 NELGRGSYGFVYKAVLVDG---RQVAVK--RANAATIIHTNIREFEMELEVLCNI-RHSN 541
+ +G G++G V KA + A+K + A+ + R+F ELEVLC + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPN 87
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRLKI 586
I+NLLG C G L E+ P G L D L + S L+ L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-------- 638
+ A+G++YL + IHRD+ NIL+ ++ A+IADFGL R
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTM 200
Query: 639 ------------------TTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALP 678
TT SDV ++G++L EI+S G Y G+
Sbjct: 201 GRLPVRWMAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGGTPY------CGMTCAELYE 252
Query: 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAI---RENPSELPTMSQVATWLEQIVK 735
+ QG R L + PL ++ +L RE P E P+ +Q+ L ++++
Sbjct: 253 KLPQGY------R---LEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300
Query: 736 D 736
+
Sbjct: 301 E 301
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 80/304 (26%)
Query: 488 NELGRGSYGFVYKAVLVDGR--------QVAVK--RANAATIIHTNIREFEMELEVLCNI 537
LG G +G V A V VAVK + +A ++ + E+E++ I
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE---KDLSDLVSEMEMMKMI 143
Query: 538 -RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWS 581
+H NI+NLLG C + G ++ E+ +G L ++L + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 582 LRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
+ + Q A+G+EYL A+ IHRD+ N+L+ + +IADFGL RD+
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL----ARDINNI 256
Query: 642 ---------------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI- 672
+SDV +FG+++ EI + G Y PGI
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------PGIP 310
Query: 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732
VE L+K+G +D+ P N +L + PS+ PT Q+ L++
Sbjct: 311 VEELFKLLKEGH---RMDK----PANCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 733 IVKD 736
I+
Sbjct: 362 ILTL 365
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 55/287 (19%)
Query: 488 NELGRGSYGFVYKAVLV-----DGRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHS 540
++LG+G++G V G VAVK + + R+F+ E+++L +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD----QQRDFQREIQILKALHSD 84
Query: 541 NIVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
IV G G + LV E++P G L D L + L+ S L S Q KG+EYL
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM---------------- 642
+HRD+ NIL++S+ +IADFGL + L D
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGL----AKLLPLDKDYYVVREPGQSPIFWY 197
Query: 643 ------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689
+SDV +FG+VL E+ + K+ ++ + + ++
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 690 DRNVALPRNVEPLFKLADIAELAIR---ENPSELPTMSQVATWLEQI 733
+ LP P A++ EL +P + P+ S + L+ +
Sbjct: 258 EEGQRLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 77/300 (25%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
ELG+GS+G VY+ V +VA+K N A + EF E V+ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 89
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------HGGLSPLNWSLRLKISMQAAK 592
+V LLG + L++ E M RG L +L + L+P + S ++++ + A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD---------- 641
G+ YL A +HRD+ N ++ D+ +I DFG+ RD+ TD
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYYRKGGKGLL 202
Query: 642 ----M------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGI-VEWALPLIKQG 683
M SDV +FG+VL EI + + Y G+ E L + +G
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------QGLSNEQVLRFVMEG 256
Query: 684 KAAAIIDRNVALPRNV-EPLFKLADIAELAIRE----NPSELPTMSQVATWLEQIVKDGL 738
++D+ P N + LF+L +R NP P+ ++ + +++ ++ G
Sbjct: 257 G---LLDK----PDNCPDMLFEL-------MRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 44/206 (21%)
Query: 488 NELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+LG+G++G V G VAVK+ +T ++R+FE E+E+L +++H NI
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNI 104
Query: 543 VNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
V G C G R L+ E++P G+L D+L ++ L+ + Q KG+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------- 641
IHRD+ T NIL++++ +I DFGL + L D
Sbjct: 165 R---YIHRDLATRNILVENENRVKIGDFGL----TKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 642 ---------MKSDVHNFGIVLLEILS 658
+ SDV +FG+VL E+ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 58/218 (26%), Positives = 86/218 (39%), Gaps = 49/218 (22%)
Query: 488 NELGRGSYGFVYKAVLVDGR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
LG G +G V + L +VAVK I EF E + + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 544 NLLGYCLEMG-----ERLLVYEFMPRGTLHDHL-----HGGLSPLNWSLRLKISMQAAKG 593
LLG C+EM + +++ FM G LH +L G + LK + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD----------- 641
+EYL + +HRD+ N +L D +ADFGL + + + D
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGL----SKKIYSGDYYRQGRIAKMP 212
Query: 642 ---M------------KSDVHNFGIVLLEILS-GRKAY 663
+ KSDV FG+ + EI + G Y
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 80/304 (26%)
Query: 488 NELGRGSYGFVYKAVLVD--------GRQVAVK--RANAATIIHTNIREFEMELEVLCNI 537
LG G++G V A + +VAVK +++A ++ + E+E++ I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMI 131
Query: 538 -RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWS 581
+H NI+NLLG C + G ++ E+ +G L ++L H L+
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 582 LRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
+ + Q A+G+EYL A+ IHRD+ N+L+ D +IADFGL RD+
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL----ARDIHHI 244
Query: 642 ---------------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI- 672
+SDV +FG++L EI + G Y PG+
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVP 298
Query: 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732
VE L+K+G +D+ P N +L + PS+ PT Q+ L++
Sbjct: 299 VEELFKLLKEGH---RMDK----PSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 733 IVKD 736
IV
Sbjct: 350 IVAL 353
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 76/256 (29%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNIRH 539
LG G +G V KA + VAVK + NA+ + +R+ E VL + H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVLKQVNH 85
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-----------------------HGGLS 576
+++ L G C + G LL+ E+ G+L L H
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 577 PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636
L + + Q ++G++YL A ++HRD+ NIL+ +I+DFGL R
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL----SR 198
Query: 637 DLTTD---------------M------------KSDVHNFGIVLLEILS-GRKAYDIEYV 668
D+ + M +SDV +FG++L EI++ G Y
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY----- 253
Query: 669 PPGI-VEWALPLIKQG 683
PGI E L+K G
Sbjct: 254 -PGIPPERLFNLLKTG 268
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 70/248 (28%), Positives = 102/248 (41%), Gaps = 68/248 (27%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNI-R 538
LG G++G V +A +VAVK ++ A EL+++ ++ +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH---ADEKEALMSELKIMSHLGQ 108
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-------------HGGLSPLNWSLRLK 585
H NIVNLLG C G L++ E+ G L + L S + L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM--- 642
S Q A+G+ +L A+ IHRDV N+LL + A+I DFGL RD+ D
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL----ARDIMNDSNYI 221
Query: 643 ------------------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA- 676
+SDV ++GI+L EI S G Y PGI+ +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY------PGILVNSK 275
Query: 677 -LPLIKQG 683
L+K G
Sbjct: 276 FYKLVKDG 283
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 44/206 (21%)
Query: 488 NELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+LG+G++G V G VAVK+ +T ++R+FE E+E+L +++H NI
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNI 73
Query: 543 VNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
V G C G R L+ E++P G+L D+L ++ L+ + Q KG+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------- 641
IHRD+ T NIL++++ +I DFGL + L D
Sbjct: 134 R---YIHRDLATRNILVENENRVKIGDFGL----TKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 642 ---------MKSDVHNFGIVLLEILS 658
+ SDV +FG+VL E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
E+G G +G V+ ++ +VA+K + +F E EV+ + H +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
CLE LV EFM G L D+L L + + +G+ YL +IH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127
Query: 608 RDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------------------------- 642
RD+ N L+ + +++DFG+ R + D
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGM----TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 643 -KSDVHNFGIVLLEILS-GRKAY 663
KSDV +FG+++ E+ S G+ Y
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPY 206
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 37/203 (18%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
ELG G +G V VA+K + + EF E +V+ N+ H +V L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
C + ++ E+M G L ++L L++ + +EYL + +H
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 608 RDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------------------------- 642
RD+ N L++ +++DFGL R + D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGL----SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 643 -KSDVHNFGIVLLEILS-GRKAY 663
KSD+ FG+++ EI S G+ Y
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPY 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 37/202 (18%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
ELG G +G V VAVK + + EF E + + + H +V G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608
C + +V E++ G L ++L L S L++ +G+ +L + IHR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 609 DVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-------------------------- 642
D+ N L+D D +++DFG+ R + D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGM----TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 643 KSDVHNFGIVLLEILS-GRKAY 663
KSDV FGI++ E+ S G+ Y
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPY 206
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 56/287 (19%)
Query: 488 NELGRGSYGFVYKAVLVD-----GRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHS 540
+LG G +G V G VAVK +A+A + ++ E+++L + H
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---QHRSGWKQEIDILRTLYHE 93
Query: 541 NIVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
+I+ G C + G LV E++P G+L D+L + + L + Q +G+ YLH
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLH 151
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----------------- 641
IHRD+ N+LLD+D +I DFGL + +
Sbjct: 152 AQH---YIHRDLAARNVLLDNDRLVKIGDFGL----AKAVPEGHEYYRVREDGDSPVFWY 204
Query: 642 -----------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689
SDV +FG+ L E+L+ + ++ A + + ++
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 690 DRNVALPRNVEPLFKLADIAELAIR---ENPSELPTMSQVATWLEQI 733
+R LPR P A++ L S PT + L+ +
Sbjct: 265 ERGERLPR---PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 80/304 (26%), Positives = 118/304 (38%), Gaps = 80/304 (26%)
Query: 488 NELGRGSYGFVYKAVLVD------GRQVAVK--RANAATIIHTNIREFEMELEVLCNI-R 538
LGRG++G V +A R VAVK + A + R EL++L +I
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGH 89
Query: 539 HSNIVNLLGYCLEMGE-RLLVYEFMPRGTLHDHL---------------HGGLSPLNWSL 582
H N+VNLLG C + G +++ EF G L +L L
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD- 641
+ S Q AKG+E+L A+ IHRD+ NILL +I DFGL RD+ D
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGL----ARDIYKDP 202
Query: 642 --------------------------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVE 674
++SDV +FG++L EI S G Y PG+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVKI 256
Query: 675 WA--LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732
+K+G + P P ++ PS+ PT S++ L
Sbjct: 257 DEEFCRRLKEGT---RMRA----PDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
Query: 733 IVKD 736
+++
Sbjct: 308 LLQA 311
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 57/219 (26%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
ELG G++G V+ A + VAVK T+ ++F+ E E+L N++H +
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEH 78
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRLKI 586
IV G C + ++V+E+M G L+ L L S L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----- 641
+ Q A G+ YL A+ +HRD+ T N L+ ++ +I DFG+ RD+ +
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM----SRDVYSTDYYRV 191
Query: 642 ----------M------------KSDVHNFGIVLLEILS 658
M +SDV +FG++L EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 43/211 (20%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+GRG +G VY L+D AVK N T I + +F E ++ + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVL 89
Query: 544 NLLGYCLEM-GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
+LLG CL G L+V +M G L + + + +Q AKG++YL A+
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD-----------------M--- 642
+HRD+ N +LD + ++ADFGL RD+ M
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGL----ARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 643 ---------KSDVHNFGIVLLEILS-GRKAY 663
KSDV +FG++L E+++ G Y
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 37/201 (18%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+G+G +G V G +VAVK + F E V+ +RHSN+V LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLH-GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+E L +V E+M +G+L D+L G S L LK S+ + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM----------------------K 643
+HRD+ N+L+ D A+++DFGL ++ ++ K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 644 SDVHNFGIVLLEILS-GRKAY 663
SDV +FGI+L EI S GR Y
Sbjct: 195 SDVWSFGILLWEIYSFGRVPY 215
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 71/252 (28%), Positives = 97/252 (38%), Gaps = 72/252 (28%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNI-R 538
LG G++G V +A VAVK + +A T EL+VL +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGN 85
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-----------------HGGLSPLNWS 581
H NIVNLLG C G L++ E+ G L + L L+
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 582 LRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
L S Q AKG+ +L A+ IHRD+ NILL +I DFGL RD+ D
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGL----ARDIKND 198
Query: 642 M---------------------------KSDVHNFGIVLLEILS-GRKAYDIEYVPPGIV 673
+SDV ++GI L E+ S G Y PG+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMP 252
Query: 674 EWA--LPLIKQG 683
+ +IK+G
Sbjct: 253 VDSKFYKMIKEG 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 58/271 (21%)
Query: 447 HELDTDAIADSLPHPASACPGMAQVFRLSELKDAT-----NGFKEFNELGRGSYGFVYKA 501
+ D D + L P V E + K +G+G +G V
Sbjct: 156 YTTDADGLCTRLIKP---KVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212
Query: 502 VLVDGRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL-LV 558
G +VAVK + +A + F E V+ +RHSN+V LLG +E L +V
Sbjct: 213 DY-RGNKVAVKCIKNDATA------QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265
Query: 559 YEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616
E+M +G+L D+L G S L LK S+ + +EYL + +HRD+ N+L
Sbjct: 266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVL 321
Query: 617 LDSDWGARIADFGLLTSCERDLTTD----------------------MKSDVHNFGIVLL 654
+ D A+++DFGL ++ ++ KSDV +FGI+L
Sbjct: 322 VSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 377
Query: 655 EILS-GRKAYDIEYVPPGI-VEWALPLIKQG 683
EI S GR Y P I ++ +P +++G
Sbjct: 378 EIYSFGRVPY------PRIPLKDVVPRVEKG 402
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 70/257 (27%), Positives = 100/257 (38%), Gaps = 77/257 (29%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNI-R 538
LG G++G V A QVAVK + A + + EL+++ +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGS 107
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL----------------------HGGLS 576
H NIVNLLG C G L++E+ G L ++L L+
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 577 PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636
L + L + Q AKG+E+L +HRD+ N+L+ +I DFGL R
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGL----AR 220
Query: 637 DLTTDM---------------------------KSDVHNFGIVLLEILS-GRKAYDIEYV 668
D+ +D KSDV ++GI+L EI S G Y
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY----- 275
Query: 669 PPGIVEWA--LPLIKQG 683
PGI A LI+ G
Sbjct: 276 -PGIPVDANFYKLIQNG 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 43/214 (20%)
Query: 485 KEFNELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
+G+G +G VY +D Q A+K + T + + F E ++ + H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLREGLLMRGLNHP 82
Query: 541 NIVNLLGYCL-EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
N++ L+G L G ++ +M G L + + +Q A+G+EYL
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------ 641
A +HRD+ N +LD + ++ADFGL RD+
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGL----ARDILDREYYSVQQHRHARLPVKWT 195
Query: 642 -----------MKSDVHNFGIVLLEILS-GRKAY 663
KSDV +FG++L E+L+ G Y
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 73/314 (23%), Positives = 124/314 (39%), Gaps = 95/314 (30%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNIRH 539
++G G++G V++A VAVK + A+ +F+ E ++ +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA---DMQADFQREAALMAEFDN 109
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-----------------------HGGLS 576
NIV LLG C L++E+M G L++ L G
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 577 PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636
PL+ + +L I+ Q A G+ YL + +HRD+ T N L+ + +IADFGL R
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL----SR 222
Query: 637 DL-TTD--------------M------------KSDVHNFGIVLLEILS-GRKAYDIEYV 668
++ + D M +SDV +G+VL EI S G + Y
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY----- 277
Query: 669 PPGI-VEWALPLIKQGKAAAIIDRNVALPRNV-EPLFKLADIAELAIRE----NPSELPT 722
G+ E + ++ G I+ P N L+ L +R P++ P+
Sbjct: 278 -YGMAHEEVIYYVRDGN---ILAC----PENCPLELYNL-------MRLCWSKLPADRPS 322
Query: 723 MSQVATWLEQIVKD 736
+ L+++ +
Sbjct: 323 FCSIHRILQRMCER 336
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 46/212 (21%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ-----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
LG G++G VYK + + + VA+K AT N +E E V+ ++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHV 79
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL--HKD 600
LLG CL L+ + MP G L D++ + L +Q AKG+ YL +
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------- 641
++HRD+ N+L+ + +I DFGL + L +
Sbjct: 138 ----LVHRDLAARNVLVKTPQHVKITDFGL----AKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 642 --------MKSDVHNFGIVLLEILS-GRKAYD 664
+SDV ++G+ + E+++ G K YD
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 57/221 (25%), Positives = 80/221 (36%), Gaps = 55/221 (24%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNIRH 539
LG G++G VY+ + QVAVK + + +F ME ++ H
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNH 92
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL------HGGLSPLNWSLRLKISMQAAKG 593
NIV +G L+ R ++ E M G L L S L L ++ A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGAR---IADFGLLTSCERDLTTD--------- 641
+YL IHRD+ N LL R I DFG+ RD+
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM----ARDIYRASYYRKGGCA 205
Query: 642 ------------------MKSDVHNFGIVLLEILS-GRKAY 663
K+D +FG++L EI S G Y
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 56/218 (25%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
ELG G++G V+ A + VAVK A+ + ++F+ E E+L ++H +
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQH 104
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL--------------HGGLSPLNWSLRLKIS 587
IV G C E L+V+E+M G L+ L PL L ++
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------ 641
Q A G+ YL A +HRD+ T N L+ +I DFG+ RD+ +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDYYRVG 217
Query: 642 ---------M------------KSDVHNFGIVLLEILS 658
M +SDV +FG+VL EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 43/211 (20%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+GRG +G VY L+D AVK N T I + +F E ++ + H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVL 153
Query: 544 NLLGYCLEMGE-RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
+LLG CL L+V +M G L + + + +Q AKG+++L A+
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD-----------------M--- 642
+HRD+ N +LD + ++ADFGL RD+ M
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGL----ARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 643 ---------KSDVHNFGIVLLEILS-GRKAY 663
KSDV +FG++L E+++ G Y
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 48/214 (22%)
Query: 489 ELGRGSYGFVYKAVLVDGR--------QVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
LG+G++ ++K V + +V +K + A F ++ + H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHK 72
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
++V G C+ E +LV EF+ G+L +L + +N +L+++ Q A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL--- 129
Query: 601 AAPPIIHRDVKTLNILLDSDWGAR--------IADFGLLTSCERDLTTD----------- 641
+IH +V NILL + + ++D G+ +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI----SITVLPKDILQERIPWVP 185
Query: 642 -----------MKSDVHNFGIVLLEILS-GRKAY 663
+ +D +FG L EI S G K
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 39/205 (19%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ-VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
++LG G YG VY+ V VAVK T + EF E V+ I+H N+V LL
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
G C ++ EFM G L D+L ++ + L ++ Q + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM----------------------- 642
IHRD+ N L+ + ++ADFGL R +T D
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGL----SRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 643 ---KSDVHNFGIVLLEILS-GRKAY 663
KSDV FG++L EI + G Y
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 57/221 (25%), Positives = 80/221 (36%), Gaps = 55/221 (24%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNIRH 539
LG G++G VY+ + QVAVK + + +F ME ++ H
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE---QDELDFLMEALIISKFNH 133
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL------HGGLSPLNWSLRLKISMQAAKG 593
NIV +G L+ R ++ E M G L L S L L ++ A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGAR---IADFGLLTSCERDLTTD--------- 641
+YL IHRD+ N LL R I DFG+ RD+
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM----ARDIYRAGYYRKGGCA 246
Query: 642 ------------------MKSDVHNFGIVLLEILS-GRKAY 663
K+D +FG++L EI S G Y
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 46/212 (21%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ-----VAVK--RANAATIIHTNIREFEMELEVLCNIRHS 540
LG G +G V+K V + + V +K + + + + + ++ H+
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHA 75
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+IV LLG C LV +++P G+L DH+ L L L +Q AKG+ YL
Sbjct: 76 HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------- 641
++HR++ N+LL S ++ADFG+ L D
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGV----ADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 642 --------MKSDVHNFGIVLLEILS-GRKAYD 664
+SDV ++G+ + E+++ G + Y
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 42/210 (20%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ-----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
LG G++G VYK + + + VA+K AT +E E V+ ++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHV 79
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
LLG CL L+ + MP G L D++ + L +Q AKG+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---ED 135
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD--------------------- 641
++HRD+ N+L+ + +I DFGL + L +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGL----AKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 642 ------MKSDVHNFGIVLLEILS-GRKAYD 664
+SDV ++G+ + E+++ G K YD
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 50/209 (23%), Positives = 77/209 (36%), Gaps = 41/209 (19%)
Query: 488 NELGRGSYGFVYKAVLVDGR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+G G G V L VA+K A R+F E ++ H NI+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNII 113
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G ++V E+M G+L L + + G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM--------------------- 642
+HRD+ N+L+DS+ +++DFGL R L D
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGL----SRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 643 -------KSDVHNFGIVLLEILS-GRKAY 663
SDV +FG+V+ E+L+ G + Y
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPY 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 61/227 (26%)
Query: 488 NELGRGSYGFVYKAVLVDGR------QVAVK--RANAATIIHTNIREFEMELEVLCNIRH 539
ELG +G VYK L VA+K + A EF E + ++H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE---GPLREEFRHEAMLRARLQH 71
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---------------HGGLSPLNWSLRL 584
N+V LLG + +++ + G LH+ L S L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL-TTD-- 641
+ Q A G+EYL ++ ++H+D+ T N+L+ +I+D GL R++ D
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL----FREVYAADYY 184
Query: 642 ------------------------MKSDVHNFGIVLLEILS-GRKAY 663
+ SD+ ++G+VL E+ S G + Y
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 41/205 (20%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
LG G +G V+ +VAVK + + F E ++ ++H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ ++ E+M G+L D L G L + L ++ Q A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI---EERNY 130
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM----------------------- 642
IHRD++ NIL+ +IADFGL R + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGL----ARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 643 ---KSDVHNFGIVLLEILS-GRKAY 663
KSDV +FGI+L EI++ GR Y
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 61/291 (20%), Positives = 108/291 (37%), Gaps = 70/291 (24%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---ELEVLCNIRHSNIVNL 545
LG G + +V L DG A+KR I+ ++ E E ++ H NI+ L
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKR-----ILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 546 LGYCLE----MGERLLVYEFMPRGTLHDHL---HGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ YCL E L+ F RGTL + + + L L + + +GLE +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------ 640
HRD+K NILL + + D G + +
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 641 ---------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685
D ++DV + G VL ++ G YD+ + K
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF------------QKGDSV 256
Query: 686 AAIIDRNVALPRNV---EPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
A + +++P++ L++L + + + +P + P + + + LE +
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQL--LNSM-MTVDPHQRPHIPLLLSQLEAL 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 62/206 (30%), Positives = 89/206 (43%), Gaps = 41/206 (19%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ-VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
++LG G YG VY+ V VAVK T + EF E V+ I+H N+V LL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
G C ++ EFM G L D+L ++ + L ++ Q + +EYL K
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM---------------------- 642
IHR++ N L+ + ++ADFGL R +T D
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGL----SRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 643 ----KSDVHNFGIVLLEILS-GRKAY 663
KSDV FG++L EI + G Y
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 61/282 (21%), Positives = 107/282 (37%), Gaps = 68/282 (24%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
FKE +G G +G V+KA +DG+ +K + N + E E++ L + H NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNNEKAEREVKALAKLDHVNI 66
Query: 543 VNLLGYCLEMGERL----------------LVYEFMPRGTLHDHLHG-GLSPLNWSLRLK 585
V+ G + EF +GTL + L+ L L+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD--LTT--- 640
+ Q KG++Y+H +I+RD+K NI L +I DFGL+TS + D T
Sbjct: 127 LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 641 ---------------DMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGK 684
+ D++ G++L E+L A++ ++ G
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF--------FTDLRDGI 235
Query: 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
+ + K + + + + P + P S++
Sbjct: 236 ----------ISDIFDK--KEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 34/205 (16%)
Query: 489 ELGRGSYGFVYKAVLVDGR-----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+G G +G VYK +L VA+K A +F E ++ H NI+
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNII 109
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G + +++ E+M G L L + + + A G++YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN-- 167
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM--------------------- 642
+HRD+ NIL++S+ +++DFGL E D
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 643 ---KSDVHNFGIVLLEILS-GRKAY 663
SDV +FGIV+ E+++ G + Y
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPY 251
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 51/211 (24%), Positives = 80/211 (37%), Gaps = 39/211 (18%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN---IREFEMELEVLCNIRH 539
F+E LG+G++G V KA +D R A+K I + E+ +L ++ H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIK------KIRHTEEKLSTILSEVMLLASLNH 61
Query: 540 SNIVNLLGYCLEMGERL-------------LVYEFMPRGTLHDHLHGGLSPLNWSLRLKI 586
+V LE + + E+ GTL+D +H ++
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDV 646
Q + L Y+H IIHRD+K +NI +D +I DFGL + R L
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 647 HNFGIVLL-------------EILSGRKAYD 664
+ G E+L G Y+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 7e-27
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 40/206 (19%)
Query: 489 ELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
LG G +G VY+ V + + VAVK + +F E ++ N+ H +IV
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIVK 77
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L+G E ++ E P G L +L + L + S+Q K + YL +
Sbjct: 78 LIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESIN 133
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----------------------- 641
+HRD+ NIL+ S ++ DFGL R + +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGL----SRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 642 ---MKSDVHNFGIVLLEILS-GRKAY 663
SDV F + + EILS G++ +
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPF 215
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 56/217 (25%), Positives = 83/217 (38%), Gaps = 45/217 (20%)
Query: 475 SELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM-ELE 532
E ++ + +GRGS+G V++ G Q AVK + F + EL
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELV 102
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVY-EFMPRGTLHDHL-HGGLSPLNWSLRLKISMQA 590
+ IV L G E G + ++ E + G+L + G L L QA
Sbjct: 103 ACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQA 159
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGL---LTSCERDLTT------ 640
+GLEYLH I+H DVK N+LL SD A + DFG L +
Sbjct: 160 LEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 641 -----------------DMKSDVHNFGIVLLEILSGR 660
D K D+ + ++L +L+G
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 45/209 (21%)
Query: 489 ELGRGSYGFVYKAVLVDGR---QVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G++G V + V + VA+K + + E E +++ + + IV
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIV 73
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L+G C +LV E G LH L G + S ++ Q + G++YL
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEK 129
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD---------------------- 641
+HRD+ N+LL + A+I+DFGL + L D
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGL----SKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 642 ------MKSDVHNFGIVLLEILS-GRKAY 663
+SDV ++G+ + E LS G+K Y
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
+ ++G GS+G DGRQ +K N + + E E+ VL N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLH 598
NIV E G +V ++ G L + G L +Q L+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVH 142
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTT---------------- 640
I+HRD+K+ NI L D ++ DFG+ + + +L
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 641 ---DMKSDVHNFGIVLLEILSGRKAYD 664
+ KSD+ G VL E+ + + A++
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFE 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 43/208 (20%)
Query: 489 ELGRGSYGFVYKAVLVDGR---QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
ELG G++G V K + VAVK E E V+ + + IV +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 546 LGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+G C E LV E G L+ +L + +++ Q + G++YL
Sbjct: 84 IGICE--AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL---EESN 137
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----------------------- 641
+HRD+ N+LL + A+I+DFGL + L D
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGL----SKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 642 -----MKSDVHNFGIVLLEILS-GRKAY 663
KSDV +FG+++ E S G+K Y
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPY 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 34/199 (17%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG+G+YG VY L + ++A+K + E+ + +++H NIV LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 549 CLEMGERLLVY-EFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
E + ++ E +P G+L L G N + Q +GL+YLH + I
Sbjct: 88 FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 606 IHRDVKTLNILLDSDWGA-RIADFGL---LTSCERDLTT--------------------D 641
+HRD+K N+L+++ G +I+DFG L T
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 642 MKSDVHNFGIVLLEILSGR 660
+D+ + G ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 40/206 (19%)
Query: 489 ELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+G G +G V++ + + VA+K T +F E + H +IV
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVK 80
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L+G E ++ E G L L L+ + + + Q + L YL +
Sbjct: 81 LIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----------------------- 641
+HRD+ N+L+ S+ ++ DFGL R +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGL----SRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 642 ---MKSDVHNFGIVLLEILS-GRKAY 663
SDV FG+ + EIL G K +
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPF 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+LG+G +G V+ +VA+K T+ F E +V+ +RH +V L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 246
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
E +V E+M +G+L D L G L + ++ Q A G+ Y+ +
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---Y 301
Query: 606 IHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTTDM-------------------K 643
+HRD++ NIL+ + ++ADFGL + E K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 644 SDVHNFGIVLLEILS-GRKAY 663
SDV +FGI+L E+ + GR Y
Sbjct: 362 SDVWSFGILLTELTTKGRVPY 382
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ ELG G++G VYKA G A K + + ++ +E+E+L H I
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYI 78
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
V LLG G+ ++ EF P G + + L + Q + L +LH
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR- 137
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFG 629
IIHRD+K N+L+ + R+ADFG
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 47/201 (23%), Positives = 71/201 (35%), Gaps = 25/201 (12%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSN 541
F+ + LG GSYG V+K DGR AVKR+ + + E+ + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
V L E G L E +L H + L + L +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT----------------DM 642
++H DVK NI L ++ DFGL L +
Sbjct: 178 ---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGT 234
Query: 643 KSDVHNFGIVLLEILSGRKAY 663
+DV + G+ +LE+ +
Sbjct: 235 AADVFSLGLTILEVACNMELP 255
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 42/210 (20%)
Query: 489 ELGRGSYGFVYKAVL----VDGRQVAVKRANAATIIHTNIR-EFEMELEVLCNIRHSNIV 543
+LG GS+G V + VAVK + +F E+ + ++ H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G L +V E P G+L D L + ++Q A+G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR-- 141
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD---------------------- 641
IHRD+ N+LL + +I DFGL R L +
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGL----MRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 642 ------MKSDVHNFGIVLLEILS-GRKAYD 664
SD FG+ L E+ + G++ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 66/268 (24%), Positives = 105/268 (39%), Gaps = 39/268 (14%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFE-----MELEVLCNI 537
F++ +ELG G+ G V+K G +A K +IH I+ EL+VL
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARK------LIHLEIKPAIRNQIIRELQVLHEC 88
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
IV G GE + E M G+L L + + K+S+ KGL YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYL 147
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSC-------------ER--DL 638
+ I+HRDVK NIL++S ++ DFG L+ S ER
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205
Query: 639 TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR- 697
++SD+ + G+ L+E+ GR + + + R P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 698 ----NVEPLFKLADIAELAIRENPSELP 721
+ P + ++ + + E P +LP
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 45/233 (19%), Positives = 90/233 (38%), Gaps = 33/233 (14%)
Query: 461 PASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATI 519
+ + L + F+ ++GRG + VY+A L+DG VA+K+ +
Sbjct: 15 QFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 520 IHTNIREFEM-ELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---HGGL 575
+ R + E+++L + H N++ +E E +V E G L +
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 576 SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTS 633
+ K +Q LE++H ++HRD+K N+ + + ++ D GL S
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 634 CERDLTT-------------------DMKSDVHNFGIVLLEILSGRKAYDIEY 667
+ + KSD+ + G +L E+ + + + +
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 8/163 (4%)
Query: 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE 526
+ ++ S K F +LG GSYG VYKA+ G+ VA+K+ + ++++E
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQE 70
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKI 586
E+ ++ ++V G + + +V E+ G++ D + L I
Sbjct: 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI 130
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
KGLEYLH IHRD+K NILL+++ A++ADFG
Sbjct: 131 LQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFG 170
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+LG+G +G V+ +VA+K T+ F E +V+ +RH +V L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
E +V E+M +G+L D L G L + ++ Q A G+ Y+ +
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---Y 384
Query: 606 IHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTTDM-------------------K 643
+HRD++ NIL+ + ++ADFGL + E K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 644 SDVHNFGIVLLEILS-GRKAY 663
SDV +FGI+L E+ + GR Y
Sbjct: 445 SDVWSFGILLTELTTKGRVPY 465
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 41/205 (20%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+LG G +G V+ A +VAVK + ++ F E V+ ++H +V L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ ++ EFM +G+L D L G S + S Q A+G+ ++
Sbjct: 251 VVTKEP-IYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM----------------------- 642
IHRD++ NIL+ + +IADFGL R + +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGL----ARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 643 ---KSDVHNFGIVLLEILS-GRKAY 663
KSDV +FGI+L+EI++ GR Y
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPY 386
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 43/221 (19%), Positives = 79/221 (35%), Gaps = 49/221 (22%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEME---LEVLCNIRH 539
F E ++G G +G V+K V +DG A+KR+ + + E VL H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--H 70
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL---HGGLSPLNWSLRLKISMQAAKGLEY 596
S++V E L+ E+ G+L D + + +S + + +Q +GL Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 597 LHKDAAPPIIHRDVKTLNILLDSD-------------------WGARIADFGLLTS---- 633
+H + ++H D+K NI + +I D G +T
Sbjct: 131 IHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 634 --------------CERDLTTDMKSDVHNFGIVLLEILSGR 660
+ + T K+D+ + ++
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 41/209 (19%)
Query: 488 NELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+G G +G V L + VA+K R+F E ++ H NI+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNII 109
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G + ++V E+M G+L L + + + A G++YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM--------------------- 642
+HRD+ NIL++S+ +++DFGL R L D
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGL----GRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 643 -------KSDVHNFGIVLLEILS-GRKAY 663
SDV ++GIVL E++S G + Y
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 475 SELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEV 533
+ D F + ++G+GS+G V+K + + VA+K + I + + E+ V
Sbjct: 15 NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITV 73
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKG 593
L + G L+ + ++ E++ G+ D L G PL+ + I + KG
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKG 131
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT---------- 640
L+YLH + IHRD+K N+LL ++ADFG+ LT + T
Sbjct: 132 LDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 641 --------DMKSDVHNFGIVLLEILSG 659
D K+D+ + GI +E+ G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 29/226 (12%)
Query: 459 PHPASACPGMAQVFRLSEL---KDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRA 514
P PA G + ++EL D F + E+G GS+G VY A + + VA+K+
Sbjct: 28 PMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM 87
Query: 515 N-AATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG 573
+ + + ++ E+ L +RH N + G L LV E+ G+ D L
Sbjct: 88 SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV 146
Query: 574 GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--- 630
PL ++ A +GL YLH +IHRDVK NILL ++ DFG
Sbjct: 147 HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 631 LT-----------------SCERDLTTDMKSDVHNFGIVLLEILSG 659
+ + D K DV + GI +E+
Sbjct: 204 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 46/219 (21%), Positives = 84/219 (38%), Gaps = 33/219 (15%)
Query: 475 SELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEV 533
S +D ++ +G GSYG K DG+ + K + ++ + E+ +
Sbjct: 3 SRAED----YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL 58
Query: 534 LCNIRHSNIVNLLGYCLEMGERLL--VYEFMPRGTLHDHLHGGL---SPLNWSLRLKISM 588
L ++H NIV ++ L V E+ G L + G L+ L++
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 589 QAAKGLEYLH--KDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTT---- 640
Q L+ H D ++HRD+K N+ LD ++ DFGL + + +
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 641 ---------------DMKSDVHNFGIVLLEILSGRKAYD 664
+ KSD+ + G +L E+ + +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 40/206 (19%)
Query: 489 ELGRGSYGFVYKAVLVDGRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+G G +G V++ + + VA+K T +F E + H +IV
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVK 455
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L+G E ++ E G L L L+ + + + Q + L YL +
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKR 511
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD----------------------- 641
+HRD+ N+L+ S+ ++ DFGL R +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGL----SRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 642 ---MKSDVHNFGIVLLEILS-GRKAY 663
SDV FG+ + EIL G K +
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE 526
+ ++ + + D + F ++G+G+ G VY A+ + G++VA+++ N
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKEL 63
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKI 586
E+ V+ ++ NIVN L L E +V E++ G+L D + ++ +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 121
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT--- 640
+ + LE+LH + +IHRD+K+ NILL D ++ DFG +T + +T
Sbjct: 122 CRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 641 ---------------DMKSDVHNFGIVLLEILSG 659
K D+ + GI+ +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 8/147 (5%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+ ++G GS G V A GRQVAVK + E+ ++ + +H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNV 104
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
V + L E ++ EF+ G L D + LN + + L YLH
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFG 629
+IHRD+K+ +ILL D +++DFG
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFG 186
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F+ LGRG +G V++A VD A+KR + E++ L + H I
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHPGI 65
Query: 543 VNLLGYCLE---------MGERLLVY---EFMPRGTLHDHLH--GGLSPLNWSLRLKISM 588
V LE ++ +Y + + L D ++ + S+ L I +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637
Q A+ +E+LH ++HRD+K NI D ++ DFGL+T+ ++D
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 489 ELGRGSYGFVYKAVLVDGR---QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
ELG G++G V + V + VA+K T + E E +++ + + IV L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRL 401
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+G C +LV E G LH L G + S ++ Q + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 457
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD------------------------ 641
+HR++ N+LL + A+I+DFGL + L D
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGL----SKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 642 ----MKSDVHNFGIVLLEILS-GRKAY 663
+SDV ++G+ + E LS G+K Y
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 52/195 (26%), Positives = 78/195 (40%), Gaps = 31/195 (15%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG+G +G VY A +A+K A + + E+E+ ++RH NI+ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
Y R+ L+ E+ P GT++ L + A L Y H
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTA-TYITELANALSYCHSKR--- 129
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTT-----------------DMKSD 645
+IHRD+K N+LL S +IADFG R D K D
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 646 VHNFGIVLLEILSGR 660
+ + G++ E L G+
Sbjct: 190 LWSLGVLCYEFLVGK 204
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 28/195 (14%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG+GS+ VY+A + G +VA+K + + + + + E+++ C ++H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
Y E + LV E G ++ +L + P + + Q G+ YLH I+
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 607 HRDVKTLNILLDSDWGARIADFGLLTSCERD---LTT------------------DMKSD 645
HRD+ N+LL + +IADFGL T + T ++SD
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESD 194
Query: 646 VHNFGIVLLEILSGR 660
V + G + +L GR
Sbjct: 195 VWSLGCMFYTLLIGR 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 31/195 (15%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG+G +G VY A +A+K + + + E+E+ ++RH NI+ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
Y +R+ L+ EF PRG L+ L HG + + A L Y H+
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFD--EQRSATFME-ELADALHYCHERK--- 134
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTT-----------------DMKSD 645
+IHRD+K N+L+ +IADFG R T D K D
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 646 VHNFGIVLLEILSGR 660
+ G++ E L G
Sbjct: 195 LWCAGVLCYEFLVGM 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 34/251 (13%), Positives = 75/251 (29%), Gaps = 29/251 (11%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK--RANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
G ++A+ RQVA+ ++E L I + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARV 96
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
L L+V E++ G+L + SP+ ++ A + H +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG---AIRAMQSLAAAADAAH---RAGV 150
Query: 606 IHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYDI 665
+ + D +A + + + D+ G L +L R
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMP------DANPQDDIRGIGASLYALLVNRWPLPE 204
Query: 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL--FKLADIAELAIRENPSELPTM 723
V G+ A P +++ F+++ +A +++ +
Sbjct: 205 AGVRSGL----------APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA- 253
Query: 724 SQVATWLEQIV 734
S + ++Q
Sbjct: 254 STLLNLMQQAT 264
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 461 PASACPGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATI 519
+ + LS L+D F+ +G G+YG VYK + G+ A+K + +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---V 59
Query: 520 IHTNIREFEMELEVLCNI-RHSNIVNLLG-----YCLEMGERL-LVYEFMPRGTLHDHLH 572
E + E+ +L H NI G M ++L LV EF G++ D +
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 573 GGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629
L I + +GL +LH+ +IHRD+K N+LL + ++ DFG
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 40/205 (19%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-------IREFEMELEVLCNIRHSN 541
LG G VY A + +VA+K I ++ FE E+ + H N
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIK------AIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
IV+++ E LV E++ TL +++ PL+ + + Q G+++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGL--------LT------------SCE--RDLT 639
I+HRD+K NIL+DS+ +I DFG+ LT S E +
Sbjct: 132 ---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 640 TDMKSDVHNFGIVLLEILSGRKAYD 664
TD +D+++ GIVL E+L G ++
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 44/258 (17%), Positives = 79/258 (30%), Gaps = 52/258 (20%)
Query: 452 DAIADSLPHPASACPG-------MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLV 504
+ L P S+ P + + +E + + + LG G++ VY+A
Sbjct: 28 FKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQG 87
Query: 505 DGRQVAVKRANAATIIH-TNIREFEM---ELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560
D K+ + N EF + +E L + L +LV E
Sbjct: 88 DLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147
Query: 561 FMPRGTLHDHL----HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616
GTL + + + + L + +M+ +E +H IIH D+K N +
Sbjct: 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFI 204
Query: 617 L-----------DSDWGARIADFGL---LTSCERD--LTT------------------DM 642
L D G + D G + + T +
Sbjct: 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY 264
Query: 643 KSDVHNFGIVLLEILSGR 660
+ D + +L G
Sbjct: 265 QIDYFGVAATVYCMLFGT 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFE-----MELEVLC-N 536
K+ E+GRG+YG V K V G+ +AVK I + + E E M+L+V+ +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVK------RIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR----LKISMQAAK 592
IV G G+ + E M + S L+ + KI++ K
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSC-------------- 634
L +L ++ IIHRD+K NILLD ++ DFG L+ S
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
Query: 635 ER------DLTTDMKSDVHNFGIVLLEILSGR 660
ER D++SDV + GI L E+ +GR
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ +G G+ V A +VA+KR N T++ E E++ + H NI
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNI 75
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRL-------KISMQAAKGLE 595
V+ + E LV + + G++ D + ++ + I + +GLE
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTT----------- 640
YLHK+ IHRDVK NILL D +IADFG L T +
Sbjct: 136 YLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 641 ------------DMKSDVHNFGIVLLEILSGR 660
D K+D+ +FGI +E+ +G
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 33/197 (16%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG+G + ++ D A K + ++ + RE ME+ + ++ H ++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ E + + +V E R +L + L+ R Q G +YLH++
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQYLHRNR--- 135
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERD---LTT------------------DMK 643
+IHRD+K N+ L+ D +I DFGL T E D +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 644 SDVHNFGIVLLEILSGR 660
DV + G ++ +L G+
Sbjct: 196 VDVWSIGCIMYTLLVGK 212
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 43/229 (18%), Positives = 76/229 (33%), Gaps = 41/229 (17%)
Query: 74 FCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKG 133
W N+ G T + IA G H A++G G V W G
Sbjct: 5 VAWGGNNDWGEAT---VPAEAQSGVDAIAGGYFHGLALKG--------GKVLGW-----G 48
Query: 134 NNTLSSVQTNLFYDEYVSTIVLKDVIS---GDGFSCGGVRDGGIVCWGPDSE-SLGV-FN 188
N Q + V + G+ S ++DG ++ WG + + V
Sbjct: 49 ANLNG--QLT------MPAATQSGVDAIAAGNYHSL-ALKDGEVIAWGGNEDGQTTVPAE 99
Query: 189 VTESFKVLASGKSSLCGISELSGEVKCWGNNDF--VSVPPVGIRFVSLAAGANHFCGIRE 246
+A+G + + G+V WG++ +VP V+ G + +
Sbjct: 100 ARSGVDAIAAGAWASYALK--DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVK 157
Query: 247 DNHGVECWGSFNY----SSVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
+ GV WG + SG +A F + +++ ++ W
Sbjct: 158 NG-GVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALKDGKVI--AW 203
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 55/281 (19%), Positives = 98/281 (34%), Gaps = 48/281 (17%)
Query: 11 NSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGEGLLCGILANT 70
A+ GK V+ W N + L+ +A+ S + + ++ G +
Sbjct: 33 YFHGLALK-GGK--VLGWGANLNGQ----LTMPAATQSGVDA---IAAGNYHSLALKDGE 82
Query: 71 SQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIV 130
W N G TT + + IAAG A++ G V W
Sbjct: 83 --VIAWGGNED-GQTTVPAEA---RSGVDAIAAGAWASYALKD--------GKVIAW--- 125
Query: 131 RKGNNTLSSVQTNLFYDEYVSTIVLKDV--ISGDGFSCGGVRDGGIVCWGPDSE-SLGV- 186
G++ S QT V V + G ++ V++GG++ WG + V
Sbjct: 126 --GDD--SDGQTT------VPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVP 175
Query: 187 FNVTESFKVLASGKSSLCGISELSGEVKCWGNNDF--VSVPPVGIR-FVSLAAGANHFCG 243
+A G + G+V WG+N + +VP + ++A+G +
Sbjct: 176 AEAQSGVDDVAGGIFHSLALK--DGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLA 233
Query: 244 IREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIREN 284
++ N V WGS + SG +I + ++
Sbjct: 234 LK--NGKVIAWGSSRTAPSSVQSGVSSIEAGPNAAYALKGG 272
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 59/279 (21%), Positives = 96/279 (34%), Gaps = 52/279 (18%)
Query: 25 VICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGEGLLCGILANTSQAFCWSSNSSPGN 84
V+ W N+ ++ + + S + ++A GG + W +N + G
Sbjct: 4 VVAWGGNNDWGEAT---VPAEAQSGVDAIA---GGYFHGLALKGGK--VLGWGANLN-GQ 54
Query: 85 TTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNL 144
T + IAAG H A++ G V W G N QT
Sbjct: 55 LTM---PAATQSGVDAIAAGNYHSLALKD--------GEVIAW-----GGN--EDGQTT- 95
Query: 145 FYDEYVSTIVLKDVI---SGDGFSCGGVRDGGIVCWGPDSE-SLGV-FNVTESFKVLASG 199
V V +G S ++DG ++ WG DS+ V L G
Sbjct: 96 -----VPAEARSGVDAIAAGAWASYA-LKDGKVIAWGDDSDGQTTVPAEAQSGVTALDGG 149
Query: 200 KSSLCGISELSGEVKCWGNNDF--VSVP-PVGIRFVSLAAGANHFCGIREDNHGVECWGS 256
+ + +G V WG+N F +VP +A G H +++ V WG
Sbjct: 150 VYTALAVK--NGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALKDG--KVIAWGD 205
Query: 257 FNY----SSVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
Y SG AIAS ++ + ++ ++ W
Sbjct: 206 NRYKQTTVPTEALSGVSAIASGEWYSLALKNGKVI--AW 242
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 12/90 (13%)
Query: 210 SGEVKCWGNNDF---VSVP-PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYS----S 261
+ V WG N+ +VP ++A G H + V WG+
Sbjct: 1 ATSVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLAL--KGGKVLGWGANLNGQLTMP 58
Query: 262 VPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
SG AIA+ ++ + +++ +++ W
Sbjct: 59 AATQSGVDAIAAGNYHSLALKDGEVI--AW 86
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 31/166 (18%)
Query: 485 KEFNELGRGSYGFVYKAV---LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
E ++GRG+YG VYKA D + A+K+ I + RE + +L ++H N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPN 79
Query: 542 IVNLLGYCLEMGERL--LVYEFMPRGTLHD-----HLHGGLSPLNWSLRLKISM------ 588
+++L L +R L++++ HD H ++L M
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR----IADFGL 630
Q G+ YLH + ++HRD+K NIL+ + R IAD G
Sbjct: 136 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 47/224 (20%), Positives = 79/224 (35%), Gaps = 43/224 (19%)
Query: 474 LSELKDATNGFKEFNELGRG--SYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEME 530
+S ++ +G+G V A G V V+R N + + + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 531 LEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHD----HLHGGLSPLNWSLRLKI 586
L V H NIV + E +V FM G+ D H G++ L + L+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ- 135
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTT-- 640
K L+Y+H +HR VK +IL+ D ++ +++ +R
Sbjct: 136 --GVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 641 ------------------------DMKSDVHNFGIVLLEILSGR 660
D KSD+++ GI E+ +G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 33/197 (16%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG+G + ++ D A K + ++ + RE ME+ + ++ H ++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ E + + +V E R +L + L+ R Q G +YLH++
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTE--PEAR-YYLRQIVLGCQYLHRNR--- 161
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERD---LTT------------------DMK 643
+IHRD+K N+ L+ D +I DFGL T E D +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 644 SDVHNFGIVLLEILSGR 660
DV + G ++ +L G+
Sbjct: 222 VDVWSIGCIMYTLLVGK 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 41/210 (19%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFE-----MELEVLCN- 536
+ ELGRG+YG V K V G+ +AVK I + E M+L++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVK------RIRATVNSQEQKRLLMDLDISMRT 62
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGT--LHDHLHGGLSPLNWSLRLKISMQAAKGL 594
+ V G G+ + E M + + + + KI++ K L
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSC--------------ER 636
E+LH + +IHRDVK N+L+++ ++ DFG L+ ER
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 637 ------DLTTDMKSDVHNFGIVLLEILSGR 660
+KSD+ + GI ++E+ R
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 22/181 (12%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLG 547
L G + FVY+A + GR+ A+KR + R E+ + + H NIV
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 548 YCLEMGER-------LLVYEFMPRGTLHDHL-----HGGLSPLNWSLRLKISMQAAKGLE 595
E L+ + +G L + L G LS LKI Q + ++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC---DTVLKIFYQTCRAVQ 150
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLE 655
++H+ PPIIHRD+K N+LL + ++ DFG + D +V E
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGS--ATTISHYPDYSWSAQRRALVEEE 207
Query: 656 I 656
I
Sbjct: 208 I 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 38/208 (18%), Positives = 76/208 (36%), Gaps = 39/208 (18%)
Query: 490 LGRGSYGFVYKAV--LVDGRQVAVKRANAATIIHTN----IREFEMELEVLCNIRHSNIV 543
+ G G++Y A+ V+GR V +K ++H+ E + L + H +IV
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLK-----GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 544 NLLGYCLEMGERL-----LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ + +V E++ +L L + + ++ L YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH 199
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSC------------ERDLT-TDM 642
+ +++ D+K NI+L + ++ D G + S E T +
Sbjct: 200 ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPTV 255
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVPP 670
+D++ G L + + YV
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-------IREFEMELEVLCNIRHSN 541
LG G V+ A L D R VAVK ++ + F E + + H
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVK------VLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 542 IVNLLGYCLEMGERL----LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
IV + +V E++ TL D +H P+ +++ A + L +
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFS 132
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLT--------------- 639
H++ IIHRDVK NI++ + ++ DFG+ + +T
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 640 ------TDMKSDVHNFGIVLLEILSGRKAYD 664
D +SDV++ G VL E+L+G +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 41/209 (19%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFE-----MELEVLCN- 536
+ E+G G+ G V+K G +AVK + + + E M+L+V+
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVK------QMRRSGNKEENKRILMDLDVVLKS 80
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
IV G + + + E M P+ + K+++ K L Y
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYY 139
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFG----LLTSCERDLTT------------ 640
L + +IHRDVK NILLD ++ DFG L+ +D +
Sbjct: 140 LKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197
Query: 641 ---------DMKSDVHNFGIVLLEILSGR 660
D+++DV + GI L+E+ +G+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----------TNIREFEMELE 532
++ +G GSYG V K GR VA+K+ +RE ++
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKK------FLESDDDKMVKKIAMREIKL--- 77
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK 592
L +RH N+VNLL C + LV+EF+ T+ D L + L++ + K Q
Sbjct: 78 -LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
G+ + H IIHRD+K NIL+ ++ DFG
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 25/158 (15%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----------TNIREFEMELE 532
+++ ++G GSYG V+K G+ VA+K+ +RE M
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKK------FLESEDDPVIKKIALREIRM--- 55
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK 592
L ++H N+VNLL LV+E+ T+ L + L I+ Q +
Sbjct: 56 -LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ + HK IHRDVK NIL+ ++ DFG
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+ +G GS+G V++A LV+ +VA+K+ + + R EL+++ ++H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKK------VLQDKRFKNRELQIMRIVKHPNVV 95
Query: 544 NLLGYCLEMGERL------LVYEFMPRGTLH---DHLHGGLSPLNWSLRLKISMQAAKGL 594
+L + G++ LV E++P T++ H + L Q + L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFGL 630
Y+H I HRD+K N+LLD G ++ DFG
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS 188
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 30/160 (18%), Positives = 61/160 (38%), Gaps = 12/160 (7%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNL 545
++G G V++ + + A+K N + + + E+ L ++ I+ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + +V E L+ L + P R + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG-- 128
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMK 643
I+H D+K N L+ ++ DFG+ + D T+ +K
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 166
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 4e-21
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----------TNIREFEMELE 532
F++ ++G G+YG VYKA + G VA+K+ I T IRE +
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIRE----IS 54
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMP---RGTLHDHLHGGLSPLNWSLRLKISMQ 589
+L + H NIV LL + LV+EF+ + + G+ L Q
Sbjct: 55 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQ 111
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+GL + H ++HRD+K N+L++++ ++ADFGL
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL 149
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 38/215 (17%), Positives = 80/215 (37%), Gaps = 48/215 (22%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVK--------------RANAATIIHTNIRE-FEMELEVL 534
L +G + + D + A+K ++N I + + F+ EL+++
Sbjct: 39 LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 535 CNIRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISM---- 588
+I++ + G + + + ++YE+M ++ + + N++ + I +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 589 --QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG---------LLTSC--- 634
Y+H + I HRDVK NIL+D + +++DFG + S
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY 214
Query: 635 ---------ERDLTTDMKSDVHNFGIVLLEILSGR 660
K D+ + GI L +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 30/160 (18%), Positives = 61/160 (38%), Gaps = 12/160 (7%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNL 545
++G G V++ + + A+K N + + + E+ L ++ I+ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + +V E L+ L + P R + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG-- 147
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMK 643
I+H D+K N L+ ++ DFG+ + D T+ +K
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 185
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 30/160 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH----------TNIREFEMELEV 533
+++ ++G G+YG VYKA GR VA+KR I T IRE + +
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKR------IRLDAEDEGIPSTAIRE----ISL 72
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISM-QA 590
L + H NIV+L+ LV+EFM + + D GL +KI + Q
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ----IKIYLYQL 128
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+G+ + H+ I+HRD+K N+L++SD ++ADFGL
Sbjct: 129 LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 15/153 (9%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNI 542
F + LG G+ G + + D R VAVKR I+ + E+++L H N+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR-----ILPECFSFADREVQLLRESDEHPNV 80
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
+ + + + E TL +++ + + Q GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 603 PPIIHRDVKTLNILLDSDWG-----ARIADFGL 630
I+HRD+K NIL+ A I+DFGL
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 7e-21
Identities = 30/323 (9%), Positives = 64/323 (19%), Gaps = 64/323 (19%)
Query: 466 PGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN- 523
P A+ S L K L G V+ V+ A+K +
Sbjct: 46 PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105
Query: 524 IREFEMELEVLCNIRHSNIVNLLGYC--------------------------LEMGERLL 557
+ + + + LL
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 558 VYEFM-----PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKT 612
+ + D ++ ++ Q + L + ++H
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTP 222
Query: 613 LNILLDSDWGARIADFGLLTSCERDLTT--------------------DMKSDVHNFGIV 652
N+ + D + D L + G+
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 653 LLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELA 712
+ + + + L G + LP V+ L I
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL-----IGRF- 336
Query: 713 IRENPSELPTMSQVAT--WLEQI 733
+ + + Q+
Sbjct: 337 LNFDRRRRLLPLEAMETPEFLQL 359
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 27/147 (18%), Positives = 55/147 (37%), Gaps = 12/147 (8%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNL 545
++G G V++ + + A+K N + + + E+ L ++ I+ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + +V E L+ L + P R + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG-- 175
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGL 630
I+H D+K N L+ ++ DFG+
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGI 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH---------TNIREFE 528
+++ FK+ +LG G+Y VYK + G VA+K + T IRE
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIRE-- 53
Query: 529 MELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLRL-- 584
+ ++ ++H NIV L + LV+EFM D G +P L L
Sbjct: 54 --ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Q +GL + H++ I+HRD+K N+L++ ++ DFGL
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGL 154
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 23/163 (14%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRAN-------AATIIHTNIREFEMELEVLC 535
++ E+G G+YG VYKA G VA+K + + +RE + L L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLE 69
Query: 536 NIRHSNIVNLL----GYCLEMGERL-LVYEFMP---RGTLHDHLHGGLSPLNWSLRLKIS 587
H N+V L+ + ++ LV+E + R L GL +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA---ETIKDLM 126
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
Q +GL++LH + I+HRD+K NIL+ S ++ADFGL
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 33/167 (19%)
Query: 484 FKEFNELGRGSYGFVYKA--VLVDGRQVAVKRANAATIIH----------TNIREFEMEL 531
++ E+G G+YG V+KA + GR VA+KR + + IRE + L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKR------VRVQTGEEGMPLSTIREVAV-L 65
Query: 532 EVLCNIRHSNIVNLL----GYCLEMGERL-LVYEFMP---RGTLHDHLHGGLSPLNWSLR 583
L H N+V L + +L LV+E + L G+
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETI 122
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ Q +GL++LH ++HRD+K NIL+ S ++ADFGL
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 31/161 (19%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----------TNIREFEMELE 532
+++ ++G G+YG V+KA VA+KR + + +RE +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALRE----IC 53
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISM-Q 589
+L ++H NIV L + LV+EF + D +G L P +K + Q
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI----VKSFLFQ 109
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
KGL + H ++HRD+K N+L++ + ++A+FGL
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 30/160 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH----------TNIREFEMELEV 533
+ ++G G+YG VYKA G A+K+ I T IRE + +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKK------IRLEKEDEGIPSTTIRE----ISI 53
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISM-QA 590
L ++HSNIV L +LV+E + + L D GGL + K + Q
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT----AKSFLLQL 109
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
G+ Y H ++HRD+K N+L++ + +IADFGL
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL 146
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 39/167 (23%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM----ELEVLCNIR 538
+ + +G GS+G VY+A L D G VA+K+ + + + EL+++ +
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----------VLQDKRFKNRELQIMRKLD 105
Query: 539 HSNIVNLLGYCLEMGERL------LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM---- 588
H NIV L + GE+ LV +++P T++ + + +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH-----YSRAKQTLPVIYVK 159
Query: 589 ----QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFGL 630
Q + L Y+H I HRD+K N+LLD D ++ DFG
Sbjct: 160 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 203
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 478 KDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN----IREFEMELE 532
+ + F+ G+G++G V G VA+K+ + + RE + ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK------VIQDPRFRNRELQ-IMQ 71
Query: 533 VLCNIRHSNIVNLLGYCLEMGER-------LLVYEFMPRGTLH---DHLHGGLSPLNWSL 582
L + H NIV L Y +GER +V E++P TLH + + L
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFGL 630
Q + + LH + + HRD+K N+L++ G ++ DFG
Sbjct: 131 IKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGS 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 47/201 (23%), Positives = 75/201 (37%), Gaps = 32/201 (15%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVK--RANAATIIHTNIRE-FEMELEVLCNIRHSNIVNL 545
+GRG G VY+A V R VA+K ++ R + E ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSS--DPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ G+ + + L L PL + I Q L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---A 155
Query: 606 IHRDVKTLNILLDSDWGARIADFGL--------LT------------SCE--RDLTTDMK 643
HRDVK NIL+ +D A + DFG+ LT + E + +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 644 SDVHNFGIVLLEILSGRKAYD 664
+D++ VL E L+G Y
Sbjct: 216 ADIYALTCVLYECLTGSPPYQ 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 30/160 (18%)
Query: 484 FKEFNELGRGSYGFVYKA-VLVDGRQVAVKRANAATIIH---------TNIREFEMELEV 533
+ + ++LG G+Y VYK + VA+K I T IRE + +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKE------IRLEHEEGAPCTAIRE----VSL 53
Query: 534 LCNIRHSNIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLRLKISM-QA 590
L +++H+NIV L LV+E++ + D ++ N +K+ + Q
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN----VKLFLFQL 109
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+GL Y H+ ++HRD+K N+L++ ++ADFGL
Sbjct: 110 LRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGL 146
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 4e-20
Identities = 44/204 (21%), Positives = 75/204 (36%), Gaps = 36/204 (17%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL- 546
LG G +G+V + + G QVA+K+ + N + +E++++ + H N+V+
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 547 -----GYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHK 599
LL E+ G L +L L + + L YLH+
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 600 DAAPPIIHRDVKTLNILLDSDWGAR---IADFGLLTSCERD--LTT-------------- 640
+ IIHRD+K NI+L I D G ++ T
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 196
Query: 641 ----DMKSDVHNFGIVLLEILSGR 660
+ D +FG + E ++G
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGF 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 13/151 (8%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
LG+G+ V++ G A+K N + + + E EVL + H NIV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 548 YCLEMGERL--LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
E R L+ EF P G+L+ L L S L + G+ +L ++
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 604 PIIHRDVKTLNILL----DSDWGARIADFGL 630
I+HR++K NI+ D ++ DFG
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 43/169 (25%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----------TNIREFEMELE 532
++ +LG G+YG VYKA+ V VA+KR I T IRE +
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKR------IRLEHEEEGVPGTAIRE----VS 85
Query: 533 VLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHD-----HLHGGLSPLNWSLRLKIS 587
+L ++H NI+ L L++E+ +D + +S +K
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRV----IKSF 137
Query: 588 M-QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR-----IADFGL 630
+ Q G+ + H +HRD+K N+LL + I DFGL
Sbjct: 138 LYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 34/172 (19%)
Query: 476 ELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH------------- 521
++K +++ + LG G + VYKA + VA+K+ I
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKK------IKLGHRSEAKDGINR 57
Query: 522 TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLN 579
T +RE +++L + H NI+ LL LV++FM + L+P +
Sbjct: 58 TALRE----IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH 113
Query: 580 WSLRLKISM-QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+K M +GLEYLH+ I+HRD+K N+LLD + ++ADFGL
Sbjct: 114 ----IKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 53/216 (24%), Positives = 81/216 (37%), Gaps = 40/216 (18%)
Query: 473 RLSELKDATNGFKEF----NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFE 528
R++ + + K LG GS G V GR VAVKR ++
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-----MLIDFCDIAL 56
Query: 529 MELEVLC-NIRHSNIVNLLGYCLEMGERL--LVYEFMPRGTLHD------HLHGGLSPLN 579
ME+++L + H N++ YC E +R + E L D L
Sbjct: 57 MEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-------------DWGARIA 626
+ + Q A G+ +LH IIHRD+K NIL+ + + I+
Sbjct: 114 EYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 627 DFGL---LTSCERDLTTDMKSDVHNFGIVLLEILSG 659
DFGL L S + T++ + G E+L
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 13/150 (8%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG+G+ V++ G A+K N + + + E EVL + H NIV L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 549 CLEMGERL--LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
E R L+ EF P G+L+ L L S L + G+ +L ++
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 605 IIHRDVKTLNILL----DSDWGARIADFGL 630
I+HR++K NI+ D ++ DFG
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 41/170 (24%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELE---------- 532
+++ ++G+G++G V+KA G++VA+K+ + E E E
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKK----------VL-MENEKEGFPITALREI 67
Query: 533 -VLCNIRHSNIVNLLGYCLEMGERL--------LVYEFMPRGTLHD---HLHGGLSPLNW 580
+L ++H N+VNL+ C LV++F HD L L
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTL 123
Query: 581 SLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
S ++ GL Y+H++ I+HRD+K N+L+ D ++ADFGL
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G+G++ V A ++ GR+VA+K + + T++++ E+ ++ + H NIV L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 549 -CLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+E + L L+ E+ G + D+L HG + Q ++Y H+
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQYCHQKR--- 134
Query: 605 IIHRDVKTLNILLDSDWGARIADFG----------LLTSC-----------ERDLTTDMK 643
I+HRD+K N+LLD+D +IADFG L C + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 644 SDVHNFGIVLLEILSGR 660
DV + G++L ++SG
Sbjct: 195 VDVWSLGVILYTLVSGS 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 41/163 (25%), Positives = 60/163 (36%), Gaps = 22/163 (13%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEM---------ELEVL 534
+ + GSYG V V +G VA+KR + E+ +L
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 535 CNIRHSNIVNLL-----GYCLEMGERLLVYEFMPRGT-LHDHLHGGLSPLNWSLRLKISM 588
+ H NI+ L M + LV E M T L +H ++ ++ M
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVIS-PQHIQYFM 140
Query: 589 -QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GL LH ++HRD+ NILL + I DF L
Sbjct: 141 YHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNL 180
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 16/182 (8%)
Query: 459 PHPASACPGMAQVFRLSELKDATNGFKEF----NELGRGSYGFVYKAV-LVDGRQVAVKR 513
PH AS G + +A+ F + ELG+G++ V + V G + A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 514 ANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-- 571
N + + ++ E E + ++H NIV L E LV++ + G L + +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 572 HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGA--RIADF 628
S + S ++ Q + + Y H + I+HR++K N+LL S GA ++ADF
Sbjct: 122 REFYSEADASHCIQ---QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 629 GL 630
GL
Sbjct: 176 GL 177
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 39/298 (13%), Positives = 77/298 (25%), Gaps = 83/298 (27%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVK----RANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
LG+ +A G V + ++E + L +L I++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 545 LLGYCLEMGERLLV---------------------YEFMPR-----GTLHDHLHGGLS-- 576
+ + + + + PR T + L S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 577 -PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL----- 630
L RL++++Q + L LH ++H ++ ++I+LD G + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 631 ---LTSC-------------------ERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYV 668
++ D G+ + I +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD-A 321
Query: 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
G EW I +P+ V L + +R + Q
Sbjct: 322 ALGGSEW------------IFRSCKNIPQPVRAL-----LEGF-LRYPKEDRLLPLQA 361
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 47/266 (17%), Positives = 82/266 (30%), Gaps = 95/266 (35%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKR-----------------ANAATIIHTNI- 524
F+ +GRG +G V++A VD A+KR A + H I
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 525 --------------------------------------REFEMELEVLCNIRHSNIVNLL 546
+++ + N V L
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ + + L D ++ L + L I +Q A+ +E+LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------------ 640
++HRD+K NI D ++ DFGL+T+ ++D
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 641 ---------DMKSDVHNFGIVLLEIL 657
K D+ + G++L E+L
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 43/152 (28%), Positives = 64/152 (42%), Gaps = 18/152 (11%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM------ELEVLCNIRHSNI 542
LG G++GFV+ AV ++V VK ++ E E+ +L + H+NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGT-LHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ +L E LV E G L + H L L I Q + YL
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE---PLASYIFRQLVSAVGYLR 147
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
IIHRD+K NI++ D+ ++ DFG
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG G++G V + G +VAVK N I ++ + E++ L RH +I+ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 548 Y-CLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + +V E++ G L D++ HG + ++ Q ++Y H+
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE---MEARRLFQQILSAVDYCHRHM-- 131
Query: 604 PIIHRDVKTLNILLDSDWGARIADFG----------LLTSC-----------ERDLTTDM 642
++HRD+K N+LLD+ A+IADFG L TSC L
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVP 669
+ D+ + G++L +L G +D E+VP
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 26/179 (14%)
Query: 471 VFRLSELKDATNGFKEFN-------ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHT 522
VF + D + K LG G+ G V A ++VA++ +
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 523 NIRE------FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGG 574
+ RE E E+E+L + H I+ + + + + +V E M G L D + +
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR 235
Query: 575 LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630
L Q ++YLH++ IIHRD+K N+LL S D +I DFG
Sbjct: 236 LKEATCK---LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 48/206 (23%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 432 KEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEFNELG 491
KE S + T A+A +P P + + + + LG
Sbjct: 40 KEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-VSKTEILG 98
Query: 492 RGSYGFVYKAV-LVDGRQVAVKRANAATIIHT----NIREFEMELEVLCNIRHSNIVNLL 546
G +G V+K G ++A K II T + E + E+ V+ + H+N++ L
Sbjct: 99 GGRFGQVHKCEETATGLKLAAK------IIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
+ +LV E++ G L D + L + Q +G+ ++H+ I+
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---IL 209
Query: 607 HRDVKTLNILLDSDWGARI--ADFGL 630
H D+K NIL + +I DFGL
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGL 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG G++G V + G +VAVK N I ++ E++ L RH +I+ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 548 Y-CLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + + +V E++ G L D++ +G L ++ Q G++Y H+
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLFQQILSGVDYCHRHM-- 136
Query: 604 PIIHRDVKTLNILLDSDWGARIADFG----------LLTSC 634
++HRD+K N+LLD+ A+IADFG L TSC
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 16/149 (10%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHT----NIREFEMELEVLCNIRHSNIV 543
ELG G++G V++ V GR K I+T + + E+ ++ + H ++
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAK------FINTPYPLDKYTVKNEISIMNQLHHPKLI 111
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
NL + E +L+ EF+ G L D + ++ + + QA +GL+++H+ +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS-- 169
Query: 604 PIIHRDVKTLNILLDSDWGAR--IADFGL 630
I+H D+K NI+ ++ + I DFGL
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGL 197
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTNIREFEMELEVLCNIRHS 540
+ +G G+YG V A+ G +VA+K+ + + I R + EL +L +++H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA-KRAYR-ELLLLKHMQHE 83
Query: 541 NIVNLL------GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
N++ LL + LV FM L + S + Q KGL
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY---LVYQMLKGL 139
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
+Y+H + ++HRD+K N+ ++ D +I DFGL + ++T
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 33/233 (14%), Positives = 63/233 (27%), Gaps = 65/233 (27%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVK--------------------------RANAATIIHT 522
LG+ +A G V R
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 523 NIREFEMELEVLCNIRHSNIVNLLGYC--LEMGERLLVYEFM--PRGTLHDHLHGGLS-- 576
F +++ + + ++ + + + R +Y M T + L S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 577 -PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL---- 631
L RL++++Q + L LH ++H ++ ++I+LD G + F L
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 632 ---TSC---------------------ERDLTTDMKSDVHNFGIVLLEILSGR 660
S +R D G+V+ I
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 41/168 (24%), Positives = 66/168 (39%), Gaps = 34/168 (20%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATII------HTNIREFEMELEVLCNIRHSNI 542
+G+GS+G V D +++ A+K N + + EL+++ + H +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF-----KELQIMQGLEHPFL 77
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------G 593
VNL Y + E + +V + + G L HL + + K
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---------QQNVHFKEETVKLFICELVMA 127
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTD 641
L+YL IIHRD+K NILLD I DF + R+
Sbjct: 128 LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 39/163 (23%), Positives = 68/163 (41%), Gaps = 31/163 (19%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---------ELEV 533
++ + +G GSYG V +A ++ R VA+K+ I R FE E+ +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK------IL---RVFEDLIDCKRILREIAI 105
Query: 534 LCNIRHSNIVNLL-----GYCLEMGERLLVYEFMPRGT-LHDHLHGGLSPLNWSLRLKIS 587
L + H ++V +L + E +V E + L +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLTELHIKTLL 162
Query: 588 MQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
G++Y+H + I+HRD+K N L++ D ++ DFGL
Sbjct: 163 YNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 39/212 (18%), Positives = 82/212 (38%), Gaps = 18/212 (8%)
Query: 429 TTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGFKEF- 487
+ K++ + + + + + + + ++ + +
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159
Query: 488 ---NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G++G V++ G A K ++ E++ + +RH +V
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLV 217
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL---HGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
NL + E +++YEFM G L + + H +S ++ Q KGL ++H++
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR---QVCKGLCHMHEN 274
Query: 601 AAPPIIHRDVKTLNILLDSDWGARI--ADFGL 630
+H D+K NI+ + + DFGL
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGL 303
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 47/158 (29%), Positives = 68/158 (43%), Gaps = 20/158 (12%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F +F LGRG +G V+ + G+ A K+ N + + M E ++L +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK-------- 592
IV+L Y E L LV M G + H++ A
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVS 300
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GLE+LH+ II+RD+K N+LLD D RI+D GL
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 45/204 (22%), Positives = 74/204 (36%), Gaps = 39/204 (19%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHT----NIREFEMELEVLCNIRHS--N 541
LG G +G VY + + D VA+K I N ME+ +L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 542 IVNLLGYCLEMGERL-LVYEF-MPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYL 597
++ LL + E + L+ E P L D + G L L Q + + +
Sbjct: 110 VIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHC 165
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWG-ARIADFG---------LLTSC-----------ER 636
H ++HRD+K NIL+D + G ++ DFG
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 222
Query: 637 DLTTDMKSDVHNFGIVLLEILSGR 660
+ V + GI+L +++ G
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 16/185 (8%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
+LG G+YG V V + A+K ++ ++ + E+ VL + H NI+ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ + LV E G L D + + ++ + I Q G+ YLHK
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQVLSGVTYLHKHN--- 156
Query: 605 IIHRDVKTLNILLDS---DWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRK 661
I+HRD+K N+LL+S D +I DFGL S + MK + + E+L RK
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGL--SAVFENQKKMKERLGTAYYIAPEVL--RK 212
Query: 662 AYDIE 666
YD +
Sbjct: 213 KYDEK 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 478 KDATNGFKEF----NELGRGSYGFVYKAV-LVDGRQVAVK-------RANAATIIHTNIR 525
+T+GF E LGRG V + + ++ AVK + +A +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 526 EFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSL 582
E+++L + H NI+ L LV++ M +G L D+L LS
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
++ + + LHK I+HRD+K NILLD D ++ DFG
Sbjct: 129 IMR---ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 44/171 (25%), Positives = 66/171 (38%), Gaps = 36/171 (21%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK------------------RANAATIIHTNIREFEM 529
E+G+GSYG V A D A+K I+
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 530 ------ELEVLCNIRHSNIVNLLGYC-LEMGERL---LVYEFMPRGTLHDHLHGGLSPLN 579
E+ +L + H N+V L L+ +V+E + +G + + PL+
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLS 135
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
KG+EYLH IIHRD+K N+L+ D +IADFG+
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 22/158 (13%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSN 541
F+++ LG+G +G V + G+ A K+ I + E ++L +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 542 IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK-------- 592
+V+L Y E + L LV M G L H++ + A
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-------MGQAGFPEARAVFYAAEICC 297
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GLE LH++ I++RD+K NILLD RI+D GL
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL 332
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 481 TNGFKEF----NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLC 535
+ F + ELG+G++ V + V G + A K N + + ++ E E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 536 NIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKG 593
++H NIV L E LV++ + G L + + S + S ++ Q +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILES 117
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630
+ Y H + I+HR++K N+LL S ++ADFGL
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 154
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 33/148 (22%), Positives = 65/148 (43%), Gaps = 15/148 (10%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHT---NIREFEMELEVLCNIRHSNIVN 544
+LGRG +G V++ V + K + + + E+ +L RH NI++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK------FVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L M E ++++EF+ + + ++ LN + Q + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--- 122
Query: 605 IIHRDVKTLNILLDSDWGA--RIADFGL 630
I H D++ NI+ + + +I +FG
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 35/194 (18%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM--ELEVLCNIRHSNIVNLL 546
LG GSYG V + + + AVK + E + E+++L +RH N++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 547 G-YCLEMGERL-LVYEFMPRGT--LHDHLHGGLSPLNWSLRLKISMQAAK-------GLE 595
E +++ +V E+ G + D + R + QA GLE
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK--------RFPVC-QAHGYFCQLIDGLE 123
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERD---LTTDMKSDVHNFG 650
YLH I+H+D+K N+LL + +I+ G+ T S F
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS--PAF- 177
Query: 651 IVLLEILSGRKAYD 664
EI +G +
Sbjct: 178 -QPPEIANGLDTFS 190
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 39/146 (26%), Positives = 56/146 (38%), Gaps = 14/146 (9%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G G++G + VAVK I N++ E+ ++RH NIV
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKEV 84
Query: 549 CLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
L ++ E+ G L++ + G S Q G+ Y H I
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSE---DEARFFFQQLLSGVSYCHSMQ---IC 138
Query: 607 HRDVKTLNILLDSDWGAR--IADFGL 630
HRD+K N LLD R I DFG
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGY 164
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 44/144 (30%), Positives = 63/144 (43%), Gaps = 10/144 (6%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG G+YG V AV V VAVK + + + E+ + + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYGH 73
Query: 549 CLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
E + L E+ G L D + G+ + Q G+ YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 607 HRDVKTLNILLDSDWGARIADFGL 630
HRD+K N+LLD +I+DFGL
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGL 151
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 40/158 (25%), Positives = 60/158 (37%), Gaps = 36/158 (22%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATII------HTNIREFEMELEVLCNIRHSNI 542
LG GS+ V A + R+ A+K II + E +V+ + H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-----ERDVMSRLDHPFF 92
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRL-KISMQAAK-------- 592
V L + + E+L + G L ++ ++ +
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----------KIGSFDETCTRFYTAEIVS 141
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
LEYLH IIHRD+K NILL+ D +I DFG
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 176
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 44/216 (20%), Positives = 79/216 (36%), Gaps = 16/216 (7%)
Query: 425 PRLFTTRKEEGSKKQFKSCIGKHELDTDAIADSLPHPASACPGMAQVFRLSELKDATNGF 484
R F + + +L+ + + ++ + K+ +
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96
Query: 485 KEFNELGRGSYGFVYKAV-LVDGRQVAVK------RANAATIIHTNIREFEMELEVLCNI 537
+ +GRG V + V G + AVK + + E +L +
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 538 R-HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGL 594
H +I+ L+ LV++ M +G L D+L LS I + +
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR---SIMRSLLEAV 213
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+LH + I+HRD+K NILLD + R++DFG
Sbjct: 214 SFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
LG+GS+G V K + ++ AVK N A+ + + E+E+L + H NI+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ +V E G L D + S + + +K Q G+ Y+HK I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---QVFSGITYMHKHN---I 142
Query: 606 IHRDVKTLNILLDS---DWGARIADFGL 630
+HRD+K NILL+S D +I DFGL
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGL 170
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 49/190 (25%), Positives = 76/190 (40%), Gaps = 29/190 (15%)
Query: 466 PGMAQVFRLSELKDATNGFKEF----NELGRGSYGFVYKAV-LVDGRQVAVKRANAATII 520
G+ + + +L + F + ++G GSY + + + AVK II
Sbjct: 4 VGVHSIVQ--QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK------II 55
Query: 521 HTNIREFEMELEVLC-NIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSP 577
+ R+ E+E+L +H NI+ L + +V E M G L D + S
Sbjct: 56 DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 578 LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA----RIADFGL--- 630
S + K +EYLH ++HRD+K NIL + G RI DFG
Sbjct: 116 REAS---AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 631 LTSCERDLTT 640
L + L T
Sbjct: 170 LRAENGLLMT 179
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 44/144 (30%), Positives = 63/144 (43%), Gaps = 10/144 (6%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG G+YG V AV V VAVK + + + E+ + + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGH 73
Query: 549 CLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606
E + L E+ G L D + G+ + Q G+ YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 607 HRDVKTLNILLDSDWGARIADFGL 630
HRD+K N+LLD +I+DFGL
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGL 151
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNL 545
LG+GS+G V + G++ AVK + + T+ E+++L + H NI+ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
+ + G LV E G L D + S ++ + +I Q G+ Y+HK+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKNK-- 146
Query: 604 PIIHRDVKTLNILLDS---DWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGR 660
I+HRD+K N+LL+S D RI DFGL S + + MK + + E+L
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGL--STHFEASKKMKDKIGTAYYIAPEVL--H 201
Query: 661 KAYDIE 666
YD +
Sbjct: 202 GTYDEK 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 43/153 (28%), Positives = 64/153 (41%), Gaps = 17/153 (11%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK----RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G + V K G + A K R + A+ + E E E+ +L + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L + +L+ E + G L D L LS + +K Q G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNYLHTKK 135
Query: 602 APPIIHRDVKTLNILLDSDWGA----RIADFGL 630
I H D+K NI+L ++ DFGL
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 464 ACPGM-AQVFRLSELKDATNGFKEF----NELGRGSYGFVYKAV-LVDGRQVAVK---RA 514
PG+ + ++ D F++ +G+G + V + + G+Q AVK A
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 515 NAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL-HG 573
+ + + + E + ++H +IV LL G +V+EFM L +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 574 GLSPLNWSLRL--KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGA--RIADF 628
+ +S + Q + L Y H + IIHRDVK +LL S + A ++ F
Sbjct: 121 ADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177
Query: 629 GL 630
G+
Sbjct: 178 GV 179
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE------FEMELEVLCNIRHSN 541
LG G+ G V A ++VA+K + + RE E E+E+L + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHK 599
I+ + + + + +V E M G L D + + L Q ++YLH+
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFYQMLLAVQYLHE 132
Query: 600 DAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630
+ IIHRD+K N+LL S D +I DFG
Sbjct: 133 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 17/153 (11%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK----RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G + V K G++ A K R +++ + E E E+ +L IRH NI+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L + +L+ E + G L D L L+ + LK Q G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK---QILDGVHYLHSKR 128
Query: 602 APPIIHRDVKTLNILLDS----DWGARIADFGL 630
I H D+K NI+L + ++ DFG+
Sbjct: 129 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTNIREFEMELEVLCNIRHS 540
++ +G G+ G V A + R VA+K+ + H R + EL ++ + H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-KRAYR-ELVLMKCVNHK 84
Query: 541 NIVNLL------GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
NI+ LL E + +V E M L + L S L Q G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLL---YQMLCGI 140
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
++LH + IIHRD+K NI++ SD +I DFGL
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 173
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 36/207 (17%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
LG GS+G V A ++VA+K + + +++ E E+ L +RH +I+ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 548 Y-CLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
Y + + +V E+ G L D++ ++ + Q +EY H+
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE---DEGRRFFQQIICAIEYCHRHK-- 128
Query: 604 PIIHRDVKTLNILLDSDWGARIADFG----------LLTSC-----------ERDLTTDM 642
I+HRD+K N+LLD + +IADFG L TSC L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVP 669
+ DV + GIVL +L GR +D E++P
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIP 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 44/153 (28%), Positives = 63/153 (41%), Gaps = 17/153 (11%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK----RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G + V K G + A K R + A+ E E E+ +L + H NI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L + +L+ E + G L D L LS + +K Q G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDGVNYLHTKK 135
Query: 602 APPIIHRDVKTLNILLDSDWGA----RIADFGL 630
I H D+K NI+L ++ DFGL
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 38/187 (20%), Positives = 60/187 (32%), Gaps = 48/187 (25%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK---RANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+G+GSYG V A+ A+K + I ++ + E+ ++ + H NI
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISM-------------- 588
L + LV E G L D L S ++ + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 589 ----------------QAAK-------GLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR- 624
+ L YLH I HRD+K N L ++
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 625 -IADFGL 630
+ DFGL
Sbjct: 210 KLVDFGL 216
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 31/198 (15%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLL 546
LG+GS+G V K + ++ AVK N A+ + + E+E+L + H NI+ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ +V E G L D + S + + +I Q G+ Y+HK
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMHKHN--- 141
Query: 605 IIHRDVKTLNILLDS---DWGARIADFGLLTSCERD--LTT-----------------DM 642
I+HRD+K NILL+S D +I DFGL T +++ + D
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 643 KSDVHNFGIVLLEILSGR 660
K DV + G++L +LSG
Sbjct: 202 KCDVWSAGVILYILLSGT 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTNIREFEMELEVLCNIRHS 540
++ +G G+ G V A V R VA+K+ + H R + EL ++ + H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYR-ELVLMKCVNHK 121
Query: 541 NIVNLL------GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
NI++LL E + LV E M L + L S L Q G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLL---YQMLCGI 177
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
++LH IIHRD+K NI++ SD +I DFGL
Sbjct: 178 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTN-IREFEMELEVLCNIRHSNIVNLLG 547
+GRG++ V + QV A+K N ++ + F E +VL N I L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
+ + L LV E+ G L L G P + R ++ + ++ +H+
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLA-EIVMAIDSVHRLG--- 182
Query: 605 IIHRDVKTLNILLDSDWGARIADFGL 630
+HRD+K NILLD R+ADFG
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGS 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
ELG+G++ V + V ++ G++ A N + + ++ E E + ++H NIV L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
E G L+++ + G L + + S + S Q + + + H+ +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHCHQMG---V 131
Query: 606 IHRDVKTLNILLDS-DWGA--RIADFGL 630
+HR++K N+LL S GA ++ADFGL
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGL 159
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 45/206 (21%), Positives = 76/206 (36%), Gaps = 41/206 (19%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE----FEMELEVL----CNIRH 539
LG+G +G V+ L D QVA+K ++ + +E+ +L H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 540 SNIVNLLGYCLEMGERL-LVYEFMPRGT-LHDHL--HGGLSPLNWSLRLKISMQAAKGLE 595
++ LL + E E LV E L D++ G L Q ++
Sbjct: 98 PGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGE---GPSRCFFGQVVAAIQ 153
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGA-RIADFG---------LLTSC----------- 634
+ H ++HRD+K NIL+D G ++ DFG
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWI 210
Query: 635 ERDLTTDMKSDVHNFGIVLLEILSGR 660
R + + V + GI+L +++ G
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 38/199 (19%), Positives = 71/199 (35%), Gaps = 71/199 (35%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM----ELEVLCNIR 538
+ LG GS+G V + ++ G++ A+K+ + + EL+++ +
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKK----------VLQDPRYKNRELDIMKVLD 58
Query: 539 HSNIVNLLGYCLEMGERL--------------------------------------LVYE 560
H NI+ L+ Y G+ ++ E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 561 FMPRGTLHDHLHGGLSPLNWSLRLKISM--------QAAKGLEYLHKDAAPPIIHRDVKT 612
++P TLH L I M Q + + ++H + I HRD+K
Sbjct: 119 YVP-DTLHKVLKS-----FIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKP 169
Query: 613 LNILLDSDWGA-RIADFGL 630
N+L++S ++ DFG
Sbjct: 170 QNLLVNSKDNTLKLCDFGS 188
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 490 LGRGSYGFVY---KAVLVDGRQV-AVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
LG+GS+G V+ K D RQ+ A+K AT+ + +ME ++L + H IV L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 546 LGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEY 596
Y + +L L+ +F+ G L L S + + + K L++
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRL---------SKEVMFTEEDVKFYLAELALALDH 141
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
LH II+RD+K NILLD + ++ DFGL
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIRE-FEMELEVLCNIRHSNIVNLLG 547
+GRG++G V L + +V A+K N ++ F E +VL N I L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
Y + L LV ++ G L L P + R ++ + ++ +H+
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLA-EMVIAIDSVHQLH--- 195
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM 642
+HRD+K NIL+D + R+ADFG C + +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGS---CLKLMEDGT 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 15/151 (9%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS-NIVNLL 546
ELGRG + V + + G++ A K E E+ VL + ++NL
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 547 GYCLEMGERLLVYEFMPRGTLHDHL----HGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
E +L+ E+ G + +S + +K Q +G+ YLH++
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK---QILEGVYYLHQNN- 151
Query: 603 PPIIHRDVKTLNILL---DSDWGARIADFGL 630
I+H D+K NILL +I DFG+
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 25/160 (15%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTN--IREFEMELEVLCNIR 538
+ + +GRGSYG+VY A + VA+K+ N +I +RE + +L ++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILNRLK 83
Query: 539 HSNIVNLL-----GYCLEMGERLLVYEFMPRGT-LHDHLHGG--LSPLNWSLRLKISMQA 590
I+ L L+ E +V E + L L+ + I
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKT---ILYNL 138
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
G ++H IIHRD+K N LL+ D ++ DFGL
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 44/153 (28%), Positives = 64/153 (41%), Gaps = 17/153 (11%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVK----RANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G + V K G Q A K R ++ + + E E+ +L I+H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L + +L+ E + G L D L L+ + LK Q G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK---QILNGVYYLHSLQ 134
Query: 602 APPIIHRDVKTLNILLDS----DWGARIADFGL 630
I H D+K NI+L +I DFGL
Sbjct: 135 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 42/150 (28%), Positives = 63/150 (42%), Gaps = 19/150 (12%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
LG+G++G V GR A+K I+ + + E VL N RH + L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM------QAAKGLEYLHKD 600
Y + +RL V E+ G L HL + L+YLH +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLS-------RERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+++RD+K N++LD D +I DFGL
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGL 295
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 37/165 (22%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---------ELEV 533
F+ + LG G+YG V A G VA+K+ I F+ E+++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKK----------IEPFDKPLFALRTLREIKI 62
Query: 534 LCNIRHSNIVNLL-----GYCLEMGERLLVYEFMPRGT-LHDHLHGG-LSPLNWSLRLKI 586
L + +H NI+ + E ++ E M T LH + LS ++
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDD----HIQY 116
Query: 587 SM-QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
+ Q + ++ LH +IHRD+K N+L++S+ ++ DFGL
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL 158
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 45/154 (29%), Positives = 65/154 (42%), Gaps = 28/154 (18%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFE---MELEVLCNIRHSNIVNL 545
LG+G++G V + A+K II + E E VL N RH + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTAL 70
Query: 546 LGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEY 596
Y + +RL V E+ G L HL S + + A+ LEY
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAEIVSALEY 120
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
LH +++RD+K N++LD D +I DFGL
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII------HTNIREFEMELEVLCN 536
F +GRG +G VY D G+ A+K + I E M L ++
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIM-LSLVST 248
Query: 537 IRHSNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHL--HGGLSPLNWSLRLKI-SMQAAK 592
IV + Y ++L + + M G LH HL HG S ++ + +
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAEIIL 303
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
GLE++H +++RD+K NILLD RI+D GL
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 338
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTNIREFEMELEVLCNIRHS 540
+++ +G G+YG V AV G +VA+K+ + + R + EL +L ++RH
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYR-ELRLLKHMRHE 84
Query: 541 NIVNLL------GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
N++ LL + + LV FM L + L + Q KGL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH--EKLGEDRIQFLVYQMLKGL 141
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
Y+H A IIHRD+K N+ ++ D +I DFGL + ++T
Sbjct: 142 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 37/178 (20%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEM---------ELEV 533
+ + +G G+YG V A ++ +VA+K+ I FE E+++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK----------ISPFEHQTYCQRTLREIKI 78
Query: 534 LCNIRHSNIVNLL-----GYCLEMGERLLVYEFMPRGT-LHDHLHGG-LSPLNWSLRLKI 586
L RH NI+ + +M + +V + M T L+ L LS +
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICY---F 133
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL--LTSCERDLTTDM 642
Q +GL+Y+H + ++HRD+K N+LL++ +I DFGL + + D T +
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTNIREFEMELEVLCNIRHS 540
++ + +G G+YG V A G +VAVK+ + +IIH R + EL +L +++H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYR-ELRLLKHMKHE 88
Query: 541 NIVNLL------GYCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKG 593
N++ LL E + LV M L++ + L+ + + Q +G
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF---LIYQILRG 144
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
L+Y+H + IIHRD+K N+ ++ D +I DFGL ++T
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 37/148 (25%), Positives = 64/148 (43%), Gaps = 14/148 (9%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+GRGS+G V AV + A K+ + ++ F+ E+E++ ++ H NI+ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 548 YCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+ + LV E G L + + + + +I + Y HK +
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---RIMKDVLSAVAYCHKLN---V 127
Query: 606 IHRDVKTLNILLDS---DWGARIADFGL 630
HRD+K N L + D ++ DFGL
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGL 155
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 25/152 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLCNIRHSNIVNLLG 547
+GRG++G V R+V A+K + +I + F E +++ +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 548 YCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYLH 598
Y + L +V E+MP G L + + + + A+ L+ +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMS----------NYDVPEKWARFYTAEVVLALDAIH 185
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
IHRDVK N+LLD ++ADFG
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 36/169 (21%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNI----REFEMELEVLCNIR 538
+ + LG G G V+ AV ++VA+K+ I+ T+ E++++ +
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLD 66
Query: 539 HSNIVNLL--------------GYCLEMGERLLVYEFMPRGT-LHDHLHGG-LSPLNWSL 582
H NIV + G E+ +V E+M T L + L G L + L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARL 124
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGL 630
Q +GL+Y+H + ++HRD+K N+ +++ D +I DFGL
Sbjct: 125 ---FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 30/157 (19%)
Query: 490 LGRGSYGFVY---KAVLVD-GRQVAVKRANAATIIHTNIREFE---MELEVLCNIRHSNI 542
LG+G YG V+ K + G+ A+K A I+ N ++ E +L ++H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFI 83
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------G 593
V+L+ Y + G +L L+ E++ G L L A
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLER---------EGIFMEDTACFYLAEISMA 133
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
L +LH+ II+RD+K NI+L+ ++ DFGL
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVK-----------RANAATIIHTNIREFEMELEVLC 535
+LG G+YG V + A+K ++ I E E+ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 536 NIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKG 593
++ H NI+ L + LV EF G L + + + + I Q G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSG 158
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTSCERD--LTT-------- 640
+ YLHK I+HRD+K NILL++ +I DFGL + +D L
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 641 ---------DMKSDVHNFGIVLLEILSGR 660
+ K DV + G+++ +L G
Sbjct: 216 APEVLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 37/150 (24%), Positives = 57/150 (38%), Gaps = 20/150 (13%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIR-HSNIVNL 545
LG GS+ K V + AVK II + + E+ L H NIV L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
+ LV E + G L + + S S I + + ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---YIMRKLVSAVSHMHDVG-- 126
Query: 604 PIIHRDVKTLNILL---DSDWGARIADFGL 630
++HRD+K N+L + + +I DFG
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGF 155
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 22/152 (14%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----TNIREFEMELEVLCNIRHSNIV 543
LG G++ V+ + G+ A+K I E E+ VL I+H NIV
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALK------CIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHL--HGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L LV + + G L D + G + + S + Q ++YLH++
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---LVIQQVLSAVKYLHENG 126
Query: 602 APPIIHRDVKTLNILLDS---DWGARIADFGL 630
I+HRD+K N+L + + I DFGL
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGL 155
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 34/157 (21%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATII------HTNIREFEMELEVLCNIRHSNI 542
LG GS+G V+ GR A+K ++ HTN E +L + H I
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN-----DERLMLSIVTHPFI 68
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------G 593
+ + + +++ ++ +++ G L L + AK
Sbjct: 69 IRMW-GTFQDAQQIFMIMDYIEGGELFSLL---------RKSQRFPNPVAKFYAAEVCLA 118
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
LEYLH II+RD+K NILLD + +I DFG
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 42/152 (27%), Positives = 66/152 (43%), Gaps = 23/152 (15%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATII----HTNIREFEMELEVLCNIR-HSNIV 543
LG G++ V + L+ ++ AVK II E+E+L + H N++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVK------IIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
L+ + E LV+E M G++ H+H + L S + A L++LH
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG 131
Query: 602 APPIIHRDVKTLNILL---DSDWGARIADFGL 630
I HRD+K NIL + +I DF L
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDL 160
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 78/352 (22%), Positives = 116/352 (32%), Gaps = 126/352 (35%)
Query: 488 NELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHS 540
LGRG++G V +A R VAVK H+ R EL++L +I H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHL 86
Query: 541 NIVNLLGYCLEMGERLLV-YEFMPRGTLHDHLH------GGLSPLNWSLRLKISMQAA-- 591
N+VNLLG C + G L+V EF G L +L R A
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 592 ------------------------KGLEYLHKDAAPPIIHRDVKTLNILLD--------- 618
K L + ++ AP +++D TL L+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 619 ----------SDWGAR-----------IADFGLLTSCERDLTTD---------------- 641
D AR I DFGL RD+ D
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGL----ARDIYKDPDYVRKGDARLPLKWM 262
Query: 642 -----------MKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA--LPLIKQGKAAA 687
++SDV +FG++L EI S G Y PG+ +K+G
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVKIDEEFCRRLKEGT--- 313
Query: 688 IIDRNVALPRNVEPLFKLADIAELAI---RENPSELPTMSQVATWLEQIVKD 736
R P + ++ + + PS+ PT S++ L +++
Sbjct: 314 ---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSN 541
++ +LGRG Y V++A+ + + +V VK + ++ + E+++L N+R N
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKREIKILENLRGGPN 92
Query: 542 IVNLLGYCLEMGER--LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISM-QAAKGLEYLH 598
I+ L + R LV+E + L+ + ++ M + K L+Y H
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-LTDYD----IRFYMYEILKALDYCH 147
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGA-RIADFGL 630
I+HRDVK N+++D + R+ D+GL
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 38/156 (24%), Positives = 63/156 (40%), Gaps = 25/156 (16%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATI----IHTNIREFEMELEVLCNIRHSNIV 543
+LG G++G V+ G + +K TI + + E E+EVL ++ H NI+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIK-----TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRL------KISMQAAKGLEYL 597
+ + +V E G L + + +S L ++ Q L Y
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERI---VSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 598 HKDAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630
H ++H+D+K NIL +I DFGL
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGL 173
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 22/157 (14%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAA--TIIHTN--IREFEMELEVLCNIR 538
++ +LG+G+YG V+K++ G VAVK+ A RE + L L
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI-LTELSG-- 67
Query: 539 HSNIVNLLGYCL--EMGERLLVYEFMPRGT-LHDHLHGG-LSPLNWSLRLKISM-QAAKG 593
H NIVNLL + LV+++M T LH + L P+ + + Q K
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV----HKQYVVYQLIKV 121
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
++YLH + ++HRD+K NILL+++ ++ADFGL
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 38/189 (20%), Positives = 69/189 (36%), Gaps = 33/189 (17%)
Query: 460 HPASACPGMAQVFRLSELKDATNGFKEF-----NELGRGSYGFVYKAV-LVDGRQVAVKR 513
H G+ +F+ E K + LG G G V + G++ A+K
Sbjct: 4 HHHHHSSGLEVLFQGPEPK--KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK- 60
Query: 514 ANAATIIHTNIREFEMELEVLC-NIRHSNIVNLLGYCLEMGER----LLVYEFMPRGTLH 568
+++ + + + E++ +IV +L M L++ E M G L
Sbjct: 61 -----LLYDSPKARQ-EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114
Query: 569 DHL----HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDW 621
+ + + +I +++LH I HRDVK N+L + D
Sbjct: 115 SRIQERGDQAFTEREAA---EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDA 168
Query: 622 GARIADFGL 630
++ DFG
Sbjct: 169 VLKLTDFGF 177
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 43/153 (28%), Positives = 66/153 (43%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEM-ELEVL-CNIRHSNIVNLL 546
LG+GS+G V+ A + A+K ++ + E M E VL H + ++
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
+ E L V E++ G L H+ K + A GL++L
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDLMYHIQ---------SCHKFDLSRATFYAAEIILGLQFL 134
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H I++RD+K NILLD D +IADFG+
Sbjct: 135 HSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 27/220 (12%)
Query: 459 PHPASACPGMAQVFRLSELKDATNGFKEF----NELGRGSYGFVYKAV-LVDGRQVAVKR 513
++A + V + +F +ELGRG+ VY+ + A+K
Sbjct: 26 VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK- 84
Query: 514 ANAATIIHTNIRE--FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHL 571
++ + + E+ VL + H NI+ L E LV E + G L D +
Sbjct: 85 -----VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI 139
Query: 572 --HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIA 626
G S + + +K Q + + YLH++ I+HRD+K N+L D +IA
Sbjct: 140 VEKGYYSERDAADAVK---QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIA 193
Query: 627 DFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYDIE 666
DFGL S + MK+ G EIL AY E
Sbjct: 194 DFGL--SKIVEHQVLMKTVCGTPGYCAPEILR-GCAYGPE 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 43/153 (28%), Positives = 63/153 (41%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLC-NIRHSNIVNLL 546
+G+GS+G V A AVK I+ + M E VL N++H +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
+ + ++L V +++ G L HL A+ L YL
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQR---------ERCFLEPRARFYAAEIASALGYL 155
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H I++RD+K NILLDS + DFGL
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGL 185
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 34/157 (21%)
Query: 490 LGRGSYGFVYKAVLVD-GRQVAVKRANAATII------HTNIREFEMELEVLCNIRHSNI 542
LG GS+G V + G A+K + ++ HT E +L + +
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-----NEKRILQAVNFPFL 103
Query: 543 VNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------G 593
V L + + L +V E++ G + HL + S A+
Sbjct: 104 VKLE-FSFKDNSNLYMVMEYVAGGEMFSHL---------RRIGRFSEPHARFYAAQIVLT 153
Query: 594 LEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
EYLH +I+RD+K N+L+D ++ DFG
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 39/162 (24%)
Query: 490 LGRGSYGFVY---KAVLVDGRQV-AVKRANAATII-------HTNIREFEMELEVLCNIR 538
LG G+YG V+ K D ++ A+K ATI+ HT E +VL +IR
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR-----TERQVLEHIR 116
Query: 539 HSN-IVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK---- 592
S +V L Y + +L L+ +++ G L HL S R + + +
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL---------SQRERFTEHEVQIYVG 166
Query: 593 ----GLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
LE+LHK II+RD+K NILLDS+ + DFGL
Sbjct: 167 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 46/302 (15%), Positives = 83/302 (27%), Gaps = 90/302 (29%)
Query: 52 SMAVLSGGEGLLCGILANTSQAFCWSSNSS----PGNTTD-LVPSVYKNTAYSR---IAA 103
S+A+LSG W G+ D P+ + +
Sbjct: 28 SVALLSGDI------------VCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTC 75
Query: 104 GTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQ------TNLFYDEYVSTIVLKD 157
G +H A V W G + ++LF + +
Sbjct: 76 GADHTVAYS------QSGMEVYSW-----GWG--DFGRLGHGNSSDLFTPLPIKALHGIR 122
Query: 158 VIS---GDGFSCGGVRDGGIVCWGPDSES-LGVFNVTESF---KV----------LASGK 200
+ GD +G + WG + LG+ + +S K+ +A+G
Sbjct: 123 IKQIACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGA 182
Query: 201 SSLCGISELSGEVKCWGNNDF----------VSVP-----PVGIRFVSLAAGANHFCGIR 245
++E G++ WG + VP G + +A G H +
Sbjct: 183 EHTAAVTE-DGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVS 241
Query: 246 EDNHGVECWGSFNY----------SSVPK------NSGFMAIASSDFTTCGIRENDLVLD 289
+ +G Y +P NS I+ T + + +
Sbjct: 242 YSGA-LYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTSDGKLY- 299
Query: 290 CW 291
W
Sbjct: 300 GW 301
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 51/297 (17%), Positives = 84/297 (28%), Gaps = 85/297 (28%)
Query: 52 SMAVLSGGEGLLCGILANTSQAFCWSSNSS----PGNTTD-LVP---SVYKNTAYSRIAA 103
+AV GE W N + G+T D LVP ++ +AA
Sbjct: 133 CLAVTMEGE------------VQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAA 180
Query: 104 GTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNT-----LSSVQTNLFYDEYVSTIVLKDV 158
G H AV G + W G L +T+ E V++ + +
Sbjct: 181 GAEHTAAVTED-------GDLYGW-----GWGRYGNLGLGD-RTDRLVPERVTSTGGEKM 227
Query: 159 IS---GDGFSCGGVRDGGIVCWGPDSES-LGVFNVT-------------ESFKVLASGKS 201
G + G + +G LG ++ ++ G
Sbjct: 228 SMVACGWRHTISVSYSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWR 287
Query: 202 SLCGISELSGEVKCWGNNDF----------VSVP-----PVGIRFVSLAAGANHFCGIRE 246
++ G++ WG N F P P + V ++ G H + E
Sbjct: 288 HTMALTS-DGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTE 346
Query: 247 DNHGVECWG----------SFNYSSVPK--NSGFMAIASSDFTTCGIRENDLVLDCW 291
N+ V WG + PK + + AS + W
Sbjct: 347 RNN-VFAWGRGTNGQLGIGESVDRNFPKIIEALSVDGASGQHIESSNIDPSSGK-SW 401
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 53/266 (19%), Positives = 79/266 (29%), Gaps = 74/266 (27%)
Query: 83 GNTTDLVPSVYKNTAYSR----IAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTL- 137
G D+ TA R I+AG +H A+ V W G
Sbjct: 1 GMAEDMAADEV--TAPPRKVLIISAGASHSVALLSG-------DIVCSW-----GRGEDG 46
Query: 138 ---SSVQTNLFYDEYVSTIVLKDVIS---GDGFSCGGVRDGGIV-CWGPDSES-LGVFNV 189
+ +S + ++S G + + G V WG LG N
Sbjct: 47 QLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNS 106
Query: 190 TESF-------------KVLASGKSSLCGISELSGEVKCWGNNDF----------VSVP- 225
++ F K +A G S ++ GEV+ WG N VP
Sbjct: 107 SDLFTPLPIKALHGIRIKQIACGDSHCLAVTM-EGEVQSWGRNQNGQLGLGDTEDSLVPQ 165
Query: 226 ----PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNY----------SSVPK------N 265
GIR +AAGA H + ED + WG Y VP+
Sbjct: 166 KIQAFEGIRIKMVAAGAEHTAAVTEDGD-LYGWGWGRYGNLGLGDRTDRLVPERVTSTGG 224
Query: 266 SGFMAIASSDFTTCGIRENDLVLDCW 291
+A T + + + +
Sbjct: 225 EKMSMVACGWRHTISVSYSGALY-TY 249
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 29/186 (15%), Positives = 47/186 (25%), Gaps = 35/186 (18%)
Query: 15 CAIDASGKQDVICWAKNSS------SPSSSFLSANSASFSNIPSMAVLSGGEGLLCGILA 68
++ SG + + + + + SN + SGG L
Sbjct: 238 ISVSYSGA--LYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQI-SGGWRHTM-ALT 293
Query: 69 NTSQAFCWSSNSS----PGNTTD-----LVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYH 119
+ + + W N GN D V +++ G H AV
Sbjct: 294 SDGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKV-VQVSCGWRHTLAVTER----- 347
Query: 120 DLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVL---KDVISGDGFSCGGVRDGGIVC 176
V W G T + D I+ D SG +
Sbjct: 348 --NNVFAW-----GRGTNGQLGIGESVDRNFPKIIEALSVDGASGQHIESSNIDPSSGKS 400
Query: 177 WGPDSE 182
W +E
Sbjct: 401 WVSPAE 406
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLCNI-RHSNIVNLL 546
+GRGSY V L ++ A+K + ++ E V H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
C + RL V E++ G L H+ + K+ + A+ L YL
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEISLALNYL 126
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H+ II+RD+K N+LLDS+ ++ D+G+
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 156
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLCNI-RHSNIVNLL 546
+GRGSY V L ++ A++ + ++ E V H +V L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
C + RL V E++ G L H+ + K+ + A+ L YL
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEISLALNYL 169
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H+ II+RD+K N+LLDS+ ++ D+G+
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 199
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVL-CNIRHSNIVNLL 546
LG+GS+G V + ++ AVK +I + E M E VL + + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
C + +RL V E++ G L H+ + A GL +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHIQQ---------VGRFKEPHAVFYAAEIAIGLFFL 137
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
II+RD+K N++LDS+ +IADFG+
Sbjct: 138 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 167
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 43/153 (28%), Positives = 66/153 (43%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVLCNI-RHSNIVNLL 546
LG+GS+G V A + + + AVK I+ + E M E +L H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
C + +RL V EF+ G L H+ + A+ L +L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQ---------KSRRFDEARARFYAAEIISALMFL 140
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
H II+RD+K N+LLD + ++ADFG+
Sbjct: 141 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGM 170
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 29/189 (15%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLL 546
LG G G V + + A+K ++ + E+E+ + +IV ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARR-EVELHWRASQCPHIVRIV 121
Query: 547 GYCLEMGER----LLVYEFMPRGTLHDHL----HGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ L+V E + G L + + S +I + ++YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH 178
Query: 599 KDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLE 655
I HRDVK N+L S + ++ DFG + E + + + V E
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF--AKETTSHNSLTTPCYTPYYVAPE 233
Query: 656 ILSGRKAYD 664
+L G + YD
Sbjct: 234 VL-GPEKYD 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 490 LGRGSYGFVYKAVLVDGRQV-AVKRANAATIIHTNIREFEM-ELEVL-CNIRHSNIVNLL 546
LG+GS+G V + ++ AVK +I + E M E VL + + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 547 GYCLEMGERL-LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK--------GLEYL 597
C + +RL V E++ G L H+ + A GL +L
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQ---------VGRFKEPHAVFYAAEIAIGLFFL 458
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630
II+RD+K N++LDS+ +IADFG+
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 488
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 8e-11
Identities = 27/196 (13%), Positives = 49/196 (25%), Gaps = 50/196 (25%)
Query: 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKR------ANAATIIHTNIREFEMELEV 533
T + ++G G +G V++ + D VA+K E E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 534 LCNI---------RHSNIVNLLGYCLEMGERL---------------------------- 556
+ R + L G
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 557 --LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLN 614
+V EF G + + + + I Q L + HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 615 ILLDSDWGARIADFGL 630
+LL ++
Sbjct: 193 VLLKKTSLKKLHYTLN 208
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 42/216 (19%), Positives = 83/216 (38%), Gaps = 55/216 (25%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREF----EMELEVLCNIR------ 538
LG G + V+ A +V+ VA+K I+ + + E E+++L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMK------IV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 539 -----HSNIVNLLG---YCLEMGERL-LVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISM 588
++I+ LL + G + +V+E + L + + +IS
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLD------SDWGARIADFGLLTSCERDLTT-- 640
Q GL+Y+H+ IIH D+K N+L++ + +IAD G + T
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 641 ----------------DMKSDVHNFGIVLLEILSGR 660
+D+ + ++ E+++G
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 57/210 (27%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREF----EMELEVLCNIRH----- 539
+G+GS+G V KA + VA+K ++ N + F E+ +L ++R
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK------MVR-NEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 540 -SNIVNLLGY-------CLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWSLRLKISMQA 590
N++++L C+ +E + L++ + + L K +
Sbjct: 158 TMNVIHMLENFTFRNHICM-------TFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA--RIADFGLLTSCERDLTT-------- 640
+ L+ LHK IIH D+K NILL + ++ DFG + + T
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR 266
Query: 641 ----------DMKSDVHNFGIVLLEILSGR 660
M D+ + G +L E+L+G
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 33/155 (21%), Positives = 59/155 (38%), Gaps = 26/155 (16%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLL 546
LG G G V + + A+K ++ + + E+E+ + +IV ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK------MLQ-DCPKARREVELHWRASQCPHIVRIV 77
Query: 547 GYCLEMGER----LLVYEFMPRGTLHDHL----HGGLSPLNWSLRLKISMQAAKGLEYLH 598
+ L+V E + G L + + S +I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH 134
Query: 599 KDAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630
I HRDVK N+L S + ++ DFG
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 7e-10
Identities = 53/352 (15%), Positives = 92/352 (26%), Gaps = 99/352 (28%)
Query: 15 CAIDASGKQDVICWAKNSS------SPSSSFLSANSASFSNIPSMAVLSGGEGLLCGILA 68
SG + W N + + + + + + + GGE L + A
Sbjct: 14 LYFQGSG--TIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQL-IGGEQTLFAVTA 70
Query: 69 NTSQAFCWSSNSS----PGNTTD-----LVPSV-YKNTAYSRIAAGTNHVCAVRGSYYSY 118
+ + + + G T L+ S+ + + +G H A+
Sbjct: 71 D-GKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALSSE---- 125
Query: 119 HDLGTVDCWDIVRKGNNT------------LSSVQTNLFYDEYVSTIVLKDVISGDGFSC 166
G V W G V DV +G S
Sbjct: 126 ---GEVYSW-----GEAEDGKLGHGNRSPCDRPRVIESLRGIEV-----VDVAAGGAHSA 172
Query: 167 GGVRDGGIVCWGPDSES-LGVFNVTESFK---------------VLASGKSSLCGISELS 210
G + WG LG + + K SG + +++
Sbjct: 173 CVTAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLCLTD-D 231
Query: 211 GEVKCWGNNDF----------VSVP-----PVGIRFVSLAAGANHFCGIREDNHGVECWG 255
V WG+ D+ VP G+ V + G+ + + V WG
Sbjct: 232 DTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKSGA-VYTWG 290
Query: 256 SFNY----------SSVP------KNSGFMAIASSDFTTCGIRENDLVLDCW 291
+Y P + +AIA+ E+ V W
Sbjct: 291 KGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCTEDGEVY-TW 341
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 32/197 (16%), Positives = 49/197 (24%), Gaps = 52/197 (26%)
Query: 101 IAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTL----SSVQTNLFYDEYVSTIVLK 156
+ +GS GT+ W G+N + +
Sbjct: 6 HHSSGRENLYFQGS-------GTIYGW-----GHNHRGQLGGIEGAKVKVPTPCEALATL 53
Query: 157 DVIS---GDGFSCGGVRDGGIVCWGPDSES-LGVFNVTESFK---------------VLA 197
+ G+ DG + G + LG+ +
Sbjct: 54 RPVQLIGGEQTLFAVTADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVN 113
Query: 198 SGKSSLCGISELSGEVKCWGNNDF----------VSVP-----PVGIRFVSLAAGANHFC 242
SG +S GEV WG + P GI V +AAG H
Sbjct: 114 SGGKHCLALSS-EGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSA 172
Query: 243 GIREDNHGVECWGSFNY 259
+ + WG Y
Sbjct: 173 CVTAAGD-LYTWGKGRY 188
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 26/185 (14%), Positives = 49/185 (26%), Gaps = 58/185 (31%)
Query: 158 VISGDGFSCGGVRDGGIVCWGPDS------------------ESLGVFNVTESFKVLASG 199
S + G I WG + E+L + L G
Sbjct: 6 HHSSGRENLYFQGSGTIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQ----LIGG 61
Query: 200 KSSLCGISELSGEVKCWGNNDF----------VSVP-------PVGIRFVSLAAGANHFC 242
+ +L ++ G++ G VS P V I+ V++ +G H
Sbjct: 62 EQTLFAVTA-DGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCL 120
Query: 243 GIREDNHGVECWGSFNY----------SSVPK------NSGFMAIASSDFTTCGIRENDL 286
+ + V WG P+ + +A+ + +
Sbjct: 121 ALSSEGE-VYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVTAAGD 179
Query: 287 VLDCW 291
+ W
Sbjct: 180 LY-TW 183
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 40/247 (16%), Positives = 66/247 (26%), Gaps = 83/247 (33%)
Query: 52 SMAVLSGGEGLLCGILANTSQAFCWSSNSS----PGNTTD-----LVPSVYKNTAYSRIA 102
S V + G+ + W ++ D LV ++ + IA
Sbjct: 171 SACVTAAGD------------LYTWGKGRYGRLGHSDSEDQLKPKLVEAL-QGHRVVDIA 217
Query: 103 --AGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNT------------LSSVQTNLFYDE 148
+G + TV W G+ ++ +
Sbjct: 218 CGSGDAQTLCLTDD-------DTVWSW-----GDGDYGKLGRGGSDGCKVPMKIDSLTGL 265
Query: 149 YVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDSE-SLGVFNVTESF---KV--------- 195
V V G FS + G + WG LG + +V
Sbjct: 266 GV-----VKVECGSQFSVALTKSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVI 320
Query: 196 -LASGKSSLCGISELSGEVKCWGNNDF----------VSVP-----PVGIRFVSLAAGAN 239
+A+G +E GEV WG+ND + P G + +A G+
Sbjct: 321 AIATGSLHCVCCTE-DGEVYTWGDNDEGQLGDGTTNAIQRPRLVAALQGKKVNRVACGSA 379
Query: 240 HFCGIRE 246
H
Sbjct: 380 HTLAWST 386
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 55/219 (25%)
Query: 481 TNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREF----EMELEVLC 535
+ ++ + +G+GS+G V KA V+ VA+K II N + F ++E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK------IIK-NKKAFLNQAQIEVRLLE 105
Query: 536 NIRH------SNIVNLLGY-------CLEMGERLLVYEFMPRGTLHDHL-HGGLSPLNWS 581
+ IV+L + CL V+E + L+D L + ++ +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCL-------VFEML-SYNLYDLLRNTNFRGVSLN 157
Query: 582 LRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL--DSDWGARIADFGLLTSCERDLT 639
L K + Q L +L IIH D+K NILL +I DFG + +
Sbjct: 158 LTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 640 T------------------DMKSDVHNFGIVLLEILSGR 660
D+ D+ + G +L+E+ +G
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 32/155 (20%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+K +G GS+G +++ L++ +QVA+K + E+ ++L I
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTG--I 68
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR--LKISMQAAKGLEYLHKD 600
N+ + E +LV + + +L D L L +S++ + Q ++ +H+
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP-SLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 601 AAPPIIHRDVKTLNILLDSDWGAR-----IADFGL 630
+ +++RD+K N L+ + DFG+
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 36/289 (12%), Positives = 66/289 (22%), Gaps = 87/289 (30%)
Query: 74 FCWSSNSS----PGNTTDLVPSVYKNTAYSR---IAAGTNHVCAVRGSYYSYHDLGTVDC 126
+ G + I+AG H + S G +
Sbjct: 46 LVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHNLVLTKS-------GDIYS 98
Query: 127 WDIVRKGNNTLSSVQ----TNLFYDEYVSTIVL-----KDVISGDGFSCGGVRDGGIVCW 177
+ G N T+ E ++ + +GD S + DG + W
Sbjct: 99 F-----GCN--DEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLEDGRVFAW 151
Query: 178 GPDSES---LGVFN---------VTESFKV--LASGKSSLCGISELSGEVKCWGNNDF-- 221
G +S +G+ + E +ASG L ++ +G+V G +
Sbjct: 152 GSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILTT-AGKVFTVGCAEQGQ 210
Query: 222 -------------------VSVP-----PVGIRFVSLAAGANHFCGIREDNHGVECWGSF 257
+ P F ++ A + G
Sbjct: 211 LGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYCTFMRESQTQVIWATGLN 270
Query: 258 NY----------SSVPK-----NSGFMAIASSDFTTCGIRENDLVLDCW 291
N+ IA T + +
Sbjct: 271 NFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILTTDLKCS-VV 318
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 43/274 (15%), Positives = 71/274 (25%), Gaps = 83/274 (30%)
Query: 83 GNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNT---LSS 139
N + K +RIA LG V GN L
Sbjct: 12 NNAGEAEQQPPKAKR-ARIAFHLELPKRRT-------VLGNVLVC-----GNGDVGQLGL 58
Query: 140 VQTNLFYDEYVSTIVLKDVISGDGFSCGGV------RDGGIVCWGPDSES-LG------- 185
+ L + D + S GG+ + G I +G + E LG
Sbjct: 59 GEDILERKRLSPVAGIPDAVD---ISAGGMHNLVLTKSGDIYSFGCNDEGALGRDTSEDG 115
Query: 186 ------VFNVTESFKVLASGKSSLCGISELSGEVKCWGNN------------DFVSVP-- 225
+ ++ +++G S + E G V WG+ P
Sbjct: 116 SESKPDLIDLPGKALCISAGDSHSACLLE-DGRVFAWGSFRDSHGNMGLTIDGNKRTPID 174
Query: 226 -PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYS------------------------ 260
G S+A+GA+H + V G
Sbjct: 175 LMEGTVCCSIASGADHLVILTTAGK-VFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRP 233
Query: 261 ---SVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
+ + F AI ++++ T V+
Sbjct: 234 TQLIITRAKPFEAIWATNYCTFMRESQTQVIWAT 267
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 34/261 (13%), Positives = 68/261 (26%), Gaps = 83/261 (31%)
Query: 52 SMAVLSGGEGLLCGILANTSQAFCWSSNSSP----GNTTD---LVP-SVYKNTAYSRIAA 103
S +L G F W S G T D P + + T IA+
Sbjct: 139 SACLLEDGR------------VFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIAS 186
Query: 104 GTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNT-----------LSSVQTNLFYDEYVST 152
G +H+ + + G V G +S D T
Sbjct: 187 GADHLVILTTA-------GKVFTV-----GCAEQGQLGRLSERSISGEGRRGKRDLLRPT 234
Query: 153 IVL-------KDVISGDGFSCGGVRDGGIV-CWGPDSES--LG------------VFNVT 190
++ + + + + + ++ G + L +
Sbjct: 235 QLIITRAKPFEAIWATNYCTFMRESQTQVIWATG-LNNFKQLAHETKGKEFALTPIKTEL 293
Query: 191 ESFKVLASGKSSLCGISELSGEVKCWGNNDF---------------VSVPPVGIRFVSLA 235
+ + +A G+ ++ + G ++ V + + VS+
Sbjct: 294 KDIRHIAGGQHHTVILTT-DLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVG 352
Query: 236 AGANHFCGIREDNHGVECWGS 256
G + D + WGS
Sbjct: 353 CGEVCSYAVTIDGK-LYSWGS 372
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 32/243 (13%), Positives = 58/243 (23%), Gaps = 60/243 (24%)
Query: 52 SMAVLSGGE---------GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIA 102
+ + + G+ G L G L+ S + + I
Sbjct: 191 LVILTTAGKVFTVGCAEQGQL-GRLSERSISGEGRRGKRDLLRPTQLIITRAKPF-EAIW 248
Query: 103 AGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIV---LKDVI 159
A + G N + E+ T + LKD+
Sbjct: 249 ATNYCTFMRE------SQTQVIWAT-----GLNNFKQLAHETKGKEFALTPIKTELKDIR 297
Query: 160 S---GDGFSCGGVRDGGIVCWGPDSES-LG-------------VFNVTESFKVLASGKSS 202
G + D G LG V +TE + G+
Sbjct: 298 HIAGGQHHTVILTTDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEVC 357
Query: 203 LCGISELSGEVKCWGNNDF----------VSVP-PV------GIRFVSLAAGANHFCGIR 245
++ G++ WG+ P V G + + G H +
Sbjct: 358 SYAVTI-DGKLYSWGSGVNNQLGVGDGDDELEPIVVVSKNTQGKHMLLASGGGQHAIFLV 416
Query: 246 EDN 248
+ +
Sbjct: 417 KAD 419
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F+ ++G G++G + L VA+K + E+ + L + I
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDG--I 67
Query: 543 VNLLGYCLEMGERLLVYEFMPRG-TLHDHLHGGLSPLNWSLR--LKISMQAAKGLEYLHK 599
+ + +V E + G +L D L +SL+ L I++Q +EY+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLFD--LCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 600 DAAPPIIHRDVKTLNILLDSDWGAR-----IADFGL 630
+I+RDVK N L+ I DF L
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 39/229 (17%), Positives = 60/229 (26%), Gaps = 57/229 (24%)
Query: 101 IAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVIS 160
A G H A+ V W G N L D + LKD+ +
Sbjct: 72 FAVGGMHTLALDEE-------SNVWSW-----GCN--DVGA--LGRDTSNAKEQLKDMDA 115
Query: 161 GDGFSCGGVRDGGIVCWGPDSESLGVFNVTESFKV--LASGKSSLCGISELSGEVKCWGN 218
D + + E KV LA+ + C + +GEV WG
Sbjct: 116 DDSSDDEDGDLNELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALFS-NGEVYAWGT 174
Query: 219 NDF--------------VSVP-----PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNY 259
P V LA G +H + E+ V WG+
Sbjct: 175 FRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDEEGM-VFAWGNGQQ 233
Query: 260 -----------------SSVPKNSGFMAIASSDFTTCGIRENDLVLDCW 291
IAS + + +++ ++ W
Sbjct: 234 NQLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFALTKDNKLV-SW 281
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 30/175 (17%), Positives = 50/175 (28%), Gaps = 24/175 (13%)
Query: 101 IAAGTNHVCAVRGSYYSYHDLGTVDCW---------DIVRKGNNTLSSVQTNLFYDEYVS 151
H+ + CW N + + N F +
Sbjct: 15 AQEDYKHMYLSVQP-------LDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEA 67
Query: 152 TIVLKDVISGDGFSCGGVRDGGIVCWGPDSES---LGVFNVTESFKVLASGKSSLCGISE 208
I+ G + + + WG + N E K + + SS +
Sbjct: 68 KII--SFAVGGMHTLALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGD 125
Query: 209 LSGEVKCWGNNDFVSVPPV--GIRFVSLAAGANHFCGIREDNHGVECWGSFNYSS 261
L+ S PP+ G + V LAA N C + + V WG+F +
Sbjct: 126 LNELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALFSNGE-VYAWGTFRCNE 179
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 39/269 (14%), Positives = 72/269 (26%), Gaps = 53/269 (19%)
Query: 15 CAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGEGLL---CG-----I 66
CA+ ++G +V W + + P ++ G
Sbjct: 161 CALFSNG--EVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILF 218
Query: 67 LANTSQAFCWSSNS---------SPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYS 117
L F W + L P + IA+G NH A+
Sbjct: 219 LDEEGMVFAWGNGQQNQLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFALTKD--- 275
Query: 118 YHDLGTVDCW---DIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVIS---GDGFSCGGVRD 171
+ W + G + + + ++ + S G+ S +D
Sbjct: 276 ----NKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVVIRSIAAGEHHSLILSQD 331
Query: 172 GGIVCWG-PDSESLGVFNVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVP---PV 227
G + G D +G+ G V +P
Sbjct: 332 GDLYSCGRLDMFEVGIPKDNLPEYTYKDVH----------------GKARAVPLPTKLNN 375
Query: 228 GIRFVSLAAGANHFCGIREDNHGVECWGS 256
+F S+AAG++H + ++ WG
Sbjct: 376 VPKFKSVAAGSHHSVAVAQNGI-AYSWGF 403
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 30/164 (18%), Positives = 60/164 (36%), Gaps = 29/164 (17%)
Query: 490 LGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEV---------------L 534
+G+G +G +Y A + V + ++ EL+
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 535 CNIRHSNIVNLLGYCLEMGE----RLLVYEFMPR-GT-LHDHLHGGLSPLNWSLRLKISM 588
+++ + G L R ++ M R G+ L + L++S+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI--ADFGL 630
+ LEY+H+ +H D+K N+LL+ ++ D+GL
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 38/150 (25%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREF----EMELEVLCNIRH----- 539
+G G++G V + + + AVK ++ NI+++ ++E ++L I++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVK------VVR-NIKKYTRSAKIEADILKKIQNDDINN 95
Query: 540 SNIVNLLGY-------CLEMGERLL--VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQA 590
+NIV G CL E L +YE + R + + ++
Sbjct: 96 NNIVKYHGKFMYYDHMCLIF-EPLGPSLYEIITRN--------NYNGFHIEDIKLYCIEI 146
Query: 591 AKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620
K L YL K + + H D+K NILLD
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDP 173
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 34/175 (19%), Positives = 63/175 (36%), Gaps = 40/175 (22%)
Query: 490 LGRGSYGFVYKAV--LVDGRQVAVKRANAATIIHTNIREF----EMELEVLCNIRH---- 539
LG G++G V + + QVA+K II N+ ++ +E+ VL I+
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALK------IIR-NVGKYREAARLEINVLKKIKEKDKE 79
Query: 540 --SNIVNLLGY-------CLEMGERLL--VYEFMPRGTLHDHLHGGLSPLNWSLRLKISM 588
V + + C+ E L +EF+ P ++
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAF-ELLGKNTFEFLKEN--------NFQPYPLPHVRHMAY 130
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMK 643
Q L +LH++ + H D+K NIL + + + + T ++
Sbjct: 131 QLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 19/157 (12%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
N F+ ++G GS+G +Y + +VA+K N T + E ++ +L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGGTG- 64
Query: 541 NIVNLLGYCLEMGERLLVYEFMPR--GTLHDHLHGGLSPLNWSLR--LKISMQAAKGLEY 596
I N+ + +E +LV + + L + LS L+ L ++ Q +E+
Sbjct: 65 -IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLS-----LKTVLMLADQMINRVEF 118
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGAR---IADFGL 630
+H + +HRD+K N L+ A I DFGL
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 42/306 (13%), Positives = 71/306 (23%), Gaps = 97/306 (31%)
Query: 66 ILANTSQAFCWSSNSS----PGNTTDLVPSVYKNTAYSR---IAAGTNHVCAVRGSYYSY 118
G + AG H + S
Sbjct: 22 HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKS---- 77
Query: 119 HDLGTVDCWDIVRKGNNTLSSVQ----TNLFYDEYVSTIVL-----KDVISGDGFSCGGV 169
G V + G N T++ E V V V +GD +
Sbjct: 78 ---GQVYSF-----GCN--DEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALT 127
Query: 170 RDGGIVCWGPDSES---LGVFNVTESFKV------------LASGKSSLCGISELSGEVK 214
DG + WG ++ +G+ + V +ASG L ++ G++
Sbjct: 128 DDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTA-DGDLY 186
Query: 215 CWGNNDF---------------------VSVP----------PVGIRFVSLAAGANHFCG 243
G + + VP +RF GA
Sbjct: 187 TLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFA 246
Query: 244 IREDNHGVECWGSFNY----------SSVPK--------NSGFMAIASSDFTTCGIREND 285
I + H V +G NY +P+ ++ + T +
Sbjct: 247 ISHEGH-VYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEG 305
Query: 286 LVLDCW 291
Sbjct: 306 KAY-SL 310
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 29/181 (16%), Positives = 55/181 (30%), Gaps = 48/181 (26%)
Query: 156 KDVISGDGFSCGGVRDGGIVCWGPDSES-LG------------VFNVTESFKVLASGKSS 202
K G ++ G LG + ++ E +G
Sbjct: 11 KSKKVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMH 70
Query: 203 LCGISELSGEVKCWGNNDF------------VSVP---PVGIRFVSLAAGANHFCGIRED 247
+S+ SG+V +G ND VP + + V ++AG +H + +D
Sbjct: 71 TVCLSK-SGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDD 129
Query: 248 NHGVECWGSFNYSS-----------------VPKNSGFMAIASSDFTTCGIRENDLVLDC 290
V WGSF ++ V + + +AS + + + +
Sbjct: 130 GR-VFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTADGDLY-T 187
Query: 291 W 291
Sbjct: 188 L 188
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 44/367 (11%), Positives = 86/367 (23%), Gaps = 116/367 (31%)
Query: 15 CAIDASGKQDVICWAKNS-------SSPSSSFLSANSASFSNIPSMAVLSGGEGLLCG-- 65
G V+ + + A + ++ G
Sbjct: 21 SHSTEPG--LVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAE---------AGGM 69
Query: 66 ---ILANTSQAFCWSSNSS----PGNTTD-------LVPSVYKNTAYSRIAAGTNHVCAV 111
L+ + Q + + N + + V K ++AG +H A+
Sbjct: 70 HTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQ---VSAGDSHTAAL 126
Query: 112 RGSYYSYHDLGTVDCWDIVRK-----GNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSC 166
G V W R G + +V V SG+
Sbjct: 127 TDD-------GRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVV--KVASGNDHLV 177
Query: 167 GGVRDGGIVCWG---------------PDSESLGVFNVTESFKVLASGKSSL-------- 203
DG + G G+ + V+ + S
Sbjct: 178 MLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDA 237
Query: 204 -CG------ISELSGEVKCWGNNDF----------VSVP-------PVGIRFVSLAAGAN 239
CG IS G V +G +++ +P +V + G +
Sbjct: 238 FCGAYFTFAISH-EGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQH 296
Query: 240 HFCGIREDNHGVECWGSFNY---------------SSVPKNSGFMAIASSDFTTCGIREN 284
H + + G Y + + + ++A + ++
Sbjct: 297 HTVCMDSEGK-AYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTKD 355
Query: 285 DLVLDCW 291
V W
Sbjct: 356 GRVF-AW 361
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 31/197 (15%), Positives = 53/197 (26%), Gaps = 60/197 (30%)
Query: 101 IAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNT-----LSSVQTNLFYDEYVSTIVL 155
+H G V G L VS
Sbjct: 13 KKVKVSHRSHSTEP-------GLVLTL-----GQGDVGQLGLGENVMERKKPALVSI--P 58
Query: 156 KDVISGDGFSCGGV------RDGGIVCWGPDSES-LGVFNVTES-------------FKV 195
+DV+ GG+ + G + +G + E LG E
Sbjct: 59 EDVVQ---AEAGGMHTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQ 115
Query: 196 LASGKSSLCGISELSGEVKCWGNN-------------DFVSVP---PVGIRFVSLAAGAN 239
+++G S +++ G V WG+ VP + + V +A+G +
Sbjct: 116 VSAGDSHTAALTD-DGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGND 174
Query: 240 HFCGIREDNHGVECWGS 256
H + D + G
Sbjct: 175 HLVMLTADGD-LYTLGC 190
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 31/250 (12%), Positives = 59/250 (23%), Gaps = 70/250 (28%)
Query: 52 SMAVLSGGE------------GLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYS 99
+ + + G+ G + + AN P + +
Sbjct: 176 LVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQ 235
Query: 100 RIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNN------------TLSSVQTNLFYD 147
G A+ G V + G + F +
Sbjct: 236 DAFCGAYFTFAISHE-------GHVYGF-----GLSNYHQLGTPGTESCFIPQNLTSFKN 283
Query: 148 EYVSTIVLKDVISGDGFSCGGVRDGGIVCWG-PDSESLGVFNVTESFKV----------- 195
ST G + +G G + LG+ E +
Sbjct: 284 ---STKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVS 340
Query: 196 -LASGKSSLCGISELSGEVKCWGNNDF----------VSVP-PV------GIRFVSLAAG 237
+A G S +++ G V WG P + +S+++G
Sbjct: 341 SVACGASVGYAVTK-DGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSG 399
Query: 238 ANHFCGIRED 247
H + +D
Sbjct: 400 GQHTVLLVKD 409
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/153 (24%), Positives = 64/153 (41%), Gaps = 15/153 (9%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ ++G GS+G +Y + G +VA+K T E ++ +++ I
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--I 67
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR--LKISMQAAKGLEYLHKD 600
+ E ++V E + +L D + +SL+ L ++ Q +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 601 AAPPIIHRDVKTLNILLDSDWGA---RIADFGL 630
IHRDVK N L+ I DFGL
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 28/180 (15%), Positives = 66/180 (36%), Gaps = 34/180 (18%)
Query: 477 LKDATNG-FKEFNELGRGSYGFVYKAV---------LVDGRQVAVKRANAATIIHTNIRE 526
L D + +K + R + G +Y+A ++ ++K +
Sbjct: 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95
Query: 527 FE-----MELEVLC---NIRHSNIVNLLGYCLEMGE-RLLVYEFMPR-----GTLHDHLH 572
F+ +++ + I +G+ + + R LV +P + D
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSP 152
Query: 573 GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI--ADFGL 630
+ L+++ + LE+LH++ +H +V NI +D + +++ A +G
Sbjct: 153 KHVLSE--RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGF 207
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 42/156 (26%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREF----EMELEVLCNIRHSN--- 541
LG G + V+ + + + VA+K + + + E+ +L ++R+S+
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-------VVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 542 -----IVNLLGY-----------CLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRL 584
+V LL C+ V+E + L + L
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGLPLPCVK 149
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620
KI Q +GL+YLH IIH D+K NILL +
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 38/175 (21%), Positives = 66/175 (37%), Gaps = 40/175 (22%)
Query: 490 LGRGSYGFVYKAV--LVDGRQVAVKRANAATIIHTNIREF----EMELEVLCNIRH---- 539
LG G++G V + + GR VAVK I+ N+ + E++VL ++
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVK------IVK-NVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 540 --SNIVNLLGY-------CLEMGERLL--VYEFMPRGTLHDHLHGGLSPLNWSLRLKISM 588
V +L + C+ E L Y+F+ + G P K++
Sbjct: 75 STFRCVQMLEWFEHHGHICIVF-ELLGLSTYDFI-KEN-------GFLPFRLDHIRKMAY 125
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMK 643
Q K + +LH + + H D+K NIL + + + D+K
Sbjct: 126 QICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
|
| >1du3_A Death receptor 5; trail, DR5, complex; 2.20A {Homo sapiens} SCOP: g.24.1.1 g.24.1.1 g.24.1.1 PDB: 1d0g_R 2h9g_R 1za3_R 1d4v_A Length = 130 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 9e-06
Identities = 8/38 (21%), Positives = 12/38 (31%)
Query: 339 CVRKDLKICSPCGSNCSEGFFLSSPCTAIADRVCTACS 376
++C C + C G CT +D C
Sbjct: 92 REEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECVHKE 129
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 32/164 (19%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVL---------CNIRH 539
+G G +G +Y A + A + + EL+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH---VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 540 SNIVNLLG-----YCLEMGERLLVYEF--MPR-GT-LHDHL--HGGLSPLNWSLRLKISM 588
++ LG + Y F M R G L +G S L++ +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK---STVLQLGI 158
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI--ADFGL 630
+ LEY+H++ +H D+K N+LL ++ AD+GL
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGL 199
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 740 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.82 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.34 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.24 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.68 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.91 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.08 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.14 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.08 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 83.62 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.13 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 80.8 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=427.56 Aligned_cols=237 Identities=28% Similarity=0.425 Sum_probs=195.2
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|...++||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++|+|||||+++|+|.+.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56888899999999999999974 36789999997643 34457899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCE
Q 040687 556 LLVYEFMPRGTLHDHLHGG------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA 623 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 623 (740)
+||||||++|+|.++|+.. ...++|.++++|+.|||+||+|||+++ ||||||||+||||++++++
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999753 246999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhH
Q 040687 624 RIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPL 679 (740)
Q Consensus 624 ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 679 (740)
||+|||+|+.... ...++.|+|||||||+||||+| |+.||..... ..+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~~~ 242 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIEC 242 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 9999999864321 1234789999999999999999 9999974321 112222
Q ss_pred HhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 680 IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 680 ~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
+..+. ..+.+...+.++.+||.+||+.||++||||+||+++|+++.+..
T Consensus 243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22221 12223344557889999999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=428.94 Aligned_cols=236 Identities=29% Similarity=0.405 Sum_probs=192.3
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++|...++||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++|+|||||+++|+|.+.+..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 56778889999999999999974 37889999997643 34557899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL--------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW 621 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~ 621 (740)
+||||||++|+|.++|+... .+++|.++++|+.|||+||+|||+.+ ||||||||+||||++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 99999999999999997532 35999999999999999999999998 99999999999999999
Q ss_pred CEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhh
Q 040687 622 GARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 622 ~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~ 677 (740)
++||+|||+|+.... ...++.|+|||||||+||||+| |+.||..... ..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~~ 270 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAI 270 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence 999999999875422 2234679999999999999999 9999964321 1112
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+..+ .+.+.+.....++.+||.+||+.||++||||+||+++|+.+.+.
T Consensus 271 ~~i~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222221 12223334455788999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=421.66 Aligned_cols=242 Identities=27% Similarity=0.394 Sum_probs=194.9
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
...++|...++||+|+||+||+|++. ..||||+++.........++|.+|+++|++++|||||+++|++.+ +.++||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34467888999999999999999864 369999997655445566789999999999999999999999865 568999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||||++|+|.++|+....+++|.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999877778999999999999999999999998 99999999999999999999999999865321
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.|+|||||||+||||+||+.||....... .....+..+... +.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~~~~~~~~----p~ 258 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFMVGRGYAS----PD 258 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHTTCCC----CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCC----CC
Confidence 1124679999999999999999999997433211 111122211111 11
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
. ...+.+...++.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 11123344578899999999999999999999999987754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=425.41 Aligned_cols=234 Identities=25% Similarity=0.359 Sum_probs=192.3
Q ss_pred cCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++++..++||+|+||+||+|++. +++.||||+++... .....++|.+|+.+|++|+|||||+|+|+|.+.+..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34667789999999999999973 46789999997543 234457899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
+||||||++|+|.++|+... ..++|.++++|+.|||+||+|||+++ ||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 99999999999999996432 35899999999999999999999998 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 676 (740)
+++||+|||+|+.... ...++.|+|||||||+||||+| |+.||..... . .+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~----~~ 256 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-Q----DV 256 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-H----HH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-H----HH
Confidence 9999999999875422 1234679999999999999999 8999964321 1 11
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
...+.. ....+.+.+++.++.+||.+||+.||++||||+||++.|+.+
T Consensus 257 ~~~i~~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRN---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHc---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222222 222333445566889999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=417.02 Aligned_cols=249 Identities=30% Similarity=0.417 Sum_probs=202.8
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCC-CCcce
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-SNIVN 544 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~ 544 (740)
++.++++...++|+..++||+|+||+||+|++.. ++.||||+++.... ....++|.+|+++|++++| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3445677778899999999999999999999753 35799999976543 3445789999999999965 89999
Q ss_pred EEeEEEeC-CeEEEEEecCCCCChHHhHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 040687 545 LLGYCLEM-GERLLVYEFMPRGTLHDHLHGG---------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHR 608 (740)
Q Consensus 545 l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHr 608 (740)
++|+|.+. ...+||||||++|+|.++|+.. ...++|.+++.|+.|||+||+|||+++ ||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence 99999765 5689999999999999999743 235899999999999999999999999 9999
Q ss_pred CCCCCCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCC
Q 040687 609 DVKTLNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYD 664 (740)
Q Consensus 609 Dlk~~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~ 664 (740)
||||+||||++++++||+|||+|+....+ ..++.|+|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999765321 234679999999999999999 999997
Q ss_pred CCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 665 IEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
....... +...+.++ .+++.+.....++.+||.+||+.||++||||.||++.|+++++..
T Consensus 290 ~~~~~~~----~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 290 GVKIDEE----FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TCCCSHH----HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCHHHH----HHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 5432221 12222222 222333334557889999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=406.39 Aligned_cols=233 Identities=24% Similarity=0.396 Sum_probs=188.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+++.. +++.||||+++.........+.|.+|+++|++|+|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999975 58999999998766555566789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++|+|.++|.... ..+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999997543 45799999999999999999999999 99999999999999999999999999875432
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++|||||||+||||+||+.||.... ..+.. ..+..+. . .+.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~-~~i~~~~--------~-~~~~ 246 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS----MKNLV-LKIISGS--------F-PPVS 246 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHH-HHHHHTC--------C-CCCC
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHH-HHHHcCC--------C-CCCC
Confidence 2345789999999999999999999997432 11111 1121111 1 1122
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
.....++.+|+.+||+.||++|||+.|+++ +|.
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 233457889999999999999999999986 454
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=399.61 Aligned_cols=241 Identities=24% Similarity=0.304 Sum_probs=186.5
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC----eEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----ERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 557 (740)
++|.+.++||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||++++++.+.+ .++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4577888999999999999998 68999999987542 11122345666667899999999999998764 5799
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-----AAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
|||||++|+|.++|+.. +++|..+++|+.|+|+||+|||++ ..++||||||||+||||++++++||+|||+|+
T Consensus 79 V~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999999864 599999999999999999999987 23459999999999999999999999999986
Q ss_pred cccCCC-------------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCc-h---------
Q 040687 633 SCERDL-------------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP-G--------- 671 (740)
Q Consensus 633 ~~~~~~-------------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~-~--------- 671 (740)
...... .++.|+|||||||+||||+||+.||....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 432210 12458999999999999999988875322110 0
Q ss_pred hHHhhhhHHhhCccchhcccccCC--C---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVAL--P---RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~--~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+..... +.+...+. | ...+....+.+||.+||+.||++||||.||++.|+++.++
T Consensus 237 ~~~~~~~~--------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHH--------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHH--------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 01111111 12222221 1 1234566789999999999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=393.79 Aligned_cols=230 Identities=28% Similarity=0.357 Sum_probs=184.4
Q ss_pred cccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCeEEEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MGERLLVY 559 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 559 (740)
+..++||+|+||+||+|++.. ++.||||++..........+.|.+|+++|++|+|||||++++++.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 566789999999999999854 8899999998766555566789999999999999999999999875 24589999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~-- 636 (740)
|||++|+|.++|+.. ..+++.++..|+.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 999999999999754 57999999999999999999999875 46999999999999985 78999999999864332
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++|||||||+||||+||+.||........ ....+..+..... .+..
T Consensus 187 ~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~~~i~~~~~~~~--------~~~~ 254 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVKPAS--------FDKV 254 (290)
T ss_dssp BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCCCGG--------GGGC
T ss_pred cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----HHHHHHcCCCCCC--------CCcc
Confidence 12357899999999999999999999964322111 1122221111110 1111
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...++.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2236789999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=397.26 Aligned_cols=233 Identities=24% Similarity=0.255 Sum_probs=190.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.+.|+..++||+|+||+||+++.. +++.||||+++.... +.+|+.+|++|+|||||++++++.+.+..||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456888899999999999999985 489999999976432 246999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~-- 636 (740)
|||++|+|.++|+.. .++++.++..|+.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+....
T Consensus 130 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999754 46999999999999999999999999 99999999999999987 699999999975421
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++|||||||+||||+||+.||.......-+ ..+...... .
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~i~~~~~~-----~ 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-----LKIASEPPP-----I 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-----HHHHHSCCG-----G
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HHHHcCCCC-----c
Confidence 123467999999999999999999999754322211 111111110 0
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
... +......+.+|+.+||+.||++|||+.||++.|.+++++
T Consensus 276 ~~~--~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 276 REI--PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GGS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhc--CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 011 223334678999999999999999999999999888765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=397.48 Aligned_cols=228 Identities=24% Similarity=0.372 Sum_probs=189.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+.|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999985 589999999976542 334568999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
||++|+|.+++... .+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 152 y~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 152 FLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999999763 5999999999999999999999999 99999999999999999999999999876532
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++|||||||+||||+||+.||..... .+ ....+.... ....+...
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~-~~~~i~~~~-------~~~~~~~~ 294 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LK-AMKMIRDNL-------PPRLKNLH 294 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH-HHHHHHHSS-------CCCCSCGG
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HH-HHHHHHcCC-------CCCCCccc
Confidence 12347799999999999999999999974321 11 112222111 11112223
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+|+.+||+.||++|||+.|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33457889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=389.50 Aligned_cols=227 Identities=22% Similarity=0.284 Sum_probs=189.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||+||+++.. +++.||||++.+.... ....+.+.+|+++|++|+|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999975 5899999999865432 234577999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.++|... ..+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999754 46999999999999999999999999 99999999999999999999999999976532
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||+||+||||+||+.||.... ..+ .... ++...+..|
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~-~~~~--------i~~~~~~~p 254 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EGL-IFAK--------IIKLEYDFP 254 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHH--------HHHTCCCCC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHH-HHHH--------HHcCCCCCC
Confidence 1223668999999999999999999997432 111 1112 222233333
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVA 727 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 727 (740)
.. ...++.+|+.+||+.||++|||++|++
T Consensus 255 ~~--~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EK--FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TT--CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cc--cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 32 234678999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=379.13 Aligned_cols=230 Identities=26% Similarity=0.367 Sum_probs=182.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.. +++.||||++++..... ...+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999974 58999999997654332 23567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+ +|+|.++|..+ .++++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 999 68999999754 57999999999999999999999999 99999999999999999999999999875432
Q ss_pred -----------------CC-CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DL-TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~-~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
.. .++.++||||+||+||||+||+.||.... ..+ ....+ .+.....|..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~----~~~-~~~~i--------~~~~~~~p~~ 234 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES----IPV-LFKNI--------SNGVYTLPKF 234 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHH--------HHTCCCCCTT
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC----HHH-HHHHH--------HcCCCCCCCC
Confidence 11 12568999999999999999999997432 111 11222 2222233332
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
...++.+|+.+||+.||++|||++|+++ |++
T Consensus 235 --~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 235 --LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 2346789999999999999999999997 554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=397.11 Aligned_cols=229 Identities=24% Similarity=0.373 Sum_probs=189.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.+.|+..++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 467999999999999999999985 489999999976542 33456899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|||++|+|.++++.. .+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999999754 5999999999999999999999999 99999999999999999999999999876532
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++|||||||+||||++|+.||..... .+ .+..+.... ... .+..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~-~~~~i~~~~-----~~~--~~~~ 370 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LK-AMKMIRDNL-----PPR--LKNL 370 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH-HHHHHHHSC-----CCC--CSCT
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HH-HHHHHHcCC-----CCC--Cccc
Confidence 22347799999999999999999999964321 11 112222111 111 1222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 233447889999999999999999999987
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=390.10 Aligned_cols=279 Identities=16% Similarity=0.249 Sum_probs=230.4
Q ss_pred eeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCC-----CceEEeccCCeEeEEecCCCceEeccC
Q 040687 4 ISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIP-----SMAVLSGGEGLLCGILANTSQAFCWSS 78 (740)
Q Consensus 4 ~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~-----~~~~i~~G~~~~Cal~~~~~~~~cWg~ 78 (740)
|..++.|..|+|||..+| +|||||.|.+||||.+++.++..|..++ .+.+|++|..|+|||..+++.+||||.
T Consensus 18 v~~ia~G~~hs~al~~~g--~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~i~~va~G~~ht~al~~~gg~v~~wG~ 95 (406)
T 4d9s_A 18 VLIISAGASHSVALLSGD--IVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAYSQSGMEVYSWGW 95 (406)
T ss_dssp EEEEEECSSEEEEEETTT--EEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEETTTTEEEEEEC
T ss_pred eEEEecCCCeEEEEEeCC--EEEEEeCCCCCCCCCCCcccCcCCEEecccCCCCEEEEEeCcceEEEEECCCCEEEEEcC
Confidence 444555558999999999 9999999999999999998888888774 468999999999999887667999999
Q ss_pred CCC--CCCCcc---ccc---ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCcccccccccccc
Q 040687 79 NSS--PGNTTD---LVP---SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYV 150 (740)
Q Consensus 79 ~~~--~g~g~~---~~~---~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~ 150 (740)
|.+ +|.+.. ..| ..+.+..+.+|++|..|++||. .+|+||+| |.|..||||.+...+...
T Consensus 96 n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~alt-------~~G~v~~w-----G~n~~GqLG~g~~~~~~~ 163 (406)
T 4d9s_A 96 GDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVT-------MEGEVQSW-----GRNQNGQLGLGDTEDSLV 163 (406)
T ss_dssp CGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEE-------TTSCEEEE-----ECCTTSTTCSSSCCCEEE
T ss_pred CCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEEc-------CCCcEEEe-----CCCCCccCCCCCCCCccc
Confidence 987 444432 223 2334558999999999999999 89999999 999999999886555444
Q ss_pred cee-------eEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCc-------------cCCCCcEEEEeeCCceeeeeecC
Q 040687 151 STI-------VLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGV-------------FNVTESFKVLASGKSSLCGISEL 209 (740)
Q Consensus 151 ~~~-------~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~-------------~~~~~~~~~iaaG~~h~Cai~~~ 209 (740)
|.. .+++|++|..|+|+|+.+|.|||||.|..+ ++. .....++.+|++|.+|+++|. .
T Consensus 164 p~~v~~~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~i~~va~G~~ht~~l~-~ 242 (406)
T 4d9s_A 164 PQKIQAFEGIRIKMVAAGAEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVS-Y 242 (406)
T ss_dssp EEECGGGTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSSCCEEEEEECCCSTTCCEEEEEECSSEEEEEE-T
T ss_pred ceEecccCCCcEEEEecCCCeEEEEeCCCCEEEeeCCCCCCCCCCCCCCcCccEEecccCCceEEEEEECCCcEEEEc-C
Confidence 433 489999999999999999999999999875 111 111256899999999999994 5
Q ss_pred CCcEEEeecCCCCCC---------CC------CcccEEEEecccceeeeeeecCCcEEecCCCCCCCCCCC---------
Q 040687 210 SGEVKCWGNNDFVSV---------PP------VGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKN--------- 265 (740)
Q Consensus 210 ~g~v~CWG~n~~g~~---------~~------~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~--------- 265 (740)
+|+||+||.|.+||. .| ....+++|++|.+|+|+|+ .||+|++||.|.+||+..+
T Consensus 243 ~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt-~~G~v~~wG~n~~GqLG~g~~~~~~~p~ 321 (406)
T 4d9s_A 243 SGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALT-SDGKLYGWGWNKFGQVGVGNNLDQCSPV 321 (406)
T ss_dssp TCCEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTTCSSSSSCEEEEE
T ss_pred CCCEEEeeCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEc-CCCeEEEeeCCCCCCCCCCCCCCCccCE
Confidence 999999999999982 01 1234999999999999998 9999999999999996432
Q ss_pred -------CceEEEEecCceeeEEEeCCceeecccccCCCCC
Q 040687 266 -------SGFMAIASSDFTTCGIRENDLVLDCWFANVSSPT 299 (740)
Q Consensus 266 -------~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~~ 299 (740)
..+.+|++|..|+++++ +++.|++||.|..++.
T Consensus 322 ~v~~~~~~~v~~va~G~~hs~alt-~~G~v~~wG~n~~GqL 361 (406)
T 4d9s_A 322 QVRFPDDQKVVQVSCGWRHTLAVT-ERNNVFAWGRGTNGQL 361 (406)
T ss_dssp EECCGGGCCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTT
T ss_pred EEeccCCCcEEEEEeCCCeEEEEe-CCCCEEEecCCCCCcc
Confidence 35899999999999998 8889999999987764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=388.65 Aligned_cols=228 Identities=23% Similarity=0.338 Sum_probs=182.5
Q ss_pred cCccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||+||+++.. .++.||||.++...........+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999863 36789999998765444444578999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.++|... ..+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999754 47999999999999999999999999 99999999999999999999999999875321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++|||||||+||||+||+.||..... .+ .... +....+..|
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~-~~~~--------i~~~~~~~p 246 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----KE-TMTM--------ILKAKLGMP 246 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHH--------HHHCCCCCC
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----HH-HHHH--------HHcCCCCCC
Confidence 22346799999999999999999999974321 11 1111 222233333
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
.. ...++.+|+.+||+.||++||| ++|+++
T Consensus 247 ~~--~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 247 QF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp TT--SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred Cc--CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 32 3346789999999999999998 567775
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=370.31 Aligned_cols=227 Identities=24% Similarity=0.373 Sum_probs=174.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-------
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------- 553 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 553 (740)
++|+..+.||+|+||+||+++.. +++.||||+++.... ....+.|.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45899999999999999999975 589999999875442 234467999999999999999999999987654
Q ss_pred -----eEEEEEecCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEe
Q 040687 554 -----ERLLVYEFMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIA 626 (740)
Q Consensus 554 -----~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 626 (740)
..||||||+++|+|.+++.... ...++..++.|+.||++||+|||+++ ||||||||+||||+.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998653 23577888999999999999999999 9999999999999999999999
Q ss_pred ecCCCccccC---------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhH
Q 040687 627 DFGLLTSCER---------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIV 673 (740)
Q Consensus 627 DFGla~~~~~---------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 673 (740)
|||+|+.... ...++.++|||||||+||||++ ||.... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHH
Confidence 9999875422 1234779999999999999996 775321 000
Q ss_pred HhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 674 EWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 674 ~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+....... ...+....+.+|+++||+.||++|||+.|+++
T Consensus 235 -~~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 -RTLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111111111111 11122234668999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.79 Aligned_cols=262 Identities=39% Similarity=0.609 Sum_probs=221.1
Q ss_pred cccChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEE
Q 040687 470 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549 (740)
Q Consensus 470 ~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (740)
..+++.+++..+++|+..+.||+|+||.||++++.+++.||||++.... ....+.|.+|++++++++||||+++++++
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456667788899999999999999999999998889999999987653 33457899999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEe
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIA 626 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 626 (740)
.+.+..++||||+++++|.+++.... ..++|.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999997543 35899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCC--CchhHHhhhhHHh
Q 040687 627 DFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYV--PPGIVEWALPLIK 681 (740)
Q Consensus 627 DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~--~~~~~~~~~~~~~ 681 (740)
|||++..... ...++.++||||||+++|||+||+.||..... .....++......
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 9999864321 12236789999999999999999999975432 2344555555555
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+..++++........+....+.+++.+||+.||++||++.||++.|+.+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 5566667776666666677788999999999999999999999999999998763
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.59 Aligned_cols=274 Identities=14% Similarity=0.140 Sum_probs=223.3
Q ss_pred cCCceEEEEecCCcceEEEccCCCCCCCCCCCC-CCCCccccCC---CceEEeccCCeEeEEecCCCceEeccCCCC--C
Q 040687 9 GQNSFFCAIDASGKQDVICWAKNSSSPSSSFLS-ANSASFSNIP---SMAVLSGGEGLLCGILANTSQAFCWSSNSS--P 82 (740)
Q Consensus 9 g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~-~~~~~~~~v~---~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~--~ 82 (740)
-|..|.|++..+| +|||||.|.+||||.+++ .+...|..|+ .+.+|++|..|+|+|..++. +||||.|.+ +
T Consensus 31 ~g~~~~~~l~~~G--~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~v~~va~G~~h~~~l~~~G~-v~~wG~n~~GqL 107 (423)
T 3mvd_K 31 FHLELPKRRTVLG--NVLVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHNLVLTKSGD-IYSFGCNDEGAL 107 (423)
T ss_dssp CCCCCCCCCCCCE--EEEEEEECTTSTTCSCSSCCEEEEEEECCSCSSEEEEEECSSEEEEEETTSC-EEEEECCSSSTT
T ss_pred cCCccceeecCCC--cEEEEeCCCCCCCCCCCCCccCcCCeEccCCCCceEEeeCCCeEEEEeCCCe-EEEeECCCCcCC
Confidence 3448999999999 999999999999999865 3445666663 56899999999999988865 999999987 4
Q ss_pred CCCcc-----ccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCC--CccCccccccccccccce--
Q 040687 83 GNTTD-----LVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGN--NTLSSVQTNLFYDEYVST-- 152 (740)
Q Consensus 83 g~g~~-----~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~--n~~gqlg~~~~~~~~~~~-- 152 (740)
|.+.. ..| .+.....+.+|++|..|+|||. .+|+||+| |. |..||||.+.......|.
T Consensus 108 G~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al~-------~~G~v~~w-----G~~~n~~GqlG~~~~~~~~~p~~~ 175 (423)
T 3mvd_K 108 GRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLL-------EDGRVFAW-----GSFRDSHGNMGLTIDGNKRTPIDL 175 (423)
T ss_dssp CSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEEE-------TTSCEEEE-----ECEECSSSEEESBTTBCEEEEEES
T ss_pred CCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEEe-------CCCeEEEE-----eCCCCCCCCcCcCCCCCCceeeEe
Confidence 44432 345 3433458999999999999999 89999999 87 899999987544443333
Q ss_pred ---eeEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCcc------------------------CCCCcEEEEeeCCceee
Q 040687 153 ---IVLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGVF------------------------NVTESFKVLASGKSSLC 204 (740)
Q Consensus 153 ---~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~~------------------------~~~~~~~~iaaG~~h~C 204 (740)
..+++|++|..|+|+|+.+|+|||||.|..+ ++.. +....+..|++|..|++
T Consensus 176 ~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~p~~v~~~~~~~v~~i~~g~~~~~ 255 (423)
T 3mvd_K 176 MEGTVCCSIASGADHLVILTTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYCTF 255 (423)
T ss_dssp STTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTSSCCTTTTTSCSTTTTTTTSSCEEECCTTCCCEEEEEEETTEEE
T ss_pred cCCCcEEEEecCCCeEEEEecCCeEEEeeCCcCCccCCCcccccccccccccccccCCeEEeecCCccEEEEEECCcEEE
Confidence 2499999999999999999999999999874 2211 11245899999999999
Q ss_pred eeecCCCcEEEeecCCCCCCCC--------------CcccEEEEecccceeeeeeecCCcEEecCCCCCCCCCCCC----
Q 040687 205 GISELSGEVKCWGNNDFVSVPP--------------VGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNS---- 266 (740)
Q Consensus 205 ai~~~~g~v~CWG~n~~g~~~~--------------~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~~---- 266 (740)
++.+.+|+|+|||.|.++|.-. ....+++|++|.+|+|+|+ .||+|||||.|.+||+..+.
T Consensus 256 ~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ht~alt-~~G~v~~wG~n~~GqLG~g~~~~~ 334 (423)
T 3mvd_K 256 MRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILT-TDLKCSVVGRPEYGRLGLGDVKDV 334 (423)
T ss_dssp EEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSSEEEEEE-TTCCEEEEECCGGGTTCSSSCCSC
T ss_pred EEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccCeEEEEe-CCCcEEEEECCCCCCCCCCCcccc
Confidence 9966799999999999988211 1246899999999999998 99999999999998853221
Q ss_pred ------------ceEEEEecCceeeEEEeCCceeecccccCCCCC
Q 040687 267 ------------GFMAIASSDFTTCGIRENDLVLDCWFANVSSPT 299 (740)
Q Consensus 267 ------------~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~~ 299 (740)
.+.+|++|..|+|+++ +++.|++||.|..++.
T Consensus 335 ~~~p~~v~~l~~~v~~ia~G~~hs~alt-~~G~v~~wG~n~~GqL 378 (423)
T 3mvd_K 335 VEKPTIVKKLTEKIVSVGCGEVCSYAVT-IDGKLYSWGSGVNNQL 378 (423)
T ss_dssp EEEEEECTTCCSCEEEEEEETTEEEEEE-TTSCEEEEECCTTSCS
T ss_pred ccCceEeccCCCCEEEEEcCCCeEEEEc-CCCCEEEECCCCCCCC
Confidence 5889999999999997 8999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=372.42 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=185.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (740)
.++|+..++||+|+||+||+|+.. +++.||||+++.........+.+.+|+++|++|+|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999975 589999999976654444567789999999999999999999997643 5
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..|||||||+ |+|.++|... .++++.++..|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999995 7899999764 57999999999999999999999999 99999999999999999999999999875
Q ss_pred ccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh------
Q 040687 634 CER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK------ 681 (740)
Q Consensus 634 ~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~------ 681 (740)
... ...++.++||||+||+||||+||+.||........+ ..+.....
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l-~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL-QLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-HHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH-HHHHHhcCCCChHH
Confidence 321 122367899999999999999999999754321111 11110000
Q ss_pred -----hCccchhccccc-CCCCC-----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 682 -----QGKAAAIIDRNV-ALPRN-----VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 682 -----~~~~~~i~d~~~-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+.... ..+.+ .....++.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 00111 112246779999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=359.23 Aligned_cols=263 Identities=37% Similarity=0.634 Sum_probs=221.6
Q ss_pred ccccChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 469 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 469 ~~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
...+++.++....++|+..+.||+|+||.||+++..+++.||||++...... .....|.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4678899999999999999999999999999999878999999998765422 222468999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEE
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARI 625 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki 625 (740)
+......++||||+++++|.++++... .++++..++.|+.|++.||+|||+...++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999998643 35999999999999999999999993233999999999999999999999
Q ss_pred eecCCCccccCC----------------------CCCCcccceehhHHHHHHHHhCCCCCCC----CCCCchhHHhhhhH
Q 040687 626 ADFGLLTSCERD----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDI----EYVPPGIVEWALPL 679 (740)
Q Consensus 626 ~DFGla~~~~~~----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~----~~~~~~~~~~~~~~ 679 (740)
+|||++...... ..++.++||||||+++|||+||+.||+. ......+.++....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998754321 1125689999999999999999999962 23334455566566
Q ss_pred HhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 680 IKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 680 ~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
........+.+.........+....+.+++.+||+.||++|||+.||++.|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 66666677777777666677778899999999999999999999999999975
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=365.80 Aligned_cols=270 Identities=17% Similarity=0.204 Sum_probs=219.2
Q ss_pred ceEEEEecCCcceEEEccCCCCCCCCCCCCCC-CCccccCC---CceEEeccCCeEeEEecCCCceEeccCCCC--CCCC
Q 040687 12 SFFCAIDASGKQDVICWAKNSSSPSSSFLSAN-SASFSNIP---SMAVLSGGEGLLCGILANTSQAFCWSSNSS--PGNT 85 (740)
Q Consensus 12 ~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~-~~~~~~v~---~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~--~g~g 85 (740)
.|+|+|..+| .||+||.|.+||||.+++.+ ...|..|+ .+..|++|..|+|+|..++ .+|+||.|.+ +|.+
T Consensus 18 ~h~~~l~~~g--~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~va~G~~hs~~l~~~G-~v~~wG~n~~GqLG~~ 94 (413)
T 1a12_A 18 SHRSHSTEPG--LVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSG-QVYSFGCNDEGALGRD 94 (413)
T ss_dssp CCTTCCCCCB--EEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEEETTS-CEEEEECCTTSTTCSC
T ss_pred ccceeecCCC--cEEEEECCCCCcCCCCCCccccccceEccCCCCeEEEEeCCCeEEEEcCCC-CEEEEECCCCCCCCCC
Confidence 7999999999 99999999999999987654 45666553 5789999999999998875 4999999986 4443
Q ss_pred cc-----ccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCC--CccCcccccccccc-ccce----
Q 040687 86 TD-----LVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGN--NTLSSVQTNLFYDE-YVST---- 152 (740)
Q Consensus 86 ~~-----~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~--n~~gqlg~~~~~~~-~~~~---- 152 (740)
.. ..| .+.....+.+|++|..|+|||. .+|+||+| |. |..||||.+..... ..|.
T Consensus 95 ~~~~~~~~~P~~v~l~~~i~~va~G~~hs~alt-------~~G~v~~w-----G~~~n~~GqlG~~~~~~~~~~P~~v~~ 162 (413)
T 1a12_A 95 TSVEGSEMVPGKVELQEKVVQVSAGDSHTAALT-------DDGRVFLW-----GSFRDNNGVIGLLEPMKKSMVPVQVQL 162 (413)
T ss_dssp CCSTTGGGSCEECCCCSCEEEEEECSSEEEEEE-------TTSCEEEE-----ECEEETTEEEESSBBTBCEEEEEEECC
T ss_pred CCCCccccCCeEecCCCcEEEEecCCCeEEEEc-------CCCcEEEe-----eCCcCCCCccCcCCccccccCCEEecC
Confidence 22 345 3333448999999999999999 89999999 77 88999997653322 1122
Q ss_pred -eeEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCc------------------cC-----------CCCcEEEEeeCCc
Q 040687 153 -IVLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGV------------------FN-----------VTESFKVLASGKS 201 (740)
Q Consensus 153 -~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~------------------~~-----------~~~~~~~iaaG~~ 201 (740)
..+++|++|..|+++|+.+|+|||||.|..+ ++. .| ....+.+|++|.+
T Consensus 163 ~~~i~~ia~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~P~~v~~~~~g~~~~~~i~~ia~G~~ 242 (413)
T 1a12_A 163 DVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAY 242 (413)
T ss_dssp SSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETT
T ss_pred CCCEEEEEecCceEEEEcCCCCEEEeeCCCCCccCCCccccccccccccccccccCceEeeccccccCCccEEEEEeCCC
Confidence 2489999999999999999999999999874 221 11 2356999999999
Q ss_pred eeeeeecCCCcEEEeecCCCCCC---------CCC------c--ccEEEEecccceeeeeeecCCcEEecCCCCCCCCCC
Q 040687 202 SLCGISELSGEVKCWGNNDFVSV---------PPV------G--IRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPK 264 (740)
Q Consensus 202 h~Cai~~~~g~v~CWG~n~~g~~---------~~~------~--~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~ 264 (740)
|+++|. .+|+||+||.|.+||. .|. . ..+++|++|.+|+++|+ .||+||+||.|.+||+..
T Consensus 243 hs~alt-~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~v~~ia~G~~hs~al~-~~G~v~~wG~n~~GqLG~ 320 (413)
T 1a12_A 243 FTFAIS-HEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMD-SEGKAYSLGRAEYGRLGL 320 (413)
T ss_dssp EEEEEE-TTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEE-TTSCEEEEECCGGGTTCS
T ss_pred EEEEEe-CCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCceEEEEecccceEEEEe-CCCCEEEeeCCCCCccCC
Confidence 999995 5999999999999881 111 1 34999999999999998 999999999999998744
Q ss_pred C---------------CceEEEEecCceeeEEEeCCceeecccccCCCCC
Q 040687 265 N---------------SGFMAIASSDFTTCGIRENDLVLDCWFANVSSPT 299 (740)
Q Consensus 265 ~---------------~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~~ 299 (740)
+ ..+.+|++|..|+++++ +++.|++||.|..++.
T Consensus 321 g~~~~~~~~P~~v~~l~~v~~v~~G~~hs~alt-~~G~v~~wG~n~~gqL 369 (413)
T 1a12_A 321 GEGAEEKSIPTLISRLPAVSSVACGASVGYAVT-KDGRVFAWGMGTNYQL 369 (413)
T ss_dssp CTTCCCEEEEEECCSSSSEEEEEECSSEEEEEE-TTSCEEEEECCTTSTT
T ss_pred CCCCccccCCEEecccCceeEEEECcceEEEEe-CCCCEEEecCCCCCCC
Confidence 3 25899999999999998 8889999999977653
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=372.47 Aligned_cols=280 Identities=17% Similarity=0.225 Sum_probs=219.7
Q ss_pred CCeeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCC---CCCccccCC-------CceEEeccCCeEeEEecCCC
Q 040687 2 GPISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSA---NSASFSNIP-------SMAVLSGGEGLLCGILANTS 71 (740)
Q Consensus 2 ~~~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~---~~~~~~~v~-------~~~~i~~G~~~~Cal~~~~~ 71 (740)
..|.-..-...|+|++..++ .|||||.|.+||||.|++. +...|..++ .+.+|++|..|+|+|..++.
T Consensus 10 ~~~~~~~~~~~h~~~~~~~g--~v~~wG~n~~GqLG~G~~~~~~~~~~P~~~~~~~~~~~~i~~va~G~~Ht~alt~~G~ 87 (473)
T 3of7_A 10 SHIINAQEDYKHMYLSVQPL--DIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFAVGGMHTLALDEESN 87 (473)
T ss_dssp TTCCCCGGGGHHHHCCSSCC--EEEEEEECTTSTTCSCSCGGGGEEEEEEECTTSCTTTTCEEEEEECSSEEEEEETTCC
T ss_pred hhhhhhcccccccccCCCCc--cEEEEcCCCCCccCCCCCcccccccCcccccccccCCCCEEEEEeCCCeEEEEecCCe
Confidence 34455555556899999999 9999999999999999743 234444442 46899999999999988755
Q ss_pred ceEeccCCCC--CCCCcc--------------------------ccc-ccc--------cCCceEEEeeCCCeeeeEEcc
Q 040687 72 QAFCWSSNSS--PGNTTD--------------------------LVP-SVY--------KNTAYSRIAAGTNHVCAVRGS 114 (740)
Q Consensus 72 ~~~cWg~~~~--~g~g~~--------------------------~~~-~~~--------~~~~~~~is~G~~h~Cal~~~ 114 (740)
+||||.|.+ +|.+.. ..| .+. .+..+.+|++|..|+|||.
T Consensus 88 -v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~~~~~~~~i~~va~G~~hs~alt-- 164 (473)
T 3of7_A 88 -VWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALF-- 164 (473)
T ss_dssp -EEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCHHHHTTCCEEEEEECSSEEEEEE--
T ss_pred -EEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCCcccCCCcEEEEEccCCEEEEEe--
Confidence 999999987 444321 134 221 2468999999999999999
Q ss_pred ccccCCCceeeecccccCCC--CccCccccccc--ccccccee-------eEEEEEecCCeeeeeeeCCeEEEecCCCCC
Q 040687 115 YYSYHDLGTVDCWDIVRKGN--NTLSSVQTNLF--YDEYVSTI-------VLKDVISGDGFSCGGVRDGGIVCWGPDSES 183 (740)
Q Consensus 115 ~~~~~~~g~v~cW~~~~~G~--n~~gqlg~~~~--~~~~~~~~-------~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~ 183 (740)
.+|+||+| |. |..||||.+.. .....|.. .+++|++|..|+|+|+.+|.|||||.|..+
T Consensus 165 -----~~G~vy~w-----G~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~G 234 (473)
T 3of7_A 165 -----SNGEVYAW-----GTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDEEGMVFAWGNGQQN 234 (473)
T ss_dssp -----TTSCEEEE-----ECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEEEETTSCEEEEECCTTS
T ss_pred -----CCCeEEEe-----eCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEEEeCCCeEEEEeCCCCC
Confidence 89999999 66 57899996421 12222222 389999999999999999999999999874
Q ss_pred -CCc-----------cC---CCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCC-----C--------------CCcc
Q 040687 184 -LGV-----------FN---VTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSV-----P--------------PVGI 229 (740)
Q Consensus 184 -~~~-----------~~---~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~-----~--------------~~~~ 229 (740)
++. .| ....+.+|++|.+|+|||. .+|+||+||.|.+||. . +...
T Consensus 235 qLG~~~~~~~~~~~~~p~~~~~~~v~~Ia~G~~hs~alt-~~G~v~~wG~n~~GqlG~~~~~~~~~~~~~P~~v~~~~~~ 313 (473)
T 3of7_A 235 QLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFALT-KDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNV 313 (473)
T ss_dssp TTSSCCCGGGTTTTCSCEECSCCSEEEEEECSSEEEEEE-TTSCEEEEEECTTSTTCCCSCCCTTCEEEEEEECCCCTTC
T ss_pred CCCCCccccccccccCceecCCcceEEEecCCCeEEEEe-cCCCEEEeCCCCCCCcCCCCcccCCceeeccccccccCCc
Confidence 221 11 1146899999999999995 5999999999999881 0 1124
Q ss_pred cEEEEecccceeeeeeecCCcEEecCCCCCCCCCCCC----------------------------ceEEEEecCceeeEE
Q 040687 230 RFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNS----------------------------GFMAIASSDFTTCGI 281 (740)
Q Consensus 230 ~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~~----------------------------~~~~i~ag~~~~Cg~ 281 (740)
.+++|++|.+|+++|+ .+|+||+||.|.+||+..+. .+.+|++|..|++++
T Consensus 314 ~i~~ia~G~~hs~~lt-~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~~v~~Ia~G~~hs~al 392 (473)
T 3of7_A 314 VIRSIAAGEHHSLILS-QDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFKSVAAGSHHSVAV 392 (473)
T ss_dssp CEEEEEECSSEEEEEE-TTSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCSSCCEEEEEECSSEEEEE
T ss_pred cEEEEEeCCCeEEEEe-CCCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCCCCceEEEEeCCCeEEEE
Confidence 6999999999999998 99999999999999874321 689999999999999
Q ss_pred EeCCceeecccccCCCCC
Q 040687 282 RENDLVLDCWFANVSSPT 299 (740)
Q Consensus 282 ~~~~~~~~cWG~n~~~~~ 299 (740)
+ +++.|++||.|..++.
T Consensus 393 ~-~~G~vy~wG~n~~GqL 409 (473)
T 3of7_A 393 A-QNGIAYSWGFGETYAV 409 (473)
T ss_dssp E-TTSCEEEEECCTTCTT
T ss_pred e-CCCcEEEeeCCCCCCC
Confidence 7 8889999999977663
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.63 Aligned_cols=180 Identities=22% Similarity=0.332 Sum_probs=156.6
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL 550 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (740)
.+....+.|+..++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+++ +|||||++++++.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 34456688999999999999999999864 36789999986542 345788999999998 6999999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecC
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFG 629 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFG 629 (740)
+.+..||||||+++|+|.+++. .+++.++..++.||+.||+|||+.+ ||||||||+|||++.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999994 4899999999999999999999999 9999999999999877 799999999
Q ss_pred CCccccC--------------------------------------------------CCCCCcccceehhHHHHHHHHhC
Q 040687 630 LLTSCER--------------------------------------------------DLTTDMKSDVHNFGIVLLEILSG 659 (740)
Q Consensus 630 la~~~~~--------------------------------------------------~~~~~~ksDVwSfGvvl~ElltG 659 (740)
+|+.... ...++.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9863211 12246789999999999999999
Q ss_pred CCCCCCC
Q 040687 660 RKAYDIE 666 (740)
Q Consensus 660 ~~p~~~~ 666 (740)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9999643
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=362.38 Aligned_cols=270 Identities=18% Similarity=0.261 Sum_probs=209.5
Q ss_pred ceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCC-----CceEEeccCCeEeEEecCCCceEeccCCCC--CCC
Q 040687 12 SFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIP-----SMAVLSGGEGLLCGILANTSQAFCWSSNSS--PGN 84 (740)
Q Consensus 12 ~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~-----~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~--~g~ 84 (740)
.++.+|.+|| +|||||.|.+||||.++.++...|..++ .+.+|++|..|+|+|..++. +|+||.|.+ +|.
T Consensus 11 ~~~~~l~~~G--~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~~~~~i~~i~~G~~~~~~l~~~G~-v~~wG~n~~GqLG~ 87 (389)
T 3kci_A 11 RENLYFQGSG--TIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQLIGGEQTLFAVTADGK-LYATGYGAGGRLGI 87 (389)
T ss_dssp ------------CEEEEEECTTSTTSSCSCSEEEEEEECHHHHHTCEEEEEEETTEEEEEETTSC-EEEEECCGGGTTSS
T ss_pred ccceeECCCC--eEEEeeCCCCccCCCCcCccccCCEecccccCCceEEEEeCCCeEEEEcCCCc-EEEEECCCCCCCCC
Confidence 4678999999 9999999999999988777777777663 45789999999999988865 999999987 444
Q ss_pred Ccc---ccc-ccc--cCC--ceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCcccccccccccccee---
Q 040687 85 TTD---LVP-SVY--KNT--AYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTI--- 153 (740)
Q Consensus 85 g~~---~~~-~~~--~~~--~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~~~--- 153 (740)
|.. ..| .+. ... .+.+|++|..|++||. .+|+||+| |.|..||||.+.......|..
T Consensus 88 g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al~-------~~G~v~~w-----G~n~~GqLG~g~~~~~~~p~~v~~ 155 (389)
T 3kci_A 88 GGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALS-------SEGEVYSW-----GEAEDGKLGHGNRSPCDRPRVIES 155 (389)
T ss_dssp SSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEEE-------TTSCEEEE-----ECCGGGTTCSSSCCCEEEEEECGG
T ss_pred CCcCCccCCEEcccccCCceeEEEECcCCCeEEEEc-------CCCCEEEE-----eCCCCCcCCCCCCccCcCCeEecc
Confidence 432 233 221 122 4478999999999999 89999999 999999999876544433332
Q ss_pred ----eEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCc-------------cCCCCcEEEEeeCC--ceeeeeecCCCcE
Q 040687 154 ----VLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGV-------------FNVTESFKVLASGK--SSLCGISELSGEV 213 (740)
Q Consensus 154 ----~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~-------------~~~~~~~~~iaaG~--~h~Cai~~~~g~v 213 (740)
.+++|++|..|+++|+.+|+|||||.|..+ ++. .....++.+|++|. .|+++| +.+|+|
T Consensus 156 l~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~~~~~v~~ia~G~g~~~t~~l-~~~G~v 234 (389)
T 3kci_A 156 LRGIEVVDVAAGGAHSACVTAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLCL-TDDDTV 234 (389)
T ss_dssp GTTSCEEEEEECSSEEEEEETTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECCSSCEEEEE-ETTTEE
T ss_pred cCCCeEEEEEeCcCeEEEEeCCCeEEEeCCCCCCCcCCCCCcccccceEecccCCCeEEEEEEcCCCcEEEEE-ccCCEE
Confidence 489999999999999999999999999764 111 11234688999995 899999 459999
Q ss_pred EEeecCCCCCC---------CC------CcccEEEEecccceeeeeeecCCcEEecCCCCCCCCCCC-------------
Q 040687 214 KCWGNNDFVSV---------PP------VGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKN------------- 265 (740)
Q Consensus 214 ~CWG~n~~g~~---------~~------~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~------------- 265 (740)
|+||.|.+||. .| ....+++|++|.+|+++|+ .||+|++||.|.++|+..+
T Consensus 235 ~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt-~~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~ 313 (389)
T 3kci_A 235 WSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALT-KSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQG 313 (389)
T ss_dssp EEEECCGGGTTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEE-TTSCEEEEECCGGGTTCSSSCCCEEEEEECGG
T ss_pred EEEeCCCCCCCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEe-CCCeEEEEeCCCCCCCCCCCCccccCCeEecc
Confidence 99999999881 11 1235999999999999998 9999999999999986432
Q ss_pred ---CceEEEEecCceeeEEEeCCceeecccccCCCCC
Q 040687 266 ---SGFMAIASSDFTTCGIRENDLVLDCWFANVSSPT 299 (740)
Q Consensus 266 ---~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~~ 299 (740)
..+.+|++|..|+++++ +++.|++||.|..++.
T Consensus 314 l~~~~v~~ia~G~~h~~al~-~~G~v~~wG~n~~GqL 349 (389)
T 3kci_A 314 LQGKKVIAIATGSLHCVCCT-EDGEVYTWGDNDEGQL 349 (389)
T ss_dssp GTTCCEEEEEECSSEEEEEE-TTCCEEEEECCTTSTT
T ss_pred CCCCCEEEEEeccCeEEEEC-CCCCEEEeeCCCCCcC
Confidence 35899999999999987 8899999999987764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=342.46 Aligned_cols=238 Identities=27% Similarity=0.444 Sum_probs=198.1
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..+.||+|+||.||++++.+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 357899999999999999999998899999999986542 34679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999877777999999999999999999999999 99999999999999999999999999864322
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||+| |+.||...... .....+... .....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~~~---------~~~~~ 228 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTG---------FRLYK 228 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTT---------CCCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHhcC---------ccCCC
Confidence 1233668999999999999999 99999643211 111111111 11111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
+......+.+++.+||+.||++||+++|+++.|+++.+.||
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~gl 269 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHccC
Confidence 22233478899999999999999999999999999999886
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=378.64 Aligned_cols=230 Identities=21% Similarity=0.311 Sum_probs=189.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||.||+++.+ +++.||||++..... ...+.+.+|+++|++|+|||||+|++++.+...+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 368999999999999999999985 489999999876542 33467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC--CCEEEeecCCCccccC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD--WGARIADFGLLTSCER- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~ki~DFGla~~~~~- 636 (740)
|||++|+|.++|......+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999999876667999999999999999999999999 9999999999999864 7899999999976543
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++|||||||+||||++|+.||..... .+ ....+... ....+.
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~~-~~~~i~~~--------~~~~~~ 377 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DE-TLRNVKSC--------DWNMDD 377 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HH-HHHHHHTT--------CCCCCS
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HH-HHHHHHhC--------CCCCCc
Confidence 23346789999999999999999999974321 11 11122111 111111
Q ss_pred --CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 --NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 --~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......++.+|+.+||+.||++||++.|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346779999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=349.74 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=195.9
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++....++|+..+.||+|+||+||+++. +++.||||++..........++|.+|+++|++++||||+++++++.+...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34444567899999999999999999987 68899999998766555556789999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLS--PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~--~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
.++||||+++++|.+++..... .+++..++.++.||++||+|||+.+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999986532 3899999999999999999999875 459999999999999999999999999986
Q ss_pred cccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 633 SCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 633 ~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.... ...++.++||||||+++|||+||+.||...... .. ...+.. ...
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~----~~~~~~------~~~ 256 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-QV----VAAVGF------KCK 256 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-HH----HHHHHH------SCC
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHh------cCC
Confidence 4322 122467999999999999999999999643211 11 111100 011
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
....+ .....++.+|+.+||+.||++|||+.||++.|+++++..
T Consensus 257 ~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 RLEIP--RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11222 233347889999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.80 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=197.0
Q ss_pred hcCccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.++|+..+.||+|+||.||++++. .+..||||+++... .....+.|.+|+++|++++||||+++++++.+....+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 457889999999999999999984 34569999997643 2344567999999999999999999999999988999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++++|.++++.....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999877678999999999999999999999999 99999999999999999999999999875432
Q ss_pred C------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 D------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ~------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ..++.++||||||+++|||++ |+.||...... .....+. .
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~---------~ 269 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSVE---------E 269 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHH---------T
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHH---------c
Confidence 1 122568999999999999999 99999643211 1111111 1
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+......+.+|+.+||+.||++||++.||++.|+++++.
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 122233334455788999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.05 Aligned_cols=238 Identities=28% Similarity=0.437 Sum_probs=195.1
Q ss_pred hcCccccceecccCceEEEEEEEe--------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV--------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
.++|+..+.||+|+||.||++++. ++..||||+++... .....+++.+|+++|+++ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467999999999999999999863 24579999997653 234557899999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNIL 616 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NIL 616 (740)
.+..+|||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999997543 34899999999999999999999999 999999999999
Q ss_pred ECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchh
Q 040687 617 LDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGI 672 (740)
Q Consensus 617 l~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~ 672 (740)
++.++.+||+|||+++.... ...++.++||||||++||||+| |+.||...... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-E- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-G-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-H-
Confidence 99999999999999874322 1123668999999999999999 99999643211 1
Q ss_pred HHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 673 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+... ...+.+.....++.+|+.+||+.||++||++.||++.|+++++.
T Consensus 314 ---~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 314 ---LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ---HHHHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11112111 11222233445788999999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.32 Aligned_cols=241 Identities=26% Similarity=0.331 Sum_probs=198.6
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
....++|...+.||+|+||.||+|++. +++.||||.++... ......+|.+|+++|++++||||+++++++...+..+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 344567999999999999999999986 68999999987542 2233457899999999999999999999999989999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++|+|.++++.....+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999865556999999999999999999999999 99999999999999999999999999865322
Q ss_pred C-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 D-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
. ..++.++||||||++||||+| |+.||..... ......+ ...
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~---------~~~ 331 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFV---------EKG 331 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHH---------HTT
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH---------HcC
Confidence 1 112568999999999999999 9999964321 1111111 122
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+......+.+||.+||+.||++|||+.+|++.|+++.+.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 22333334455788999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.19 Aligned_cols=262 Identities=33% Similarity=0.569 Sum_probs=210.8
Q ss_pred ccccChhHHHHhhcCcccc------ceecccCceEEEEEEEeCCcEEEEEEeccccc--chhcHHHHHHHHHHHHhCCCC
Q 040687 469 AQVFRLSELKDATNGFKEF------NELGRGSYGFVYKAVLVDGRQVAVKRANAATI--IHTNIREFEMELEVLCNIRHS 540 (740)
Q Consensus 469 ~~~~~~~~l~~~~~~~~~~------~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~--~~~~~~~~~~E~~~l~~l~H~ 540 (740)
...|++.+++.++++|... +.||+|+||.||+++. +++.||||++..... .....+.|.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3568899999999999887 8899999999999986 688999999875431 123356799999999999999
Q ss_pred CcceEEeEEEeCCeEEEEEecCCCCChHHhHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 040687 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGG--LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD 618 (740)
Q Consensus 541 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 618 (740)
||+++++++.+.+..++||||+++++|.+++... ..++++..++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 9999999999999999999999999999999743 246999999999999999999999998 99999999999999
Q ss_pred CCCCEEEeecCCCccccCC----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh
Q 040687 619 SDWGARIADFGLLTSCERD----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 619 ~~~~~ki~DFGla~~~~~~----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 676 (740)
+++.+||+|||++...... ..++.++||||||+++|||+||+.||+.......+....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 9999999999998654321 112568999999999999999999997644333222211
Q ss_pred hhHHh-hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 677 LPLIK-QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 677 ~~~~~-~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
..... ...+...++.... +........+.+++.+||+.||++||++++|++.|+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111 1122333443332 2344556788999999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=359.07 Aligned_cols=238 Identities=24% Similarity=0.364 Sum_probs=191.3
Q ss_pred hcCccccceecccCceEEEEEEEe----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.++|+..+.||+|+||.||+|++. ++..||||+++... .....++|.+|+++|++++||||+++++++.+....+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357999999999999999999975 46789999997643 2344568999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++++|.++++.....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999877667999999999999999999999998 99999999999999999999999999875432
Q ss_pred C------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 D------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ~------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ..++.++||||||++||||++ |+.||..... . .....+ +.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~----~~~~~i---------~~ 265 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-Q----DVIKAV---------DE 265 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-H----HHHHHH---------HT
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-H----HHHHHH---------Hc
Confidence 1 123568999999999999998 9999964321 1 111111 12
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+......+.+|+.+||+.||++||++.||++.|+++++.
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 222333334455788999999999999999999999999999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=341.34 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=194.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...+.||+|+||+||+++.. +++.||+|++.... ....+.|.+|+++|++++||||+++++++.+.+..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 56888999999999999999985 48899999886532 3456789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.+++......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999999876678999999999999999999999999 99999999999999999999999999864321
Q ss_pred -------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 637 -------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 637 -------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
...++.++||||||+++|||++|..|+........... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~ 236 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNV 236 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhh
Confidence 12236799999999999999999999864321111000 001
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.... ......+.+|+.+||+.||++|||+.|++++|+++.+.
T Consensus 237 ~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 237 RGFLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 11223577899999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=372.80 Aligned_cols=231 Identities=22% Similarity=0.265 Sum_probs=185.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh-cHHHHH---HHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-NIREFE---MELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..++||+|+||+||+++.. +++.||||++.+..+... ....+. .++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999985 489999999976543222 222333 4466777889999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++|+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 269 lVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999754 46999999999999999999999999 99999999999999999999999999875432
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++|||||||+||||++|+.||....... ..+ .. ..+....+..|
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~-i~--------~~i~~~~~~~p 414 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHE-ID--------RMTLTMAVELP 414 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHH-HH--------HHHHHCCCCCC
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHH-HH--------HhhcCCCCCCC
Confidence 1235779999999999999999999997533221 111 11 11222233333
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
.. ...++.+|+.+||+.||++|++ ++||.+
T Consensus 415 ~~--~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TT--SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cc--CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 32 2346789999999999999998 678765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=362.97 Aligned_cols=241 Identities=29% Similarity=0.425 Sum_probs=199.0
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-eEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-ERL 556 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~ 556 (740)
+...++|+..+.||+|+||.||++++ .++.||||+++... ..++|.+|+++|++++||||+++++++.+.. ..+
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34457789999999999999999987 47899999997643 3468999999999999999999999988765 789
Q ss_pred EEEecCCCCChHHhHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 557 LVYEFMPRGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
|||||+++|+|.++|+.... .+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999976433 4799999999999999999999999 9999999999999999999999999986433
Q ss_pred C------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 636 R------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 636 ~------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
. ...++.++||||||++||||+| |+.||....... + ...+. .....+
T Consensus 341 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~----~~~i~---------~~~~~~ 406 (450)
T 1k9a_A 341 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-V----VPRVE---------KGYKMD 406 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-H----HHHHH---------TTCCCC
T ss_pred ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-H----HHHHH---------cCCCCC
Confidence 2 1234679999999999999999 999997543211 1 11121 112223
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhccCC
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGLIL 740 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~~~ 740 (740)
.+......+.+||++||+.||++|||+.+|++.|+++.+..+.|
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l~l 450 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELHL 450 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTTTC
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhccC
Confidence 33344558889999999999999999999999999999877653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.99 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=196.7
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
+....++|+..+.||+|+||.||++++.+++.||||+++.... ..+++.+|++++++++||||+++++++.+....+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 3445578999999999999999999998888999999986542 3467999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++++|.+++......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999999875567999999999999999999999998 99999999999999999999999999864321
Q ss_pred ----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 ----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 ----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...++.++||||||+++|||+| |+.||...... .....+.. ..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~---------~~ 238 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQ---------GL 238 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHT---------TC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHHhc---------cc
Confidence 1224668999999999999999 99999643211 11111111 11
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
....+......+.+|+.+||+.||++||+++|+++.|++++++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11112222347889999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.15 Aligned_cols=249 Identities=28% Similarity=0.414 Sum_probs=194.9
Q ss_pred hcCccccceecccCceEEEEEEEe-----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~ 553 (740)
.++|+..++||+|+||+||++++. +++.||||++.... ....+.|.+|+++|++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 357899999999999999999852 58899999987543 34457899999999999999999999998654 4
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++||||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 589999999999999999876667999999999999999999999998 99999999999999999999999999875
Q ss_pred ccCC------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh----hHHhhCcc
Q 040687 634 CERD------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL----PLIKQGKA 685 (740)
Q Consensus 634 ~~~~------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~----~~~~~~~~ 685 (740)
.... ..++.++||||||+++|||+||..|+..... ....... ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHHHCTTCCTHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--HHHhhhcCccccchhHHHH
Confidence 4321 1236689999999999999999999863210 0000000 00000011
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.+......+.+.....++.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 112222233334444556888999999999999999999999999998764
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.13 Aligned_cols=260 Identities=16% Similarity=0.258 Sum_probs=210.4
Q ss_pred EecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCCCc-------eEEeccCCeEeEEecCCCceEeccCC
Q 040687 7 SFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSM-------AVLSGGEGLLCGILANTSQAFCWSSN 79 (740)
Q Consensus 7 ~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~~~-------~~i~~G~~~~Cal~~~~~~~~cWg~~ 79 (740)
+++|..|+|+|..+| +|||||.|.+||||.+++.+...|..++.+ .+|++|..|+|||..++. +|+||.|
T Consensus 58 i~~G~~~~~~l~~~G--~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al~~~G~-v~~wG~n 134 (389)
T 3kci_A 58 LIGGEQTLFAVTADG--KLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALSSEGE-VYSWGEA 134 (389)
T ss_dssp EEEETTEEEEEETTS--CEEEEECCGGGTTSSSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEEETTSC-EEEEECC
T ss_pred EEeCCCeEEEEcCCC--cEEEEECCCCCCCCCCCcCCccCCEEcccccCCceeEEEECcCCCeEEEEcCCCC-EEEEeCC
Confidence 344448999999999 999999999999999988887777776422 578999999999988754 9999999
Q ss_pred CC--CCCCcc---ccc-c--cccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccccccc
Q 040687 80 SS--PGNTTD---LVP-S--VYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVS 151 (740)
Q Consensus 80 ~~--~g~g~~---~~~-~--~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~ 151 (740)
.+ +|.+.. ..| . .+.+..+.+|++|..|++||. .+|+||+| |.|.+||||.+...+...|
T Consensus 135 ~~GqLG~g~~~~~~~p~~v~~l~~~~i~~va~G~~hs~alt-------~~G~v~~w-----G~n~~GqLG~~~~~~~~~p 202 (389)
T 3kci_A 135 EDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVT-------AAGDLYTW-----GKGRYGRLGHSDSEDQLKP 202 (389)
T ss_dssp GGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEE-------TTSCEEEE-----ECCGGGTTCSSSCCCEEEE
T ss_pred CCCcCCCCCCccCcCCeEecccCCCeEEEEEeCcCeEEEEe-------CCCeEEEe-----CCCCCCCcCCCCCcccccc
Confidence 86 444432 234 2 223457999999999999999 89999999 9999999998865555444
Q ss_pred ee-------eEEEEEecC--CeeeeeeeCCeEEEecCCCCC-CCc-------c------CCCCcEEEEeeCCceeeeeec
Q 040687 152 TI-------VLKDVISGD--GFSCGGVRDGGIVCWGPDSES-LGV-------F------NVTESFKVLASGKSSLCGISE 208 (740)
Q Consensus 152 ~~-------~~~~ia~G~--~~~C~l~~~g~v~CwG~~~~~-~~~-------~------~~~~~~~~iaaG~~h~Cai~~ 208 (740)
.. .+++|++|. .|+++|+.+|+|+|||.|.++ ++. . .....+.+|++|.+|+++| +
T Consensus 203 ~~v~~~~~~~v~~ia~G~g~~~t~~l~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~al-t 281 (389)
T 3kci_A 203 KLVEALQGHRVVDIACGSGDAQTLCLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVAL-T 281 (389)
T ss_dssp EECGGGTTSCEEEEEECCSSCEEEEEETTTEEEEEECCGGGTTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEE-E
T ss_pred eEecccCCCeEEEEEEcCCCcEEEEEccCCEEEEEeCCCCCCCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEE-e
Confidence 43 388999984 899999999999999999774 211 0 1123589999999999999 4
Q ss_pred CCCcEEEeecCCCCCC-------------C--CCcccEEEEecccceeeeeeecCCcEEecCCCCCCCCCCC--------
Q 040687 209 LSGEVKCWGNNDFVSV-------------P--PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKN-------- 265 (740)
Q Consensus 209 ~~g~v~CWG~n~~g~~-------------~--~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~-------- 265 (740)
.+|+|++||.|.+||. + .....+++|++|..|+++|+ +||+|||||.|.+||+..+
T Consensus 282 ~~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~ia~G~~h~~al~-~~G~v~~wG~n~~GqLG~g~~~~~~~P 360 (389)
T 3kci_A 282 KSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCT-EDGEVYTWGDNDEGQLGDGTTNAIQRP 360 (389)
T ss_dssp TTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEE-TTCCEEEEECCTTSTTCSSSCCCEEEE
T ss_pred CCCeEEEEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEEEeccCeEEEEC-CCCCEEEeeCCCCCcCCCCCCCCccCc
Confidence 5999999999998881 1 11246999999999999998 9999999999999996433
Q ss_pred --------CceEEEEecCceeeEEEe
Q 040687 266 --------SGFMAIASSDFTTCGIRE 283 (740)
Q Consensus 266 --------~~~~~i~ag~~~~Cg~~~ 283 (740)
..+.+|++|..||+++..
T Consensus 361 ~~v~~~~~~~v~~va~G~~ht~al~~ 386 (389)
T 3kci_A 361 RLVAALQGKKVNRVACGSAHTLAWST 386 (389)
T ss_dssp EECGGGTTSCCCEEEEETTEEEEECC
T ss_pred EEecccCCCCEEEEEecCCcEEEEec
Confidence 248899999999999973
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=367.71 Aligned_cols=241 Identities=28% Similarity=0.418 Sum_probs=199.5
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG 553 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (740)
..+++...++|+..++||+|+||+||+|++.++..||||+++... ...++|.+|+++|++++||||+++++++. .+
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 344556678899999999999999999999888999999998643 34578999999999999999999999986 56
Q ss_pred eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..+|||||+++|+|.++|+... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 7899999999999999997542 35899999999999999999999998 9999999999999999999999999987
Q ss_pred cccC----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 633 SCER----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 633 ~~~~----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
.... ...++.++||||||++||||+| |+.||..... . .....+.
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~----~~~~~i~-------- 399 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-P----EVIRALE-------- 399 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-H----HHHHHHH--------
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-H----HHHHHHH--------
Confidence 5432 1223678999999999999999 9999964321 1 1111111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.....+.+.....++.+||.+||+.||++|||+++|++.|+++..
T Consensus 400 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 400 -RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 122333344455688899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.42 Aligned_cols=230 Identities=23% Similarity=0.353 Sum_probs=191.2
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..+.||+|+||.||+++. .+++.||||++..........+.+.+|+++|++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999998 4689999999987655455567799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999754 46999999999999999999999999 999999999999999999999999998654321
Q ss_pred -------------------CC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 -------------------LT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 -------------------~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
.. .+.++||||||++||||+||+.||+... ..+ .... +.......|.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~-~~~~--------i~~~~~~~p~ 235 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----LKE-LRER--------VLRGKYRIPF 235 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHH--------HHHCCCCCCT
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC----HHH-HHHH--------HHhCCCCCCC
Confidence 11 2468999999999999999999997432 111 1111 1222233333
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ...++.+|+.+||+.||++|||++|+++
T Consensus 236 ~--~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 236 Y--MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp T--SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C--CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2 2336779999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=335.50 Aligned_cols=237 Identities=26% Similarity=0.396 Sum_probs=195.1
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..++|+..+.||+|+||.||++++.++..||+|+++.... ..+++.+|++++++++||||+++++++.+....++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 3467999999999999999999998888999999976542 3467999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999999876556999999999999999999999998 999999999999999999999999998644321
Q ss_pred --------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
..++.++||||||+++|||+| |+.||+...... ....+... ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~---------~~~~ 225 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQG---------HRLY 225 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTT---------CCCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHHHcC---------CCCC
Confidence 123568999999999999999 999996432111 11111111 1111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+......+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1122234688999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=343.54 Aligned_cols=249 Identities=25% Similarity=0.312 Sum_probs=190.6
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC----eE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----ER 555 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 555 (740)
..++|+..++||+|+||+||++++. ++.||||++.... .....+..|+.+|++++||||+++++++.... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 3467999999999999999999874 7899999987543 23345677999999999999999999998754 47
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCEEECCCCCEEE
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD----------AAPPIIHRDVKTLNILLDSDWGARI 625 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------~~~~iiHrDlk~~NILl~~~~~~ki 625 (740)
+|||||+++|+|.++++.. .+++.+++.++.|+++||+|||+. + |+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999999764 499999999999999999999998 7 999999999999999999999
Q ss_pred eecCCCccccCCC----------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCch--hHHh
Q 040687 626 ADFGLLTSCERDL----------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG--IVEW 675 (740)
Q Consensus 626 ~DFGla~~~~~~~----------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~--~~~~ 675 (740)
+|||+++...... .++.++||||||+++|||+||+.||........ ....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 9999986432211 112467999999999999999999975432211 1100
Q ss_pred hhhHHhhCccch-hcccccCCC-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 676 ALPLIKQGKAAA-IIDRNVALP-----RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 676 ~~~~~~~~~~~~-i~d~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
............ +........ .......++.+|+++||+.||++|||+.||++.|+++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000000000000 111111111 12234556899999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=332.19 Aligned_cols=238 Identities=27% Similarity=0.444 Sum_probs=197.2
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..+.||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 357889999999999999999998889999999986542 34679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999876667999999999999999999999999 99999999999999999999999999865421
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||+| |+.||..... .+ ....+... .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~-~~~~i~~~---------~~~~~ 226 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SE-VVEDISTG---------FRLYK 226 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH-HHHHHHTT---------CCCCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----HH-HHHHHhcC---------CcCCC
Confidence 1223568999999999999999 8999964321 11 11111111 11111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
+......+.+++.+||+.||++||++.|+++.|+++.+++|
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~l 267 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 22233478899999999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.98 Aligned_cols=236 Identities=26% Similarity=0.426 Sum_probs=189.2
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||+||+|++.. ++ +||+|.+.... .....++|.+|+.++++++||||+++++++.+.. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 568999999999999999999743 43 46888876543 2345578999999999999999999999998754 77
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+|+||+++|+|.+++......+++..++.|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999877778999999999999999999999998 99999999999999999999999999764321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+| |+.||+..... . +...+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~-------------~~~~~~~~ 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-------------ISSILEKG 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G-------------HHHHHHTT
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-H-------------HHHHHHcC
Confidence 1223678999999999999999 99999743211 1 11122222
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+.....++.+|+.+||+.||++||++.||++.|+++.++
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 22333334455788999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=368.45 Aligned_cols=240 Identities=28% Similarity=0.426 Sum_probs=199.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
++...++|+..++||+|+||.||+|++.. +..||||+++... ...++|.+|+++|++++||||+++++++.+....
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 33445678999999999999999999865 8899999997643 3457899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 556 LLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+|||||+++|+|.++|+.. ...+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999753 346899999999999999999999999 999999999999999999999999998754
Q ss_pred cCC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 635 ERD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 635 ~~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
... ..++.++||||||++||||+| |+.||...... . +.. .+..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~----~~~---------~~~~ 434 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-Q----VYE---------LLEK 434 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-G----HHH---------HHHT
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-H----HHH---------HHHc
Confidence 321 112568999999999999999 99999643211 1 111 1222
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+.....++.+||.+||+.||++||++.+|++.|+++.++
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 233333444456788999999999999999999999999987644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.05 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=197.6
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (740)
++....++|...+.||+|+||.||+++.. +++.||||++.... .....+.+.+|+++|++++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 33445678999999999999999999863 34789999987543 234457899999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGL-----------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPII 606 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ii 606 (740)
.+.+..++||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 99999999999999999999997542 23899999999999999999999999 99
Q ss_pred ecCCCCCCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCC
Q 040687 607 HRDVKTLNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKA 662 (740)
Q Consensus 607 HrDlk~~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p 662 (740)
||||||+|||+++++.+||+|||++...... ..++.++||||||+++|||+| |+.|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654221 112568999999999999999 9999
Q ss_pred CCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 663 YDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
|...... . ....+... ...+.+......+.+|+.+||+.||++||++.||++.|++++++.
T Consensus 253 ~~~~~~~-~----~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 253 YPGIPPE-R----LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp STTCCGG-G----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCHH-H----HHHHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 9643211 1 11112111 111222233457889999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.90 Aligned_cols=249 Identities=30% Similarity=0.426 Sum_probs=201.3
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcce
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVN 544 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 544 (740)
+...+++...++|+..+.||+|+||.||++++. +++.||||+++.... ....+.|.+|+++|.++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceee
Confidence 456677778899999999999999999999853 357899999976432 33456799999999999 8999999
Q ss_pred EEeEEEeCC-eEEEEEecCCCCChHHhHhCCCC-----------------------------------------------
Q 040687 545 LLGYCLEMG-ERLLVYEFMPRGTLHDHLHGGLS----------------------------------------------- 576 (740)
Q Consensus 545 l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 576 (740)
+++++.+.+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998765 48999999999999999976432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 577 ------------------PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 577 ------------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
.+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1899999999999999999999998 99999999999999999999999999865422
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...++.++||||||+++|||+| |+.||........+. ..+... ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~---------~~ 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEG---------TR 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH----HHHHHT---------CC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH----HHHHcC---------CC
Confidence 1223679999999999999999 999997544332221 111111 11
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
.+.+.....++.+++.+||+.||++||++.||++.|+++++..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1122223347889999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.91 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=191.2
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..++|+..++||+|+||+||+++..+++.||+|++..........+.+.+|+++|++++||||+++++++.+....+|||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34779999999999999999999988999999999765543344567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||++ ++|.+++......+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9997 5999999877677999999999999999999999998 99999999999999999999999999865321
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc---ch------h
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA---AA------I 688 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------i 688 (740)
...++.++||||||+++|||++|+.||........+.. .......... .. .
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTTSGGGTTSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHHhhhhhccchh
Confidence 12346789999999999999999999976543332221 1111110000 00 0
Q ss_pred cccccCC--CC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 689 IDRNVAL--PR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 689 ~d~~~~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.+..... .. ......++.+|+.+||+.||++|||++|+++ ++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 0000000 00 0112246789999999999999999999987 4443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.93 Aligned_cols=241 Identities=29% Similarity=0.423 Sum_probs=196.7
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGY 548 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 548 (740)
+...++|...++||+|+||+||+++... +..||||+++... .....+++.+|+++++++ +||||++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 4455789999999999999999999632 3579999997653 234457899999999999 99999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
+...+..+|||||+++|+|.+++.... ..+++.+++.|+.||++||+|||+.+ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 999999999999999999999997543 35899999999999999999999998 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVP 669 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 669 (740)
|||+++++.+||+|||+++.... ...++.++||||||+++|||+| |+.||.....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~- 299 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 299 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999875432 1123568999999999999999 9999964321
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+.....+... ...+.+.....++.+|+.+||+.||++||+++||++.|++++..
T Consensus 300 ----~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 ----EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ----HHHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111222211 11222233345788999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=333.21 Aligned_cols=230 Identities=23% Similarity=0.347 Sum_probs=188.7
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..++||+|+||+||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 346799999999999999999996 458999999987654 23456789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999999764 5899999999999999999999998 99999999999999999999999999765432
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||+||+.||...... +........ .......
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~--------~~~~~~~ 238 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIATN--------GTPELQN 238 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHH--------CSCCCSC
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC--------CCCCCCC
Confidence 122467899999999999999999999643211 111111111 1111122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+......+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2333457889999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=362.02 Aligned_cols=240 Identities=28% Similarity=0.423 Sum_probs=195.9
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++...++|+..++||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3445567899999999999999999999888889999998654 234689999999999999999999999876 678
Q ss_pred EEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+|||||+++|+|.++|+... ..+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999997432 45899999999999999999999999 999999999999999999999999998754
Q ss_pred cCC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 635 ERD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 635 ~~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
... ..++.++||||||++||||+| |+.||..... ......+. .
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~---------~ 396 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVE---------R 396 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHH---------T
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH---------c
Confidence 321 123668999999999999999 9999964321 11111111 1
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+......+.+||.+||+.||++|||+++|++.|+++...
T Consensus 397 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 222333344556788999999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.98 Aligned_cols=239 Identities=20% Similarity=0.329 Sum_probs=193.2
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 559 (740)
++|+..+.||+|+||.||++++ +++.||||+++.........+.|.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5688999999999999999998 488999999987655455567899999999999999999999999877 6789999
Q ss_pred ecCCCCChHHhHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 560 EFMPRGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~-~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
||+++++|.++++.... .+++.+++.++.|+++||+|||+.+ ++|+||||||+|||++.++.+||.||+++......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~ 167 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG 167 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTT
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecccC
Confidence 99999999999987543 5899999999999999999999865 45999999999999999999999988876433211
Q ss_pred ------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 638 ------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 638 ------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...+.++||||||+++|||+||+.||...... +...... ......+.+.
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~---------~~~~~~~~~~ 234 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----EIGMKVA---------LEGLRPTIPP 234 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH----HHHHHHH---------HSCCCCCCCT
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH----HHHHHHH---------hcCCCCCCCC
Confidence 01123799999999999999999999643211 1111111 1111122222
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.....+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 334578899999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.75 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=185.2
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCC----cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDG----RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g----~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
++....++|+..+.||+|+||.||++++... ..||||.++.........++|.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3444567899999999999999999996542 279999998765445566789999999999999999999999987
Q ss_pred CCeE------EEEEecCCCCChHHhHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 552 MGER------LLVYEFMPRGTLHDHLHGGL-----SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 552 ~~~~------~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
.... ++||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7654 99999999999999995321 25899999999999999999999999 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 676 (740)
+.+||+|||++..... ...++.++||||||+++|||+| |+.||....... +
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~---- 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-I---- 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-H----
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-H----
Confidence 9999999999865322 1123678999999999999999 999997533211 1
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.. ....+.+.....++.+|+.+||+.||++|||+.++++.|+++++.
T Consensus 249 ~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 YNYLIG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111 111122233345788999999999999999999999999998864
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=342.80 Aligned_cols=263 Identities=16% Similarity=0.169 Sum_probs=209.7
Q ss_pred eEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCC--CCccccCC---CceEEeccCCeEeEEecCCCceEeccC-
Q 040687 5 SASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSAN--SASFSNIP---SMAVLSGGEGLLCGILANTSQAFCWSS- 78 (740)
Q Consensus 5 ~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~--~~~~~~v~---~~~~i~~G~~~~Cal~~~~~~~~cWg~- 78 (740)
+++.|+ .|+|+|..|| .|||||.|.+||||.+++.+ ...|..|. .+..|++|..|+|+|..++. +|+||.
T Consensus 79 ~va~G~-~h~~~l~~~G--~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al~~~G~-v~~wG~~ 154 (423)
T 3mvd_K 79 DISAGG-MHNLVLTKSG--DIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLEDGR-VFAWGSF 154 (423)
T ss_dssp EEEECS-SEEEEEETTS--CEEEEECCSSSTTCSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEEETTSC-EEEEECE
T ss_pred EEeeCC-CeEEEEeCCC--eEEEeECCCCcCCCCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEEeCCCe-EEEEeCC
Confidence 345554 8999999999 99999999999999987765 45666662 57899999999999988755 999998
Q ss_pred -CCC--CCCCcc---ccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCcccccccc-----
Q 040687 79 -NSS--PGNTTD---LVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFY----- 146 (740)
Q Consensus 79 -~~~--~g~g~~---~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~----- 146 (740)
|.+ +|.+.. ..| .+..+..+.+|++|..|+|||. .+|+||+| |.|.+||||.+...
T Consensus 155 ~n~~GqlG~~~~~~~~~p~~~~~~~~i~~va~G~~hs~alt-------~~G~v~~w-----G~n~~GqLG~~~~~~~~~~ 222 (423)
T 3mvd_K 155 RDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILT-------TAGKVFTV-----GCAEQGQLGRLSERSISGE 222 (423)
T ss_dssp ECSSSEEESBTTBCEEEEEESSTTCCEEEEEECSSEEEEEE-------TTSCEEEE-----ECCTTSTTSSCCTTTTTSC
T ss_pred CCCCCCcCcCCCCCCceeeEecCCCcEEEEecCCCeEEEEe-------cCCeEEEe-----eCCcCCccCCCcccccccc
Confidence 765 222211 344 4555678999999999999999 89999999 99999999986431
Q ss_pred ------cccccee-------eEEEEEecCCeeeee-eeCCeEEEecCCCCC-CCccC------------CCCcEEEEeeC
Q 040687 147 ------DEYVSTI-------VLKDVISGDGFSCGG-VRDGGIVCWGPDSES-LGVFN------------VTESFKVLASG 199 (740)
Q Consensus 147 ------~~~~~~~-------~~~~ia~G~~~~C~l-~~~g~v~CwG~~~~~-~~~~~------------~~~~~~~iaaG 199 (740)
+...|.. .+.+|++|..|++++ +.+|.|+|||.|.++ ++... ....+.+|++|
T Consensus 223 ~~~~~~~~~~p~~v~~~~~~~v~~i~~g~~~~~~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G 302 (423)
T 3mvd_K 223 GRRGKRDLLRPTQLIITRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGG 302 (423)
T ss_dssp STTTTTTTSSCEEECCTTCCCEEEEEEETTEEEEEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEEC
T ss_pred cccccccccCCeEEeecCCccEEEEEECCcEEEEEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcc
Confidence 1223322 389999999999999 479999999999875 22211 12468999999
Q ss_pred CceeeeeecCCCcEEEeecCCCCCC--------------CCC-cccEEEEecccceeeeeeecCCcEEecCCCCCCCCCC
Q 040687 200 KSSLCGISELSGEVKCWGNNDFVSV--------------PPV-GIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPK 264 (740)
Q Consensus 200 ~~h~Cai~~~~g~v~CWG~n~~g~~--------------~~~-~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~ 264 (740)
..|+|+|. .+|+|||||.|.+||. ++. ...+++|++|.+|+|+|+ .||+|||||.|.+||+..
T Consensus 303 ~~ht~alt-~~G~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~~v~~ia~G~~hs~alt-~~G~v~~wG~n~~GqLG~ 380 (423)
T 3mvd_K 303 QHHTVILT-TDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEVCSYAVT-IDGKLYSWGSGVNNQLGV 380 (423)
T ss_dssp SSEEEEEE-TTCCEEEEECCGGGTTCSSSCCSCEEEEEECTTCCSCEEEEEEETTEEEEEE-TTSCEEEEECCTTSCSSS
T ss_pred cCeEEEEe-CCCcEEEEECCCCCCCCCCCccccccCceEeccCCCCEEEEEcCCCeEEEEc-CCCCEEEECCCCCCCCCC
Confidence 99999995 5999999999999881 111 126999999999999998 999999999999998532
Q ss_pred ------------------CCceEEEEecCceeeEEEeCC
Q 040687 265 ------------------NSGFMAIASSDFTTCGIREND 285 (740)
Q Consensus 265 ------------------~~~~~~i~ag~~~~Cg~~~~~ 285 (740)
+..+.+|++|..|+++++.++
T Consensus 381 g~~~~~~~P~~v~~~~~~~~~v~~va~G~~ht~~l~~~~ 419 (423)
T 3mvd_K 381 GDGDDELEPIVVVSKNTQGKHMLLASGGGQHAIFLVKAD 419 (423)
T ss_dssp SSSCCEEEEEECCSTTTTTCCEEEEEECSSEEEEEEECC
T ss_pred CCCCCcccCeEEeCcccCCCEEEEEEECCCcEEEEEccc
Confidence 235899999999999998554
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.80 Aligned_cols=241 Identities=18% Similarity=0.289 Sum_probs=199.9
Q ss_pred eeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCCCceEEeccCCeEeEEecCCCceEeccCCCCCC
Q 040687 4 ISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGEGLLCGILANTSQAFCWSSNSSPG 83 (740)
Q Consensus 4 ~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~~g 83 (740)
|..++.|..|+|+|. || .||+||.|.+||||.+.. ....+..|++|..|+++|. + +++|+||.|.+
T Consensus 26 i~~ia~G~~h~~~l~-~G--~v~~wG~n~~Gqlg~p~~-------~~~~i~~ia~G~~hs~~l~-~-G~v~~wG~n~~-- 91 (282)
T 3qhy_B 26 VDAIAGGYFHGLALK-GG--KVLGWGANLNGQLTMPAA-------TQSGVDAIAAGNYHSLALK-D-GEVIAWGGNED-- 91 (282)
T ss_dssp CCEEEECSSEEEEEE-TT--EEEEEECCSSSTTSCCGG-------GGSCCCEEEECSSEEEEEE-T-TEEEEEECCTT--
T ss_pred CcEEEeCCCeEEEEE-CC--EEEEEeCCCCCCCCCCcc-------CCCCEEEEEeCCCEEEEEE-C-CEEEEeeCCCC--
Confidence 334445558999997 88 999999999999996521 1136788999999999995 5 46999999987
Q ss_pred CCccccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccccccceeeEEEEEecC
Q 040687 84 NTTDLVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGD 162 (740)
Q Consensus 84 ~g~~~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~ia~G~ 162 (740)
||+.+| .+ ...+.+|++|..|+++|+ +|+||+| |.|..|||+..... ...+++|++|.
T Consensus 92 -Gqlg~P~~~--~~~v~~ia~G~~hs~al~--------~G~v~~w-----G~n~~gqlg~~~~~-----~~~i~~i~~G~ 150 (282)
T 3qhy_B 92 -GQTTVPAEA--RSGVDAIAAGAWASYALK--------DGKVIAW-----GDDSDGQTTVPAEA-----QSGVTALDGGV 150 (282)
T ss_dssp -STTCCCGGG--SSSEEEEEEETTEEEEEE--------TTEEEEE-----ECCTTSTTSCCGGG-----GSSEEEEEECS
T ss_pred -CCCCCCccc--CCCeEEEECcCCEEEEEe--------CCeEEEe-----cCCCCCcCCCCccC-----CCCeEEEEccc
Confidence 777778 33 357999999999999997 5899999 99999999843221 22489999999
Q ss_pred CeeeeeeeCCeEEEecCCCCCCCccC--CCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCC---CCCcccEEEEecc
Q 040687 163 GFSCGGVRDGGIVCWGPDSESLGVFN--VTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSV---PPVGIRFVSLAAG 237 (740)
Q Consensus 163 ~~~C~l~~~g~v~CwG~~~~~~~~~~--~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~---~~~~~~~~~la~G 237 (740)
.|+|+++ +|+|++||.|..+.-..| ....+.+|++|.+|+|+| + ||+|++||.|.++|. .+....+++|++|
T Consensus 151 ~~~~~l~-~G~v~~wG~n~~gqlg~p~~~~~~v~~i~~G~~hs~al-~-~G~v~~wG~n~~gqlg~p~~~~~~v~~i~~G 227 (282)
T 3qhy_B 151 YTALAVK-NGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLAL-K-DGKVIAWGDNRYKQTTVPTEALSGVSAIASG 227 (282)
T ss_dssp SEEEEEE-TTEEEEEECCTTSTTSCCGGGGSSEEEEEECSSEEEEE-E-TTEEEEEECCTTSTTCCCGGGGSSCCEEEEC
T ss_pred CEEEEEE-CCEEEEecCCCCCCCCCceecCCCeEEEEecCCEEEEE-E-CCeEEEEECCCCCCCCCCcccCCCceEEEcC
Confidence 9999998 899999999987532222 235799999999999999 6 899999999999984 2234679999999
Q ss_pred cceeeeeeecCCcEEecCCCCCCCCCCCCceEEEEecCceeeEEEeC
Q 040687 238 ANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIREN 284 (740)
Q Consensus 238 ~~h~C~l~~~~g~v~CWG~~~~g~~~~~~~~~~i~ag~~~~Cg~~~~ 284 (740)
.+|+|+|+ ||+|++||.|.++|......+.+|++|..|+|+|+.+
T Consensus 228 ~~h~~al~--~g~v~~wG~n~~gq~~v~~~v~~iaaG~~h~~al~~~ 272 (282)
T 3qhy_B 228 EWYSLALK--NGKVIAWGSSRTAPSSVQSGVSSIEAGPNAAYALKGG 272 (282)
T ss_dssp SSCEEEEE--TTEEEEESTTCCCCGGGSSCEEEEEECSSCEEEEEC-
T ss_pred CCEEEEEE--CCEEEEecCCCCccccCCCCcEEEEECcCeEEEEecC
Confidence 99999997 9999999999999987778999999999999999843
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.31 Aligned_cols=251 Identities=21% Similarity=0.245 Sum_probs=197.0
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC--eEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG--ERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 558 (740)
++|...+.||+|+||+||+++... ++.||||+++.... ....+.+.+|+++|++++||||+++++++.... ..+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 568999999999999999999864 89999999976543 234577899999999999999999999998765 78999
Q ss_pred EecCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCCEEEeecCCCc
Q 040687 559 YEFMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL----DSDWGARIADFGLLT 632 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DFGla~ 632 (740)
|||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998643 23899999999999999999999999 9999999999999 888889999999986
Q ss_pred cccC----------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 633 SCER----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 633 ~~~~----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
.... ...++.++||||||+++|||+||+.||.....+....+.....+....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 5322 133467899999999999999999999754433333333333332211
Q ss_pred cch------h----cc--cccCC--CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 685 AAA------I----ID--RNVAL--PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 685 ~~~------i----~d--~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
... . ++ ..... .........+.+++++||+.||++|||++|+++...+-...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 100 0 00 01111 12344556788999999999999999999999987765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.42 Aligned_cols=238 Identities=23% Similarity=0.330 Sum_probs=187.1
Q ss_pred hhcCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
..++|+..+.||+|+||.||+++... +..||+|++.... .....+.|.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34679999999999999999999743 4579999987543 2334567999999999999999999999984 4578
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 8999999999999999876667999999999999999999999998 9999999999999999999999999986543
Q ss_pred CC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 636 RD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 636 ~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
.. ..++.++||||||+++|||++ |+.||...... .. ...+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~----~~~i~~~--------- 233 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DV----IGRIENG--------- 233 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GH----HHHHHTT---------
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HH----HHHHHcC---------
Confidence 21 223568999999999999997 99999743221 11 1111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+......+.+++.+||+.||++||++.||++.|++++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11122223345788999999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.73 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=193.9
Q ss_pred cccChhHHHHhhcC----------ccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC
Q 040687 470 QVFRLSELKDATNG----------FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR 538 (740)
Q Consensus 470 ~~~~~~~l~~~~~~----------~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~ 538 (740)
..++.++++.+++. |+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+|++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCC
Confidence 34677777777764 677789999999999999986 69999999987544 334567999999999999
Q ss_pred CCCcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC
Q 040687 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD 618 (740)
Q Consensus 539 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~ 618 (740)
||||+++++++...+..+|||||+++++|.+++... .+++.++..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999999999753 5999999999999999999999998 99999999999999
Q ss_pred CCCCEEEeecCCCccccCC---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh
Q 040687 619 SDWGARIADFGLLTSCERD---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 619 ~~~~~ki~DFGla~~~~~~---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 677 (740)
.++.+||+|||++...... ..++.++||||||+++|||++|+.||..... .+ ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~-~~ 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQ-AM 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH-HH
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH-HH
Confidence 9999999999998654321 1236789999999999999999999964321 11 11
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+..... + ...........+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~~~~~~-----~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KRLRDSPP-----P--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHSSC-----C--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcCCC-----C--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111110 0 11112223346889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=343.26 Aligned_cols=249 Identities=18% Similarity=0.225 Sum_probs=193.9
Q ss_pred hhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchh---------cHHHHHHHHHHHHhCCCCCcce
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHT---------NIREFEMELEVLCNIRHSNIVN 544 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~ 544 (740)
..++|+..+.||+|+||.||++++.. ++.||||++........ ....+..|+..+++++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999865 47899999875431100 1123455667778889999999
Q ss_pred EEeEEEeC----CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--
Q 040687 545 LLGYCLEM----GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-- 618 (740)
Q Consensus 545 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-- 618 (740)
+++++... ...+|||||+ +++|.+++......+++.+++.|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 99998765 4589999999 99999999876678999999999999999999999998 99999999999999
Q ss_pred CCCCEEEeecCCCccccC----------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc
Q 040687 619 SDWGARIADFGLLTSCER----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP 670 (740)
Q Consensus 619 ~~~~~ki~DFGla~~~~~----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 670 (740)
.++.+||+|||+++.... ...++.++||||||++||||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999864321 1123568999999999999999999998544333
Q ss_pred hhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 671 GIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 671 ~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.......... ...+..+++..+..+ ....++.+++..||+.||++||++.+|++.|++++++
T Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 KYVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 3332222222 223444444443222 2234688999999999999999999999999998875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=328.24 Aligned_cols=237 Identities=29% Similarity=0.415 Sum_probs=184.1
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccc--hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATII--HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||++++ .++.||||+++..... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35789999999999999999997 4889999998764322 22356799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--------CCCEEEeecCC
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS--------DWGARIADFGL 630 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--------~~~~ki~DFGl 630 (740)
|||+++++|.+++.. ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999965 36999999999999999999999998667999999999999986 67899999999
Q ss_pred CccccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 631 LTSCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 631 a~~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
+...... ..++.++||||||+++|||+||+.||...... .. .. .+...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~-~~--------~~~~~ 229 (271)
T 3dtc_A 163 AREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AV-AY--------GVAMN 229 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HH-HH--------HHHTS
T ss_pred ccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH-HH--------hhhcC
Confidence 8654321 22467899999999999999999999643211 00 01 11111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
....+.+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 222222333445788999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.60 Aligned_cols=242 Identities=28% Similarity=0.460 Sum_probs=188.5
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..++|+..++||+|+||+||++++. ..||||+++.........+.|.+|+++|++++||||++++++.. ....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 3467999999999999999999853 46999999876544555678999999999999999999999754 45688999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999877678999999999999999999999999 99999999999999999999999999864321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...++.++||||||+++|||++|+.||........+ ...+........+.
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~--- 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI----IEMVGRGSLSPDLS--- 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH----HHHHHHTSCCCCTT---
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH----HHHhcccccCcchh---
Confidence 122355899999999999999999999754322222 12222211111000
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.........+.+|+.+||+.||++||++.||++.|+++.++
T Consensus 249 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 249 --KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp --SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred --hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 01123345788999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.38 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=197.8
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
..+....++|+..+.||+|+||.||+++... ++.||||.++.... ....+.|.+|++++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445567889999999999999999999853 47899999976432 3345679999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGL-----------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 605 (740)
+.+.+..+|||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 999999999999999999999997532 46899999999999999999999999 9
Q ss_pred EecCCCCCCEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCC
Q 040687 606 IHRDVKTLNILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRK 661 (740)
Q Consensus 606 iHrDlk~~NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~ 661 (740)
+||||||+|||++.++.+||+|||++..... ...++.++||||||+++|||+| |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999754321 1223678999999999999999 999
Q ss_pred CCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 662 AYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 662 p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
||..... ......+..+.. .+.+......+.+|+++||+.||++||++.||++.|+++.++
T Consensus 276 p~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAH-----EEVIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCH-----HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCCh-----HHHHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9964321 111122222111 111223344788999999999999999999999999998653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.94 Aligned_cols=244 Identities=30% Similarity=0.409 Sum_probs=198.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYC 549 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 549 (740)
+....++|+..+.||+|+||.||++++. +++.||||+++.... ....+.+.+|+++|+++ +||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3444578999999999999999999862 367899999976532 23456799999999999 999999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGLS-----------------PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKT 612 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~ 612 (740)
...+..++||||+++|+|.+++..... .+++.+++.++.||++||+|||+.+ |+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 999999999999999999999975432 4899999999999999999999998 99999999
Q ss_pred CCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCC
Q 040687 613 LNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYV 668 (740)
Q Consensus 613 ~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~ 668 (740)
+|||++.++.+||+|||++...... ..++.++||||||+++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999998654321 123568999999999999999 9999975433
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+. ..+. .....+.+......+.+|+.+||+.||++||++.||++.|++++++.
T Consensus 254 ~~~~~----~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 254 DSKFY----KMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SHHHH----HHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hhHHH----HHhc---------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 22211 1111 11112222233457889999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.55 Aligned_cols=236 Identities=26% Similarity=0.354 Sum_probs=183.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHh--CCCCCcceEEeEEEeC----Ce
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN--IRHSNIVNLLGYCLEM----GE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~ 554 (740)
.++|+..+.||+|+||+||++++ +++.||||++... ....+..|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 46799999999999999999987 7899999998653 33566777777776 7999999999997653 45
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEECCCCCEEEe
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH--------KDAAPPIIHRDVKTLNILLDSDWGARIA 626 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~iiHrDlk~~NILl~~~~~~ki~ 626 (740)
.++||||+++|+|.++++. ..+++..++.++.||++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 8999999999999999965 36999999999999999999999 666 9999999999999999999999
Q ss_pred ecCCCccccCCC-------------------------------CCCcccceehhHHHHHHHHhC----------CCCCCC
Q 040687 627 DFGLLTSCERDL-------------------------------TTDMKSDVHNFGIVLLEILSG----------RKAYDI 665 (740)
Q Consensus 627 DFGla~~~~~~~-------------------------------~~~~ksDVwSfGvvl~ElltG----------~~p~~~ 665 (740)
|||+++...... .++.++||||||+++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999985332100 112589999999999999999 777754
Q ss_pred CCCCchhHHhhhhHHhhCccchhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
........+......... ......+. ......++.+|+.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322211111111111111 01111111 223556899999999999999999999999999986
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=338.88 Aligned_cols=264 Identities=15% Similarity=0.220 Sum_probs=207.9
Q ss_pred eeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCC--CCCccccC---CCceEEeccCCeEeEEecCCCceEeccC
Q 040687 4 ISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSA--NSASFSNI---PSMAVLSGGEGLLCGILANTSQAFCWSS 78 (740)
Q Consensus 4 ~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~--~~~~~~~v---~~~~~i~~G~~~~Cal~~~~~~~~cWg~ 78 (740)
|..++.|..|+|+|..+| .|||||.|.+||||.+++. +...|..| ..+.+|++|+.|+|+|..++. +|+||.
T Consensus 61 i~~va~G~~hs~~l~~~G--~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~l~~~i~~va~G~~hs~alt~~G~-v~~wG~ 137 (413)
T 1a12_A 61 VVQAEAGGMHTVCLSKSG--QVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGR-VFLWGS 137 (413)
T ss_dssp EEEEEECSSEEEEEETTS--CEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTSC-EEEEEC
T ss_pred eEEEEeCCCeEEEEcCCC--CEEEEECCCCCCCCCCCCCCccccCCeEecCCCcEEEEecCCCeEEEEcCCCc-EEEeeC
Confidence 333444448999999999 9999999999999988763 34456555 257899999999999988754 999998
Q ss_pred --CCC--CCCCcc----ccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCcccccccc---
Q 040687 79 --NSS--PGNTTD----LVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFY--- 146 (740)
Q Consensus 79 --~~~--~g~g~~----~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~--- 146 (740)
|.+ +|.+.. ..| .+.....+.+|++|..|+++|. .+|+||+| |.|.+||||.+...
T Consensus 138 ~~n~~GqlG~~~~~~~~~~P~~v~~~~~i~~ia~G~~hs~alt-------~~G~v~~w-----G~n~~GqLG~~~~~~~~ 205 (413)
T 1a12_A 138 FRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLT-------ADGDLYTL-----GCGEQGQLGRVPELFAN 205 (413)
T ss_dssp EEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEEE-------TTSCEEEE-----ECCTTSTTCSCGGGTSS
T ss_pred CcCCCCccCcCCccccccCCEEecCCCCEEEEEecCceEEEEc-------CCCCEEEe-----eCCCCCccCCCcccccc
Confidence 665 222221 236 5555678999999999999999 89999999 99999999976321
Q ss_pred --------ccccc------------eeeEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCcc-------C------CC--
Q 040687 147 --------DEYVS------------TIVLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGVF-------N------VT-- 190 (740)
Q Consensus 147 --------~~~~~------------~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~~-------~------~~-- 190 (740)
....| ...+++|++|..|+++|+.+|.||+||.|.++ ++.. | ..
T Consensus 206 ~~~~~~~~~~~~P~~v~~~~~g~~~~~~i~~ia~G~~hs~alt~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~ 285 (413)
T 1a12_A 206 RGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNST 285 (413)
T ss_dssp SCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTT
T ss_pred ccccccccccccCceEeeccccccCCccEEEEEeCCCEEEEEeCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCC
Confidence 01112 23589999999999999999999999999874 2110 1 01
Q ss_pred CcEEEEeeCCceeeeeecCCCcEEEeecCCCCCC--------------CCCcccEEEEecccceeeeeeecCCcEEecCC
Q 040687 191 ESFKVLASGKSSLCGISELSGEVKCWGNNDFVSV--------------PPVGIRFVSLAAGANHFCGIREDNHGVECWGS 256 (740)
Q Consensus 191 ~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~--------------~~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~ 256 (740)
..+.+|++|..|+++|. .+|+||+||.|.+||. ++....+.+|++|.+|+++|+ .||+||+||.
T Consensus 286 ~~v~~ia~G~~hs~al~-~~G~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~l~~v~~v~~G~~hs~alt-~~G~v~~wG~ 363 (413)
T 1a12_A 286 KSWVGFSGGQHHTVCMD-SEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVT-KDGRVFAWGM 363 (413)
T ss_dssp CCEEEEEECSSEEEEEE-TTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEE-TTSCEEEEEC
T ss_pred ceEEEEecccceEEEEe-CCCCEEEeeCCCCCccCCCCCCccccCCEEecccCceeEEEECcceEEEEe-CCCCEEEecC
Confidence 34999999999999995 5999999999988871 111237999999999999999 9999999999
Q ss_pred CCCCCCCCC------------------CceEEEEecCceeeEEEeC
Q 040687 257 FNYSSVPKN------------------SGFMAIASSDFTTCGIREN 284 (740)
Q Consensus 257 ~~~g~~~~~------------------~~~~~i~ag~~~~Cg~~~~ 284 (740)
|.++|+..+ ..+.+|++|..|+++++.+
T Consensus 364 n~~gqLG~g~~~~~~~P~~v~~~~~~~~~v~~v~~G~~ht~~l~~~ 409 (413)
T 1a12_A 364 GTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKD 409 (413)
T ss_dssp CTTSTTCSSSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEE
T ss_pred CCCCCCCCCCCCCcccCeEccccccCCCeEEEEeeCCCcEEEEEec
Confidence 999885322 2489999999999999843
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=331.54 Aligned_cols=242 Identities=29% Similarity=0.433 Sum_probs=199.5
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
+++...++|+..+.||+|+||.||++++.+ ++.||+|.+.... ...+.|.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 344456789999999999999999999865 8899999987543 345689999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999997633 46899999999999999999999999 99999999999999999999999999865
Q ss_pred ccCC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 634 CERD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 634 ~~~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
.... ..++.++||||||+++|||++ |+.||...... .+ ...+ .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~----~~~~---------~ 226 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QV----YELL---------E 226 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GH----HHHH---------H
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HH----HHHH---------h
Confidence 4321 223568999999999999999 99999643211 11 1111 1
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
.....+.+......+.+|+.+||+.||++||++.|+++.|+++.++.
T Consensus 227 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 12222223334457889999999999999999999999999988753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=329.25 Aligned_cols=239 Identities=29% Similarity=0.496 Sum_probs=189.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh-----cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT-----NIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++|+..+.||+|+||+||++++. +++.||||++........ ..+.|.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367999999999999999999984 589999999865432211 1267999999999999999999999986654
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC-----EEEeecC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG-----ARIADFG 629 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~ki~DFG 629 (740)
++||||+++++|.+++.....++++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999999999877778999999999999999999999875 45999999999999988776 9999999
Q ss_pred CCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 630 LLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 630 la~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
+++.... ...++.++||||||+++|||++|+.||........ ... ..+.
T Consensus 175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~-------- 243 (287)
T 4f0f_A 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFI-NMIR-------- 243 (287)
T ss_dssp TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHH-HHHH--------
T ss_pred ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHH-HHHh--------
Confidence 9864322 11235689999999999999999999975432211 101 1111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
......+.+......+.+|+.+||+.||++||+++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11112222233345788999999999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.42 Aligned_cols=227 Identities=23% Similarity=0.247 Sum_probs=181.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||+||+|++. +++.||||++...........++..|+..+.++ +||||+++++++.+.+..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 689999999876543334445667777776665 9999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+ +++|.+++......++|..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999 67999999876667999999999999999999999998 999999999999999999999999997654321
Q ss_pred -----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
..++.++||||||+++|||++|..|+.... . ...+........+ ...
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~----~~~~~~~~~~~~~--------~~~ 276 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE----G----WQQLRQGYLPPEF--------TAG 276 (311)
T ss_dssp --CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H----HHHHTTTCCCHHH--------HTT
T ss_pred CcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----H----HHHHhccCCCccc--------ccC
Confidence 124678999999999999999977664211 0 1111111111100 112
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...++.+|+.+||+.||++|||++|+++
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2346889999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.15 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=191.8
Q ss_pred cCccccceecccCceEEEEEEE-----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--Ce
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 554 (740)
+.|+..+.||+|+||.||++++ .+++.||||++.... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4588899999999999999984 358899999987654 234557899999999999999999999999876 56
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++||||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999766667999999999999999999999999 999999999999999999999999998654
Q ss_pred cCCC------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh---HHhhCccch
Q 040687 635 ERDL------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP---LIKQGKAAA 687 (740)
Q Consensus 635 ~~~~------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 687 (740)
.... .++.++||||||+++|||+||+.|+..... .......+ .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--LFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HHHHHHCSCCGGGHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--HHhhccCCcccccCHHHHHH
Confidence 3211 124589999999999999999998742210 00000000 000001111
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.+......+.+.....++.+|+.+||+.||++|||+.|+++.|+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 222222333334445578899999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.85 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=191.4
Q ss_pred hcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++|+..+.||+|+||.||++++. +++.||||+++.... .....++.+|+.++++++||||+++++++.+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467899999999999999999953 367899999875432 3445679999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---CEEE
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW---GARI 625 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki 625 (740)
.+|||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997532 35899999999999999999999999 99999999999999544 5999
Q ss_pred eecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHh
Q 040687 626 ADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 626 ~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
+|||+++.... ...++.++||||||++||||+| |+.||..... ......+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~~i~ 300 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFVT 300 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 99999853211 1234678999999999999999 9999964321 11111121
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.. ...+.+......+.+|+.+||+.||++||++.||++.|+.+.++
T Consensus 301 ~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 11122223344788999999999999999999999999988764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.20 Aligned_cols=240 Identities=28% Similarity=0.425 Sum_probs=195.0
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
+++...++|+..+.||+|+||.||+++..+++.||||.+.... ...+.|.+|+++|++++||||+++++++.+ +..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 3444557899999999999999999998888899999987643 234689999999999999999999999864 568
Q ss_pred EEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 89999999999999997532 25899999999999999999999999 999999999999999999999999998754
Q ss_pred cCC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 635 ERD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 635 ~~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
... ..++.++||||||+++|||+| |+.||...... . ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~----~~~~~~~~-------- 226 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-E----VIQNLERG-------- 226 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-H----HHHHHHTT--------
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-H----HHHHHhcc--------
Confidence 321 112558999999999999999 99999643211 1 11111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.....+.....++.+|+.+||+.||++||++.+|++.|+++...
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11122223345788999999999999999999999999998865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.50 Aligned_cols=238 Identities=23% Similarity=0.359 Sum_probs=192.3
Q ss_pred hcCccccceecccCceEEEEEEEeC-----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++|+..+.||+|+||.||+|++.. +..||||+++... ......+|.+|++++++++||||+++++++.+.+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3567888999999999999999753 2369999987543 233456799999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+|||||+++++|.+++......+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999876667999999999999999999999998 9999999999999999999999999986542
Q ss_pred C------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 636 R------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 636 ~------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
. ...++.++||||||+++|||+| |+.||..... . .....+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~----~~~~~~~~-------- 265 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-H----EVMKAIND-------- 265 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-H----HHHHHHHT--------
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-H----HHHHHHHC--------
Confidence 2 1223568999999999999999 9999964321 1 11111111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+......+.+|+.+||+.||++||++.||++.|+++++.
T Consensus 266 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 266 -GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 112222333445788999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=339.32 Aligned_cols=243 Identities=27% Similarity=0.369 Sum_probs=194.3
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYC 549 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 549 (740)
++...++|+..+.||+|+||.||+++.. +++.||||.+..... ....+.+.+|+.+|+++ +||||+++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4445678999999999999999999962 356899999975432 23446799999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGLS----------------------PLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiH 607 (740)
...+..+|||||+++|+|.+++..... .+++.+++.++.||++||+|||+.+ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999999976532 3799999999999999999999998 999
Q ss_pred cCCCCCCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCC
Q 040687 608 RDVKTLNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAY 663 (740)
Q Consensus 608 rDlk~~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~ 663 (740)
|||||+|||++.++.+||+|||++...... ..++.++||||||++||||+| |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998644221 223668999999999999999 99999
Q ss_pred CCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 664 DIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
........+. ..+. .....+.+.....++.+|+.+||+.||++||++.||++.|+.++++
T Consensus 276 ~~~~~~~~~~----~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDANFY----KLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHHHH----HHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHHHH----HHHh---------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 7543322221 1111 1122222223345788999999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.14 Aligned_cols=239 Identities=28% Similarity=0.417 Sum_probs=197.1
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++...++|+..++||+|+||.||++++.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 3445567899999999999999999999888889999998654 234689999999999999999999999876 678
Q ss_pred EEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+|||||+++|+|.++|+... ..+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999997432 45899999999999999999999999 999999999999999999999999998754
Q ss_pred cC----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 635 ER----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 635 ~~----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. ...++.++||||||++||||+| |+.||..... ......+. .
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~~i~---------~ 479 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVE---------R 479 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHHHHH---------T
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH---------c
Confidence 32 1223668999999999999999 9999964321 11111221 1
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
....+.+......+.+||.+||+.||++||++++|++.|+++..
T Consensus 480 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 22233333445578899999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=334.33 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=195.4
Q ss_pred ccccceecccCceEEEEEEEe-----CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEE
Q 040687 484 FKEFNELGRGSYGFVYKAVLV-----DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERL 556 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 556 (740)
|+..++||+|+||+||++.+. +++.||||+++... .....+.|.+|+++|++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488899999999999998753 57899999997653 233456799999999999999999999999884 5789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++++|.+++... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999999764 4999999999999999999999999 99999999999999999999999999875432
Q ss_pred CC------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCc-hhHHhhhhHHhhCccchhccc
Q 040687 637 DL------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP-GIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ~~------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. .++.++||||||+++|||+||+.||....... ....+...........+.++.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 11 12458899999999999999999996421100 000000011111122233333
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+.....++.+|+++||+.||++||++.|+++.|+++.++
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 444444445556889999999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=364.14 Aligned_cols=236 Identities=25% Similarity=0.358 Sum_probs=193.1
Q ss_pred cCccccc-eecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFN-ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
+++...+ +||+|+||.||+|.+. ++..||||+++... .....++|.+|+++|++++|||||++++++.. +..+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 4455444 7999999999999875 35679999997653 23456789999999999999999999999976 56899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 637 (740)
||||+++|+|.++|......+++.+++.|+.||++||+|||+.+ ||||||||+||||++++.+||+|||+++.....
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999999877677999999999999999999999998 999999999999999999999999998764321
Q ss_pred ------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 638 ------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 638 ------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
..++.++||||||++||||+| |+.||...... . +...+.. .
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~----~~~~i~~---------~ 555 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E----VMAFIEQ---------G 555 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-H----HHHHHHT---------T
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-H----HHHHHHc---------C
Confidence 223668999999999999998 99999753321 1 1122222 1
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+.....++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 556 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 22233334455888999999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=335.01 Aligned_cols=232 Identities=20% Similarity=0.299 Sum_probs=189.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. +++.||+|.+.... .....+.+|+++|++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 468999999999999999999985 48899999987543 33457899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--CCCEEEeecCCCccccCC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS--DWGARIADFGLLTSCERD 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~ki~DFGla~~~~~~ 637 (740)
||+++++|.+++......+++.+++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999876667999999999999999999999998 999999999999997 789999999998764321
Q ss_pred --------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
..++.++||||||+++|||++|+.||...... + ....+.. .....+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~-~~~~i~~--------~~~~~~~ 224 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----Q-IIENIMN--------AEYTFDE 224 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----H-HHHHHHH--------TCCCCCH
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----H-HHHHHHc--------CCCCCCh
Confidence 12367899999999999999999999743211 1 1111111 1111111
Q ss_pred --CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 698 --NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 698 --~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
......++.+|+.+||+.||++|||+.|+++ ++.
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 0122346789999999999999999999997 544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.48 Aligned_cols=238 Identities=25% Similarity=0.337 Sum_probs=190.3
Q ss_pred hhcCccccc-eecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 480 ATNGFKEFN-ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 480 ~~~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
..++|...+ .||+|+||.||++.+. .++.||||+++.........++|.+|++++++++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345687777 8999999999999753 367899999986654344467899999999999999999999999 56678
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999999864 46899999999999999999999998 9999999999999999999999999986543
Q ss_pred CCC------------------------CCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 636 RDL------------------------TTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 636 ~~~------------------------~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
... .++.++||||||+++|||+| |+.||..... ......+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~------- 236 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKG------- 236 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTT-------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcC-------
Confidence 211 12458999999999999999 9999964321 1111122111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+......+.+++.+||+.||++||++.||++.|+++...
T Consensus 237 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 --ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11122223345788999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.55 Aligned_cols=237 Identities=27% Similarity=0.383 Sum_probs=192.9
Q ss_pred hcCccccc-eecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 481 TNGFKEFN-ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 481 ~~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.++|.... .||+|+||.||++++. +++.||||.++... .....+++.+|++++++++||||+++++++ ..+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 34566665 8999999999999863 57889999997653 234557799999999999999999999999 456789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++++|.+++......+++.+++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999876677999999999999999999999999 99999999999999999999999999865432
Q ss_pred C------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 D------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ~------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ..++.++||||||+++|||+| |+.||..... ..+ ...+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~----~~~i~~~~------- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEV----MAFIEQGK------- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHH----HHHHHTTC-------
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHH----HHHHhcCC-------
Confidence 1 112568999999999999999 9999964332 111 11221111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+.+.....++.+++.+||+.||++||++.|+++.|+++..+
T Consensus 231 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 231 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122223345788999999999999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=337.85 Aligned_cols=236 Identities=25% Similarity=0.412 Sum_probs=188.3
Q ss_pred cCccccceecccCceEEEEEEEeC-CcE----EEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQ----VAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~----vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||+||++++.. ++. ||+|.+..... ......+.+|+.++++++||||+++++++.+ ...+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 568899999999999999999753 443 78887754332 2233567889999999999999999999864 5688
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999876667999999999999999999999999 99999999999999999999999999875432
Q ss_pred C-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 D-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
. ..++.++||||||+++|||+| |+.||....... + ...+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~----~~~~~~~--------- 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-V----PDLLEKG--------- 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-H----HHHHHTT---------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-H----HHHHHcC---------
Confidence 1 123568999999999999999 999997543211 1 1111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+.....++.+|+.+||+.||++||++.|+++.|+++.++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111112223567899999999999999999999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.95 Aligned_cols=244 Identities=29% Similarity=0.410 Sum_probs=196.9
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGY 548 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 548 (740)
+++...++|+..+.||+|+||.||+++... ...||+|.+..... ....+.+.+|+++|+++ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 445556889999999999999999999743 24799999876532 23456799999999999 89999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGG-------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
+.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 99999999999999999999999642 235899999999999999999999998 99999999999
Q ss_pred EECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCch
Q 040687 616 LLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPG 671 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 671 (740)
|++.++.+||+|||++...... ..++.++||||||+++|||+| |+.||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999998643221 123668999999999999999 9999975433222
Q ss_pred hHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+. ..+. .....+.+......+.+|+.+||+.||++||++.||++.|+++.++
T Consensus 276 ~~----~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 FY----KLVK---------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HH----HHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHh---------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111 1111222222344788999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.69 Aligned_cols=246 Identities=29% Similarity=0.414 Sum_probs=190.3
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEE
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (740)
+.++....++|...+.||+|+||.||++++.. ++.||+|+++.........+.|.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34444456789999999999999999998753 45899999986654445567899999999999999999999999
Q ss_pred EeCC-----eEEEEEecCCCCChHHhHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC
Q 040687 550 LEMG-----ERLLVYEFMPRGTLHDHLHG-----GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS 619 (740)
Q Consensus 550 ~~~~-----~~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 619 (740)
.+.. ..++||||+++++|.+++.. ....+++.+++.++.||++||.|||+.+ |+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 8765 35999999999999999842 2356999999999999999999999998 999999999999999
Q ss_pred CCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHh
Q 040687 620 DWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEW 675 (740)
Q Consensus 620 ~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~ 675 (740)
++.+||+|||++..... ...++.++||||||+++|||+| |+.||...... .+.
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~-- 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMY-- 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHH--
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHH--
Confidence 99999999999865421 1223568999999999999999 88998643221 111
Q ss_pred hhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 676 ALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 676 ~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+... ...+.+......+.+|+.+||+.||++||++.+|++.|+++++.
T Consensus 260 --~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 --DYLLHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --HHHHTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 11112223345788999999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.73 Aligned_cols=236 Identities=22% Similarity=0.337 Sum_probs=188.6
Q ss_pred hcCccccceecccCceEEEEEEEeC-C-------cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-G-------RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
.++|...+.||+|+||.||+++... + ..||+|.+.... ....+.|.+|+++|++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3578899999999999999999753 3 479999987543 34457899999999999999999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC--------EE
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG--------AR 624 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~k 624 (740)
+..++||||+++++|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999876556999999999999999999999999 999999999999998887 99
Q ss_pred EeecCCCccccC-----------------C-CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 625 IADFGLLTSCER-----------------D-LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 625 i~DFGla~~~~~-----------------~-~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
|+|||++..... . ..++.++||||||+++|||+||..|+......... ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~----~~~~------ 231 (289)
T 4fvq_A 162 LSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK----LQFY------ 231 (289)
T ss_dssp ECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHH------
T ss_pred eccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH----HHHh------
Confidence 999999864422 1 33577999999999999999965544322111110 0111
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
......+... ..++.+|+.+||+.||++|||+.|+++.|++++..
T Consensus 232 ---~~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 ---EDRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ---HTTCCCCCCS--SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ---hccCCCCCCC--CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111112111 22567899999999999999999999999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=329.34 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=189.0
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..+.||+|+||+||+++..+++.||+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999997799999999976554334456789999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++ +|.+++......+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 975 999999876677999999999999999999999998 99999999999999999999999998753211
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc------cch--hccc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK------AAA--IIDR 691 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~--i~d~ 691 (740)
...++.++||||||+++|||+||+.||........+. .......... ..+ ..++
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM-RIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHHCCCChhhchhhhccccccc
Confidence 1234779999999999999999999997543211111 1111110000 000 0011
Q ss_pred ccCC--C-----CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVAL--P-----RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~--~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.... + .......++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1000 0 01123346789999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.45 Aligned_cols=239 Identities=28% Similarity=0.427 Sum_probs=193.9
Q ss_pred hhcCccccceecccCceEEEEEEEe--------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV--------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL 550 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (740)
..++|+..+.||+|+||.||++++. +++.||||+++... .....+.+.+|+++|+++ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 4578999999999999999999873 46789999987643 234457799999999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
+.+..++||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 9999999999999999999997643 24899999999999999999999998 99999999999
Q ss_pred EECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCch
Q 040687 616 LLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPG 671 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 671 (740)
|++.++.+||+|||++...... ..++.++||||||+++|||+| |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 9999999999999998654321 112568999999999999999 9999964321
Q ss_pred hHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
+.....+... ...+.+.....++.+|+.+||+.||++||++.||++.|+++++.
T Consensus 266 --~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 266 --EELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp --HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111122111 11112223345788999999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.53 Aligned_cols=243 Identities=19% Similarity=0.240 Sum_probs=187.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+++.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999985 48899999998665444455788999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++ +|.+++......+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9975 777777665567999999999999999999999999 99999999999999999999999999864321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---ccchhc---ccc
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---KAAAII---DRN 692 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~i~---d~~ 692 (740)
...++.++||||||+++|||+||..||.................... ...... +..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 11247799999999999999999888643322222222111111000 000000 000
Q ss_pred ---------cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 ---------VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ---------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...........++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000011123447789999999999999999999986
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=341.25 Aligned_cols=261 Identities=20% Similarity=0.335 Sum_probs=203.4
Q ss_pred eEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCC-----------------------CCccccCC----------
Q 040687 5 SASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSAN-----------------------SASFSNIP---------- 51 (740)
Q Consensus 5 ~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~-----------------------~~~~~~v~---------- 51 (740)
+++.| ..|+|||..+| .|||||.|..||||.+++.+ ...|..|+
T Consensus 71 ~va~G-~~Ht~alt~~G--~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~~~~~~ 147 (473)
T 3of7_A 71 SFAVG-GMHTLALDEES--NVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFPPLAEG 147 (473)
T ss_dssp EEEEC-SSEEEEEETTC--CEEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCHHHHTT
T ss_pred EEEeC-CCeEEEEecCC--eEEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCCcccCC
Confidence 34445 48999999999 99999999999999887655 33455543
Q ss_pred -CceEEeccCCeEeEEecCCCceEeccCC--CC--CCCCcc-----ccc-cc--ccCCceEEEeeCCCeeeeEEcccccc
Q 040687 52 -SMAVLSGGEGLLCGILANTSQAFCWSSN--SS--PGNTTD-----LVP-SV--YKNTAYSRIAAGTNHVCAVRGSYYSY 118 (740)
Q Consensus 52 -~~~~i~~G~~~~Cal~~~~~~~~cWg~~--~~--~g~g~~-----~~~-~~--~~~~~~~~is~G~~h~Cal~~~~~~~ 118 (740)
.+.+|++|+.|+|+|..++. +|+||.| .+ +|.+.. ..| .+ +.+..+.+|++|..|+|||.
T Consensus 148 ~~i~~va~G~~hs~alt~~G~-vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~alt------ 220 (473)
T 3of7_A 148 HKVVQLAATDNMSCALFSNGE-VYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLD------ 220 (473)
T ss_dssp CCEEEEEECSSEEEEEETTSC-EEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEEEE------
T ss_pred CcEEEEEccCCEEEEEeCCCe-EEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEEEe------
Confidence 46899999999999988755 9999984 33 222111 234 22 22345999999999999999
Q ss_pred CCCceeeecccccCCCCccCccccccccc----cccce----eeEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCcc--
Q 040687 119 HDLGTVDCWDIVRKGNNTLSSVQTNLFYD----EYVST----IVLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGVF-- 187 (740)
Q Consensus 119 ~~~g~v~cW~~~~~G~n~~gqlg~~~~~~----~~~~~----~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~~-- 187 (740)
.+|+||+| |.|..||||.+.... ...|. ..+++|++|..|+|+|+.+|.|||||.|.++ ++..
T Consensus 221 -~~G~v~~w-----G~n~~GqLG~~~~~~~~~~~~~p~~~~~~~v~~Ia~G~~hs~alt~~G~v~~wG~n~~GqlG~~~~ 294 (473)
T 3of7_A 221 -EEGMVFAW-----GNGQQNQLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSED 294 (473)
T ss_dssp -TTSCEEEE-----ECCTTSTTSSCCCGGGTTTTCSCEECSCCSEEEEEECSSEEEEEETTSCEEEEEECTTSTTCCCSC
T ss_pred -CCCeEEEE-----eCCCCCCCCCCccccccccccCceecCCcceEEEecCCCeEEEEecCCCEEEeCCCCCCCcCCCCc
Confidence 89999999 999999999874332 22232 2489999999999999999999999999874 2211
Q ss_pred ---------------CCCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCCC-----------------------CC--
Q 040687 188 ---------------NVTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVP-----------------------PV-- 227 (740)
Q Consensus 188 ---------------~~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~~-----------------------~~-- 227 (740)
+....+.+|++|..|+++| +.+|+||+||.|.+||.- |.
T Consensus 295 ~~~~~~~~~P~~v~~~~~~~i~~ia~G~~hs~~l-t~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v 373 (473)
T 3of7_A 295 VEDGALVTKPKRLALPDNVVIRSIAAGEHHSLIL-SQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKL 373 (473)
T ss_dssp CCTTCEEEEEEECCCCTTCCEEEEEECSSEEEEE-ETTSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEEC
T ss_pred ccCCceeeccccccccCCccEEEEEeCCCeEEEE-eCCCeEEEEECCCCCccCCCccccccccccccCCceeeeccCccc
Confidence 1124689999999999999 459999999999998821 10
Q ss_pred --cccEEEEecccceeeeeeecCCcEEecCCCCCCCCCCCC-------------------ceEEEEecCceeeEEEe
Q 040687 228 --GIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNS-------------------GFMAIASSDFTTCGIRE 283 (740)
Q Consensus 228 --~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~~-------------------~~~~i~ag~~~~Cg~~~ 283 (740)
...+++|++|..|+++|+ .+|+||+||.|.+||+..+. .+..|++|..||+.+..
T Consensus 374 ~~~~~v~~Ia~G~~hs~al~-~~G~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~~~~~v~~v~cG~~~s~~~~~ 449 (473)
T 3of7_A 374 NNVPKFKSVAAGSHHSVAVA-QNGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTATQDHNIILVGCGGQFSVSGGV 449 (473)
T ss_dssp CSSCCEEEEEECSSEEEEEE-TTSCEEEEECCTTCTTCCCSCCSCEEEEEECCCTTTTTEEEEEEEECSSEEEEEEE
T ss_pred CCCCceEEEEeCCCeEEEEe-CCCcEEEeeCCCCCCCCCCCCCccccCCeEecccccCCCeEEEEeeCCCeEEEEEe
Confidence 116899999999999998 99999999999999864332 38899999999999873
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.45 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=193.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++.. +++.||+|++...... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999975 5889999998654322 23456799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... .++++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999754 46999999999999999999999999 99999999999999999999999999865432
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||||+++|||+||+.||..... .+.....+.. ..... .. .
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~~~~~~-~~~~~-~~----~ 235 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAIKHIQD-SVPNV-TT----D 235 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH----HHHHHHHHSS-CCCCH-HH----H
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhc-cCCCc-ch----h
Confidence 11236789999999999999999999975321 1111111111 11100 00 0
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHh
Q 040687 697 RNVEPLFKLADIAELAIRENPSELP-TMSQVATWLEQIVKD 736 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~Le~l~~~ 736 (740)
........+.+++.+||+.||++|| ++.++.+.|++++.+
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1112234688999999999999998 899999999887654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.68 Aligned_cols=237 Identities=26% Similarity=0.428 Sum_probs=190.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++|+..+.||+|+||.||++++.. ++ +||+|.+.... .....+++.+|+.++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 3679999999999999999999743 44 35777775433 2345678999999999999999999999998764 7
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++|+||+++|+|.+++......+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 8999999999999999877678999999999999999999999999 9999999999999999999999999986542
Q ss_pred C-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 636 R-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 636 ~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
. ...++.++||||||+++|||++ |+.||...... . ....+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~-------------~~~~~~~ 234 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-------------ISSILEK 234 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G-------------HHHHHHT
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-H-------------HHHHHHc
Confidence 2 1123668999999999999999 99999743211 1 1111222
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+.....++.+|+++||+.||++||++.|+++.|+++.++
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222333334455788999999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.76 Aligned_cols=230 Identities=26% Similarity=0.361 Sum_probs=180.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch------------------------hcHHHHHHHHHHHH
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH------------------------TNIREFEMELEVLC 535 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~------------------------~~~~~~~~E~~~l~ 535 (740)
.++|+..+.||+|+||.||+++.. +++.||||++....... ...+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999974 58899999987653211 11356899999999
Q ss_pred hCCCCCcceEEeEEEe--CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 040687 536 NIRHSNIVNLLGYCLE--MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTL 613 (740)
Q Consensus 536 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~ 613 (740)
+++||||+++++++.+ ....+|||||+++++|.+++.. .++++.+++.++.||++||+|||+.+ |+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 9999999999999987 5688999999999999987654 46999999999999999999999998 999999999
Q ss_pred CEEECCCCCEEEeecCCCccccCCC---------------------C---CCcccceehhHHHHHHHHhCCCCCCCCCCC
Q 040687 614 NILLDSDWGARIADFGLLTSCERDL---------------------T---TDMKSDVHNFGIVLLEILSGRKAYDIEYVP 669 (740)
Q Consensus 614 NILl~~~~~~ki~DFGla~~~~~~~---------------------~---~~~ksDVwSfGvvl~ElltG~~p~~~~~~~ 669 (740)
|||++.++.+||+|||++....... . .+.++||||||+++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-- 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--
Confidence 9999999999999999986543210 0 1457899999999999999999996432
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... ....+.. .....+.......++.+|+.+||+.||++||++.|+++
T Consensus 245 --~~~-~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 --IMC-LHSKIKS--------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --HHH-HHHHHHH--------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --HHH-HHHHHhc--------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111 1111111 12222322334457889999999999999999999985
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.16 Aligned_cols=237 Identities=22% Similarity=0.367 Sum_probs=195.0
Q ss_pred eEEEccCCCCCCCCCCCCCCCCccc-cCCCceEEeccCCeEeEEecCCCceEeccCCCCCCCCcccccccccCCceEEEe
Q 040687 24 DVICWAKNSSSPSSSFLSANSASFS-NIPSMAVLSGGEGLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIA 102 (740)
Q Consensus 24 ~v~cwg~n~~gqlg~~~~~~~~~~~-~v~~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~~g~g~~~~~~~~~~~~~~~is 102 (740)
+|+|||+|...++..+ |. ....+.+|++|..|+|+|. + +.+|+||.|.+ ||+.+|.. ....+.+|+
T Consensus 3 ~v~~WG~n~~~~~~~~-------p~~~~~~i~~ia~G~~h~~~l~-~-G~v~~wG~n~~---Gqlg~p~~-~~~~i~~ia 69 (282)
T 3qhy_B 3 SVVAWGGNNDWGEATV-------PAEAQSGVDAIAGGYFHGLALK-G-GKVLGWGANLN---GQLTMPAA-TQSGVDAIA 69 (282)
T ss_dssp EEEEECSCCTTSTTCC-------CGGGSSSCCEEEECSSEEEEEE-T-TEEEEEECCSS---STTSCCGG-GGSCCCEEE
T ss_pred EEEEeCCCCCcCcccC-------CccccCCCcEEEeCCCeEEEEE-C-CEEEEEeCCCC---CCCCCCcc-CCCCEEEEE
Confidence 7999999976666533 22 1236789999999999997 5 46999999986 77777722 234799999
Q ss_pred eCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccccccceeeEEEEEecCCeeeeeeeCCeEEEecCCCC
Q 040687 103 AGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDSE 182 (740)
Q Consensus 103 ~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~ 182 (740)
+|..|+++|+ +|+||+| |.|..||||..... ...+++|++|..|+++|+ +|+|+|||.|..
T Consensus 70 ~G~~hs~~l~--------~G~v~~w-----G~n~~Gqlg~P~~~-----~~~v~~ia~G~~hs~al~-~G~v~~wG~n~~ 130 (282)
T 3qhy_B 70 AGNYHSLALK--------DGEVIAW-----GGNEDGQTTVPAEA-----RSGVDAIAAGAWASYALK-DGKVIAWGDDSD 130 (282)
T ss_dssp ECSSEEEEEE--------TTEEEEE-----ECCTTSTTCCCGGG-----SSSEEEEEEETTEEEEEE-TTEEEEEECCTT
T ss_pred eCCCEEEEEE--------CCEEEEe-----eCCCCCCCCCCccc-----CCCeEEEECcCCEEEEEe-CCeEEEecCCCC
Confidence 9999999996 5999999 99999999853221 124899999999999999 999999999987
Q ss_pred C-CCccC-CCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCC-CC--CcccEEEEecccceeeeeeecCCcEEecCCC
Q 040687 183 S-LGVFN-VTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSV-PP--VGIRFVSLAAGANHFCGIREDNHGVECWGSF 257 (740)
Q Consensus 183 ~-~~~~~-~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~-~~--~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~ 257 (740)
+ .+.+. ....+.+|++|..|+|+| + ||+|++||.|.++|. .| ....+++|++|.+|+|+| +||+|++||.|
T Consensus 131 gqlg~~~~~~~~i~~i~~G~~~~~~l-~-~G~v~~wG~n~~gqlg~p~~~~~~v~~i~~G~~hs~al--~~G~v~~wG~n 206 (282)
T 3qhy_B 131 GQTTVPAEAQSGVTALDGGVYTALAV-K-NGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLAL--KDGKVIAWGDN 206 (282)
T ss_dssp STTSCCGGGGSSEEEEEECSSEEEEE-E-TTEEEEEECCTTSTTSCCGGGGSSEEEEEECSSEEEEE--ETTEEEEEECC
T ss_pred CcCCCCccCCCCeEEEEcccCEEEEE-E-CCEEEEecCCCCCCCCCceecCCCeEEEEecCCEEEEE--ECCeEEEEECC
Confidence 5 33222 246799999999999998 5 799999999999994 23 245799999999999999 49999999999
Q ss_pred CCCCCCCC----CceEEEEecCceeeEEEeCCceeecccccCCCC
Q 040687 258 NYSSVPKN----SGFMAIASSDFTTCGIRENDLVLDCWFANVSSP 298 (740)
Q Consensus 258 ~~g~~~~~----~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~ 298 (740)
.++|++.+ ..+.+|++|..|+|+++ ++.|++||.|..++
T Consensus 207 ~~gqlg~p~~~~~~v~~i~~G~~h~~al~--~g~v~~wG~n~~gq 249 (282)
T 3qhy_B 207 RYKQTTVPTEALSGVSAIASGEWYSLALK--NGKVIAWGSSRTAP 249 (282)
T ss_dssp TTSTTCCCGGGGSSCCEEEECSSCEEEEE--TTEEEEESTTCCCC
T ss_pred CCCCCCCCcccCCCceEEEcCCCEEEEEE--CCEEEEecCCCCcc
Confidence 99997544 46999999999999998 89999999997554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.48 Aligned_cols=237 Identities=24% Similarity=0.366 Sum_probs=189.8
Q ss_pred CccccceecccCceEEEEEEEeC-C---cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE-EE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD-G---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER-LL 557 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~l 557 (740)
.|...+.||+|+||+||+|++.+ + ..||+|.+..... ....+.|.+|++++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35666899999999999999643 2 3799999875432 33457899999999999999999999999876654 99
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+.+++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999999887678999999999999999999999998 99999999999999999999999999864321
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||+++|||+||..|+........+.. .+.. .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~---------~ 244 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH----FLAQ---------G 244 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH----HHHT---------T
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH----Hhhc---------C
Confidence 11236689999999999999996666543322222211 1111 1
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+......+.+++.+||+.||.+|||++++++.|+++++.
T Consensus 245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11222223344788999999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.70 Aligned_cols=236 Identities=27% Similarity=0.422 Sum_probs=184.9
Q ss_pred CccccceecccCceEEEEEEEeC--C--cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCeEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVD--G--RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGERLL 557 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~--g--~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 557 (740)
.|+..+.||+|+||+||+|++.+ + ..||||.++... .....++|.+|+.+|++++||||+++++++.+ .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 46777899999999999999743 2 368999987533 23445789999999999999999999999765 457899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.++++.....+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877677999999999999999999999999 99999999999999999999999999864321
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
...++.++||||||++||||+| |..||....... +.. .+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~~~----~~~~~~------- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITV----YLLQGR------- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-HHH----HHHTTC-------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-HHH----HHHcCC-------
Confidence 1223668999999999999999 677776433221 111 111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+.+......+.+++.+||+.||++||++.||++.|++++.+
T Consensus 314 --~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 314 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111223344788999999999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=332.36 Aligned_cols=229 Identities=24% Similarity=0.316 Sum_probs=188.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||+||+++.. +++.||||+++.... .......+.+|+++|++++||||+++++++...+..+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999985 489999999976532 233456789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999999754 46899999999999999999999999 99999999999999999999999999864321
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||++|+.||..... ......+ +......|.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i--------~~~~~~~p~ 226 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELI--------LMEEIRFPR 226 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--------HHCCCCCCT
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHH--------HcCCCCCCC
Confidence 12346799999999999999999999964321 1111111 122233333
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
. ...++.+|+.+||+.||++|| +++||++
T Consensus 227 ~--~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 227 T--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp T--SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 2 234678999999999999999 8999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=330.42 Aligned_cols=251 Identities=25% Similarity=0.300 Sum_probs=195.2
Q ss_pred ChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHh--CCCCCcceEEeEEE
Q 040687 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCN--IRHSNIVNLLGYCL 550 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~ 550 (740)
++..-....++|+..+.||+|+||.||+++. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3344455567899999999999999999997 5899999998643 33678889999987 79999999999998
Q ss_pred eCC----eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEC
Q 040687 551 EMG----ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH--------KDAAPPIIHRDVKTLNILLD 618 (740)
Q Consensus 551 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~iiHrDlk~~NILl~ 618 (740)
... ..++||||+++|+|.+++... .+++.+++.++.|+++||+||| +.+ |+||||||+|||++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 875 789999999999999999764 5899999999999999999999 666 99999999999999
Q ss_pred CCCCEEEeecCCCccccCCC-------------------------------CCCcccceehhHHHHHHHHhC--------
Q 040687 619 SDWGARIADFGLLTSCERDL-------------------------------TTDMKSDVHNFGIVLLEILSG-------- 659 (740)
Q Consensus 619 ~~~~~ki~DFGla~~~~~~~-------------------------------~~~~ksDVwSfGvvl~ElltG-------- 659 (740)
.++.+||+|||++....... ..+.++||||||+++|||+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999985432211 011579999999999999999
Q ss_pred --CCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 660 --RKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 660 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
+.||..........+.....+........+..+. ...+....+.+|+.+||+.||++||++.||++.|+++.++.
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 6777543222211121112221111111000000 12355668899999999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=361.84 Aligned_cols=230 Identities=25% Similarity=0.348 Sum_probs=189.6
Q ss_pred ceecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
++||+|+||.||+|.+. .++.||||+++.........++|.+|+++|++++|||||++++++.. +..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 35789999998765444556789999999999999999999999965 568899999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD------- 637 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~------- 637 (740)
|+|.++|... ..+++.+++.|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+++.....
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999754 46999999999999999999999999 999999999999999999999999998644221
Q ss_pred -----------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
..++.++||||||++||||+| |+.||..... ..+...+. .....+.+.
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~---------~~~~~~~p~ 595 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLE---------KGERMGCPA 595 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHH---------TTCCCCCCT
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH---------cCCCCCCCC
Confidence 134668999999999999999 9999964321 11112222 122222333
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....++.+||..||+.||++||++.+|++.|+++..+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 4455788999999999999999999999999998765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.01 Aligned_cols=240 Identities=18% Similarity=0.204 Sum_probs=191.2
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||+||+++. .+++.||||.+.... ..+.+.+|+++++++ +||||+++++++......+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46799999999999999999997 468999999986543 224688999999999 999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC-----EEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG-----ARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~ki~DFGla~~ 633 (740)
|||+ +++|.+++......+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 99999999866567999999999999999999999998 999999999999999887 99999999875
Q ss_pred ccCC----------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 634 CERD----------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 634 ~~~~----------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
.... ..++.++||||||++||||++|+.||...... .+.+.. ..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-~~~~~~-~~i~~~~~ 237 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-TLKERY-QKIGDTKR 237 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-SHHHHH-HHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-cHHHHH-HHHHhhhc
Confidence 4221 11356899999999999999999999754322 221111 11111100
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+ .. ....+ ++.+|+..||+.||.+||++.+|.+.|+++.++
T Consensus 238 ~~~~~-~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 238 ATPIE-VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HSCHH-HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCHH-HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00000 00 01122 788999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=332.89 Aligned_cols=231 Identities=26% Similarity=0.273 Sum_probs=185.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||+||+++.. +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 367999999999999999999986 588999999875432 223356899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999999754 46999999999999999999999999 99999999999999999999999999864321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
....+.++||||||++||||+||+.||........... ... ......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~--------~~~~~~ 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWK--------EKKTYL 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH----HHH--------TTCTTS
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH----HHh--------cccccC
Confidence 01124579999999999999999999975433221111 111 111111
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+........+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 112233446789999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.01 Aligned_cols=232 Identities=22% Similarity=0.315 Sum_probs=190.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..+.||+|+||.||+++.. +++.||+|++..........+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999975 488999999987655445567899999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---CEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW---GARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki~DFGla~~~~ 635 (740)
|||+++|+|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.+. .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999754 46899999999999999999999999 99999999999998654 59999999986543
Q ss_pred CC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 636 RD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 636 ~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
.. ..++.++||||||+++|||++|+.||..... ......+..+ ....
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~~~--------~~~~ 249 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAG--------AYDY 249 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHT--------CCCC
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhC--------CCCC
Confidence 21 1346789999999999999999999964321 1111112111 1111
Q ss_pred CC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+. ......++.+|+.+||+.||++||++.|+++
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 21 1233457889999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.36 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=188.0
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC--CCCCcceEEeEEEeC
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI--RHSNIVNLLGYCLEM 552 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~ 552 (740)
.......++|+..++||+|+||.||+++.. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 334445678999999999999999999874 899999998643 224556666666654 999999999999887
Q ss_pred ----CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEECCCCCE
Q 040687 553 ----GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA-----APPIIHRDVKTLNILLDSDWGA 623 (740)
Q Consensus 553 ----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~ 623 (740)
...+|||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6899999999999999999764 5999999999999999999999881 1129999999999999999999
Q ss_pred EEeecCCCccccCCC-------------------------CCCc------ccceehhHHHHHHHHhC----------CCC
Q 040687 624 RIADFGLLTSCERDL-------------------------TTDM------KSDVHNFGIVLLEILSG----------RKA 662 (740)
Q Consensus 624 ki~DFGla~~~~~~~-------------------------~~~~------ksDVwSfGvvl~ElltG----------~~p 662 (740)
||+|||++....... ..+. ++||||||+++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999985432110 0112 38999999999999999 555
Q ss_pred CCCCCCCchhHHhhhhHHhhCccchhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 663 YDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
|...................... +...+. ..+...++.+|+.+||+.||++||++.||++.|+++.++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKL------RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCC------CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCchhhhHHHHhhhcc------CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 54322111111111111111111 111111 2355678999999999999999999999999999998763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.22 Aligned_cols=238 Identities=26% Similarity=0.353 Sum_probs=191.5
Q ss_pred hhcCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
..++|+..+.||+|+||.||++++.+ +..||+|.+..... ....+.|.+|++++++++||||+++++++.+ +..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 34679999999999999999999753 23699999876532 3345789999999999999999999999765 456
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 8999999999999999876667999999999999999999999999 9999999999999999999999999986443
Q ss_pred CC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 636 RD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 636 ~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
.. ..++.++||||||+++|||+| |+.||....... .. ..+...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~----~~~~~~--------- 230 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VI----GVLEKG--------- 230 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HH----HHHHHT---------
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HH----HHHhcC---------
Confidence 21 223568999999999999999 999996432211 11 111111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+......+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11122223344788999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=325.43 Aligned_cols=241 Identities=16% Similarity=0.211 Sum_probs=192.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++. .+++.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46799999999999999999997 468999999986543 224678899999999 899999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC-----EEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG-----ARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~ki~DFGla~~ 633 (740)
|||+ +++|.+++.....++++.+++.++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 99999999876667999999999999999999999998 999999999999987776 99999999865
Q ss_pred ccCC----------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 634 CERD----------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 634 ~~~~----------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
.... ..++.++||||||+++|||++|+.||......... + ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~-~~~~~~~~~~ 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-Q-KYERIGEKKQ 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-H-HHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-H-HHHHHHhhcc
Confidence 4321 12356899999999999999999999764322211 1 1111111100
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.... ... ......++.+|+.+||+.||++||++++|++.|+++.++
T Consensus 239 ~~~~-~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 239 STPL-REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HSCH-HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CccH-HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000 000 012234788999999999999999999999999998865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=334.01 Aligned_cols=232 Identities=22% Similarity=0.271 Sum_probs=188.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh----cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT----NIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
..+.|+..+.||+|+||.||+++.. +++.||+|.++....... ..+.+.+|+.+|++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999985 489999999986543221 35679999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----CEEEeecCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW----GARIADFGL 630 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DFGl 630 (740)
.+|||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999754 47999999999999999999999998 99999999999998877 799999999
Q ss_pred CccccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 631 LTSCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 631 a~~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
+...... ..++.++||||||+++|||++|+.||...... + ....+..
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----~-~~~~i~~-------- 232 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----E-TLANITA-------- 232 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----H-HHHHHHT--------
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHHHh--------
Confidence 8654321 23467899999999999999999999653211 1 1111111
Q ss_pred cccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RNVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111110 0122346779999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.76 Aligned_cols=231 Identities=24% Similarity=0.315 Sum_probs=187.2
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.+.|+..+.||+|+||+||+++. .+++.||||++..... .....++|.+|+++|++++||||+++++++.+.+..+||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45689999999999999999997 4689999999875432 223446799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||++ |+|.+++.....++++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence 99997 6899988765567999999999999999999999998 99999999999999999999999999865432
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||+||+.||..... .+....... .. ......
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~~~-~~--------~~~~~~ 275 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ-NE--------SPALQS 275 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH-SC--------CCCCCC
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHh-cC--------CCCCCC
Confidence 23356789999999999999999999964321 111111111 11 111111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+.+|+.+||+.||++|||++++++
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 223346789999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.45 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=193.8
Q ss_pred cCccccceecccCceEEEEEEE-----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEE--eCCe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCL--EMGE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~ 554 (740)
++|+..+.||+|+||.||++++ .+++.||||++.... ....+.|.+|++++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5689999999999999999985 357899999987653 334567999999999999999999999987 4457
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+|||||+++++|.+++......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 89999999999999999865556999999999999999999999998 999999999999999999999999998754
Q ss_pred cCCC------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh---hHHhhCccch
Q 040687 635 ERDL------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL---PLIKQGKAAA 687 (740)
Q Consensus 635 ~~~~------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 687 (740)
.... .++.++||||||+++|||++|+.||.....+ ...... .........+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE--FLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHCC----CCHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch--hhhhcccccccccHHHHHH
Confidence 3211 1245899999999999999999998632110 000000 0000001122
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+......+.+......+.+|+.+||+.||++||++.||++.|+++...
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 2223333344445556788999999999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.77 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=199.0
Q ss_pred ccChhHHHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcce
Q 040687 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544 (740)
Q Consensus 471 ~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 544 (740)
.+..++++...++|+..+.||+|+||.||+|+.. +++.||||.+..... .....+|.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEee
Confidence 3455666777889999999999999999999864 367899999875432 234567999999999999999999
Q ss_pred EEeEEEeCCeEEEEEecCCCCChHHhHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGG---------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 545 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
+++++.+.+..++||||+++++|.+++... ..++++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 999999999999999999999999999642 145799999999999999999999998 99999999999
Q ss_pred EECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCch
Q 040687 616 LLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPG 671 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 671 (740)
|++.++.+||+|||++..... ...++.++||||||+++|||+| |+.||.....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 246 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 246 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---
Confidence 999999999999999864321 1223678999999999999999 8999864321
Q ss_pred hHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
......+..... .+........+.+|+.+||+.||++||++.|+++.|+++.+
T Consensus 247 --~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 --EQVLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111211111 11122334478899999999999999999999999988654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.19 Aligned_cols=245 Identities=21% Similarity=0.224 Sum_probs=189.4
Q ss_pred hcCccccceeccc--CceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRG--SYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G--~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
.++|+..++||+| +||+||+++.. +++.||||+++.........+.+.+|+++|++++||||+++++++.+.+..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999986 58999999998765545556778999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc-
Q 040687 558 VYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE- 635 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~- 635 (740)
||||+++++|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999997642 56999999999999999999999999 9999999999999999999999999764211
Q ss_pred ---------------------------CC--CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh----
Q 040687 636 ---------------------------RD--LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---- 682 (740)
Q Consensus 636 ---------------------------~~--~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---- 682 (740)
.. ..++.++||||||+++|||++|+.||........+..........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 01 245779999999999999999999997544333222111100000
Q ss_pred -----C-------------ccchhccc---------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 -----G-------------KAAAIIDR---------NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 -----~-------------~~~~i~d~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. .....+.. ....+.......++.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 00000000 0000111223346889999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=330.41 Aligned_cols=248 Identities=30% Similarity=0.421 Sum_probs=199.0
Q ss_pred ChhHHHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceE
Q 040687 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNL 545 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 545 (740)
...++....++|+..+.||+|+||.||++++. +++.||||+++.... ....+.+.+|+++++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556666789999999999999999999853 357899999876532 33456799999999999 79999999
Q ss_pred EeEEEeCC-eEEEEEecCCCCChHHhHhCCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040687 546 LGYCLEMG-ERLLVYEFMPRGTLHDHLHGGLS---------------PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRD 609 (740)
Q Consensus 546 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~---------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrD 609 (740)
++++...+ ..++||||+++++|.+++..... .+++..++.++.||++||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988764 58999999999999999986542 2899999999999999999999998 99999
Q ss_pred CCCCCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCC
Q 040687 610 VKTLNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDI 665 (740)
Q Consensus 610 lk~~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~ 665 (740)
|||+|||++.++.+||+|||++...... ..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999998654221 123668999999999999999 9999975
Q ss_pred CCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
......+. ..+.... ..+.+.....++.+++.+||+.||++||++.||++.|+++++..
T Consensus 254 ~~~~~~~~----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEEFC----RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHHHH----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHH----HHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 43322221 1121111 11112223347889999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=339.68 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=199.3
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC--eEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG--ERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~l 557 (740)
.++|...+.||+|+||+||+++... ++.||||+++.... ....+.+.+|+++|++++||||+++++++.... ..+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3578999999999999999999864 89999999976543 234577899999999999999999999998765 7899
Q ss_pred EEecCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCCEEEeecCCC
Q 040687 558 VYEFMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL----DSDWGARIADFGLL 631 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ki~DFGla 631 (740)
||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999997643 23899999999999999999999999 9999999999999 78888999999998
Q ss_pred ccccCCC----------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC
Q 040687 632 TSCERDL----------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG 683 (740)
Q Consensus 632 ~~~~~~~----------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 683 (740)
+...... .++.++||||||+++|||+||+.||.....+....+.....+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 7543211 123478999999999999999999975443333333333333221
Q ss_pred ccchh----------cc--cccCC--CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 684 KAAAI----------ID--RNVAL--PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 684 ~~~~i----------~d--~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
....+ ++ ..... .........+.+++++||+.||++||++.|+++.|+++++.-+
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~ 312 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV 312 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence 11000 00 01111 1124455678899999999999999999999999999987543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=342.53 Aligned_cols=234 Identities=23% Similarity=0.310 Sum_probs=189.4
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..++||+|+||.||++... +++.||+|.+..........+.+.+|+++|++++||||+++++++.+.+..+||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467999999999999999999974 589999999987665555567799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD---SDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DFGla~~~~ 635 (740)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++....
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999765 46999999999999999999999999 99999999999998 46789999999986543
Q ss_pred CC---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 636 RD---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 636 ~~---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
.. ..++.++||||||++||||++|+.||..... ......+..+... ..
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~------~~ 233 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIKAGAYD------FP 233 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCC------CC
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhCCCC------CC
Confidence 21 1346789999999999999999999964321 1111222211111 11
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+.......++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1112233457889999999999999999999987
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.07 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=199.5
Q ss_pred eeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCC-----CceEEeccCCeEeEEecCCCceEeccC
Q 040687 4 ISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIP-----SMAVLSGGEGLLCGILANTSQAFCWSS 78 (740)
Q Consensus 4 ~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~-----~~~~i~~G~~~~Cal~~~~~~~~cWg~ 78 (740)
|..++.|..|+|||..++ ..|||||.|..||||.+++.+...|..++ .+.+|++|+.|+|+|..++. +|+||.
T Consensus 70 i~~va~G~~ht~al~~~g-g~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~alt~~G~-v~~wG~ 147 (406)
T 4d9s_A 70 IVSVTCGADHTVAYSQSG-MEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVTMEGE-VQSWGR 147 (406)
T ss_dssp EEEEEECSSEEEEEETTT-TEEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEETTSC-EEEEEC
T ss_pred EEEEEeCcceEEEEECCC-CEEEEEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEEcCCCc-EEEeCC
Confidence 334444448999998764 29999999999999999887776776663 46899999999999988754 999999
Q ss_pred CCC--CCCCcc---ccc-cc--ccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCcccccccccccc
Q 040687 79 NSS--PGNTTD---LVP-SV--YKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYV 150 (740)
Q Consensus 79 ~~~--~g~g~~---~~~-~~--~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~ 150 (740)
|.+ +|.+.. ..| .+ +.+..+.+|++|..|+|||. .+|+||+| |.|.+||||.+...+...
T Consensus 148 n~~GqLG~g~~~~~~~p~~v~~~~~~~i~~va~G~~hs~alt-------~~G~v~~w-----G~n~~GqlG~g~~~~~~~ 215 (406)
T 4d9s_A 148 NQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEHTAAVT-------EDGDLYGW-----GWGRYGNLGLGDRTDRLV 215 (406)
T ss_dssp CTTSTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEE-------TTSCEEEE-----ECCTTSTTCSSSSCCEEE
T ss_pred CCCccCCCCCCCCcccceEecccCCCcEEEEecCCCeEEEEe-------CCCCEEEe-----eCCCCCCCCCCCCCCcCc
Confidence 987 444432 234 22 33458999999999999999 89999999 999999999886555444
Q ss_pred cee-------eEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCcc-------------CCCCcEEEEeeCCceeeeeecC
Q 040687 151 STI-------VLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGVF-------------NVTESFKVLASGKSSLCGISEL 209 (740)
Q Consensus 151 ~~~-------~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~~-------------~~~~~~~~iaaG~~h~Cai~~~ 209 (740)
|.. .+++|++|..|+++|+.+|+|||||.|.++ ++.. .....+.+|++|.+|+|+|. .
T Consensus 216 p~~v~~~~~~~i~~va~G~~ht~~l~~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt-~ 294 (406)
T 4d9s_A 216 PERVTSTGGEKMSMVACGWRHTISVSYSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALT-S 294 (406)
T ss_dssp EEECCCSTTCCEEEEEECSSEEEEEETTCCEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEE-T
T ss_pred cEEecccCCceEEEEEECCCcEEEEcCCCCEEEeeCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEc-C
Confidence 433 489999999999999999999999999875 2111 11235899999999999994 5
Q ss_pred CCcEEEeecCCCCCC---------------CCCcccEEEEecccceeeeeeecCCcEEecCCCCCCCCCCCC
Q 040687 210 SGEVKCWGNNDFVSV---------------PPVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPKNS 266 (740)
Q Consensus 210 ~g~v~CWG~n~~g~~---------------~~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~~~ 266 (740)
||+|+|||.|.+||. .+....+++|++|.+|+++|+ ++|+|++||.|.+||+..+.
T Consensus 295 ~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~va~G~~hs~alt-~~G~v~~wG~n~~GqLG~g~ 365 (406)
T 4d9s_A 295 DGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVT-ERNNVFAWGRGTNGQLGIGE 365 (406)
T ss_dssp TSCEEEEECCTTSTTCSSSSSCEEEEEEECCGGGCCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTTCSSS
T ss_pred CCeEEEeeCCCCCCCCCCCCCCCccCEEEeccCCCcEEEEEeCCCeEEEEe-CCCCEEEecCCCCCccCCCC
Confidence 999999999999981 122356999999999999999 99999999999999986665
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.61 Aligned_cols=239 Identities=33% Similarity=0.515 Sum_probs=191.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcE--EEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQ--VAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~--vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..+.||+|+||.||+++.. ++.. ||||+++... .....+.+.+|+++|+++ +||||+++++++.+.+..+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 56889999999999999999975 4554 4999887532 233456799999999999 99999999999999999999
Q ss_pred EEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 558 VYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997653 36899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccCC--------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHh
Q 040687 623 ARIADFGLLTSCERD--------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 623 ~ki~DFGla~~~~~~--------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
+||+|||+++..... ..++.++||||||+++|||+| |+.||..... .+ ....+.
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~-~~~~~~ 255 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AE-LYEKLP 255 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH-HHHHGG
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH----HH-HHHHhh
Confidence 999999998632210 112568999999999999999 9999964321 11 111111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhcc
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~ 738 (740)
.....+.+......+.+|+.+||+.||++||++.|+++.|++++++..
T Consensus 256 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 256 ---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111122222334578899999999999999999999999999988753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.64 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=194.8
Q ss_pred hcCccccceecccCceEEEEEEE-----eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC--
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-----VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG-- 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 553 (740)
.++|+..+.||+|+||.||++++ .+++.||||++.... ....+.|.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35688999999999999999985 358899999987643 344578999999999999999999999987654
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++||||+++++|.+++......+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 679999999999999999876667999999999999999999999998 99999999999999999999999999875
Q ss_pred ccCCC------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh----HHhhCcc
Q 040687 634 CERDL------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP----LIKQGKA 685 (740)
Q Consensus 634 ~~~~~------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~----~~~~~~~ 685 (740)
..... ..+.++||||||+++|||+||+.|+.... ..+.+.... ......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHHHHHCTTCCTHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHHHhhccccchhhhHHHH
Confidence 43211 12458999999999999999999985320 000000000 0000011
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.+......+.+.....++.+|+++||+.||++||++.||++.|+++.++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 122222223333344456788999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.09 Aligned_cols=243 Identities=20% Similarity=0.288 Sum_probs=187.7
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
..++|+..+.||+|+||.||+++. .+++.||||++..... ......++.+|++++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 345799999999999999999997 4689999999875332 22345678999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 558 VYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
||||+++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999864 3356899999999999999999999998 999999999999999999999999997643
Q ss_pred cC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 635 ER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 635 ~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
.. ...++.++||||||+++|||++|+.||...... ..+. ...+.....
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~-~~~~~~~~~-------- 255 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSL-CKKIEQCDY-------- 255 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHH-HHHHHTTCS--------
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHH-HHHhhcccC--------
Confidence 22 122366899999999999999999999643221 1111 111111111
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..........++.+|+.+||+.||++||++.+|++.|+++...
T Consensus 256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111122334788999999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=324.69 Aligned_cols=237 Identities=27% Similarity=0.403 Sum_probs=188.5
Q ss_pred cCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe-CCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-MGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 556 (740)
.+|+..+.||+|+||+||+|++.+ ...||+|.++.... ....+.|.+|+.++++++||||+++++++.+ .+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468888999999999999999643 23689999875432 3345679999999999999999999999754 45789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++++|.+++......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999877677999999999999999999999998 99999999999999999999999999864322
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
...++.++||||||+++|||++ +..||..... ..+.. .+...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~----~~~~~------- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV----YLLQG------- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHH----HHHTT-------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHH----HHhcC-------
Confidence 1123668999999999999999 5556643322 11111 11111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.....+......+.+++.+||+.||++||++.|+++.|++++++
T Consensus 249 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111122234688999999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.37 Aligned_cols=228 Identities=22% Similarity=0.324 Sum_probs=188.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||+|.++..... ....+.+.+|..+|++++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999985 5899999999765432 234567889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999999865432
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++||||||+++|||++|+.||..... .+. ...++......|.. .
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~---------~~~i~~~~~~~p~~--~ 226 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKT---------YEKILNAELRFPPF--F 226 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHH---------HHHHHHCCCCCCTT--S
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHH---------HHHHHhCCCCCCCC--C
Confidence 12346789999999999999999999964321 111 11222223333332 2
Q ss_pred HHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
..++.+++.+||+.||++|| +++||++
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 34678999999999999999 8888885
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.74 Aligned_cols=243 Identities=20% Similarity=0.232 Sum_probs=194.1
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEE
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYC 549 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (740)
+.+.+++..+++|+..++||+|+||+||++++.+ ++.||||++++..... .....+.+|..+|.+++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666778899999999999999999999865 7899999997643222 1223488999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
.+.+..+|||||+++|+|.++|......+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999999876567999999999999999999999999 9999999999999999999999999
Q ss_pred CCccccC---------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh
Q 040687 630 LLTSCER---------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682 (740)
Q Consensus 630 la~~~~~---------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 682 (740)
+++.... ...++.++|||||||+||||+||+.||..... .+.. ..+..
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~-~~i~~ 295 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETY-GKIMN 295 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHH-HHHHT
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHH-Hhhhh
Confidence 9864321 11246689999999999999999999974321 1111 11110
Q ss_pred CccchhcccccCCCCC-chhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 040687 683 GKAAAIIDRNVALPRN-VEPLFKLADIAELAIRENPSE--LPTMSQVAT 728 (740)
Q Consensus 683 ~~~~~i~d~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 728 (740)
. ...+..|.. .....++.+|+++||..+|++ ||+++||++
T Consensus 296 ~------~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 H------KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp H------HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c------cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 011222221 223346789999999888888 999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.76 Aligned_cols=230 Identities=27% Similarity=0.453 Sum_probs=187.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++. .+++.||||.+....... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999997 468999999987543222 2346799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++.....++++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999877678999999999999999999999998 99999999999999999999999999865431
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
....+.++||||||+++|||++|+.||........+ ..+.......+.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~ 233 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------------NKVVLADYEMPS 233 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCCCCCT
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------------HHHhhcccCCcc
Confidence 112356999999999999999999999754322111 111111122222
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+|+.+||+.||++||+++|+++
T Consensus 234 --~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 --FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 22347789999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.17 Aligned_cols=238 Identities=29% Similarity=0.438 Sum_probs=189.3
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-CeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-GERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 558 (740)
..++|+..+.||+|+||.||+++. +++.||||.++... ..+.|.+|++++++++||||+++++++.+. +..++|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 356799999999999999999987 58899999987542 446799999999999999999999997654 468999
Q ss_pred EecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 559 YEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
|||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999997543 23899999999999999999999998 99999999999999999999999999864432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||+| |+.||...... .+ ...+.. ....+.+
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~----~~~~~~---------~~~~~~~ 236 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DV----VPRVEK---------GYKMDAP 236 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GH----HHHHTT---------TCCCCCC
T ss_pred ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HH----HHHHhc---------CCCCCCc
Confidence 1224678999999999999999 99999643211 11 111111 1112222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhccC
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGLI 739 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~~~ 739 (740)
......+.+++.+||+.||++||++.|+++.|+++....+.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~~ 277 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC-
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhcc
Confidence 33345788999999999999999999999999999887664
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.17 Aligned_cols=231 Identities=23% Similarity=0.279 Sum_probs=187.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch----hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH----TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++|+..+.||+|+||.||+++.. +++.||+|.+....... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999985 48899999987654321 1357899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----CEEEeecCCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW----GARIADFGLL 631 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DFGla 631 (740)
++||||+++++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999754 57999999999999999999999999 99999999999999887 7999999998
Q ss_pred ccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 632 TSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 632 ~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
..... ...++.++||||||+++|||++|+.||...... + ....+...
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~-~~~~~~~~-------- 232 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----E-TLANVSAV-------- 232 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----H-HHHHHHHT--------
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----H-HHHHHHhc--------
Confidence 75432 123467899999999999999999999643211 1 11111111
Q ss_pred ccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111110 0112346779999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=332.80 Aligned_cols=229 Identities=23% Similarity=0.322 Sum_probs=187.5
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
.++|+..+.||+|+||+||+++... ++.||||+++..... ......+.+|.++|+++ +||||+++++++.+.+..||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4789999999999999999999854 889999999865322 23456788999999988 79999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 637 (740)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999754 46999999999999999999999999 999999999999999999999999998753211
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
..++.++||||||+++|||++|+.||..... .+ .. ..++......|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~-~~--------~~i~~~~~~~p 244 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----DD-LF--------EAILNDEVVYP 244 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HH--------HHHHHCCCCCC
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----HH-HH--------HHHHcCCCCCC
Confidence 1136789999999999999999999974321 11 11 12222333333
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCH------HHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTM------SQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~ev~~ 728 (740)
.. ....+.+|+.+||+.||++||++ .||++
T Consensus 245 ~~--~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 TW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TT--SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC--CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 32 23367899999999999999998 77765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=325.09 Aligned_cols=236 Identities=27% Similarity=0.442 Sum_probs=184.3
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..+.||+|+||.||++++ .++.||||++... ...+.|.+|+++|++++||||+++++++. +..+|||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 5688899999999999999987 4788999998643 34468999999999999999999999876 347899999
Q ss_pred CCCCChHHhHhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC-EEEeecCCCccccC--
Q 040687 562 MPRGTLHDHLHGGLS--PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCER-- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~--~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~-~ki~DFGla~~~~~-- 636 (740)
+++++|.++++.... .+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 999999999986542 4789999999999999999999932223999999999999998886 79999999864322
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++||||||+++|||+||+.||+....+..... ....... ..+....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~---------~~~~~~~ 228 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGT---------RPPLIKN 228 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHTTC---------CCCCBTT
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhcCC---------CCCcccc
Confidence 12346799999999999999999999974332211111 1111111 1111122
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 334688999999999999999999999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.78 Aligned_cols=228 Identities=22% Similarity=0.354 Sum_probs=180.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (740)
.++|+..+.||+|+||.||+++.. +++.||||+++... .....+.+.+|+++|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 356899999999999999999986 68999999987544 2334577999999999999999999999986643
Q ss_pred ---------------------------------------------------eEEEEEecCCCCChHHhHhCCC--CCCCH
Q 040687 554 ---------------------------------------------------ERLLVYEFMPRGTLHDHLHGGL--SPLNW 580 (740)
Q Consensus 554 ---------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~--~~l~~ 580 (740)
..++||||+++++|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2799999999999999998654 24677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-----------------------
Q 040687 581 SLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD----------------------- 637 (740)
Q Consensus 581 ~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~----------------------- 637 (740)
..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999999 999999999999999999999999998754321
Q ss_pred ----------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHH
Q 040687 638 ----------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLAD 707 (740)
Q Consensus 638 ----------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~ 707 (740)
..++.++||||||+++|||++|..|+... .+ ............ .......++.+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~-~~~~~~~~~~~~---------~~~~~~~~~~~ 304 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VR-IITDVRNLKFPL---------LFTQKYPQEHM 304 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HH-HHHHHHTTCCCH---------HHHHHCHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HH-HHHHhhccCCCc---------ccccCChhHHH
Confidence 12367899999999999999987765210 00 111111111110 01122345678
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 040687 708 IAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 708 l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
|+.+||+.||++||++.|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=325.82 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=188.9
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCe
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MGE 554 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~ 554 (740)
..++|+..+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 457899999999999999999997 468999999986543 3445679999999999999999999999873 347
Q ss_pred EEEEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 555 RLLVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
.++||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999875 3457999999999999999999999998 999999999999999999999999986
Q ss_pred ccccC--------------------------C----C---CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh
Q 040687 632 TSCER--------------------------D----L---TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP 678 (740)
Q Consensus 632 ~~~~~--------------------------~----~---~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 678 (740)
..... + . .++.++||||||+++|||++|+.||+......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------- 253 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-------- 253 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--------
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--------
Confidence 53210 0 0 13679999999999999999999995311000
Q ss_pred HHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 679 ~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
......+......+........+.+|+.+||+.||++||++.||++.|+++.
T Consensus 254 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 254 ----DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ----SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ----chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0111111112223333334457889999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.68 Aligned_cols=233 Identities=22% Similarity=0.311 Sum_probs=189.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||++... +++.||+|++..........+.+.+|++++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 4889999999876655556678999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC---EEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG---ARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DFGla~~~~~ 636 (740)
||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999998754 46899999999999999999999999 999999999999987655 99999999865432
Q ss_pred C--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 D--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 ~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
. ..++.++||||||+++|||++|+.||...... .....+..... ....+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~------~~~~~ 229 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQIKAGAY------DYPSP 229 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCC------CCCTT
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHHHHHHhccc------cCCch
Confidence 1 12367899999999999999999999643211 11111211111 11111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22233457889999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.50 Aligned_cols=235 Identities=23% Similarity=0.308 Sum_probs=186.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch---hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH---TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.+.|+..+.||+|+||.||+++.. +++.||||++....... ...+.+.+|+++|++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999975 58999999987543221 13578999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC---EEEeecCC
Q 040687 557 LVYEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG---ARIADFGL 630 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DFGl 630 (740)
|||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.+.. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888542 235899999999999999999999999 999999999999987654 99999999
Q ss_pred CccccCC---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 631 LTSCERD---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 631 a~~~~~~---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
+...... ..++.++||||||++||||++|+.||.... +.....+...
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~i~~~------ 247 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFEGIIKG------ 247 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHHHHHHT------
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHHHHHcC------
Confidence 8654321 224678999999999999999999996421 1111111111
Q ss_pred ccccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 690 DRNVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 690 d~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
....+. ......++.+|+.+||+.||++||++.|+++ ++++
T Consensus 248 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 248 --KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp --CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred --CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 111110 0122346789999999999999999999986 5543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.40 Aligned_cols=230 Identities=20% Similarity=0.292 Sum_probs=186.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC--CCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||++...+++.||||++..........+.|.+|+++|++++| |||+++++++......+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45699999999999999999998889999999998665445556789999999999976 9999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
||| .+++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||++......
T Consensus 88 ~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 588999999864 57899999999999999999999998 99999999999997 578999999998654211
Q ss_pred ---------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 638 ---------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 638 ---------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
..++.++||||||++||||++|+.||...... . . .
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~-~---------~ 229 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--I-S---------K 229 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--H-H---------H
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--H-H---------H
Confidence 22356899999999999999999999643211 1 1 1
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+++.......+.....++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 12222222222222223346889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=332.62 Aligned_cols=232 Identities=20% Similarity=0.261 Sum_probs=185.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||+||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....+|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 467999999999999999999985 588999999876432 2357889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC--EEEeecCCCccccC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG--ARIADFGLLTSCER- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~ki~DFGla~~~~~- 636 (740)
||+++|+|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 96 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 96 EYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999653 46999999999999999999999999 999999999999988766 99999999863221
Q ss_pred -------------------CCCC-CcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 -------------------DLTT-DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~~-~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...+ +.++||||||+++|||++|+.||........+.... ..+.......+
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~ 242 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---------QRILSVKYSIP 242 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH---------HHHHTTCCCCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH---------HHHhcCCCCCC
Confidence 1111 234899999999999999999997644333332211 12222233334
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......++.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 33334457889999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=330.67 Aligned_cols=241 Identities=24% Similarity=0.382 Sum_probs=188.7
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEe--
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLE-- 551 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~-- 551 (740)
.++....+|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 33444567999999999999999999975 58999999986543 334567899999999996 9999999999953
Q ss_pred ------CCeEEEEEecCCCCChHHhHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCE
Q 040687 552 ------MGERLLVYEFMPRGTLHDHLHG--GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA 623 (740)
Q Consensus 552 ------~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 623 (740)
....++||||++ |+|.+++.. ...++++.+++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCE
Confidence 345899999995 799999864 3356999999999999999999999875 459999999999999999999
Q ss_pred EEeecCCCccccC------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 040687 624 RIADFGLLTSCER------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEY 667 (740)
Q Consensus 624 ki~DFGla~~~~~------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~ 667 (740)
||+|||++..... ...++.++||||||+++|||+||+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999865321 1123568999999999999999999996422
Q ss_pred CCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 668 VPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
. ..+++.....+........+.+|+++||+.||++||++.|+++.|+++.+..
T Consensus 258 ~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 258 K-----------------LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H-----------------HHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 1111222222222222335778999999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=336.81 Aligned_cols=229 Identities=20% Similarity=0.292 Sum_probs=185.6
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC--CCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR--HSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||++...+++.||||++..........+.|.+|+++|++++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999877999999999766544455678999999999996 599999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
| +.+++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5688999999865 47899999999999999999999998 99999999999996 578999999998754211
Q ss_pred --------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 638 --------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 638 --------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
..++.++|||||||+||||++|+.||...... .. .+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~---------~~ 277 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---IS---------KL 277 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HH---------HH
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HH---------HH
Confidence 13466899999999999999999999643211 11 11
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+++.....+.+.....++.+|+.+||+.||++||++.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 2223333322222222347889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.08 Aligned_cols=237 Identities=19% Similarity=0.270 Sum_probs=192.2
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
+.+++...++|+..++||+|+||+||+++... ++.||+|++++..... .....+.+|+.+|+.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 45566677899999999999999999999864 8899999987643221 223458899999999999999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
....||||||+++|+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999764 5899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCC--------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 632 TSCERDL--------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 632 ~~~~~~~--------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
+...... .++.++|||||||+||||+||+.||..... .+. ..
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~-~~------- 283 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGT-YS------- 283 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----HHH-HH-------
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----hhH-HH-------
Confidence 6543210 135689999999999999999999974321 111 11
Q ss_pred chhccc--ccCCCCCchhHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 040687 686 AAIIDR--NVALPRNVEPLFKLADIAELAIRENPSE--LPTMSQVAT 728 (740)
Q Consensus 686 ~~i~d~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 728 (740)
.++.. .+..|.......++.+|+.+||+.+|.+ ||+++||++
T Consensus 284 -~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 284 -KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11111 1223333333457889999999999988 999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.51 Aligned_cols=228 Identities=19% Similarity=0.280 Sum_probs=188.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||||++...... ....+.+.+|+++|++++||||+++++++.+....+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999985 5899999999765432 234567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 999999999999754 46899999999999999999999999 99999999999999999999999999875432
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++||||||+++|||++|+.||..... .+ ....+ .......|.. .
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~-~~~~i--------~~~~~~~p~~--~ 261 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQ-IYEKI--------VSGKVRFPSH--F 261 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHH--------HHCCCCCCTT--C
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----HH-HHHHH--------HcCCCCCCCC--C
Confidence 12346799999999999999999999964321 11 11112 2222333322 2
Q ss_pred HHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 702 LFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
..++.+|+.+||+.||++||+ ++||++
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 347889999999999999998 888875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=330.24 Aligned_cols=228 Identities=25% Similarity=0.329 Sum_probs=186.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|...+.||+|+||.||+++. .+++.||||++....... .....+.+|+++|++++||||+++++++......+||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999997 458899999987643222 2235789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||+ +|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 78999998654 46999999999999999999999999 999999999999999999999999998654321
Q ss_pred -------------------CC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 -------------------LT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 -------------------~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
.. .+.++||||||+++|||++|+.||+....+. ....+.......|.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------------~~~~i~~~~~~~p~ 229 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------------LFKKVNSCVYVMPD 229 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------------CBCCCCSSCCCCCT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------------HHHHHHcCCCCCcc
Confidence 11 1468999999999999999999997543211 11111122222222
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+|+++||+.||.+|||++|+++
T Consensus 230 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 230 --FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22346789999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.65 Aligned_cols=237 Identities=22% Similarity=0.312 Sum_probs=191.4
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..+.||+|+||.||+++... +..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 34679999999999999999999855 7789999987654 23457899999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~~~ 635 (740)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999998754 46899999999999999999999999 9999999999999 888999999999986543
Q ss_pred CC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 636 RD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 636 ~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
.. ..++.++||||||+++|||+||+.||...... .....+... ....+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~--------~~~~~ 227 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLKIREG--------TFTFP 227 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHC--------CCCCC
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhC--------CCCCC
Confidence 21 12367999999999999999999999643211 111111111 11111
Q ss_pred CC--chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 040687 697 RN--VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVK 735 (740)
Q Consensus 697 ~~--~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~ 735 (740)
.. ......+.+|+.+||+.||++||++.|+++ ++++...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 10 122347889999999999999999999996 6666543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.75 Aligned_cols=234 Identities=23% Similarity=0.363 Sum_probs=186.3
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
.++|+..++||+|+||+||+++... ++.||||++++..... ...+.+.+|..+|.++ +||||+++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3679999999999999999999864 7899999998654322 2234578899999887 89999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999754 46999999999999999999999999 99999999999999999999999999875221
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCch----hHHhhhhHHhhCccchhcccc
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG----IVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~----~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.++||||||++||||++|+.||........ ..+.... .+....
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~--------~i~~~~ 278 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VILEKQ 278 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH--------HHHHCC
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH--------HHhccc
Confidence 12346789999999999999999999964322111 1111111 222333
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCH------HHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTM------SQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~ev~~ 728 (740)
+..|... ..++.+|+.+||+.||++||++ .||++
T Consensus 279 ~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 279 IRIPRSL--SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCCCTTS--CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred cCCCCcC--CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 3444332 3367899999999999999985 56665
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.25 Aligned_cols=233 Identities=14% Similarity=0.134 Sum_probs=188.0
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++... ++.||||.+...... ....+.|.+|+.++++++||||+++++++.+.+..|||
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999854 899999999865432 23456799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 638 (740)
|||+++++|.+++... ....++.+|+.|+++||+|||+.+ |+||||||+|||+++++.+||++++...
T Consensus 110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~------ 177 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP------ 177 (286)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT------
T ss_pred EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC------
Confidence 9999999999999653 356678899999999999999999 9999999999999999999999887643
Q ss_pred CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC--CCchhHHHHHHHHHHhhhcC
Q 040687 639 TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP--RNVEPLFKLADIAELAIREN 716 (740)
Q Consensus 639 ~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~--~~~~~~~~l~~l~~~Cl~~d 716 (740)
.++.++||||||++||||+||+.||........+.. ....+......+ .......++.+|+.+||+.|
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 247 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTT
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccC
Confidence 458899999999999999999999975432211100 000001111000 01122346889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHh
Q 040687 717 PSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 717 P~~RPt~~ev~~~Le~l~~~ 736 (740)
|++| |+.|+++.|+++...
T Consensus 248 P~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 248 GGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SSCC-CHHHHHHHHHHHHC-
T ss_pred CccC-CHHHHHHHHHHHhcc
Confidence 9999 999999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.82 Aligned_cols=233 Identities=24% Similarity=0.281 Sum_probs=178.9
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
....++|+..+.||+|+||.||+++... ++.||||+++... ..+.+.+|+++|++++||||+++++++.+....+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4456789999999999999999999864 7899999987543 3356889999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCCCcc
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTS 633 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGla~~ 633 (740)
|||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999999999754 46899999999999999999999998 999999999999975 88999999999865
Q ss_pred ccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 634 CER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 634 ~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
... ...++.++||||||++||||++|+.||......... ...+..... ..
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~i~~~~~------~~ 270 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM----FRRILNCEY------YF 270 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH----HHHHHTTCC------CC
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH----HHHHHhCCC------cc
Confidence 432 123467999999999999999999999643322111 111111111 01
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+...+...++.+|+++||+.||++||++.|+++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112233457889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.46 Aligned_cols=232 Identities=22% Similarity=0.322 Sum_probs=188.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+++|++++||||+++++++.+....+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999985 58899999987643 223457899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--CCCEEEeecCCCccccCC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS--DWGARIADFGLLTSCERD 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~ki~DFGla~~~~~~ 637 (740)
||+++++|.+++......+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999876567999999999999999999999999 999999999999974 467999999998754321
Q ss_pred --------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
..++.++||||||+++|||+||+.||..... .+ ....+..... ....+.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~-~~~~i~~~~~------~~~~~~ 273 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LE-TLQNVKRCDW------EFDEDA 273 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HH-HHHHHHHCCC------CCCSST
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HH-HHHHHHhCCC------CCCccc
Confidence 2246789999999999999999999974321 11 1111111111 011111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......++.+|+.+||+.||++|||+.|+++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1223447889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.60 Aligned_cols=240 Identities=23% Similarity=0.291 Sum_probs=188.4
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+++... ++.||||++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 679999999999999999999854 8999999987655434445678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999988754 46999999999999999999999999 99999999999999999999999999865331
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-----------hhCccch
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI-----------KQGKAAA 687 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 687 (740)
...++.++||||||+++|||+||+.||........+.. ..... ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~- 236 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL-IRKTLGDLIPRHQQVFSTNQYF- 236 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHHHHTCGGG-
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhccccccccccccccccc-
Confidence 13347799999999999999999999975432211111 11100 000000
Q ss_pred hcccccCCCCC--------chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 688 IIDRNVALPRN--------VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 688 i~d~~~~~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+.. ......+.+|+.+||+.||++|||++|+++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 -SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp -TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred -ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000111100 122346789999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.72 Aligned_cols=230 Identities=21% Similarity=0.266 Sum_probs=180.8
Q ss_pred cccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCC
Q 040687 485 KEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMP 563 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 563 (740)
...+.||+|+||.||+++.. +++.||+|+++.... ...++|.+|+++|++++||||+++++++.+.+..+|||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 34567999999999999974 589999999876542 345679999999999999999999999999999999999999
Q ss_pred CCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--CCCCCEEEeecCCCccccCC----
Q 040687 564 RGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL--DSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 564 ~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl--~~~~~~ki~DFGla~~~~~~---- 637 (740)
+++|.+++......+++.+++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999999766567999999999999999999999999 9999999999999 66789999999998754321
Q ss_pred ----------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC--Cc
Q 040687 638 ----------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR--NV 699 (740)
Q Consensus 638 ----------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~--~~ 699 (740)
..++.++||||||++||||+||+.||...... +.. ..+ +......+. ..
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~-~~i--------~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----ETL-NNI--------LACRWDLEDEEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHH-HHH--------HHTCCCSCSGGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHH-HHH--------HhccCCCChhhhc
Confidence 12356899999999999999999999754211 111 111 111111111 11
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
....++.+|+.+||+.||++||++.|+++ +|.+
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 22347889999999999999999999997 5554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.69 Aligned_cols=232 Identities=23% Similarity=0.312 Sum_probs=186.8
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCe
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (740)
....++|...+.||+|+||.||+++.. +++.||||+++..... ......+..|..+|.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345578999999999999999999985 4889999999765322 23456788999999977 99999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+|||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999753 46899999999999999999999999 999999999999999999999999998753
Q ss_pred cC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 635 ER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 635 ~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
.. ...++.++||||||+++|||++|+.||..... ......+. ....
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~--------~~~~ 235 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIR--------MDNP 235 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH--------HCCC
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH--------hCCC
Confidence 21 12246789999999999999999999964321 11111121 1222
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMS-QVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~~ 728 (740)
..|.. ...++.+|+.+||+.||++||++. ||.+
T Consensus 236 ~~p~~--~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCCTT--SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCcc--cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 22322 234678999999999999999997 6653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=325.94 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=181.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHH--HHhCCCCCcceEEeEEEeC-----C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEV--LCNIRHSNIVNLLGYCLEM-----G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~-----~ 553 (740)
.++|+..+.||+|+||.||+++. +++.||||++.... ...+..|.++ +..++||||+++++.+... .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46799999999999999999986 68999999986532 2445555555 4458999999999866532 2
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCEEECCCCCEE
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD---------AAPPIIHRDVKTLNILLDSDWGAR 624 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------~~~~iiHrDlk~~NILl~~~~~~k 624 (740)
..+|||||+++|+|.+++... .+++..++.++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 578999999999999999765 368999999999999999999998 6 99999999999999999999
Q ss_pred EeecCCCccccCC------------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCC
Q 040687 625 IADFGLLTSCERD------------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYV 668 (740)
Q Consensus 625 i~DFGla~~~~~~------------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~ 668 (740)
|+|||++...... ..++.++||||||+++|||+||+.||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999998654211 0112478999999999999999877643221
Q ss_pred CchhHHhhhhHHhhC----ccchhc---ccccCC----CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 669 PPGIVEWALPLIKQG----KAAAII---DRNVAL----PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~----~~~~i~---d~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
............... .....+ ..+... +.......++.+|+.+||+.||++|||+.|+++.|+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 111100000000000 000000 001111 12233556799999999999999999999999999998863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=322.15 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=183.9
Q ss_pred hcCccccceecccCceEEEEEEEeC--Cc--EEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD--GR--QVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~--~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++|+..+.||+|+||+||++++.. ++ .||||.++..... ....+.|.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3579999999999999999999643 33 6899998765322 234567999999999999999999999998765 8
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
++||||+++++|.+++......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999865567999999999999999999999998 9999999999999999999999999986543
Q ss_pred CC------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 636 RD------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 636 ~~------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
.. ..++.++||||||+++|||++ |+.||..... .+ ....+ ..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~-~~~~~--------~~ 239 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQ-ILHKI--------DK 239 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH-HHHHH--------HT
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HH-HHHHH--------Hc
Confidence 21 112458999999999999999 9999964321 11 11111 11
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
.....+.......++.+++.+||+.||++||++.++++.|+++....
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11222333344457889999999999999999999999999986653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.28 Aligned_cols=240 Identities=19% Similarity=0.240 Sum_probs=184.7
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEE-EeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC-LEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~l 557 (740)
..++|+..+.||+|+||.||+++. .+++.||||++..... ..++.+|++++++++|+|++..+..+ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999997 4588999998665432 23588899999999988877666655 56678899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCccc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTSC 634 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~~ 634 (740)
||||+ +++|.+++......+++.+++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999 99999999865567999999999999999999999999 9999999999999 78899999999998654
Q ss_pred cCC----------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCc--hhHHhhhhHHhhCc
Q 040687 635 ERD----------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP--GIVEWALPLIKQGK 684 (740)
Q Consensus 635 ~~~----------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~--~~~~~~~~~~~~~~ 684 (740)
... ..++.++||||||+++|||++|+.||....... ..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 321 123568999999999999999999997532221 11111111110000
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
... + ......++.+|+.+||+.||++||++.+|++.|+++.++
T Consensus 239 ~~~-~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 IEV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHH-H--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhh-h--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 000 0 011234788999999999999999999999999998875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.03 Aligned_cols=228 Identities=21% Similarity=0.328 Sum_probs=185.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||+||+++.. +++.||||++...........++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999985 689999999986544444567889999999999 999999999999999999999
Q ss_pred EecCCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC----------------
Q 040687 559 YEFMPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---------------- 619 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---------------- 619 (740)
|||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997532 46899999999999999999999998 999999999999984
Q ss_pred ---CCCEEEeecCCCccccCC------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh
Q 040687 620 ---DWGARIADFGLLTSCERD------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP 678 (740)
Q Consensus 620 ---~~~~ki~DFGla~~~~~~------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 678 (740)
...+||+|||++...... ...+.++||||||+++|||++|+.|+.... . ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~----~~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q----WH 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H----HH
T ss_pred cCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H----HH
Confidence 447999999998654321 123468999999999999999987764221 1 11
Q ss_pred HHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 679 ~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+...... ..+ ......+.+|+.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~-------~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 EIRQGRLP-------RIP--QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHTTCCC-------CCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCC-------CCC--cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111111 111 223347889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.34 Aligned_cols=242 Identities=22% Similarity=0.268 Sum_probs=190.1
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc---chhcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI---IHTNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
++....++|+..+.||+|+||.||+++.. +++.||+|++..... .....+.+.+|+++|++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 44566678999999999999999999974 478999999876532 22345789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGG---------------------------------------LSPLNWSLRLKISMQAAK 592 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~ia~~ia~ 592 (740)
.+..+|||||+++|+|.+++... ...+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 012357778899999999
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEECCCC--CEEEeecCCCccccC---------------------------CCCCCcc
Q 040687 593 GLEYLHKDAAPPIIHRDVKTLNILLDSDW--GARIADFGLLTSCER---------------------------DLTTDMK 643 (740)
Q Consensus 593 gL~yLH~~~~~~iiHrDlk~~NILl~~~~--~~ki~DFGla~~~~~---------------------------~~~~~~k 643 (740)
||+|||+.+ |+||||||+|||++.++ .+||+|||++..... ...++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 899999999864311 1234679
Q ss_pred cceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC--CCchhHHHHHHHHHHhhhcCCCCCC
Q 040687 644 SDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP--RNVEPLFKLADIAELAIRENPSELP 721 (740)
Q Consensus 644 sDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RP 721 (740)
+||||||+++|||++|+.||...... +.... +++.....+ ........+.+|+.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~----~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA----DTISQ---------VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH---------HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH----HHHHH---------HHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999643211 11111 111111111 1112344788999999999999999
Q ss_pred CHHHHHH--HHHHH
Q 040687 722 TMSQVAT--WLEQI 733 (740)
Q Consensus 722 t~~ev~~--~Le~l 733 (740)
++.|+++ ++.++
T Consensus 324 s~~~~l~hp~~~~~ 337 (345)
T 3hko_A 324 DAMRALQHPWISQF 337 (345)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhcChhhccC
Confidence 9999997 66554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.44 Aligned_cols=229 Identities=22% Similarity=0.326 Sum_probs=178.7
Q ss_pred hcCccccceecccCceEEEEEEE----eCCcEEEEEEecccccc--hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL----VDGRQVAVKRANAATII--HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vAiK~l~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++|+..+.||+|+||.||+++. .+++.||+|+++..... ......+.+|+++|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999997 36889999999865422 1234568899999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+|||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999754 46899999999999999999999998 999999999999999999999999998643
Q ss_pred cC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 635 ER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 635 ~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
.. ...++.++||||||+++|||++|+.||...... + ... .++....
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~-~~~--------~i~~~~~ 238 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK----K-TID--------KILKCKL 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----H-HHH--------HHHHTCC
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----H-HHH--------HHHhCCC
Confidence 21 122367899999999999999999999743211 1 111 1122222
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
..+. ....++.+|+.+||+.||++|| ++.|+++
T Consensus 239 ~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 NLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 2332 2234778999999999999999 7788876
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=330.93 Aligned_cols=231 Identities=24% Similarity=0.350 Sum_probs=187.9
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++... ++.||+|.+..... .....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 679999999999999999999754 78999999876542 2234578899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 999999999999864 46999999999999999999999999 99999999999999999999999999864321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||||++||||++|+.||....... ..+ ....+. ......|
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~-~~~~~~--------~~~~~~p 240 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKE-IVHTFE--------TTVVTYP 240 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHH-HHHHHH--------HCCCCCC
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHH-HHHHHh--------hcccCCC
Confidence 1124678999999999999999999997433221 111 111111 1112222
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPT-MSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 728 (740)
. .....+.+|+.+||+.||++||+ +.+|.+
T Consensus 241 ~--~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 S--AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp T--TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred C--cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2 23347889999999999999998 777764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.15 Aligned_cols=241 Identities=19% Similarity=0.240 Sum_probs=188.6
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEE-EeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC-LEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~l 557 (740)
..++|+..+.||+|+||.||+++. .+++.||||++.... ..+++.+|++++++++|++++..+.++ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999997 568999999986543 224689999999999988866666555 56678899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCccc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTSC 634 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~~ 634 (740)
||||+ +++|.+++......+++.+++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999 89999999865567999999999999999999999999 9999999999999 48889999999998653
Q ss_pred cCC----------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCC--chhHHhhhhHHhhCc
Q 040687 635 ERD----------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVP--PGIVEWALPLIKQGK 684 (740)
Q Consensus 635 ~~~----------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~--~~~~~~~~~~~~~~~ 684 (740)
... ..++.++||||||+++|||+||+.||...... ...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 321 12356899999999999999999999753221 111111111110000
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
... + ......++.+|+.+||+.||++||++.+|++.|+++.++.
T Consensus 239 ~~~-~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IEV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHH-H--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hHH-H--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 000 0 0112346889999999999999999999999999988753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.27 Aligned_cols=233 Identities=24% Similarity=0.364 Sum_probs=186.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
++|+..+.||+|+||.||+++... ++.||||+++...... ...+.+.+|..+|.++ +||||+++++++.+....+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 568999999999999999999854 8899999998654322 3345688999999988 899999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999754 46999999999999999999999999 99999999999999999999999999875321
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc----hhHHhhhhHHhhCccchhccccc
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP----GIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...++.++||||||+++|||++|+.||....... ...+..... +.....
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------i~~~~~ 236 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQI 236 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH--------HHHCCC
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH--------HHcCCC
Confidence 1234678999999999999999999996432211 111111111 222233
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCH------HHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTM------SQVAT 728 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~ev~~ 728 (740)
..|.. ...++.+|+.+||+.||++||++ .|+++
T Consensus 237 ~~p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 RIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CCCTT--SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCCCC--CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 33332 33467899999999999999995 56654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.27 Aligned_cols=224 Identities=22% Similarity=0.363 Sum_probs=185.3
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch------hcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH------TNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..++|+..+.||+|+||.||+++.. +++.||||+++...... .....+.+|+++|++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467999999999999999999974 58899999988654221 1334678899999999999999999999999
Q ss_pred CeEEEEEecCCCC-ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 553 GERLLVYEFMPRG-TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 553 ~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
+..++||||+..| +|.+++... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999877 999999765 46999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCC--------------------CC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 632 TSCERD--------------------LT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 632 ~~~~~~--------------------~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
...... .. .+.++||||||+++|||++|+.||.... +...
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------------------~~~~ 238 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-------------------ETVE 238 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-------------------GGTT
T ss_pred eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-------------------HHHh
Confidence 754321 11 2568899999999999999999996311 1111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.. ...++.+|+.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~--~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 239 AAIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp TCCCCSSC--CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCCcc--cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222221 2346889999999999999999999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=339.01 Aligned_cols=242 Identities=21% Similarity=0.235 Sum_probs=191.8
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEE
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYC 549 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (740)
+.+.+.+...++|+..+.||+|+||+||+++.+ +++.||||++++..... ...+.+.+|..+|.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445666677889999999999999999999985 58999999997643221 2334588999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
.+.+..||||||+++|+|.++|......+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999765457999999999999999999999999 9999999999999999999999999
Q ss_pred CCccccCC-----------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH
Q 040687 630 LLTSCERD-----------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI 680 (740)
Q Consensus 630 la~~~~~~-----------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 680 (740)
+++..... ..++.++|||||||++|||++|+.||...... +. ...+
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~-~~~i 282 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA----ET-YGKI 282 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HH-HHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH----HH-HHHH
Confidence 98654221 12467899999999999999999999643211 11 1111
Q ss_pred hhCccchhcccccCCCC-CchhHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 040687 681 KQGKAAAIIDRNVALPR-NVEPLFKLADIAELAIRENPSEL---PTMSQVAT 728 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ev~~ 728 (740)
... ......|. ......++.+|+++||+ +|.+| |+++||++
T Consensus 283 ~~~------~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHY------KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTH------HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred Hhc------ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 110 01111221 12233467899999999 99998 68998875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.38 Aligned_cols=233 Identities=27% Similarity=0.407 Sum_probs=188.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++... ++.||+|++....... .....+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999999754 7789999987644222 2356789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999754 46899999999999999999999998 99999999999999999999999998754322
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
....+.++||||||+++|||++|+.||...... + ....+.. .....+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~-~~~~~~~--------~~~~~~~-- 228 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----E-TYKRISR--------VEFTFPD-- 228 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----H-HHHHHHH--------TCCCCCT--
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----H-HHHHHHh--------CCCCCCC--
Confidence 123367899999999999999999999743211 1 1111111 1112222
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.....+.+|+.+||+.||++||+++||++ +|..
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 23346789999999999999999999997 5544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.71 Aligned_cols=232 Identities=22% Similarity=0.318 Sum_probs=184.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|...++||+|+||.||+++.. +++.||+|++..... ....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 356899999999999999999975 488999999876542 334578999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCcc
Q 040687 560 EFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTS 633 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~ 633 (740)
||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999998542 256999999999999999999999999 9999999999999 4567899999999865
Q ss_pred ccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 634 CERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 634 ~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
.... ..++.++||||||+++|||++|+.||..... .+ ......... ....
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----~~-~~~~~~~~~------~~~~ 245 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----EE-VQQKATYKE------PNYA 245 (285)
T ss_dssp ----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHCC------CCCC
T ss_pred cCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCH----HH-HHhhhccCC------cccc
Confidence 4321 1235689999999999999999999974321 11 111111110 1111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. ......++.+|+.+||+.||++||++.||++
T Consensus 246 ~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 1112346779999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=327.11 Aligned_cols=242 Identities=22% Similarity=0.328 Sum_probs=172.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||.||+++.. +++.||||+++.... ....+.+.+|+++|++++||||+++++++...+..+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999974 489999999876542 233467889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 560 EFMPRGTLHDHLHGG-----LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
||++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 6999998642 135899999999999999999999998 999999999999999999999999998653
Q ss_pred cC----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccchh-
Q 040687 635 ER----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAAAI- 688 (740)
Q Consensus 635 ~~----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i- 688 (740)
.. ...++.++||||||+++|||+||+.||........ .......... .....+
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhhh
Confidence 21 12346789999999999999999999975432111 1111111100 000000
Q ss_pred ----ccccc------------CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 ----IDRNV------------ALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 ----~d~~~------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..... ..........++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00001122346889999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=338.99 Aligned_cols=231 Identities=25% Similarity=0.406 Sum_probs=190.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|...+.||+|+||.||+|+.. +++.||||++....... .....+.+|+++|++++||||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999985 58999999997654322 23567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD-- 637 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~-- 637 (740)
||+++++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999999754 46999999999999999999999998 999999999999999999999999998754321
Q ss_pred -------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 638 -------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 638 -------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...+.++||||||+++|||++|+.||+..... .+ ...+ .+.....|..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~----~~~i--------~~~~~~~p~~ 238 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TL----FKKI--------CDGIFYTPQY 238 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HH----HHHH--------HTTCCCCCTT
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HH----HHHH--------hcCCcCCCcc
Confidence 11246899999999999999999999754321 11 1111 1222222222
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
...++.+|+.+||+.||++|||++||++ ++.
T Consensus 239 --~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 239 --LNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp --CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred --CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 2336789999999999999999999997 554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=326.81 Aligned_cols=229 Identities=24% Similarity=0.312 Sum_probs=187.1
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
.++|+..+.||+|+||+||+++... ++.||||+++..... ......+.+|..+|.++ +||||+++++++.+.+..||
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999999865 789999999865432 23456788999999988 89999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999753 46999999999999999999999998 99999999999999999999999999875321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||||+++|||++|+.||..... .+ ... .++......|
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~-~~~--------~i~~~~~~~p 241 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DE-LFQ--------SIMEHNVAYP 241 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHH--------HHHHCCCCCC
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----HH-HHH--------HHHhCCCCCC
Confidence 12246789999999999999999999964321 11 111 1222233333
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
.. ...++.+|+.+||+.||++||+ ++||++
T Consensus 242 ~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 KS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TT--SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CC--CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 32 2347789999999999999995 577764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=314.67 Aligned_cols=239 Identities=23% Similarity=0.334 Sum_probs=192.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh----cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT----NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||.||+++.. +++.||+|.++....... ..+.|.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56899999999999999999986 589999999876543221 3578999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----CEEEeecCCCc
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW----GARIADFGLLT 632 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DFGla~ 632 (740)
+||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999753 46899999999999999999999998 99999999999999877 89999999986
Q ss_pred cccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 633 SCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 633 ~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
.... ...++.++||||||+++|||++|+.||....... ....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~-------- 227 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-----TLTNISAVN-------- 227 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHTTC--------
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-----HHHHhHhcc--------
Confidence 5432 1234678999999999999999999997432111 111111111
Q ss_pred cCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHhc
Q 040687 693 VALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKDG 737 (740)
Q Consensus 693 ~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~~ 737 (740)
...+. .......+.+|+.+||+.||++||++.|+++ +++.+....
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 228 YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 11100 0122346789999999999999999999998 787776544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=331.08 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=191.7
Q ss_pred ChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
.+.++....++|+..+.||+|+||.||+++... .||+|.++.........+.|.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 445556667889999999999999999998743 599999876543334445688999999999999999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
...++||||+++++|.+++......+++.+++.++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999999876667999999999999999999999998 99999999999998 6799999999865
Q ss_pred cccC-----------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh
Q 040687 633 SCER-----------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL 677 (740)
Q Consensus 633 ~~~~-----------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 677 (740)
.... ...++.++||||||+++|||+||+.||..... +...
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~ 252 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAII 252 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 3210 01236689999999999999999999974321 1111
Q ss_pred hHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 678 ~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
..+....... . .......++.+|+.+||+.||++||++.+|++.|+++.++.
T Consensus 253 ~~~~~~~~~~-----~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 253 WQMGTGMKPN-----L---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHTTCCCC-----C---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHhccCCCCC-----C---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111111 1 11112235779999999999999999999999999877653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.95 Aligned_cols=241 Identities=23% Similarity=0.297 Sum_probs=180.5
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..+.||+|+||+||+++.. +++.||||+++.........+.+..+...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3467999999999999999999974 589999999976543333334455555668889999999999999999999999
Q ss_pred EecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 559 YEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
|||++ ++|.+++.. ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 588887753 345799999999999999999999997 8 999999999999999999999999997543
Q ss_pred cC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 635 ER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 635 ~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
.. ...++.++||||||+++|||+||+.||+....+.. .....+.
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~--------- 228 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQVVE--------- 228 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---HHHHHHH---------
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---HHHHHhc---------
Confidence 21 12235689999999999999999999964322111 1111111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKD 736 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~ 736 (740)
.............++.+|+.+||+.||++|||+.|+++ ++......
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~ 276 (290)
T 3fme_A 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276 (290)
T ss_dssp SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence 11111111223447889999999999999999999998 66655443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.56 Aligned_cols=232 Identities=28% Similarity=0.348 Sum_probs=184.9
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCeEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MGERLL 557 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 557 (740)
.|+..+.||+|+||.||+|... ++..||+|.+..........+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4778889999999999999975 47889999998766555566789999999999999999999999875 346899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGla~~~~~ 636 (740)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++|+||||||+|||++ +++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999999753 46899999999999999999999875 4599999999999998 789999999999854322
Q ss_pred C------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 D------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ~------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
. ..++.++||||||+++|||+||+.||.......... ..+........ .+
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~--------~~ 252 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----RRVTSGVKPAS--------FD 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----HHHTTTCCCGG--------GG
T ss_pred cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH----HHHhccCCccc--------cC
Confidence 1 124679999999999999999999996433221111 11111111110 11
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112236889999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.11 Aligned_cols=230 Identities=23% Similarity=0.309 Sum_probs=180.0
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
..++|+..+.||+|+||.||+++.. +++.||||++..... .......+.+|+.+|++++||||+++++++...+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999974 488999999976532 22334568899999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||||+++|+|.+++... ..+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++....
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999999754 468999999999999999999998 88 99999999999999999999999999875321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
...++.++||||||++||||++|+.||..... .+ ....+ .......
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~-~~~~i--------~~~~~~~ 368 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EK-LFELI--------LMEEIRF 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHH--------HHCCCCC
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HH-HHHHH--------HhCCCCC
Confidence 12346799999999999999999999964321 11 11111 1122223
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
|.. ...++.+|+.+||+.||++|| +++|+++
T Consensus 369 p~~--~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTT--SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred Ccc--CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 322 234678999999999999999 9999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=319.88 Aligned_cols=236 Identities=20% Similarity=0.315 Sum_probs=187.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--CCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE--MGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 557 (740)
.++|+..+.||+|+||.||+++.. +++.||+|.+..........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999985 58999999998765444556789999999999999999999998865 568999
Q ss_pred EEecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 558 VYEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDA--APPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999643 245899999999999999999999876 2359999999999999999999999999875
Q ss_pred cccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 633 SCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 633 ~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.... ...++.++||||||+++|||+||+.||..... . .....+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~----~~~~~i~~~~~~----- 234 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-K----ELAGKIREGKFR----- 234 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-H----HHHHHHHHTCCC-----
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-H----HHHHHHhhcccc-----
Confidence 4322 12346789999999999999999999974321 1 111122222111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 730 (740)
.. +.....++.+++.+||+.||++||++.||++.+
T Consensus 235 --~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 --RI--PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp --CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred --cC--CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11 122334788999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.44 Aligned_cols=244 Identities=19% Similarity=0.203 Sum_probs=182.3
Q ss_pred hcCccccceecccCceEEEEEEEe----CCcEEEEEEecccccch---------hcHHHHHHHHHHHHhCCCCCcceEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIH---------TNIREFEMELEVLCNIRHSNIVNLLG 547 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g 547 (740)
.++|...+.||+|+||.||+++.. .+..||||++....... .....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999985 46789999987543110 11234778899999999999999999
Q ss_pred EEEe----CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC--
Q 040687 548 YCLE----MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-- 621 (740)
Q Consensus 548 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-- 621 (740)
++.. ....+|||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 9988 67899999999 999999997653 7999999999999999999999998 99999999999999887
Q ss_pred CEEEeecCCCccccC----------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhH
Q 040687 622 GARIADFGLLTSCER----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIV 673 (740)
Q Consensus 622 ~~ki~DFGla~~~~~----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 673 (740)
.+||+|||+++.... ...++.++||||||++||||+||+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999864321 1123668999999999999999999996433222222
Q ss_pred HhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 674 EWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 674 ~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
.......... ....+..... ......++.+++..||+.||++||++.+|++.|+++
T Consensus 271 ~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 271 QTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 2111111111 1111111110 112334788999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=319.08 Aligned_cols=240 Identities=20% Similarity=0.228 Sum_probs=188.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++.. +++.||||++....... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 58899999987654322 2346789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... .++++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999754 46899999999999999999999998 99999999999999999999999998754322
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||||+++|||+||+.||..... ......+... ... . ...
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~-~~~---~-~~~- 257 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQA-IPR---P-STV- 257 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHHHHHSC-CCC---G-GGT-
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHHHhccC-CCC---c-ccc-
Confidence 12236689999999999999999999964321 1111111111 100 0 001
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHh
Q 040687 697 RNVEPLFKLADIAELAIRENPSELP-TMSQVATWLEQIVKD 736 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~Le~l~~~ 736 (740)
......++.+|+.+||+.||++|| +++++++.|+++++.
T Consensus 258 -~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 258 -RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 112223677999999999999999 999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=317.47 Aligned_cols=228 Identities=27% Similarity=0.373 Sum_probs=185.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-------- 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 551 (740)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 456999999999999999999986 68999999987543 356789999999999999999998864
Q ss_pred --------CCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 552 --------MGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 552 --------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
....++||||+++++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+|||+++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345799999999999999997532 46899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh
Q 040687 623 ARIADFGLLTSCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682 (740)
Q Consensus 623 ~ki~DFGla~~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 682 (740)
+||+|||++...... ..++.++||||||+++|||++|..|+... ......+..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~~~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTDLRD 233 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHHHHT
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHHhhc
Confidence 999999998654321 22367899999999999999999887411 001111111
Q ss_pred CccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 683 GKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 683 ~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
. .+ + ......+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 234 ~--------~~--~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 234 G--------II--S--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp T--------CC--C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred c--------cc--c--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 11 1 11223677999999999999999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.40 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=188.1
Q ss_pred hcCccccceecccCceEEEEEEE------eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL------VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
.++|+..+.||+|+||.||++++ .+++.||||++.... ......+|.+|+.++++++||||+++++++.+...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46799999999999999999984 246789999986443 23445679999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEE
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARI 625 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki 625 (740)
.+|||||+++++|.+++.... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999997543 34899999999999999999999998 999999999999994 456999
Q ss_pred eecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHh
Q 040687 626 ADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 626 ~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
+|||++..... ...++.++||||||+++|||+| |+.||..... ......+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~ 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFVT 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHHHHHHh
Confidence 99998753211 1224679999999999999999 9999964321 11111121
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
... ..+.+......+.+|+.+||+.||++||++.||++.|+.+.++
T Consensus 260 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111 1111223334788999999999999999999999999988654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.49 Aligned_cols=241 Identities=17% Similarity=0.216 Sum_probs=188.1
Q ss_pred hcCccccceecccCceEEEEEEEeC---------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcce-------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD---------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN------- 544 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~---------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~------- 544 (740)
.++|...+.||+|+||.||+++... ++.||||.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3679999999999999999999764 789999998643 36789999999999999987
Q ss_pred --------EEeEEEe-CCeEEEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 040687 545 --------LLGYCLE-MGERLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLN 614 (740)
Q Consensus 545 --------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~N 614 (740)
+++++.. ....+|||||+ +++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777776 67899999999 99999999864 356999999999999999999999998 9999999999
Q ss_pred EEECCCC--CEEEeecCCCccccC----------------------------CCCCCcccceehhHHHHHHHHhCCCCCC
Q 040687 615 ILLDSDW--GARIADFGLLTSCER----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYD 664 (740)
Q Consensus 615 ILl~~~~--~~ki~DFGla~~~~~----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~ 664 (740)
||++.++ .+||+|||+++.... ...++.++||||||++||||+||+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 899999999864321 1123568999999999999999999997
Q ss_pred CCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 665 IEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...............+.. ....+.+.. ........++.+|+.+||+.||++||++.+|++.|++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVD-KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GGTTCHHHHHHHHHHHHH-SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccC-Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 543222111111111111 111111111 01112234788999999999999999999999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.02 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=186.5
Q ss_pred cCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..+.||+|+||.||+++... ++.||||++..........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 569999999999999999999854 8999999987655434445678899999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp CCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99999898887643 46999999999999999999999999 99999999999999999999999999864321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhh----------hHHhhCcc-ch
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL----------PLIKQGKA-AA 687 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~----------~~~~~~~~-~~ 687 (740)
...++.++||||||+++|||++|+.||........+..... ........ ..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 12346789999999999999999999975432221111100 00000000 00
Q ss_pred hcccccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 688 IIDRNVALPR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 688 i~d~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+...... .......+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 1123457889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=320.43 Aligned_cols=231 Identities=22% Similarity=0.270 Sum_probs=187.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh----cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT----NIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.++|+..+.||+|+||.||+++.. +++.||+|.+........ ..+++.+|+.+|++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456999999999999999999985 488999999876543221 357799999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----CEEEeecCCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW----GARIADFGLL 631 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DFGla 631 (740)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999764 46899999999999999999999998 99999999999999888 7999999998
Q ss_pred ccccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 632 TSCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 632 ~~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
...... ..++.++||||||+++|||+||+.||...... + ....+...
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~-~~~~i~~~-------- 233 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----E-TLANITSV-------- 233 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----H-HHHHHHTT--------
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----H-HHHHHHhc--------
Confidence 654321 23467899999999999999999999643211 1 11111111
Q ss_pred ccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111110 0112346789999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.45 Aligned_cols=242 Identities=25% Similarity=0.374 Sum_probs=177.3
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCC--eE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMG--ER 555 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 555 (740)
..++|+..+.||+|+||.||++... +++.||||++..........+.+.+|+.+|+++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999974 5899999998765443445667889999999997 999999999997654 68
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
|||||||+ ++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 6999999764 6899999999999999999999999 9999999999999999999999999986431
Q ss_pred C-------------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchh
Q 040687 636 R-------------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGI 672 (740)
Q Consensus 636 ~-------------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 672 (740)
. ...++.++||||||++||||++|+.||........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 123467899999999999999999999754321111
Q ss_pred HHhhhhHHhhCccc-----------hhcc---c-----ccC--------------CCCCchhHHHHHHHHHHhhhcCCCC
Q 040687 673 VEWALPLIKQGKAA-----------AIID---R-----NVA--------------LPRNVEPLFKLADIAELAIRENPSE 719 (740)
Q Consensus 673 ~~~~~~~~~~~~~~-----------~i~d---~-----~~~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~ 719 (740)
......+...... ..++ . ... .........++.+|+.+||+.||++
T Consensus 241 -~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 -ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp -HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred -HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 1111100000000 0000 0 000 0001122346789999999999999
Q ss_pred CCCHHHHHH
Q 040687 720 LPTMSQVAT 728 (740)
Q Consensus 720 RPt~~ev~~ 728 (740)
|||++|+++
T Consensus 320 R~t~~e~l~ 328 (388)
T 3oz6_A 320 RISANDALK 328 (388)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhC
Confidence 999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=319.57 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=184.1
Q ss_pred cCcccc-ceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 482 NGFKEF-NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 482 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
+.|... +.||+|+||+||+++.. +++.||||++.... ......+.+|+++|.++ +||||+++++++.+.+..+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 457664 67999999999999964 58999999987653 23457899999999985 799999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC---EEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG---ARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DFGla~~~~ 635 (740)
|||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999754 46899999999999999999999998 999999999999998776 9999999986432
Q ss_pred CC---------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchh--HHhhhhHH
Q 040687 636 RD---------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGI--VEWALPLI 680 (740)
Q Consensus 636 ~~---------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~--~~~~~~~~ 680 (740)
.. ..++.++||||||+++|||+||+.||......... .....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 10 11356899999999999999999999754321100 00000000
Q ss_pred hhCccchhcccccCCCCC--chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 681 KQGKAAAIIDRNVALPRN--VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 681 ~~~~~~~i~d~~~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.......+.......+.. ......+.+|+.+||+.||++|||+.|+++ +++.
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 000011111122222210 122346889999999999999999999997 4444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.02 Aligned_cols=245 Identities=9% Similarity=-0.028 Sum_probs=174.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhC--CCCCcceEE-------eEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNI--RHSNIVNLL-------GYC 549 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 549 (740)
..+|+..+.||+|+||.||++++. +++.||||++..... .....+.+.+|+++++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456899999999999999999975 589999999987543 223445677885544444 699988755 444
Q ss_pred EeC-----------------CeEEEEEecCCCCChHHhHhCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 040687 550 LEM-----------------GERLLVYEFMPRGTLHDHLHGGLSPLNWSLR------LKISMQAAKGLEYLHKDAAPPII 606 (740)
Q Consensus 550 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~------~~ia~~ia~gL~yLH~~~~~~ii 606 (740)
... ...+|||||++ ++|.+++......+.+..+ +.++.||++||+|||+++ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 433 23799999998 8999999764344566666 788899999999999999 99
Q ss_pred ecCCCCCCEEECCCCCEEEeecCCCccccC------------------C--CCCCcccceehhHHHHHHHHhCCCCCCCC
Q 040687 607 HRDVKTLNILLDSDWGARIADFGLLTSCER------------------D--LTTDMKSDVHNFGIVLLEILSGRKAYDIE 666 (740)
Q Consensus 607 HrDlk~~NILl~~~~~~ki~DFGla~~~~~------------------~--~~~~~ksDVwSfGvvl~ElltG~~p~~~~ 666 (740)
||||||+|||++.++.+||+|||+++.... . ..++.++||||||++||||+||+.||...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999999864432 1 23477999999999999999999999754
Q ss_pred CCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 040687 667 YVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVK 735 (740)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~ 735 (740)
..... ..................+........+.+|+.+||+.||++|||+.|+++ +++++..
T Consensus 297 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 297 TPGIK------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp CTTCT------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred Ccccc------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 21110 000000111111222333333344557889999999999999999999986 6665543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.10 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=191.2
Q ss_pred cccChhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-----CCCcc
Q 040687 470 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-----HSNIV 543 (740)
Q Consensus 470 ~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv 543 (740)
..+++.+.....++|+..++||+|+||+||+++.. +++.||||+++... ...+.+..|++++++++ ||||+
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 34555566667789999999999999999999984 58899999987532 34467888999999986 99999
Q ss_pred eEEeEEEeCCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---
Q 040687 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS--- 619 (740)
Q Consensus 544 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--- 619 (740)
++++++...+..+|||||+ +++|.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999999 899999997653 45999999999999999999999999 999999999999986
Q ss_pred ----------------------CCCEEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhC
Q 040687 620 ----------------------DWGARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSG 659 (740)
Q Consensus 620 ----------------------~~~~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG 659 (740)
++.+||+|||++..... ...++.++||||||++||||+||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 78899999999865432 22347799999999999999999
Q ss_pred CCCCCCCCCCchhHHhhhhHHh-----------hCccchhccc---ccCCCCCch------------------hHHHHHH
Q 040687 660 RKAYDIEYVPPGIVEWALPLIK-----------QGKAAAIIDR---NVALPRNVE------------------PLFKLAD 707 (740)
Q Consensus 660 ~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~i~d~---~~~~~~~~~------------------~~~~l~~ 707 (740)
+.||........ ......... .......++. ....+.... ....+.+
T Consensus 256 ~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 256 SLLFRTHEHMEH-LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SCSCCCSSHHHH-HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCcHHHH-HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 999975322111 111100000 0000000000 001111100 0145779
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 040687 708 IAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 708 l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
|+.+||+.||++|||++|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.85 Aligned_cols=231 Identities=26% Similarity=0.270 Sum_probs=187.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. +++.||||.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 367899999999999999999985 589999999875442 234567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999999864311
Q ss_pred --------------------CCC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 --------------------DLT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 --------------------~~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
... .+.++||||||+++|||++|+.||+......... ..+... ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~--------~~~~ 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEK--------KTYL 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH----HHHHTT--------CTTS
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH----HHhhhc--------cccc
Confidence 011 2457999999999999999999997543322111 111111 1111
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+........+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 111223346789999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=328.02 Aligned_cols=233 Identities=24% Similarity=0.315 Sum_probs=187.0
Q ss_pred hcCccccceecccCceEEEEEEEe----CCcEEEEEEecccccc--hhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCC
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATII--HTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMG 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (740)
.++|+..+.||+|+||.||+++.. +++.||||+++..... ......+.+|+++|+++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999999999999973 6899999998764321 12335678899999999 6999999999999999
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..+|||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999754 46899999999999999999999998 99999999999999999999999999864
Q ss_pred ccC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 634 CER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 634 ~~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
... ...++.++||||||++||||+||+.||..........+......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------- 279 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--------- 279 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH---------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh---------
Confidence 321 11235789999999999999999999975443332222111111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
......+ .+....+.+|+.+||+.||++|| +++|+++
T Consensus 280 ~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 280 KSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 1112222 22334678999999999999999 9999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=325.42 Aligned_cols=234 Identities=17% Similarity=0.192 Sum_probs=188.7
Q ss_pred HHHHhhcCccccceecccCceEEEEEE------EeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC---CCCcceEE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAV------LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR---HSNIVNLL 546 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~------~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~ 546 (740)
+++...++|...++||+|+||+||+|. ...++.||||++... ...++..|++++.+++ |+||++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 444556789999999999999999994 345889999998753 3467888999999887 99999999
Q ss_pred eEEEeCCeEEEEEecCCCCChHHhHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---
Q 040687 547 GYCLEMGERLLVYEFMPRGTLHDHLHG----GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS--- 619 (740)
Q Consensus 547 g~~~~~~~~~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--- 619 (740)
+++...+..+|||||+++|+|.++++. ....+++.+++.|+.||++||+|||+.+ ||||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence 999999999999999999999999964 3356999999999999999999999998 999999999999998
Q ss_pred --------CCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCC
Q 040687 620 --------DWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYV 668 (740)
Q Consensus 620 --------~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~ 668 (740)
++.+||+|||+++.... ...++.++||||||++||||+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999954320 12247799999999999999999999953211
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHh
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSEL-PTMSQVATWLEQIVKD 736 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~ev~~~Le~l~~~ 736 (740)
.. .. ++...... .....+.+++..|++.+|.+| |++.++.+.|+++++.
T Consensus 291 ~~------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 291 GE------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TE------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Cc------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00 00 11111111 123366789999999999998 7788999888888765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.60 Aligned_cols=244 Identities=24% Similarity=0.273 Sum_probs=181.0
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccc---hhcHHHHHHHHHHHHhC---CCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATII---HTNIREFEMELEVLCNI---RHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 552 (740)
..++|+..++||+|+||+||+++. .+++.||||++...... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 45889999998754321 11234667788877766 499999999999876
Q ss_pred C-----eEEEEEecCCCCChHHhHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEe
Q 040687 553 G-----ERLLVYEFMPRGTLHDHLHGGLS-PLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIA 626 (740)
Q Consensus 553 ~-----~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 626 (740)
. ..++||||++ ++|.+++..... .+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 5799999997 699999986543 4899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---
Q 040687 627 DFGLLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG--- 683 (740)
Q Consensus 627 DFGla~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~--- 683 (740)
|||++..... ...++.++||||||+++|||++|+.||........+ ..........
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH-HHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChh
Confidence 9999865432 123467999999999999999999999754321111 1111111000
Q ss_pred ccch---hcccccC--CCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAA---IIDRNVA--LPR-----NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~---i~d~~~~--~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.... ....... .+. ..+....+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 0000000 000 1123346789999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.67 Aligned_cols=233 Identities=25% Similarity=0.368 Sum_probs=189.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||.||+++.. +++.||||.+....... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999985 47889999987643222 23467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999999999754 46899999999999999999999998 99999999999999999999999998754322
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++||||||+++|||++|+.||..... .+ ... .+.......+. .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~-~~~--------~~~~~~~~~~~--~ 234 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----TE-THR--------RIVNVDLKFPP--F 234 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HH-HHH--------HHHTTCCCCCT--T
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----hH-HHH--------HHhccccCCCC--c
Confidence 12346799999999999999999999964321 11 111 11112222222 2
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
....+.+++.+||+.||++||+++|+++ ++...
T Consensus 235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 2346789999999999999999999997 66543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.82 Aligned_cols=226 Identities=24% Similarity=0.274 Sum_probs=175.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-hcHHHHHHHHHH-HHhCCCCCcceEEeEEEeCCeEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-TNIREFEMELEV-LCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
.++|+..+.||+|+||.||+++... ++.||||++++..... .....+.+|..+ ++.++||||+++++++.+.+..||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999854 7899999998765332 234557778777 567899999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999754 46899999999999999999999999 99999999999999999999999999875321
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||||+++|||++|+.||.... ..+ ... .++......+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~-~~~--------~i~~~~~~~~ 259 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAE-MYD--------NILNKPLQLK 259 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----HHH-HHH--------HHHHSCCCCC
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHH-HHH--------HHHhcccCCC
Confidence 1223678999999999999999999996432 111 111 1222222233
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQ 725 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 725 (740)
.. ....+.+|+.+||+.||++||++.+
T Consensus 260 ~~--~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 260 PN--ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp SS--SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CC--CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 22 2346789999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.34 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=173.7
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
...++|+..+.||+|+||.||+++.. +++.||||++..... ....+++.+|++++++++||||+++++++...+..++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34578999999999999999999864 588999999875432 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 558 VYEFMPRGTLHDHLHG-------GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
||||+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999863 2346899999999999999999999998 99999999999999999999999998
Q ss_pred CccccC---------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC
Q 040687 631 LTSCER---------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG 683 (740)
Q Consensus 631 a~~~~~---------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 683 (740)
+..... ...++.++||||||+++|||+||+.||........+ .... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~-~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----MLTL-QN 242 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----HHHH-TS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH----HHHh-cc
Confidence 653221 012467899999999999999999999754321111 1111 11
Q ss_pred ccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 040687 684 KAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKD 736 (740)
Q Consensus 684 ~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~ 736 (740)
....................++.+|+.+||+.||++||++.|+++ ++.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 111111100011111223346889999999999999999999997 66655443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.98 Aligned_cols=229 Identities=21% Similarity=0.347 Sum_probs=187.4
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|...+.||+|+||.||+++..+ ++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3678999999999999999999864 788999998765422 23456789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999998653 46899999999999999999999998 99999999999999999999999999865431
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
....+.++||||||+++|||+||+.||...... +. ...+ .......+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~-~~~~--------~~~~~~~~~ 236 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ET-YLRI--------KKNEYSIPK 236 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HH-HHHH--------HTTCCCCCT
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH-HHHH--------hhccCCCcc
Confidence 112356899999999999999999999643211 11 1111 111222222
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+.+++.+||+.||++||+++|+++
T Consensus 237 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 237 --HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 22346789999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=338.35 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=186.8
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..+.|+..++||+|+||+||+++.. +++.||||.+............+.+|+.+|++++||||+++++++.+....+||
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999985 588999999987654444457899999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGla~~~~ 635 (740)
|||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999998654 46899999999999999999999999 999999999999976 4559999999986543
Q ss_pred CC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 636 RD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 636 ~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
.. ..++.++||||||+++|||++|+.||..... ......+...... ...+
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~------~~~~ 259 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEKGKYT------FDSP 259 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCC------CCSG
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC------CCch
Confidence 21 2246799999999999999999999974321 1111222211111 0111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
........+.+|+.+||+.||.+|||+.|+++ +|.+..
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11223346789999999999999999999996 666653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=321.18 Aligned_cols=241 Identities=20% Similarity=0.268 Sum_probs=185.0
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEe--CCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLE--MGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~l 557 (740)
++|+..+.||+|+||+||+++. .+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6799999999999999999997 45889999998743 3467899999999997 9999999999987 567899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~ 636 (740)
||||+++++|.+++.. +++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||++.....
T Consensus 111 v~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999853 889999999999999999999999 99999999999999776 899999999864322
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc------
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII------ 689 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~------ 689 (740)
...++.++||||||+++|||++|+.||.........................+
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 12346789999999999999999999954322211111111110000000000
Q ss_pred -----------------ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 690 -----------------DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 690 -----------------d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
+.............++.+|+.+||+.||++|||++|+++ ++..+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 000111111123457889999999999999999999997 554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.37 Aligned_cols=231 Identities=20% Similarity=0.264 Sum_probs=182.2
Q ss_pred cCcccc-ceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHH-HhCCCCCcceEEeEEEe----CCe
Q 040687 482 NGFKEF-NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVL-CNIRHSNIVNLLGYCLE----MGE 554 (740)
Q Consensus 482 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~ 554 (740)
++|... +.||+|+||.||+++.. +++.||||+++.. ..+.+|++++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 557776 77999999999999974 5889999998642 4577889888 55699999999999987 567
Q ss_pred EEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGl 630 (740)
.+|||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 899999999999999997653 46999999999999999999999999 999999999999998 78899999999
Q ss_pred CccccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC--CchhHHHHHHH
Q 040687 631 LTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR--NVEPLFKLADI 708 (740)
Q Consensus 631 a~~~~~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~--~~~~~~~l~~l 708 (740)
+..... ..++.++||||||+++|||+||+.||........ .......+.......+. ......++.+|
T Consensus 167 a~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (299)
T 3m2w_A 167 AKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGMKTRIRMGQYEFPNPEWSEVSEEVKML 236 (299)
T ss_dssp CEECTT-CGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHH
T ss_pred cccccc-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------hHHHHHHHhhccccCCchhcccCCHHHHHH
Confidence 987653 4467899999999999999999999964321110 00011111111111111 01234478899
Q ss_pred HHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 709 AELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 709 ~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
+.+||+.||++|||+.|+++ ++.+
T Consensus 237 i~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 237 IRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHHcccChhhCCCHHHHhcChhhcc
Confidence 99999999999999999997 4443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.21 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=192.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..+.||+|+||.||+++.. +++.||+|++.... .....+.+.+|+.+|++++||||+++++++.+.+..+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 357999999999999999999985 58899999987653 2334567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
||+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred ECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999754 4689999999999999999999985 7 99999999999999999999999999853211
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH-------------------
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI------------------- 680 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~------------------- 680 (740)
...++.++||||||+++|||+||+.||....... + .......
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-L-ELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-H-HHHHC---------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H-HHHhcccccccCCCCCCCcccCCCcc
Confidence 2234678999999999999999999997432110 0 0000000
Q ss_pred --------hhCcc----chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 040687 681 --------KQGKA----AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKD 736 (740)
Q Consensus 681 --------~~~~~----~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~~ 736 (740)
..... ..+...............++.+|+.+||+.||++|||++|+++ ++++...+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 00000 0011111111111223447889999999999999999999997 77665544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.21 Aligned_cols=233 Identities=16% Similarity=0.147 Sum_probs=179.0
Q ss_pred HhhcCccccceecccCceEEEEEEE-eCCcEEEEEEeccccc-chhcHHHHHHHH---HHHHhCCCCCcceEE-------
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATI-IHTNIREFEMEL---EVLCNIRHSNIVNLL------- 546 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~-~~~~~~~~~~E~---~~l~~l~H~niv~l~------- 546 (740)
...++|+..+.||+|+||+||+|+. .+++.||||++..... .....+.|.+|+ ++|++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457799999999999999999996 4589999999875432 223456789999 555566899999998
Q ss_pred eEEEeCC-----------------eEEEEEecCCCCChHHhHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 040687 547 GYCLEMG-----------------ERLLVYEFMPRGTLHDHLHGGL------SPLNWSLRLKISMQAAKGLEYLHKDAAP 603 (740)
Q Consensus 547 g~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 603 (740)
+++...+ ..+|||||+ +|+|.+++.... ..+++..++.|+.||++||+|||+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6665543 278999999 689999997531 12446888999999999999999999
Q ss_pred CeEecCCCCCCEEECCCCCEEEeecCCCccccC-----------------CC-----------CCCcccceehhHHHHHH
Q 040687 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCER-----------------DL-----------TTDMKSDVHNFGIVLLE 655 (740)
Q Consensus 604 ~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-----------------~~-----------~~~~ksDVwSfGvvl~E 655 (740)
|+||||||+|||++.++.+||+|||+++.... .. .++.++||||||++|||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999999999999999999875332 11 46789999999999999
Q ss_pred HHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 656 ILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 656 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
|+||+.||....... ....+... . .....++.+|+.+||+.||++||++.|+++ +++++
T Consensus 306 lltg~~Pf~~~~~~~-------------~~~~~~~~----~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 306 IWCADLPITKDAALG-------------GSEWIFRS----C--KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHSSCCC------C-------------CSGGGGSS----C--CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHCCCCCccccccc-------------chhhhhhh----c--cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999996432111 11111111 0 122346789999999999999999999996 65554
Q ss_pred H
Q 040687 734 V 734 (740)
Q Consensus 734 ~ 734 (740)
.
T Consensus 367 ~ 367 (377)
T 3byv_A 367 R 367 (377)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.05 Aligned_cols=239 Identities=24% Similarity=0.304 Sum_probs=184.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC----e
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----E 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 554 (740)
.++|+..+.||+|+||.||+++. .+++.||||+++...... .....|.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999997 458999999997654322 33457899999999999999999999987654 3
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+|||||+++++|.++++.. .++++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999999754 46999999999999999999999998 999999999999999999999999998643
Q ss_pred cC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 635 ER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 635 ~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
.. ...++.++||||||+++|||+||+.||..... .+.............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~--- 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIPP--- 239 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCCH---
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCCCc---
Confidence 22 12236689999999999999999999964321 111111111111100
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHH-HHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVA-TWLEQIV 734 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~-~~Le~l~ 734 (740)
.. .......++.+|+.+||+.||++||+..+++ ..|.++.
T Consensus 240 -~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 -SA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -HH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -cc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00 0112234678999999999999999766555 4565543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=313.51 Aligned_cols=228 Identities=25% Similarity=0.394 Sum_probs=187.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.+.|+..+.||+|+||.||+++.. +++.||||.+..... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 456999999999999999999974 588999999876542 234678999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++++|.+++.. .++++.+++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999975 46999999999999999999999999 99999999999999999999999999865332
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||++|+.||..... .+ ....+.... .....
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~-~~~~~~~~~---------~~~~~ 240 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MK-VLFLIPKNN---------PPTLE 240 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH-HHHHHHHSC---------CCCCC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HH-HHHHhhcCC---------CCCCc
Confidence 12236789999999999999999999964321 11 111111111 11111
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+.+|+.+||+.||++||++.|+++
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 223346889999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.91 Aligned_cols=242 Identities=21% Similarity=0.309 Sum_probs=185.3
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--------
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-------- 552 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 552 (740)
++|+..++||+|+||.||+++. .+++.||||++............+.+|+++|++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999998 4589999999876654444456788999999999999999999999874
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
+..+|||||+++ +|.+.+......+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999974 898888877677999999999999999999999999 9999999999999999999999999986
Q ss_pred cccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---C
Q 040687 633 SCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---G 683 (740)
Q Consensus 633 ~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~ 683 (740)
.... ...++.++||||||+++|||+||+.||........+ ......... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChh
Confidence 4321 122467999999999999999999999754321111 111110000 0
Q ss_pred ccchh-----ccc---ccCCCCCc-h------hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAI-----IDR---NVALPRNV-E------PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i-----~d~---~~~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..... .+. ........ + ....+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000 000 00000000 0 0235779999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.80 Aligned_cols=225 Identities=20% Similarity=0.250 Sum_probs=176.6
Q ss_pred cceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 487 FNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
.+.||+|+||.||+++.. +++.||||++... ....+.+|+.++++++ ||||+++++++.+....+|||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 367999999999999985 4899999998643 3367889999999997 99999999999999999999999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---CEEEeecCCCccccC-----
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW---GARIADFGLLTSCER----- 636 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ki~DFGla~~~~~----- 636 (740)
++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++.....
T Consensus 91 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 91 GELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 9999999865 57999999999999999999999999 99999999999997765 899999999864322
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc--hhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP--GIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++||||||+++|||++|+.||....... .........+ .......+.+
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i--------~~~~~~~~~~ 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--------KKGDFSFEGE 238 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH--------TTTCCCCCSH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH--------HcCCCCCCcc
Confidence 1224678999999999999999999997533211 0011111112 1112211111
Q ss_pred --chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 --VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 --~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 123447889999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.06 Aligned_cols=233 Identities=25% Similarity=0.376 Sum_probs=189.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|...+.||+|+||.||+++.. +++.||||.+...... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999985 5899999998764322 23456789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD- 637 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~- 637 (740)
|||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999754 46899999999999999999999999 999999999999999999999999987654321
Q ss_pred --------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 638 --------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 638 --------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...+.++||||||+++|||++|+.||+.... ......+... ....+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~--------~~~~~~ 232 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKIRGG--------VFYIPE 232 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC--------CCCCCT
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcC--------cccCch
Confidence 1124689999999999999999999964321 1111112111 111222
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.....+.+++.+||+.||++||++.|+++ ++.+
T Consensus 233 --~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 233 --YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred --hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 22346789999999999999999999997 4543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.64 Aligned_cols=230 Identities=21% Similarity=0.354 Sum_probs=187.9
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
..++|...+.||+|+||.||+++..+ ++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34679999999999999999999864 789999998765422 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 119 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999998753 46899999999999999999999998 99999999999999999999999999865431
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++||||||+++|||++|+.||..... .+. ...+.. .....+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~-~~~~~~--------~~~~~~ 261 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KET-YLRIKK--------NEYSIP 261 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHH-HHHHHH--------TCCCCC
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHH-HHHHhc--------CCCCCC
Confidence 11235689999999999999999999964321 111 111111 112222
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. .....+.+|+.+||+.||++||++.|+++
T Consensus 262 ~--~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 K--HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp T--TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred c--cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 22336789999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.45 Aligned_cols=241 Identities=21% Similarity=0.239 Sum_probs=191.7
Q ss_pred hhHHHHhhcCcccc-ceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE
Q 040687 474 LSELKDATNGFKEF-NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL 550 (740)
Q Consensus 474 ~~~l~~~~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (740)
+...+...+.|... +.||+|+||.||+++.. +++.||||++...........++.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44445556677776 88999999999999985 489999999987655445567899999999999 5699999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEe
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIA 626 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~ 626 (740)
+....++||||+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999998654 356899999999999999999999999 999999999999998 7899999
Q ss_pred ecCCCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 627 DFGLLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 627 DFGla~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
|||++..... ...++.++||||||+++|||++|+.||........ ...+....
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~-- 249 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-----YLNISQVN-- 249 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTC--
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHHHhcc--
Confidence 9999865432 12346799999999999999999999964321111 11111110
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+........+.+|+.+||+.||++|||++|+++
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 ----VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 11111112233446889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.21 Aligned_cols=240 Identities=28% Similarity=0.385 Sum_probs=188.9
Q ss_pred cccChhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEe
Q 040687 470 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLG 547 (740)
Q Consensus 470 ~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g 547 (740)
..+.+.++....++|+..+.||+|+||.||+++.. +++.||||++.... .....+.+|+.+++++ +||||+++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence 34556677778899999999999999999999984 58899999987543 2346789999999999 8999999999
Q ss_pred EEEe------CCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 548 YCLE------MGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 548 ~~~~------~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
++.. ....+|||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCC
Confidence 9987 457899999999999999997543 46899999999999999999999998 9999999999999999
Q ss_pred CCEEEeecCCCccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHH
Q 040687 621 WGARIADFGLLTSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVE 674 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 674 (740)
+.+||+|||++..... ...++.++||||||+++|||+||+.||...... +
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~ 241 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----R 241 (326)
T ss_dssp CCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----H
T ss_pred CCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----H
Confidence 9999999999764321 123467899999999999999999999643211 1
Q ss_pred hhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 675 WALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 675 ~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. ..+...... . .........+.+|+.+||+.||++||++.|+++
T Consensus 242 ~~-~~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 AL-FLIPRNPAP-----R---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HH-HHHHHSCCC-----C---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH-HHhhcCccc-----c---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11 111111111 1 111222347889999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.41 Aligned_cols=230 Identities=19% Similarity=0.235 Sum_probs=178.7
Q ss_pred cCcccc-ceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHh-CCCCCcceEEeEEEe----CCe
Q 040687 482 NGFKEF-NELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCN-IRHSNIVNLLGYCLE----MGE 554 (740)
Q Consensus 482 ~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~ 554 (740)
++|... +.||+|+||+||+++.. +++.||||+++.. ..+.+|++++.+ .+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 68999999999999985 4889999998632 456788888754 589999999999875 457
Q ss_pred EEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGL 630 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGl 630 (740)
.+|||||+++|+|.+++.... ..+++.++..|+.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998653 46999999999999999999999998 999999999999998 78999999999
Q ss_pred CccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 631 LTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 631 a~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
++.... ...++.++|||||||+||||++|+.||......... ......+..+..
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~----- 284 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQY----- 284 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCC-----
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCcc-----
Confidence 865432 223467999999999999999999999754321100 001111111111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.......++.+|+++||+.||++|||+.||++
T Consensus 285 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111112233457889999999999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=322.24 Aligned_cols=244 Identities=18% Similarity=0.262 Sum_probs=180.5
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
...++|+..++||+|+||+||+++.. +++.||||+++.........+.+.+|+++|++++||||+++++++.+....+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999974 58899999997665434445678899999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-----CCCCCEEEeecCCCc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL-----DSDWGARIADFGLLT 632 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-----~~~~~~ki~DFGla~ 632 (740)
||||++ ++|.+++... ..+++.++..|+.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 111 v~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999997 5999999765 46999999999999999999999998 9999999999999 455569999999875
Q ss_pred cccC----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccc-
Q 040687 633 SCER----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAA- 686 (740)
Q Consensus 633 ~~~~----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~- 686 (740)
.... ...++.++||||||+++|||++|+.||........+.. ....... ....
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK-IFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTTSTT
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH-HHHHhCCCchhhhhh
Confidence 3221 12357899999999999999999999975432111111 1110000 0000
Q ss_pred --hhcccccCCCC----------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 --AIIDRNVALPR----------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 --~i~d~~~~~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.....+. ......++.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000 0012346789999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.89 Aligned_cols=235 Identities=23% Similarity=0.295 Sum_probs=182.7
Q ss_pred HhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch------hcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH------TNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
...++|...+.||+|+||+||++.... ++.||||++....... .....+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 346789999999999999999999754 7899999987654221 11234889999999999999999999975
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CCEEEeec
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD---WGARIADF 628 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DF 628 (740)
.+..+|||||+++++|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.+ ..+||+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 45689999999999999999754 57999999999999999999999998 9999999999999754 45999999
Q ss_pred CCCccccCC-----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 629 GLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 629 Gla~~~~~~-----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
|+++..... ..++.++||||||++||||+||+.||........+.+ .+.....
T Consensus 287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~----~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD----QITSGKY 362 (419)
T ss_dssp STTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH----HHHTTCC
T ss_pred ccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH----HHhcCCC
Confidence 998654321 1234589999999999999999999975433322221 1111111
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
... . +........+.+|+.+||+.||++||++.|+++
T Consensus 363 ~~~-~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NFI-P-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCC-H-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-c-----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 100 0 000122346789999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=348.91 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=195.2
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
+.+...++|+..+.||+|+||.||+|++.. +..||||+++... .....+.|.+|+.+|++++||||+++++++.+
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 334445779999999999999999999743 4579999987543 23345679999999999999999999999854
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
+..+|||||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 5689999999999999999876667999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCC----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 632 TSCERD----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 632 ~~~~~~----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
+..... ..++.++||||||+++|||++ |+.||..... .. ....+...
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~----~~~~i~~~----- 608 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-ND----VIGRIENG----- 608 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH----HHHHHHHT-----
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HH----HHHHHHcC-----
Confidence 754321 123568999999999999998 9999964321 11 11112111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+.+......+.+|+.+||+.||++||++.||++.|++++++
T Consensus 609 ----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11122223345788999999999999999999999999999765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.93 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=185.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|...++||+|+||+||+++.. +++.||||+++..... .....+.+|+++|++++||||+++++++...+..+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57899999999999999999985 5889999998754321 111245679999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|++ ++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 997 5999999877677999999999999999999999999 99999999999999999999999998753321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh---Cccchhccc----
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ---GKAAAIIDR---- 691 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~i~d~---- 691 (740)
...++.++||||||+++|||+||+.||....... ........... .........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhhc
Confidence 1234778999999999999999999997543211 11111111100 000000000
Q ss_pred ccCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 692 NVALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 692 ~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
....+. ......++.+|+.+||+.||++|||++|+++ ++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000000 1122346789999999999999999999987 55443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=338.09 Aligned_cols=235 Identities=21% Similarity=0.250 Sum_probs=190.3
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
..++|+..+.||+|+||.||+++.. +++.||||++...... ......+.+|+++|++++||||+++++++.+.+..+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999985 5899999999765432 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999997643 35999999999999999999999999 99999999999999999999999999875432
Q ss_pred C--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 D--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 ~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
. ..++.++|||||||+||||++|+.||.......... .....+.. .....+
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~i~~--------~~~~~p 409 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE--------VPEEYS 409 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHHHHH--------CCCCCC
T ss_pred CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHHhhc--------ccccCC
Confidence 1 123678999999999999999999997543222111 11111111 111222
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
.....++.+|+.+||+.||++|| +++||++
T Consensus 410 --~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 --ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 22334778999999999999999 7888875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.26 Aligned_cols=241 Identities=28% Similarity=0.372 Sum_probs=193.4
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
...++|+..+.||+|+||.||+++.. +++.||||++..........+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999985 58899999997665444566789999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC---CCEEEeecCCCccc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD---WGARIADFGLLTSC 634 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~ki~DFGla~~~ 634 (740)
||||+++++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999998654 36899999999999999999999998 9999999999999764 46999999998654
Q ss_pred cCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 635 ERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 635 ~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
... ..++.++||||||+++|||++|+.||..... .+ ....+...... ...
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~-~~~~~~~~~~~------~~~ 243 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE----YD-ILKRVETGKYA------FDL 243 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHCCCC------CCS
T ss_pred cCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HH-HHHHHHcCCCC------CCc
Confidence 321 1246789999999999999999999964321 11 11122221111 111
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
+.......++.+++.+||+.||++|||+.|+++ ++++..
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 111223347889999999999999999999998 666653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=336.01 Aligned_cols=239 Identities=23% Similarity=0.324 Sum_probs=187.4
Q ss_pred HhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccch-----------hcHHHHHHHHHHHHhCCCCCcceEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIH-----------TNIREFEMELEVLCNIRHSNIVNLL 546 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~l~ 546 (740)
...++|...++||+|+||+||+++... ++.||||++....... ...+.+.+|+.+|++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 346789999999999999999999854 7899999987654321 2356789999999999999999999
Q ss_pred eEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC---CE
Q 040687 547 GYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW---GA 623 (740)
Q Consensus 547 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~ 623 (740)
+++.+....+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999999754 46999999999999999999999999 99999999999998775 69
Q ss_pred EEeecCCCccccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 624 RIADFGLLTSCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 624 ki~DFGla~~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
||+|||++...... ..++.++||||||+++|||++|+.||..... ......+....
T Consensus 189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~ 263 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDIIKKVEKGK 263 (504)
T ss_dssp EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC
T ss_pred EEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence 99999998654321 1236799999999999999999999975321 11112222221
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
... ..+.......++.+|+.+||+.||.+|||+.|+++ |+.+
T Consensus 264 ~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 264 YYF------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCC------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 110 00001122346789999999999999999999986 5554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.99 Aligned_cols=230 Identities=20% Similarity=0.289 Sum_probs=181.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|.....||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 34556668999999999999974 58899999987643 2345679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCccccCC
Q 040687 561 FMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLTSCERD 637 (740)
Q Consensus 561 y~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~~~~~~ 637 (740)
|+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999997653 34678999999999999999999998 999999999999987 899999999998654320
Q ss_pred -----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 638 -----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 638 -----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
..++.++||||||+++|||++|+.||.......... .... .......
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~-------~~~~~~~ 246 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVG-------MFKVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHH-------HHCCCCC
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhc-------ccccccc
Confidence 114568999999999999999999996432111100 0000 0011111
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. +.....++.+|+.+||+.||++||++.|+++
T Consensus 247 ~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 I--PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C--CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c--cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 2233347889999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.58 Aligned_cols=231 Identities=24% Similarity=0.311 Sum_probs=182.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
..++|+..+.||+|+||.||+++.. +++.||||++.... ..+.+|+++|.++ +||||+++++++.+....+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3467999999999999999999985 48899999987543 2345688889888 79999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC----CCEEEeecCCCcc
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD----WGARIADFGLLTS 633 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~ki~DFGla~~ 633 (740)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+.++ ..+||+|||++..
T Consensus 94 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999999764 46999999999999999999999999 9999999999998543 3499999999875
Q ss_pred ccCCC---------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 634 CERDL---------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 634 ~~~~~---------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
..... .++.++||||||+++|||++|+.||...... ..+.....+..+...
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~------ 241 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFS------ 241 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCC------
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcc------
Confidence 43211 0245899999999999999999999743211 111122222222111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+.......++.+|+.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111233447789999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=329.11 Aligned_cols=246 Identities=21% Similarity=0.321 Sum_probs=181.2
Q ss_pred HHhhcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC----
Q 040687 478 KDATNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM---- 552 (740)
Q Consensus 478 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---- 552 (740)
+...++|+..+.||+|+||.||+++. .+++.||||++.... ..+.+|+++|++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44567899999999999999999997 458999999986543 2234799999999999999999998543
Q ss_pred ----------------------------------CeEEEEEecCCCCChHHhHhC---CCCCCCHHHHHHHHHHHHHHHH
Q 040687 553 ----------------------------------GERLLVYEFMPRGTLHDHLHG---GLSPLNWSLRLKISMQAAKGLE 595 (740)
Q Consensus 553 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~ia~~ia~gL~ 595 (740)
...+|||||++ ++|.+.+.. ....+++..+..++.||++||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34889999998 588877753 3357999999999999999999
Q ss_pred HHHhCCCCCeEecCCCCCCEEEC-CCCCEEEeecCCCccccC---------------------CCCCCcccceehhHHHH
Q 040687 596 YLHKDAAPPIIHRDVKTLNILLD-SDWGARIADFGLLTSCER---------------------DLTTDMKSDVHNFGIVL 653 (740)
Q Consensus 596 yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGla~~~~~---------------------~~~~~~ksDVwSfGvvl 653 (740)
|||+.+ |+||||||+|||++ .++.+||+|||+++.... ...++.++||||||+++
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999998 99999999999998 688999999999864321 12247789999999999
Q ss_pred HHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc--cc---ccCCC----------CCchhHHHHHHHHHHhhhcCCC
Q 040687 654 LEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII--DR---NVALP----------RNVEPLFKLADIAELAIRENPS 718 (740)
Q Consensus 654 ~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~--d~---~~~~~----------~~~~~~~~l~~l~~~Cl~~dP~ 718 (740)
|||++|+.||........+... ...........+. ++ ....+ .+.....++.+|+.+||+.||+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHHHHHHH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999754322222111 1110000000000 00 00000 1112234688999999999999
Q ss_pred CCCCHHHHHH--HHHHHH
Q 040687 719 ELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 719 ~RPt~~ev~~--~Le~l~ 734 (740)
+|||+.|+++ +++++.
T Consensus 312 ~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GSCCHHHHHTSGGGHHHH
T ss_pred hCCCHHHHhcCHHHHHHH
Confidence 9999999996 666554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.94 Aligned_cols=232 Identities=26% Similarity=0.390 Sum_probs=186.0
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..+.||+|+||.||+++... ++.||+|.+.... ....+.|.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 45679999999999999999999864 8899999987643 34567899999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc---
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE--- 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~--- 635 (740)
|||+++++|.+++......+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999998765567999999999999999999999998 9999999999999999999999999753210
Q ss_pred -----------------------CCCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 636 -----------------------RDLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 636 -----------------------~~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
....++.++||||||+++|||++|+.||..... .+...... ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~------- 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIA-KSDP------- 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH-HSCC-------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHh-ccCC-------
Confidence 123346799999999999999999999964321 11111111 1110
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111112233447889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.54 Aligned_cols=252 Identities=20% Similarity=0.211 Sum_probs=191.1
Q ss_pred cChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccch---------hcHHHHHHHHHHHHhCCCCCc
Q 040687 472 FRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH---------TNIREFEMELEVLCNIRHSNI 542 (740)
Q Consensus 472 ~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~---------~~~~~~~~E~~~l~~l~H~ni 542 (740)
....++....++|+..+.||+|+||.||++...+++.||||++....... ...+.+.+|+++|++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34667888899999999999999999999998889999999986543211 123679999999999999999
Q ss_pred ceEEeEEEeC-----CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 040687 543 VNLLGYCLEM-----GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL 617 (740)
Q Consensus 543 v~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl 617 (740)
+++++++... ...++||||++ |+|.+++......+++..+..++.||++||+|||+.+ |+||||||+|||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999998643 36899999997 6999999877678999999999999999999999998 9999999999999
Q ss_pred CCCCCEEEeecCCCccccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh
Q 040687 618 DSDWGARIADFGLLTSCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 618 ~~~~~~ki~DFGla~~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 676 (740)
+.++.+||+|||++..... ...++.++||||||+++|||++|+.||....... .....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i 246 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNKI 246 (362)
T ss_dssp CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 9999999999999853221 1334678999999999999999999997543111 11111
Q ss_pred hhHHhhCc-----------cchhccccc-CCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 677 LPLIKQGK-----------AAAIIDRNV-ALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 677 ~~~~~~~~-----------~~~i~d~~~-~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........ ....+.... ..+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11110000 000000000 0010 1122346789999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.95 Aligned_cols=230 Identities=25% Similarity=0.378 Sum_probs=182.4
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..+.||+|+||.||+++... ++.||||.+.... ..+++.+|+.++++++||||+++++++......++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 45679999999999999999999854 8999999987542 346789999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++++|.+++......+++.+++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999999755567999999999999999999999999 99999999999999999999999999864332
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||++|+.||..... .+.. ..+.... ......
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~-------~~~~~~ 247 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAI-FMIPTNP-------PPTFRK 247 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH-HHHHHSC-------CCCCSS
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHH-HHHhcCC-------CcccCC
Confidence 11236789999999999999999999964321 1111 1111111 011111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+......+.+|+.+||+.||++||++.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2223347889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.32 Aligned_cols=238 Identities=23% Similarity=0.329 Sum_probs=188.5
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc------hhcHHHHHHHHHHHHhC-CCCCcceEEe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII------HTNIREFEMELEVLCNI-RHSNIVNLLG 547 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~------~~~~~~~~~E~~~l~~l-~H~niv~l~g 547 (740)
......++|+..+.||+|+||.||++++. +++.||||+++..... ....+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34445578999999999999999999985 5899999998754311 11245688999999999 8999999999
Q ss_pred EEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
++......+|||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999999754 46999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccCC--------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh
Q 040687 628 FGLLTSCERD--------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 628 FGla~~~~~~--------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 681 (740)
||++...... ..++.++||||||++||||+||+.||..... . .....+.
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~-~~~~~i~ 318 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----I-LMLRMIM 318 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H-HHHHHHH
T ss_pred cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----H-HHHHHHH
Confidence 9998644321 1245689999999999999999999964321 1 1111111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..... ...+........+.+|+.+||+.||++||++.|+++
T Consensus 319 ~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11110 000001122346889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=332.35 Aligned_cols=174 Identities=23% Similarity=0.356 Sum_probs=142.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----Ce
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----GE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (740)
.++|+..+.||+|+||.||+++.. +++.||||++..........+.+.+|+++|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999975 588999999876543344567899999999999999999999998543 46
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.||||||+ +++|.+++... ..+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 57999999764 46999999999999999999999999 999999999999999999999999998754
Q ss_pred cC-------------------------------------------------CCCCCcccceehhHHHHHHHHhC
Q 040687 635 ER-------------------------------------------------DLTTDMKSDVHNFGIVLLEILSG 659 (740)
Q Consensus 635 ~~-------------------------------------------------~~~~~~ksDVwSfGvvl~ElltG 659 (740)
.. ...++.++|||||||+||||+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 12346789999999999999993
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.67 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=180.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC-----
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----- 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 553 (740)
..++|+..+.||+|+||.||+++.. +++.||||++..........+.+.+|+++|++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3568999999999999999999984 5899999998665433344567899999999999999999999997653
Q ss_pred -eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 554 -ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 554 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..+|||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 7899999976 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh-----------h
Q 040687 633 SCER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK-----------Q 682 (740)
Q Consensus 633 ~~~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-----------~ 682 (740)
.... ...++.++||||||+++|||++|+.||........+.. ...... .
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~-i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 177 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE-IMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp ECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCHHHHHTCSC
T ss_pred ccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHHhhh
Confidence 5432 13357799999999999999999999975432111111 100000 0
Q ss_pred CccchhcccccCC------CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 GKAAAIIDRNVAL------PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ~~~~~i~d~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......+...... .........+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000000 001122346789999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.71 Aligned_cols=240 Identities=18% Similarity=0.263 Sum_probs=190.3
Q ss_pred ccChhHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC--CCCcceEEeE
Q 040687 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR--HSNIVNLLGY 548 (740)
Q Consensus 471 ~~~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~ 548 (740)
.+.+..+....++|+..+.||+|+||.||+++..+++.||||.+............+.+|++++++++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34455556667789999999999999999999888999999999765544455678999999999997 5999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
+......+|||| +.+++|.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||+++ +.+||+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 999999999999 5588999999764 47899999999999999999999998 999999999999965 78999999
Q ss_pred CCCccccCC----------------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHH
Q 040687 629 GLLTSCERD----------------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVE 674 (740)
Q Consensus 629 Gla~~~~~~----------------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 674 (740)
|++...... ..++.++||||||+++|||++|+.||...... . .
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~-~ 247 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--I-S 247 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--H-H
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--H-H
Confidence 998643210 13456899999999999999999999643211 1 1
Q ss_pred hhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 675 WALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 675 ~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ...+++.....+.+.....++.+|+.+||+.||++||++.|+++
T Consensus 248 ~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 K---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp H---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H---------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1 11122222222222222347889999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=334.63 Aligned_cols=233 Identities=24% Similarity=0.334 Sum_probs=188.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|...+.||+|+||.||+++.. +++.||||++....... .....+.+|+++|++++||||+++++++......+|||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67889999999999999999985 48999999997654322 34567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGGL---SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997542 46999999999999999999999999 99999999999999999999999999865432
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
...++.++|||||||+||||+||+.||..........+. .. .++......
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~-~~--------~i~~~~~~~ 412 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQ--------RVLEQAVTY 412 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH-HH--------HHHHCCCCC
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH-HH--------HHhhcccCC
Confidence 112367899999999999999999999764332222111 11 112222233
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTM-----SQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 728 (740)
|. .....+.+|+.+||+.||++||++ .+|++
T Consensus 413 p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 PD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CT--TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred Cc--ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 32 233467899999999999999975 56654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.43 Aligned_cols=240 Identities=20% Similarity=0.281 Sum_probs=181.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (740)
.++|+..++||+|+||+||+++.. +++.||||++..........+.+.+|+.+|++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999975 488999999986544445567889999999999999999999999654 3
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..||||||+++ +|.+.+.. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 57999999975 67777754 3899999999999999999999999 99999999999999999999999999865
Q ss_pred ccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh--------h--C
Q 040687 634 CER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK--------Q--G 683 (740)
Q Consensus 634 ~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~--------~--~ 683 (740)
... ...++.++||||||++||||++|+.||........+.. ....+. . .
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~-i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK-VIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCSCCHHHHTTSCH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHHHHHcch
Confidence 432 12346799999999999999999999975432111110 000000 0 0
Q ss_pred ccchhcccccC--------------CCCCc----hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAIIDRNVA--------------LPRNV----EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i~d~~~~--------------~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.... .+... ....++.+|+.+||+.||++|||++|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001111000 01111 11446889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.59 Aligned_cols=237 Identities=29% Similarity=0.386 Sum_probs=191.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||+||+++.. +++.||||++............+.+|+++|++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999985 5899999999765544455678999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD---SDWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DFGla~~~~~ 636 (740)
||+++++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999998654 46999999999999999999999999 99999999999995 456799999999865432
Q ss_pred C-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 D-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 ~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
. ..++.++||||||+++|||++|+.||..... .+ ....+...... ...+.
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~-~~~~i~~~~~~------~~~~~ 245 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE----YD-ILKRVETGKYA------FDLPQ 245 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHTCCC------SCSGG
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHHHhCCCC------CCCcc
Confidence 1 1245789999999999999999999964321 11 11122211111 11122
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
......++.+|+.+||+.||++|||+.|+++ ++++
T Consensus 246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 2233457889999999999999999999997 5554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.93 Aligned_cols=234 Identities=24% Similarity=0.303 Sum_probs=181.5
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccc------hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII------HTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..++|...+.||+|+||.||+++... ++.||||.+...... ......+.+|+++|++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999854 789999998754321 11234588999999999999999999998765
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC---EEEeecC
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG---ARIADFG 629 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DFG 629 (740)
. .++||||+++++|.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 4 89999999999999999754 57999999999999999999999998 999999999999987654 9999999
Q ss_pred CCccccC-----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 630 LLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 630 la~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
++..... ...++.++||||||+++|||++|+.||........+... +......
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYN 238 (322)
T ss_dssp TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH----HHHTCCC
T ss_pred cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH----HHhCccc
Confidence 9865422 123467999999999999999999999754433222221 1111110
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. +.. .......+.+|+.+||+.||++||++.|+++
T Consensus 239 ~~--~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC--chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 000 0122346789999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=329.05 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=188.8
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC-CCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-SNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..++||+|+||.||+++. .+++.||||++..... ..++.+|+++++.|+| +++..+..+..+.+..+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 46899999999999999999997 4589999998765432 2458899999999987 5666777777788899999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~~~ 635 (740)
|||+ +++|.+++......+++.+++.|+.||+.||+|||+.+ ||||||||+|||| +.++.+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 99999999865567999999999999999999999999 9999999999999 688999999999987543
Q ss_pred CC----------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccch
Q 040687 636 RD----------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAA 687 (740)
Q Consensus 636 ~~----------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (740)
.. ..++.++||||||++||||++|+.||......... + .+..+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~-~~~~i~~~~~~~ 235 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-Q-KYEKISEKKVAT 235 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-H-HHHHHHHHHHHS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-H-HHHHHhhccccc
Confidence 21 11255899999999999999999999754322111 1 111111111111
Q ss_pred hcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 688 IIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 688 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.++... .....++.+|+..||+.||++||++.+|++.|++++..
T Consensus 236 ~~~~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 236 SIEALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp CHHHHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111000 01234788999999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.59 Aligned_cols=231 Identities=23% Similarity=0.276 Sum_probs=184.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|...+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 457899999999999999999985 589999999876432 23357899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~~~~ 636 (740)
||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 86 QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999998654 46899999999999999999999998 9999999999999 7889999999999764332
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++||||||+++|||++|+.||..... ......+...... ...+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~------~~~~~ 230 (304)
T 2jam_A 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKIKEGYYE------FESPF 230 (304)
T ss_dssp BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHCCCC------CCTTT
T ss_pred CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCC------CCccc
Confidence 12346689999999999999999999964321 1111222221110 11111
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2233457889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.04 Aligned_cols=245 Identities=24% Similarity=0.275 Sum_probs=180.6
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh---cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT---NIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
...++|+..+.||+|+||.||+++.. +++.||||++........ ..+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 489999999875432211 12468899999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++||||+++ +|.+++......+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999985 999999877667999999999999999999999999 999999999999999999999999998654
Q ss_pred cC----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc--
Q 040687 635 ER----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID-- 690 (740)
Q Consensus 635 ~~----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d-- 690 (740)
.. ...++.++||||||+++|||++|+.||........+. ...............+
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~-~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-RIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTSSSTT
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH-HHHHHcCCCChhhhhhhc
Confidence 21 1123568999999999999999999987543211111 1111110000000000
Q ss_pred ---cccC---CC-CC-----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 691 ---RNVA---LP-RN-----VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 691 ---~~~~---~~-~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.... .+ .+ .....++.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00 00 122357889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.80 Aligned_cols=239 Identities=23% Similarity=0.292 Sum_probs=190.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-------chhcHHHHHHHHHHHHhCC-CCCcceEEeEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-------IHTNIREFEMELEVLCNIR-HSNIVNLLGYCLE 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-------~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 551 (740)
.++|+..+.||+|+||.||+++.. +++.||||++..... .....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999985 488999999875421 1123456889999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
....++||||+++++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999754 46899999999999999999999999 999999999999999999999999998
Q ss_pred ccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 632 TSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 632 ~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
..... ...++.++||||||+++|||++|+.||..... .+ ....+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~-~~~~~~~~~~ 246 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----ML-MLRMIMSGNY 246 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHTCC
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----HH-HHHHHhcCCc
Confidence 65322 11235689999999999999999999964321 11 1111111111
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
....+........+.+|+.+||+.||++||++.|+++ ++++..
T Consensus 247 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 ------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1111222234457889999999999999999999986 444433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=334.48 Aligned_cols=239 Identities=28% Similarity=0.379 Sum_probs=193.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++.. +++.||||++...... ......+.+|+++|++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999985 5899999998765432 23467899999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---CCCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL---DSDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~ki~DFGla~~~~ 635 (740)
|||+++++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999764 46999999999999999999999999 9999999999999 567899999999876443
Q ss_pred CC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 636 RD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 636 ~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
.. ..++.++||||||+++|||++|+.||...... .....+...... ...+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~------~~~~ 249 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY-----DILKKVEKGKYT------FELP 249 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCC------CCSG
T ss_pred cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCCC------CCCc
Confidence 21 13477999999999999999999999743211 111222221111 1112
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.......++.+|+.+||+.||++|||+.|+++ |+++..
T Consensus 250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 250 QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 22233457889999999999999999999997 666543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=345.54 Aligned_cols=230 Identities=23% Similarity=0.296 Sum_probs=188.4
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEeccccc-chhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATI-IHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 556 (740)
..++|+..+.||+|+||.||+++... ++.||||+++.... .......+..|..+|..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34679999999999999999999854 78899999986532 223456788999999987 7999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++|+|.++|+.. ..+++.+++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999754 46999999999999999999999999 99999999999999999999999999875321
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
...++.++||||||++||||++|+.||..... .+ . ...++...+..
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~-~--------~~~i~~~~~~~ 561 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DE-L--------FQSIMEHNVAY 561 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-H--------HHHHHSSCCCC
T ss_pred CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----HH-H--------HHHHHhCCCCC
Confidence 12346789999999999999999999975321 11 1 12223333444
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTM-----SQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 728 (740)
|.. ...++.+|+++||+.||++||++ +||++
T Consensus 562 p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 PKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CTT--SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred Ccc--CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 433 33478899999999999999997 67664
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=325.35 Aligned_cols=179 Identities=24% Similarity=0.352 Sum_probs=154.7
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----Ce
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----GE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (740)
.++|...+.||+|+||.||+++... ++.||||++..........+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999754 78999999976543344567899999999999999999999999776 56
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.||||||++ ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999996 5999999864 46999999999999999999999999 999999999999999999999999998653
Q ss_pred cC--------------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCC
Q 040687 635 ER--------------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYD 664 (740)
Q Consensus 635 ~~--------------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~ 664 (740)
.. ...++.++|||||||+||||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 21 1224678999999999999998655553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.86 Aligned_cols=229 Identities=24% Similarity=0.374 Sum_probs=181.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE-------- 551 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 551 (740)
.++|+..+.||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 467999999999999999999974 6899999998653 2345779999999999999999999999865
Q ss_pred -----CCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEe
Q 040687 552 -----MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIA 626 (740)
Q Consensus 552 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~ 626 (740)
....++||||+++++|.+++......+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34679999999999999999866566889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccccC------------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc
Q 040687 627 DFGLLTSCER------------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP 670 (740)
Q Consensus 627 DFGla~~~~~------------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 670 (740)
|||++..... ...++.++||||||+++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999865421 1134678999999999999998 5532110
Q ss_pred hhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 671 GIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 671 ~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+... ...............+.+|+++||+.||++|||+.|+++
T Consensus 234 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 --RVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 01111111111 111111122333446789999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=308.93 Aligned_cols=229 Identities=22% Similarity=0.307 Sum_probs=180.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc--hhcHHHHHHHHHHHHhCCCCCcceEEeEEE--eCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII--HTNIREFEMELEVLCNIRHSNIVNLLGYCL--EMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 555 (740)
.++|...+.||+|+||.||++... +++.||+|.++..... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999974 5889999999765422 134567999999999999999999999984 44578
Q ss_pred EEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 556 LLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
++||||++++ |.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 77777543 356999999999999999999999998 999999999999999999999999998654
Q ss_pred cCC-------------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 635 ERD-------------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 635 ~~~-------------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
... ...+.++||||||+++|||++|+.||.... ..+ ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~i~~------- 227 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYK-LFENIGK------- 227 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHH-HHHHHHH-------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHH-HHHHHhc-------
Confidence 210 111458999999999999999999997432 111 1111111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+. .....+.+++.+||+.||++||++.|+++
T Consensus 228 -~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 228 -GSYAIPG--DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -CCCCCCS--SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCCCCCC--ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122222 23347789999999999999999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=318.50 Aligned_cols=242 Identities=20% Similarity=0.292 Sum_probs=183.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (740)
.++|+..+.||+|+||.||+++.. +++.||||++..........+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999975 5889999999765433445567899999999999999999999997664
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..+|||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999997 589998864 4899999999999999999999998 99999999999999999999999999865
Q ss_pred ccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH--------------
Q 040687 634 CER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL-------------- 679 (740)
Q Consensus 634 ~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~-------------- 679 (740)
... ...++.++||||||+++|||++|+.||........+.. ....
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK-VIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHC-CCCCCHHHHTTSCH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHHHHhhh
Confidence 432 12346799999999999999999999975422111100 0000
Q ss_pred -----HhhC------ccchhcccccCCCCCc----hhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 680 -----IKQG------KAAAIIDRNVALPRNV----EPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 680 -----~~~~------~~~~i~d~~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
.... ...... +....+... ....++.+|+.+||+.||++|||++|+++ ++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLF-PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHS-CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHHhhCccccccchhhhc-ccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 0000 000000 001111111 12457889999999999999999999997 554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.49 Aligned_cols=240 Identities=20% Similarity=0.302 Sum_probs=188.1
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhc---------------HHHHHHHHHHHHhCCCCCcceE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTN---------------IREFEMELEVLCNIRHSNIVNL 545 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~---------------~~~~~~E~~~l~~l~H~niv~l 545 (740)
.++|...+.||+|+||.||+++. +++.||||++......... .+.|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998765432211 2789999999999999999999
Q ss_pred EeEEEeCCeEEEEEecCCCCChHHh------HhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEE
Q 040687 546 LGYCLEMGERLLVYEFMPRGTLHDH------LHGG-LSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILL 617 (740)
Q Consensus 546 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl 617 (740)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||+|||+ .+ |+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999999 6543 3579999999999999999999999 88 9999999999999
Q ss_pred CCCCCEEEeecCCCccccCC-------------------C-CCCc-ccceehhHHHHHHHHhCCCCCCCCCCCchhHHhh
Q 040687 618 DSDWGARIADFGLLTSCERD-------------------L-TTDM-KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676 (740)
Q Consensus 618 ~~~~~~ki~DFGla~~~~~~-------------------~-~~~~-ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 676 (740)
+.++.+||+|||++...... . .++. ++||||||+++|||++|+.||........+.+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-- 263 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN-- 263 (348)
T ss_dssp CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH--
T ss_pred cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--
Confidence 99999999999998653211 1 1223 89999999999999999999975443222221
Q ss_pred hhHHhhCccchhccccc------C---CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 677 LPLIKQGKAAAIIDRNV------A---LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~------~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+.........+... . ..........+.+|+.+||+.||.+||++.|+++
T Consensus 264 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 --NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111110000000 0 0000223447889999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=309.87 Aligned_cols=240 Identities=22% Similarity=0.311 Sum_probs=176.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
...++|+..+.||+|+||.||+++.. +++.||||++..........+.+..+..+++.++||||+++++++.+.+..+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34567999999999999999999985 58999999997654333333445555567888899999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
||||+ ++.+..++......+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999 4556555554345799999999999999999999985 8 99999999999999999999999999854321
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
...++.++||||||+++|||++|+.||......... ..... ...
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~-~~~------- 246 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---LTKVL-QEE------- 246 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHH-HSC-------
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH---HHHHh-ccC-------
Confidence 122356899999999999999999999743221111 11111 111
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
....+.......++.+|+.+||+.||.+||++.||++ ++++.
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 1112222223447889999999999999999999987 55554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.64 Aligned_cols=181 Identities=24% Similarity=0.323 Sum_probs=156.0
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhC------CCCCcceEEeEEEeC
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNI------RHSNIVNLLGYCLEM 552 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~ 552 (740)
..++|+..++||+|+||+||+++... ++.||||+++... ...+++.+|+++++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 34679999999999999999999754 8899999997543 3345778888888877 577999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC--EEEeecC
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG--ARIADFG 629 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~ki~DFG 629 (740)
...+|||||+. ++|.+++.... ..+++..+..|+.||++||+|||+.+ |+||||||+||||+.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999996 69999987654 45999999999999999999999998 999999999999999987 9999999
Q ss_pred CCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 040687 630 LLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEY 667 (740)
Q Consensus 630 la~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~ 667 (740)
++..... ...++.++|||||||+||||+||+.||....
T Consensus 248 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9854332 1234779999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=312.99 Aligned_cols=245 Identities=23% Similarity=0.266 Sum_probs=183.5
Q ss_pred HhhcCccccceecccCceEEEEEEEe--CCcEEEEEEecccccchhcHHHHHHHHHHHHhC---CCCCcceEEeEEE---
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLV--DGRQVAVKRANAATIIHTNIREFEMELEVLCNI---RHSNIVNLLGYCL--- 550 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~--- 550 (740)
...++|+..+.||+|+||.||+++.. +++.||+|++............+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999983 578999999876543222234567788777766 8999999999987
Q ss_pred --eCCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEee
Q 040687 551 --EMGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIAD 627 (740)
Q Consensus 551 --~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~D 627 (740)
.....++||||++ ++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4457899999997 69999997643 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---c
Q 040687 628 FGLLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---K 684 (740)
Q Consensus 628 FGla~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~ 684 (740)
||++..... ...++.++||||||+++|||+||+.||........ ........... .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCccc
Confidence 999865432 12246789999999999999999999975432111 11111111000 0
Q ss_pred cc-------hhcccccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 AA-------AIIDRNVAL---PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ~~-------~i~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. ......... .........+.+|+.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000000 001223346789999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.82 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=171.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (740)
.++|+..+.||+|+||.||+++.. +++.||||++..........+.+.+|+++|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999974 588999999876543334556789999999999999999999998754 4
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 6899999875 46999999999999999999999999 99999999999999999999999999865
Q ss_pred ccC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh-----------C
Q 040687 634 CER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ-----------G 683 (740)
Q Consensus 634 ~~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-----------~ 683 (740)
... ...++.++||||||+++|||++|+.||........+ ......+.. .
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHTTCCCH
T ss_pred ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHHhhhH
Confidence 322 134577999999999999999999999754321111 111111000 0
Q ss_pred ccchhcccccCCCC-C-----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAIIDRNVALPR-N-----VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i~d~~~~~~~-~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+..-...+. . ......+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00001100000010 0 112346789999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.02 Aligned_cols=241 Identities=20% Similarity=0.263 Sum_probs=181.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC--------CCCcceEEeEEE-
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR--------HSNIVNLLGYCL- 550 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~- 550 (740)
.++|+..++||+|+||+||+++.. +++.||||+++... ...+.+.+|+++|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 478999999999999999999974 48899999987542 34467899999999985 788999999987
Q ss_pred ---eCCeEEEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCC----
Q 040687 551 ---EMGERLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDW---- 621 (740)
Q Consensus 551 ---~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~---- 621 (740)
.....+|||||+ +++|.+++... ...+++.+++.|+.||++||+|||++ + |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 445789999999 56776666543 35799999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CEEEeecCCCccccC------------------CC
Q 040687 622 ---------------------------------------------GARIADFGLLTSCER------------------DL 638 (740)
Q Consensus 622 ---------------------------------------------~~ki~DFGla~~~~~------------------~~ 638 (740)
.+||+|||++..... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTS
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCC
Confidence 799999999864432 12
Q ss_pred CCCcccceehhHHHHHHHHhCCCCCCCCCCCch---h--HHhhhhHHhh--------Cc-cchhcccc------------
Q 040687 639 TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG---I--VEWALPLIKQ--------GK-AAAIIDRN------------ 692 (740)
Q Consensus 639 ~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~---~--~~~~~~~~~~--------~~-~~~i~d~~------------ 692 (740)
.++.++||||||++||||+||+.||........ . .......... .. ........
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 346799999999999999999999975432211 0 1111110000 00 00000000
Q ss_pred -------cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 -------VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 -------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...+...+....+.+|+.+||+.||++|||+.|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001123344567889999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.17 Aligned_cols=228 Identities=21% Similarity=0.353 Sum_probs=175.1
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch----hcHHHHHHHHHHHHhC----CCCCcceEE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH----TNIREFEMELEVLCNI----RHSNIVNLL 546 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~----~~~~~~~~E~~~l~~l----~H~niv~l~ 546 (740)
+.+...++|+..+.||+|+||.||+++.. +++.||||++....... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34445678999999999999999999864 58899999987654221 1223467799999998 899999999
Q ss_pred eEEEeCCeEEEEEec-CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEE
Q 040687 547 GYCLEMGERLLVYEF-MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGAR 624 (740)
Q Consensus 547 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 624 (740)
+++...+..++|||| +++++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 999998899999999 7899999999754 46999999999999999999999998 99999999999999 889999
Q ss_pred EeecCCCccccCCC--------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc
Q 040687 625 IADFGLLTSCERDL--------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK 684 (740)
Q Consensus 625 i~DFGla~~~~~~~--------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 684 (740)
|+|||++....... ..+.++||||||+++|||++|+.||....
T Consensus 181 l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------------- 243 (312)
T 2iwi_A 181 LIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------------- 243 (312)
T ss_dssp ECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------------
T ss_pred EEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------------
Confidence 99999987543211 11348999999999999999999996320
Q ss_pred cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
++.+.....+. ....++.+|+.+||+.||++||++.|+++
T Consensus 244 --~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --EILEAELHFPA--HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HHHHTCCCCCT--TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHhhhccCCcc--cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111222222 22346789999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=309.40 Aligned_cols=237 Identities=24% Similarity=0.373 Sum_probs=181.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHH-HHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELE-VLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++.. +++.||||++..... .....++..|+. +++.++||||+++++++.+.+..+||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 467899999999999999999985 589999999976532 233345666666 67778999999999999999999999
Q ss_pred EecCCCCChHHhHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLHG----GLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
|||+++ +|.+++.. ....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 88887752 235689999999999999999999998 8 99999999999999999999999999864
Q ss_pred ccC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 634 CER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 634 ~~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
... ...++.++||||||+++|||++|+.||........ ....++
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~~~~ 243 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------------QLTQVV 243 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CCCC
T ss_pred cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------------HHHHHh
Confidence 321 11246789999999999999999999964321100 011111
Q ss_pred cc---ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 690 DR---NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 690 d~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.. .+...........+.+|+.+||+.||++||++.||++ ++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 11 1111112233457889999999999999999999987 555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=326.88 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=177.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC----C--e
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM----G--E 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~ 554 (740)
.+|+..+.||+|+||.||++++. +++.||||++.... +.+.+|+++|++++||||+++++++... + .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 45888999999999999999985 48999999986532 2234799999999999999999998642 2 3
Q ss_pred EEEEEecCCCCChHHhHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-CCEEEeecCC
Q 040687 555 RLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-WGARIADFGL 630 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~ki~DFGl 630 (740)
.+|||||+++ +|.+.+. .....+++..++.++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999975 6766654 23457999999999999999999999998 9999999999999965 5689999999
Q ss_pred CccccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh-
Q 040687 631 LTSCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI- 688 (740)
Q Consensus 631 a~~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i- 688 (740)
++.... ...++.++|||||||+||||++|+.||........+.+.. ..+.......+
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~-~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII-KVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HHHCSCCHHHHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCCHHHHH
Confidence 875321 1234678999999999999999999997543222222211 11000000000
Q ss_pred -ccc---ccCCCC----------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 689 -IDR---NVALPR----------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 689 -~d~---~~~~~~----------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
+++ ....+. ......++.+|+.+||+.||++||++.|+++ +++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 000 011110 1122347889999999999999999999986 55544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=309.55 Aligned_cols=239 Identities=22% Similarity=0.343 Sum_probs=176.8
Q ss_pred hcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEE---------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCL--------- 550 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--------- 550 (740)
.++|+..+.||+|+||.||+++... ++.||||++.... ....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 4679999999999999999999865 8999999987543 344578999999999999999999999873
Q ss_pred -----eCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEE
Q 040687 551 -----EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGAR 624 (740)
Q Consensus 551 -----~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 624 (740)
+....++||||++ |+|.+++.. .++++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 699999975 46899999999999999999999999 99999999999997 567999
Q ss_pred EeecCCCccccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH
Q 040687 625 IADFGLLTSCER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL 679 (740)
Q Consensus 625 i~DFGla~~~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~ 679 (740)
|+|||++..... ...++.++||||||+++|||+||+.||........+ ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHh
Confidence 999999875321 123466899999999999999999999754321111 100000
Q ss_pred Hh---h-------CccchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 680 IK---Q-------GKAAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 680 ~~---~-------~~~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. . ......+......+. ......++.+|+.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00 0 000000001111110 0122347889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=323.12 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=178.2
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------e
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------E 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 554 (740)
..+|+..+.||+|+||.||+++..++..||+|++.... +...+|+++|++++||||+++++++.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35699999999999999999999887789999886533 12246999999999999999999996543 2
Q ss_pred EEEEEecCCCCChHHhHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEEEeecCC
Q 040687 555 RLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGARIADFGL 630 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGl 630 (740)
.+|||||++++ |.+.+. .....+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 78999999864 444332 22356999999999999999999999999 99999999999999 799999999999
Q ss_pred CccccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc----
Q 040687 631 LTSCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA---- 685 (740)
Q Consensus 631 a~~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 685 (740)
++.... ...++.++||||||++||||++|+.||........+.+... .+.....
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~-~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK-VLGTPSREQIK 267 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-HHCCCCHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCCHHHHH
Confidence 865321 12357799999999999999999999975432222221111 0000000
Q ss_pred ---chhcccccCC--C------CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 686 ---AAIIDRNVAL--P------RNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 686 ---~~i~d~~~~~--~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
....+..... + .......++.+|+.+||+.||++|||+.|+++ +++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0000000000 0 01113347889999999999999999999986 44443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.94 Aligned_cols=240 Identities=23% Similarity=0.317 Sum_probs=183.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE----
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER---- 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 555 (740)
.++|...+.||+|+||.||+++.. +++.||||++..........+.+.+|+.++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999975 589999999986554444567899999999999999999999999876654
Q ss_pred --EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 556 --LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 556 --~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
++||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 699988854 4899999999999999999999998 99999999999999999999999999864
Q ss_pred ccC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh-----------C
Q 040687 634 CER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ-----------G 683 (740)
Q Consensus 634 ~~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-----------~ 683 (740)
... ...++.++||||||+++|||+||+.||........+.. ....... .
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ-ILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCHHHHTTCSCH
T ss_pred cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCcHHHHHHhhhh
Confidence 322 13457799999999999999999999975432111111 1000000 0
Q ss_pred ccchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+......+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000000010 0122347889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.65 Aligned_cols=240 Identities=22% Similarity=0.274 Sum_probs=183.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----Ce
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----GE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (740)
.++|+..+.||+|+||.||+++.. +++.||||++.... .......+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 468999999999999999999985 58899999986533 123446788999999999999999999998764 57
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++||||++ ++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999997 6999999763 5999999999999999999999998 999999999999999999999999998643
Q ss_pred cC--------------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh
Q 040687 635 ER--------------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682 (740)
Q Consensus 635 ~~--------------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 682 (740)
.. ...++.++||||||+++|||++|+.||........+.. .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL-IFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCC
Confidence 21 12346689999999999999999999975432111110 0000000
Q ss_pred C------------ccchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 683 G------------KAAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 683 ~------------~~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ...+.+......+. ......++.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000000000000 0122346789999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.38 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=184.5
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----C
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----G 553 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 553 (740)
..++|+..+.||+|+||.||+++.. +++.||||++.... .....+.+.+|+++|++++||||+++++++... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 3568999999999999999999975 58899999987533 233446789999999999999999999999765 3
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..++||||++ ++|.+++... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 6899999997 5999999764 5999999999999999999999999 99999999999999999999999999864
Q ss_pred ccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc---c
Q 040687 634 CER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK---A 685 (740)
Q Consensus 634 ~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 685 (740)
... ...++.++||||||+++|||+||+.||........+.. ....+.... .
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQEDL 256 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH-HHHHHCSCCHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH-HHHHhCCCCHHHH
Confidence 321 12246789999999999999999999975433222211 111100000 0
Q ss_pred c--------hhcc---cccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 A--------AIID---RNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 ~--------~i~d---~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. .... .....+. ......++.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000 0000000 0112346789999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.54 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=176.9
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM 552 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (740)
..+.....++|+..+.||+|+||.||+++.. +++.||||++.... .....+.+|++.+++++||||+++++++...
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 3456667789999999999999999999985 58999999886543 2224567888899999999999999999764
Q ss_pred Ce-------EEEEEecCCCCChHHhHh---CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEECC-
Q 040687 553 GE-------RLLVYEFMPRGTLHDHLH---GGLSPLNWSLRLKISMQAAKGLEYLH--KDAAPPIIHRDVKTLNILLDS- 619 (740)
Q Consensus 553 ~~-------~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~ia~~ia~gL~yLH--~~~~~~iiHrDlk~~NILl~~- 619 (740)
.. .++||||+++ +|.+.+. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCC
Confidence 33 7899999986 6555443 23456899999999999999999999 887 999999999999997
Q ss_pred CCCEEEeecCCCccccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh
Q 040687 620 DWGARIADFGLLTSCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP 678 (740)
Q Consensus 620 ~~~~ki~DFGla~~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 678 (740)
++.+||+|||++..... ...++.++||||||+++|||+||+.||........+.. ...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-~~~ 246 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE-IVR 246 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHH
T ss_pred CCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH-HHH
Confidence 89999999999865432 12246789999999999999999999975432221111 111
Q ss_pred HHhhCccchhc---c----------------cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 679 LIKQGKAAAII---D----------------RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 679 ~~~~~~~~~i~---d----------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
... ....+.+ + .............++.+|+.+||+.||++|||+.|+++ +++++
T Consensus 247 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 247 VLG-CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHC-CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HcC-CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000 0000000 0 00001112224567889999999999999999999987 55543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=311.30 Aligned_cols=228 Identities=22% Similarity=0.328 Sum_probs=183.4
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch----hcHHHHHHHHHHHHhCC--CCCcceEEeE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH----TNIREFEMELEVLCNIR--HSNIVNLLGY 548 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~----~~~~~~~~E~~~l~~l~--H~niv~l~g~ 548 (740)
+.....++|+..+.||+|+||.||+++.. +++.||||++....... .....+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 44445678999999999999999999974 58899999987654322 12245778999999996 5999999999
Q ss_pred EEeCCeEEEEEecCCC-CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEEEe
Q 040687 549 CLEMGERLLVYEFMPR-GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGARIA 626 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~ 626 (740)
+...+..++||||+.. ++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999999976 8999999754 46899999999999999999999999 99999999999999 78899999
Q ss_pred ecCCCccccCC--------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 627 DFGLLTSCERD--------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 627 DFGla~~~~~~--------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
|||++...... ...+.++||||||+++|||+||+.||.... .
T Consensus 193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~-------- 254 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E-------- 254 (320)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H--------
T ss_pred eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------h--------
Confidence 99998754321 111457899999999999999999996321 0
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.......+. ....++.+|+++||+.||++||+++||++
T Consensus 255 -~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -IIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHHCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hhcccccccc--cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111111 22346789999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.04 Aligned_cols=245 Identities=19% Similarity=0.300 Sum_probs=186.9
Q ss_pred hcCccccceecccCceEEEEEEE-e-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC------cceEEeEEEeC
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-V-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN------IVNLLGYCLEM 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~ 552 (740)
.++|+..+.||+|+||.||++.. . +++.||||+++... ...+.+.+|++++++++|+| ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46799999999999999999997 3 58899999987532 33467889999999887654 99999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC------------
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS------------ 619 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~------------ 619 (740)
+..+|||||+ +++|.+++.... .++++.++..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 889999997653 46899999999999999999999998 999999999999987
Q ss_pred -------CCCEEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHH
Q 040687 620 -------DWGARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVE 674 (740)
Q Consensus 620 -------~~~~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 674 (740)
++.+||+|||++..... ...++.++||||||+++|||+||+.||........+ .
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~ 244 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL-A 244 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH-H
T ss_pred cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH-H
Confidence 66899999999865432 123467999999999999999999999754321111 1
Q ss_pred hhhhHHh--------hCccchh---------------------cccc-cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHH
Q 040687 675 WALPLIK--------QGKAAAI---------------------IDRN-VALPRNVEPLFKLADIAELAIRENPSELPTMS 724 (740)
Q Consensus 675 ~~~~~~~--------~~~~~~i---------------------~d~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 724 (740)
....... ....... ..+. ...........++.+|+.+||+.||++|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 1100000 0000000 0000 00112234456788999999999999999999
Q ss_pred HHHH--HHHHH
Q 040687 725 QVAT--WLEQI 733 (740)
Q Consensus 725 ev~~--~Le~l 733 (740)
|+++ +|+++
T Consensus 325 ell~hp~f~~~ 335 (339)
T 1z57_A 325 EALKHPFFDLL 335 (339)
T ss_dssp HHTTSGGGGGG
T ss_pred HHhcCHHHHHH
Confidence 9986 45543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.92 Aligned_cols=240 Identities=22% Similarity=0.299 Sum_probs=183.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe-----
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE----- 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 554 (740)
.++|...+.||+|+||.||+++.. +++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999975 58999999997654334445678999999999999999999999987653
Q ss_pred -EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 555 -RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 555 -~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.++||||++ ++|.+++.. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 699988854 4899999999999999999999998 99999999999999999999999999864
Q ss_pred ccC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhh-----------C
Q 040687 634 CER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ-----------G 683 (740)
Q Consensus 634 ~~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-----------~ 683 (740)
... ...++.++||||||+++|||++|+.||........+ ......... .
T Consensus 176 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH-HHHHHHHCBCCHHHHTTCSCH
T ss_pred CCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHHHhhH
Confidence 321 133467899999999999999999999754321111 111100000 0
Q ss_pred ccchhcc---c--ccCCC-CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 684 KAAAIID---R--NVALP-RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 684 ~~~~i~d---~--~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....+. . +...+ .......++.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0 00000 11233457889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=306.21 Aligned_cols=235 Identities=21% Similarity=0.275 Sum_probs=172.6
Q ss_pred hhcCccccc-eecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CC
Q 040687 480 ATNGFKEFN-ELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MG 553 (740)
Q Consensus 480 ~~~~~~~~~-~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~ 553 (740)
..++|...+ .||+|+||+||+++.. +++.||||++.... .........++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 346788855 5999999999999986 58999999986532 122222334567799999999999876 34
Q ss_pred eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecC
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFG 629 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFG 629 (740)
..+|||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 5899999999999999998654 46999999999999999999999998 999999999999986 4559999999
Q ss_pred CCccccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 630 LLTSCERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 630 la~~~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
++...... ..++.++||||||+++|||++|+.||........ .. .....+..
T Consensus 177 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~--------~~~~~~~~ 247 (336)
T 3fhr_A 177 FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-SP--------GMKRRIRL 247 (336)
T ss_dssp TCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-hh--------hHHHhhhc
Confidence 98654321 1124589999999999999999999964322110 00 00011111
Q ss_pred cc--cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 691 RN--VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 691 ~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.. ...+.......++.+|+.+||+.||++|||+.|+++ ++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 11 112222334457889999999999999999999998 5543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.11 Aligned_cols=183 Identities=25% Similarity=0.325 Sum_probs=154.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CC-----CcceEEeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HS-----NIVNLLGYC 549 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~ 549 (740)
.....++|+..+.||+|+||+||+++.. +++.||||+++... ....++..|+++++.++ |+ +|+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 3445678999999999999999999975 47899999987542 33467788999998885 55 499999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCEEEC--CCCCEE
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHK--DAAPPIIHRDVKTLNILLD--SDWGAR 624 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~--~~~~~iiHrDlk~~NILl~--~~~~~k 624 (740)
...+..+|||||++ ++|.+++.... ..+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 99999999999996 59999997654 569999999999999999999995 45 99999999999995 478899
Q ss_pred EeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 040687 625 IADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE 666 (740)
Q Consensus 625 i~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~ 666 (740)
|+|||++..... ...++.++||||||++||||+||+.||...
T Consensus 202 L~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 202 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999865432 123467999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.54 Aligned_cols=177 Identities=24% Similarity=0.384 Sum_probs=141.4
Q ss_pred cCccc-cceecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe--CCeE
Q 040687 482 NGFKE-FNELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE--MGER 555 (740)
Q Consensus 482 ~~~~~-~~~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 555 (740)
+.|.. .++||+|+||+||+++.. +++.||||++..... ...+.+|+++|++++||||+++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34554 457999999999999975 478899999875432 2468899999999999999999999965 5689
Q ss_pred EEEEecCCCCChHHhHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----CCCCCE
Q 040687 556 LLVYEFMPRGTLHDHLHGG--------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL----DSDWGA 623 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~ 623 (740)
+|||||++ ++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 5888887521 124899999999999999999999999 9999999999999 778899
Q ss_pred EEeecCCCccccC-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 040687 624 RIADFGLLTSCER-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIE 666 (740)
Q Consensus 624 ki~DFGla~~~~~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~ 666 (740)
||+|||+++.... ...++.++|||||||+||||+||+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999864321 122467899999999999999999999653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.33 Aligned_cols=243 Identities=19% Similarity=0.286 Sum_probs=184.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-C-cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC------cceEEeEEEeC
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD-G-RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN------IVNLLGYCLEM 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g-~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~ 552 (740)
.++|+..+.||+|+||+||+++... + +.||||+++... ...+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4689999999999999999999743 4 689999987532 33467889999999997766 99999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--------------
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILL-------------- 617 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl-------------- 617 (740)
...+|||||+ +++|.+++.... .++++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 667777776543 56999999999999999999999998 9999999999999
Q ss_pred -----CCCCCEEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHH
Q 040687 618 -----DSDWGARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVE 674 (740)
Q Consensus 618 -----~~~~~~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 674 (740)
+.++.+||+|||++..... ...++.++||||||++||||+||+.||........+ .
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~ 249 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL-V 249 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-H
T ss_pred ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-H
Confidence 5678999999999864332 223467899999999999999999999754321111 1
Q ss_pred hhhhHHhhCccchh----------ccc---------------------ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 040687 675 WALPLIKQGKAAAI----------IDR---------------------NVALPRNVEPLFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 675 ~~~~~~~~~~~~~i----------~d~---------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
...... ....... ... ............++.+|+.+||+.||++|||+
T Consensus 250 ~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 250 MMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 111100 0000000 000 00011223334578899999999999999999
Q ss_pred HHHHH--HHHH
Q 040687 724 SQVAT--WLEQ 732 (740)
Q Consensus 724 ~ev~~--~Le~ 732 (740)
.|+++ ++.+
T Consensus 329 ~e~l~hp~f~~ 339 (355)
T 2eu9_A 329 AEALLHPFFAG 339 (355)
T ss_dssp HHHTTSGGGGG
T ss_pred HHHhcChhhcC
Confidence 99985 4444
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.19 Aligned_cols=239 Identities=19% Similarity=0.291 Sum_probs=180.8
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-----------CCCcceEEeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-----------HSNIVNLLGY 548 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~ 548 (740)
.++|...+.||+|+||+||+++. .+++.||||++.... .....+.+|++++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 36799999999999999999997 458999999987543 23467889999999886 8999999999
Q ss_pred EEeCC----eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEEC----
Q 040687 549 CLEMG----ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLD---- 618 (740)
Q Consensus 549 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~---- 618 (740)
+.... ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 88654 789999999 889999997543 4599999999999999999999998 8 99999999999994
Q ss_pred --CCCCEEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCc-----hhH
Q 040687 619 --SDWGARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPP-----GIV 673 (740)
Q Consensus 619 --~~~~~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~-----~~~ 673 (740)
..+.+||+|||++..... ...++.++||||||++||||+||+.||....... ...
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 445899999999865432 1234678999999999999999999997532111 001
Q ss_pred HhhhhHHh--------hCc----------------------cchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCH
Q 040687 674 EWALPLIK--------QGK----------------------AAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTM 723 (740)
Q Consensus 674 ~~~~~~~~--------~~~----------------------~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 723 (740)
......+. ... ...++.. ....+.....++.+|+.+||+.||++|||+
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111000 000 0000111 112234556688899999999999999999
Q ss_pred HHHHH
Q 040687 724 SQVAT 728 (740)
Q Consensus 724 ~ev~~ 728 (740)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=313.76 Aligned_cols=227 Identities=25% Similarity=0.266 Sum_probs=172.9
Q ss_pred CccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEEEec
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.|...+.||+|+||+||.....+++.||||++... ..+.+.+|+++|+++ +||||+++++++.+....+|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 35556789999999998776778999999998653 235678999999986 899999999999999999999999
Q ss_pred CCCCChHHhHhCCCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC-------------CC
Q 040687 562 MPRGTLHDHLHGGLSP------LNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD-------------WG 622 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~------l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~ 622 (740)
++ |+|.+++...... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ ..
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999765321 133456789999999999999998 9999999999999754 48
Q ss_pred EEEeecCCCccccCC--------------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCC
Q 040687 623 ARIADFGLLTSCERD--------------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVP 669 (740)
Q Consensus 623 ~ki~DFGla~~~~~~--------------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 669 (740)
+||+|||++...... ..++.++||||||+++|||+| |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999998643221 234678999999999999999 99999643221
Q ss_pred chhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 670 PGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ...+. .... ........+.....++.+|+.+||+.||++||++.||++
T Consensus 247 ~------~~i~~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E------SNIIR-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H------HHHHH-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H------HHHhc-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 01111 1000 001111123344568889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.95 Aligned_cols=228 Identities=22% Similarity=0.264 Sum_probs=174.9
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
...+|+..+.||+|+||+||.....+++.||||++..... ..+.+|+++|+++ +||||+++++++.+....+||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3456889999999999997765566899999999875432 2356799999999 799999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-----CCCEEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-----DWGARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~ki~DFGla~~ 633 (740)
|||++ |+|.+++......+.+.+++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99996 6999999876655666677899999999999999999 999999999999953 34688999999764
Q ss_pred ccC---------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 634 CER---------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 634 ~~~---------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
... ....+.++||||||+++|||+| |+.||....... . ..+.....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~-~~~~~~~~ 246 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----A-NILLGACS 246 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----H-HHHTTCCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----H-HHHhccCC
Confidence 321 1122458999999999999999 999996432110 0 01100000
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ............+.+|+.+||+.||++||++.||++
T Consensus 247 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 L------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 011112233445779999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=329.32 Aligned_cols=226 Identities=17% Similarity=0.245 Sum_probs=179.5
Q ss_pred cCccccceecccCceEEEEEEEe--CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe-----
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV--DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE----- 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 554 (740)
++|+..+.||+|+||.||++++. +++.||||++..... ......|.+|+++|++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 67999999999999999999985 589999999865432 2345678999999999999999999999987655
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.||||||+++++|.+++.. .+++.+++.|+.||++||+|||+.+ ||||||||+|||++.+ .+||+|||++...
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998864 6999999999999999999999999 9999999999999986 8999999998754
Q ss_pred cCCC----------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 635 ERDL----------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 635 ~~~~----------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
.... ..+.++||||||++||||++|..||....... .. .....
T Consensus 232 ~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------~~-------~~~~~ 290 (681)
T 2pzi_A 232 NSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------LP-------EDDPV 290 (681)
T ss_dssp TCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------CC-------TTCHH
T ss_pred ccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc--------------cc-------ccccc
Confidence 3311 12568999999999999999998886321100 00 00000
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHHHHHh
Q 040687 699 VEPLFKLADIAELAIRENPSELPT-MSQVATWLEQIVKD 736 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~~Le~l~~~ 736 (740)
......+.+|+.+||+.||++||+ ++++.+.|..++++
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 111246789999999999999995 66777777776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-33 Score=308.94 Aligned_cols=229 Identities=17% Similarity=0.154 Sum_probs=167.2
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCCC-CCcc----------
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIRH-SNIV---------- 543 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~H-~niv---------- 543 (740)
+...+.+|+..+.||+|+||.||++++. +++.||||++..... .....+.|.+|+.+++.++| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3444566888899999999999999974 589999999874322 12235679999999999987 3211
Q ss_pred -----------eEEeEEEe-----CCeEEEEEecCCCCChHHhHh------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 040687 544 -----------NLLGYCLE-----MGERLLVYEFMPRGTLHDHLH------GGLSPLNWSLRLKISMQAAKGLEYLHKDA 601 (740)
Q Consensus 544 -----------~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 601 (740)
.++.+... ....+++|+++ .++|.+++. .....+++..++.|+.||++||+|||+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11111111 12356777766 689999984 22345889999999999999999999999
Q ss_pred CCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---------------------------CCCCCcccceehhHHHHH
Q 040687 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---------------------------DLTTDMKSDVHNFGIVLL 654 (740)
Q Consensus 602 ~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---------------------------~~~~~~ksDVwSfGvvl~ 654 (740)
||||||||+||||+.++.+||+|||+++.... ...++.++|||||||+||
T Consensus 232 ---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 232 ---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ---EECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ---cccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999754321 112356999999999999
Q ss_pred HHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 655 EILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 655 ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
||+||+.||...... .....++.... ....++.+|+.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~-------------~~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAAL-------------GGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGG-------------SCSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchh-------------hhHHHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999643211 11111222111 12246889999999999999999888865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-33 Score=322.98 Aligned_cols=249 Identities=21% Similarity=0.288 Sum_probs=185.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe------CCe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE------MGE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 554 (740)
++|+..+.||+|+||.||++... +++.||||+++... .....+.|.+|+++|++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 67999999999999999999974 58899999987643 23445679999999999999999999998765 567
Q ss_pred EEEEEecCCCCChHHhHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC---EEEeecC
Q 040687 555 RLLVYEFMPRGTLHDHLHGGL--SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG---ARIADFG 629 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~ki~DFG 629 (740)
.+|||||+++++|.+++.... ..+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998643 35899999999999999999999998 999999999999997665 9999999
Q ss_pred CCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC----cc
Q 040687 630 LLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG----KA 685 (740)
Q Consensus 630 la~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~----~~ 685 (740)
++..... ...++.++||||||+++|||+||+.||.....+ ..|........ ..
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHSSTTCC------CCS
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhhhhhhhcccchhhhh
Confidence 9865432 123467999999999999999999999643211 11110000000 00
Q ss_pred chhcccc------cCCC--CCchhHHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHHHHhc
Q 040687 686 AAIIDRN------VALP--RNVEPLFKLADIAELAIRENPSELPTMSQ-----VATWLEQIVKDG 737 (740)
Q Consensus 686 ~~i~d~~------~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e-----v~~~Le~l~~~~ 737 (740)
....... ...+ ........+.+|+.+||+.||++|||+.| ..+.+++++...
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 1111111 1111 12345678999999999999999999988 455666666544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=282.59 Aligned_cols=229 Identities=14% Similarity=0.140 Sum_probs=170.7
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEeccccc------chhcHHHHHHHHHHHHhCC---------CCCcceE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATI------IHTNIREFEMELEVLCNIR---------HSNIVNL 545 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~------~~~~~~~~~~E~~~l~~l~---------H~niv~l 545 (740)
.++|+..++||+|+||+||+++. +++.||||++..... .....+.+.+|+.+|++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688999999999999999998 789999999986532 1234578899999999885 8888888
Q ss_pred EeEEE------------------------------eCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHH
Q 040687 546 LGYCL------------------------------EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE 595 (740)
Q Consensus 546 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~ 595 (740)
.+.+. +....+|||||+++|++.+.+.+ ..+++.+++.|+.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 88753 25789999999999988777754 45899999999999999999
Q ss_pred HHH-hCCCCCeEecCCCCCCEEECCCC--------------------CEEEeecCCCccccCC---------------CC
Q 040687 596 YLH-KDAAPPIIHRDVKTLNILLDSDW--------------------GARIADFGLLTSCERD---------------LT 639 (740)
Q Consensus 596 yLH-~~~~~~iiHrDlk~~NILl~~~~--------------------~~ki~DFGla~~~~~~---------------~~ 639 (740)
||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ..
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCC
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCC
Confidence 999 888 99999999999999887 8999999998754321 11
Q ss_pred CCcccceehhHHH-HHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCC
Q 040687 640 TDMKSDVHNFGIV-LLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPS 718 (740)
Q Consensus 640 ~~~ksDVwSfGvv-l~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 718 (740)
.+.++|||||+.+ .+++++|..||.... ........+.... ........+.......++.+|+++||+.|
T Consensus 253 ~~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 253 GDYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp SSHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred CccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 2678999998776 788888999984210 0000111111000 00001111112245567889999999976
Q ss_pred CCCCHHHHH
Q 040687 719 ELPTMSQVA 727 (740)
Q Consensus 719 ~RPt~~ev~ 727 (740)
|++|++
T Consensus 324 ---sa~e~l 329 (336)
T 2vuw_A 324 ---SATDLL 329 (336)
T ss_dssp ---SHHHHH
T ss_pred ---CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-26 Score=260.03 Aligned_cols=167 Identities=22% Similarity=0.225 Sum_probs=126.0
Q ss_pred eecccCceEEEEEEE-eCCcEEEEEEeccccc--------chhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEEE
Q 040687 489 ELGRGSYGFVYKAVL-VDGRQVAVKRANAATI--------IHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 489 ~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~--------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (740)
.+..|.+|.+..++. --|+.+++|.+..... .+.+.++|.+|+++|+++ +|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456777777766553 3488899999875421 123456799999999999 799999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCC
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~ 638 (740)
|||+++++|.++|... .+++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....+.
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999865 466654 48899999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccceehhHHHHHHHHhCCCCC
Q 040687 639 TTDMKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 639 ~~~~ksDVwSfGvvl~ElltG~~p~ 663 (740)
....+++++++++..|+++|+.++
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g~~~~ 417 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAENKSW 417 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------
T ss_pred -ccccCceechhhccHHHhCCCCCC
Confidence 235677888888888888877554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=232.87 Aligned_cols=137 Identities=18% Similarity=0.233 Sum_probs=109.0
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEecccccchh------cHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHT------NIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
...+.||+|+||.||+++. .++.+++|+......... ..+.|.+|+++|++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 578899998655432211 234589999999999999999666666677788999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||+++++|.+++.. ++.++.|+++||+|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 4689999999999999999 999999999999999 999999999987644
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.2e-21 Score=200.37 Aligned_cols=143 Identities=15% Similarity=0.112 Sum_probs=113.7
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccch----------------hcHHHHHHHHHHHHhCCC
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIH----------------TNIREFEMELEVLCNIRH 539 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~----------------~~~~~~~~E~~~l~~l~H 539 (740)
.+......|+..+.||+|+||.||+++..+++.||||.++...... .....+.+|+++|++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 4444455677779999999999999999669999999986533111 124568999999999994
Q ss_pred CCcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC
Q 040687 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS 619 (740)
Q Consensus 540 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~ 619 (740)
+++.+++.. +..++||||+++++|.+ +.. .+...++.|+++||.|||+.+ |+||||||+|||++
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 555554433 45699999999999998 532 124579999999999999999 99999999999999
Q ss_pred CCCEEEeecCCCccc
Q 040687 620 DWGARIADFGLLTSC 634 (740)
Q Consensus 620 ~~~~ki~DFGla~~~ 634 (740)
++.+||+|||+++..
T Consensus 228 ~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 228 EEGIWIIDFPQSVEV 242 (282)
T ss_dssp TTEEEECCCTTCEET
T ss_pred CCcEEEEECCCCeEC
Confidence 999999999998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-19 Score=185.87 Aligned_cols=138 Identities=20% Similarity=0.155 Sum_probs=107.7
Q ss_pred ccccceecccCceEEEEEEE-eCCcE--EEEEEecccccch----------------------hcHHHHHHHHHHHHhCC
Q 040687 484 FKEFNELGRGSYGFVYKAVL-VDGRQ--VAVKRANAATIIH----------------------TNIREFEMELEVLCNIR 538 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~-~~g~~--vAiK~l~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 538 (740)
|+..+.||+|+||.||++.. .+|+. ||||.++...... .....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67889 9999875432110 01135889999999998
Q ss_pred CCC--cceEEeEEEeCCeEEEEEecCCC-C----ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCC
Q 040687 539 HSN--IVNLLGYCLEMGERLLVYEFMPR-G----TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH-KDAAPPIIHRDV 610 (740)
Q Consensus 539 H~n--iv~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~iiHrDl 610 (740)
|++ +..++.+ ...+|||||+.+ | +|.+++.. .++.++..++.|++.+|.||| +.+ |+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 875 3455543 356899999942 4 67766532 234567789999999999999 888 999999
Q ss_pred CCCCEEECCCCCEEEeecCCCccc
Q 040687 611 KTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 611 k~~NILl~~~~~~ki~DFGla~~~ 634 (740)
||+|||+++ .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.9e-16 Score=169.92 Aligned_cols=137 Identities=14% Similarity=0.126 Sum_probs=101.4
Q ss_pred CccccceecccCceEEEEEEEeCCcEEEEEEecccccc------------hhcHHH--------HHHHHHHHHhCCCCCc
Q 040687 483 GFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATII------------HTNIRE--------FEMELEVLCNIRHSNI 542 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~------------~~~~~~--------~~~E~~~l~~l~H~ni 542 (740)
-|+....||+|+||.||+|...+|+.||||+++..... ...... ..+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48899999999999999999888999999987643211 001111 2456777777755443
Q ss_pred --ceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 543 --VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 543 --v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
...+.+ . ..+|||||+++++|.++... .....++.|++.+|.|||+.+ ||||||||.|||++++
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 233322 2 23799999999888765432 123567899999999999998 9999999999999887
Q ss_pred C----------CEEEeecCCCcc
Q 040687 621 W----------GARIADFGLLTS 633 (740)
Q Consensus 621 ~----------~~ki~DFGla~~ 633 (740)
+ .+.|+||+-+-.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 389999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.4e-11 Score=125.32 Aligned_cols=148 Identities=16% Similarity=0.101 Sum_probs=115.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGER 555 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 555 (740)
+....++|+....++.|+++.||+... +++.+++|+...... .....+.+|+++|+.+. |.++.+++++....+..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 344556788888889999999999875 468899999865321 12235889999999984 67888999999988899
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA---------------------------------- 601 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~---------------------------------- 601 (740)
|+||||+++.+|.+.+.. ......++.++++.|..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999999876421 1223468889999999999811
Q ss_pred ----------------------CCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 602 ----------------------APPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 602 ----------------------~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998766667999998743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=1.6e-10 Score=118.36 Aligned_cols=139 Identities=18% Similarity=0.145 Sum_probs=102.4
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC--cceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN--IVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~ 559 (740)
.++......+.|..+.||+....+++.+++|...... ...+.+|+++|+.+.+.+ +.+++++....+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3444433334666799999987667889999876431 245788999999886544 567899888777899999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA-------------------------------------- 601 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-------------------------------------- 601 (740)
||+++.+|. ... .+ ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998884 221 22 2356778888888888643
Q ss_pred -----------------CCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 602 -----------------APPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 602 -----------------~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+.++|+|++|.|||++++..++|+||+.+...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 113999999999999988766789999997543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-09 Score=118.29 Aligned_cols=144 Identities=16% Similarity=0.253 Sum_probs=108.1
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEec--ccccchhcHHHHHHHHHHHHhCC--CCCcceEEeEEEeC---CeEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRAN--AATIIHTNIREFEMELEVLCNIR--HSNIVNLLGYCLEM---GERLL 557 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~--~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~l 557 (740)
...+.|+.|.+..||+.... +..+++|+.. .... ......+.+|..+|+.|. +.++.+++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34667999999999998864 4678888765 3221 112346788999999997 45688999998776 35899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA------------------------------------ 601 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------ 601 (740)
||||+++..+.+... ..++..++..++.++++.|..||...
T Consensus 119 vme~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999988754221 24778888999999999999999831
Q ss_pred -------------------CCCeEecCCCCCCEEECCCCC--EEEeecCCCcc
Q 040687 602 -------------------APPIIHRDVKTLNILLDSDWG--ARIADFGLLTS 633 (740)
Q Consensus 602 -------------------~~~iiHrDlk~~NILl~~~~~--~ki~DFGla~~ 633 (740)
.+.++|+|+++.|||++.+.. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-08 Score=107.79 Aligned_cols=166 Identities=20% Similarity=0.200 Sum_probs=119.2
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCC--cceEEeEEEeCC---eEEEEEe
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSN--IVNLLGYCLEMG---ERLLVYE 560 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E 560 (740)
.+.++.|.+..||+.. +.+++|+.... .....+.+|.++|+.+. +.. +.+++....... ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999863 56888886532 23457889999999884 332 455655543333 3589999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA--------------------------------------- 601 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--------------------------------------- 601 (740)
++++.+|.+... ..++..++..++.++++.|..||+..
T Consensus 97 ~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 97 KIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999988875433 23677888888999999999998621
Q ss_pred ----------------CCCeEecCCCCCCEEECC--CCCEEEeecCCCccccC---------C---CC------------
Q 040687 602 ----------------APPIIHRDVKTLNILLDS--DWGARIADFGLLTSCER---------D---LT------------ 639 (740)
Q Consensus 602 ----------------~~~iiHrDlk~~NILl~~--~~~~ki~DFGla~~~~~---------~---~~------------ 639 (740)
.+.++|+|+++.|||+++ ...+.|+||+.+..... . ..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 135899999999999998 55678999998643221 0 00
Q ss_pred -CC---------cccceehhHHHHHHHHhCCCCC
Q 040687 640 -TD---------MKSDVHNFGIVLLEILSGRKAY 663 (740)
Q Consensus 640 -~~---------~ksDVwSfGvvl~ElltG~~p~ 663 (740)
.+ ...+.|+++.++|++.+|+.+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01 1258899999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.5e-06 Score=87.95 Aligned_cols=137 Identities=18% Similarity=0.184 Sum_probs=96.3
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC---CcceEEeEEE-eCCeEEEEEecC
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS---NIVNLLGYCL-EMGERLLVYEFM 562 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~ 562 (740)
.+.++.|....||+. ++.+++|+.... .....+.+|.++|+.|.+. .+.+.+.+.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888888899987 567888874321 2345789999999999753 3667777764 345678999999
Q ss_pred CCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 040687 563 PRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD------------------------------------------ 600 (740)
Q Consensus 563 ~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------ 600 (740)
++.+|.+..-. .++..++..++.++++.|..||+.
T Consensus 96 ~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99888763221 234555555556666666555542
Q ss_pred ---------------CCCCeEecCCCCCCEEECC---CCC-EEEeecCCCccc
Q 040687 601 ---------------AAPPIIHRDVKTLNILLDS---DWG-ARIADFGLLTSC 634 (740)
Q Consensus 601 ---------------~~~~iiHrDlk~~NILl~~---~~~-~ki~DFGla~~~ 634 (740)
..+.++|+|+++.|||++. ++. ..|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999997 455 489999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=8.8e-06 Score=83.61 Aligned_cols=136 Identities=15% Similarity=0.106 Sum_probs=97.7
Q ss_pred eecccCce-EEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 489 ELGRGSYG-FVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 489 ~LG~G~fG-~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
.+..|..+ .||+.... ++..+.+|+-... ...++..|..+|+.|. +-.+.+++.++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34445444 68987754 3667899976532 2356788999998884 444778999999999999999999998
Q ss_pred ChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 040687 566 TLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA-------------------------------------------- 601 (740)
Q Consensus 566 sL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-------------------------------------------- 601 (740)
++.+..... ......+..++++.|.-||...
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765321 1223345666667777777521
Q ss_pred -----------CCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 602 -----------APPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 602 -----------~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+.++|+|+.+.|||++.+..+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 113899999999999998877789999997644
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=3.4e-06 Score=90.67 Aligned_cols=83 Identities=8% Similarity=-0.024 Sum_probs=56.7
Q ss_pred cccee-cccCceEEEEEEEe-------CCcEEEEEEeccccc-chhcHHHHHHHHHHHHhCC-C--CCcceEEeEEEeC-
Q 040687 486 EFNEL-GRGSYGFVYKAVLV-------DGRQVAVKRANAATI-IHTNIREFEMELEVLCNIR-H--SNIVNLLGYCLEM- 552 (740)
Q Consensus 486 ~~~~L-G~G~fG~Vy~~~~~-------~g~~vAiK~l~~~~~-~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~- 552 (740)
..+.| +.|....+|+.... +++.+++|+...... .......+.+|..+|+.|. + -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34567 88999999998764 267888997654320 0001135678888888874 2 3577888887665
Q ss_pred --CeEEEEEecCCCCChH
Q 040687 553 --GERLLVYEFMPRGTLH 568 (740)
Q Consensus 553 --~~~~lV~Ey~~~gsL~ 568 (740)
+..++||||+++..|.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.3e-05 Score=79.23 Aligned_cols=139 Identities=17% Similarity=0.248 Sum_probs=79.8
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-----CCCcceEE-e--EEEeCCeEEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-----HSNIVNLL-G--YCLEMGERLLV 558 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV 558 (740)
.+.|+.|....||+....++ .+++|+..... .++..|..+++.|. .|.++... | +....+..++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 34566678899999887544 58999886521 23334555555442 34444310 1 12345678999
Q ss_pred EecCCCCChH--------------HhHhC---CC----------CCCCHHHHH---------------------------
Q 040687 559 YEFMPRGTLH--------------DHLHG---GL----------SPLNWSLRL--------------------------- 584 (740)
Q Consensus 559 ~Ey~~~gsL~--------------~~l~~---~~----------~~l~~~~~~--------------------------- 584 (740)
|||+++..+. ..||. .. ..-.|...+
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 11221 00 012343211
Q ss_pred ----HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 585 ----KISMQAAKGLEYLHK----------DAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 585 ----~ia~~ia~gL~yLH~----------~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
.+...+.+.+++|+. ...+.++|+|+++.|||++.+..+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446677763 123459999999999999888899999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=80.14 Aligned_cols=77 Identities=16% Similarity=0.160 Sum_probs=50.0
Q ss_pred cceecccCceEEEEEEEe-CCcEEEEEEeccccc--c---hhcHHHHHHHHHHHHhCCC--C-CcceEEeEEEeCCeEEE
Q 040687 487 FNELGRGSYGFVYKAVLV-DGRQVAVKRANAATI--I---HTNIREFEMELEVLCNIRH--S-NIVNLLGYCLEMGERLL 557 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~--~---~~~~~~~~~E~~~l~~l~H--~-niv~l~g~~~~~~~~~l 557 (740)
.+.||.|.++.||++... +++.++||....... . ......+..|.++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 467899997653211 0 0122356778888887742 3 34566654 3445689
Q ss_pred EEecCCCC
Q 040687 558 VYEFMPRG 565 (740)
Q Consensus 558 V~Ey~~~g 565 (740)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00026 Score=74.57 Aligned_cols=139 Identities=19% Similarity=0.220 Sum_probs=94.3
Q ss_pred ccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC---CCCcceEEeEEEeCCeEEEEEe
Q 040687 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR---HSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 484 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E 560 (740)
....+.|+.|.+..+|+... +++.+++|+.... ....|..|.+.|+.|. ...+.+++.+....+..++|||
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 34556799999999999875 5678888976532 2356888999998884 3568899999888888999999
Q ss_pred cCCCCChH--------H---hHhCCCC---------------------CCCHHHHH---HHHH--H--------------
Q 040687 561 FMPRGTLH--------D---HLHGGLS---------------------PLNWSLRL---KISM--Q-------------- 589 (740)
Q Consensus 561 y~~~gsL~--------~---~l~~~~~---------------------~l~~~~~~---~ia~--~-------------- 589 (740)
|+++..+. + .||.... .-+|.... ++.. +
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99987642 1 2232110 12565432 1111 1
Q ss_pred HHHH-HHHHHh-CCCCCeEecCCCCCCEEECCCCCEEEeecC
Q 040687 590 AAKG-LEYLHK-DAAPPIIHRDVKTLNILLDSDWGARIADFG 629 (740)
Q Consensus 590 ia~g-L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~ki~DFG 629 (740)
+.+- ...|.. ...|.++|+|+.+.|+|++.++ +.|.||.
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 123422 2356799999999999999887 8999983
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00034 Score=72.53 Aligned_cols=80 Identities=20% Similarity=0.200 Sum_probs=58.1
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC---CCcceEEeEEEeCCeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH---SNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV 558 (740)
..+...+.+|.|....||+.++.||+.|.+|+...... .....|..|.+.|+.|.- -.+.+.+++. ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 34666788999999999999999999999998654321 122357889999988842 2356666552 24789
Q ss_pred EecCCCCCh
Q 040687 559 YEFMPRGTL 567 (740)
Q Consensus 559 ~Ey~~~gsL 567 (740)
|||++.+..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0011 Score=72.59 Aligned_cols=76 Identities=17% Similarity=0.231 Sum_probs=47.1
Q ss_pred ccceecccCceEEEEEEEeCCcEEEEEEeccccc--ch-----hcHHHHHHHHHHHH-hCCCCCcceEEeEEEeCCeEEE
Q 040687 486 EFNELGRGSYGFVYKAVLVDGRQVAVKRANAATI--IH-----TNIREFEMELEVLC-NIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~--~~-----~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~l 557 (740)
..+.||.|....||+... +++.++||....... .. .....+..|+..+. ......+.+++.+. ....++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999864 567899994332110 00 12233444544332 22335667777765 466789
Q ss_pred EEecC-CC
Q 040687 558 VYEFM-PR 564 (740)
Q Consensus 558 V~Ey~-~~ 564 (740)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0053 Score=64.32 Aligned_cols=141 Identities=13% Similarity=0.162 Sum_probs=80.3
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC--cceEEeE------EEeCCeEEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN--IVNLLGY------CLEMGERLLV 558 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV 558 (740)
.+.|+.|....+|+....++ .+++|...... ...++..|..++..|.... +.+++.. ....+..++|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 45577788899999987555 67889876521 1124556777777663211 2333321 1234567899
Q ss_pred EecCCCCChHH--------------hHhC---CC-CC-------CCHHHHHH------------HHHHHHHHHHHHHhC-
Q 040687 559 YEFMPRGTLHD--------------HLHG---GL-SP-------LNWSLRLK------------ISMQAAKGLEYLHKD- 600 (740)
Q Consensus 559 ~Ey~~~gsL~~--------------~l~~---~~-~~-------l~~~~~~~------------ia~~ia~gL~yLH~~- 600 (740)
|||+++..+.. .+|. .. .+ ..|...+. +...+.+.+++|+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99998765311 1221 00 00 12433211 111244556666532
Q ss_pred ---CCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 601 ---AAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 601 ---~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
..+.++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12359999999999999987666899999864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0026 Score=67.16 Aligned_cols=140 Identities=11% Similarity=0.081 Sum_probs=73.0
Q ss_pred ceecccCce-EEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC--CCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYG-FVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH--SNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG-~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
+.|..|... .+|+....+++.+++|....... .++..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 345545333 36676543467777776543210 233456666666632 23567777644333 789999977
Q ss_pred CChHHhHhC---------------------C----CCCCCHHHHH-------H-------------HHHHHHHHHHHHHh
Q 040687 565 GTLHDHLHG---------------------G----LSPLNWSLRL-------K-------------ISMQAAKGLEYLHK 599 (740)
Q Consensus 565 gsL~~~l~~---------------------~----~~~l~~~~~~-------~-------------ia~~ia~gL~yLH~ 599 (740)
..+.+++.. . ...++..... . ....+.+.++.|..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 666543321 1 0112111100 0 00111222233311
Q ss_pred ---CCCCCeEecCCCCCCEEECCC----CCEEEeecCCCccc
Q 040687 600 ---DAAPPIIHRDVKTLNILLDSD----WGARIADFGLLTSC 634 (740)
Q Consensus 600 ---~~~~~iiHrDlk~~NILl~~~----~~~ki~DFGla~~~ 634 (740)
...+.++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123459999999999999875 67999999987644
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0024 Score=66.53 Aligned_cols=137 Identities=15% Similarity=0.095 Sum_probs=75.1
Q ss_pred cceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-ceEEeEEEeCCeEEEEEecC-CC
Q 040687 487 FNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-VNLLGYCLEMGERLLVYEFM-PR 564 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~ 564 (740)
.+.|..|....+|+. +.+.+|+...... ...+..+|..+++.+....+ .+++.+. .+.-++|+||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 567989999999998 5688887654321 11123467777776642222 4666543 33457899999 55
Q ss_pred CChHH------------------hHhCCCCCC----CH-HHHHHHHH--------------HHHHHHH----HHHh-CCC
Q 040687 565 GTLHD------------------HLHGGLSPL----NW-SLRLKISM--------------QAAKGLE----YLHK-DAA 602 (740)
Q Consensus 565 gsL~~------------------~l~~~~~~l----~~-~~~~~ia~--------------~ia~gL~----yLH~-~~~ 602 (740)
-+|.. .||.....+ +. .....+.. .+.+.+. .|.. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44321 112211111 11 11111110 0111111 1211 223
Q ss_pred CCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+.++|+|+.+.||| ..++.+.|+||..+...
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 45899999999999 55667899999987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0037 Score=68.73 Aligned_cols=73 Identities=11% Similarity=0.142 Sum_probs=49.7
Q ss_pred ccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC-cceEEeEEEeCCeEE
Q 040687 486 EFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN-IVNLLGYCLEMGERL 556 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~ 556 (740)
..+.|+.|-...+|+....+ ++.+.+|+..... ....+.+|..+++.|...+ ..++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 34568888889999998753 4789999874311 1135567999988884333 3677776532 3
Q ss_pred EEEecCCCCC
Q 040687 557 LVYEFMPRGT 566 (740)
Q Consensus 557 lV~Ey~~~gs 566 (740)
+|+||+++-+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.013 Score=61.35 Aligned_cols=141 Identities=15% Similarity=0.125 Sum_probs=81.5
Q ss_pred ceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCC--CcceEEeE-----EEeCCeEEEEEe
Q 040687 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS--NIVNLLGY-----CLEMGERLLVYE 560 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~E 560 (740)
+.|+ |....||+....+|+.+++|....... ....+..|..+++.|... .+.+++.. ....+..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 777899988776677899999864321 234566788888777421 23444432 123456789999
Q ss_pred cCCCCChH-----H------h---HhC----C----CCCCCHHHHH----HH---------------HHHHHHHHHHHHh
Q 040687 561 FMPRGTLH-----D------H---LHG----G----LSPLNWSLRL----KI---------------SMQAAKGLEYLHK 599 (740)
Q Consensus 561 y~~~gsL~-----~------~---l~~----~----~~~l~~~~~~----~i---------------a~~ia~gL~yLH~ 599 (740)
|+++..+. . . +|. . ...+++.... .+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875431 1 1 111 0 0122332210 01 0111122333332
Q ss_pred C----CCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 600 D----AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 600 ~----~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
. ..+.++|+|+++.|||++ + .+.|+||..+...
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1 233489999999999999 4 8999999887543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.023 Score=62.95 Aligned_cols=74 Identities=19% Similarity=0.219 Sum_probs=47.5
Q ss_pred cceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-ceEEeEEEeCCeEEEEEecCCC
Q 040687 487 FNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-VNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
.+.|..|-...+|+....+ ++.+.+|+..... ...-+-.+|..+|+.|...++ .++++.+. + .+||||+++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4568888889999998755 4788888764322 111112578899998865444 57777762 2 259999987
Q ss_pred CCh
Q 040687 565 GTL 567 (740)
Q Consensus 565 gsL 567 (740)
-+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.01 Score=64.00 Aligned_cols=154 Identities=18% Similarity=0.207 Sum_probs=91.3
Q ss_pred ceecccCceEEEEEEEe--------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEEE
Q 040687 488 NELGRGSYGFVYKAVLV--------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~--------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 558 (740)
+.|..|-...+|+.... +++.+.+|+..... .....+.+|.++++.|. +.-..++++++.+ -+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45767777889998864 24789998853321 23456678999998874 3233677766543 289
Q ss_pred EecCCCCChHH-----------------hHhCCC----CCCC--HHHHHHHHHHHH-------------------HHHHH
Q 040687 559 YEFMPRGTLHD-----------------HLHGGL----SPLN--WSLRLKISMQAA-------------------KGLEY 596 (740)
Q Consensus 559 ~Ey~~~gsL~~-----------------~l~~~~----~~l~--~~~~~~ia~~ia-------------------~gL~y 596 (740)
|||+++.+|.. .||... ++.. |.++.++..++. +.+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998755431 112211 1122 445555544332 12333
Q ss_pred HH----hC-CCCCeEecCCCCCCEEECCC----CCEEEeecCCCccccCCCCCCcccceehhHHHHHHHH
Q 040687 597 LH----KD-AAPPIIHRDVKTLNILLDSD----WGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEIL 657 (740)
Q Consensus 597 LH----~~-~~~~iiHrDlk~~NILl~~~----~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~Ell 657 (740)
|. .. ....++|+|+.+.|||++.+ ..+.|+||..+... .=.|-+|..+.|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~---------~~~~Dla~~~~~~~ 269 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN---------YRGFDIGNHFCEWV 269 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE---------EHHHHHHHHHHHTT
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC---------ChHHHHHHHHHHHH
Confidence 32 22 22359999999999999876 68999999987433 22445677777776
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0065 Score=65.16 Aligned_cols=154 Identities=14% Similarity=0.141 Sum_probs=83.1
Q ss_pred cceecccCceEEEEEEEeC---------CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC-cceEEeEEEeCCeEE
Q 040687 487 FNELGRGSYGFVYKAVLVD---------GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN-IVNLLGYCLEMGERL 556 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~---------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~ 556 (740)
.+.|+.|..-.+|+....+ ++.+.+|+...... ...+...|.++++.|...+ ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3467788888999988754 26788887654321 1112356888888774333 44676543 2 36
Q ss_pred EEEecCCCCChHH-----------------hHhC----C--CCCCC-----HHHHHHHH--------------------H
Q 040687 557 LVYEFMPRGTLHD-----------------HLHG----G--LSPLN-----WSLRLKIS--------------------M 588 (740)
Q Consensus 557 lV~Ey~~~gsL~~-----------------~l~~----~--~~~l~-----~~~~~~ia--------------------~ 588 (740)
+||||+++..+.. .||. . ...++ |.....+. .
T Consensus 111 ~v~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (369)
T 3c5i_A 111 RIEEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIK 190 (369)
T ss_dssp EEEECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHH
T ss_pred EEEEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHH
Confidence 8999998754310 1121 0 00111 11111111 1
Q ss_pred HHHHHHHHHHh-------CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHH
Q 040687 589 QAAKGLEYLHK-------DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEIL 657 (740)
Q Consensus 589 ~ia~gL~yLH~-------~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~Ell 657 (740)
.+.+-+++|.. ...+.++|+|+.+.|||++++. +.|+||..+.... . .|=||.++.++.
T Consensus 191 ~~~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g~------~---~~Dla~~~~~~~ 256 (369)
T 3c5i_A 191 ESDKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGFNF------L---ATDIANFFIETS 256 (369)
T ss_dssp HHHHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEEEE------H---HHHHHHHHHGGG
T ss_pred HHHHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCCCc------h---HHHHHHHHHHHh
Confidence 11222344432 1123599999999999998664 8999998874331 1 234566666654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.054 Score=57.29 Aligned_cols=32 Identities=19% Similarity=0.225 Sum_probs=27.7
Q ss_pred CCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 603 ~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
+.++|+|+.+.|||++.++.+.|+||..+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45999999999999998888999999876543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.05 E-value=0.074 Score=52.13 Aligned_cols=91 Identities=16% Similarity=0.141 Sum_probs=63.7
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc-----cccCC--
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT-----SCERD-- 637 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~-----~~~~~-- 637 (740)
-+|.+.|.....++++.+++.++.|.++.|.-+-....+ ..+=+-|..|+|..+|.+...+ ..+. .....
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~~~~~~~~~pe~~ 109 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADDAGEPPPVAGKLG 109 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------CCS
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-ccccccccCCCChhhc
Confidence 379999988778999999999999999998776322211 1233457899999999988774 2221 01111
Q ss_pred -CCCCcccceehhHHHHHHHHh
Q 040687 638 -LTTDMKSDVHNFGIVLLEILS 658 (740)
Q Consensus 638 -~~~~~ksDVwSfGvvl~Ellt 658 (740)
...+.|.=|||+|++||.-+-
T Consensus 110 ~~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 110 YSQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp SSSSCHHHHHHHHHHHHHHHHT
T ss_pred cccchHHHHHHHHHHHHHHHhh
Confidence 122567789999999999887
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.08 E-value=0.31 Score=53.13 Aligned_cols=155 Identities=14% Similarity=0.171 Sum_probs=92.4
Q ss_pred ccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEE
Q 040687 486 EFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 556 (740)
..+.|..|-.-.+|+....+ ++.+.+|+..... ...-+..+|..+++.|. +.-..++++.+ . -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CC
Confidence 34567778888999998753 5789998864422 11112356888887774 32345666533 2 26
Q ss_pred EEEecCCCCChHH-----------------hHhC------------CCCCCCHHHHHHHHHHH-----------------
Q 040687 557 LVYEFMPRGTLHD-----------------HLHG------------GLSPLNWSLRLKISMQA----------------- 590 (740)
Q Consensus 557 lV~Ey~~~gsL~~-----------------~l~~------------~~~~l~~~~~~~ia~~i----------------- 590 (740)
+||||+++.+|.. .||. ...+.-|.++.++..++
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8999999865321 0111 01112244443333222
Q ss_pred --HHHHHHHHh---------------------CCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCCCCCccccee
Q 040687 591 --AKGLEYLHK---------------------DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVH 647 (740)
Q Consensus 591 --a~gL~yLH~---------------------~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ksDVw 647 (740)
...+.+|.+ .....++|+|+.+.||| +.+..+.|+||..+... -=.|
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~---------~~~~ 296 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN---------FAGA 296 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE---------EHHH
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC---------ChHH
Confidence 223334331 11235899999999999 78889999999887432 2245
Q ss_pred hhHHHHHHHH
Q 040687 648 NFGIVLLEIL 657 (740)
Q Consensus 648 SfGvvl~Ell 657 (740)
-+|.++.|..
T Consensus 297 Dla~~~~~~~ 306 (424)
T 3mes_A 297 DIANYFCEYI 306 (424)
T ss_dssp HHHHHHHTTT
T ss_pred HHHHHHHHHH
Confidence 5787777776
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.43 E-value=0.042 Score=60.87 Aligned_cols=63 Identities=6% Similarity=0.096 Sum_probs=18.6
Q ss_pred ccceecccCceEEEEEEEeC-CcEEEE------EEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe
Q 040687 486 EFNELGRGSYGFVYKAVLVD-GRQVAV------KRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE 551 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~~-g~~vAi------K~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (740)
..++|| ||.||+|.+.. ..+||| |..+......+...+|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999854 467898 7776555545556679999999999999999999888754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.14 E-value=0.65 Score=50.10 Aligned_cols=44 Identities=25% Similarity=0.271 Sum_probs=33.7
Q ss_pred eEecCCCCCCEEE------CCCCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHH
Q 040687 605 IIHRDVKTLNILL------DSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEIL 657 (740)
Q Consensus 605 iiHrDlk~~NILl------~~~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~Ell 657 (740)
++|.|+.+.|||+ +++..++++||-.|..... .|=+|..+.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~~---------~fDlan~f~ew~ 295 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYR---------GFDIGNHFCEWM 295 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEEH---------HHHHHHHHHHTT
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCCc---------hHhHHHHHHHHh
Confidence 5799999999999 4567799999988754322 344688888875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.08 E-value=0.84 Score=44.53 Aligned_cols=118 Identities=8% Similarity=0.055 Sum_probs=81.7
Q ss_pred hCCCCCcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 536 NIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 536 ~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
...||+.+.. .+-...+.+.+.|+.-+++.=...++ .++..++++++..|+.-..+++. =+|--|.|+||
T Consensus 41 ~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 41 EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred hccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 3468988866 45556666666666544322222233 47889999999999887766553 35888999999
Q ss_pred EECCCCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHHhCCCCCC
Q 040687 616 LLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILSGRKAYD 664 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~ElltG~~p~~ 664 (740)
+++.++.+++.-.|+-..+.+. ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P~-~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDPL-PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSCC-CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCCC-CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999986555433 11222223357788899999998884
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=83.62 E-value=1.3 Score=43.59 Aligned_cols=62 Identities=21% Similarity=0.265 Sum_probs=33.9
Q ss_pred EEEEeeCCceeeeeecCCCcEEEeecCCCCCC-CCC-cccEEEEecccceeeeeeecCCcEEecCC
Q 040687 193 FKVLASGKSSLCGISELSGEVKCWGNNDFVSV-PPV-GIRFVSLAAGANHFCGIREDNHGVECWGS 256 (740)
Q Consensus 193 ~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~-~~~-~~~~~~la~G~~h~C~l~~~~g~v~CWG~ 256 (740)
+.+|+--..|+-.| -.|++++-+|+++.||. +|. ..+|.+++||.++|--+. .-..|.-||+
T Consensus 311 i~~VsG~y~H~vvi-~gd~el~sFG~~sNGQ~~ip~tagPfla~~AG~~fTVTVn-~~nyv~FWGD 374 (400)
T 4gbf_A 311 IGGVSGLYTHYTVM-YGDGQIAFFGNNDNGQCDVDDHAGPYIQLAAGHNFTVTVN-TLNQVMFWGD 374 (400)
T ss_dssp CCCCBCSSSEEEC--CTTTCCCEEECCTTSTTCCCGGGCCEEEEEECSSEEEEEE-TTCCEEEEEC
T ss_pred cccccccccceEEE-ecCceeEEeccCCCCceecCCCcchHHhHhccCCeEEEEe-ceeeEEEecC
Confidence 34455555565555 34666666666666663 222 345666666666666665 4445666663
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.13 E-value=2.3 Score=41.59 Aligned_cols=115 Identities=10% Similarity=0.046 Sum_probs=79.1
Q ss_pred CCCCCcceEEeEEEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCCE
Q 040687 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE-YLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 537 l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~-yLH~~~~~~iiHrDlk~~NI 615 (740)
-.||++ -...-.+.+.+.+.|+.-+++.=...++ .++..++++++..|+.-.. +++. -+|--|.|+||
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 368888 3344466677777777664543334443 3788899998888777555 4433 46788899999
Q ss_pred EECCCCCEEEeecCCCccccCCCCCCcccce-ehhHHHHHHHHhCCCCCC
Q 040687 616 LLDSDWGARIADFGLLTSCERDLTTDMKSDV-HNFGIVLLEILSGRKAYD 664 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~~~~~~~ksDV-wSfGvvl~ElltG~~p~~ 664 (740)
++|.++.++|.-.|+-..+.+.. ...-|. -.+=+++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lpP~e--~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLPPDE--WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBSSCS--CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCCCCC--CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999865554333 122233 346778888888888774
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=80.80 E-value=3.1 Score=40.96 Aligned_cols=122 Identities=19% Similarity=0.214 Sum_probs=77.8
Q ss_pred ceEE-EeeCCCeeee-----EEccccccCCCceeeecccccCCCCccCcccccc-----cccc--ccceeeEEEEEecCC
Q 040687 97 AYSR-IAAGTNHVCA-----VRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNL-----FYDE--YVSTIVLKDVISGDG 163 (740)
Q Consensus 97 ~~~~-is~G~~h~Ca-----l~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~-----~~~~--~~~~~~~~~ia~G~~ 163 (740)
.+.. |+-|..|.-- |..+.-.-....+|+...+|+.|+-..-.+-... .++. ......+.+||.=..
T Consensus 240 ~V~D~~rIg~n~iv~~~~~~iv~t~~~Ta~~~kv~V~~In~ggniTltdV~~t~~v~nh~tg~~~~ansn~i~~VsG~y~ 319 (400)
T 4gbf_A 240 HVIDSMSIGCTHIIMHSIDPLVAPEDYTSESSKVHVMEIIRNGNDTSFMVISPLWFDGRGNDVTANVNSNPIGGVSGLYT 319 (400)
T ss_dssp CEEEEEEECSSEEEEEEECTTSCGGGCCTTTEEEEEEEEEEETTEEEEEEECCCCBCTTSCBCHHHHHTSCCCCCBCSSS
T ss_pred eeeeeEEecccEEEEecccceeccCCCcceeeEEEEEEEecCCceEEEEeeceeEEecCCCCeEEEecCCcccccccccc
Confidence 4554 9999999874 2211111124467888777766653211111000 0000 000012556777778
Q ss_pred eeeeeeeCCeEEEecCCCCCCCccCC-CCcEEEEeeCCceeeeeecCCCcEEEeecC
Q 040687 164 FSCGGVRDGGIVCWGPDSESLGVFNV-TESFKVLASGKSSLCGISELSGEVKCWGNN 219 (740)
Q Consensus 164 ~~C~l~~~g~v~CwG~~~~~~~~~~~-~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n 219 (740)
|.-.+.-++.++-+|+++.|....|. ...|.+++||.+++--+ +.-..|.-||+.
T Consensus 320 H~vvi~gd~el~sFG~~sNGQ~~ip~tagPfla~~AG~~fTVTV-n~~nyv~FWGDS 375 (400)
T 4gbf_A 320 HYTVMYGDGQIAFFGNNDNGQCDVDDHAGPYIQLAAGHNFTVTV-NTLNQVMFWGDS 375 (400)
T ss_dssp EEEC-CTTTCCCEEECCTTSTTCCCGGGCCEEEEEECSSEEEEE-ETTCCEEEEECC
T ss_pred ceEEEecCceeEEeccCCCCceecCCCcchHHhHhccCCeEEEE-eceeeEEEecCC
Confidence 88777779999999999998766665 47899999999999999 667889999985
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 740 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-19 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 9e-06 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 7e-04 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 1e-04 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 0.003 | |
| d2heyr3 | 54 | g.24.1.1 (R:29-82) Tumor necrosis factor receptor | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 68/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+G GS+G VYK VAVK N ++ F+ E+ VL RH NI+
Sbjct: 10 ITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
+GY + +V ++ +L+ HLH + + I+ Q A+G++YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---K 123
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------- 640
IIHRD+K+ NI L D +I DFGL T R +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 641 ---DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697
+SDV+ FGIVL E+++G+ Y + + ++ +G + + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSK---VRS 236
Query: 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
N + + +++ E P Q+ +E + +
Sbjct: 237 NCPK--AMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 41/270 (15%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
K +G+G +G V G +VAVK + F E V+ +RHSN+V
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 63
Query: 544 NLLGYCLEMGERL-LVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDA 601
LLG +E L +V E+M +G+L D+L G S L LK S+ + +EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------DMK 643
+HRD+ N+L+ D A+++DFGL T K
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 644 SDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703
SDV +FGI+L EI S + P ++ +P +++G + P P
Sbjct: 181 SDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPRVEKGY-------KMDAPDGCPP-- 227
Query: 704 KLADIAELAIRENPSELPTMSQVATWLEQI 733
+ ++ + + + P+ Q+ LE I
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-51
Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 41/276 (14%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
E+G G +G V+ ++ +VA+K + + +F E EV+ + H +V
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLV 63
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G CLE LV+EFM G L D+L L + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---A 120
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------D 641
+IHRD+ N L+ + +++DFG+ D T
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701
KSDV +FG+++ E+ S K +VE I G + PR
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGF-------RLYKPRLAST 229
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737
+ I +E P + P S++ L +I + G
Sbjct: 230 --HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-50
Identities = 62/273 (22%), Positives = 108/273 (39%), Gaps = 43/273 (15%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
K LG G +G V+ +VAVK ++ + F E ++ ++H +V
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLV 71
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
L + ++ E+M G+L D L L + L ++ Q A+G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCE----------------------RDLTT 640
IHRD++ NIL+ +IADFGL E T
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 641 DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
+KSDV +FGI+L EI++ + P +++ ++R + R
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------------LERGYRMVRPDN 234
Query: 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
+L + L +E P + PT + + LE
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 6e-50
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 53/295 (17%)
Query: 489 ELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
+G+G +G V++ G +VAVK ++ E E+ +RH NI+ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 549 CLEMG----ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA-- 602
+ + LV ++ G+L D+L+ + +K+++ A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 603 ---PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------- 640
P I HRD+K+ NIL+ + IAD GL + T
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 641 ------------DMKSDVHNFGIVLLEILSGRKAYDIE------YVPPGIVEWALPLIKQ 682
++D++ G+V EI I Y + ++ +++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 683 GKAAAIIDRNV-ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
+ N+ ++ E L +A I N + T ++ L Q+ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 4e-49
Identities = 58/304 (19%), Positives = 115/304 (37%), Gaps = 56/304 (18%)
Query: 472 FRLSELKDATNGF-KEF--------NELGRGSYGFVYKAVLVDGRQ----VAVKRANAAT 518
F + +A F KE +G G +G V L + VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG- 65
Query: 519 IIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPL 578
R+F E ++ H N+++L G + +++ EFM G+L L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 579 NWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDL 638
+ + A G++YL +HRD+ NIL++S+ +++DFGL E D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 639 TTDM--------------------------KSDVHNFGIVLLEILSGRKAYDIEYVPPGI 672
+ SDV ++GIV+ E++S + + +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 673 VEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732
+ I+++ LP ++ L + +++ + P Q+ L++
Sbjct: 243 INA-------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 733 IVKD 736
++++
Sbjct: 290 MIRN 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 1e-48
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 43/277 (15%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++LG G YG VY+ V VAVK T+ + EF E V+ I+H N+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNL 75
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLH-GGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
V LLG C ++ EFM G L D+L ++ + L ++ Q + +EYL K
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 133
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--------------------- 640
IHRD+ N L+ + ++ADFGL D T
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 641 -DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699
+KSDV FG++L EI + + P I + +++++ + R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLSQVYELLEKDYRMERPE 239
Query: 700 EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
K+ ++ + NPS+ P+ +++ E + ++
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 7e-48
Identities = 63/283 (22%), Positives = 105/283 (37%), Gaps = 42/283 (14%)
Query: 466 PGMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN- 523
P +A++F D F + E+G GS+G VY A + + VA+K+ + +
Sbjct: 2 PDVAELF---FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 524 IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLR 583
++ E+ L +RH N + G L LV E+ PL
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI 117
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--- 640
++ A +GL YLH +IHRDVK NILL ++ DFG + +
Sbjct: 118 AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 174
Query: 641 -----------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG 683
D K DV + GI +E+ + AL I Q
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----FNMNAMSALYHIAQN 229
Query: 684 KAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
++ A+ + F+ + + +++ P + PT +
Sbjct: 230 ESPALQ------SGHWSEYFR--NFVDSCLQKIPQDRPTSEVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 58/272 (21%), Positives = 95/272 (34%), Gaps = 41/272 (15%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
ELG G +G V VA+K ++ EF E +V+ N+ H +V
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 62
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L G C + ++ E+M G L ++L L++ + +EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------D 641
+HRD+ N L++ +++DFGL D T
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701
KSD+ FG+++ EI S K + E I + + L R
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------IAQGLRLYRPHLA 226
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLEQI 733
K+ I E E PT + + + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 56/294 (19%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVDG---RQVAVKRANAATIIHTNIREFEMELEVLCNI- 537
N K + +G G++G V KA + A+KR + R+F ELEVLC +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 68
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG---------------GLSPLNWSL 582
H NI+NLLG C G L E+ P G L D L S L+
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 583 RLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-- 640
L + A+G++YL + IHRD+ NIL+ ++ A+IADFGL E +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 641 ------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQ 682
SDV ++G++L EI+S + E
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------- 238
Query: 683 GKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
+ + L + + ++ D+ RE P E P+ +Q+ L +++++
Sbjct: 239 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 476 ELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVL 534
ELKD + F++ +ELG G+ G V+K G +A K + I + EL+VL
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVL 58
Query: 535 CNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
IV G GE + E M G+L L + + K+S+ KGL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGL 117
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------- 640
YL + I+HRDVK NIL++S ++ DFG+ +
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 175
Query: 641 -----DMKSDVHNFGIVLLEILSGRKAYD 664
++SD+ + G+ L+E+ GR
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 45/272 (16%)
Query: 489 ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNL 545
ELG G++G V + V VA+K T + E E +++ + + IV L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRL 74
Query: 546 LGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPI 605
+G C + +LV E G LH L G + S ++ Q + G++YL +
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 130
Query: 606 IHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT---------------------D 641
+HRD+ N+LL + A+I+DFGL L + + T
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701
+SDV ++G+ + E LS + + P ++ + I+QGK + P P
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQGK-------RMECPPECPP 239
Query: 702 LFKLADIAELAIRENPSELPTMSQVATWLEQI 733
+L + + P V +
Sbjct: 240 --ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 67/268 (25%), Positives = 107/268 (39%), Gaps = 39/268 (14%)
Query: 484 FKEFN-ELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
F +F+ E+GRGS+ VYK + + +VA + + + F+ E E+L ++H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 542 IVNLLGYCLEMGER----LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
IV + +LV E M GTL +L + + Q KGL++L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFL 128
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCERDLTT---------------- 640
H PPIIHRD+K NI + G +I D GL T
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 187
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698
D DV+ FG+ +LE+ + Y I + G + + +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----VTSGV------KPASFDKV 237
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQV 726
P ++ +I E IR+N E ++ +
Sbjct: 238 AIP--EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 64/275 (23%), Positives = 111/275 (40%), Gaps = 43/275 (15%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+ +LG+G +G V+ +VA+K T+ + F E +V+ +RH +V
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLV 75
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
L +V E+M +G+L D L G L + ++ Q A G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT---------------------- 640
+HRD++ NIL+ + ++ADFGL E + T
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 641 DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
+KSDV +FGI+L E+ + + V +++ ++R +P E
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------------VERGYRMPCPPE 238
Query: 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
L D+ R+ P E PT + +LE
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 6e-47
Identities = 67/315 (21%), Positives = 119/315 (37%), Gaps = 69/315 (21%)
Query: 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVL------VDGRQVAVKRANAATIIHTNIRE 526
+L L+ N + ++G G++G V++A VAVK +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQAD 62
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG------------- 573
F+ E ++ + NIV LLG C L++E+M G L++ L
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 574 ----------GLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGA 623
G PL+ + +L I+ Q A G+ YL + +HRD+ T N L+ +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 624 RIADFGLLTSCERDLTT-----------------------DMKSDVHNFGIVLLEILSGR 660
+IADFGL + +SDV +G+VL EI S
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 661 KAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSEL 720
++ + ++ G +A P N +L ++ L + P++
Sbjct: 240 LQPYYGMAHEEVIYY----VRDGNI-------LACPENCPL--ELYNLMRLCWSKLPADR 286
Query: 721 PTMSQVATWLEQIVK 735
P+ + L+++ +
Sbjct: 287 PSFCSIHRILQRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 52/272 (19%), Positives = 97/272 (35%), Gaps = 43/272 (15%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ +G GSYG K DG+ + K + ++ + E+ +L ++H NI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 543 VNLLGYCLEMGERLL--VYEFMPRGTLHDHLHGGLS---PLNWSLRLKISMQAAKGLEYL 597
V ++ L V E+ G L + G L+ L++ Q L+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 598 HK--DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--------------- 640
H+ D ++HRD+K N+ LD ++ DFGL D +
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 641 ------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
+ KSD+ + G +L E+ + + + I++GK I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELAGKIREGKFRRI------ 234
Query: 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
P +I + P++ ++
Sbjct: 235 -PYRYSDELN--EIITRMLNLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 45/280 (16%)
Query: 486 EFNELGRGSYGFVYKAVLVD---GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
E ELG G++G V K + VAVK E E V+ + + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
V ++G C E +LV E G L+ +L + +++ Q + G++YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT---------------------- 640
+HRD+ N+LL + A+I+DFGL + D
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698
KSDV +FG+++ E S + P +K + A++++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ-------KP------YRGMKGSEVTAMLEKGERMGCP 232
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738
++ D+ L + P + V L D +
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 487 FNE-LGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN 541
FNE +GRG +G VY L+D AVK N T I + +F E ++ + H N
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPN 89
Query: 542 IVNLLGYCLEM-GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+++LLG CL G L+V +M G L + + + +Q AKG+++L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS- 148
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGL---LTSCERDLTT----------------- 640
+HRD+ N +LD + ++ADFGL + E D
Sbjct: 149 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 641 -----DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695
KSDV +FG++L E+++ + I + + QG R +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQG-------RRLLQ 255
Query: 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
P L ++ P+ S++ + + I
Sbjct: 256 PEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 68/300 (22%), Positives = 102/300 (34%), Gaps = 63/300 (21%)
Query: 484 FKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
LG G++G V +A VAVK + + T EL+VL +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYL 83
Query: 538 -RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG-----------------GLSPLN 579
H NIVNLLG C G L++ E+ G L + L L+
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 580 WSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT 639
L S Q AKG+ +L IHRD+ NILL +I DFGL + D
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 640 T-----------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWA 676
+SDV ++GI L E+ S +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-- 258
Query: 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
+I + ++ DI + +P + PT Q+ +E+ + +
Sbjct: 259 ----------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 65/264 (24%), Positives = 101/264 (38%), Gaps = 40/264 (15%)
Query: 484 FKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIRHSN 541
F+ LG+G +G VY A +A+K A + + E+E+ ++RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
I+ L GY + L+ E+ P GT++ L S + + A L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS-- 124
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------------DM 642
+IHRD+K N+LL S +IADFG T D
Sbjct: 125 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702
K D+ + G++ E L G+ PP K+ I P V
Sbjct: 184 KVDLWSLGVLCYEFLVGK--------PPFEANTYQETYKR-----ISRVEFTFPDFVTEG 230
Query: 703 FKLADIAELAIRENPSELPTMSQV 726
+ D+ ++ NPS+ P + +V
Sbjct: 231 AR--DLISRLLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 64/275 (23%), Positives = 103/275 (37%), Gaps = 44/275 (16%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+ + ++ ELG G++G VYKA + A K + + + ++ +E+++L +
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASC 66
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
H NIV LL ++ EF G + + PL S + Q L YL
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------- 640
H IIHRD+K NIL D ++ADFG+ R +
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 641 ---------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691
D K+DV + GI L+E+ + L I + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPH-----HELNPMRVLLKIAKSE-----PP 233
Query: 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
+A P FK D + + +N T SQ+
Sbjct: 234 TLAQPSRWSSNFK--DFLKKCLEKNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 46/282 (16%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDG-----RQVAVKRANAATIIHTNIREFEMELEVLCNIR 538
+G G +G VYK +L VA+K A +F E ++
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGIMGQFS 67
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
H NI+ L G + +++ E+M G L L + + + A G++YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM---------------- 642
+HRD+ NIL++S+ +++DFGL E D
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 643 --------KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
SDV +FGIV+ E+++ + E +++ I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-------------AINDGFR 231
Query: 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
LP ++ + + ++ + P + + + L+++++
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-43
Identities = 55/274 (20%), Positives = 97/274 (35%), Gaps = 44/274 (16%)
Query: 489 ELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVN 544
+G G +G V++ + + VA+K T + +F E + H +IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVK 72
Query: 545 LLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPP 604
L+G E ++ E G L L L+ + + + Q + L YL
Sbjct: 73 LIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------DM 642
+HRD+ N+L+ S+ ++ DFGL E
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 643 KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPL 702
SDV FG+ + EIL ++ I+ G+ + +P N P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGER-------LPMPPNCPP- 236
Query: 703 FKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
L + +PS P +++ L I+++
Sbjct: 237 -TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 57/279 (20%), Positives = 98/279 (35%), Gaps = 45/279 (16%)
Query: 484 FKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTN-IREFEMELEVLCNIR 538
+ +LG GS+G V + VAVK + + +F E+ + ++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLH 598
H N++ L G L +V E P G+L D L + ++Q A+G+ YL
Sbjct: 70 HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 599 KDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------ 640
IHRD+ N+LL + +I DFGL+ + ++
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 641 ------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
SD FG+ L E+ + + I I+ I
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------IDKEGER 233
Query: 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
LPR + + ++ P + PT + +L +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 65/301 (21%), Positives = 105/301 (34%), Gaps = 70/301 (23%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
+ LG G++G V A QVAVK + EL+++ +
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQL 97
Query: 538 -RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHG----------------------G 574
H NIVNLLG C G L++E+ G L ++L
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 575 LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634
L+ L + L + Q AKG+E+L +HRD+ N+L+ +I DFGL
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 635 ERDLTT-----------------------DMKSDVHNFGIVLLEILS-GRKAYDIEYVPP 670
D +KSDV ++GI+L EI S G Y V
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 671 GIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWL 730
+ +I + + ++ I + + + P+ + ++L
Sbjct: 275 NFYK-------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 731 E 731
Sbjct: 322 G 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 60/298 (20%), Positives = 115/298 (38%), Gaps = 53/298 (17%)
Query: 467 GMAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLVD-----GRQVAVKRANAATIIH 521
+ ++ + +E FK+ LG G++G VYK + + VA+K AT
Sbjct: 1 ALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 53
Query: 522 TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWS 581
N +E E V+ ++ + ++ LLG CL L+ + MP G L D++ +
Sbjct: 54 AN-KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 111
Query: 582 LRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT- 640
L +Q AKG+ YL ++HRD+ N+L+ + +I DFGL +
Sbjct: 112 YLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 641 ----------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP 678
+SDV ++G+ + E+++ P
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-------KP------YD 215
Query: 679 LIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
I + ++I+++ LP+ + I + P ++ ++ +D
Sbjct: 216 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-41
Identities = 54/281 (19%), Positives = 112/281 (39%), Gaps = 41/281 (14%)
Query: 468 MAQVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE 526
+ ++ + + D + F ++G+G+ G VY A+ + G++VA+++ N
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKEL 63
Query: 527 FEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKI 586
E+ V+ ++ NIVN L L E +V E++ G+L D + ++ +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 121
Query: 587 SMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------ 640
+ + LE+LH + +IHRD+K+ NILL D ++ DFG + +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 641 ---------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685
K D+ + GI+ +E++ G Y + + G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL----NENPLRALYLIATNGT- 233
Query: 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
+ P + +F+ D + + + + ++
Sbjct: 234 -----PELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (379), Expect = 2e-40
Identities = 49/268 (18%), Positives = 99/268 (36%), Gaps = 39/268 (14%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
+ + ELG G++G V++ G A K ++ E++ + +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHP 83
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+VNL + E +++YEFM G L + + + ++ ++ Q KGL ++H+
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 601 AAPPIIHRDVKTLNILLDSDWGARI--ADFGLLTSCERDLTT------------------ 640
+H D+K NI+ + + DFGL + +
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698
+D+ + G++ +LSG + E L +K + + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVKSCD----WNMDDSAFSG 251
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQV 726
+ K D + +P+ T+ Q
Sbjct: 252 ISEDGK--DFIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 64/281 (22%), Positives = 101/281 (35%), Gaps = 44/281 (15%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+ LG G+YG V AV V VAVK + + + E+ + + H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENV 65
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
V G+ E + L E+ G L D + + + Q G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-------------------- 642
I HRD+K N+LLD +I+DFGL T + +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 643 ----KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698
DV + GIVL +L+G +D P K+ K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKK------TYLNPWKK 231
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVKDG 737
++ + + ENPS T+ + W + +K G
Sbjct: 232 IDSAPL--ALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (375), Expect = 5e-40
Identities = 52/266 (19%), Positives = 103/266 (38%), Gaps = 39/266 (14%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+ ELG G++G V++ V GR K N + + E+ ++ + H +
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHPKL 88
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
+NL + E +L+ EF+ G L D + ++ + + QA +GL+++H+
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--- 145
Query: 603 PPIIHRDVKTLNILLDSDWGARI--ADFGLLTSCERDLTT-------------------- 640
I+H D+K NI+ ++ + + DFGL T D
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 641 DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
+D+ G++ +LSG + L +K+ + + +V
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQNVKRCD----WEFDEDAFSSVS 256
Query: 701 PLFKLADIAELAIRENPSELPTMSQV 726
P K D + +++ P + T+
Sbjct: 257 PEAK--DFIKNLLQKEPRKRLTVHDA 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 54/273 (19%), Positives = 93/273 (34%), Gaps = 44/273 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSN 541
FK LG GS+ V A L R+ A+K II N + E +V+ + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
V L + + + G L ++ + + + + LEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--------------------- 640
IIHRD+K NILL+ D +I DFG +
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698
SD+ G ++ ++++G PP + ++ II P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGL--------PPFRAGNEYLIFQK-----IIKLEYDFPEK 232
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLE 731
P + D+ E + + ++ ++ +
Sbjct: 233 FFPKAR--DLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 78/298 (26%), Positives = 113/298 (37%), Gaps = 62/298 (20%)
Query: 484 FKEFNELGRGSYGFVYKAV------LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
K LGRG++G V +A R VAVK H+ R EL++L +I
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHI 73
Query: 538 RH-SNIVNLLGYCLEMGERL-LVYEFMPRGTLHDHLHG---------------GLSPLNW 580
H N+VNLLG C + G L ++ EF G L +L L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 581 SLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT 640
+ S Q AKG+E+L IHRD+ NILL +I DFGL +D
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 641 -----------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWAL 677
++SDV +FG++L EI S + Y I E
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFC 247
Query: 678 PLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735
+K+G + P P ++ PS+ PT S++ L +++
Sbjct: 248 RRLKEGT-------RMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 5e-38
Identities = 51/269 (18%), Positives = 89/269 (33%), Gaps = 41/269 (15%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTN----IREFEMELEVLCN 536
N F +GRG +G VY D G+ A+K + I + L ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 537 IRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
IV + + + + M G LH HL + + + + GLE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEH 122
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT---------------- 640
+H +++RD+K NILLD RI+D GL +
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 179
Query: 641 ----DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696
D +D + G +L ++L G + K + V LP
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK----------TKDKHEIDRMTLTMAVELP 229
Query: 697 RNVEPLFKLADIAELAIRENPSELPTMSQ 725
+ P + + E ++ + +
Sbjct: 230 DSFSPELR--SLLEGLLQRDVNRRLGCLG 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 64/294 (21%)
Query: 488 NELGRGSYGFVYKAVLV--------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-R 538
LG G++G V A + +VAVK + ++ + E+E++ I +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGK 77
Query: 539 HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH---------------GGLSPLNWSLR 583
H NI+NLLG C + G ++ E+ +G L ++L L+
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 584 LKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--- 640
+ + Q A+G+EYL IHRD+ N+L+ D +IADFGL
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 641 --------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI 680
+SDV +FG++L EI + + P VE L+
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY----PGVPVEELFKLL 250
Query: 681 KQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734
K+G + P N +L + PS+ PT Q+ L++IV
Sbjct: 251 KEGH-------RMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-38
Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 55/293 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVL------VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
ELG+GS+G VY+ V +VA+K N A EF E V+
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEF 80
Query: 538 RHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLH---------GGLSPLNWSLRLKISM 588
++V LLG + L++ E M RG L +L L+P + S ++++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 589 QAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------- 640
+ A G+ YL+ +HRD+ N ++ D+ +I DFG+
Sbjct: 141 EIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 641 ---------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685
SDV +FG+VL EI + + E L + +G
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFVMEGGL 253
Query: 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDGL 738
+ P N L ++ + + NP P+ ++ + +++ ++ G
Sbjct: 254 -------LDKPDNCPD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 44/261 (16%), Positives = 93/261 (35%), Gaps = 40/261 (15%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+LGRG +G V++ V + K + T+ + E+ +L RH NI++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
M E ++++EF+ + + ++ LN + Q + L++LH I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 608 RDVKTLNILLDSDWGAR--IADFGLLTSCERDLTT--------------------DMKSD 645
D++ NI+ + + I +FG + +D
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 646 VHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKL 705
+ + G ++ +LSG + E + + I + + + +
Sbjct: 186 MWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAE----YTFDEEAFKEISIEAM- 235
Query: 706 ADIAELAIRENPSELPTMSQV 726
D + + + T S+
Sbjct: 236 -DFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (340), Expect = 4e-36
Identities = 55/290 (18%), Positives = 101/290 (34%), Gaps = 56/290 (19%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-------FEMELEVLC 535
++ LGRG V + + ++ AVK + + E E+++L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 536 NIR-HSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
+ H NI+ L LV++ M +G L D+L L+ KI + +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVI 123
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------- 640
LHK I+HRD+K NILLD D ++ DFG +
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 641 ------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688
+ D+ + G+++ +L+G PP + +++ I
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--------PPFWHRKQMLMLRM-----I 227
Query: 689 IDRNVALPRNVEPLF--KLADIAELAIRENPSELPTMSQVAT--WLEQIV 734
+ N + + D+ + P + T + + +Q V
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 3e-35
Identities = 51/274 (18%), Positives = 84/274 (30%), Gaps = 38/274 (13%)
Query: 476 ELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVL 534
+ +D + + + LG G++ V A + VA+K + E E+ VL
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVL 61
Query: 535 CNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
I+H NIV L G L+ + + G L D + ++ Q +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAV 120
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------- 640
+YLH + L LD D I+DFGL +
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180
Query: 641 ------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
D + G++ +L G PP E L +Q I+
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGY--------PPFYDENDAKLFEQ-----ILKAEYE 227
Query: 695 LPRNVEPLF--KLADIAELAIRENPSELPTMSQV 726
D + ++P + T Q
Sbjct: 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 5e-35
Identities = 55/291 (18%), Positives = 109/291 (37%), Gaps = 42/291 (14%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
F++ ++G G+YG VYKA + G VA+K+ T E+ +L + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
V LL + LV+EF+ + L+ + L Q +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--- 120
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLT----------------------T 640
++HRD+K N+L++++ ++ADFGL + +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 641 DMKSDVHNFGIVLLEILSGR-------------KAYDIEYVPPGIVEWALPLIKQGKAAA 687
D+ + G + E+++ R + + P +V + + K +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 688 IIDRNVALPRNVEPLFKLA-DIAELAIRENPSELPTMSQVAT--WLEQIVK 735
+ V PL + + + +P++ + + + + K
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 132 bits (332), Expect = 5e-35
Identities = 51/279 (18%), Positives = 94/279 (33%), Gaps = 40/279 (14%)
Query: 484 FKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV 543
+ ++G G+YG VYKA G A+K+ E+ +L ++HSNIV
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
L +LV+E + + L +Q G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------D 641
++HRD+K N+L++ + +IADFGL + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 642 MKSDVHNFGIVLLEILSGRKAYD-------IEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
D+ + G + E+++G + + + + D N
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 695 LPRNVEPLFKLADIAELAI-------RENPSELPTMSQV 726
+ + L + E I + +P++ T Q
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (332), Expect = 1e-34
Identities = 58/282 (20%), Positives = 101/282 (35%), Gaps = 46/282 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRHSN 541
F+ LG GS+G V+ +GR A+K ++ + E +L + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
I+ + G + + ++ +++ G L L N + + + LEYLH
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHS-- 122
Query: 602 APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------DMK 643
II+RD+K NILLD + +I DFG T +
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 644 SDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLF 703
D +FGI++ E+L+G + I++ + P
Sbjct: 182 IDWWSFGILIYEMLAGYTPF------YDSNTMKT-------YEKILNAELRFPPFFNEDV 228
Query: 704 KLADIAELAIRENPSELPTMSQVAT-------WLEQIVKDGL 738
K D+ I + S+ Q T W +++V + L
Sbjct: 229 K--DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 54/212 (25%), Positives = 82/212 (38%), Gaps = 40/212 (18%)
Query: 484 FKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+ + +G GS+G VY+A L D G VA+K + + R EL+++ + H NI
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHCNI 75
Query: 543 VNLLGYCLEMGER------LLVYEFMPRGTLHDHLHGGLS--PLNWSLRLKISMQAAKGL 594
V L + GE+ LV +++P H + L Q + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCERDLTT------------- 640
Y+H I HRD+K N+LLD D ++ DFG R
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 641 --------DMKSDVHNFGIVLLEILSGRKAYD 664
DV + G VL E+L G+ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 129 bits (325), Expect = 5e-34
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 50/286 (17%)
Query: 481 TNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIRE-FEMELEVLCNIR 538
++ ++ LG G V+ A L R VAVK A + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 539 HSNIVNLLGYCLEMGERL----LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
H IV + +V E++ TL D +H P+ +++ A + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQAL 124
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------- 640
+ H+ IIHRDVK NI++ + ++ DFG+ + +
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 641 ----------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690
D +SDV++ G VL E+L+G + G ++ A +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSV-------AYQHVR 228
Query: 691 RNVALPRNVEPLF--KLADIAELAIRENPSE-LPTMSQVATWLEQI 733
+ P L + A+ +NP T +++ L ++
Sbjct: 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 7e-33
Identities = 52/276 (18%), Positives = 96/276 (34%), Gaps = 54/276 (19%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIH----TNIREFEMELEVL--CNIRHSN 541
LG G +G VY + + D VA+K I N ME+ +L + S
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 542 IVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA 601
++ LL + +L+ E L L Q + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 602 APPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCERDLTTDM------------------ 642
++HRD+K NIL+D + G ++ DFG + + TD
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 643 --KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
+ V + GI+L +++ G ++ + II V + V
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD-------------------EEIIRGQVFFRQRVS 228
Query: 701 PLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734
+ + + PS+ PT ++ W++ ++
Sbjct: 229 SECQ--HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 56/282 (19%), Positives = 97/282 (34%), Gaps = 46/282 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-IREFEMELEVL-CNIRHS 540
F LG+GS+G V+ A + A+K ++ + + +E VL H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+ ++ V E++ G L H+ + S + + GL++LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS- 121
Query: 601 AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT-------------------- 640
I++RD+K NILLD D +IADFG+
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 641 -DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699
+ D +FG++L E+L G+ + + + I N PR +
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHS------------IRMDNPFYPRWL 226
Query: 700 EPLFKLADIAELAIRENPSELPTMSQVAT---WLEQIVKDGL 738
E K D+ P + + +I + L
Sbjct: 227 EKEAK--DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 59/278 (21%), Positives = 90/278 (32%), Gaps = 43/278 (15%)
Query: 488 NELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN---IREFEMELEVLCNIRHSNIV 543
+ LG G + VYKA + VA+K+ R E+++L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 544 NLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
LL LV++FM L L S + +GLEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-VLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 604 PIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------------D 641
I+HRD+K N+LLD + ++ADFGL S
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIE------------YVPPGIVEWALPLIKQGKAAAII 689
+ D+ G +L E+L + P +W
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 690 DRNVALPRNVEPLFKLA-DIAELAIRENPSELPTMSQV 726
+ L D+ + NP T +Q
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-32
Identities = 59/267 (22%), Positives = 90/267 (33%), Gaps = 42/267 (15%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRH 539
N F LG+G++G V GR A+K II + + E VL N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
+ L V E+ G L HL + LEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS 123
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------- 640
+++RD+K N++LD D +I DFGL D T
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698
D G+V+ E++ GR P + L + I+ + PR
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFEL-----ILMEEIRFPRT 227
Query: 699 VEPLFKLADIAELAIRENPSELPTMSQ 725
+ P K + ++++P +
Sbjct: 228 LSPEAK--SLLAGLLKKDPKQRLGGGP 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 46/266 (17%), Positives = 85/266 (31%), Gaps = 45/266 (16%)
Query: 490 LGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGY 548
LG G G V + + A+K RE E+ + +IV ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVELHWRAS---QCPHIVRIVDV 73
Query: 549 CLEMGER----LLVYEFMPRGTLHDHLHG-GLSPLNWSLRLKISMQAAKGLEYLHKDAAP 603
+ L+V E + G L + G +I + ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 604 PIIHRDVKTLNILLDSDWG---ARIADFGLLTSCERDLTT-------------------- 640
I HRDVK N+L S ++ DFG +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 641 DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700
D D+ + G+++ +L G + + I I+ G+ + V
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNH-GLAISPGMKTRIRMGQ----YEFPNPEWSEVS 245
Query: 701 PLFKLADIAELAIRENPSELPTMSQV 726
K + ++ P++ T+++
Sbjct: 246 EEVK--MLIRNLLKTEPTQRMTITEF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 58/300 (19%), Positives = 106/300 (35%), Gaps = 51/300 (17%)
Query: 480 ATNGFKEFNELGRGSYGFVYKAVLV--DGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
A ++ E+G G+YG V+KA + GR VA+KR T E+ VL ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 538 ---RHSNIVNLLGYCLEMGER-----LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQ 589
H N+V L C LV+E + + + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--------- 640
+GL++LH ++HRD+K NIL+ S ++ADFGL +
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 641 -----------DMKSDVHNFGIVLLEILSGRKAYDIE------------YVPPGIVEWA- 676
D+ + G + E+ + + PG +W
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 677 -LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733
+ L +Q + +++ L K D+ + NP++ + + + + +
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISAYSALSHPYFQDL 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 49/281 (17%), Positives = 99/281 (35%), Gaps = 42/281 (14%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+++ ++G G+YG V+KA VA+KR E+ +L ++H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 543 VNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA 602
V L + LV+EF + L+ + Q KGL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS--- 119
Query: 603 PPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT---------------------- 640
++HRD+K N+L++ + ++A+FGL + +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 641 DMKSDVHNFGIVLLEILSGR--------------KAYDIEYVPPGIVEWALPLIKQGKAA 686
D+ + G + E+ + + + + P ++ + K
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 687 AIIDRNVALPRNVEPLFKLA-DIAELAIRENPSELPTMSQV 726
+ +L V L D+ + ++ NP + + +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 4e-31
Identities = 44/284 (15%), Positives = 86/284 (30%), Gaps = 46/284 (16%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHS 540
N ++ ++G GS+G +Y + G +VA+K + T + +E ++ ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC----VKTKHPQLHIESKIYKMMQGG 62
Query: 541 NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD 600
+ + +C G+ ++ + +L D + + L ++ Q +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS- 121
Query: 601 AAPPIIHRDVKTLNIL---LDSDWGARIADFGLLTSCERDLTT----------------- 640
IHRDVK N L I DFGL T
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 641 -----------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689
+ D+ + G VL+ G + ++ +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK-----AATKRQKYERISEKKMS 234
Query: 690 DRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733
L + F + P S + +
Sbjct: 235 TPIEVLCKGYPSEFA--TYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-31
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 42/221 (19%)
Query: 470 QVFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFE 528
QVF D + + +G G+YG V A V+ +VA+K+ + T +
Sbjct: 2 QVF------DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTL 54
Query: 529 MELEVLCNIRHSNIVNLLGYC----LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRL 584
E+++L RH NI+ + +E + + + + L+ L L+
Sbjct: 55 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHIC 112
Query: 585 KISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-- 642
Q +GL+Y+H ++HRD+K N+LL++ +I DFGL + D
Sbjct: 113 YFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
Query: 643 -----------------------KSDVHNFGIVLLEILSGR 660
D+ + G +L E+LS R
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 52/300 (17%), Positives = 103/300 (34%), Gaps = 56/300 (18%)
Query: 479 DATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNI 537
D + +++ ++G+G++G V+KA G++VA+K+ E+++L +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 538 RHSNIVNLLGYCLEMGER--------LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQ 589
+H N+VNL+ C LV++F + L S ++
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQM 125
Query: 590 AAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT--------- 640
GL Y+H+ I+HRD+K N+L+ D ++ADFGL + +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 641 -----------------DMKSDVHNFGIVLLEILSGRKAYD----------IEYVPPGIV 673
D+ G ++ E+ + I + I
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 674 EWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAI-------RENPSELPTMSQV 726
P + + ++ R V+ K A+ +P++
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (303), Expect = 6e-31
Identities = 36/282 (12%), Positives = 86/282 (30%), Gaps = 48/282 (17%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547
+G GS+G +++ L++ +QVA+K ++ + E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 548 YCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIH 607
Y + G ++ + +L D L + + Q ++ +H+ +++
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 608 RDVKTLNILLDS-----DWGARIADFGLLTSCERDLTT---------------------- 640
RD+K N L+ + DFG++ +T
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 641 ------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694
+ D+ G V + L G + + + I + K + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQ--GLKAATNKQKYERIGEKKQSTPLRE--- 239
Query: 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736
L + A P + ++++
Sbjct: 240 LCAGFPE--EFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 9e-31
Identities = 57/285 (20%), Positives = 95/285 (33%), Gaps = 47/285 (16%)
Query: 471 VFRLSELKDATNGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN----IR 525
VFR + D + ELG G + V K G Q A K +
Sbjct: 2 VFRQENVDD---YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 526 EFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLK 585
+ E E+ +L I+H N++ L + +L+ E + G L D L L +
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATE 117
Query: 586 ISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGAR----IADFGLLTSCERDLTT- 640
Q G+ YLH I H D+K NI+L + I DFGL +
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 641 -------------------DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK 681
+++D+ + G++ +LSG + + + L +
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVS 229
Query: 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQV 726
+ N L K D + ++P + T+
Sbjct: 230 AVN----YEFEDEYFSNTSALAK--DFIRRLLVKDPKKRMTIQDS 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 59/299 (19%), Positives = 108/299 (36%), Gaps = 60/299 (20%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
+++ +G G+YG V AV G +VA+K+ + EL +L ++RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 543 VNLLGYCLE------MGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
+ LL + LV FM H L + Q KGL Y
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRY 136
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT---------------- 640
+H IIHRD+K N+ ++ D +I DFGL + ++T
Sbjct: 137 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNW 193
Query: 641 ---DMKSDVHNFGIVLLEILSGR-------------KAYDIEYVPPGIVEWALPLIKQGK 684
D+ + G ++ E+++G+ + + PP + ++ +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP---AEFVQRLQSDE 250
Query: 685 AAAIIDRNVALPR--------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733
A + L + N PL ++ E + + + T + + E +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAV--NLLEKMLVLDAEQRVTAGEALAHPYFESL 307
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 5e-30
Identities = 48/275 (17%), Positives = 85/275 (30%), Gaps = 43/275 (15%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTN-IREFEMELEVLCNIRH 539
+ F LG GS+G V G A+K + ++ I E +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 540 SNIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHK 599
+V L + +V E++ G + HL + + Q EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS 159
Query: 600 DAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT------------------D 641
+I+RD+K N+L+D ++ DFG + T +
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 642 MKSDVHNFGIVLLEILSGRKAYDIE--------------YVPPGIVEWALPLIKQGKAAA 687
D G+++ E+ +G + + P L++
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 688 IIDRNVALPRNVE-----PLFKLADIAELAIRENP 717
+ R L V F D + R+
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 46/275 (16%)
Query: 482 NGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIHTN--IREFEMELEVLC 535
F+ LG G+YG V+ + G+ A+K ATI+ E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 536 NIRHS-NIVNLLGYCLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGL 594
+IR S +V L + L+ +++ G L HL + L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLAL 142
Query: 595 EYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM------------ 642
E+LHK II+RD+K NILLDS+ + DFGL D T
Sbjct: 143 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 643 ------------KSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690
D + G+++ E+L+G + ++ E + I+
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------SRRILK 250
Query: 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQ 725
P+ + L K D+ + + ++P +
Sbjct: 251 SEPPYPQEMSALAK--DLIQRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (266), Expect = 7e-26
Identities = 53/306 (17%), Positives = 103/306 (33%), Gaps = 63/306 (20%)
Query: 482 NGFKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-H 539
+ ++ +LGRG Y V++A+ + + +V VK + ++ + E+++L N+R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKREIKILENLRGG 89
Query: 540 SNIVNLLGYCLEMGERL--LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
NI+ L + R LV+E + L + K L+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 145
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWG-ARIADFGLLTSCERDLTT---------------- 640
H I+HRDVK N+++D + R+ D+GL
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202
Query: 641 -----DMKSDVHNFGIVLLEILSGRKAYDIEYVPPGI---------VEWALPLIKQGKAA 686
D D+ + G +L ++ ++ + + E I +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 687 AIIDRNVALPRNVEPLFK--------------LADIAELAIRENPSELPTMSQVAT--WL 730
N L R+ ++ D + +R + T + +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 731 EQIVKD 736
+VKD
Sbjct: 323 YTVVKD 328
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 59/286 (20%), Positives = 109/286 (38%), Gaps = 50/286 (17%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ + +G G+YG V A G +VAVK+ + + + EL +L +++H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 543 VNLLGYC-----LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYL 597
+ LL LE + + + L++ + L + Q +GL+Y+
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI 137
Query: 598 HKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT----------------- 640
H IIHRD+K N+ ++ D +I DFGL + ++T
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 641 --DMKSDVHNFGIVLLEILSGRKAYD----------IEYVPPGIVEWALPLIKQGKAAAI 688
+ D+ + G ++ E+L+GR + I + L I A
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 689 IDRNVALPR--------NVEPLFKLADIAELAIRENPSELPTMSQV 726
I +P+ PL D+ E + + + T +Q
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAV--DLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 34/207 (16%)
Query: 484 FKEFNELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI 542
++ +G G+ G V A V R VA+K+ + T+ + EL ++ + H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 543 VNLLGYCL------EMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEY 596
++LL E + LV E M L+ + Q G+++
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKH 134
Query: 597 LHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTT---------------- 640
LH IIHRD+K NI++ SD +I DFGL +
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 641 ----DMKSDVHNFGIVLLEILSGRKAY 663
D+ + G ++ E++ + +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 2e-20
Identities = 22/175 (12%), Positives = 47/175 (26%), Gaps = 25/175 (14%)
Query: 488 NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIR--------EFEMELEVLCNIRH 539
+G G V+ + VK ++ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 540 SNIVNLLGYC----LEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLE 595
+ L G ++ E + L+ ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 596 YLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDM-KSDVHNF 649
+ I+H D+ N+L+ + G I DF + ++ + DV N
Sbjct: 118 KFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI 168
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.6 bits (213), Expect = 7e-19
Identities = 39/216 (18%), Positives = 78/216 (36%), Gaps = 45/216 (20%)
Query: 489 ELGRGSYGFVYKAV-LVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN------ 541
+LG G + V+ A +V+ VA+K + E E+++L + ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---EAAEDEIKLLQRVNDADNTKEDS 76
Query: 542 -----IVNLLGYCLEMGERL----LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAK 592
I+ LL + G +V+E + L + +IS Q
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 593 GLEYLHKDAAPPIIHRDVKTLNILLDSD----WGARIADFGLLTSCE------------- 635
GL+Y+H+ IIH D+K N+L++ +I L +C
Sbjct: 137 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 636 -------RDLTTDMKSDVHNFGIVLLEILSGRKAYD 664
+D+ + ++ E+++G ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 9e-06
Identities = 26/219 (11%), Positives = 51/219 (23%), Gaps = 28/219 (12%)
Query: 57 SGGEGLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVR--GS 114
G G + + AN P + + G A+ G
Sbjct: 181 QGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGH 240
Query: 115 YYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGI 174
Y + + ++ + + + S G G
Sbjct: 241 VYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGR 300
Query: 175 VCWGPDSESLGVFNVTESFKV--------LASGKSSLCGISELSGEVKCWGNNDF----- 221
+G G + + +A G S +++ G V WG
Sbjct: 301 AEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQLGT 359
Query: 222 -----VSVP-------PVGIRFVSLAAGANHFCGIREDN 248
P +S+++G H + +D
Sbjct: 360 GQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKDK 398
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 12/70 (17%), Positives = 18/70 (25%), Gaps = 16/70 (22%)
Query: 204 CGISELSGEVKCWGNNDF-----------VSVP---PVGIRFVSLAAGANHFCGIREDNH 249
+E G V G D P + V AG H + +
Sbjct: 9 SHSTE-PGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSGQ 67
Query: 250 GVECWGSFNY 259
V +G +
Sbjct: 68 -VYSFGCNDE 76
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 23/144 (15%), Positives = 46/144 (31%), Gaps = 14/144 (9%)
Query: 104 GTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDG 163
+ V A+ G Y+ + + + ++G
Sbjct: 141 AQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDD---------VAGGI 191
Query: 164 FSCGGVRDGGIVCWGPDSE-SLGVF-NVTESFKVLASGKSSLCGISELSGEVKCWGNNDF 221
F ++DG ++ WG + V +ASG+ + +G+V WG++
Sbjct: 192 FHSLALKDGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLALK--NGKVIAWGSSRT 249
Query: 222 VSVPPVGIRFVSLAAGANHFCGIR 245
V S+ AG N ++
Sbjct: 250 APS-SVQSGVSSIEAGPNAAYALK 272
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 37.8 bits (86), Expect = 0.003
Identities = 44/258 (17%), Positives = 80/258 (31%), Gaps = 31/258 (12%)
Query: 67 LANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRIAAGTNHVCAVR-GSYYS-------- 117
+A TS W N+ G T + + IA G H A++ G
Sbjct: 1 VAATS-VVAWGGNNDWGEATVPAEA---QSGVDAIAGGYFHGLALKGGKVLGWGANLNGQ 56
Query: 118 -YHDLGTVDCWDIVRKGNNTLSSVQTNLFYDE----------YVSTIVLKDVISGDGFSC 166
T D + GN +++ D I+ ++
Sbjct: 57 LTMPAATQSGVDAIAAGNYHSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWAS 116
Query: 167 GGVRDGGIVCWGPDSESLGVFNVTESFKVLAS-GKSSLCGISELSGEVKCWGNNDFVSVP 225
++DG ++ WG DS+ V A G + G + N +
Sbjct: 117 YALKDGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTV 176
Query: 226 PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNY----SSVPKNSGFMAIASSDFTTCGI 281
P + F + + V WG Y SG AIAS ++ + +
Sbjct: 177 PAEAQSGVDDVAGGIFHSLALKDGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLAL 236
Query: 282 RENDLVLDCWFANVSSPT 299
+ ++ W ++ ++P+
Sbjct: 237 KNGKVI--AWGSSRTAPS 252
|
| >d2heyr3 g.24.1.1 (R:29-82) Tumor necrosis factor receptor superfamily member 4, OX40L receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 54 | Back information, alignment and structure |
|---|
class: Small proteins fold: TNF receptor-like superfamily: TNF receptor-like family: TNF receptor-like domain: Tumor necrosis factor receptor superfamily member 4, OX40L receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.4 bits (79), Expect = 0.003
Identities = 8/26 (30%), Positives = 11/26 (42%)
Query: 350 CGSNCSEGFFLSSPCTAIADRVCTAC 375
C C G + S C+ + VC C
Sbjct: 14 CCHECRPGNGMVSRCSRSQNTVCRPC 39
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 740 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.35 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=404.72 Aligned_cols=237 Identities=26% Similarity=0.411 Sum_probs=193.5
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..++||+|+||+||+|++.+++.||||+++... ...++|.+|+++|++++|||||+++|++.+++..+|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4688899999999999999999888999999997643 3346899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++|+|.+++......++|..++.|+.|||+||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999999887778999999999999999999999998 99999999999999999999999999865432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.|+|||||||+||||+|+..|+........+ ...+..+ ...+.+.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~----~~~i~~~---------~~~~~p~ 225 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDISTG---------FRLYKPR 225 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH----HHHHHHT---------CCCCCCT
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH----HHHHHhc---------CCCCCcc
Confidence 123467999999999999999954444322211111 1222211 1222223
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
....++.+|+.+||+.||++||||+||++.|+++.+.|
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~esg 263 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhCC
Confidence 33457889999999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-48 Score=407.58 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=191.3
Q ss_pred cCccccceecccCceEEEEEEEeC-C---cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-G---RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..++||+|+||+||+|++.. + ..||||++..... ....++|.+|+++|++++|||||+++|++.+.+..+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 456677899999999999999753 2 3689998875432 3445789999999999999999999999999999999
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
||||+++|+|.+++......++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++++||+|||+++....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999887778999999999999999999999998 99999999999999999999999999875432
Q ss_pred -------------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 637 -------------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 637 -------------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
...++.++|||||||+||||+| |+.||..... .. ....+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-~~----~~~~i~--------- 247 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QD----VINAIE--------- 247 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH----HHHHHH---------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-HH----HHHHHH---------
Confidence 1234668999999999999998 8999964321 11 111121
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.....+.+.+...++.+|+.+||+.||++||||.||++.|+++++.
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1223333444556888999999999999999999999999998864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=403.66 Aligned_cols=241 Identities=28% Similarity=0.423 Sum_probs=194.8
Q ss_pred hhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
..++|+..++||+|+||+||+|++. ..||||+++.........++|.+|+++|++++|||||++++++.+ ...+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4567899999999999999999863 469999998766555667889999999999999999999999765 5689999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.++|+....++++.+++.|+.|||+||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999877678999999999999999999999998 99999999999999999999999999864321
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...++.|+|||||||+||||+||+.||........ ....+..+.... ..
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~----~~~~~~~~~~~p----~~ 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIFMVGRGYLSP----DL 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----HHHHHHHTSCCC----CG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH----HHHHHhcCCCCC----cc
Confidence 11246789999999999999999999974322111 112222221111 00
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.........++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01122334578899999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-48 Score=405.62 Aligned_cols=242 Identities=27% Similarity=0.398 Sum_probs=200.0
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC-CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCe
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLVD-GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGE 554 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (740)
+++...++|+..++||+|+||+||+|++.+ ++.||||+++... ...++|.+|+++|++++|||||++++++.+.+.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 344456789999999999999999999864 8899999987643 345789999999999999999999999999999
Q ss_pred EEEEEecCCCCChHHhHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 555 RLLVYEFMPRGTLHDHLHGG-LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.+|||||+++|+|.++|... ...+++..++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999753 457899999999999999999999998 99999999999999999999999999976
Q ss_pred ccCC----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 634 CERD----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 634 ~~~~----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
...+ ..++.|+|||||||+||||+||..|+........+ .. ++..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~----~~---------~i~~ 231 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YE---------LLEK 231 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HH---------HHHT
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH----HH---------HHhc
Confidence 5331 23467999999999999999977776433221111 11 2222
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
....+.+.....++.+|+.+||+.||++||||.||+++|+.+.++
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 233333334455788999999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=398.63 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=194.2
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++...++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|+++|++++|||||++++++.+ +..+
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 334457799999999999999999999888999999997643 345689999999999999999999998865 5678
Q ss_pred EEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 557 LVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
|||||+++|+|.+++.... .+++|.++++|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 9999999999999886543 35999999999999999999999998 9999999999999999999999999997653
Q ss_pred CC----------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 636 RD----------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 636 ~~----------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
.. ..++.|+|||||||+||||+||..|+........+ ...+.. ..
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~----~~~i~~---------~~ 227 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNLER---------GY 227 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHT---------TC
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH----HHHHHh---------cC
Confidence 21 12256899999999999999976665432221111 112211 12
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+.+.....++.+|+++||+.||++||||+||++.|+.+...
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 2222333445788999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=388.68 Aligned_cols=231 Identities=25% Similarity=0.350 Sum_probs=195.2
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57889999999999999999998888999999986542 346899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+++|+|.+++......+++..+++|+.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999998877778999999999999999999999998 99999999999999999999999999875432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.|+||||||+++|||+| |+.||..... . .....+.. ..+.+.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-~----~~~~~i~~---------~~~~~~p 223 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-S----ETAEHIAQ---------GLRLYRP 223 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-H----HHHHHHHT---------TCCCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-H----HHHHHHHh---------CCCCCCc
Confidence 1223679999999999999999 8999964321 1 11222221 1222223
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVATWLEQ 732 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~ 732 (740)
.....++.+|+.+||+.||++|||+.||++.|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3344578899999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=393.02 Aligned_cols=238 Identities=22% Similarity=0.352 Sum_probs=193.2
Q ss_pred cCccccceecccCceEEEEEEEeCC-----cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDG-----RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g-----~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
+.|+..+.||+|+||+||+|+++.. ..||||+++.... .....+|.+|+++|++++|||||+++|++.+....+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4688889999999999999997642 4799999875442 344567999999999999999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+.+++|.+++......++|.++++++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999877778999999999999999999999998 99999999999999999999999999875432
Q ss_pred ------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 ------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 ------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.|+|||||||+||||+|+..|+........+ ...+ ...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~----~~~i---------~~~ 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----MKAI---------NDG 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHH---------HTT
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH----HHHH---------hcc
Confidence 122366899999999999999976666433221111 1112 222
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.+.+.....++.+|+.+||+.||++||||.||++.|+++++.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 33344444556789999999999999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=390.80 Aligned_cols=235 Identities=26% Similarity=0.375 Sum_probs=191.7
Q ss_pred cCccccc-eecccCceEEEEEEEe---CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFN-ELGRGSYGFVYKAVLV---DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (740)
++|...+ +||+|+||+||+|.++ ++..||||+++... .....++|.+|+++|++++|||||++++++.. +..+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 4566666 4999999999999864 35579999997653 23456789999999999999999999999865 46899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD 637 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~ 637 (740)
||||+++|+|.+++......+++.++++|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999999877678999999999999999999999998 999999999999999999999999998754321
Q ss_pred ------------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 638 ------------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 638 ------------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
..++.|+|||||||+||||+| |+.||..... ..+ ...+..+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~----~~~i~~~--------- 228 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEV----MAFIEQG--------- 228 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHH----HHHHHTT---------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHH----HHHHHcC---------
Confidence 112569999999999999998 9999974321 111 1222222
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
.+.+.+...+.++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1222233444578899999999999999999999999988654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=389.63 Aligned_cols=230 Identities=25% Similarity=0.346 Sum_probs=185.0
Q ss_pred ceecccCceEEEEEEEeC---CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEecCCC
Q 040687 488 NELGRGSYGFVYKAVLVD---GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEFMPR 564 (740)
Q Consensus 488 ~~LG~G~fG~Vy~~~~~~---g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 564 (740)
++||+|+||+||+|.+.+ ++.||||+++.........++|.+|+++|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999999754 4689999997655444456789999999999999999999999865 467899999999
Q ss_pred CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC-------
Q 040687 565 GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD------- 637 (740)
Q Consensus 565 gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~------- 637 (740)
|+|.++++.. .++++.++++|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999864 46999999999999999999999998 999999999999999999999999999754321
Q ss_pred -----------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 638 -----------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 638 -----------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
..++.|+|||||||+||||+| |+.||..... ..+...+.. ..+.+.+.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~~i~~---------~~~~~~p~ 233 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEK---------GERMGCPA 233 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHT---------TCCCCCCT
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHHHHHHc---------CCCCCCCc
Confidence 112569999999999999998 8999964321 111222222 12223333
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+.++.+|+.+||+.||++||||++|++.|+....+
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 4455788999999999999999999999988876544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=378.31 Aligned_cols=231 Identities=26% Similarity=0.398 Sum_probs=191.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+++.+ +++.||||++....... ...+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999985 48899999987654322 34567899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++.++..++.||++||+|||+++ ||||||||+||||++++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 999999999999754 46999999999999999999999999 99999999999999999999999999875543
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++|||||||+||||+||+.||..... ......+ .......|. .
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i--------~~~~~~~p~--~ 226 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRI--------SRVEFTFPD--F 226 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH--------HTTCCCCCT--T
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHH--------HcCCCCCCc--c
Confidence 23347899999999999999999999964321 1111112 122222332 2
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
...++.+|+.+||+.||++|||++|+++ +|.
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 3347789999999999999999999987 554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=382.86 Aligned_cols=230 Identities=27% Similarity=0.351 Sum_probs=189.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
+.|+..++||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+.+..+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 56899999999999999999985 58899999987653 3345679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++|+|.+++.+...++++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 99999999998765567999999999999999999999999 99999999999999999999999999853311
Q ss_pred ----------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccC
Q 040687 637 ----------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVA 694 (740)
Q Consensus 637 ----------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~ 694 (740)
...++.|+|||||||+||||+||+.||....... . ...+..... ..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~----~~~i~~~~~-------~~ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-V----LLKIAKSEP-------PT 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-H----HHHHHHSCC-------CC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-H----HHHHHcCCC-------CC
Confidence 2234678999999999999999999997532111 1 111111111 11
Q ss_pred CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 695 LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 695 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+.+.....++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222333457889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=391.86 Aligned_cols=236 Identities=27% Similarity=0.376 Sum_probs=190.5
Q ss_pred HhhcCccccceecccCceEEEEEEEeC-C-----cEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe
Q 040687 479 DATNGFKEFNELGRGSYGFVYKAVLVD-G-----RQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE 551 (740)
Q Consensus 479 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (740)
...++|+..++||+|+||+||+|++.. + ..||+|.+..... ......|.+|+.+|+++ +|||||++++++.+
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 345789999999999999999999753 2 3699999875442 23446799999999998 89999999999999
Q ss_pred CCeEEEEEecCCCCChHHhHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040687 552 MGERLLVYEFMPRGTLHDHLHGGL----------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRD 609 (740)
Q Consensus 552 ~~~~~lV~Ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrD 609 (740)
.+..+|||||+++|+|.++|+.+. ..++|.+++.|+.||++||+|||+++ |||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 999999999999999999997643 24899999999999999999999998 99999
Q ss_pred CCCCCEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCC
Q 040687 610 VKTLNILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDI 665 (740)
Q Consensus 610 lk~~NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~ 665 (740)
|||+|||++.++++||+|||+|+.... ...++.|+|||||||+||||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999865432 1223679999999999999998 8999975
Q ss_pred CCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040687 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLE 731 (740)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le 731 (740)
......+. . ++....+++.+.....++.+||.+||+.||++||||+||++.|.
T Consensus 270 ~~~~~~~~----~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDANFY----K---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHHHH----H---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHH----H---------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43322221 1 12222233333444557889999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=389.35 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=197.6
Q ss_pred hhHHHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEe
Q 040687 474 LSELKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLG 547 (740)
Q Consensus 474 ~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g 547 (740)
+.+++-+.++|+..++||+|+||+||+|+++ +++.||||+++.... ....++|.+|+++|++++||||+++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCccccee
Confidence 4556667889999999999999999999975 357899999876442 334568999999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCChHHhHhCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 040687 548 YCLEMGERLLVYEFMPRGTLHDHLHGGL-----------------------SPLNWSLRLKISMQAAKGLEYLHKDAAPP 604 (740)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 604 (740)
++......++||||+++|+|.++|+... ..+++.+++.|+.|+|.||+|||+++
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--- 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence 9999999999999999999999996321 24899999999999999999999998
Q ss_pred eEecCCCCCCEEECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHhCC-
Q 040687 605 IIHRDVKTLNILLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGR- 660 (740)
Q Consensus 605 iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~- 660 (740)
||||||||+|||||.++++||+|||+++.... ...++.|+|||||||+||||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999864321 123467999999999999999986
Q ss_pred CCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040687 661 KAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIV 734 (740)
Q Consensus 661 ~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~ 734 (740)
.||.... +.. ....+..+. ..+.+...+.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 241 ~p~~~~~-~~e----~~~~v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMA-HEE----VIYYVRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSC-HHH----HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCC-HHH----HHHHHHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5665322 111 112222221 12223334457889999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=380.53 Aligned_cols=230 Identities=26% Similarity=0.277 Sum_probs=184.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+|+.. +++.||||+++.... ....+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 56999999999999999999985 589999999876542 2234578999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++|+|.++|... ..+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999754 57999999999999999999999999 99999999999999999999999999875421
Q ss_pred -------------------CCC-CCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 -------------------DLT-TDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 -------------------~~~-~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
... ++.++|||||||+||||+||+.||+......... ..... .....+
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~----~~~~~--------~~~~~~ 227 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKE--------KKTYLN 227 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH----HHHHT--------TCTTST
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH----HHHhc--------CCCCCC
Confidence 111 2457999999999999999999997543222111 11111 111111
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......++.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12223346779999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=386.75 Aligned_cols=235 Identities=27% Similarity=0.412 Sum_probs=191.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
.++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 46799999999999999999999888899999997553 344689999999999999999999999854 56789999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++|+|.+++.... ..++|.+++.|+.|||+||+|||+.+ |+||||||+|||||+++++||+|||+++....
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999999986532 46999999999999999999999998 99999999999999999999999999875432
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.|+||||||++||||+||..|+........+ ...+.. ....+.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~----~~~i~~---------~~~~~~ 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----LDQVER---------GYRMPC 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHT---------TCCCCC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH----HHHHHh---------cCCCCC
Confidence 123367999999999999999977766433222111 122211 122233
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVK 735 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~ 735 (740)
+....+++.+|+.+||+.||++||+|++|+++|+++..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 33445578899999999999999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=379.57 Aligned_cols=237 Identities=23% Similarity=0.325 Sum_probs=188.4
Q ss_pred hcCccccceecccCceEEEEEEEeC----CcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
.++|+..+.||+|+||.||+|++.. +..||||.++.... ....+.|.+|+++|++++|||||++++++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4679999999999999999999743 35689999865432 334567999999999999999999999986 46789
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++|+|.+++.....++++.+++.++.||++||+|||+.+ ||||||||+|||+++++.+||+|||+|+....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999998877778999999999999999999999999 99999999999999999999999999875432
Q ss_pred ----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccccc
Q 040687 637 ----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV 693 (740)
Q Consensus 637 ----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~ 693 (740)
...++.++|||||||+||||+| |+.||..... ..+ ...+..+ .
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~----~~~i~~~---------~ 226 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDV----IGRIENG---------E 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGH----HHHHHTT---------C
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHH----HHHHHcC---------C
Confidence 1233679999999999999998 8999864321 111 1122221 1
Q ss_pred CCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 694 ALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 694 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+.+.....++.+|+.+||+.||++|||+.||++.|++++++
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1222334445788999999999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=381.53 Aligned_cols=233 Identities=21% Similarity=0.329 Sum_probs=181.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC--CeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM--GERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (740)
++|+..+.||+|+||+||+++.. +++.||||.++.....+...+.|.+|+++|++++|||||++++++.+. ...|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999975 589999999987765555667799999999999999999999998653 468999
Q ss_pred EecCCCCChHHhHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLHGG---LSPLNWSLRLKISMQAAKGLEYLHKDA--APPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
|||+++|+|.+++... ...+++.+++.++.||+.||+|||+++ ..+||||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 356999999999999999999999864 23599999999999999999999999999865
Q ss_pred ccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 634 CER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 634 ~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
... ...++.|+|||||||+||||+||+.||..... ......+......
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i~~~~~~------ 232 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFR------ 232 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCC------
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCC------
Confidence 422 22346799999999999999999999964321 1112222222211
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.. +.....++.+|+.+||+.||++|||+.||++
T Consensus 233 -~~--~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -RI--PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC--CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 2223347889999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=377.68 Aligned_cols=228 Identities=24% Similarity=0.371 Sum_probs=188.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 57999999999999999999974 58999999987654 2345679999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+++|+|.+++..+ .+++.++..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999999998754 5999999999999999999999999 99999999999999999999999999875432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.++|||||||+||||+||+.||..... .+......... ....+.+.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~~~~--------~~~~~~~~ 240 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNG--------TPELQNPE 240 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHC--------SCCCSSGG
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH----HHHHHHHHhCC--------CCCCCCcc
Confidence 12346799999999999999999999964321 11111111111 11122223
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+|+.+||+.||++|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33457889999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=375.73 Aligned_cols=230 Identities=28% Similarity=0.360 Sum_probs=183.5
Q ss_pred cccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEe----CCeEEEEE
Q 040687 485 KEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLE----MGERLLVY 559 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 559 (740)
+..++||+|+||+||+|+.. +++.||+|++..........+.|.+|+++|++++|||||++++++.+ +...+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999985 47899999998766555556789999999999999999999999875 34579999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC-CCCCEEEeecCCCccccC--
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD-SDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~ki~DFGla~~~~~-- 636 (740)
||+++|+|.+++.+. ..+++.++..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 999999999999754 46999999999999999999999875 5599999999999996 578999999999864332
Q ss_pred ----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++|||||||+||||+||+.||........+ ...+..+..... .+..
T Consensus 170 ~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~----~~~i~~~~~~~~--------~~~~ 237 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YRRVTSGVKPAS--------FDKV 237 (270)
T ss_dssp BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH----HHHHTTTCCCGG--------GGGC
T ss_pred cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH----HHHHHcCCCCcc--------cCcc
Confidence 123477999999999999999999999643222111 112211111111 1111
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2336789999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=378.37 Aligned_cols=235 Identities=24% Similarity=0.368 Sum_probs=182.8
Q ss_pred cCccccceecccCceEEEEEEEeC----CcEEEEEEecccccch-hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD----GRQVAVKRANAATIIH-TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAiK~l~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||+||+|++.. ...||||+++...... ...++|.+|+++|++++|||||+++|++.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 468899999999999999999743 2379999987654322 3356899999999999999999999999764 678
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+||||+++|+|.+++..+..++++..+++++.|||+||+|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999998776667999999999999999999999998 99999999999999999999999999886533
Q ss_pred CC------------------------CCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 637 DL------------------------TTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 637 ~~------------------------~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
.. .++.++||||||+++|||+| |+.||..... .+.. .. +...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----~~~~-~~--------i~~~ 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQIL-HK--------IDKE 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH-HH--------HHTS
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----HHHH-HH--------HHhC
Confidence 11 12558999999999999998 8999964321 1111 11 1122
Q ss_pred ccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040687 692 NVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQI 733 (740)
Q Consensus 692 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l 733 (740)
....+.+...+.++.+|+.+||+.||++||||.||++.|+++
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 223333334445788999999999999999999999998875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=375.90 Aligned_cols=234 Identities=29% Similarity=0.429 Sum_probs=187.3
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-CeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-GERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 560 (740)
++|+..++||+|+||.||+|++ .++.||||+++... ..++|.+|+++|++++||||++++|++.+. +.++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 5688889999999999999998 57899999997543 346799999999999999999999999654 56899999
Q ss_pred cCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+++|+|.++|+... ..++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCc
Confidence 999999999997543 35899999999999999999999998 99999999999999999999999999876432
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCch
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVE 700 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~ 700 (740)
...++.++||||||+++|||+| |+.||.... ...+.. .+.. ..+.+.+..
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-~~~~~~----~i~~---------~~~~~~~~~ 224 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVP----RVEK---------GYKMDAPDG 224 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHH----HHTT---------TCCCCCCTT
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-HHHHHH----HHHc---------CCCCCCCcc
Confidence 1234779999999999999999 677775432 122221 1211 122223333
Q ss_pred hHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 701 PLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 701 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...++.+|+.+||+.||++||||.||+++|+++....
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 4457889999999999999999999999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=379.23 Aligned_cols=233 Identities=25% Similarity=0.406 Sum_probs=188.1
Q ss_pred cceecccCceEEEEEEEeCC----cEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-CeEEEEEec
Q 040687 487 FNELGRGSYGFVYKAVLVDG----RQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-GERLLVYEF 561 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g----~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 561 (740)
.++||+|+||+||+|++.+. ..||||+++... .....++|.+|+++|++++||||++++|++.+. ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999998542 368999987533 244567899999999999999999999998764 589999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccCC----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCERD---- 637 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~---- 637 (740)
+++|+|.++++.....+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999987778899999999999999999999998 999999999999999999999999998754321
Q ss_pred ---------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 638 ---------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 638 ---------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
..++.|+||||||++||||+||+.||........+.. .+..+. +. +
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~----~i~~g~-------~~--~ 254 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV----YLLQGR-------RL--L 254 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH----HHHTTC-------CC--C
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCC-------CC--C
Confidence 1236699999999999999998888764432222211 111111 11 1
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.....++.+||.+||+.||++||+|.||++.|++++++
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 2223345788999999999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=384.23 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=193.1
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..++|+..++||+|+||+||+|+.. +++.||+|+++... .......+.+|+.+|++++|||||++++++.+.+..+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3578999999999999999999975 58999999987643 233456799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKD-AAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~- 636 (740)
|||+++|+|.+++.+. ..+++.++..++.|+++||.|||++ + |+||||||+||||++++.+||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999999754 4699999999999999999999974 7 99999999999999999999999999874321
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHH------------------
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLI------------------ 680 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~------------------ 680 (740)
...++.++|||||||++|||+||+.||.................
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 23457899999999999999999999975432211000000000
Q ss_pred ----h---hCccchhccc---ccCCCC-CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHH
Q 040687 681 ----K---QGKAAAIIDR---NVALPR-NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIVK 735 (740)
Q Consensus 681 ----~---~~~~~~i~d~---~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~~ 735 (740)
. .....+.++. ...... ......++.+|+.+||+.||++|||++|+++ +|++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0 0000000000 000000 1112346789999999999999999999997 6766543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=381.47 Aligned_cols=236 Identities=26% Similarity=0.427 Sum_probs=191.4
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc----EEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR----QVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~----~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..++||+|+||+||+|++.. ++ +||+|+++... .....++|.+|+++|++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 359999999999999999999753 43 68999887543 234567899999999999999999999999865 567
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
+++||+.+++|.+++......+++..+++|+.|||+||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 889999999999999887778999999999999999999999998 99999999999999999999999999865422
Q ss_pred -----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 637 -----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 637 -----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...++.|+|||||||+||||+| |+.||+.... ..+ ...+ ...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~----~~~i---------~~~ 229 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI----SSIL---------EKG 229 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGH----HHHH---------HHT
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHH----HHHH---------HcC
Confidence 1223679999999999999999 8888864321 111 1122 222
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.+.+.....++.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 23333444556788999999999999999999999999988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-44 Score=380.40 Aligned_cols=230 Identities=24% Similarity=0.294 Sum_probs=187.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
+.|+..++||+|+||+||+|+.. +++.||||++...... ....+.|.+|+++|++++|||||++++++.+++..||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999974 5889999998765432 234567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|..++..+ .++++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 999999998776543 57999999999999999999999999 99999999999999999999999999875432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCc
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNV 699 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~ 699 (740)
...++.|+|||||||+||||++|+.||..... .+...... . .......+.
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~i~-~--------~~~~~~~~~ 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIA-Q--------NESPALQSG 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH-H--------SCCCCCSCT
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHH-h--------CCCCCCCCC
Confidence 12357799999999999999999999964321 11111111 1 111111222
Q ss_pred hhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 700 EPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 700 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 33447889999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=380.07 Aligned_cols=238 Identities=32% Similarity=0.495 Sum_probs=190.2
Q ss_pred cCccccceecccCceEEEEEEEeC-Cc--EEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEeCCeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVD-GR--QVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~--~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (740)
++|+..++||+|+||+||+|++++ +. .||||+++.... ....++|.+|+++|+++ +|||||++++++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 568888999999999999999854 44 578888764332 33456799999999999 79999999999999999999
Q ss_pred EEecCCCCChHHhHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCC
Q 040687 558 VYEFMPRGTLHDHLHGG---------------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWG 622 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 622 (740)
||||+++|+|.++|+.. ...++|.++++++.|||+||.|||+.+ ||||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999754 246899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccccC--------------------CCCCCcccceehhHHHHHHHHhCCC-CCCCCCCCchhHHhhhhHHh
Q 040687 623 ARIADFGLLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRK-AYDIEYVPPGIVEWALPLIK 681 (740)
Q Consensus 623 ~ki~DFGla~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~~~~~~~~~~ 681 (740)
+||+|||+++.... ...++.|+||||||+++|||++|.. ||... ....+. ..+.
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~~----~~i~ 240 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELY----EKLP 240 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHH----HHGG
T ss_pred eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHHHH----HHHH
Confidence 99999999864332 1223679999999999999999765 56422 111111 1111
Q ss_pred hCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 682 QGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 682 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+.+.+.....++.+|+.+||+.||++||||+||++.|++++++.
T Consensus 241 ---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 ---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11222333344457889999999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=377.12 Aligned_cols=244 Identities=30% Similarity=0.401 Sum_probs=197.9
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEE
Q 040687 477 LKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYC 549 (740)
Q Consensus 477 l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 549 (740)
++...++|+..++||+|+||.||+|++. .++.||||+++.... .....+|.+|+.+++++ +|||||++++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4445578999999999999999999863 356899999976543 34456799999999999 799999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGGL-----------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKT 612 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~ 612 (740)
.+....+|||||+++|+|.++|+... ..+++.+++.++.||++||+|||+++ ||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997532 25899999999999999999999999 99999999
Q ss_pred CCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHh-CCCCCCCCCC
Q 040687 613 LNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILS-GRKAYDIEYV 668 (740)
Q Consensus 613 ~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~ 668 (740)
+|||++.++.+||+|||+++..... ..++.++||||||++||||+| |+.||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999998754331 223679999999999999999 5555543322
Q ss_pred CchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 669 PPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
...+ .++++...+...+.....++.+|+.+||+.||++||||.||+++|++++.+.
T Consensus 254 ~~~~-------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 254 DSKF-------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SHHH-------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHH-------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 1111 1122222333333334457889999999999999999999999999988875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=372.11 Aligned_cols=228 Identities=22% Similarity=0.285 Sum_probs=188.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..+.||+|+||+||+|+.. +++.||||++...... ....+.+.+|+++|++++||||+++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999985 5899999998765432 234567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999998754 46999999999999999999999999 99999999999999999999999999975431
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++|||||||+||||+||+.||..... .+ .... +....+..|
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~-~~~~--------i~~~~~~~p 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YL-IFQK--------IIKLEYDFP 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHH--------HHTTCCCCC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH----HH-HHHH--------HHcCCCCCC
Confidence 12346799999999999999999999974321 11 1111 222223333
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
. ....++.+|+.+||+.||++|||++|++.
T Consensus 231 ~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 E--KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp T--TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred c--cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 3 22346789999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=373.40 Aligned_cols=247 Identities=30% Similarity=0.404 Sum_probs=187.6
Q ss_pred ChhHHHHhhcCccccceecccCceEEEEEEEeC------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceE
Q 040687 473 RLSELKDATNGFKEFNELGRGSYGFVYKAVLVD------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNL 545 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 545 (740)
+.++++...++|+..++||+|+||.||+|++.. ++.||||+++.... ....++|.+|+.++.++ +|+||+++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 344555556789999999999999999999743 46899999875443 33456788899888887 68999999
Q ss_pred EeEEEeCC-eEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 040687 546 LGYCLEMG-ERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRD 609 (740)
Q Consensus 546 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrD 609 (740)
++++.+.+ ..++||||+++|+|.++|+... ..+++.+++.++.||++||+|||+++ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 99987654 6899999999999999996432 34899999999999999999999998 99999
Q ss_pred CCCCCEEECCCCCEEEeecCCCccccCC-----------------------CCCCcccceehhHHHHHHHHhC-CCCCCC
Q 040687 610 VKTLNILLDSDWGARIADFGLLTSCERD-----------------------LTTDMKSDVHNFGIVLLEILSG-RKAYDI 665 (740)
Q Consensus 610 lk~~NILl~~~~~~ki~DFGla~~~~~~-----------------------~~~~~ksDVwSfGvvl~ElltG-~~p~~~ 665 (740)
|||+||||++++++||+|||+|+..... ..++.|+|||||||++|||+|+ +.||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998654321 1236799999999999999996 457754
Q ss_pred CCCCchhHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 666 EYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
......+ ...+..+ ...+.+.....++.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 240 ~~~~~~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDEEF----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSHHH----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHH----HHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 3322221 1222221 22222233345788999999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-43 Score=376.52 Aligned_cols=230 Identities=21% Similarity=0.311 Sum_probs=189.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||+||+++.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999975 589999999876542 34467899999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC--CCCEEEeecCCCccccC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS--DWGARIADFGLLTSCER- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~ki~DFGla~~~~~- 636 (740)
||+++|+|.+++......+++.++..|+.||+.||+|||+.+ ||||||||+||||+. ++.+||+|||+++....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999999766667999999999999999999999999 999999999999964 57899999999876543
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++|||||||++|||+||+.||..... .+ ....+... ....+.
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~-~~~~i~~~--------~~~~~~ 246 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DE-TLRNVKSC--------DWNMDD 246 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHT--------CCCSCC
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH----HH-HHHHHHhC--------CCCCCc
Confidence 12346799999999999999999999964321 11 11112111 111111
Q ss_pred --CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 698 --NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 698 --~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......++.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222346789999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-43 Score=373.91 Aligned_cols=233 Identities=22% Similarity=0.246 Sum_probs=179.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
..+.|+..+.||+|+||+||+++.. +++.||||++...... .....+.+|+++|++++|||||++++++.+.+..|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467999999999999999999985 4889999999765432 2345688999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC---CCCCEEEeecCCCcccc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD---SDWGARIADFGLLTSCE 635 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~ki~DFGla~~~~ 635 (740)
|||+++|+|.++|... ..+++.++..++.||+.||+|||+.+ ||||||||+|||+. +++.+||+|||+++...
T Consensus 86 mE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp ECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999754 57999999999999999999999999 99999999999995 57899999999986543
Q ss_pred C--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCC
Q 040687 636 R--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVAL 695 (740)
Q Consensus 636 ~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~ 695 (740)
. ...++.++|||||||+||||+||+.||..... .+ ....+..... ....
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~-~~~~i~~~~~------~~~~ 230 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AK-LFEQILKAEY------EFDS 230 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HH-HHHHHHTTCC------CCCT
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HH-HHHHHhccCC------CCCC
Confidence 2 22357899999999999999999999964321 11 1111111111 1112
Q ss_pred CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 696 PRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 696 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
+.......++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 222333457889999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=371.03 Aligned_cols=239 Identities=29% Similarity=0.422 Sum_probs=190.3
Q ss_pred hhcCccccceecccCceEEEEEEEeC--------CcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEE
Q 040687 480 ATNGFKEFNELGRGSYGFVYKAVLVD--------GRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCL 550 (740)
Q Consensus 480 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (740)
..++|...++||+|+||.||+|+... +..||||+++.... .....++.+|...+.++ +|||||++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34678899999999999999998643 24799999976542 34457899999999988 8999999999999
Q ss_pred eCCeEEEEEecCCCCChHHhHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 040687 551 EMGERLLVYEFMPRGTLHDHLHGGL---------------SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNI 615 (740)
Q Consensus 551 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NI 615 (740)
++...++||||+++|+|.++|.... ..+++.+++.++.||+.||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 9999999999999999999997543 35899999999999999999999999 99999999999
Q ss_pred EECCCCCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHh-CCCCCCCCCCCch
Q 040687 616 LLDSDWGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILS-GRKAYDIEYVPPG 671 (740)
Q Consensus 616 Ll~~~~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 671 (740)
|++.++.+||+|||+++.... ...++.|+||||||++||||+| |..||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 999999999999999875432 1234679999999999999999 6888853221
Q ss_pred hHHhhhhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 672 IVEWALPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 672 ~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
..+...+.. ....+.+.....++.+|+.+||+.||++|||+.||++.|+++++-
T Consensus 244 --~~~~~~i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 --EELFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --HHHHHHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 112222222 222233333445788999999999999999999999999999763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=375.58 Aligned_cols=243 Identities=27% Similarity=0.394 Sum_probs=194.7
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe------CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEE
Q 040687 476 ELKDATNGFKEFNELGRGSYGFVYKAVLV------DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYC 549 (740)
Q Consensus 476 ~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (740)
+++...++|+..++||+|+||+||+|++. +++.||||+++... .......|.+|++++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 34444578999999999999999999874 25789999997543 234456799999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCChHHhHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC
Q 040687 550 LEMGERLLVYEFMPRGTLHDHLHGG---------LSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD 620 (740)
Q Consensus 550 ~~~~~~~lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~ 620 (740)
......++||||+++|+|.++++.. ...+++..+++++.|+|+||.|||+++ |+||||||+||||+++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 9999999999999999999998632 245799999999999999999999998 9999999999999999
Q ss_pred CCEEEeecCCCccccC-----------------------CCCCCcccceehhHHHHHHHHhCC-CCCCCCCCCchhHHhh
Q 040687 621 WGARIADFGLLTSCER-----------------------DLTTDMKSDVHNFGIVLLEILSGR-KAYDIEYVPPGIVEWA 676 (740)
Q Consensus 621 ~~~ki~DFGla~~~~~-----------------------~~~~~~ksDVwSfGvvl~ElltG~-~p~~~~~~~~~~~~~~ 676 (740)
+++||+|||+++.... ...++.|+||||||++||||+||+ .||.... ..+ .
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~----~~~-~ 244 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQ-V 244 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHH-H
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC----HHH-H
Confidence 9999999999975432 122366999999999999999985 5664321 111 1
Q ss_pred hhHHhhCccchhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 677 LPLIKQGKAAAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 677 ~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
...+..+ ...+.+......+.+||.+||+.||++||||+||++.|++.++.
T Consensus 245 ~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 245 LRFVMEG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHhC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1222221 11222233345788999999999999999999999999876553
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-43 Score=376.35 Aligned_cols=231 Identities=22% Similarity=0.309 Sum_probs=189.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++|++|+|||||++++++.+++..|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999974 589999999876542 334678999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEC--CCCCEEEeecCCCccccC--
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLD--SDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~ki~DFGla~~~~~-- 636 (740)
|+++|+|.+++.....++++.++..|+.||+.||+|||+.+ ||||||||+||||+ .++.+||+|||+|.....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999998776667999999999999999999999999 99999999999998 678999999999876543
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCC
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRN 698 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~ 698 (740)
...++.++|||||||+||||+||+.||...... + ....+..... ....+..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~-~~~~i~~~~~------~~~~~~~ 252 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----E-TLQNVKRCDW------EFDEDAF 252 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----H-HHHHHHHCCC------CCCSSTT
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHHHhCCC------CCCcccc
Confidence 223467999999999999999999999643211 1 1111211111 1111112
Q ss_pred chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 699 VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 699 ~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233447789999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.4e-43 Score=363.54 Aligned_cols=232 Identities=22% Similarity=0.270 Sum_probs=189.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-------hcHHHHHHHHHHHHhCC-CCCcceEEeEEEeC
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-------TNIREFEMELEVLCNIR-HSNIVNLLGYCLEM 552 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 552 (740)
++|+..+.||+|+||+||+++.. +++.||||++....... ...+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67999999999999999999974 58999999987654321 12345889999999997 99999999999999
Q ss_pred CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCc
Q 040687 553 GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLT 632 (740)
Q Consensus 553 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~ 632 (740)
+..||||||+++|+|.++|+.+ .++++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999754 47999999999999999999999999 9999999999999999999999999987
Q ss_pred cccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccc
Q 040687 633 SCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAA 686 (740)
Q Consensus 633 ~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 686 (740)
.... ...++.++||||+||+||||+||+.||..... ......+..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~~~i~~~~~- 232 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIMSGNY- 232 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC-
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HHHHHHHHhCCC-
Confidence 5432 11235689999999999999999999974321 111122222111
Q ss_pred hhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 687 AIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 687 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+.......++.+|+.+||+.||++|||++||++
T Consensus 233 -----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 -----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122222334457889999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=367.41 Aligned_cols=231 Identities=23% Similarity=0.279 Sum_probs=188.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch----hcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH----TNIREFEMELEVLCNIRHSNIVNLLGYCLEMGER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (740)
.+.|+..++||+|+||+||+|+.. +++.||||+++...... ...+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999984 58999999987654322 2357899999999999999999999999999999
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC----CEEEeecCCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW----GARIADFGLL 631 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ki~DFGla 631 (740)
||||||+++|+|.++|... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999754 46999999999999999999999999 99999999999998876 4999999998
Q ss_pred ccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccc
Q 040687 632 TSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDR 691 (740)
Q Consensus 632 ~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~ 691 (740)
..... ...++.++|||||||+||||+||+.||...... + ....+...
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~-~~~~i~~~-------- 231 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----E-TLANVSAV-------- 231 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----H-HHHHHHTT--------
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----H-HHHHHHhc--------
Confidence 65432 123467999999999999999999999743211 1 11112111
Q ss_pred ccCCCC--CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 692 NVALPR--NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 692 ~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+. ......++.+|+++||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 1122346779999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=369.05 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=185.3
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHH--HHHHHHhCCCCCcceEEeEEEeCC----eE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEM--ELEVLCNIRHSNIVNLLGYCLEMG----ER 555 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~ 555 (740)
..|...++||+|+||+||+|++ +++.||||+++... .+++.. |+..+.+++|||||++++++.+.+ ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4577888999999999999996 68999999986532 234444 555556789999999999998754 57
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDA-----APPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
+||||||++|+|.++|++. +++|..+++++.|+|+||+|||+.. .++||||||||+||||+.++++||+|||+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999999864 5999999999999999999999742 24599999999999999999999999999
Q ss_pred CccccCCC-------------------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCch-hHH----
Q 040687 631 LTSCERDL-------------------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG-IVE---- 674 (740)
Q Consensus 631 a~~~~~~~-------------------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-~~~---- 674 (740)
++...... .++.|+|||||||+||||+||..||........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 86542210 124578999999999999999988754221110 000
Q ss_pred -hhhhHHhhCccchhcccccCCCC-----CchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhc
Q 040687 675 -WALPLIKQGKAAAIIDRNVALPR-----NVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKDG 737 (740)
Q Consensus 675 -~~~~~~~~~~~~~i~d~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~~ 737 (740)
.....+. ..+.+...+.+. ..+....+.+|+.+||+.||++||||.||++.|+++.++.
T Consensus 235 ~~~~~~~~----~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 235 DPSVEEMR----KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHH----HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHH----HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0001111 111222221111 2345567899999999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=370.36 Aligned_cols=232 Identities=20% Similarity=0.308 Sum_probs=189.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
.++|+..++||+|+||+||+++.. +++.||||.++... .....+.+|+++|++++|||||++++++.+++..||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 467999999999999999999985 58899999997654 23356889999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCC--CCEEEeecCCCccccC-
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSD--WGARIADFGLLTSCER- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~ki~DFGla~~~~~- 636 (740)
||+++|+|.++|......+++.++..|+.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999999876667999999999999999999999999 9999999999999854 5899999999876533
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++|||||||+||||++|+.||..... ......+ .......+.
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~~i--------~~~~~~~~~ 224 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIENI--------MNAEYTFDE 224 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH--------HHTCCCCCH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHHHHH--------HhCCCCCCh
Confidence 12236789999999999999999999974321 1111112 111222111
Q ss_pred C--chhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 040687 698 N--VEPLFKLADIAELAIRENPSELPTMSQVAT--WLE 731 (740)
Q Consensus 698 ~--~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le 731 (740)
. .....++.+|+.+||+.||++|||+.|+++ ++.
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 0 112336779999999999999999999987 454
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.8e-42 Score=358.30 Aligned_cols=239 Identities=24% Similarity=0.301 Sum_probs=192.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC----e
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----E 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 554 (740)
.++|+..+.||+|+||+||+|+.. +++.||||.++..... ......|.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 5899999999765432 233567999999999999999999999988654 3
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.||||||+++++|.+++... .++++.+++.|+.||++||+|||+.+ ||||||||+|||++.++..+|+|||++...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 78999999999999998754 46999999999999999999999999 999999999999999999999999986532
Q ss_pred cC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 635 ER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 635 ~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
.. ...++.++|||||||+||||+||+.||.... ..+.....+......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~~~~~~~~~---- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVREDPIP---- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHCCCCC----
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC----HHHHHHHHHhcCCCC----
Confidence 21 2234779999999999999999999997432 112222222221111
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELP-TMSQVATWLEQIV 734 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~Le~l~ 734 (740)
..........++.+++++||+.||++|| |++++.+.|.++.
T Consensus 234 ---~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0011122334788999999999999999 8999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=362.07 Aligned_cols=246 Identities=21% Similarity=0.344 Sum_probs=183.5
Q ss_pred cCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+|+. .+++.||||+++.....+....++.+|+++|++++|||||++++++.+....|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999997 458999999997665434445789999999999999999999999999999999999
Q ss_pred cCCCCChHHhH-hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 561 FMPRGTLHDHL-HGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 561 y~~~gsL~~~l-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
|+.+ ++.+++ ......+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9975 444444 444567999999999999999999999999 99999999999999999999999998754322
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHh---hC---ccchhccc
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIK---QG---KAAAIIDR 691 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---~~---~~~~i~d~ 691 (740)
....+.++|||||||++|||++|+.||........+.. ...... +. ......+.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH-HHHhcCCCchhhcccccccccc
Confidence 12236789999999999999999999975422111111 000000 00 00000000
Q ss_pred ccCCCC---------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 692 NVALPR---------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 692 ~~~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
....+. ......++.+|+.+||+.||++|||++|+++ +|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 000000 0112246789999999999999999999987 4543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=363.94 Aligned_cols=229 Identities=24% Similarity=0.317 Sum_probs=189.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..+.||+|+||.||+++.. +++.||||++++.... ....+.+.+|+.+|++++||||+++++++.+.+..|||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999974 5899999999865432 33467799999999999999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999999764 46899999999999999999999999 99999999999999999999999999875432
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++|||||||+||||++|+.||..... .+ ....+ ....+..|.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~-~~~~i--------~~~~~~~p~ 226 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ER-LFELI--------LMEEIRFPR 226 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHH--------HHCCCCCCT
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HH-HHHHH--------hcCCCCCCc
Confidence 22346799999999999999999999975431 11 11122 222333333
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
. ...++.+|+.+||+.||++||+ +.|+++
T Consensus 227 ~--~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 T--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp T--SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred c--CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 3 2346789999999999999995 788876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-41 Score=361.19 Aligned_cols=228 Identities=22% Similarity=0.332 Sum_probs=188.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||+||+++.+ +++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999984 5899999999765432 234677999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 999999999998755 46889999999999999999999998 99999999999999999999999999876533
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++|||||||+||||+||+.||.... ..+ ... .++......|.. .
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~-~~~--------~i~~~~~~~p~~--~ 224 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMK-TYE--------KILNAELRFPPF--F 224 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHH-HHH--------HHHHCCCCCCTT--S
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC----HHH-HHH--------HHHcCCCCCCCC--C
Confidence 2234779999999999999999999997432 111 111 122222233322 2
Q ss_pred HHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
..++.+++.+||+.||.+|| +++|+++
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 34678999999999999996 8999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7e-42 Score=358.74 Aligned_cols=242 Identities=20% Similarity=0.270 Sum_probs=187.6
Q ss_pred cCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
++|+..++||+|+||+||+|+.++++.||||+++.....+...+.|.+|+.+|++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 67999999999999999999998899999999977654444567899999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
+.++.+..+.. ....+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 98766655554 4467999999999999999999999998 99999999999999999999999998754321
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---c---cchh-----
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---K---AAAI----- 688 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~---~~~i----- 688 (740)
...++.++|||||||+||||++|+.||........+.. ........ . ....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH-HHHhhCCCChhhccchhhhhhccc
Confidence 22347899999999999999999999975432111111 11100000 0 0000
Q ss_pred -cccccCCC---CCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 689 -IDRNVALP---RNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 689 -~d~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.......+ .......++.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 01122346789999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-41 Score=362.98 Aligned_cols=228 Identities=19% Similarity=0.278 Sum_probs=189.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||.||+++.+ +++.||||++...... ....+.+.+|+++|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 5899999998765432 234567999999999999999999999999999999999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC---
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER--- 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~--- 636 (740)
||+.+|+|.+++... ..+++.++..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999999754 46999999999999999999999999 99999999999999999999999999876543
Q ss_pred ---------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCCCchh
Q 040687 637 ---------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPRNVEP 701 (740)
Q Consensus 637 ---------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~ 701 (740)
...++.++|||||||+||||+||+.||.... ..+ ....+ .......+. ..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~-~~~~i--------~~~~~~~p~--~~ 261 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQ-IYEKI--------VSGKVRFPS--HF 261 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHH--------HHCCCCCCT--TC
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HHH-HHHHH--------hcCCCCCCc--cC
Confidence 2234779999999999999999999996432 111 11112 222222332 22
Q ss_pred HHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 702 LFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 702 ~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
..++.+|+.+||+.||++|+ +++||++
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 34778999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-41 Score=363.43 Aligned_cols=231 Identities=22% Similarity=0.264 Sum_probs=183.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccch-hcHHHHHH---HHHHHHhCCCCCcceEEeEEEeCCeEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIH-TNIREFEM---ELEVLCNIRHSNIVNLLGYCLEMGERL 556 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~-~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (740)
++|+..+.||+|+||.||+++.. +++.||||++....... .....+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999985 58999999987544322 12233444 467777889999999999999999999
Q ss_pred EEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC
Q 040687 557 LVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER 636 (740)
Q Consensus 557 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~ 636 (740)
|||||+++|+|.++|... ..+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999754 46899999999999999999999999 99999999999999999999999999875432
Q ss_pred --------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCC
Q 040687 637 --------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALP 696 (740)
Q Consensus 637 --------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~ 696 (740)
...++.++|||||||+||||+||+.||........ .+ .. ..+.......+
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~----~~-----~~~~~~~~~~~ 229 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE----ID-----RMTLTMAVELP 229 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HH----HH-----HHSSSCCCCCC
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HH----HH-----HhcccCCCCCC
Confidence 22347799999999999999999999975432211 10 01 11111122222
Q ss_pred CCchhHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 040687 697 RNVEPLFKLADIAELAIRENPSELPT-----MSQVAT 728 (740)
Q Consensus 697 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 728 (740)
. ....++.+|+.+||+.||++||| ++|+++
T Consensus 230 ~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 D--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp S--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2 23346789999999999999999 688875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=358.65 Aligned_cols=228 Identities=23% Similarity=0.325 Sum_probs=185.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccc-hhcHHHHHHHHHHHH-hCCCCCcceEEeEEEeCCeEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATII-HTNIREFEMELEVLC-NIRHSNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~-~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 558 (740)
++|...++||+|+||+||+|+.. +++.||||++++.... ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999985 5899999999765422 334566788888776 68999999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC--
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER-- 636 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~-- 636 (740)
|||+++|+|.++++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999754 46899999999999999999999999 99999999999999999999999999875432
Q ss_pred -------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccccCCCC
Q 040687 637 -------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNVALPR 697 (740)
Q Consensus 637 -------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~~~~~ 697 (740)
...++.++|||||||++|||+||+.||..... ......+.. ..+..|.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~--------~~~~~p~ 224 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRM--------DNPFYPR 224 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH--------CCCCCCT
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHc--------CCCCCCc
Confidence 22346799999999999999999999974321 111222221 2222232
Q ss_pred CchhHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 040687 698 NVEPLFKLADIAELAIRENPSELPTMS-QVAT 728 (740)
Q Consensus 698 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~~ 728 (740)
. ...++.+|+.+||+.||++||++. ||++
T Consensus 225 ~--~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 W--LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp T--SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred c--CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2 234678999999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=354.46 Aligned_cols=237 Identities=24% Similarity=0.249 Sum_probs=175.9
Q ss_pred ccceecccCceEEEEEEEe-CCcEEEEEEecccccchhc---HHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEec
Q 040687 486 EFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTN---IREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYEF 561 (740)
Q Consensus 486 ~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 561 (740)
.+++||+|+||+||+|+.. +++.||||+++........ .+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3568999999999999974 5899999998765432211 24689999999999999999999999999999999999
Q ss_pred CCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC-----
Q 040687 562 MPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER----- 636 (740)
Q Consensus 562 ~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~----- 636 (740)
++++++..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 98876665554 4457899999999999999999999999 99999999999999999999999999865432
Q ss_pred -----------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhccccc------
Q 040687 637 -----------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRNV------ 693 (740)
Q Consensus 637 -----------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~~------ 693 (740)
...++.++|||||||++|||+||+.||........+ ......+.. ...+......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l-~~i~~~~~~-~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLGT-PTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCC-CCTTTSSSTTSSTTCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH-HHHHHhcCC-CChhhccchhccchhh
Confidence 122367899999999999999999999654321111 111111100 0000000000
Q ss_pred ---CCCC-C-----chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 694 ---ALPR-N-----VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 694 ---~~~~-~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+. + .....++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 0 112346889999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=355.65 Aligned_cols=229 Identities=19% Similarity=0.229 Sum_probs=179.8
Q ss_pred hcCccccc-eecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhC-CCCCcceEEeEEEe----CC
Q 040687 481 TNGFKEFN-ELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNI-RHSNIVNLLGYCLE----MG 553 (740)
Q Consensus 481 ~~~~~~~~-~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~ 553 (740)
.++|.... .||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35788765 599999999999997 45899999998642 4577899987665 89999999999875 35
Q ss_pred eEEEEEecCCCCChHHhHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecC
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGL-SPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFG 629 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFG 629 (740)
..|||||||++|+|.++|.... ..+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 6899999999999999997643 46999999999999999999999999 999999999999986 4579999999
Q ss_pred CCccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhc
Q 040687 630 LLTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAII 689 (740)
Q Consensus 630 la~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~ 689 (740)
+|+.... ...++.++|||||||+||||+||+.||......... .. ....+.
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~--------~~~~i~ 230 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PG--------MKTRIR 230 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CCC
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HH--------HHHHHh
Confidence 9875432 122467999999999999999999999754321111 00 011122
Q ss_pred ccccCCCCC--chhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 DRNVALPRN--VEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 d~~~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
......|.+ .....++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222333322 233457889999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=347.23 Aligned_cols=226 Identities=23% Similarity=0.355 Sum_probs=182.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchh----cHHHHHHHHHHHHhCC--CCCcceEEeEEEeCCe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHT----NIREFEMELEVLCNIR--HSNIVNLLGYCLEMGE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~----~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 554 (740)
++|+..+.||+|+||+||+|+.. +++.||||+++....... ....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999974 589999999876543221 1234778999999996 8999999999999999
Q ss_pred EEEEEecCCC-CChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-CCCEEEeecCCCc
Q 040687 555 RLLVYEFMPR-GTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-DWGARIADFGLLT 632 (740)
Q Consensus 555 ~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~ki~DFGla~ 632 (740)
.++||||+.+ +++.+++... ..+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 6788888654 46999999999999999999999999 999999999999985 4789999999987
Q ss_pred cccCCC--------------------CCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcccc
Q 040687 633 SCERDL--------------------TTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIIDRN 692 (740)
Q Consensus 633 ~~~~~~--------------------~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d~~ 692 (740)
...... .++.++|||||||+||||+||+.||.... +++...
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------------~i~~~~ 220 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------------EIIRGQ 220 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------------HHHHCC
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------------HHhhcc
Confidence 543311 12457899999999999999999996321 011111
Q ss_pred cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 693 VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 693 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
...+. ....++.+|+.+||+.||++|||++|+++ +|++
T Consensus 221 ~~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 221 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp CCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred cCCCC--CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 22222 22346789999999999999999999987 4543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=344.74 Aligned_cols=243 Identities=19% Similarity=0.218 Sum_probs=189.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCCeEEEEEe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMGERLLVYE 560 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 560 (740)
++|+..++||+|+||+||+|+.. +++.||||+++...........+.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 58899999997665444556789999999999999999999999999999999999
Q ss_pred cCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccccC----
Q 040687 561 FMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCER---- 636 (740)
Q Consensus 561 y~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~---- 636 (740)
|+.+++|..++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999888887644 57899999999999999999999999 99999999999999999999999999875432
Q ss_pred ------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---cc---chhc---
Q 040687 637 ------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---KA---AAII--- 689 (740)
Q Consensus 637 ------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~i~--- 689 (740)
....+.++|||||||++|||++|+.||............+....... .. ....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 11236789999999999999999999754322222211111111000 00 0000
Q ss_pred -----ccccC-CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 690 -----DRNVA-LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 690 -----d~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..... ..........+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0011122346779999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=347.76 Aligned_cols=248 Identities=21% Similarity=0.255 Sum_probs=183.7
Q ss_pred hcCccccceecccCceEEEEEEEe-C-CcEEEEEEecccccchhcHHHHHHHHHHHHhC---CCCCcceEEeEEEeC---
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-D-GRQVAVKRANAATIIHTNIREFEMELEVLCNI---RHSNIVNLLGYCLEM--- 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~--- 552 (740)
.++|+..++||+|+||+||+|+.. + ++.||||+++...........+.+|+++|+.| +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 3 66799999876543333334567788777665 899999999998642
Q ss_pred --CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCC
Q 040687 553 --GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGL 630 (740)
Q Consensus 553 --~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGl 630 (740)
...+++|||++++.+..........+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 4689999999988777666666677999999999999999999999999 99999999999999999999999999
Q ss_pred CccccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC---cc--
Q 040687 631 LTSCER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG---KA-- 685 (740)
Q Consensus 631 a~~~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~-- 685 (740)
+..... ...++.++|||||||+||||+||+.||........+.. ........ ..
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK-ILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCGGGSCT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH-HHHhhCCCchhcccc
Confidence 764322 23457899999999999999999999975432111111 11110000 00
Q ss_pred -----chhcccccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 686 -----AAIIDRNVAL---PRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 686 -----~~i~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
.......... .........+.+|+.+||+.||++|||++|+++ +|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0000000000 001122346778999999999999999999986 4443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=351.31 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=177.4
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------CeE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------GER 555 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 555 (740)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4888899999999999999985 489999999876431 234799999999999999999998653 247
Q ss_pred EEEEecCCCCChHHhHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCc
Q 040687 556 LLVYEFMPRGTLHDHLH--GGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLT 632 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~ 632 (740)
+|||||++++.+....+ .....+++.++..++.||++||+|||+.+ |+||||||+||||+.++ .+||+|||++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 89999998654333322 23457999999999999999999999998 99999999999999775 89999999986
Q ss_pred cccC---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC-------c
Q 040687 633 SCER---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG-------K 684 (740)
Q Consensus 633 ~~~~---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~-------~ 684 (740)
.... ...++.++|||||||++|||++|+.||........+.... ...... .
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~-~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII-KVLGTPTREQIREM 250 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH-HHHCCCCHHHHHHH
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH-HHhCCChHHhhhhh
Confidence 5432 1234779999999999999999999997543221111110 000000 0
Q ss_pred cchhcccccC--------CCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 040687 685 AAAIIDRNVA--------LPRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQIV 734 (740)
Q Consensus 685 ~~~i~d~~~~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l~ 734 (740)
.....+.... .........++.+|+.+||+.||++|||+.|+++ +|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000000 0001122346789999999999999999999996 566543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=337.76 Aligned_cols=242 Identities=20% Similarity=0.286 Sum_probs=179.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------- 552 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 552 (740)
.++|+..++||+|+||+||+|+.. +++.||||++..........+.+.+|+++|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367999999999999999999974 689999999876654444557789999999999999999999998653
Q ss_pred -CeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCC
Q 040687 553 -GERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLL 631 (740)
Q Consensus 553 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla 631 (740)
...++||||++++.+..+. .....++...+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 3579999999876665444 44457899999999999999999999999 999999999999999999999999998
Q ss_pred ccccC--------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 632 TSCER--------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 632 ~~~~~--------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
+.... ...++.|+|||||||++|||++|+.||+...... ......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~-~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLC-GSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH-CCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhc-CCCC
Confidence 64321 1234679999999999999999999997432111 111111111 0000
Q ss_pred chh------------cccccCCCCCch-------hHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 686 AAI------------IDRNVALPRNVE-------PLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 686 ~~i------------~d~~~~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
.+. +......+.... ....+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 000000011110 1224568999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=343.85 Aligned_cols=232 Identities=25% Similarity=0.329 Sum_probs=185.2
Q ss_pred cCccccceecccCceEEEEEEEe----CCcEEEEEEecccccch--hcHHHHHHHHHHHHhCCC-CCcceEEeEEEeCCe
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV----DGRQVAVKRANAATIIH--TNIREFEMELEVLCNIRH-SNIVNLLGYCLEMGE 554 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAiK~l~~~~~~~--~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 554 (740)
++|+..++||+|+||+||+++.. +++.||||.++...... ...+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999862 37899999987654322 234568899999999976 899999999999999
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++||||+.+|+|.+++... ..++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999755 35778889999999999999999999 999999999999999999999999998654
Q ss_pred cC------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchhcc
Q 040687 635 ER------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAIID 690 (740)
Q Consensus 635 ~~------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i~d 690 (740)
.. ...++.|+|||||||+||||+||+.||............. ... ..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~-~~~--------~~ 250 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRI--------LK 250 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-HHH--------HH
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-Hhc--------cc
Confidence 22 1123668999999999999999999997654333222111 111 11
Q ss_pred cccCCCCCchhHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 040687 691 RNVALPRNVEPLFKLADIAELAIRENPSELP-----TMSQVAT 728 (740)
Q Consensus 691 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 728 (740)
.....+ .....++.+|+.+||+.||++|| |++|+++
T Consensus 251 ~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112222 23445788999999999999999 4788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=344.20 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=180.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC------
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG------ 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (740)
.++|+..++||+|+||+||+|+.. +++.||||+++.........+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467999999999999999999975 4899999999865544445667999999999999999999999997654
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..+|||||+ +.+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 579999999 55788777643 5999999999999999999999999 99999999999999999999999999876
Q ss_pred ccCC-------------------CCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhh-------HHhhCc---
Q 040687 634 CERD-------------------LTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALP-------LIKQGK--- 684 (740)
Q Consensus 634 ~~~~-------------------~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~-------~~~~~~--- 684 (740)
.... ...+.++||||+||+||||++|+.||........+...... ......
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 5431 22367999999999999999999999754221111100000 000000
Q ss_pred ---cchhcccccCC---CCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHH
Q 040687 685 ---AAAIIDRNVAL---PRNVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQI 733 (740)
Q Consensus 685 ---~~~i~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~l 733 (740)
....+...... .........+.+|+.+||+.||++|||++|+++ +|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000000000 001112236779999999999999999999997 45543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-38 Score=331.23 Aligned_cols=240 Identities=19% Similarity=0.233 Sum_probs=181.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcc-eEEeEEEeCCeEEEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIV-NLLGYCLEMGERLLVY 559 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~ 559 (740)
++|+..++||+|+||+||+|+.. +++.||||.+.... ...++..|++++++++|+|++ .+..+..+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 57999999999999999999974 58999999877543 224578899999999877655 5555667778899999
Q ss_pred ecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC---CCCEEEeecCCCccccC
Q 040687 560 EFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS---DWGARIADFGLLTSCER 636 (740)
Q Consensus 560 Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~ki~DFGla~~~~~ 636 (740)
||+ +++|.+++......+++.+++.++.|++.||+|||+++ ||||||||+|||++. +..+||+|||+|+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 56787777666678999999999999999999999999 999999999999864 56799999999875432
Q ss_pred ----------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCccchh
Q 040687 637 ----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKAAAI 688 (740)
Q Consensus 637 ----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~i 688 (740)
...++.++|||||||++|||+||+.||............ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--ERISEKKMSTP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H--HHHHHHHHHSC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH--HHhhcccCCCC
Confidence 112367999999999999999999999754322211110 00000000000
Q ss_pred cccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 689 IDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 689 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.+.. ....+.++.+|+..||+.||++||++.+|.+.|+++..+
T Consensus 237 -~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 -IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 112234688999999999999999999999999987653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=340.13 Aligned_cols=241 Identities=21% Similarity=0.298 Sum_probs=177.3
Q ss_pred hcCccccceecccCceEEEEEEE-eCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeCC----eE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVL-VDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEMG----ER 555 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 555 (740)
+++|+..++||+|+||+||+|+. .+++.||||+++.... ....+.+.+|+++|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45799999999999999999997 4689999999975432 334567899999999999999999999987653 23
Q ss_pred EEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcccc
Q 040687 556 LLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSCE 635 (740)
Q Consensus 556 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~ 635 (740)
+++++|+.+|+|.+++... .+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 4555667799999999754 5999999999999999999999999 9999999999999999999999999985432
Q ss_pred C-------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCc------
Q 040687 636 R-------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGK------ 684 (740)
Q Consensus 636 ~-------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 684 (740)
. ...++.++||||+|+++|||++|+.||......... ...........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhccCCChhhhhh
Confidence 1 122356899999999999999999999754321111 10000000000
Q ss_pred --------cchhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 --------AAAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 --------~~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
....+......+. ......++.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 0111236789999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.7e-38 Score=336.03 Aligned_cols=235 Identities=20% Similarity=0.268 Sum_probs=179.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeC--CeEEE
Q 040687 482 NGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEM--GERLL 557 (740)
Q Consensus 482 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~l 557 (740)
++|+..++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 57999999999999999999974 5899999998643 3467899999999995 99999999998754 46899
Q ss_pred EEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCC-CEEEeecCCCccccC
Q 040687 558 VYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDW-GARIADFGLLTSCER 636 (740)
Q Consensus 558 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~ki~DFGla~~~~~ 636 (740)
||||+++++|.++. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999999998764 35899999999999999999999999 99999999999998655 589999999865432
Q ss_pred ---------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhH---------HhhCc--
Q 040687 637 ---------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPL---------IKQGK-- 684 (740)
Q Consensus 637 ---------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~---------~~~~~-- 684 (740)
...++.++||||+|+++|||++|+.||................ .....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 1123678999999999999999999997543222111100000 00000
Q ss_pred ----cchhcc--------cccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 685 ----AAAIID--------RNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 685 ----~~~i~d--------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
...... .....+.......++.+|+++||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00111111223346789999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-37 Score=324.44 Aligned_cols=241 Identities=16% Similarity=0.209 Sum_probs=189.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCC-CCcceEEeEEEeCCeEEEE
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRH-SNIVNLLGYCLEMGERLLV 558 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV 558 (740)
.++|+..++||+|+||+||+|+.. +++.||||.+.... ....+.+|+++++.|+| +|++.++++.......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 367999999999999999999975 58899999876543 22357789999999965 8999999999999999999
Q ss_pred EecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECC-----CCCEEEeecCCCcc
Q 040687 559 YEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDS-----DWGARIADFGLLTS 633 (740)
Q Consensus 559 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~ki~DFGla~~ 633 (740)
|||+ +++|.+++......+++.+++.++.|++.||+|||+.+ ||||||||+|||++. ++.+||+|||+|+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999 68999999876678999999999999999999999999 999999999999975 56799999999975
Q ss_pred ccC----------------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhCcc
Q 040687 634 CER----------------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQGKA 685 (740)
Q Consensus 634 ~~~----------------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 685 (740)
... ...++.++||||||+++|||+||+.||........... ...+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~--~~~i~~~~~ 233 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YERIGEKKQ 233 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH--HHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH--HHHHHhccC
Confidence 421 11235689999999999999999999975443322211 111111100
Q ss_pred chhcccccCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 040687 686 AAIIDRNVALPRNVEPLFKLADIAELAIRENPSELPTMSQVATWLEQIVKD 736 (740)
Q Consensus 686 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~Le~l~~~ 736 (740)
.... +.+. ...+.++.+++..|++.+|++||+++.+.+.|++++++
T Consensus 234 ~~~~-~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 STPL-RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HSCH-HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCh-HHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 0000 0000 11223688999999999999999999999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-38 Score=338.33 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=183.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC-----Ce
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM-----GE 554 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (740)
.++|+..++||+|+||+||+|+.. +++.||||+++.........+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999974 599999999986654444556789999999999999999999998643 33
Q ss_pred EEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 555 RLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 555 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.++|+||+.+|+|.+++..+ .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 46677888899999999653 6999999999999999999999999 999999999999999999999999997654
Q ss_pred cC-------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHhhhhHHhhC-----------c
Q 040687 635 ER-------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEWALPLIKQG-----------K 684 (740)
Q Consensus 635 ~~-------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 684 (740)
.. ....+.++|||||||++|||++|+.||........ ........... .
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTCCCHH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhccchh
Confidence 32 22347799999999999999999999975421111 11000000000 0
Q ss_pred cchhcccccCCCC------CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 040687 685 AAAIIDRNVALPR------NVEPLFKLADIAELAIRENPSELPTMSQVAT--WLEQ 732 (740)
Q Consensus 685 ~~~i~d~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~Le~ 732 (740)
...........+. ......++.+|+.+||+.||++|||++|+++ +|.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0000000001110 0112236779999999999999999999997 5544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=327.83 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=178.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCcceEEeEEEeC------C
Q 040687 481 TNGFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNIVNLLGYCLEM------G 553 (740)
Q Consensus 481 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (740)
.++|+..++||+|+||+||+|+.. +++.||||+++.........+.+.+|+.+|++++|||||++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999975 599999999987655455566799999999999999999999999643 5
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
..|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccch-HHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 78999999965 55555543 4899999999999999999999999 99999999999999999999999998654
Q ss_pred ccC--------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCchhHHh------------------
Q 040687 634 CER--------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPGIVEW------------------ 675 (740)
Q Consensus 634 ~~~--------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~------------------ 675 (740)
... ...++.++||||+||++|||++|+.||............
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 322 234577999999999999999999999643211110000
Q ss_pred hhhHHhhC------ccchhcccccCCCC---CchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 676 ALPLIKQG------KAAAIIDRNVALPR---NVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 676 ~~~~~~~~------~~~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
........ .............. ......++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00001111111111 1123456789999999999999999999986
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-36 Score=325.82 Aligned_cols=270 Identities=16% Similarity=0.171 Sum_probs=213.0
Q ss_pred ceEEEEecCCcceEEEccCCCCCCCCCCCCC-CCCccccCC---CceEEeccCCeEeEEecCCCceEeccCCCC--CCCC
Q 040687 12 SFFCAIDASGKQDVICWAKNSSSPSSSFLSA-NSASFSNIP---SMAVLSGGEGLLCGILANTSQAFCWSSNSS--PGNT 85 (740)
Q Consensus 12 ~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~-~~~~~~~v~---~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~--~g~g 85 (740)
.|+|++..+| .|||||.|.+||||.|.+. ++..|..|+ .+..|++|..|+|||..++. |||||.|.+ +|.|
T Consensus 6 ~h~~~~~~~G--~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~ia~G~~h~~al~~~G~-vy~wG~n~~GQLG~g 82 (401)
T d1a12a_ 6 SHRSHSTEPG--LVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSGQ-VYSFGCNDEGALGRD 82 (401)
T ss_dssp CCTTCCCCCB--EEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEEETTSC-EEEEECCTTSTTCSC
T ss_pred eEEEEECCCC--EEEEEeCCCCCCCCCCCCCceeccCEEeCCCCCeEEEEeCCCEEEEEeCCCE-EEEEeCCCCCCCCcc
Confidence 4889999999 9999999999999998664 567777764 57899999999999988765 999999987 4544
Q ss_pred cc-----ccc-ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccc--ccccccccc------c
Q 040687 86 TD-----LVP-SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQ--TNLFYDEYV------S 151 (740)
Q Consensus 86 ~~-----~~~-~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg--~~~~~~~~~------~ 151 (740)
+. .+| .+.....+.+|++|..|+|++. ++|.|+|| |.+...+.+ ......... .
T Consensus 83 ~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~-------~~g~v~~w-----G~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (401)
T d1a12a_ 83 TSVEGSEMVPGKVELQEKVVQVSAGDSHTAALT-------DDGRVFLW-----GSFRDNNGVIGLLEPMKKSMVPVQVQL 150 (401)
T ss_dssp CCSTTGGGSCEECCCCSCEEEEEECSSEEEEEE-------TTSCEEEE-----ECEEETTEEEESSBBTBCEEEEEEECC
T ss_pred cccccccccccccccccceeeecccccceeecc-------ccccceec-----cccccccccccccCCccccceeeeecc
Confidence 33 344 4445568999999999999999 89999999 665544443 222211111 1
Q ss_pred eeeEEEEEecCCeeeeeeeCCeEEEecCCCCC-CCc-----------------------------cCCCCcEEEEeeCCc
Q 040687 152 TIVLKDVISGDGFSCGGVRDGGIVCWGPDSES-LGV-----------------------------FNVTESFKVLASGKS 201 (740)
Q Consensus 152 ~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~-~~~-----------------------------~~~~~~~~~iaaG~~ 201 (740)
...+..|++|..|+++++.+|.+++||.|..+ ++. ......+..|++|..
T Consensus 151 ~~~i~~i~~g~~~~~~~~~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~ 230 (401)
T d1a12a_ 151 DVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAY 230 (401)
T ss_dssp SSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETT
T ss_pred CCceeEEEecccceeeeecCCcccccccCCccccCCCCccccccCCccccccccccceeeccccCCCCCceEEEEEecCC
Confidence 12388999999999999999999999998764 110 011235889999999
Q ss_pred eeeeeecCCCcEEEeecCCCCCCC-----------------CCcccEEEEecccceeeeeeecCCcEEecCCCCCCCCCC
Q 040687 202 SLCGISELSGEVKCWGNNDFVSVP-----------------PVGIRFVSLAAGANHFCGIREDNHGVECWGSFNYSSVPK 264 (740)
Q Consensus 202 h~Cai~~~~g~v~CWG~n~~g~~~-----------------~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~~~~g~~~~ 264 (740)
|+|+|. .+|++++||.|..++.. .....++.+++|..|++++. ++++|+|||.|.++|+..
T Consensus 231 ~~~~l~-~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~g~~~~~~l~-~~g~v~~wG~n~~gqlG~ 308 (401)
T d1a12a_ 231 FTFAIS-HEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMD-SEGKAYSLGRAEYGRLGL 308 (401)
T ss_dssp EEEEEE-TTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEE-TTSCEEEEECCGGGTTCS
T ss_pred eEEEEe-cCCeEeeecccceecccccccccceeccccccccccceeEEEEeeeccceeeec-cCCCEEEecccccCccCC
Confidence 999995 59999999999887711 11245899999999999998 999999999998887532
Q ss_pred C---------------CceEEEEecCceeeEEEeCCceeecccccCCCCC
Q 040687 265 N---------------SGFMAIASSDFTTCGIRENDLVLDCWFANVSSPT 299 (740)
Q Consensus 265 ~---------------~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~~ 299 (740)
+ ..+.+|++|..|+|+++ +++.|+|||.|..+++
T Consensus 309 g~~~~~~~~P~~i~~~~~i~~Is~G~~hs~alt-~dG~v~~WG~n~~GQL 357 (401)
T d1a12a_ 309 GEGAEEKSIPTLISRLPAVSSVACGASVGYAVT-KDGRVFAWGMGTNYQL 357 (401)
T ss_dssp CTTCCCEEEEEECCSSSSEEEEEECSSEEEEEE-TTSCEEEEECCTTSTT
T ss_pred CcccccccCCEEcCCCCCeEEEEeeCCEEEEEe-CCCeEEEEecCCCCCC
Confidence 2 36899999999999987 8899999999987764
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=9.3e-34 Score=294.49 Aligned_cols=241 Identities=19% Similarity=0.321 Sum_probs=189.2
Q ss_pred CeeEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccccCCCceEEeccCCeEeEEecCCCceEeccCCCCC
Q 040687 3 PISASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFSNIPSMAVLSGGEGLLCGILANTSQAFCWSSNSSP 82 (740)
Q Consensus 3 ~~~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~~v~~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~~ 82 (740)
.|..++.|+.|+|||. || +|||||.|.+||||.++..+. .+.+|++|+.|+|+|. + +.++|||.+.+
T Consensus 27 ~i~~va~G~~h~~al~-dG--~v~~wG~N~~GQlG~~~~~~~-------~v~~v~~G~~~~~al~-d-g~v~~wG~~~~- 93 (273)
T d1jtdb_ 27 GVDAIAGGYFHGLALK-GG--KVLGWGANLNGQLTMPAATQS-------GVDAIAAGNYHSLALK-D-GEVIAWGGNED- 93 (273)
T ss_dssp SEEEEEECSSEEEEEE-TT--EEEEEECCTTSTTSCCGGGGS-------CCCEEEECSSEEEEEE-T-TEEEEEECCTT-
T ss_pred CcEEEEccCCEEEEEE-CC--EEEEEeCCCCCceeeeecccc-------cceEEecCCCceeeee-e-eeeeccCCCcc-
Confidence 4455566668999996 88 999999999999998744332 4567999999999986 4 36999999876
Q ss_pred CCCcccccccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccccccceeeEEEEEecC
Q 040687 83 GNTTDLVPSVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGD 162 (740)
Q Consensus 83 g~g~~~~~~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~ia~G~ 162 (740)
|++.+|+. ....+..|++|..|+|++. +++++|| |.+..++...... ....+..++ |.
T Consensus 94 --gq~~~~~~-~~~~~~~i~~~~~~~~~~~--------dg~v~~~-----g~~~~~~~~~~~~-----~~~~v~~~~-~~ 151 (273)
T d1jtdb_ 94 --GQTTVPAE-ARSGVDAIAAGAWASYALK--------DGKVIAW-----GDDSDGQTTVPAE-----AQSGVTALD-GG 151 (273)
T ss_dssp --STTCCCGG-GGSSCCEEEEETTEEEEEE--------TTEEEEE-----ECCTTSTTSCCGG-----GGSSEEEEE-EC
T ss_pred --eeeccccc-cccceeEEeeecccccccc--------cccceec-----ccCCCCceeeecc-----CCceEEEEe-cc
Confidence 77766622 2345778999999999886 5899999 6665555442211 111244454 55
Q ss_pred CeeeeeeeCCeEEEecCCCCCCCccC--CCCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCCCC---CcccEEEEecc
Q 040687 163 GFSCGGVRDGGIVCWGPDSESLGVFN--VTESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVPP---VGIRFVSLAAG 237 (740)
Q Consensus 163 ~~~C~l~~~g~v~CwG~~~~~~~~~~--~~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~~~---~~~~~~~la~G 237 (740)
.|+|++..++.++|||.+..+....+ ...++.+|++|..|+|+| + ||+|+|||.|.+||... ....+++|++|
T Consensus 152 ~~~~~~~~~g~~~~~G~~~~g~~~~~~~~~~~v~~Is~G~~h~~~l-~-dG~v~~WG~n~~Gql~~~~~~~~~v~~I~~G 229 (273)
T d1jtdb_ 152 VYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLAL-K-DGKVIAWGDNRYKQTTVPTEALSGVSAIASG 229 (273)
T ss_dssp SSEEEEEETTEEEEEECCTTSTTSCCGGGSSSEEEEEECSSEEEEE-E-TTEEEEEECCTTSTTCCCGGGGSSCCEEEEC
T ss_pred ceeeeeecccceeEeecccCCcccccccccCCccceeccceeeEEE-e-cCcEEEcCCCCCCccCCCccCCCCcEEEEeC
Confidence 67777778999999999877533222 346799999999999998 5 79999999999999432 23568999999
Q ss_pred cceeeeeeecCCcEEecCCCCCCCCCCCCceEEEEecCceeeEEE
Q 040687 238 ANHFCGIREDNHGVECWGSFNYSSVPKNSGFMAIASSDFTTCGIR 282 (740)
Q Consensus 238 ~~h~C~l~~~~g~v~CWG~~~~g~~~~~~~~~~i~ag~~~~Cg~~ 282 (740)
..|+|+|. |++|+|||.|..++.+.+..+.+|.+|.+|+++++
T Consensus 230 ~~~~~~l~--~g~v~~WG~~~~~~~~~~~~~~~i~~~~~~~~al~ 272 (273)
T d1jtdb_ 230 EWYSLALK--NGKVIAWGSSRTAPSSVQSGVSSIEAGPNAAYALK 272 (273)
T ss_dssp SSCEEEEE--TTEEEEESTTCCCCGGGSSCEEEEEECSSCEEEEE
T ss_pred cceEEEEE--CCEEEEECCCCCCCCCCCCCceeEEeCcceEEEec
Confidence 99999984 79999999999999999999999999999999986
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-33 Score=302.86 Aligned_cols=261 Identities=16% Similarity=0.208 Sum_probs=202.2
Q ss_pred eEEecCCceEEEEecCCcceEEEccCCCCCCCCCCCCCCCCccc--cC---CCceEEeccCCeEeEEecCCCceEeccCC
Q 040687 5 SASFGQNSFFCAIDASGKQDVICWAKNSSSPSSSFLSANSASFS--NI---PSMAVLSGGEGLLCGILANTSQAFCWSSN 79 (740)
Q Consensus 5 ~~~~g~~~~~Cal~~~g~~~v~cwg~n~~gqlg~~~~~~~~~~~--~v---~~~~~i~~G~~~~Cal~~~~~~~~cWg~~ 79 (740)
.++.|+ .|+|||..+| .|||||.|.+||||.+++.+...|. .+ ..+.+|++|..|+|++..++. +||||.+
T Consensus 51 ~ia~G~-~h~~al~~~G--~vy~wG~n~~GQLG~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~~~g~-v~~wG~~ 126 (401)
T d1a12a_ 51 QAEAGG-MHTVCLSKSG--QVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGR-VFLWGSF 126 (401)
T ss_dssp EEEECS-SEEEEEETTS--CEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTSC-EEEEECE
T ss_pred EEEeCC-CEEEEEeCCC--EEEEEeCCCCCCCCcccccccccccccccccccceeeecccccceeecccccc-ceecccc
Confidence 345554 8999999999 9999999999999999877664433 33 246899999999999988754 9999987
Q ss_pred CCCCCCcc-------ccc---ccccCCceEEEeeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccc--
Q 040687 80 SSPGNTTD-------LVP---SVYKNTAYSRIAAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYD-- 147 (740)
Q Consensus 80 ~~~g~g~~-------~~~---~~~~~~~~~~is~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~-- 147 (740)
.. ..++. ..+ .......+..|++|..|++++. .+|.+++| |.|..+|||......
T Consensus 127 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~-------~~g~~~~~-----G~n~~gqlg~~~~~~~~ 193 (401)
T d1a12a_ 127 RD-NNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLT-------ADGDLYTL-----GCGEQGQLGRVPELFAN 193 (401)
T ss_dssp EE-TTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEEE-------TTSCEEEE-----ECCTTSTTCSCGGGTSS
T ss_pred cc-ccccccccCCccccceeeeeccCCceeEEEecccceeeee-------cCCccccc-----ccCCccccCCCCccccc
Confidence 53 11111 111 1223457899999999999999 89999999 888999998652110
Q ss_pred ---------cccc------------eeeEEEEEecCCeeeeeeeCCeEEEecCCCCCC-Cc---------------cCCC
Q 040687 148 ---------EYVS------------TIVLKDVISGDGFSCGGVRDGGIVCWGPDSESL-GV---------------FNVT 190 (740)
Q Consensus 148 ---------~~~~------------~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~~~~-~~---------------~~~~ 190 (740)
...| ...+.+|++|..|+|+|+.+|.+++||.|..+. +. ....
T Consensus 194 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~l~~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~ 273 (401)
T d1a12a_ 194 RGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNST 273 (401)
T ss_dssp SCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTT
T ss_pred cCCccccccccccceeeccccCCCCCceEEEEEecCCeEEEEecCCeEeeecccceecccccccccceeccccccccccc
Confidence 0011 124899999999999999999999999987641 11 1112
Q ss_pred CcEEEEeeCCceeeeeecCCCcEEEeecCCCCCC--------------CCCcccEEEEecccceeeeeeecCCcEEecCC
Q 040687 191 ESFKVLASGKSSLCGISELSGEVKCWGNNDFVSV--------------PPVGIRFVSLAAGANHFCGIREDNHGVECWGS 256 (740)
Q Consensus 191 ~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~--------------~~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~ 256 (740)
..+..+++|..|++++ +.+|.|+|||.|.+||. ++....+++|++|.+|+|+|+ +||+|+|||.
T Consensus 274 ~~~~~i~~g~~~~~~l-~~~g~v~~wG~n~~gqlG~g~~~~~~~~P~~i~~~~~i~~Is~G~~hs~alt-~dG~v~~WG~ 351 (401)
T d1a12a_ 274 KSWVGFSGGQHHTVCM-DSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVT-KDGRVFAWGM 351 (401)
T ss_dssp CCEEEEEECSSEEEEE-ETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEE-TTSCEEEEEC
T ss_pred eeEEEEeeeccceeee-ccCCCEEEecccccCccCCCcccccccCCEEcCCCCCeEEEEeeCCEEEEEe-CCCeEEEEec
Confidence 4588999999999999 55999999999988771 222356999999999999998 9999999999
Q ss_pred CCCCCCCCC------------------CceEEEEecCceeeEEEeC
Q 040687 257 FNYSSVPKN------------------SGFMAIASSDFTTCGIREN 284 (740)
Q Consensus 257 ~~~g~~~~~------------------~~~~~i~ag~~~~Cg~~~~ 284 (740)
|.+||+..| ..+.+|++|..|+|+|+.+
T Consensus 352 n~~GQLG~G~~~~~~~P~~v~~~~~~~~~v~~v~~G~~hs~~l~~d 397 (401)
T d1a12a_ 352 GTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKD 397 (401)
T ss_dssp CTTSTTCSSSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEE
T ss_pred CCCCCCCCCCCCCEecCEEeeccCCCCCEEEEEEEccceEEEEEEC
Confidence 999996433 2488899999999999843
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=8.9e-33 Score=287.01 Aligned_cols=238 Identities=21% Similarity=0.352 Sum_probs=182.2
Q ss_pred ceEEEccCCCCCCCCCCCCCCCCccccC-CCceEEeccCCeEeEEecCCCceEeccCCCCCCCCcccccccccCCceEEE
Q 040687 23 QDVICWAKNSSSPSSSFLSANSASFSNI-PSMAVLSGGEGLLCGILANTSQAFCWSSNSSPGNTTDLVPSVYKNTAYSRI 101 (740)
Q Consensus 23 ~~v~cwg~n~~gqlg~~~~~~~~~~~~v-~~~~~i~~G~~~~Cal~~~~~~~~cWg~~~~~g~g~~~~~~~~~~~~~~~i 101 (740)
.+|+|||.|.+++ +.+.|.++ ..+.+|++|+.|+|+|. ++ .+||||.|.+ ||+..|.. ....+.+|
T Consensus 4 ~sv~~WG~~~~~~-------~~~~~~~~~~~i~~va~G~~h~~al~-dG-~v~~wG~N~~---GQlG~~~~-~~~~v~~v 70 (273)
T d1jtdb_ 4 TSVVAWGGNNDWG-------EATVPAEAQSGVDAIAGGYFHGLALK-GG-KVLGWGANLN---GQLTMPAA-TQSGVDAI 70 (273)
T ss_dssp SEEEEESSCCSSS-------TTCCCGGGSSSEEEEEECSSEEEEEE-TT-EEEEEECCTT---STTSCCGG-GGSCCCEE
T ss_pred CEEEEECCCCCCC-------ceeccccCCCCcEEEEccCCEEEEEE-CC-EEEEEeCCCC---Cceeeeec-ccccceEE
Confidence 3899999876543 12233333 36789999999999987 54 6999999987 77766622 23468899
Q ss_pred eeCCCeeeeEEccccccCCCceeeecccccCCCCccCccccccccccccceeeEEEEEecCCeeeeeeeCCeEEEecCCC
Q 040687 102 AAGTNHVCAVRGSYYSYHDLGTVDCWDIVRKGNNTLSSVQTNLFYDEYVSTIVLKDVISGDGFSCGGVRDGGIVCWGPDS 181 (740)
Q Consensus 102 s~G~~h~Cal~~~~~~~~~~g~v~cW~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~ia~G~~~~C~l~~~g~v~CwG~~~ 181 (740)
++|..|+|+|. +|+++|| |.|.++|++..... ...+..|++|..|+|++ .+++++|||.+.
T Consensus 71 ~~G~~~~~al~--------dg~v~~w-----G~~~~gq~~~~~~~-----~~~~~~i~~~~~~~~~~-~dg~v~~~g~~~ 131 (273)
T d1jtdb_ 71 AAGNYHSLALK--------DGEVIAW-----GGNEDGQTTVPAEA-----RSGVDAIAAGAWASYAL-KDGKVIAWGDDS 131 (273)
T ss_dssp EECSSEEEEEE--------TTEEEEE-----ECCTTSTTCCCGGG-----GSSCCEEEEETTEEEEE-ETTEEEEEECCT
T ss_pred ecCCCceeeee--------eeeeecc-----CCCcceeecccccc-----ccceeEEeeeccccccc-ccccceecccCC
Confidence 99999999986 5899999 88888888743211 11256799999999987 589999999887
Q ss_pred CCCCccCC--CCcEEEEeeCCceeeeeecCCCcEEEeecCCCCCCC---CCcccEEEEecccceeeeeeecCCcEEecCC
Q 040687 182 ESLGVFNV--TESFKVLASGKSSLCGISELSGEVKCWGNNDFVSVP---PVGIRFVSLAAGANHFCGIREDNHGVECWGS 256 (740)
Q Consensus 182 ~~~~~~~~--~~~~~~iaaG~~h~Cai~~~~g~v~CWG~n~~g~~~---~~~~~~~~la~G~~h~C~l~~~~g~v~CWG~ 256 (740)
.+....+. ...+..++.+. |+|++++ +|.++|||.+..+|.. +...++.+|++|..|+|+|+ ||+|+|||.
T Consensus 132 ~~~~~~~~~~~~~v~~~~~~~-~~~~~~~-~g~~~~~G~~~~g~~~~~~~~~~~v~~Is~G~~h~~~l~--dG~v~~WG~ 207 (273)
T d1jtdb_ 132 DGQTTVPAEAQSGVTALDGGV-YTALAVK-NGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALK--DGKVIAWGD 207 (273)
T ss_dssp TSTTSCCGGGGSSEEEEEECS-SEEEEEE-TTEEEEEECCTTSTTSCCGGGSSSEEEEEECSSEEEEEE--TTEEEEEEC
T ss_pred CCceeeeccCCceEEEEeccc-eeeeeec-ccceeEeecccCCcccccccccCCccceeccceeeEEEe--cCcEEEcCC
Confidence 75333322 23456665554 5555545 7999999999998842 33467999999999999986 799999999
Q ss_pred CCCCCCCCC----CceEEEEecCceeeEEEeCCceeecccccCCCC
Q 040687 257 FNYSSVPKN----SGFMAIASSDFTTCGIRENDLVLDCWFANVSSP 298 (740)
Q Consensus 257 ~~~g~~~~~----~~~~~i~ag~~~~Cg~~~~~~~~~cWG~n~~~~ 298 (740)
|.++|++.+ ..+++|++|..|+|++. |+.|+|||.|...+
T Consensus 208 n~~Gql~~~~~~~~~v~~I~~G~~~~~~l~--~g~v~~WG~~~~~~ 251 (273)
T d1jtdb_ 208 NRYKQTTVPTEALSGVSAIASGEWYSLALK--NGKVIAWGSSRTAP 251 (273)
T ss_dssp CTTSTTCCCGGGGSSCCEEEECSSCEEEEE--TTEEEEESTTCCCC
T ss_pred CCCCccCCCccCCCCcEEEEeCcceEEEEE--CCEEEEECCCCCCC
Confidence 999998554 45899999999999873 78999999986553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.2e-32 Score=295.48 Aligned_cols=243 Identities=19% Similarity=0.253 Sum_probs=171.7
Q ss_pred CccccceecccCceEEEEEEEe-CCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-----------CCCcceEEeEEE
Q 040687 483 GFKEFNELGRGSYGFVYKAVLV-DGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-----------HSNIVNLLGYCL 550 (740)
Q Consensus 483 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 550 (740)
+|+..++||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++|++++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 4999999999999999999974 58999999998653 23356788999988875 578999998886
Q ss_pred eC--CeEEEEEecCCCCChHHh--HhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEECCCCC---
Q 040687 551 EM--GERLLVYEFMPRGTLHDH--LHGGLSPLNWSLRLKISMQAAKGLEYLHK-DAAPPIIHRDVKTLNILLDSDWG--- 622 (740)
Q Consensus 551 ~~--~~~~lV~Ey~~~gsL~~~--l~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iiHrDlk~~NILl~~~~~--- 622 (740)
.. ...+++|+++..+..... .......+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 53 456677776655543332 23334568999999999999999999998 77 999999999999987653
Q ss_pred ---EEEeecCCCccccC------------------CCCCCcccceehhHHHHHHHHhCCCCCCCCCCCch--hHHhhh--
Q 040687 623 ---ARIADFGLLTSCER------------------DLTTDMKSDVHNFGIVLLEILSGRKAYDIEYVPPG--IVEWAL-- 677 (740)
Q Consensus 623 ---~ki~DFGla~~~~~------------------~~~~~~ksDVwSfGvvl~ElltG~~p~~~~~~~~~--~~~~~~-- 677 (740)
+|++|||.+..... ...++.++||||+|++++||++|+.||........ ..+...
T Consensus 168 ~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred cceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999999864432 22346799999999999999999999974322110 000000
Q ss_pred -hHH--------hhCc-cchhccc-----c--------------cCCCCCchhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040687 678 -PLI--------KQGK-AAAIIDR-----N--------------VALPRNVEPLFKLADIAELAIRENPSELPTMSQVAT 728 (740)
Q Consensus 678 -~~~--------~~~~-~~~i~d~-----~--------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 728 (740)
..+ .... .....+. . ...........++.+|+.+||+.||.+|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0000 0000000 0 011123345567889999999999999999999987
Q ss_pred --HHH
Q 040687 729 --WLE 731 (740)
Q Consensus 729 --~Le 731 (740)
+|+
T Consensus 328 Hp~f~ 332 (362)
T d1q8ya_ 328 HPWLK 332 (362)
T ss_dssp CGGGT
T ss_pred CcccC
Confidence 454
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=4.7e-23 Score=201.37 Aligned_cols=135 Identities=15% Similarity=0.162 Sum_probs=106.5
Q ss_pred cccceecccCceEEEEEEEeCCcEEEEEEecccccc----------------hhcHHHHHHHHHHHHhCCCCCcceEEeE
Q 040687 485 KEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATII----------------HTNIREFEMELEVLCNIRHSNIVNLLGY 548 (740)
Q Consensus 485 ~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~----------------~~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (740)
...++||+|+||+||+|++.+|+.||||.++..... ......+.+|...|.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456789999999999999988999999987642211 0112345678999999999999998866
Q ss_pred EEeCCeEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEECCCCCEEEeec
Q 040687 549 CLEMGERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAAPPIIHRDVKTLNILLDSDWGARIADF 628 (740)
Q Consensus 549 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ki~DF 628 (740)
. ..+|+|||+++..+.+ ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 3 2379999998866543 233345678999999999999999 9999999999999965 5899999
Q ss_pred CCCcccc
Q 040687 629 GLLTSCE 635 (740)
Q Consensus 629 Gla~~~~ 635 (740)
|+|....
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCcccCC
Confidence 9987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=1.4e-06 Score=86.70 Aligned_cols=150 Identities=16% Similarity=0.117 Sum_probs=104.7
Q ss_pred hHHHHhhcCccccceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCC
Q 040687 475 SELKDATNGFKEFNELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMG 553 (740)
Q Consensus 475 ~~l~~~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 553 (740)
.+++...+.|+..+...-++...||+... +++.+.+|+...... .....+.+|..++..+. +--+.+++.+..+.+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 45666667777776655556678998764 566678888764431 12234677888888774 444678888888888
Q ss_pred eEEEEEecCCCCChHHhHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-------------------------------
Q 040687 554 ERLLVYEFMPRGTLHDHLHGGLSPLNWSLRLKISMQAAKGLEYLHKDAA------------------------------- 602 (740)
Q Consensus 554 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~------------------------------- 602 (740)
..++|||++++.++.+..... .. ...++.++++.|..||+...
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred ceEEEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999999998886654321 11 22345666666777775310
Q ss_pred -------------------------CCeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 603 -------------------------PPIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 603 -------------------------~~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
+.++|+|+.|.|||++++...-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1389999999999999877677999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.2e-05 Score=79.30 Aligned_cols=141 Identities=18% Similarity=0.181 Sum_probs=85.7
Q ss_pred eecccC-ceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCC--CCCcceEEeEEEeCCeEEEEEecCCCC
Q 040687 489 ELGRGS-YGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIR--HSNIVNLLGYCLEMGERLLVYEFMPRG 565 (740)
Q Consensus 489 ~LG~G~-fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~g 565 (740)
.+..|. -..||+....++..+.+|...... ...+..|...|+.+. .-.+.+++.+..+.+..++||||+++-
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344444 368999987777788889765432 134667888887663 334678888888888899999999876
Q ss_pred ChHHh-----------------HhCCC---CCC--CHHHHHHHH--------------------HHHHHHHHHHHhCC--
Q 040687 566 TLHDH-----------------LHGGL---SPL--NWSLRLKIS--------------------MQAAKGLEYLHKDA-- 601 (740)
Q Consensus 566 sL~~~-----------------l~~~~---~~l--~~~~~~~ia--------------------~~ia~gL~yLH~~~-- 601 (740)
++.+. ||... .++ .+...+.-. ......+..+....
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 55321 11100 000 111110000 00111223333221
Q ss_pred --CCCeEecCCCCCCEEECCCCCEEEeecCCCccc
Q 040687 602 --APPIIHRDVKTLNILLDSDWGARIADFGLLTSC 634 (740)
Q Consensus 602 --~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~ 634 (740)
.+.++|+|+.|.|||++++..+-|+||+.+...
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 123899999999999998877789999987543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.07 E-value=0.00072 Score=70.95 Aligned_cols=78 Identities=17% Similarity=0.222 Sum_probs=48.9
Q ss_pred cceecccCceEEEEEEEeC-CcEEEEEEecccccc-----hhcHHHHHHHHHHHHhCC-C--CCcceEEeEEEeCCeEEE
Q 040687 487 FNELGRGSYGFVYKAVLVD-GRQVAVKRANAATII-----HTNIREFEMELEVLCNIR-H--SNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~-g~~vAiK~l~~~~~~-----~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l 557 (740)
.+.||.|..-.||+....+ ++.|.+|........ .........|.+.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 678999975432100 111223456777777652 2 456677665 4455679
Q ss_pred EEecCCCCC
Q 040687 558 VYEFMPRGT 566 (740)
Q Consensus 558 V~Ey~~~gs 566 (740)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.01 E-value=0.01 Score=60.06 Aligned_cols=133 Identities=14% Similarity=0.101 Sum_probs=76.6
Q ss_pred eEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCCc-----ceEE--eEEEeCCeEEEEEecCCCCChH
Q 040687 496 GFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSNI-----VNLL--GYCLEMGERLLVYEFMPRGTLH 568 (740)
Q Consensus 496 G~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~l~--g~~~~~~~~~lV~Ey~~~gsL~ 568 (740)
=.||+.++.+|+.+++|..+.... ..+++..|...|..|....+ +..- .........+.+++++++..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 479999998999999998765432 33567788888887742221 1111 1223456788999998763321
Q ss_pred -----H------h---Hh----CC----CCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCC
Q 040687 569 -----D------H---LH----GG----LSPLNWSL-------------------RLKISMQAAKGLEYLHK----DAAP 603 (740)
Q Consensus 569 -----~------~---l~----~~----~~~l~~~~-------------------~~~ia~~ia~gL~yLH~----~~~~ 603 (740)
. . +| .. ...+++.. +-.+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 0 11 10 11122211 11122222333333332 1223
Q ss_pred CeEecCCCCCCEEECCCCCEEEeecCCCcc
Q 040687 604 PIIHRDVKTLNILLDSDWGARIADFGLLTS 633 (740)
Q Consensus 604 ~iiHrDlk~~NILl~~~~~~ki~DFGla~~ 633 (740)
.+||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999754 56899998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.58 E-value=0.026 Score=58.55 Aligned_cols=73 Identities=12% Similarity=0.132 Sum_probs=48.4
Q ss_pred cceecccCceEEEEEEEeCC--------cEEEEEEecccccchhcHHHHHHHHHHHHhCC-CCCcceEEeEEEeCCeEEE
Q 040687 487 FNELGRGSYGFVYKAVLVDG--------RQVAVKRANAATIIHTNIREFEMELEVLCNIR-HSNIVNLLGYCLEMGERLL 557 (740)
Q Consensus 487 ~~~LG~G~fG~Vy~~~~~~g--------~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 557 (740)
+++|..|-.=.+|+....++ +.|.+++.-. . ....+..+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 45788888889999987542 4566665442 2 12234567888888874 4334578887643 58
Q ss_pred EEecCCCCCh
Q 040687 558 VYEFMPRGTL 567 (740)
Q Consensus 558 V~Ey~~~gsL 567 (740)
|+||+++-+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999986544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.35 E-value=0.069 Score=53.06 Aligned_cols=172 Identities=12% Similarity=0.007 Sum_probs=86.7
Q ss_pred ChhHHHHhhcCcccc-----ceecccCceEEEEEEEeCCcEEEEEEecccccchhcHHHHHHHHHHHHhCCCCC--cceE
Q 040687 473 RLSELKDATNGFKEF-----NELGRGSYGFVYKAVLVDGRQVAVKRANAATIIHTNIREFEMELEVLCNIRHSN--IVNL 545 (740)
Q Consensus 473 ~~~~l~~~~~~~~~~-----~~LG~G~fG~Vy~~~~~~g~~vAiK~l~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 545 (740)
+.++++....+|... +.|..|---+.|+.+..++ .+++|+.+... ...+...|+++|..|...+ +...
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC----CHHHHHHHHHHHHhhhhcccccccc
Confidence 445666666667553 3345666678899887665 48889876432 1134445666666663221 1111
Q ss_pred Ee------EEEeCCeEEEEEecCCCCChHH--------------hHh---CC---C--C-CCCH-H--------------
Q 040687 546 LG------YCLEMGERLLVYEFMPRGTLHD--------------HLH---GG---L--S-PLNW-S-------------- 581 (740)
Q Consensus 546 ~g------~~~~~~~~~lV~Ey~~~gsL~~--------------~l~---~~---~--~-~l~~-~-------------- 581 (740)
+- +.........++.++.+..... .++ .. . . ...+ .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 10 1122345666777766533211 111 00 0 0 0000 0
Q ss_pred --HHHHHHHHHHHHHHHHHhCC-CCCeEecCCCCCCEEECCCCCEEEeecCCCccccCCCCCCcccceehhHHHHHHHHh
Q 040687 582 --LRLKISMQAAKGLEYLHKDA-APPIIHRDVKTLNILLDSDWGARIADFGLLTSCERDLTTDMKSDVHNFGIVLLEILS 658 (740)
Q Consensus 582 --~~~~ia~~ia~gL~yLH~~~-~~~iiHrDlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ksDVwSfGvvl~Ellt 658 (740)
.....+..+...+.-.+... ...+||.|+.+.||+++.+...-|.||+.+.... =+|=+++.+..++.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~~---------~~~DLAi~~~~~~~ 229 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDL---------LAYDVSICLNAWCF 229 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEE---------HHHHHHHHHHHHSB
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccccch---------hhhhHHHHHHHHhh
Confidence 01111222222222222211 1259999999999999998877899999874221 13335777776654
|